data_2yqe_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2yqe _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 29.5 t80 . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.904 0.383 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.8 mt -65.29 -50.99 63.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.03 -35.08 75.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -68.45 -64.16 0.92 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.935 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.486 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 6.5 tt -55.5 -33.75 33.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.16 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.98 -58.58 3.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.088 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.41 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 2.4 ttmp? -45.65 -24.66 0.37 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.892 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -85.63 -42.45 14.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.407 ' CD1' HD11 ' A' ' 100' ' ' LEU . 32.8 m95 -72.61 -59.25 2.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.462 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 2.7 pt-20 -39.31 -31.96 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.873 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.462 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 97.3 mt -74.08 -52.59 19.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.171 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -48.55 -40.34 26.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 136.58 -45.71 1.07 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.477 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.4 t -81.69 118.69 23.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.841 0.353 . . . . 0.0 110.881 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.5 p -56.49 151.86 12.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.407 HD11 ' CD1' ' A' ' 93' ' ' TRP . 13.5 tp -77.84 118.58 20.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -119.57 141.91 48.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.0 mp -107.69 128.74 25.28 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.627 0.727 . . . . 0.0 111.104 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 154.24 67.77 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.646 2.23 . . . . 0.0 112.334 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -102.18 111.32 23.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.435 HG13 ' N ' ' A' ' 106' ' ' GLU . 71.4 t -119.03 134.67 61.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.117 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.435 ' N ' HG13 ' A' ' 105' ' ' VAL . 13.2 mm-40 61.21 53.45 3.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 106' ' ' GLU . 7.7 ptp180 36.94 41.68 0.2 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.3 ttmp? -162.5 152.13 15.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.465 HG13 ' N ' ' A' ' 110' ' ' LEU . 1.8 tp -62.25 139.23 21.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.112 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.465 ' N ' HG13 ' A' ' 109' ' ' ILE . 5.7 tt -87.65 130.62 34.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.916 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -90.55 74.24 6.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -48.52 -20.91 0.48 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -71.27 -45.59 62.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.3 t -65.61 -52.81 49.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.886 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.7 tp -49.03 -60.53 2.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 52.6 p -55.11 -52.9 61.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.863 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.3 mmtt -47.96 -61.45 1.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 66.5 mt -45.34 -64.27 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.155 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 43.1 t -39.35 -64.18 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.139 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 73.4 mt -42.35 -46.35 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.092 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -65.34 -54.69 25.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -39.49 -50.91 2.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 155.36 35.15 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.525 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.92 -177.73 41.79 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.528 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.483 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 3.1 t80 -87.42 -47.92 8.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.851 0.357 . . . . 0.0 110.901 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -57.78 -40.73 80.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.91 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.09 -68.86 0.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.083 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.411 ' C ' HD12 ' A' ' 128' ' ' ILE . 1.9 pp -52.0 -31.43 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.128 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.483 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 26.2 m -70.13 -42.2 72.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -66.31 -36.92 84.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.861 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 132' ' ' ARG . 2.2 m-20 -91.99 21.44 4.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.859 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' A' ' 131' ' ' ASP . 16.8 mmm-85 35.36 41.28 0.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -71.35 -14.07 62.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.869 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.508 ' CE2' ' HG3' ' A' ' 154' ' ' ARG . 49.5 m95 -38.28 -37.44 0.29 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.24 -52.56 65.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.06 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -66.4 -39.73 89.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.842 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.3 t -57.3 -36.09 51.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.107 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.14 -49.85 21.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.094 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -57.99 -26.07 61.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.868 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -57.6 -38.93 75.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.838 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.533 HD21 ' CE2' ' A' ' 143' ' ' TYR . 13.6 tp -82.44 16.09 2.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.95 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 63.36 44.66 5.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.835 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.533 ' CE2' HD21 ' A' ' 141' ' ' LEU . 2.6 m-85 -85.21 155.96 60.18 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.657 0.741 . . . . 0.0 110.956 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 110.37 2.54 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.656 2.238 . . . . 0.0 112.345 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 108.27 2.03 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.712 2.274 . . . . 0.0 112.348 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 147.44 -34.64 1.26 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.459 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -83.93 147.24 27.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 0.0 110.923 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.418 ' CG ' ' O ' ' A' ' 148' ' ' ASN . 26.3 p-10 -66.53 72.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.857 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.42 ' O ' ' C ' ' A' ' 150' ' ' GLY . 75.4 mt -90.65 -50.04 13.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.099 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.1 -50.71 1.22 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.498 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.6 m -60.03 -49.29 78.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.887 0.375 . . . . 0.0 110.882 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.627 ' CD2' ' CD2' ' A' ' 156' ' ' HIS . 6.5 tt -51.18 -53.97 29.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.888 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 23.1 mt -54.35 -65.8 0.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.927 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.508 ' HG3' ' CE2' ' A' ' 134' ' ' TRP . 16.0 ttt180 -40.41 -41.57 1.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.889 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 156' ' ' HIS . 39.7 m -66.67 -69.78 0.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.627 ' CD2' ' CD2' ' A' ' 152' ' ' LEU . 2.4 m-70 -36.96 -39.22 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.879 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.52 ' CZ ' HG21 ' A' ' 161' ' ' ILE . 4.2 t80 -65.44 -57.23 8.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -70.82 -10.13 58.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.878 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -90.22 -48.17 7.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.824 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 60.7 mt -112.45 -41.97 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.162 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.52 HG21 ' CZ ' ' A' ' 157' ' ' TYR . 16.7 mt -78.48 3.23 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.091 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.584 ' C ' ' CD1' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -72.36 -60.66 2.07 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.691 0.758 . . . . 0.0 110.928 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.472 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.8 Cg_endo -69.72 -40.19 5.68 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.69 2.26 . . . . 0.0 112.358 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.486 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 23.8 t80 -55.57 -40.26 71.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.911 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -76.85 -66.32 0.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.883 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.447 ' SD ' ' N ' ' A' ' 167' ' ' PHE . 0.0 OUTLIER -42.7 -40.06 2.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.874 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.447 ' N ' ' SD ' ' A' ' 166' ' ' MET . 21.4 t80 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.435 ' CD2' ' HA ' ' A' ' 113' ' ' TYR . 73.0 t80 . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.876 0.37 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.6 mt -77.25 -43.14 34.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.05 -41.97 75.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.06 -62.97 1.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.529 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 15.0 tt -52.42 -39.71 29.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.143 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.1 -42.81 93.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.11 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -59.02 -29.21 67.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -77.2 -39.75 47.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.915 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 54.7 m95 -72.74 -58.39 3.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.418 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 9.6 pt-20 -39.17 -36.91 0.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.418 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 95.4 mt -69.85 -47.07 71.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.096 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -53.5 -35.34 60.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.925 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 130.56 -33.19 2.92 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.482 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.4 m -93.5 145.33 24.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.928 0.394 . . . . 0.0 110.89 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 27.7 p -79.27 159.55 27.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 39.1 tp -90.04 138.34 31.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.93 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 49.7 tttt -134.4 144.63 48.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.957 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 62.9 mt -109.82 124.51 33.44 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.608 0.718 . . . . 0.0 111.116 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 157.38 60.42 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.634 2.223 . . . . 0.0 112.296 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -107.71 121.48 44.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 62.4 t -116.09 140.84 36.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.149 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.473 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 63.1 mm-40 44.76 52.86 7.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.473 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 12.0 ptm180 47.36 36.7 5.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.835 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -154.14 150.58 28.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 6.9 tt -62.3 140.26 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.131 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.6 tt -89.22 121.86 31.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.953 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -82.46 79.75 8.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -58.71 -23.83 60.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.435 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 3.7 t80 -65.26 -56.12 14.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 115' ' ' LEU . 44.3 m -58.22 -59.84 4.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.875 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.448 ' C ' ' O ' ' A' ' 114' ' ' SER . 19.6 tp -34.48 -68.47 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.948 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.5 t -48.2 -54.71 12.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.852 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt -46.61 -54.75 8.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.904 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 81.5 mt -51.72 -54.25 13.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.141 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.4 t -53.33 -60.02 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.144 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 97.0 mt -43.28 -44.89 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.153 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -68.54 -48.61 63.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.454 ' OE2' ' CG2' ' A' ' 137' ' ' VAL . 24.7 mt-10 -44.95 -42.62 8.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.898 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 144.13 37.8 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.486 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.97 -179.45 45.49 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.516 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.516 ' C ' ' CD1' ' A' ' 125' ' ' TYR . 0.9 OUTLIER -86.88 -41.51 13.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.855 0.36 . . . . 0.0 110.934 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -62.75 -33.45 75.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.899 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.8 -69.84 0.29 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.07 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.527 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 1.9 pp -51.07 -32.6 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.163 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.488 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 27.3 m -69.6 -41.5 75.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.1 mtpp -67.11 -28.03 67.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -101.03 13.81 34.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.852 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 39.07 50.87 1.87 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -84.13 -3.6 58.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.86 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.527 ' CZ2' HD12 ' A' ' 128' ' ' ILE . 56.4 m95 -45.95 -39.06 8.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.925 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.53 -54.1 50.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.118 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -64.48 -46.85 81.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.908 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.454 ' CG2' ' OE2' ' A' ' 122' ' ' GLU . 52.0 t -50.39 -37.48 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.095 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.96 -49.35 38.2 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -59.03 -24.71 63.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -62.95 -30.54 71.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.8 tp -91.64 26.48 2.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 57.57 51.04 10.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -102.68 151.62 38.31 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.709 0.766 . . . . 0.0 110.883 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 110.31 2.52 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.739 2.293 . . . . 0.0 112.324 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 131.56 21.55 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.726 2.284 . . . . 0.0 112.358 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.65 -55.3 0.76 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.505 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -59.85 179.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.777 0.322 . . . . 0.0 110.912 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -93.97 42.22 1.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.4 ' O ' ' C ' ' A' ' 150' ' ' GLY . 61.8 mt -59.46 -50.07 81.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.115 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.22 -58.88 1.01 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.478 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.9 t -51.56 -60.49 3.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.926 0.393 . . . . 0.0 110.878 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.56 HD23 ' CD2' ' A' ' 156' ' ' HIS . 5.5 tt -38.98 -49.9 1.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.934 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 17.3 mt -59.74 -65.92 0.6 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.914 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.478 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 6.2 ttt-85 -38.3 -40.06 0.49 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.867 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 158' ' ' GLU . 3.8 m -66.84 -66.35 0.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.56 ' CD2' HD23 ' A' ' 152' ' ' LEU . 2.6 m-70 -43.6 -29.69 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.831 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.514 ' C ' ' CD1' ' A' ' 157' ' ' TYR . 2.2 t80 -79.57 -34.92 40.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.924 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 155' ' ' SER . 26.0 mt-10 -88.93 -9.9 49.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.872 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 12.7 mmt85 -102.15 -39.86 7.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 86.3 mt -109.86 -49.86 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.131 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.454 ' CG1' ' HA ' ' A' ' 157' ' ' TYR . 14.0 mt -78.47 3.3 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.095 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.641 ' C ' ' CD1' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -72.57 -60.54 2.01 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.665 0.745 . . . . 0.0 110.893 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 162' ' ' TYR . 53.7 Cg_endo -69.79 -49.35 0.56 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.668 2.245 . . . . 0.0 112.343 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.529 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 34.4 t80 -48.31 -38.02 17.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.929 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -75.2 -63.24 1.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.892 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 11.8 ptt? -48.65 -31.05 6.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.869 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 21.6 t80 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.866 -179.913 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.447 ' CD2' ' HA ' ' A' ' 113' ' ' TYR . 39.3 t80 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.901 0.382 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.9 mt -74.73 -59.13 2.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.908 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -49.61 -29.07 6.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -76.79 -68.2 0.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.959 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.54 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 9.9 tt -46.16 -34.84 2.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.16 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.27 -46.53 67.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.136 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -55.98 -22.86 29.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -84.95 -46.49 11.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.879 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 54.2 m95 -67.74 -51.25 51.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.894 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -45.88 -32.1 2.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 89.8 mt -74.93 -46.04 41.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.128 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -56.35 -36.74 69.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.88 -52.67 0.7 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.467 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 71.4 m -83.32 119.98 25.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.865 0.364 . . . . 0.0 110.874 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 59.4 p -55.51 173.26 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.84 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.1 tp -82.68 132.96 35.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.951 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -131.92 134.4 45.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.0 mt -110.0 127.45 27.07 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.594 0.712 . . . . 0.0 111.148 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.565 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 53.2 Cg_endo -69.77 166.53 27.29 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.661 2.24 . . . . 0.0 112.329 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -113.09 122.86 48.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.4 t -123.75 148.64 27.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.155 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.448 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 58.1 mm-40 41.72 52.92 4.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.448 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 13.0 ptp180 45.16 43.01 7.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.875 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -164.58 152.22 11.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.926 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.1 tt -62.29 142.89 15.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.121 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.3 tt -91.63 132.49 36.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -94.6 100.92 12.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.838 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.53 -26.64 61.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.546 ' CE1' ' HG3' ' A' ' 117' ' ' LYS . 4.4 t80 -61.06 -55.89 27.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.886 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.4 m -61.85 -56.98 13.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.83 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 26.2 tp -40.73 -60.74 1.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.1 t -58.17 -50.59 73.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.802 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.546 ' HG3' ' CE1' ' A' ' 113' ' ' TYR . 13.9 mmmt -47.92 -46.3 31.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 63.8 mt -64.45 -38.58 82.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 71.6 t -64.17 -59.96 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 83.3 mt -59.71 -43.58 91.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.118 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -58.79 -56.56 20.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -44.36 -51.07 8.84 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 159.11 34.42 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.473 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.98 -175.02 33.36 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.528 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.524 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 2.1 t80 -87.41 -46.59 9.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.838 0.352 . . . . 0.0 110.905 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -58.02 -37.53 74.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.58 -70.46 0.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.113 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.455 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 1.9 pp -50.09 -34.47 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.165 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.524 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 53.5 m -67.93 -44.18 77.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.914 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -64.53 -40.85 96.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.933 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 132' ' ' ARG . 69.5 m-20 -85.92 23.77 1.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.824 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 131' ' ' ASP . 41.3 mtp85 36.04 37.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.847 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 134' ' ' TRP . 29.7 mmt180 -66.71 -23.47 66.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.542 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 22.4 m95 -34.71 -43.85 0.19 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.89 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.35 -49.21 75.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.114 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 133' ' ' ARG . 13.0 tpp180 -69.11 -42.18 76.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.892 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 89.2 t -53.85 -34.7 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -76.78 -53.45 7.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.1 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -55.04 -28.21 50.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -64.89 -28.3 69.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.515 HD22 ' CZ ' ' A' ' 143' ' ' TYR . 12.5 tp -88.27 22.67 2.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 60.78 45.84 9.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.843 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.515 ' CZ ' HD22 ' A' ' 141' ' ' LEU . 4.4 m-85 -97.71 147.37 32.93 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.692 0.758 . . . . 0.0 110.902 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 125.43 12.12 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.689 2.259 . . . . 0.0 112.289 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 96.68 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.676 2.251 . . . . 0.0 112.324 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 165.02 -75.24 0.16 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.543 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 149' ' ' ILE . 0.3 OUTLIER -45.96 138.47 5.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.798 0.332 . . . . 0.0 110.929 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -62.87 75.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.915 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 147' ' ' LYS . 94.1 mt -87.38 -48.91 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.138 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.13 -59.0 0.99 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.472 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.1 t -53.56 -55.25 27.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.945 0.402 . . . . 0.0 110.873 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.608 ' CD2' ' CD2' ' A' ' 156' ' ' HIS . 5.6 tt -44.28 -53.31 6.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 18.6 mt -53.54 -65.85 0.49 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.542 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 16.3 ttp180 -39.75 -47.05 2.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 7.9 t -59.41 -66.51 0.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.842 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.608 ' CD2' ' CD2' ' A' ' 152' ' ' LEU . 3.2 m-70 -40.6 -34.44 0.36 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.821 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.566 ' CD2' HD12 ' A' ' 161' ' ' ILE . 9.7 t80 -68.57 -70.27 0.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.4 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 3.9 mm-40 -61.09 -10.08 5.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.867 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -85.0 -55.85 3.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 49.7 mt -109.43 -37.27 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.118 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.566 HD12 ' CD2' ' A' ' 157' ' ' TYR . 26.7 mt -75.4 -5.93 7.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.113 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.57 ' CE1' ' HE2' ' A' ' 166' ' ' MET . 0.3 OUTLIER -71.25 -59.26 3.39 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.679 0.752 . . . . 0.0 110.93 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.511 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.3 Cg_endo -69.85 -39.73 6.0 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.69 2.26 . . . . 0.0 112.335 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.54 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 3.7 t80 -64.78 -30.03 71.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.935 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 161' ' ' ILE . 17.1 mm-40 -74.13 -57.24 4.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.876 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.57 ' HE2' ' CE1' ' A' ' 162' ' ' TYR . 5.5 ptp -55.43 -29.52 58.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.461 ' N ' ' HG3' ' A' ' 166' ' ' MET . 54.3 t80 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.873 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 81.3 t80 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.891 0.376 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.2 mt -80.56 -63.22 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.947 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -44.88 -31.39 1.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -72.26 -71.03 0.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.526 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 14.7 tt -43.29 -34.87 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.099 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.433 ' N ' HG22 ' A' ' 89' ' ' ILE . . . -68.82 -50.18 52.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.107 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -51.89 -29.21 18.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.906 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.401 ' CD1' ' CD2' ' A' ' 167' ' ' PHE . 30.2 t80 -77.29 -37.81 52.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.875 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.451 ' O ' ' C ' ' A' ' 94' ' ' GLU . 67.7 m95 -76.19 -59.24 2.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.921 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 93' ' ' TRP . 11.2 pt-20 -34.65 -40.54 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.444 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 95.5 mt -66.62 -53.87 31.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.126 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -46.81 -45.32 19.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 125.83 42.14 0.32 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.436 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.4 t -167.02 110.27 0.7 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.903 0.382 . . . . 0.0 110.869 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 78.1 p -43.84 163.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.902 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.6 tp -93.58 111.44 23.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -107.35 149.1 28.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 53.7 mt -119.95 129.93 25.1 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.655 0.741 . . . . 0.0 111.134 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 160.45 49.65 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.692 2.261 . . . . 0.0 112.303 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -111.81 126.05 54.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.906 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.3 t -121.32 144.22 31.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.161 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.429 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 62.7 mm-40 41.76 54.54 3.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.429 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 1.4 ptp180 43.88 40.07 2.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.03 152.72 26.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.4 tt -63.06 141.91 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.106 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.4 tt -86.25 133.52 33.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -91.95 74.33 5.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.63 -29.69 52.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.934 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -60.57 -66.94 0.45 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.932 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.8 m -50.97 -53.96 28.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.839 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.9 tp -39.46 -61.08 0.84 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.945 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.2 t -55.13 -66.59 0.38 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.469 ' HE2' ' N ' ' A' ' 117' ' ' LYS . 1.0 OUTLIER -40.96 -64.03 0.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.849 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 80.9 mt -40.81 -63.3 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.104 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.8 t -40.82 -58.14 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.099 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 69.9 mt -48.86 -42.12 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.161 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -65.92 -50.23 65.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.856 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -47.79 -40.14 20.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.846 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 144.82 42.33 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.516 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 83.03 174.74 50.61 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.525 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.551 ' C ' ' CD1' ' A' ' 125' ' ' TYR . 0.6 OUTLIER -86.83 -37.13 18.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.846 0.355 . . . . 0.0 110.946 -179.824 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -66.06 -40.45 90.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.866 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.72 -63.44 1.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.073 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.417 ' C ' HD11 ' A' ' 128' ' ' ILE . 2.4 pp -49.11 -37.07 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.123 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 22.0 m -62.82 -50.7 69.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.849 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -62.31 -33.77 75.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 132' ' ' ARG . 2.5 m-20 -90.91 16.35 9.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 131' ' ' ASP . 78.0 mtt180 36.98 44.56 0.38 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 15.0 mtp85 -77.62 -13.6 59.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 21.4 m95 -39.66 -40.35 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.72 -45.55 81.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.129 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.4 tpp85 -73.57 -44.99 55.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.1 t -57.04 -24.25 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.148 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -85.06 -55.34 4.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.087 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -55.42 -29.57 58.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -54.2 -36.45 63.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.869 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.525 HD22 ' CE2' ' A' ' 143' ' ' TYR . 17.6 tp -83.27 14.57 3.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 68.99 44.16 1.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.525 ' CE2' HD22 ' A' ' 141' ' ' LEU . 2.7 m-85 -92.32 158.33 39.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.731 0.777 . . . . 0.0 110.91 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 110.67 2.61 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.661 2.241 . . . . 0.0 112.349 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 105.67 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.699 2.266 . . . . 0.0 112.356 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.94 -58.82 0.41 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.524 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.454 ' HD3' ' N ' ' A' ' 148' ' ' ASN . 10.7 tmtt? -61.95 150.3 38.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.79 0.329 . . . . 0.0 110.889 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.454 ' N ' ' HD3' ' A' ' 147' ' ' LYS . 46.9 t30 -66.68 81.39 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.425 ' O ' ' C ' ' A' ' 150' ' ' GLY . 42.9 mt -94.87 -52.75 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.124 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.04 -53.05 1.22 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.492 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 75.5 m -57.69 -57.88 10.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.901 0.381 . . . . 0.0 110.831 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.561 HD22 ' CD2' ' A' ' 156' ' ' HIS . 6.6 tt -43.6 -50.24 7.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.881 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 154' ' ' ARG . 26.7 mt -55.37 -65.91 0.51 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.95 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 153' ' ' LEU . 20.0 ttp180 -38.17 -50.34 1.4 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.87 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 49.0 m -55.84 -69.21 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.561 ' CD2' HD22 ' A' ' 152' ' ' LEU . 1.9 m-70 -38.84 -43.03 0.89 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.858 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.554 ' CD2' HD12 ' A' ' 161' ' ' ILE . 8.6 t80 -60.52 -66.2 0.57 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 41.4 mt-10 -63.06 -10.2 13.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.933 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -85.69 -53.81 4.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 42.8 mt -109.54 -39.35 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.091 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.554 HD12 ' CD2' ' A' ' 157' ' ' TYR . 18.4 mt -76.25 -2.28 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.156 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.544 ' CD2' ' HD3' ' A' ' 163' ' ' PRO . 0.2 OUTLIER -72.08 -60.29 2.37 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.672 0.749 . . . . 0.0 110.915 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.544 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.6 Cg_endo -69.78 -41.05 4.58 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.64 2.227 . . . . 0.0 112.323 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.526 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 8.1 t80 -63.33 -27.95 69.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.946 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.438 ' CG ' ' O ' ' A' ' 161' ' ' ILE . 9.3 mm-40 -76.97 -59.06 2.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.882 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.534 ' HE2' ' CE1' ' A' ' 162' ' ' TYR . 2.2 ptp -56.22 -25.39 47.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.858 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.401 ' CD2' ' CD1' ' A' ' 92' ' ' PHE . 67.9 t80 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.869 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.9 t80 . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.895 0.379 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.0 mt -73.03 -47.65 43.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -54.03 -29.95 45.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -83.91 -64.03 1.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.924 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.2 tt -51.15 -28.63 7.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.139 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.1 -34.21 59.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.085 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.3 tttp -69.71 -25.09 63.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.942 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -82.4 -49.19 10.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -63.79 -49.41 73.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.961 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.452 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 7.2 pt-20 -46.27 -35.84 5.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.452 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 96.4 mt -70.13 -44.53 78.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.138 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 -57.76 -36.19 71.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 130.94 -40.04 1.7 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.491 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.7 m -88.41 109.88 20.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.87 0.367 . . . . 0.0 110.841 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 88.7 p -49.88 166.68 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.869 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.9 tp -85.05 122.36 29.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.916 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -127.76 134.78 49.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.4 mp -99.04 134.16 21.62 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.64 0.733 . . . . 0.0 111.108 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.451 ' HG3' ' CD2' ' A' ' 156' ' ' HIS . 53.8 Cg_endo -69.76 159.39 53.58 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.674 2.249 . . . . 0.0 112.357 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -112.63 103.66 11.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.427 HG13 ' N ' ' A' ' 106' ' ' GLU . 87.1 t -106.35 138.35 32.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.137 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.493 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 73.5 mm-40 53.16 47.55 24.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.898 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.493 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 28.0 ptt180 47.95 32.88 3.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.82 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.5 pttm -150.48 157.47 43.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.406 HG13 ' N ' ' A' ' 110' ' ' LEU . 3.0 tp -63.09 140.12 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.097 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.42 ' C ' HD22 ' A' ' 110' ' ' LEU . 5.5 tt -84.6 142.06 30.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.869 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.404 ' N ' HD22 ' A' ' 110' ' ' LEU . 19.5 t0 -93.08 93.38 8.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.847 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -82.97 -19.88 36.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.875 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.621 ' CE1' ' CE ' ' A' ' 117' ' ' LYS . 65.7 t80 -71.04 -67.08 0.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.975 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.9 m -50.82 -54.37 24.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.885 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.3 tp -41.53 -50.07 4.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.954 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.0 t -58.04 -61.22 2.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.621 ' CE ' ' CE1' ' A' ' 113' ' ' TYR . 0.1 OUTLIER -56.12 -63.92 1.03 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.885 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.402 ' C ' ' O ' ' A' ' 117' ' ' LYS . 71.9 mt -36.06 -58.61 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.122 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 84.2 t -51.03 -54.42 10.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.168 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 65.3 mt -57.62 -29.63 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.088 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -74.48 -56.2 5.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -43.52 -50.15 7.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.419 ' O ' ' CB ' ' A' ' 127' ' ' ALA . . . 160.51 33.09 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.498 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.12 173.35 46.34 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.464 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.525 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 0.8 OUTLIER -78.44 -44.84 23.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.832 0.349 . . . . 0.0 110.897 -179.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 56.0 mp0 -59.93 -40.25 88.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.933 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 123' ' ' GLY . . . -65.52 -64.04 0.96 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.12 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.6 pp -55.1 -32.84 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.133 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.525 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 29.8 m -69.56 -42.03 75.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.8 tttm -66.55 -34.86 78.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' A' ' 132' ' ' ARG . 6.5 m-20 -94.2 23.01 5.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 131' ' ' ASP . 0.8 OUTLIER 34.39 35.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.836 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 131' ' ' ASP . 10.8 mmt85 -71.0 -1.54 12.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.553 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 44.3 m95 -49.32 -38.99 29.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.92 -47.92 76.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.103 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 -66.16 -44.7 83.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.887 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 99.2 t -56.94 -39.98 69.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.085 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.97 -57.84 6.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.084 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -52.83 -29.84 30.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.935 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.0 mmt-85 -60.73 -29.44 69.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.557 HD21 ' CE2' ' A' ' 143' ' ' TYR . 14.4 tp -87.53 13.32 10.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.91 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 71.91 35.82 1.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.882 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.557 ' CE2' HD21 ' A' ' 141' ' ' LEU . 3.1 m-85 -82.21 154.82 69.69 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.65 0.738 . . . . 0.0 110.95 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 122.77 9.45 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.673 2.248 . . . . 0.0 112.367 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 120.03 6.87 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.666 2.244 . . . . 0.0 112.305 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 134.8 -64.67 0.59 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.511 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.442 ' HE2' ' N ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -59.81 142.32 53.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.788 0.328 . . . . 0.0 110.887 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.98 85.91 2.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 56.0 mt -91.6 -34.05 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.133 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -41.02 -48.96 4.33 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.445 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.5 m -57.83 -51.58 69.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.362 . . . . 0.0 110.851 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.571 HD22 ' CD2' ' A' ' 156' ' ' HIS . 5.4 tt -48.52 -53.92 16.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.92 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 15.4 mt -53.76 -65.94 0.48 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.917 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.553 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 12.6 ttp180 -37.99 -46.01 0.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.866 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 3.3 m -61.34 -71.93 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.817 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.571 ' CD2' HD22 ' A' ' 152' ' ' LEU . 2.3 m-70 -37.37 -34.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.816 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.525 ' CD2' HD12 ' A' ' 161' ' ' ILE . 4.0 t80 -70.08 -57.48 4.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.9 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.5 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 20.2 mm-40 -71.11 -9.74 58.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.919 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.1 tpp85 -98.46 -36.87 9.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.878 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 66.3 mt -112.68 -50.12 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.101 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.525 HD12 ' CD2' ' A' ' 157' ' ' TYR . 34.3 mt -76.34 -0.14 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.546 ' C ' ' CD1' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -73.08 -60.87 1.66 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.674 0.749 . . . . 0.0 110.942 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.514 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.5 Cg_endo -69.8 -40.45 5.25 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.67 2.247 . . . . 0.0 112.331 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -61.04 -36.19 78.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.946 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -72.35 -61.31 1.84 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.908 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.508 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 11.1 ptt? -54.55 -37.96 66.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.841 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 47.2 t80 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.916 -179.929 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 41.8 t80 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.915 0.388 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.0 mt -69.3 -66.48 0.58 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.889 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -44.2 -24.39 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.935 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -80.73 -62.75 1.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.94 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.465 HG23 ' CD2' ' A' ' 100' ' ' LEU . 15.1 tt -56.89 -26.4 24.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.131 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.09 -55.17 5.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.121 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -53.46 -33.18 53.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.928 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -69.46 -53.3 19.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.871 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 21.7 m95 -54.11 -55.04 31.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.894 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.439 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 11.3 pt-20 -48.59 -43.91 36.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.921 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.439 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 62.8 mt -61.61 -45.84 97.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.111 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -54.59 -41.05 69.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.984 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 126.86 42.26 0.29 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.472 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.2 m -164.24 169.9 16.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.881 0.372 . . . . 0.0 110.836 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.7 t -100.44 151.5 21.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.843 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.465 ' CD2' HG23 ' A' ' 89' ' ' ILE . 42.4 tp -97.17 117.3 31.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.877 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -113.77 146.6 39.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.941 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 66.5 mt -111.71 124.38 32.57 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.569 0.699 . . . . 0.0 111.15 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 154.02 68.47 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.684 2.256 . . . . 0.0 112.382 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -104.14 119.77 39.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.88 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 84.5 t -127.59 135.52 62.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.126 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 62.04 48.94 4.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.876 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 42.15 39.2 1.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.843 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -163.94 154.48 15.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.864 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.1 tt -58.36 152.15 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.114 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.421 ' C ' HD22 ' A' ' 110' ' ' LEU . 5.5 tt -97.48 124.63 41.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -85.75 76.0 10.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.871 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -53.3 -28.84 30.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -58.18 -52.59 64.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.936 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.447 ' O ' ' C ' ' A' ' 115' ' ' LEU . 23.9 m -63.06 -59.86 4.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 114' ' ' SER . 28.4 tp -34.74 -67.84 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.868 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 117' ' ' LYS . 68.6 m -54.16 -60.23 3.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.857 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 116' ' ' SER . 22.8 mmtt -37.7 -49.14 1.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.9 mt -62.65 -45.04 99.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.186 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.8 t -51.06 -65.89 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.119 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 83.5 mt -51.55 -52.47 20.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.136 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -46.55 -49.16 19.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.465 ' CB ' HG23 ' A' ' 128' ' ' ILE . 44.7 mm-40 -53.28 -48.46 68.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.89 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 153.8 34.4 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.498 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 96.14 -178.12 34.29 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.478 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.499 ' C ' ' CD1' ' A' ' 125' ' ' TYR . 1.0 OUTLIER -88.07 -35.91 17.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 0.0 110.912 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -69.56 -38.91 77.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.905 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.2 -57.87 6.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.105 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.567 HD13 ' CZ2' ' A' ' 134' ' ' TRP . 2.2 pp -56.57 -35.99 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.156 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.442 ' N ' HD11 ' A' ' 128' ' ' ILE . 39.1 m -67.71 -35.91 79.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -65.27 -46.06 81.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.448 ' O ' ' C ' ' A' ' 132' ' ' ARG . 3.7 t0 -88.18 24.55 1.83 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.448 ' C ' ' O ' ' A' ' 131' ' ' ASP . 60.0 mtp180 34.31 52.23 0.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.457 ' O ' ' C ' ' A' ' 134' ' ' TRP . 16.8 mmt180 -74.27 -24.39 59.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.848 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.567 ' CZ2' HD13 ' A' ' 128' ' ' ILE . 25.2 m95 -33.57 -45.39 0.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.33 -56.51 17.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.09 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.6 -40.59 92.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 90.2 t -54.14 -39.35 41.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.097 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.87 -52.86 15.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.145 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -54.25 -29.12 45.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -60.13 -35.25 74.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.867 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.0 tp -85.22 24.65 1.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.939 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 59.18 34.59 23.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.847 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -82.34 153.41 68.64 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.663 0.744 . . . . 0.0 110.954 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 113.55 3.41 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.666 2.244 . . . . 0.0 112.32 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 94.8 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.624 2.216 . . . . 0.0 112.322 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 173.54 -71.5 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.457 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -49.56 168.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.806 0.336 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -83.39 43.8 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 63.5 mt -54.59 -49.37 67.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.146 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -37.89 -52.36 2.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.466 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.2 t -62.21 -47.82 82.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.93 0.395 . . . . 0.0 110.84 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.57 HD22 ' CD2' ' A' ' 156' ' ' HIS . 6.5 tt -52.04 -46.56 65.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.951 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 154' ' ' ARG . 6.2 mt -59.93 -66.04 0.58 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.536 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 18.3 ttp180 -37.84 -49.2 1.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 74.5 m -57.07 -68.6 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.57 ' CD2' HD22 ' A' ' 152' ' ' LEU . 1.8 m-70 -38.15 -45.26 0.92 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.843 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.545 ' CE2' HG21 ' A' ' 161' ' ' ILE . 4.0 t80 -60.22 -59.37 5.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.434 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 5.5 mm-40 -67.14 -9.97 45.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -86.89 -54.39 4.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.8 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 38.6 mt -108.85 -39.92 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.075 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.545 HG21 ' CE2' ' A' ' 157' ' ' TYR . 15.0 mt -77.33 0.66 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.118 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.586 ' CE1' ' SD ' ' A' ' 166' ' ' MET . 0.2 OUTLIER -72.53 -60.48 2.06 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.662 0.744 . . . . 0.0 110.932 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.564 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.0 Cg_endo -69.79 -42.96 2.92 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.695 2.263 . . . . 0.0 112.326 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -56.82 -39.74 74.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.916 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -72.17 -65.5 0.77 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.897 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.586 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 8.5 ptt? -47.95 -42.3 27.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.833 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 17.8 t80 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.874 -179.956 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.417 ' CD2' ' HA ' ' A' ' 113' ' ' TYR . 29.4 t80 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.916 0.388 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.1 mt -63.75 -56.4 15.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.913 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -57.75 -24.82 58.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.887 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -77.88 -60.98 2.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.539 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 20.7 tt -62.19 -31.07 50.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.151 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.41 -51.93 38.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.088 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -47.29 -27.88 1.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.875 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -80.24 -44.22 20.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -69.5 -55.35 10.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -40.1 -41.65 1.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.843 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 84.7 mt -68.02 -54.27 23.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.154 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -45.74 -32.76 2.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 129.94 -37.94 2.07 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.482 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 41.3 t -89.22 121.81 31.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.906 0.384 . . . . 0.0 110.856 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.7 t -60.09 172.45 0.79 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.85 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 19.5 tp -97.94 127.86 44.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.889 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.3 mttm -130.56 128.53 41.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 45.9 mm -95.63 123.31 56.58 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.609 0.719 . . . . 0.0 111.165 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.555 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 54.1 Cg_endo -69.77 146.82 61.31 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.625 2.217 . . . . 0.0 112.389 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -95.92 113.9 25.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.925 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 79.1 t -115.53 141.43 32.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.428 ' HG3' ' CD ' ' A' ' 144' ' ' PRO . 23.2 mm-40 47.39 53.76 10.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.908 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 19.7 ptt-85 43.04 42.58 3.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.85 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -163.6 153.52 15.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.907 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.8 tp -63.56 143.57 15.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.086 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.6 tt -89.82 123.75 34.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -86.14 68.24 10.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.846 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -47.55 -32.64 5.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.417 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 6.9 t80 -56.33 -65.28 0.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.923 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.3 p -51.79 -45.5 63.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.6 tp -45.92 -66.91 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.902 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.9 t -47.56 -51.38 21.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -47.67 -59.43 3.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.891 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 77.7 mt -50.99 -50.05 25.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.139 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 98.9 t -49.65 -63.21 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.126 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 74.4 mt -51.18 -48.74 31.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.125 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -52.58 -57.24 10.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.875 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -45.36 -49.51 12.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.916 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 154.51 36.62 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.499 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.07 175.12 40.91 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.491 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.506 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 1.2 t80 -82.78 -40.19 20.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.839 0.352 . . . . 0.0 110.892 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -64.2 -40.02 95.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.878 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.1 -64.47 0.92 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.126 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.43 ' CD1' ' CE2' ' A' ' 134' ' ' TRP . 2.0 pp -54.7 -34.5 30.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.156 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.506 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 22.5 m -66.88 -36.57 82.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.6 tptt -71.62 -42.1 68.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 132' ' ' ARG . 38.7 m-20 -88.34 22.88 2.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.868 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 131' ' ' ASP . 35.3 mtp180 34.46 43.43 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.844 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -74.76 -8.11 55.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.43 ' CE2' ' CD1' ' A' ' 128' ' ' ILE . 16.7 m95 -45.61 -47.55 14.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.902 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -46.66 -56.97 5.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.098 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -67.73 -56.67 8.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 87.0 t -43.23 -29.42 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.138 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.0 -49.18 11.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.141 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -59.56 -27.73 66.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -60.6 -26.16 66.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.837 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.467 HD22 ' CE2' ' A' ' 143' ' ' TYR . 20.3 tp -90.03 12.12 18.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.878 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 71.42 48.88 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.467 ' CE2' HD22 ' A' ' 141' ' ' LEU . 2.8 m-85 -99.94 158.59 31.78 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.681 0.753 . . . . 0.0 110.9 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.428 ' CD ' ' HG3' ' A' ' 106' ' ' GLU . 54.4 Cg_endo -69.72 111.42 2.8 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.714 2.276 . . . . 0.0 112.372 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 95.27 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.711 2.274 . . . . 0.0 112.307 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.52 -73.74 0.12 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.452 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -54.74 145.08 20.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.836 0.35 . . . . 0.0 110.888 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -63.76 81.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.864 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 71.4 mt -88.27 -45.59 15.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.101 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -37.98 -45.96 1.7 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.482 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.6 m -60.66 -51.38 69.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.372 . . . . 0.0 110.877 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.552 HD22 ' CD2' ' A' ' 156' ' ' HIS . 5.9 tt -50.2 -48.83 54.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.915 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 22.2 mt -57.32 -65.96 0.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -38.99 -46.38 1.33 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 157' ' ' TYR . 41.0 t -60.2 -68.53 0.28 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.555 ' CE1' ' HG3' ' A' ' 103' ' ' PRO . 2.4 m-70 -41.9 -24.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.842 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.55 ' CD2' HD13 ' A' ' 161' ' ' ILE . 7.9 t80 -78.42 -50.14 12.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.918 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.408 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 5.2 mm-40 -81.62 -9.86 59.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.87 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -96.0 -41.48 8.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 76.9 mt -112.49 -49.18 5.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.113 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.55 HD13 ' CD2' ' A' ' 157' ' ' TYR . 9.8 mt -76.88 6.39 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.152 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.645 ' C ' ' CD1' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -75.35 -62.63 0.79 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.666 0.745 . . . . 0.0 110.907 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.555 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.1 Cg_endo -69.81 -35.26 12.84 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.675 2.25 . . . . 0.0 112.329 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.539 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 65.3 t80 -60.51 -42.53 96.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.945 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -70.04 -55.07 10.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.883 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 2.7 mtm -62.74 -58.63 6.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.856 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.462 ' CB ' ' O ' ' A' ' 163' ' ' PRO . 29.3 t80 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.83 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.7 t80 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.891 0.376 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 12.6 mt -63.15 -66.77 0.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -44.51 -26.16 0.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -78.74 -70.58 0.49 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.9 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.532 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 7.5 tt -49.46 -32.26 6.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.131 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.442 ' N ' HG23 ' A' ' 89' ' ' ILE . . . -73.6 -49.82 24.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.103 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -52.63 -20.03 2.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -90.82 -42.12 10.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -68.3 -50.57 52.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 4.4 pt-20 -45.24 -29.36 0.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.862 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.411 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 86.5 mt -78.69 -54.67 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.089 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -45.67 -32.59 2.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 132.18 -30.0 3.25 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.479 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.3 m -98.72 146.63 25.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.904 0.383 . . . . 0.0 110.833 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 65.5 m -78.25 174.93 10.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.837 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 22.0 tp -90.67 117.12 29.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.921 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -115.84 141.98 47.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.863 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 25.8 mm -117.28 121.62 32.07 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.649 0.738 . . . . 0.0 111.116 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 166.42 27.63 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.72 2.28 . . . . 0.0 112.315 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -114.04 126.57 55.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 52.0 t -125.4 132.95 70.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.459 ' HG3' ' CD ' ' A' ' 144' ' ' PRO . 29.1 mm-40 56.9 52.05 9.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.404 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 11.8 ptp180 44.64 35.93 1.58 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.909 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.467 ' HG3' ' N ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -157.82 151.95 24.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.9 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.467 ' N ' ' HG3' ' A' ' 108' ' ' LYS . 15.7 tt -57.51 149.2 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.149 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.433 HD21 ' N ' ' A' ' 111' ' ' ASP . 5.9 tt -94.32 123.84 37.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.973 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.433 ' N ' HD21 ' A' ' 110' ' ' LEU . 22.1 t0 -79.99 69.56 6.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.851 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -51.25 -23.08 3.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.476 ' CE1' ' HG3' ' A' ' 117' ' ' LYS . 2.4 t80 -66.06 -57.51 7.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.95 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 115' ' ' LEU . 3.3 m -60.5 -59.43 5.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.867 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.423 ' C ' ' O ' ' A' ' 114' ' ' SER . 13.0 tp -36.21 -68.23 0.14 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.897 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 119' ' ' VAL . 42.0 t -50.78 -66.24 0.42 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.87 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.476 ' HG3' ' CE1' ' A' ' 113' ' ' TYR . 13.2 mmtp -36.85 -43.83 0.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.886 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 77.1 mt -64.82 -42.47 95.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.135 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.478 ' N ' ' O ' ' A' ' 116' ' ' SER . 95.2 t -59.22 -56.89 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.105 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 70.0 mt -61.46 -45.58 98.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -56.4 -52.09 65.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -50.89 -47.17 60.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.865 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 155.57 38.56 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.467 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 87.44 176.27 48.6 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.481 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.566 ' C ' ' CD1' ' A' ' 125' ' ' TYR . 0.6 OUTLIER -83.52 -36.94 23.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.368 . . . . 0.0 110.919 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -63.57 -41.09 98.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.85 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.56 -64.36 0.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.136 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.431 ' C ' HD11 ' A' ' 128' ' ' ILE . 2.2 pp -47.84 -32.17 3.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.136 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.468 ' SG ' ' CE1' ' A' ' 125' ' ' TYR . 22.1 m -70.18 -46.61 64.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.864 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -59.88 -40.62 89.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.897 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 132' ' ' ARG . 2.7 m-20 -86.65 17.35 3.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.85 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.413 ' HB3' ' NH1' ' A' ' 132' ' ' ARG . 14.5 mtp-105 37.7 45.72 0.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 134' ' ' TRP . 4.1 mmp_? -71.77 -20.15 61.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.56 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 50.5 m95 -36.01 -40.27 0.2 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.908 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.45 -52.65 64.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.076 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.5 mmt-85 -68.5 -38.85 81.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.887 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 78.2 t -56.27 -40.11 63.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -72.4 -47.69 47.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -62.04 -27.32 68.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.4 mmp_? -60.97 -35.7 77.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.854 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.55 HD22 ' CE2' ' A' ' 143' ' ' TYR . 14.8 tp -82.79 13.49 3.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.971 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 62.82 51.13 3.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.55 ' CE2' HD22 ' A' ' 141' ' ' LEU . 2.5 m-85 -91.43 159.68 38.5 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.677 0.751 . . . . 0.0 110.873 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.459 ' CD ' ' HG3' ' A' ' 106' ' ' GLU . 53.8 Cg_endo -69.78 118.47 5.7 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.683 2.255 . . . . 0.0 112.343 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 97.78 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.693 2.262 . . . . 0.0 112.36 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.54 -82.39 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.46 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 9.3 tttp -47.31 147.8 1.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.804 0.335 . . . . 0.0 110.88 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -66.68 82.68 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.895 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.444 ' CD1' ' HB3' ' A' ' 143' ' ' TYR . 64.0 mt -83.06 -50.77 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.136 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.11 -53.21 1.24 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.526 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.1 t -57.16 -61.59 2.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.903 0.382 . . . . 0.0 110.801 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.563 HD23 ' CD2' ' A' ' 156' ' ' HIS . 5.5 tt -39.12 -55.95 1.54 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.935 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 23.9 mt -50.57 -65.9 0.48 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.56 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 13.2 ttp180 -38.84 -45.78 1.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.4 t -61.12 -69.01 0.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.854 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.563 ' CD2' HD23 ' A' ' 152' ' ' LEU . 2.0 m-70 -39.91 -36.16 0.43 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.799 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.538 ' CE2' HG21 ' A' ' 161' ' ' ILE . 3.4 t80 -69.78 -58.93 3.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 18.4 mt-10 -66.92 -10.08 45.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.901 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -92.95 -53.08 4.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.812 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 60.7 mt -104.73 -43.47 8.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.07 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.538 HG21 ' CE2' ' A' ' 157' ' ' TYR . 32.3 mt -76.02 -2.29 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.163 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.624 ' C ' ' CD1' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -72.2 -60.45 2.24 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.656 0.741 . . . . 0.0 110.931 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 162' ' ' TYR . 53.9 Cg_endo -69.73 -43.56 2.61 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.699 2.266 . . . . 0.0 112.337 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.532 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 17.6 t80 -54.66 -41.55 70.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -76.26 -68.44 0.59 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.34 -30.25 0.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 24.8 t80 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.9 -179.95 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.601 ' CE1' ' NZ ' ' A' ' 117' ' ' LYS . 42.4 t80 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.905 0.384 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.3 mt -55.44 -59.88 4.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.906 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.3 -39.27 66.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.862 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -62.9 -57.83 9.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.444 HG23 ' N ' ' A' ' 90' ' ' ALA . 18.0 tt -61.02 -34.99 62.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.14 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.444 ' N ' HG23 ' A' ' 89' ' ' ILE . . . -68.26 -51.27 46.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.09 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -44.14 -35.31 2.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.929 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -72.41 -50.54 25.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.407 ' O ' ' C ' ' A' ' 94' ' ' GLU . 87.0 m95 -63.38 -58.5 6.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.949 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.438 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 21.7 pt-20 -37.68 -39.34 0.33 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.438 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 97.2 mt -71.24 -55.09 15.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.125 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -44.71 -35.81 2.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.923 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 120.31 -30.52 5.58 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.497 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.403 ' O ' ' C ' ' A' ' 99' ' ' SER . 0.7 OUTLIER -86.87 94.85 9.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.907 0.384 . . . . 0.0 110.84 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 98' ' ' SER . 51.3 p -38.02 150.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.837 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 18.5 tp -88.06 107.42 18.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.931 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -102.28 115.55 30.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.89 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.4 mp -81.12 123.1 82.08 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.647 0.737 . . . . 0.0 111.12 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 144.55 54.44 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.671 2.248 . . . . 0.0 112.325 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -102.63 109.47 21.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.916 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 90.4 t -113.32 140.48 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.105 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.47 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 5.7 mm-40 57.45 43.62 22.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.912 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.47 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 5.3 ptm180 48.22 33.49 3.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.901 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -153.71 157.47 39.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 6.8 tt -63.6 139.63 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.114 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.1 tt -84.85 122.11 28.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.941 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -80.03 74.04 6.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.4 ' HG ' ' N ' ' A' ' 113' ' ' TYR . 1.5 pt? -57.48 -32.08 66.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.901 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.529 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -56.57 -64.32 0.91 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.921 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 115' ' ' LEU . 5.3 m -53.11 -63.97 0.97 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.849 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 114' ' ' SER . 13.7 tp -34.19 -53.89 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.879 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.3 t -56.46 -64.32 0.91 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.601 ' NZ ' ' CE1' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -45.23 -51.41 10.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.9 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 69.8 mt -54.33 -40.96 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.144 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 96.9 t -66.2 -39.46 84.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.089 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 62.0 mt -70.28 -55.21 15.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.128 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.465 ' HG3' ' N ' ' A' ' 122' ' ' GLU . 5.6 pt-20 -49.31 -37.55 24.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.889 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.465 ' N ' ' HG3' ' A' ' 121' ' ' GLU . 35.7 mt-10 -65.41 -27.23 68.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.845 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 134.86 28.44 0.45 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.462 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.99 -175.65 35.37 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.495 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.485 ' C ' ' CD1' ' A' ' 125' ' ' TYR . 1.1 t80 -86.25 -38.6 17.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.827 0.346 . . . . 0.0 110.933 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -62.37 -48.39 79.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.897 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -53.75 -71.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.09 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.6 pp -46.31 -34.86 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.415 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 25.7 m -69.01 -32.58 72.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.855 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -68.46 -46.64 69.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 132' ' ' ARG . 1.1 m-20 -90.11 24.62 2.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 131' ' ' ASP . 23.6 mmt85 35.45 44.9 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.415 ' NH1' ' HB2' ' A' ' 131' ' ' ASP . 71.1 mtt85 -83.91 21.69 1.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.842 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.525 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 28.5 m95 -66.16 -42.77 88.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.45 -47.9 75.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.086 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -47.53 78.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 73.1 t -53.88 -37.89 34.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.153 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.91 -53.12 35.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.097 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -58.31 -38.22 76.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.908 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -59.19 -31.61 69.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.551 HD13 ' CE2' ' A' ' 143' ' ' TYR . 1.5 tm? -80.77 12.52 3.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 65.71 53.53 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.839 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.551 ' CE2' HD13 ' A' ' 141' ' ' LEU . 6.6 m-85 -109.0 159.01 32.69 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.636 0.731 . . . . 0.0 110.956 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 112.5 3.1 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.712 2.274 . . . . 0.0 112.333 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 122.43 9.12 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.674 2.249 . . . . 0.0 112.372 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.96 -70.1 0.3 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.488 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -58.15 171.0 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.764 0.316 . . . . 0.0 110.915 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.2 42.2 1.02 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.917 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.423 ' O ' ' C ' ' A' ' 150' ' ' GLY . 92.1 mt -44.5 -45.02 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.151 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.05 -54.78 1.19 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.511 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.9 m -58.93 -50.26 74.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.948 0.404 . . . . 0.0 110.834 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.556 HD21 ' CD2' ' A' ' 156' ' ' HIS . 8.3 tt -51.74 -50.13 61.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.956 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 25.5 mt -52.94 -64.73 0.72 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.902 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.525 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 14.3 ttp180 -41.1 -46.02 2.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 47.3 t -57.92 -58.88 6.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.841 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.556 ' CD2' HD21 ' A' ' 152' ' ' LEU . 1.8 m-70 -51.98 -49.21 63.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.542 ' CD2' HD11 ' A' ' 161' ' ' ILE . 3.8 t80 -57.79 -57.59 12.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.963 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.471 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 39.0 mt-10 -66.88 -9.8 41.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.877 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 37.4 ttt-85 -87.76 -57.4 2.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.857 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 78.6 mt -104.76 -41.22 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.169 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.542 HD11 ' CD2' ' A' ' 157' ' ' TYR . 14.2 mt -75.96 -0.48 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.113 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.634 ' C ' ' CD1' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -73.32 -61.31 1.48 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.716 0.769 . . . . 0.0 110.941 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.468 ' CD ' ' CB ' ' A' ' 162' ' ' TYR . 53.8 Cg_endo -69.7 -33.65 16.38 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.737 2.292 . . . . 0.0 112.341 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.405 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 24.5 t80 -64.75 -46.38 82.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.887 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -69.29 -55.46 10.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.865 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.412 ' CG ' ' HA ' ' A' ' 163' ' ' PRO . 0.5 OUTLIER -55.02 -40.83 70.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 44.7 t80 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.878 -179.961 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.5 ' CD2' ' HA ' ' A' ' 113' ' ' TYR . 29.9 t80 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.905 0.384 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.6 mt -62.55 -41.99 99.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.899 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -61.76 -18.06 58.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -91.55 -57.33 2.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.96 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.6 tt -63.5 -39.39 85.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.149 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.03 -38.86 86.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.09 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -61.29 -28.5 69.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -82.58 -39.44 22.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.875 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.487 ' O ' ' N ' ' A' ' 96' ' ' GLN . 27.0 m95 -68.35 -61.05 2.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.432 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 5.7 pt-20 -36.96 -31.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.925 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 93' ' ' TRP . 96.7 mt -73.4 -45.41 52.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.101 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 93' ' ' TRP . 61.2 mm-40 -56.51 -33.07 65.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 131.78 -42.24 1.41 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.472 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 37.9 m -86.71 140.32 29.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.913 0.387 . . . . 0.0 110.848 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.0 p -71.17 175.31 5.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.87 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 25.5 tp -104.35 112.12 25.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.1 ttpt -109.67 130.46 55.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.1 mp -96.04 124.17 52.82 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.586 0.707 . . . . 0.0 111.15 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.445 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 54.2 Cg_endo -69.76 142.87 49.1 Favored 'Trans proline' 0 N--CA 1.466 -0.125 0 C-N-CA 122.707 2.272 . . . . 0.0 112.363 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -94.27 113.7 25.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.898 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.5 t -113.17 142.68 24.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.091 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 19.1 mm-40 50.61 48.62 22.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.911 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.434 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 18.4 ptt-85 45.72 33.22 1.41 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.868 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.8 pttm -151.6 164.76 36.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.856 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.4 tt -69.22 144.82 13.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.119 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.433 HD21 ' N ' ' A' ' 112' ' ' LEU . 6.4 tt -92.97 121.76 34.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.939 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -79.88 57.36 2.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.876 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.433 ' N ' HD21 ' A' ' 110' ' ' LEU . 1.5 pt? -41.57 -29.29 0.16 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.5 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 4.9 t80 -59.31 -58.72 7.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.934 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 115' ' ' LEU . 11.0 t -56.05 -57.67 11.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.89 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 114' ' ' SER . 11.1 tp -36.76 -62.76 0.45 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.915 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.7 p -51.13 -53.93 29.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.853 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 18.2 mmtm -49.27 -54.2 17.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.409 ' O ' ' C ' ' A' ' 119' ' ' VAL . 64.6 mt -49.06 -69.22 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.13 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.409 ' C ' ' O ' ' A' ' 118' ' ' ILE . 90.8 t -37.09 -62.37 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.107 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 89.0 mt -45.18 -56.43 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -52.57 -56.89 12.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -38.36 -50.35 1.48 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 151.26 39.25 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.492 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.3 -179.43 40.65 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.504 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.516 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 1.9 t80 -87.56 -43.79 11.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.845 0.355 . . . . 0.0 110.931 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -61.28 -36.1 79.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.912 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.92 -65.58 0.66 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.13 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.592 ' CD1' ' CE2' ' A' ' 134' ' ' TRP . 1.8 pp -54.15 -31.8 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.087 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.516 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 26.8 m -70.81 -41.92 70.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.831 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -68.88 -26.44 65.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.855 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -103.03 15.71 28.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.821 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 67.5 mtp85 41.91 29.36 0.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.856 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 27.7 mtt-85 -62.15 -8.78 6.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.839 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.592 ' CE2' ' CD1' ' A' ' 128' ' ' ILE . 20.7 m95 -44.13 -52.18 7.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -40.83 -51.18 3.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.099 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -63.63 -51.38 65.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.857 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.6 t -49.4 -38.39 12.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.24 -57.48 4.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -57.87 -18.25 21.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -69.94 -25.36 63.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.857 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.516 HD21 ' CE2' ' A' ' 143' ' ' TYR . 14.6 tp -94.28 27.18 3.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 62.25 36.48 14.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.849 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.516 ' CE2' HD21 ' A' ' 141' ' ' LEU . 5.3 m-85 -92.2 147.29 34.33 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.706 0.765 . . . . 0.0 110.925 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 118.95 5.99 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.68 2.253 . . . . 0.0 112.34 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 125.81 12.58 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.702 2.268 . . . . 0.0 112.338 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 131.76 -55.61 0.76 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.427 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -54.6 168.67 0.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.762 0.315 . . . . 0.0 110.947 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.422 ' CG ' ' O ' ' A' ' 148' ' ' ASN . 13.1 p-10 -83.86 43.36 0.91 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.91 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.424 ' O ' ' C ' ' A' ' 150' ' ' GLY . 70.5 mt -67.74 -52.51 39.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.096 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.28 -53.07 1.3 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.488 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.2 t -57.53 -58.62 7.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 0.0 110.849 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.554 HD22 ' CD2' ' A' ' 156' ' ' HIS . 7.2 tt -42.06 -49.46 4.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.943 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 23.6 mt -55.98 -65.84 0.53 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.938 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.458 ' HD2' ' NE1' ' A' ' 134' ' ' TRP . 32.0 ttt180 -39.21 -39.97 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 156' ' ' HIS . 9.3 t -67.56 -70.01 0.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.861 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.554 ' CD2' HD22 ' A' ' 152' ' ' LEU . 2.0 m-70 -37.17 -33.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.86 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.549 ' CD2' HD11 ' A' ' 161' ' ' ILE . 12.0 t80 -70.38 -56.27 7.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -73.59 -9.81 59.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.858 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? -92.07 -49.0 6.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.908 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 88.3 mt -109.91 -44.18 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.118 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.549 HD11 ' CD2' ' A' ' 157' ' ' TYR . 14.3 mt -77.45 4.24 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.148 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.606 ' CE1' ' SD ' ' A' ' 166' ' ' MET . 0.1 OUTLIER -74.24 -61.48 1.21 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.662 0.744 . . . . 0.0 110.905 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.567 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 54.2 Cg_endo -69.73 -30.71 21.98 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.649 2.232 . . . . 0.0 112.354 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -69.2 -42.58 75.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.973 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -67.8 -57.65 5.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.878 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.606 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 24.7 ptm -53.42 -47.7 69.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 31.8 t80 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.897 -179.926 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.412 ' CE1' ' HE2' ' A' ' 117' ' ' LYS . 40.3 t80 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.883 0.373 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.2 mt -76.48 -44.29 36.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -59.33 -38.81 81.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.859 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -66.25 -63.76 1.01 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.898 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.557 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 19.4 tt -52.54 -30.5 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.03 -56.24 6.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.059 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -44.24 -27.5 0.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.939 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -78.68 -46.75 18.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.43 ' O ' ' N ' ' A' ' 95' ' ' ILE . 66.2 m95 -69.2 -57.68 5.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.96 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 93' ' ' TRP . 9.2 pt-20 -36.91 -32.53 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.43 ' N ' ' O ' ' A' ' 93' ' ' TRP . 96.7 mt -76.22 -51.75 19.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.173 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -47.58 -40.12 18.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.06 -40.57 1.17 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.47 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.7 m -96.56 144.51 26.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.892 0.377 . . . . 0.0 110.833 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.5 t -76.64 171.68 14.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.86 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.5 tp -82.46 104.71 12.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.964 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -96.13 111.07 23.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.0 mt -94.35 119.56 66.33 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.603 0.716 . . . . 0.0 111.158 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.405 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 53.5 Cg_endo -69.75 151.22 69.1 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.676 2.251 . . . . 0.0 112.36 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -102.52 115.17 30.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.853 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.499 ' CG1' ' CD ' ' A' ' 106' ' ' GLU . 26.2 t -122.04 144.61 30.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.174 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.499 ' CD ' ' CG1' ' A' ' 105' ' ' VAL . 49.1 mp0 60.76 44.74 10.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.92 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.496 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 15.2 ptm180 46.43 39.79 7.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.876 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -171.0 154.0 3.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.865 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.8 tt -52.29 138.67 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.4 tt -75.04 144.73 42.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -103.41 75.05 1.31 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.873 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -65.12 -36.18 83.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.9 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -46.71 -64.76 0.69 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 115' ' ' LEU . 36.6 m -56.93 -60.01 4.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.87 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 114' ' ' SER . 13.1 tp -34.93 -65.24 0.23 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.917 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 52.4 m -48.37 -56.88 7.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.868 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.412 ' HE2' ' CE1' ' A' ' 85' ' ' TYR . 2.2 mptp? -49.77 -62.58 1.48 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.891 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 95.6 mt -38.46 -64.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.157 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.2 t -45.0 -59.13 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.112 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 79.2 mt -45.91 -34.81 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.141 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -76.67 -51.77 10.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.895 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.422 ' CB ' HG22 ' A' ' 128' ' ' ILE . 21.0 mt-10 -43.54 -46.36 6.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.896 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 151.69 37.15 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.505 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.59 173.97 47.08 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.477 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 2.4 t80 -82.47 -44.34 16.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.849 0.357 . . . . 0.0 110.929 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -59.67 -42.59 93.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.848 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.15 -70.96 0.18 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.094 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.422 HG22 ' CB ' ' A' ' 122' ' ' GLU . 1.9 pp -45.28 -32.74 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.157 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 22.3 m -68.77 -39.66 80.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -66.27 -41.77 89.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 132' ' ' ARG . 2.1 t70 -88.56 19.89 3.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.886 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.429 ' C ' ' O ' ' A' ' 131' ' ' ASP . 26.1 mtt180 35.47 51.92 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 134' ' ' TRP . 23.4 mtp180 -80.75 -14.54 58.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.827 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.549 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 42.6 m95 -37.56 -56.61 1.01 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.921 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -40.08 -55.83 2.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.105 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 19.8 mmt85 -60.97 -51.49 69.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 84.1 t -46.17 -37.94 3.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.124 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -73.61 -45.47 52.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.088 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -62.99 -17.41 62.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.932 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.9 mmt85 -76.61 -28.99 56.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.528 HD23 ' CE2' ' A' ' 143' ' ' TYR . 14.7 tp -91.88 20.1 6.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.938 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 54.62 52.98 11.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.841 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.528 ' CE2' HD23 ' A' ' 141' ' ' LEU . 4.9 m-85 -89.42 148.33 40.19 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.676 0.75 . . . . 0.0 110.9 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.468 ' CD ' ' HG2' ' A' ' 106' ' ' GLU . 54.0 Cg_endo -69.71 114.57 3.74 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.733 2.288 . . . . 0.0 112.362 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 132.62 23.77 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.701 2.267 . . . . 0.0 112.37 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.36 -63.14 0.6 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.459 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -70.23 156.78 38.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.822 0.344 . . . . 0.0 110.911 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.417 ' CG ' ' O ' ' A' ' 148' ' ' ASN . 16.5 p-10 -75.14 83.84 2.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.873 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.428 ' O ' ' C ' ' A' ' 150' ' ' GLY . 51.5 mt -92.2 -52.09 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.124 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.25 -54.97 1.24 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.473 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 68.0 m -57.91 -53.83 53.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.862 0.363 . . . . 0.0 110.862 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.64 ' CD2' ' CD2' ' A' ' 156' ' ' HIS . 5.3 tt -46.37 -49.76 17.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.928 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 26.5 mt -56.33 -66.07 0.5 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.549 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 9.7 ttt-85 -38.32 -40.31 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 156' ' ' HIS . 11.5 t -68.16 -71.15 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.64 ' CD2' ' CD2' ' A' ' 152' ' ' LEU . 2.2 m-70 -37.03 -37.91 0.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.872 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.414 ' CD2' HD13 ' A' ' 161' ' ' ILE . 7.8 t80 -65.01 -66.58 0.52 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.933 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 20.2 mm-40 -64.91 -9.94 25.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.911 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 20.3 mmm-85 -86.81 -56.25 3.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.845 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 62.2 mt -105.7 -43.74 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.096 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.414 HD13 ' CD2' ' A' ' 157' ' ' TYR . 13.2 mt -72.61 -0.69 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.159 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.647 ' C ' ' CD1' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -75.67 -63.24 0.68 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.675 0.75 . . . . 0.0 110.89 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.561 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 54.3 Cg_endo -69.75 -31.26 20.93 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.661 2.241 . . . . 0.0 112.355 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.557 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 14.5 t80 -64.5 -36.31 83.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.925 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -77.32 -56.17 4.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.846 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.51 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 13.1 ptt? -52.4 -43.79 64.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.878 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.408 ' N ' ' CG ' ' A' ' 166' ' ' MET . 54.5 t80 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.888 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 33.0 t80 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.953 0.406 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.456 ' CD2' HD21 ' A' ' 112' ' ' LEU . 28.1 mt -70.13 -59.31 2.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.945 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.42 -33.14 42.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -66.49 -67.75 0.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.548 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 8.2 tt -50.18 -37.27 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.093 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.28 -52.76 44.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.073 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.0 tttm -45.32 -30.68 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.551 ' CD1' ' CD2' ' A' ' 167' ' ' PHE . 8.3 t80 -79.46 -39.67 31.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.891 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.478 ' O ' ' N ' ' A' ' 95' ' ' ILE . 61.9 m95 -70.31 -64.21 0.94 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.924 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 93' ' ' TRP . 6.0 pt-20 -34.82 -33.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' A' ' 93' ' ' TRP . 96.5 mt -74.02 -50.33 29.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.116 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 93' ' ' TRP . 28.8 mm-40 -55.59 -18.64 8.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.929 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 104.12 -37.42 3.77 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.496 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.7 p -79.35 92.77 5.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.824 0.345 . . . . 0.0 110.842 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 40.8 t -41.46 159.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.832 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.405 HD11 ' CD1' ' A' ' 93' ' ' TRP . 64.4 tp -93.29 143.78 25.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.958 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -138.61 121.14 16.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.918 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 60.8 mt -88.68 123.11 68.61 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.627 0.727 . . . . 0.0 111.118 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 158.8 55.7 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.665 2.243 . . . . 0.0 112.388 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -110.76 107.38 16.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.906 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 58.3 t -110.72 136.1 47.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.092 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.499 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 36.2 mm-40 61.35 44.46 9.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.944 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.499 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 14.3 ptp180 46.57 33.55 2.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.873 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.3 ptmm? -155.82 155.47 33.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.926 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.4 tt -57.5 145.57 8.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.158 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.8 tt -96.14 113.66 25.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.935 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -79.84 80.72 6.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.463 ' HG ' ' N ' ' A' ' 113' ' ' TYR . 1.9 pt? -53.13 -42.42 66.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.926 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.463 ' N ' ' HG ' ' A' ' 112' ' ' LEU . 15.0 t80 -41.25 -53.59 3.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.918 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.8 m -61.27 -45.84 92.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.85 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.6 tp -55.95 -63.76 1.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 73.5 m -50.52 -44.69 56.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.857 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.438 ' HE2' ' CE1' ' A' ' 113' ' ' TYR . 28.7 mmtt -60.44 -66.11 0.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.908 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.466 ' CG2' HG11 ' A' ' 137' ' ' VAL . 21.3 mt -43.72 -28.17 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.133 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 43.3 t -77.12 -40.88 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.12 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 67.9 mt -72.3 -41.4 65.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.171 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -62.42 -37.15 84.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.404 ' OE1' ' CG2' ' A' ' 128' ' ' ILE . 10.5 mt-10 -66.21 -26.96 67.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.905 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 135.08 29.86 0.38 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.461 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.3 -173.37 34.21 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.494 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.537 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 2.6 t80 -86.98 -43.79 12.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.884 0.373 . . . . 0.0 110.914 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -60.97 -37.43 82.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.876 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.8 -68.64 0.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.058 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.496 HD12 ' CE2' ' A' ' 134' ' ' TRP . 1.6 pp -52.34 -35.78 20.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.119 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.537 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 54.5 m -64.5 -36.47 84.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.59 -41.39 79.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 132' ' ' ARG . 16.3 m-20 -94.78 20.48 8.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.892 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 131' ' ' ASP . 24.7 ptt85 35.21 48.2 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.839 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -85.72 17.92 3.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.841 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.553 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 41.8 m95 -60.39 -48.85 79.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.938 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -48.42 -47.4 37.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.126 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.431 ' NH1' ' HB3' ' A' ' 136' ' ' ARG . 5.4 mmm180 -61.91 -58.56 7.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.466 HG11 ' CG2' ' A' ' 118' ' ' ILE . 98.5 t -46.75 -31.88 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.61 -58.34 4.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.088 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -52.59 -29.51 26.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 140' ' ' ARG . 5.9 mmm180 -52.82 -39.68 62.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.883 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.557 HD21 ' CE2' ' A' ' 143' ' ' TYR . 14.8 tp -82.93 17.93 1.77 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.92 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 61.67 43.09 10.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.557 ' CE2' HD21 ' A' ' 141' ' ' LEU . 3.3 m-85 -83.25 152.37 64.57 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.689 0.757 . . . . 0.0 110.947 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 114.13 3.6 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.692 2.261 . . . . 0.0 112.331 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 109.33 2.28 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.679 2.252 . . . . 0.0 112.349 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 154.94 -67.95 0.3 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.49 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -60.93 152.02 28.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.801 0.334 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -68.11 82.55 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.849 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 90.5 mt -92.61 -46.52 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -37.39 -58.3 1.36 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.491 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.8 m -56.71 -48.01 78.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.91 0.386 . . . . 0.0 110.846 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.55 HD22 ' CD2' ' A' ' 156' ' ' HIS . 6.7 tt -50.57 -51.34 49.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.9 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 11.1 mt -57.51 -65.96 0.54 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.553 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 23.9 ttp180 -38.45 -55.02 1.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.86 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.428 ' OG ' ' N ' ' A' ' 156' ' ' HIS . 48.1 p -50.41 -64.72 0.72 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.824 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.55 ' CD2' HD22 ' A' ' 152' ' ' LEU . 2.0 m-70 -43.04 -34.06 0.95 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.543 ' CD2' HD12 ' A' ' 161' ' ' ILE . 3.1 t80 -69.71 -69.55 0.34 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.476 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 3.3 mp0 -61.24 -10.11 6.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.88 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 10.6 tpp85 -84.59 -53.35 5.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 74.1 mt -110.48 -39.18 3.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.151 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.543 HD12 ' CD2' ' A' ' 157' ' ' TYR . 13.7 mt -77.04 -0.69 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.115 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.543 ' C ' ' CD1' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -72.02 -60.34 2.38 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.65 0.738 . . . . 0.0 110.882 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.499 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.8 Cg_endo -69.78 -36.69 10.29 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.668 2.245 . . . . 0.0 112.324 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.548 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 15.3 t80 -59.47 -46.32 89.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.975 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -69.03 -60.17 2.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.924 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -39.33 66.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.551 ' CD2' ' CD1' ' A' ' 92' ' ' PHE . 57.5 t80 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.866 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.452 ' CD2' ' HA ' ' A' ' 113' ' ' TYR . 69.3 t80 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.936 0.398 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 35.0 mt -70.15 -63.68 1.04 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -44.46 -27.21 0.42 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.849 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -78.15 -67.6 0.72 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.93 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.569 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 7.9 tt -45.64 -43.0 3.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.34 -53.42 55.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.079 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -42.07 -41.54 2.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.867 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -68.77 -43.8 74.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.871 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.427 ' O ' ' C ' ' A' ' 94' ' ' GLU . 45.4 m95 -62.27 -64.52 0.9 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 93' ' ' TRP . 7.7 pt-20 -36.37 -41.38 0.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.858 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.425 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 85.6 mt -65.09 -49.82 77.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.133 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -49.61 -44.56 47.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.39 -49.64 0.61 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.488 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 32.5 t -90.15 130.98 36.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.908 0.385 . . . . 0.0 110.884 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.7 m -65.14 164.51 12.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.862 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.8 tp -93.34 154.17 18.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.942 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.7 mmmt -145.09 126.47 14.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.873 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.65 122.67 67.94 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.661 0.743 . . . . 0.0 111.149 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.457 ' HG2' ' CD1' ' A' ' 110' ' ' LEU . 53.9 Cg_endo -69.77 161.49 45.74 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.709 2.273 . . . . 0.0 112.329 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -117.08 117.66 30.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 72.2 t -121.57 140.26 46.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.143 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 107' ' ' ARG . 2.6 mm-40 56.29 54.99 7.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.415 ' HB3' ' NH1' ' A' ' 107' ' ' ARG . 4.2 ptp180 37.09 39.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -157.42 150.16 23.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.9 tt -54.47 140.03 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.155 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.457 ' CD1' ' HG2' ' A' ' 103' ' ' PRO . 4.1 tt -86.45 119.13 26.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -86.76 88.62 7.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -73.72 -22.38 59.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.452 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 5.6 t80 -59.65 -54.71 43.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 115' ' ' LEU . 58.9 p -61.13 -55.22 34.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.887 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.448 ' C ' ' O ' ' A' ' 114' ' ' SER . 27.3 tp -34.67 -59.28 0.47 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.917 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.8 t -59.99 -55.77 29.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.863 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -43.42 -45.54 6.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.884 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 27.3 mt -63.44 -45.69 97.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.13 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.9 t -51.33 -56.03 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.135 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 84.1 mt -56.32 -46.58 81.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.123 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -56.46 -56.8 16.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.447 ' HB2' ' CG2' ' A' ' 128' ' ' ILE . 33.2 mm-40 -40.69 -52.85 2.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 155.26 34.16 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.488 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.39 178.58 34.13 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.479 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.574 ' CE2' ' SG ' ' A' ' 129' ' ' CYS . 3.4 t80 -81.7 -55.77 4.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.889 0.376 . . . . 0.0 110.951 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -51.47 -29.64 17.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.905 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.06 -71.21 0.29 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.091 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.561 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.9 pp -50.38 -31.7 8.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.096 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.574 ' SG ' ' CE2' ' A' ' 125' ' ' TYR . 94.3 m -69.5 -44.07 71.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.886 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.1 tttm -64.26 -39.57 94.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 132' ' ' ARG . 80.2 m-20 -91.83 23.31 3.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.453 ' C ' ' O ' ' A' ' 131' ' ' ASP . 83.9 mtm180 34.24 35.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.9 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 131' ' ' ASP . 10.7 mmp_? -60.23 -19.49 54.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.846 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.561 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 24.8 m95 -36.6 -43.44 0.41 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.925 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.42 -56.99 14.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.036 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.426 ' NH1' ' HB2' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -59.91 -43.28 94.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 69.2 t -54.76 -36.61 37.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.107 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.09 -52.41 24.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.083 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -56.23 -37.24 69.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -51.39 -32.44 26.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.839 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.561 HD23 ' CE2' ' A' ' 143' ' ' TYR . 14.6 tp -83.52 17.48 2.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.931 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 66.65 33.99 6.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.84 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.561 ' CE2' HD23 ' A' ' 141' ' ' LEU . 2.5 m-85 -84.34 157.81 61.5 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.658 0.742 . . . . 0.0 110.947 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.403 ' HA ' ' HD2' ' A' ' 145' ' ' PRO . 53.8 Cg_endo -69.78 110.36 2.54 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.685 2.257 . . . . 0.0 112.364 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 53.6 Cg_endo -69.74 94.51 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.695 2.264 . . . . 0.0 112.315 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 165.25 -61.46 0.24 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.445 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 61.5 mttt -57.12 152.98 12.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.816 0.341 . . . . 0.0 110.913 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -69.88 75.75 0.46 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.401 ' O ' ' C ' ' A' ' 150' ' ' GLY . 84.7 mt -89.22 -54.94 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.146 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.46 -47.99 1.19 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.455 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.3 m -61.64 -53.3 57.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.905 0.384 . . . . 0.0 110.889 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.46 HD23 ' CD2' ' A' ' 156' ' ' HIS . 5.5 tt -51.33 -51.56 53.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.927 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 30.4 mt -57.61 -65.79 0.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.943 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.521 ' HG3' ' CE2' ' A' ' 134' ' ' TRP . 1.7 ttm105 -39.93 -38.77 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.844 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 69.6 m -66.6 -57.82 6.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.46 ' CD2' HD23 ' A' ' 152' ' ' LEU . 2.5 m-70 -56.03 -26.2 47.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.866 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.53 ' CD2' HD11 ' A' ' 161' ' ' ILE . 5.0 t80 -78.82 -46.92 17.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.923 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.488 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 2.5 mm-40 -79.97 -10.14 59.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.873 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 44.6 ttt85 -100.85 -35.19 9.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 62.0 mt -112.54 -50.93 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.108 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.53 HD11 ' CD2' ' A' ' 157' ' ' TYR . 18.9 mt -77.17 0.04 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.152 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.52 ' C ' ' CD1' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -72.29 -60.46 2.19 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.63 0.728 . . . . 0.0 110.92 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.507 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.8 Cg_endo -69.79 -37.66 8.79 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.654 2.236 . . . . 0.0 112.355 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.569 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 28.7 t80 -60.31 -38.83 84.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -74.45 -58.09 3.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.899 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 16.7 ptt? -51.17 -40.23 58.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 36.2 t80 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.882 -179.94 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 58.7 t80 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.893 0.378 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.8 mt -71.21 -61.02 1.92 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.896 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -52.11 -24.05 6.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.817 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -77.89 -69.96 0.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.423 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 9.0 tt -43.98 -36.11 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.133 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.8 -44.78 54.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.086 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -54.61 -27.93 42.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.849 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.48 ' CE2' ' HA ' ' A' ' 164' ' ' TYR . 4.4 t80 -85.71 -29.97 23.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.874 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 30.4 m95 -75.42 -59.23 2.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.929 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -42.45 -29.55 0.28 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.885 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 85.9 mt -75.72 -47.61 32.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.166 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -51.91 -42.39 62.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 148.54 -36.49 1.08 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.476 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 40.1 m -101.77 155.9 17.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 110.9 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.5 t -83.27 178.08 8.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.851 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 29.4 tp -93.79 138.58 31.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.871 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -137.55 123.6 20.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 51.0 mm -96.25 124.24 52.15 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.584 0.706 . . . . 0.0 111.193 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.523 ' HG3' ' CD2' ' A' ' 156' ' ' HIS . 53.9 Cg_endo -69.72 152.05 69.44 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.679 2.252 . . . . 0.0 112.321 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -101.96 111.41 23.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.876 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.3 t -108.79 137.57 40.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.13 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.413 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 57.7 mm-40 50.07 54.22 11.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.413 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 1.2 ptp180 43.61 37.51 1.55 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.822 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -155.32 169.88 23.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.867 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.5 tt -75.05 143.96 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.6 tt -89.86 119.28 30.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.935 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -73.32 71.36 1.24 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -56.24 -21.26 22.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -71.67 -62.59 1.36 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.929 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 115' ' ' LEU . 4.2 t -50.02 -58.9 4.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.884 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.449 ' C ' ' O ' ' A' ' 114' ' ' SER . 10.0 tp -34.59 -67.48 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.928 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.1 p -48.07 -52.88 18.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -48.36 -52.51 21.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.944 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 77.7 mt -57.82 -42.15 81.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.111 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.2 t -59.81 -38.45 76.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.135 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 82.3 mt -71.27 -57.92 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.15 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.529 ' CG ' ' N ' ' A' ' 122' ' ' GLU . 8.1 pt-20 -56.57 -49.49 74.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.916 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.529 ' N ' ' CG ' ' A' ' 121' ' ' GLU . 38.0 mm-40 -47.91 -35.05 9.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.905 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 139.1 43.16 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.448 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.79 -179.42 52.58 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.472 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.51 ' C ' ' CD1' ' A' ' 125' ' ' TYR . 1.1 t80 -89.06 -40.12 13.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.853 0.359 . . . . 0.0 110.931 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -60.94 -45.85 93.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.858 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 130' ' ' LYS . . . -62.09 -71.35 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.086 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.558 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 2.2 pp -41.96 -36.32 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.145 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.462 ' N ' HD12 ' A' ' 128' ' ' ILE . 22.1 m -65.83 -40.97 92.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 127' ' ' ALA . 12.9 ttmm -68.95 -26.24 64.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 132' ' ' ARG . 4.2 t0 -100.87 19.38 17.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 131' ' ' ASP . 13.3 mmt85 36.11 54.6 0.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' A' ' 134' ' ' TRP . 14.7 mmt180 -81.81 -25.21 35.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.864 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.558 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 24.2 m95 -34.04 -40.06 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.59 -59.86 4.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.113 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.455 ' O ' ' CD ' ' A' ' 140' ' ' ARG . 38.2 mmt180 -62.28 -50.38 71.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.859 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 89.4 t -43.57 -46.84 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.146 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.87 -47.85 73.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.075 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -55.27 -32.97 62.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.455 ' CD ' ' O ' ' A' ' 136' ' ' ARG . 0.2 OUTLIER -59.81 -32.04 70.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.848 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.568 HD22 ' CE2' ' A' ' 143' ' ' TYR . 12.8 tp -80.38 13.74 2.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.911 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 65.0 51.31 1.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.568 ' CE2' HD22 ' A' ' 141' ' ' LEU . 2.5 m-85 -94.87 156.78 37.7 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.679 0.752 . . . . 0.0 110.94 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 122.23 8.89 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.718 2.279 . . . . 0.0 112.328 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 118.34 5.62 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.701 2.267 . . . . 0.0 112.295 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.53 -67.56 0.56 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.476 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.04 135.61 12.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.802 0.334 . . . . 0.0 110.9 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -65.86 75.43 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.412 ' O ' ' C ' ' A' ' 150' ' ' GLY . 89.9 mt -86.93 -51.17 13.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.165 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -37.12 -47.66 1.41 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.492 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.0 t -63.86 -52.39 60.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.923 0.392 . . . . 0.0 110.887 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.57 HD23 ' CD2' ' A' ' 156' ' ' HIS . 7.2 tt -47.21 -53.3 13.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.878 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 30.9 mt -56.04 -65.72 0.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.929 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.54 ' NE ' ' CD1' ' A' ' 134' ' ' TRP . 6.4 ttm180 -40.64 -33.2 0.26 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.882 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 36.1 t -71.86 -52.57 16.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.862 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.57 ' CD2' HD23 ' A' ' 152' ' ' LEU . 3.6 m-70 -60.46 -31.48 70.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.845 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.492 ' C ' ' CD1' ' A' ' 157' ' ' TYR . 2.3 t80 -79.25 -30.54 43.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.891 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.505 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 1.9 mm-40 -91.06 -9.93 43.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.913 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -107.5 -45.81 3.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.868 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 59.3 mt -97.07 -53.73 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.142 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.428 ' CG1' ' HA ' ' A' ' 157' ' ' TYR . 20.0 mt -75.17 -6.07 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.13 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.528 ' CD2' ' HD3' ' A' ' 163' ' ' PRO . 0.3 OUTLIER -70.57 -59.79 3.61 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.619 0.723 . . . . 0.0 110.907 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.528 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.9 Cg_endo -69.71 -36.34 11.12 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.699 2.266 . . . . 0.0 112.313 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.48 ' HA ' ' CE2' ' A' ' 92' ' ' PHE . 4.6 t80 -64.77 -35.76 82.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.924 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -75.09 -61.14 1.99 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.914 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -47.96 -40.27 21.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.875 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 13.7 t80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.863 -179.933 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.564 ' CD2' ' HA ' ' A' ' 113' ' ' TYR . 89.4 t80 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.893 0.378 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.419 ' HA ' ' CG2' ' A' ' 89' ' ' ILE . 29.2 mt -80.72 -33.57 35.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.932 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.01 -39.1 66.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.447 ' NE2' ' HH ' ' A' ' 164' ' ' TYR . 7.5 pt20 -73.56 -37.67 65.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.919 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.42 ' HA ' ' CE1' ' A' ' 164' ' ' TYR . 7.2 tt -78.6 -29.93 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.143 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.63 -43.31 56.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.13 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -51.27 -25.68 6.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.908 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -86.33 -41.26 14.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.565 ' CD1' HD12 ' A' ' 100' ' ' LEU . 55.6 m95 -70.7 -56.58 6.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 4.2 pt-20 -42.66 -29.55 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.883 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.424 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 96.8 mt -77.54 -48.98 23.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.164 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -48.87 -42.27 36.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.14 -37.44 1.5 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.476 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.2 m -101.77 112.15 24.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.858 0.361 . . . . 0.0 110.895 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 58.8 m -54.28 162.08 1.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.82 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.565 HD12 ' CD1' ' A' ' 93' ' ' TRP . 27.9 tp -74.01 135.32 43.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.924 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -135.48 128.96 32.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.6 mp -94.95 121.16 63.25 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.619 0.723 . . . . 0.0 111.108 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.488 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 53.5 Cg_endo -69.78 161.82 44.44 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.66 2.24 . . . . 0.0 112.359 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -107.43 121.02 43.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.85 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.43 HG12 ' N ' ' A' ' 106' ' ' GLU . 67.7 t -124.79 134.51 66.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.117 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.43 ' N ' HG12 ' A' ' 105' ' ' VAL . 27.4 mm-40 61.01 52.3 4.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.849 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 42.4 37.93 1.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.457 ' HD3' ' N ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -159.55 153.1 22.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.457 ' N ' ' HD3' ' A' ' 108' ' ' LYS . 7.8 tt -60.06 142.9 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.142 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.417 ' C ' HD22 ' A' ' 110' ' ' LEU . 6.2 tt -95.98 139.23 32.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -97.58 108.54 21.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.86 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.24 -24.89 32.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.564 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 5.7 t80 -63.26 -56.26 18.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.953 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 115' ' ' LEU . 32.0 p -59.4 -61.03 2.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.834 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 114' ' ' SER . 22.2 tp -35.04 -68.88 0.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.914 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.8 t -51.24 -52.73 42.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.835 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.1 mmtt -46.79 -63.7 0.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.933 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 62.1 mt -43.09 -53.54 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.137 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 43.1 t -49.47 -57.47 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.122 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 76.3 mt -46.1 -52.18 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.118 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -57.73 -58.93 6.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.891 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.467 ' CB ' HG22 ' A' ' 128' ' ' ILE . 29.1 mm-40 -35.01 -54.66 0.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 152.93 33.8 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.467 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.02 -178.71 33.49 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.445 ' CE2' ' SG ' ' A' ' 129' ' ' CYS . 4.8 t80 -85.0 -43.8 13.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.845 0.355 . . . . 0.0 110.908 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -62.05 -36.23 81.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.924 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.49 -68.91 0.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.149 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.467 HG22 ' CB ' ' A' ' 122' ' ' GLU . 2.2 pp -50.01 -36.23 11.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.164 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.445 ' SG ' ' CE2' ' A' ' 125' ' ' TYR . 49.1 m -66.33 -41.0 90.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -66.45 -44.48 82.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.92 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 132' ' ' ARG . 1.2 m-20 -85.02 22.61 1.37 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.449 ' C ' ' O ' ' A' ' 131' ' ' ASP . 57.8 mtt-85 34.63 43.93 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.88 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' A' ' 134' ' ' TRP . 20.4 mtp85 -71.5 -22.45 61.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.535 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 12.2 m95 -34.33 -42.29 0.13 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.927 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.6 -54.19 49.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.112 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 5.0 tpp85 -66.21 -42.54 88.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 84.3 t -59.41 -28.22 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -78.37 -48.69 15.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.116 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -60.06 -28.63 67.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -56.53 -38.85 72.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.56 HD23 ' CE2' ' A' ' 143' ' ' TYR . 13.8 tp -83.81 21.31 1.3 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.927 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 58.12 51.8 8.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.872 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.56 ' CE2' HD23 ' A' ' 141' ' ' LEU . 2.5 m-85 -96.73 159.1 32.42 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.667 0.746 . . . . 0.0 110.915 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 111.74 2.88 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.673 2.249 . . . . 0.0 112.375 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 117.13 4.9 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.69 2.26 . . . . 0.0 112.328 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 136.6 -59.64 0.63 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.477 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -55.38 159.55 2.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.761 0.315 . . . . 0.0 110.907 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -78.06 79.13 4.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.422 ' O ' ' C ' ' A' ' 150' ' ' GLY . 78.3 mt -95.07 -55.47 6.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.09 -44.91 0.82 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.464 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.3 t -65.92 -52.18 52.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.898 0.38 . . . . 0.0 110.861 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.533 HD23 ' CD2' ' A' ' 156' ' ' HIS . 6.7 tt -50.02 -49.37 51.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.921 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 25.7 mt -57.06 -64.79 0.76 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.535 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 11.8 ttt180 -40.47 -36.21 0.54 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 25.2 m -68.89 -62.08 1.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.805 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.533 ' CD2' HD23 ' A' ' 152' ' ' LEU . 2.5 m-70 -47.49 -34.06 6.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.848 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.565 ' CD2' HD13 ' A' ' 161' ' ' ILE . 3.9 t80 -70.22 -53.16 18.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.911 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 29.3 mm-40 -74.23 -9.47 58.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.877 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -96.15 -42.94 7.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.858 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 89.2 mt -110.4 -47.31 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.15 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.565 HD13 ' CD2' ' A' ' 157' ' ' TYR . 21.4 mt -76.88 1.08 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.089 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.602 ' CE1' ' SD ' ' A' ' 166' ' ' MET . 0.2 OUTLIER -73.52 -60.75 1.57 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.674 0.75 . . . . 0.0 110.879 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.57 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.6 Cg_endo -69.78 -41.76 3.96 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.663 2.242 . . . . 0.0 112.348 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.447 ' HH ' ' NE2' ' A' ' 88' ' ' GLN . 11.4 t80 -53.79 -35.25 61.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.922 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -78.81 -62.47 1.68 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.875 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.602 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 5.3 ptt? -48.46 -42.76 33.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 31.0 t80 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.872 -179.952 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 61.9 t80 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.959 0.409 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 65.8 mt -56.18 -63.71 1.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.951 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -46.45 -38.45 9.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.856 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -61.5 -62.15 2.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.947 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 90' ' ' ALA . 14.8 tt -61.11 -27.46 41.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.126 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.403 ' N ' HG22 ' A' ' 89' ' ' ILE . . . -73.18 -46.67 49.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.087 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.7 tttp -54.54 -22.63 13.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -85.24 -49.1 8.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 56.6 m95 -62.53 -56.54 17.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -40.91 -35.32 0.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 90.1 mt -71.98 -51.26 32.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.135 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -48.44 -39.55 23.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.956 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.31 -47.3 0.91 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.526 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.9 t -85.22 151.9 23.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.888 0.375 . . . . 0.0 110.847 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 55.7 p -81.24 172.46 13.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.88 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 29.1 tp -96.95 116.98 30.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.935 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.76 147.03 30.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 45.0 mm -119.79 121.84 29.51 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.578 0.704 . . . . 0.0 111.117 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.443 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 54.2 Cg_endo -69.72 163.66 37.41 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.69 2.26 . . . . 0.0 112.361 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -107.9 128.15 54.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 65.3 t -132.44 135.32 57.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.108 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 56.06 54.26 8.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 40.97 38.84 0.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.9 ttpp -162.63 152.78 16.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.9 tt -57.69 152.0 3.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.123 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.464 HD23 ' N ' ' A' ' 111' ' ' ASP . 5.9 tt -95.11 127.28 41.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.464 ' N ' HD23 ' A' ' 110' ' ' LEU . 8.2 t70 -86.57 69.99 10.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.821 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -47.96 -22.56 0.61 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -68.45 -44.25 75.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.4 t -71.23 -51.11 26.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.873 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.4 tp -47.07 -54.89 9.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.9 t -60.52 -58.85 6.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.83 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.1 mmtt -43.92 -54.74 5.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.901 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.44 ' O ' ' N ' ' A' ' 121' ' ' GLU . 29.6 mt -51.5 -67.49 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 50.6 t -37.73 -48.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.162 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 74.6 mt -64.91 -39.74 86.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.108 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 118' ' ' ILE . 5.5 mm-40 -59.11 -50.91 72.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.42 ' OE1' ' CG2' ' A' ' 137' ' ' VAL . 28.3 mt-10 -51.84 -42.6 62.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.912 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 150.64 35.27 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.512 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.02 -175.13 34.86 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.496 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.433 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 1.9 t80 -88.83 -41.03 12.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.855 0.359 . . . . 0.0 110.915 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -66.13 -37.53 85.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.898 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.5 -61.56 2.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.128 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.458 HD11 ' CE2' ' A' ' 134' ' ' TRP . 1.7 pp -58.44 -35.41 54.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.442 ' N ' HD12 ' A' ' 128' ' ' ILE . 22.1 m -65.1 -38.03 89.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.859 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -68.46 -39.45 81.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.45 ' O ' ' C ' ' A' ' 132' ' ' ARG . 0.7 OUTLIER -93.39 22.03 5.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.843 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 131' ' ' ASP . 25.1 mtp85 34.45 46.74 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.889 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -87.33 18.72 3.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.482 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 27.5 m95 -63.9 -47.65 79.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.913 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.55 -41.7 61.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.092 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -68.24 -63.11 1.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.854 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.42 ' CG2' ' OE1' ' A' ' 122' ' ' GLU . 86.4 t -41.17 -38.12 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.115 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.433 ' HB1' ' CD1' ' A' ' 153' ' ' LEU . . . -68.02 -53.93 22.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -51.22 -33.44 27.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.468 ' HA ' ' CZ ' ' A' ' 140' ' ' ARG . 1.7 mmp_? -52.72 -35.7 56.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.489 HD22 ' CE2' ' A' ' 143' ' ' TYR . 14.9 tp -84.73 23.32 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 62.91 28.0 16.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.817 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.489 ' CE2' HD22 ' A' ' 141' ' ' LEU . 3.4 m-85 -75.89 147.77 81.14 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.653 0.739 . . . . 0.0 110.914 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 115.72 4.22 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.706 2.271 . . . . 0.0 112.343 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.79 89.18 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.69 2.26 . . . . 0.0 112.323 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 177.13 -80.03 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.474 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 32.0 mttp -45.38 166.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.817 0.341 . . . . 0.0 110.89 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.79 80.8 3.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.419 ' O ' ' C ' ' A' ' 150' ' ' GLY . 76.9 mt -91.6 -57.41 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.21 -50.1 1.23 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.503 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.3 t -61.11 -55.18 35.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.871 0.367 . . . . 0.0 110.839 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.568 HD23 ' CD2' ' A' ' 156' ' ' HIS . 6.4 tt -46.92 -52.02 15.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.878 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.433 ' CD1' ' HB1' ' A' ' 138' ' ' ALA . 15.1 mt -54.52 -65.94 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.954 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.482 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 11.2 ttp180 -38.75 -47.75 1.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.864 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.6 t -57.87 -66.11 0.53 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.844 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.568 ' CD2' HD23 ' A' ' 152' ' ' LEU . 2.0 m-70 -42.9 -39.97 2.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.907 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.509 ' CZ ' HG22 ' A' ' 161' ' ' ILE . 4.6 t80 -63.81 -55.07 25.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 43.6 mt-10 -72.23 -9.97 59.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.898 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -88.87 -48.17 7.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.867 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 77.3 mt -112.56 -43.66 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.509 HG22 ' CZ ' ' A' ' 157' ' ' TYR . 11.0 mt -77.02 5.08 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.128 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.635 ' C ' ' CD1' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -74.4 -62.22 1.03 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.673 0.749 . . . . 0.0 110.895 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.516 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.3 Cg_endo -69.76 -35.66 12.22 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.689 2.259 . . . . 0.0 112.336 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -60.87 -38.32 85.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -79.94 -65.02 1.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.858 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.455 ' SD ' ' N ' ' A' ' 167' ' ' PHE . 0.0 OUTLIER -40.64 -39.42 1.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.862 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.455 ' N ' ' SD ' ' A' ' 166' ' ' MET . 2.4 t80 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.85 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 69.5 t80 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.932 0.396 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.425 ' HA ' ' CG2' ' A' ' 89' ' ' ILE . 36.5 mt -81.13 -39.32 25.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.924 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -64.09 -39.42 94.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -72.96 -55.71 6.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.88 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.568 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 12.3 tt -55.46 -47.65 78.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.117 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.16 -47.96 83.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.14 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.404 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 21.5 ttmt -44.54 -37.83 3.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.957 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.665 ' CD1' ' CG ' ' A' ' 167' ' ' PHE . 3.2 t80 -71.89 -51.63 21.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.452 ' O ' ' C ' ' A' ' 94' ' ' GLU . 80.5 m95 -61.59 -62.36 1.87 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 93' ' ' TRP . 8.9 pt-20 -34.48 -37.97 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.426 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 52.1 mt -72.4 -49.48 41.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.13 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 93' ' ' TRP . 73.2 mm-40 -45.0 -46.21 11.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.889 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.21 -36.87 1.35 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.49 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.6 m -96.39 109.55 22.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.91 0.386 . . . . 0.0 110.888 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.7 m -47.18 158.69 0.14 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.854 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.4 tp -75.41 126.82 31.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.91 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -129.83 110.61 11.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.1 mt -77.17 123.88 87.17 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.628 0.728 . . . . 0.0 111.165 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 147.17 62.5 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.696 2.264 . . . . 0.0 112.359 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -100.36 111.05 23.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.935 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 106' ' ' GLU . 87.1 t -119.82 136.55 56.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.115 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.455 ' N ' HG12 ' A' ' 105' ' ' VAL . 46.6 mm-40 62.9 49.15 3.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.903 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 42.61 38.39 1.27 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.84 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.2 tttp -166.92 152.95 8.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.6 tt -50.4 150.01 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.124 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.412 ' C ' ' CD2' ' A' ' 110' ' ' LEU . 4.5 tt -92.96 112.06 23.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -69.05 75.11 0.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.79 -36.65 78.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -53.61 -59.93 3.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.963 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.457 ' O ' ' C ' ' A' ' 115' ' ' LEU . 4.8 t -59.07 -59.21 5.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.867 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' A' ' 114' ' ' SER . 9.0 tp -32.89 -58.7 0.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.924 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.6 t -57.12 -54.64 44.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.824 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -43.48 -48.25 7.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.888 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 53.2 mt -61.98 -48.3 89.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.127 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.4 t -50.8 -63.0 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.108 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 61.7 mt -52.11 -53.33 18.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.141 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -46.69 -51.11 16.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.893 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.426 ' HB2' ' CG2' ' A' ' 128' ' ' ILE . 40.6 mt-10 -50.92 -49.27 59.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.86 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 154.49 40.94 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.467 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.55 -177.93 42.47 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.448 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -88.95 -45.68 9.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.847 0.356 . . . . 0.0 110.94 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -59.51 -36.49 76.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.876 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.75 -71.26 0.21 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.096 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.426 ' CG2' ' HB2' ' A' ' 122' ' ' GLU . 2.1 pp -44.76 -34.53 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.123 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 64.8 m -69.37 -39.57 77.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -63.89 -39.66 94.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 132' ' ' ARG . 28.1 m-20 -92.1 29.76 1.56 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.877 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.465 ' C ' ' O ' ' A' ' 131' ' ' ASP . 3.0 mpt_? 33.48 40.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.462 ' O ' ' C ' ' A' ' 134' ' ' TRP . 22.5 mmt180 -65.29 -26.99 68.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.476 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 28.4 m95 -33.22 -44.19 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.913 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.82 -61.71 2.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.107 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -58.98 -45.09 91.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 92.6 t -54.03 -39.73 42.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.153 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.2 -52.88 52.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -58.88 -35.99 73.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.933 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.2 mmp_? -69.53 -28.04 65.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.868 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.557 ' HB3' ' CD2' ' A' ' 143' ' ' TYR . 1.5 tm? -78.46 10.23 3.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.913 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 62.99 38.42 11.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.557 ' CD2' ' HB3' ' A' ' 141' ' ' LEU . 9.6 m-85 -89.72 158.61 44.92 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.702 0.763 . . . . 0.0 110.937 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 113.76 3.48 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.65 2.234 . . . . 0.0 112.359 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.72 132.47 23.46 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.731 2.287 . . . . 0.0 112.34 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.61 -66.58 0.57 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.511 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -70.46 140.64 51.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.785 0.326 . . . . 0.0 110.934 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -64.58 76.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.421 ' O ' ' C ' ' A' ' 150' ' ' GLY . 97.0 mt -80.45 -39.85 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.165 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -35.98 -51.35 1.19 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.459 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.5 t -56.94 -54.86 41.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.886 0.374 . . . . 0.0 110.892 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.565 HD22 ' CD2' ' A' ' 156' ' ' HIS . 5.4 tt -45.58 -51.17 12.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.948 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' A' ' 154' ' ' ARG . 18.9 mt -53.99 -66.09 0.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.937 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.476 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 15.0 ttt180 -37.35 -41.56 0.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.1 m -65.04 -68.74 0.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.824 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.565 ' CD2' HD22 ' A' ' 152' ' ' LEU . 3.0 m-70 -43.12 -36.95 1.84 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.889 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.571 ' CD2' HD13 ' A' ' 161' ' ' ILE . 3.0 t80 -71.82 -43.88 64.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.933 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -79.87 -8.68 59.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.876 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 9.0 tpt85 -106.43 -30.3 9.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 70.7 mt -112.83 -59.0 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.107 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.571 HD13 ' CD2' ' A' ' 157' ' ' TYR . 66.3 mt -67.01 -11.95 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.119 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.593 ' CE1' ' SD ' ' A' ' 166' ' ' MET . 0.1 OUTLIER -74.21 -61.58 1.2 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.656 0.741 . . . . 0.0 110.934 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.555 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 54.0 Cg_endo -69.7 -27.82 26.27 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.714 2.276 . . . . 0.0 112.345 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.568 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 3.8 t80 -68.11 -41.91 81.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -72.84 -60.33 2.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.897 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.593 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 6.7 ptt? -47.08 -43.2 20.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.665 ' CG ' ' CD1' ' A' ' 92' ' ' PHE . 61.0 t80 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.503 ' CD2' ' HA ' ' A' ' 113' ' ' TYR . 86.8 t80 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.906 0.384 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 37.9 mt -79.95 -36.08 36.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.942 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -78.78 -47.55 16.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.835 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.428 ' CG ' ' N ' ' A' ' 89' ' ' ILE . 2.2 pt20 -54.72 -45.82 74.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.467 ' HA ' ' CE1' ' A' ' 164' ' ' TYR . 15.7 tt -72.84 -32.04 38.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.139 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 93' ' ' TRP . . . -67.48 -57.1 7.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.095 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.8 tptm -40.94 -31.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -78.45 -43.05 28.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.404 ' N ' ' O ' ' A' ' 90' ' ' ALA . 41.3 m95 -68.23 -55.17 13.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.911 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -43.52 -35.12 1.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.929 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.3 mt -73.03 -51.49 26.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.143 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -42.45 -47.57 5.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 136.88 30.63 0.27 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.483 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.8 m -161.05 161.78 31.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.893 0.378 . . . . 0.0 110.864 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.2 m -89.52 155.95 18.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.829 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.9 tp -91.57 103.89 16.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.909 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.8 pttt -97.48 152.59 18.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.909 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 18.7 mt -115.62 123.87 30.75 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.604 0.716 . . . . 0.0 111.155 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 148.07 64.3 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.687 2.258 . . . . 0.0 112.36 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -99.73 121.07 40.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.3 t -118.26 147.36 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.136 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.452 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 65.4 mm-40 39.8 53.21 2.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.863 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.452 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 11.8 ptm180 45.8 38.47 4.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.3 tptp -160.91 151.11 17.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.8 tt -56.75 145.36 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.113 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.426 HD23 ' N ' ' A' ' 111' ' ' ASP . 4.9 tt -90.72 129.49 36.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.426 ' N ' HD23 ' A' ' 110' ' ' LEU . 26.3 t0 -79.42 66.82 4.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -54.02 -23.02 11.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.503 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 3.9 t80 -72.4 -58.63 3.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.4 t -55.78 -41.46 74.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.864 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.4 tp -52.71 -55.8 20.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.915 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 18.0 p -60.26 -42.9 96.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -58.33 -61.2 2.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.878 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 64.9 mt -49.62 -36.36 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.176 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.2 t -71.27 -48.43 54.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.175 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 85.5 mt -62.4 -37.17 78.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.074 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -72.84 -54.79 7.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.913 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -38.95 -53.87 1.71 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.892 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 158.28 34.79 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.501 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.15 179.12 37.2 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.449 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.502 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 9.3 t80 -82.52 -39.98 21.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.826 0.346 . . . . 0.0 110.899 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -66.11 -43.03 88.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.92 -61.71 2.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.142 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.557 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 1.7 pp -60.09 -33.67 54.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.116 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.502 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 22.1 m -70.41 -28.42 65.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -81.05 -36.48 30.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.439 ' O ' ' C ' ' A' ' 132' ' ' ARG . 0.5 OUTLIER -91.15 21.04 4.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 131' ' ' ASP . 8.7 mmm180 35.53 50.76 0.6 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.88 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.425 ' O ' ' C ' ' A' ' 134' ' ' TRP . 4.3 mmp_? -80.03 -19.49 47.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.9 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.557 ' CZ2' HD12 ' A' ' 128' ' ' ILE . 28.2 m95 -36.34 -41.64 0.29 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.19 -55.32 34.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.092 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -66.82 -41.35 87.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 82.7 t -51.16 -43.58 27.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.078 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.64 -53.5 15.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.069 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -56.04 -22.44 27.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -68.74 -32.03 71.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.54 HD21 ' CE2' ' A' ' 143' ' ' TYR . 10.2 tp -89.84 25.57 2.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 61.55 51.17 4.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.815 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.54 ' CE2' HD21 ' A' ' 141' ' ' LEU . 3.7 m-85 -103.7 150.65 38.35 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.698 0.761 . . . . 0.0 110.886 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 113.48 3.39 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.677 2.252 . . . . 0.0 112.319 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 99.99 0.79 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.671 2.248 . . . . 0.0 112.333 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 161.96 -70.27 0.22 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.493 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -51.99 151.45 3.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.816 0.341 . . . . 0.0 110.915 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.406 ' O ' ' CG ' ' A' ' 148' ' ' ASN . 15.5 p-10 -65.0 75.51 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.423 ' O ' ' C ' ' A' ' 150' ' ' GLY . 75.5 mt -92.44 -54.06 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.17 -52.05 1.26 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.445 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 8.7 t -58.44 -56.94 15.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.927 0.394 . . . . 0.0 110.85 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.566 HD23 ' CD2' ' A' ' 156' ' ' HIS . 5.6 tt -42.05 -49.39 4.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.926 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 15.5 mt -58.94 -65.97 0.58 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.494 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 15.5 ttp180 -38.82 -45.39 1.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.818 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 41.0 m -60.19 -62.75 1.63 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.842 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.566 ' CD2' HD23 ' A' ' 152' ' ' LEU . 2.8 m-70 -47.27 -27.1 1.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.855 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.55 ' CD2' ' CD1' ' A' ' 161' ' ' ILE . 7.7 t80 -83.65 -31.26 26.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.49 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 11.4 mt-10 -91.04 -10.16 43.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 14.8 tpt85 -105.02 -30.7 9.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.858 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 42.0 mt -112.12 -54.38 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.55 ' CD1' ' CD2' ' A' ' 157' ' ' TYR . 15.5 mt -77.07 -0.8 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.101 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.537 ' CD2' ' HD3' ' A' ' 163' ' ' PRO . 0.2 OUTLIER -71.9 -60.31 2.46 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.643 0.735 . . . . 0.0 110.905 -179.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.537 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.5 Cg_endo -69.79 -34.96 13.43 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.708 2.272 . . . . 0.0 112.294 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.467 ' CE1' ' HA ' ' A' ' 89' ' ' ILE . 55.2 t80 -62.36 -44.09 97.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.911 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -68.72 -55.45 11.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.44 -35.07 74.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.899 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.463 ' CB ' ' O ' ' A' ' 163' ' ' PRO . 40.7 t80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.914 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.419 ' CE2' HD13 ' A' ' 112' ' ' LEU . 59.5 t80 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.941 0.4 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.2 mt -80.94 -59.11 2.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.891 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -52.63 -25.85 11.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.845 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -77.42 -67.32 0.73 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.558 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 10.0 tt -47.5 -35.59 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.17 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.74 -47.75 68.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.093 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -53.09 -26.2 15.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.593 ' CD1' ' CD2' ' A' ' 167' ' ' PHE . 0.8 OUTLIER -81.27 -50.83 9.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.52 ' CD1' HD12 ' A' ' 100' ' ' LEU . 81.3 m95 -64.51 -55.98 17.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.95 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -41.02 -29.77 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.913 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.5 mt -78.3 -49.33 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.171 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 88.6 mm-40 -50.21 -44.73 53.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 142.11 -46.94 0.85 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.453 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.6 m -83.22 108.85 16.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.887 0.375 . . . . 0.0 110.874 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.6 m -50.69 162.35 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.52 HD12 ' CD1' ' A' ' 93' ' ' TRP . 40.4 tp -86.82 100.47 12.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.91 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -102.41 106.2 16.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 44.0 mm -69.16 124.86 91.32 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.579 0.704 . . . . 0.0 111.134 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.519 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 54.0 Cg_endo -69.76 151.29 69.03 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.725 2.283 . . . . 0.0 112.334 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -101.12 110.93 23.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.843 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.8 t -119.19 137.9 51.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.143 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 107' ' ' ARG . 49.4 mm-40 58.9 55.02 4.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 106' ' ' GLU . 6.6 ptp85 35.53 43.05 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.857 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -168.14 150.71 5.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.874 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.1 tt -57.69 144.42 10.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.143 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.543 ' CD2' ' N ' ' A' ' 111' ' ' ASP . 6.2 tt -93.12 151.0 20.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.543 ' N ' ' CD2' ' A' ' 110' ' ' LEU . 11.9 t0 -107.81 121.7 45.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.835 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.419 HD13 ' CE2' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -98.3 -28.12 13.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.92 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -67.19 -61.56 1.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.903 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 115' ' ' LEU . 23.3 m -51.64 -58.76 5.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 114' ' ' SER . 17.3 tp -38.0 -63.09 0.5 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.907 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.9 t -50.28 -53.1 30.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.837 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -51.22 -43.73 61.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 58.6 mt -62.33 -48.68 87.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.1 t -58.41 -58.91 4.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.159 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 82.4 mt -49.4 -45.58 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.124 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 122' ' ' GLU . 38.5 mt-10 -62.92 -58.36 7.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.865 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.438 ' OE2' ' CG2' ' A' ' 137' ' ' VAL . 42.7 mt-10 -37.73 -54.27 1.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.855 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 157.85 37.25 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.52 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.98 -173.55 39.75 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.472 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.583 ' CE2' ' SG ' ' A' ' 129' ' ' CYS . 7.7 t80 -88.84 -56.63 3.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.806 0.336 . . . . 0.0 110.884 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -51.14 -34.73 32.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.886 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.38 -71.36 0.21 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.122 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.427 HG23 ' CB ' ' A' ' 122' ' ' GLU . 1.8 pp -51.5 -32.04 12.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.583 ' SG ' ' CE2' ' A' ' 125' ' ' TYR . 99.3 m -69.63 -36.47 76.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.885 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -71.12 -43.28 67.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' A' ' 132' ' ' ARG . 0.9 OUTLIER -85.61 23.57 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 131' ' ' ASP . 59.1 mtt180 34.23 38.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.833 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' A' ' 134' ' ' TRP . 21.1 mmm180 -66.08 -19.14 65.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.435 ' C ' ' O ' ' A' ' 133' ' ' ARG . 29.5 m95 -35.54 -37.22 0.08 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.33 -57.12 14.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.116 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 -60.09 -43.87 95.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.438 ' CG2' ' OE2' ' A' ' 122' ' ' GLU . 59.4 t -58.21 -34.11 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.121 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.19 -59.06 3.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.138 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -53.99 -31.07 49.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.97 -38.38 64.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.899 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.518 HD23 ' CE2' ' A' ' 143' ' ' TYR . 14.8 tp -85.39 20.94 1.87 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 64.22 40.33 6.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.841 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.518 ' CE2' HD23 ' A' ' 141' ' ' LEU . 3.1 m-85 -89.67 153.16 47.71 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.662 0.744 . . . . 0.0 110.929 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 114.07 3.58 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.732 2.288 . . . . 0.0 112.337 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 90.88 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.678 2.252 . . . . 0.0 112.365 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.67 -73.93 0.1 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.468 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -50.56 153.18 1.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.832 0.348 . . . . 0.0 110.852 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -67.29 81.33 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.427 ' O ' ' C ' ' A' ' 150' ' ' GLY . 90.1 mt -92.97 -53.85 8.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.19 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.0 -48.52 1.08 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.511 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.0 t -61.5 -53.87 50.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.864 0.364 . . . . 0.0 110.866 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.476 HD22 ' CD2' ' A' ' 156' ' ' HIS . 8.2 tt -47.14 -50.6 20.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.885 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.415 ' O ' ' C ' ' A' ' 154' ' ' ARG . 24.1 mt -55.02 -65.91 0.5 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 153' ' ' LEU . 11.4 ttt-85 -36.89 -44.99 0.53 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.918 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.7 t -59.76 -65.37 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.911 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.519 ' CE1' ' HG3' ' A' ' 103' ' ' PRO . 2.1 m-70 -39.6 -49.11 2.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.564 ' CD2' HD12 ' A' ' 161' ' ' ILE . 3.6 t80 -52.83 -67.6 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.916 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -62.15 -8.53 5.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.857 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.94 -53.82 5.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.908 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.407 ' CG2' ' HE1' ' A' ' 93' ' ' TRP . 27.0 mt -112.91 -46.3 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.133 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.564 HD12 ' CD2' ' A' ' 157' ' ' TYR . 73.7 mt -61.2 -14.14 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.661 ' C ' ' CD1' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -76.88 -63.3 0.54 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.707 0.765 . . . . 0.0 110.927 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.567 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.9 Cg_endo -69.73 -23.44 30.92 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.744 2.296 . . . . 0.0 112.328 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.558 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 1.0 OUTLIER -74.25 -46.62 40.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.875 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -69.11 -49.38 57.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.893 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.401 ' CG ' ' HA ' ' A' ' 163' ' ' PRO . 0.0 OUTLIER -61.23 -38.14 85.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.593 ' CD2' ' CD1' ' A' ' 92' ' ' PHE . 18.3 t80 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 55.1 t80 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.924 0.393 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.21 -64.08 1.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.966 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -52.74 -32.28 42.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 44.8 mm-40 -67.16 -69.08 0.33 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.485 HG13 ' CG ' ' A' ' 164' ' ' TYR . 19.7 tt -51.09 -39.28 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.133 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.51 -40.82 93.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -59.73 -23.96 63.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.918 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.459 ' O ' ' CD1' ' A' ' 92' ' ' PHE . 1.1 t80 -84.7 -36.56 21.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.893 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.48 ' O ' ' N ' ' A' ' 95' ' ' ILE . 69.4 m95 -78.03 -56.72 4.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -39.41 -25.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.48 ' N ' ' O ' ' A' ' 93' ' ' TRP . 87.3 mt -81.81 -50.35 16.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -49.18 -34.08 13.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.889 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 130.21 -25.11 4.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.47 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.5 m -103.97 115.52 30.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 0.0 110.868 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.4 t -53.75 167.88 0.22 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.875 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.9 tp -85.28 124.5 31.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.967 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -125.96 134.51 51.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 81.9 mt -107.05 129.64 24.04 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.586 0.707 . . . . 0.0 111.132 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 174.64 9.18 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.69 2.26 . . . . 0.0 112.325 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -124.73 111.83 16.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.7 t -115.2 133.27 61.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.153 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 60.06 54.72 4.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.916 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 38.42 36.91 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.841 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.71 153.66 28.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.9 tt -60.31 137.04 23.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.109 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.1 tt -78.47 140.55 38.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.946 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -90.43 76.25 6.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.827 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -61.77 -22.46 65.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.936 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -71.73 -65.84 0.71 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 115' ' ' LEU . 3.7 t -54.34 -54.08 45.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.845 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.43 ' C ' ' O ' ' A' ' 114' ' ' SER . 16.9 tp -35.3 -65.43 0.23 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.941 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.5 t -53.15 -51.89 60.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.871 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -46.78 -54.22 10.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.905 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 65.3 mt -56.67 -46.81 83.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.084 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.1 t -56.88 -61.99 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.154 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 84.6 mt -56.97 -40.31 71.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.141 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -60.1 -57.99 10.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -44.87 -45.1 10.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.434 ' O ' ' CB ' ' A' ' 127' ' ' ALA . . . 152.48 38.12 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.487 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.16 -170.04 32.61 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.467 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -88.8 -43.3 11.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.945 0.402 . . . . 0.0 110.951 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -64.24 -39.37 93.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.866 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' A' ' 123' ' ' GLY . . . -58.37 -68.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.075 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.422 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 1.7 pp -51.73 -34.88 16.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.087 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 53.6 m -67.74 -33.95 75.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.845 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.3 mtpp -68.05 -46.85 69.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.429 ' OD2' ' CZ ' ' A' ' 133' ' ' ARG . 2.3 t70 -84.61 12.23 7.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 44.63 54.12 6.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.849 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.449 ' O ' ' C ' ' A' ' 134' ' ' TRP . 3.2 mmp_? -80.32 -19.07 47.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.905 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.534 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 18.8 m95 -34.27 -44.54 0.19 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.2 -52.12 66.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.11 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 37.5 mmt-85 -68.93 -51.22 42.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 97.5 t -44.4 -44.47 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.127 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.53 -53.09 25.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.08 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -55.72 -25.92 42.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.908 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 23.9 mtt180 -64.21 -26.5 68.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.912 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.0 tp -89.54 18.45 5.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.939 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 64.45 46.73 3.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -95.36 152.59 39.43 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.656 0.741 . . . . 0.0 110.948 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 120.1 6.94 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.652 2.235 . . . . 0.0 112.356 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 115.65 4.19 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.683 2.255 . . . . 0.0 112.344 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.66 -64.25 0.44 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.465 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -53.08 160.33 1.04 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.79 0.329 . . . . 0.0 110.925 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -80.96 52.43 1.75 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.407 ' O ' ' C ' ' A' ' 150' ' ' GLY . 42.6 mt -62.92 -49.8 82.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.165 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.21 -56.94 1.14 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.452 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.8 t -57.29 -61.0 2.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.914 0.387 . . . . 0.0 110.897 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.571 HD22 ' CD2' ' A' ' 156' ' ' HIS . 7.3 tt -38.94 -55.11 1.59 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.926 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 25.1 mt -51.9 -65.99 0.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.534 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 20.0 ttp180 -41.18 -46.23 3.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.823 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.9 m -58.99 -64.5 0.92 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.845 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.571 ' CD2' HD22 ' A' ' 152' ' ' LEU . 1.7 m-70 -42.05 -53.38 3.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.864 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.538 ' CD2' HD13 ' A' ' 161' ' ' ILE . 5.3 t80 -50.81 -65.35 0.57 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 42.6 mt-10 -63.53 -9.8 14.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.906 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 41.5 ttt-85 -84.08 -50.74 7.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 40.6 mt -112.54 -40.07 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.152 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.538 HD13 ' CD2' ' A' ' 157' ' ' TYR . 22.9 mt -76.2 0.28 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.139 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.588 ' CE1' ' SD ' ' A' ' 166' ' ' MET . 0.1 OUTLIER -73.34 -61.17 1.51 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.7 0.762 . . . . 0.0 110.897 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.565 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 54.4 Cg_endo -69.73 -32.56 18.47 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.68 2.253 . . . . 0.0 112.393 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.485 ' CG ' HG13 ' A' ' 89' ' ' ILE . 12.3 t80 -66.07 -39.04 89.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.931 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -72.02 -53.37 13.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.935 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.588 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 6.7 ptt? -63.48 -41.58 98.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.851 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.468 ' CB ' ' O ' ' A' ' 163' ' ' PRO . 47.9 t80 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.901 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.1 m -131.33 154.35 48.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.9 0.381 . . . . 0.0 110.846 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.8 m -132.33 166.62 21.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -125.21 -137.68 4.81 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.51 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 92.6 p -170.53 135.4 1.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.856 0.36 . . . . 0.0 110.878 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 76.8 p -55.84 138.5 48.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.832 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -144.7 -135.24 2.87 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.459 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.0 t -94.84 38.58 1.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.78 0.324 . . . . 0.0 111.122 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -79.29 -74.14 0.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.872 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.462 ' O ' ' N ' ' A' ' 84' ' ' ASN . 88.8 t -64.85 -40.53 89.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.086 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.533 ' HG3' ' CD2' ' A' ' 113' ' ' TYR . 41.4 tttm -39.86 -27.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.948 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.425 ' N ' ' O ' ' A' ' 81' ' ' VAL . 32.7 mt -82.22 -41.62 20.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 81' ' ' VAL . 39.3 t-20 -45.56 -40.5 8.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -60.01 -45.3 93.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.8 mt -65.29 -50.99 63.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.03 -35.08 75.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -68.45 -64.16 0.92 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.935 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.486 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 6.5 tt -55.5 -33.75 33.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.16 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.98 -58.58 3.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.088 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.41 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 2.4 ttmp? -45.65 -24.66 0.37 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.892 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -85.63 -42.45 14.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.407 ' CD1' HD11 ' A' ' 100' ' ' LEU . 32.8 m95 -72.61 -59.25 2.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.462 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 2.7 pt-20 -39.31 -31.96 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.873 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.462 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 97.3 mt -74.08 -52.59 19.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.171 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -48.55 -40.34 26.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 136.58 -45.71 1.07 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.477 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.4 t -81.69 118.69 23.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.841 0.353 . . . . 0.0 110.881 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.5 p -56.49 151.86 12.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.407 HD11 ' CD1' ' A' ' 93' ' ' TRP . 13.5 tp -77.84 118.58 20.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -119.57 141.91 48.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.0 mp -107.69 128.74 25.28 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.627 0.727 . . . . 0.0 111.104 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 154.24 67.77 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.646 2.23 . . . . 0.0 112.334 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -102.18 111.32 23.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.435 HG13 ' N ' ' A' ' 106' ' ' GLU . 71.4 t -119.03 134.67 61.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.117 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.435 ' N ' HG13 ' A' ' 105' ' ' VAL . 13.2 mm-40 61.21 53.45 3.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 106' ' ' GLU . 7.7 ptp180 36.94 41.68 0.2 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.3 ttmp? -162.5 152.13 15.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.465 HG13 ' N ' ' A' ' 110' ' ' LEU . 1.8 tp -62.25 139.23 21.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.112 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.465 ' N ' HG13 ' A' ' 109' ' ' ILE . 5.7 tt -87.65 130.62 34.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.916 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -90.55 74.24 6.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -48.52 -20.91 0.48 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.533 ' CD2' ' HG3' ' A' ' 82' ' ' LYS . 11.7 t80 -71.27 -45.59 62.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.3 t -65.61 -52.81 49.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.886 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.7 tp -49.03 -60.53 2.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 52.6 p -55.11 -52.9 61.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.863 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.3 mmtt -47.96 -61.45 1.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 66.5 mt -45.34 -64.27 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.155 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 43.1 t -39.35 -64.18 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.139 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 73.4 mt -42.35 -46.35 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.092 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -65.34 -54.69 25.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -39.49 -50.91 2.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 155.36 35.15 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.525 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.92 -177.73 41.79 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.528 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.483 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 3.1 t80 -87.42 -47.92 8.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.851 0.357 . . . . 0.0 110.901 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -57.78 -40.73 80.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.91 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.09 -68.86 0.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.083 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.411 ' C ' HD12 ' A' ' 128' ' ' ILE . 1.9 pp -52.0 -31.43 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.128 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.483 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 26.2 m -70.13 -42.2 72.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -66.31 -36.92 84.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.861 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 132' ' ' ARG . 2.2 m-20 -91.99 21.44 4.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.859 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' A' ' 131' ' ' ASP . 16.8 mmm-85 35.36 41.28 0.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -71.35 -14.07 62.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.869 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.508 ' CE2' ' HG3' ' A' ' 154' ' ' ARG . 49.5 m95 -38.28 -37.44 0.29 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.24 -52.56 65.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.06 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -66.4 -39.73 89.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.842 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.3 t -57.3 -36.09 51.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.107 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.14 -49.85 21.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.094 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -57.99 -26.07 61.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.868 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -57.6 -38.93 75.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.838 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.533 HD21 ' CE2' ' A' ' 143' ' ' TYR . 13.6 tp -82.44 16.09 2.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.95 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 63.36 44.66 5.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.835 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.533 ' CE2' HD21 ' A' ' 141' ' ' LEU . 2.6 m-85 -85.21 155.96 60.18 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.657 0.741 . . . . 0.0 110.956 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 110.37 2.54 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.656 2.238 . . . . 0.0 112.345 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 108.27 2.03 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.712 2.274 . . . . 0.0 112.348 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 147.44 -34.64 1.26 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.459 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -83.93 147.24 27.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 0.0 110.923 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.418 ' CG ' ' O ' ' A' ' 148' ' ' ASN . 26.3 p-10 -66.53 72.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.857 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.42 ' O ' ' C ' ' A' ' 150' ' ' GLY . 75.4 mt -90.65 -50.04 13.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.099 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.1 -50.71 1.22 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.498 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.6 m -60.03 -49.29 78.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.887 0.375 . . . . 0.0 110.882 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.627 ' CD2' ' CD2' ' A' ' 156' ' ' HIS . 6.5 tt -51.18 -53.97 29.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.888 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 23.1 mt -54.35 -65.8 0.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.927 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.508 ' HG3' ' CE2' ' A' ' 134' ' ' TRP . 16.0 ttt180 -40.41 -41.57 1.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.889 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 156' ' ' HIS . 39.7 m -66.67 -69.78 0.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.627 ' CD2' ' CD2' ' A' ' 152' ' ' LEU . 2.4 m-70 -36.96 -39.22 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.879 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.52 ' CZ ' HG21 ' A' ' 161' ' ' ILE . 4.2 t80 -65.44 -57.23 8.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -70.82 -10.13 58.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.878 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -90.22 -48.17 7.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.824 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 60.7 mt -112.45 -41.97 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.162 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.52 HG21 ' CZ ' ' A' ' 157' ' ' TYR . 16.7 mt -78.48 3.23 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.091 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.584 ' C ' ' CD1' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -72.36 -60.66 2.07 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.691 0.758 . . . . 0.0 110.928 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.472 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.8 Cg_endo -69.72 -40.19 5.68 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.69 2.26 . . . . 0.0 112.358 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.486 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 23.8 t80 -55.57 -40.26 71.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.911 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -76.85 -66.32 0.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.883 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.447 ' SD ' ' N ' ' A' ' 167' ' ' PHE . 0.0 OUTLIER -42.7 -40.06 2.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.874 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.447 ' N ' ' SD ' ' A' ' 166' ' ' MET . 21.4 t80 -71.15 -52.07 21.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -84.69 41.27 0.84 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.916 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 5.2 t -123.61 120.47 32.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 90.35 109.73 1.41 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.476 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.784 0.326 . . . . 0.0 111.117 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.448 -0.261 . . . . 0.0 112.448 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.4 m 51.53 41.92 29.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.896 0.379 . . . . 0.0 110.895 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 79.9 p -138.33 164.85 28.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.845 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.15 178.42 51.58 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.451 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.7 t -131.02 134.17 46.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.904 0.383 . . . . 0.0 110.863 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.5 t -45.75 123.9 4.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.891 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.07 -83.17 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.507 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 53.8 m -49.42 95.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.804 0.335 . . . . 0.0 111.183 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 21.1 tpt85 -118.09 -56.7 2.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 83' ' ' LEU . 49.0 t -87.98 -35.42 8.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.099 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -40.14 -27.43 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.431 ' N ' ' O ' ' A' ' 81' ' ' VAL . 33.7 mt -74.58 -55.11 6.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.916 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.431 ' O ' ' N ' ' A' ' 87' ' ' ASP . 50.5 t30 -40.9 -61.71 0.93 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.87 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.435 ' CD2' ' HA ' ' A' ' 113' ' ' TYR . 73.0 t80 -39.53 -32.89 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.6 mt -77.25 -43.14 34.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 84' ' ' ASN . 1.0 OUTLIER -56.05 -41.97 75.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 179.832 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.06 -62.97 1.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.529 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 15.0 tt -52.42 -39.71 29.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.143 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.1 -42.81 93.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.11 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -59.02 -29.21 67.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -77.2 -39.75 47.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.915 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 54.7 m95 -72.74 -58.39 3.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.418 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 9.6 pt-20 -39.17 -36.91 0.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.418 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 95.4 mt -69.85 -47.07 71.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.096 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -53.5 -35.34 60.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.925 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 130.56 -33.19 2.92 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.482 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.4 m -93.5 145.33 24.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.928 0.394 . . . . 0.0 110.89 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 27.7 p -79.27 159.55 27.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 39.1 tp -90.04 138.34 31.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.93 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 49.7 tttt -134.4 144.63 48.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.957 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 62.9 mt -109.82 124.51 33.44 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.608 0.718 . . . . 0.0 111.116 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 157.38 60.42 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.634 2.223 . . . . 0.0 112.296 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -107.71 121.48 44.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 62.4 t -116.09 140.84 36.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.149 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.473 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 63.1 mm-40 44.76 52.86 7.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.473 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 12.0 ptm180 47.36 36.7 5.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.835 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -154.14 150.58 28.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 6.9 tt -62.3 140.26 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.131 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.6 tt -89.22 121.86 31.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.953 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -82.46 79.75 8.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -58.71 -23.83 60.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.435 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 3.7 t80 -65.26 -56.12 14.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 115' ' ' LEU . 44.3 m -58.22 -59.84 4.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.875 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.448 ' C ' ' O ' ' A' ' 114' ' ' SER . 19.6 tp -34.48 -68.47 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.948 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.5 t -48.2 -54.71 12.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.852 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt -46.61 -54.75 8.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.904 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 81.5 mt -51.72 -54.25 13.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.141 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.4 t -53.33 -60.02 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.144 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 97.0 mt -43.28 -44.89 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.153 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -68.54 -48.61 63.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.454 ' OE2' ' CG2' ' A' ' 137' ' ' VAL . 24.7 mt-10 -44.95 -42.62 8.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.898 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 144.13 37.8 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.486 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.97 -179.45 45.49 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.516 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.516 ' C ' ' CD1' ' A' ' 125' ' ' TYR . 0.9 OUTLIER -86.88 -41.51 13.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.855 0.36 . . . . 0.0 110.934 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -62.75 -33.45 75.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.899 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.8 -69.84 0.29 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.07 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.527 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 1.9 pp -51.07 -32.6 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.163 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.488 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 27.3 m -69.6 -41.5 75.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.1 mtpp -67.11 -28.03 67.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -101.03 13.81 34.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.852 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 39.07 50.87 1.87 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -84.13 -3.6 58.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.86 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.527 ' CZ2' HD12 ' A' ' 128' ' ' ILE . 56.4 m95 -45.95 -39.06 8.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.925 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.53 -54.1 50.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.118 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -64.48 -46.85 81.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.908 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.454 ' CG2' ' OE2' ' A' ' 122' ' ' GLU . 52.0 t -50.39 -37.48 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.095 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.96 -49.35 38.2 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -59.03 -24.71 63.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -62.95 -30.54 71.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.8 tp -91.64 26.48 2.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 57.57 51.04 10.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -102.68 151.62 38.31 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.709 0.766 . . . . 0.0 110.883 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 110.31 2.52 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.739 2.293 . . . . 0.0 112.324 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 131.56 21.55 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.726 2.284 . . . . 0.0 112.358 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.65 -55.3 0.76 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.505 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -59.85 179.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.777 0.322 . . . . 0.0 110.912 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -93.97 42.22 1.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.4 ' O ' ' C ' ' A' ' 150' ' ' GLY . 61.8 mt -59.46 -50.07 81.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.115 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.22 -58.88 1.01 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.478 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.9 t -51.56 -60.49 3.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.926 0.393 . . . . 0.0 110.878 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.56 HD23 ' CD2' ' A' ' 156' ' ' HIS . 5.5 tt -38.98 -49.9 1.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.934 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 17.3 mt -59.74 -65.92 0.6 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.914 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.478 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 6.2 ttt-85 -38.3 -40.06 0.49 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.867 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 158' ' ' GLU . 3.8 m -66.84 -66.35 0.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.56 ' CD2' HD23 ' A' ' 152' ' ' LEU . 2.6 m-70 -43.6 -29.69 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.831 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.514 ' C ' ' CD1' ' A' ' 157' ' ' TYR . 2.2 t80 -79.57 -34.92 40.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.924 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 155' ' ' SER . 26.0 mt-10 -88.93 -9.9 49.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.872 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 12.7 mmt85 -102.15 -39.86 7.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 86.3 mt -109.86 -49.86 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.131 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.454 ' CG1' ' HA ' ' A' ' 157' ' ' TYR . 14.0 mt -78.47 3.3 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.095 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.641 ' C ' ' CD1' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -72.57 -60.54 2.01 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.665 0.745 . . . . 0.0 110.893 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 162' ' ' TYR . 53.7 Cg_endo -69.79 -49.35 0.56 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.668 2.245 . . . . 0.0 112.343 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.529 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 34.4 t80 -48.31 -38.02 17.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.929 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -75.2 -63.24 1.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.892 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 11.8 ptt? -48.65 -31.05 6.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.869 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -75.1 -46.93 31.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.866 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -56.21 -44.41 79.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.888 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.7 t -73.75 95.54 2.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.881 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 174.81 -100.16 0.14 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.511 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.755 0.312 . . . . 0.0 111.141 179.923 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.7 p -100.97 168.34 9.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.846 0.355 . . . . 0.0 110.886 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.1 t 40.58 41.66 1.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.858 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -138.86 105.26 0.47 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.516 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 74.4 p -125.84 167.22 15.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.925 0.393 . . . . 0.0 110.841 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.7 p -149.79 170.79 17.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.852 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.94 -48.27 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.477 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 25.8 m -91.94 96.48 10.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.76 0.314 . . . . 0.0 111.156 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -124.87 -63.42 1.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.876 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.485 ' O ' ' N ' ' A' ' 83' ' ' LEU . 81.0 t -71.49 -43.36 72.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.137 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 81' ' ' VAL . 23.5 ttmt -35.13 -31.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.943 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 81' ' ' VAL . 13.8 mt -81.63 -48.18 12.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.922 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 81' ' ' VAL . 47.4 t30 -42.02 -47.55 4.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.857 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.447 ' CD2' ' HA ' ' A' ' 113' ' ' TYR . 39.3 t80 -57.62 -37.71 73.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.956 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.9 mt -74.73 -59.13 2.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.908 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -49.61 -29.07 6.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -76.79 -68.2 0.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.959 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.54 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 9.9 tt -46.16 -34.84 2.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.16 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.27 -46.53 67.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.136 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -55.98 -22.86 29.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -84.95 -46.49 11.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.879 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 54.2 m95 -67.74 -51.25 51.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.894 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -45.88 -32.1 2.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 89.8 mt -74.93 -46.04 41.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.128 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -56.35 -36.74 69.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.88 -52.67 0.7 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.467 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 71.4 m -83.32 119.98 25.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.865 0.364 . . . . 0.0 110.874 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 59.4 p -55.51 173.26 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.84 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.1 tp -82.68 132.96 35.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.951 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -131.92 134.4 45.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.0 mt -110.0 127.45 27.07 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.594 0.712 . . . . 0.0 111.148 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.565 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 53.2 Cg_endo -69.77 166.53 27.29 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.661 2.24 . . . . 0.0 112.329 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -113.09 122.86 48.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.4 t -123.75 148.64 27.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.155 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.448 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 58.1 mm-40 41.72 52.92 4.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.448 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 13.0 ptp180 45.16 43.01 7.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.875 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -164.58 152.22 11.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.926 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.1 tt -62.29 142.89 15.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.121 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.3 tt -91.63 132.49 36.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -94.6 100.92 12.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.838 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.53 -26.64 61.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.546 ' CE1' ' HG3' ' A' ' 117' ' ' LYS . 4.4 t80 -61.06 -55.89 27.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.886 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.4 m -61.85 -56.98 13.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.83 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 26.2 tp -40.73 -60.74 1.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.1 t -58.17 -50.59 73.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.802 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.546 ' HG3' ' CE1' ' A' ' 113' ' ' TYR . 13.9 mmmt -47.92 -46.3 31.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 63.8 mt -64.45 -38.58 82.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 71.6 t -64.17 -59.96 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 83.3 mt -59.71 -43.58 91.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.118 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -58.79 -56.56 20.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -44.36 -51.07 8.84 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 159.11 34.42 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.473 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.98 -175.02 33.36 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.528 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.524 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 2.1 t80 -87.41 -46.59 9.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.838 0.352 . . . . 0.0 110.905 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -58.02 -37.53 74.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.58 -70.46 0.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.113 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.455 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 1.9 pp -50.09 -34.47 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.165 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.524 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 53.5 m -67.93 -44.18 77.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.914 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -64.53 -40.85 96.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.933 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 132' ' ' ARG . 69.5 m-20 -85.92 23.77 1.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.824 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 131' ' ' ASP . 41.3 mtp85 36.04 37.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.847 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 134' ' ' TRP . 29.7 mmt180 -66.71 -23.47 66.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.542 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 22.4 m95 -34.71 -43.85 0.19 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.89 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.35 -49.21 75.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.114 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 133' ' ' ARG . 13.0 tpp180 -69.11 -42.18 76.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.892 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 89.2 t -53.85 -34.7 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -76.78 -53.45 7.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.1 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -55.04 -28.21 50.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -64.89 -28.3 69.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.515 HD22 ' CZ ' ' A' ' 143' ' ' TYR . 12.5 tp -88.27 22.67 2.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 60.78 45.84 9.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.843 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.515 ' CZ ' HD22 ' A' ' 141' ' ' LEU . 4.4 m-85 -97.71 147.37 32.93 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.692 0.758 . . . . 0.0 110.902 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 125.43 12.12 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.689 2.259 . . . . 0.0 112.289 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 96.68 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.676 2.251 . . . . 0.0 112.324 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 165.02 -75.24 0.16 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.543 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 149' ' ' ILE . 0.3 OUTLIER -45.96 138.47 5.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.798 0.332 . . . . 0.0 110.929 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -62.87 75.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.915 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 147' ' ' LYS . 94.1 mt -87.38 -48.91 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.138 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.13 -59.0 0.99 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.472 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.1 t -53.56 -55.25 27.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.945 0.402 . . . . 0.0 110.873 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.608 ' CD2' ' CD2' ' A' ' 156' ' ' HIS . 5.6 tt -44.28 -53.31 6.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 18.6 mt -53.54 -65.85 0.49 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.542 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 16.3 ttp180 -39.75 -47.05 2.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 7.9 t -59.41 -66.51 0.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.842 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.608 ' CD2' ' CD2' ' A' ' 152' ' ' LEU . 3.2 m-70 -40.6 -34.44 0.36 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.821 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.566 ' CD2' HD12 ' A' ' 161' ' ' ILE . 9.7 t80 -68.57 -70.27 0.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.4 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 3.9 mm-40 -61.09 -10.08 5.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.867 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -85.0 -55.85 3.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 49.7 mt -109.43 -37.27 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.118 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.566 HD12 ' CD2' ' A' ' 157' ' ' TYR . 26.7 mt -75.4 -5.93 7.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.113 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.57 ' CE1' ' HE2' ' A' ' 166' ' ' MET . 0.3 OUTLIER -71.25 -59.26 3.39 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.679 0.752 . . . . 0.0 110.93 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.511 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.3 Cg_endo -69.85 -39.73 6.0 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.69 2.26 . . . . 0.0 112.335 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.54 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 3.7 t80 -64.78 -30.03 71.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.935 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 161' ' ' ILE . 17.1 mm-40 -74.13 -57.24 4.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.876 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.57 ' HE2' ' CE1' ' A' ' 162' ' ' TYR . 5.5 ptp -55.43 -29.52 58.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.461 ' N ' ' HG3' ' A' ' 166' ' ' MET . 54.3 t80 -71.83 -55.72 7.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.873 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -54.81 -50.23 69.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.3 t -53.74 -53.94 45.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.836 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 127.9 117.98 2.1 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.48 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 120.795 0.331 . . . . 0.0 111.119 179.988 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.0 p -55.37 -52.63 62.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.9 0.381 . . . . 0.0 110.881 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.5 t -53.45 140.73 26.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.849 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -109.84 -138.14 7.96 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.491 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.7 m -130.79 114.04 14.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.919 0.39 . . . . 0.0 110.858 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.9 p -69.77 -44.07 70.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.836 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.422 ' HA3' ' NH1' ' A' ' 80' ' ' ARG . . . -173.89 -155.55 12.12 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.487 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 99.3 m -85.27 94.76 9.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.774 0.321 . . . . 0.0 111.129 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.422 ' NH1' ' HA3' ' A' ' 78' ' ' GLY . 7.4 mpt_? -119.39 -67.81 0.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.841 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.429 ' O ' ' N ' ' A' ' 84' ' ' ASN . 93.7 t -53.7 -48.31 60.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.099 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.564 ' HG3' ' CD2' ' A' ' 113' ' ' TYR . 9.9 mtmt -45.48 -21.91 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.885 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.5 mt -88.01 -34.12 18.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.941 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 81' ' ' VAL . 30.9 t30 -63.39 -38.99 93.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.927 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -71.04 -27.13 63.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.2 mt -80.56 -63.22 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.947 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -44.88 -31.39 1.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -72.26 -71.03 0.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.526 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 14.7 tt -43.29 -34.87 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.099 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.433 ' N ' HG22 ' A' ' 89' ' ' ILE . . . -68.82 -50.18 52.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.107 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -51.89 -29.21 18.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.906 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.401 ' CD1' ' CD2' ' A' ' 167' ' ' PHE . 30.2 t80 -77.29 -37.81 52.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.875 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.451 ' O ' ' C ' ' A' ' 94' ' ' GLU . 67.7 m95 -76.19 -59.24 2.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.921 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 93' ' ' TRP . 11.2 pt-20 -34.65 -40.54 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.444 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 95.5 mt -66.62 -53.87 31.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.126 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -46.81 -45.32 19.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 125.83 42.14 0.32 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.436 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.4 t -167.02 110.27 0.7 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.903 0.382 . . . . 0.0 110.869 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 78.1 p -43.84 163.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.902 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.6 tp -93.58 111.44 23.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -107.35 149.1 28.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 53.7 mt -119.95 129.93 25.1 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.655 0.741 . . . . 0.0 111.134 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 160.45 49.65 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.692 2.261 . . . . 0.0 112.303 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -111.81 126.05 54.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.906 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.3 t -121.32 144.22 31.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.161 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.429 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 62.7 mm-40 41.76 54.54 3.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.429 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 1.4 ptp180 43.88 40.07 2.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.03 152.72 26.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.4 tt -63.06 141.91 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.106 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.4 tt -86.25 133.52 33.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -91.95 74.33 5.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.63 -29.69 52.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.934 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.564 ' CD2' ' HG3' ' A' ' 82' ' ' LYS . 1.3 t80 -60.57 -66.94 0.45 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.932 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.8 m -50.97 -53.96 28.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.839 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.9 tp -39.46 -61.08 0.84 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.945 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.2 t -55.13 -66.59 0.38 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.469 ' HE2' ' N ' ' A' ' 117' ' ' LYS . 1.0 OUTLIER -40.96 -64.03 0.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.849 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 80.9 mt -40.81 -63.3 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.104 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.8 t -40.82 -58.14 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.099 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 69.9 mt -48.86 -42.12 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.161 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -65.92 -50.23 65.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.856 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -47.79 -40.14 20.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.846 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 144.82 42.33 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.516 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 83.03 174.74 50.61 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.525 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.551 ' C ' ' CD1' ' A' ' 125' ' ' TYR . 0.6 OUTLIER -86.83 -37.13 18.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.846 0.355 . . . . 0.0 110.946 -179.824 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -66.06 -40.45 90.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.866 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.72 -63.44 1.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.073 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.417 ' C ' HD11 ' A' ' 128' ' ' ILE . 2.4 pp -49.11 -37.07 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.123 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 22.0 m -62.82 -50.7 69.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.849 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -62.31 -33.77 75.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 132' ' ' ARG . 2.5 m-20 -90.91 16.35 9.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 131' ' ' ASP . 78.0 mtt180 36.98 44.56 0.38 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 15.0 mtp85 -77.62 -13.6 59.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 21.4 m95 -39.66 -40.35 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.72 -45.55 81.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.129 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.4 tpp85 -73.57 -44.99 55.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.1 t -57.04 -24.25 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.148 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -85.06 -55.34 4.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.087 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -55.42 -29.57 58.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -54.2 -36.45 63.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.869 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.525 HD22 ' CE2' ' A' ' 143' ' ' TYR . 17.6 tp -83.27 14.57 3.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 68.99 44.16 1.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.525 ' CE2' HD22 ' A' ' 141' ' ' LEU . 2.7 m-85 -92.32 158.33 39.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.731 0.777 . . . . 0.0 110.91 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 110.67 2.61 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.661 2.241 . . . . 0.0 112.349 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 105.67 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.699 2.266 . . . . 0.0 112.356 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.94 -58.82 0.41 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.524 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.454 ' HD3' ' N ' ' A' ' 148' ' ' ASN . 10.7 tmtt? -61.95 150.3 38.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.79 0.329 . . . . 0.0 110.889 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.454 ' N ' ' HD3' ' A' ' 147' ' ' LYS . 46.9 t30 -66.68 81.39 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.425 ' O ' ' C ' ' A' ' 150' ' ' GLY . 42.9 mt -94.87 -52.75 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.124 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.04 -53.05 1.22 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.492 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 75.5 m -57.69 -57.88 10.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.901 0.381 . . . . 0.0 110.831 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.561 HD22 ' CD2' ' A' ' 156' ' ' HIS . 6.6 tt -43.6 -50.24 7.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.881 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 154' ' ' ARG . 26.7 mt -55.37 -65.91 0.51 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.95 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 153' ' ' LEU . 20.0 ttp180 -38.17 -50.34 1.4 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.87 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 49.0 m -55.84 -69.21 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.561 ' CD2' HD22 ' A' ' 152' ' ' LEU . 1.9 m-70 -38.84 -43.03 0.89 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.858 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.554 ' CD2' HD12 ' A' ' 161' ' ' ILE . 8.6 t80 -60.52 -66.2 0.57 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 41.4 mt-10 -63.06 -10.2 13.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.933 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -85.69 -53.81 4.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 42.8 mt -109.54 -39.35 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.091 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.554 HD12 ' CD2' ' A' ' 157' ' ' TYR . 18.4 mt -76.25 -2.28 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.156 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.544 ' CD2' ' HD3' ' A' ' 163' ' ' PRO . 0.2 OUTLIER -72.08 -60.29 2.37 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.672 0.749 . . . . 0.0 110.915 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.544 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.6 Cg_endo -69.78 -41.05 4.58 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.64 2.227 . . . . 0.0 112.323 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.526 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 8.1 t80 -63.33 -27.95 69.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.946 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.438 ' CG ' ' O ' ' A' ' 161' ' ' ILE . 9.3 mm-40 -76.97 -59.06 2.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.882 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.534 ' HE2' ' CE1' ' A' ' 162' ' ' TYR . 2.2 ptp -56.22 -25.39 47.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.858 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.401 ' CD2' ' CD1' ' A' ' 92' ' ' PHE . 67.9 t80 -78.25 -49.28 14.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.869 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -53.08 -48.32 67.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.962 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 5.8 t -60.12 96.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.836 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -92.91 -66.38 1.09 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.493 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.775 0.322 . . . . 0.0 111.128 179.971 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.0 m -133.03 157.27 45.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.856 0.36 . . . . 0.0 110.89 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 96.9 p -124.1 149.99 45.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.832 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.78 130.41 3.04 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.513 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.5 t -151.86 156.55 40.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.832 0.348 . . . . 0.0 110.874 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 66.5 m -146.86 156.8 43.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.818 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.82 -163.31 34.1 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.494 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 86.7 m -82.16 91.23 6.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.784 0.326 . . . . 0.0 111.173 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -119.53 -56.93 2.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.876 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 83' ' ' LEU . 43.6 t -81.51 -34.13 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.147 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.564 ' HG2' ' CD2' ' A' ' 113' ' ' TYR . 22.8 mtpt -41.02 -27.47 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 81' ' ' VAL . 23.4 mt -82.34 -54.23 5.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.926 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -42.84 -33.71 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.892 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -66.83 -45.11 79.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.0 mt -73.03 -47.65 43.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -54.03 -29.95 45.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -83.91 -64.03 1.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.924 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.2 tt -51.15 -28.63 7.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.139 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.1 -34.21 59.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.085 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.3 tttp -69.71 -25.09 63.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.942 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -82.4 -49.19 10.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -63.79 -49.41 73.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.961 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.452 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 7.2 pt-20 -46.27 -35.84 5.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.452 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 96.4 mt -70.13 -44.53 78.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.138 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 -57.76 -36.19 71.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 130.94 -40.04 1.7 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.491 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.7 m -88.41 109.88 20.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.87 0.367 . . . . 0.0 110.841 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 88.7 p -49.88 166.68 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.869 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.9 tp -85.05 122.36 29.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.916 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -127.76 134.78 49.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.4 mp -99.04 134.16 21.62 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.64 0.733 . . . . 0.0 111.108 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.451 ' HG3' ' CD2' ' A' ' 156' ' ' HIS . 53.8 Cg_endo -69.76 159.39 53.58 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.674 2.249 . . . . 0.0 112.357 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -112.63 103.66 11.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.427 HG13 ' N ' ' A' ' 106' ' ' GLU . 87.1 t -106.35 138.35 32.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.137 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.493 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 73.5 mm-40 53.16 47.55 24.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.898 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.493 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 28.0 ptt180 47.95 32.88 3.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.82 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.5 pttm -150.48 157.47 43.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.406 HG13 ' N ' ' A' ' 110' ' ' LEU . 3.0 tp -63.09 140.12 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.097 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.42 ' C ' HD22 ' A' ' 110' ' ' LEU . 5.5 tt -84.6 142.06 30.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.869 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.404 ' N ' HD22 ' A' ' 110' ' ' LEU . 19.5 t0 -93.08 93.38 8.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.847 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -82.97 -19.88 36.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.875 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.621 ' CE1' ' CE ' ' A' ' 117' ' ' LYS . 65.7 t80 -71.04 -67.08 0.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.975 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.9 m -50.82 -54.37 24.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.885 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.3 tp -41.53 -50.07 4.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.954 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.0 t -58.04 -61.22 2.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.621 ' CE ' ' CE1' ' A' ' 113' ' ' TYR . 0.1 OUTLIER -56.12 -63.92 1.03 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.885 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.402 ' C ' ' O ' ' A' ' 117' ' ' LYS . 71.9 mt -36.06 -58.61 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.122 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 84.2 t -51.03 -54.42 10.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.168 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 65.3 mt -57.62 -29.63 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.088 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -74.48 -56.2 5.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -43.52 -50.15 7.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.419 ' O ' ' CB ' ' A' ' 127' ' ' ALA . . . 160.51 33.09 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.498 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.12 173.35 46.34 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.464 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.525 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 0.8 OUTLIER -78.44 -44.84 23.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.832 0.349 . . . . 0.0 110.897 -179.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 56.0 mp0 -59.93 -40.25 88.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.933 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 123' ' ' GLY . . . -65.52 -64.04 0.96 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.12 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.6 pp -55.1 -32.84 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.133 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.525 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 29.8 m -69.56 -42.03 75.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.8 tttm -66.55 -34.86 78.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' A' ' 132' ' ' ARG . 6.5 m-20 -94.2 23.01 5.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 131' ' ' ASP . 0.8 OUTLIER 34.39 35.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.836 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 131' ' ' ASP . 10.8 mmt85 -71.0 -1.54 12.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.553 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 44.3 m95 -49.32 -38.99 29.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.92 -47.92 76.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.103 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 -66.16 -44.7 83.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.887 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 99.2 t -56.94 -39.98 69.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.085 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.97 -57.84 6.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.084 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -52.83 -29.84 30.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.935 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.0 mmt-85 -60.73 -29.44 69.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.557 HD21 ' CE2' ' A' ' 143' ' ' TYR . 14.4 tp -87.53 13.32 10.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.91 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 71.91 35.82 1.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.882 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.557 ' CE2' HD21 ' A' ' 141' ' ' LEU . 3.1 m-85 -82.21 154.82 69.69 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.65 0.738 . . . . 0.0 110.95 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 122.77 9.45 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.673 2.248 . . . . 0.0 112.367 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 120.03 6.87 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.666 2.244 . . . . 0.0 112.305 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 134.8 -64.67 0.59 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.511 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.442 ' HE2' ' N ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -59.81 142.32 53.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.788 0.328 . . . . 0.0 110.887 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.98 85.91 2.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 56.0 mt -91.6 -34.05 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.133 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -41.02 -48.96 4.33 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.445 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.5 m -57.83 -51.58 69.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.362 . . . . 0.0 110.851 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.571 HD22 ' CD2' ' A' ' 156' ' ' HIS . 5.4 tt -48.52 -53.92 16.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.92 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 15.4 mt -53.76 -65.94 0.48 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.917 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.553 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 12.6 ttp180 -37.99 -46.01 0.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.866 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 3.3 m -61.34 -71.93 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.817 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.571 ' CD2' HD22 ' A' ' 152' ' ' LEU . 2.3 m-70 -37.37 -34.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.816 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.525 ' CD2' HD12 ' A' ' 161' ' ' ILE . 4.0 t80 -70.08 -57.48 4.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.9 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.5 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 20.2 mm-40 -71.11 -9.74 58.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.919 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.1 tpp85 -98.46 -36.87 9.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.878 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 66.3 mt -112.68 -50.12 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.101 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.525 HD12 ' CD2' ' A' ' 157' ' ' TYR . 34.3 mt -76.34 -0.14 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.546 ' C ' ' CD1' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -73.08 -60.87 1.66 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.674 0.749 . . . . 0.0 110.942 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.514 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.5 Cg_endo -69.8 -40.45 5.25 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.67 2.247 . . . . 0.0 112.331 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -61.04 -36.19 78.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.946 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -72.35 -61.31 1.84 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.908 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.508 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 11.1 ptt? -54.55 -37.96 66.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.841 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -65.4 -44.19 88.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.916 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 -96.03 38.07 1.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.96 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.7 m -142.29 118.7 10.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 162.86 -54.53 0.3 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.793 0.33 . . . . 0.0 111.111 179.978 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.6 t -95.17 130.3 41.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.85 0.357 . . . . 0.0 110.861 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.7 p -49.85 142.67 8.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.878 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.2 115.17 1.98 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.464 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.0 m 46.87 30.1 1.15 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.851 0.357 . . . . 0.0 110.879 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.7 t -67.22 132.28 47.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -133.3 63.83 0.61 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.5 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 48.4 m -109.41 102.76 11.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.807 0.337 . . . . 0.0 111.149 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 9.7 mmp_? -123.94 -53.69 1.74 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.46 ' O ' ' N ' ' A' ' 83' ' ' LEU . 66.4 t -83.86 -43.23 17.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.152 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.569 ' HG3' ' CD2' ' A' ' 113' ' ' TYR . 1.0 OUTLIER -36.93 -30.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.836 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.46 ' N ' ' O ' ' A' ' 81' ' ' VAL . 13.5 mt -72.11 -60.6 2.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.927 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 83' ' ' LEU . 49.9 t30 -37.04 -56.75 0.87 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -50.03 -44.81 51.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.92 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.0 mt -69.3 -66.48 0.58 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.889 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -44.2 -24.39 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.935 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -80.73 -62.75 1.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.94 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.465 HG23 ' CD2' ' A' ' 100' ' ' LEU . 15.1 tt -56.89 -26.4 24.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.131 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.09 -55.17 5.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.121 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -53.46 -33.18 53.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.928 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -69.46 -53.3 19.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.871 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 21.7 m95 -54.11 -55.04 31.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.894 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.439 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 11.3 pt-20 -48.59 -43.91 36.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.921 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.439 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 62.8 mt -61.61 -45.84 97.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.111 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -54.59 -41.05 69.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.984 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 126.86 42.26 0.29 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.472 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.2 m -164.24 169.9 16.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.881 0.372 . . . . 0.0 110.836 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.7 t -100.44 151.5 21.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.843 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.465 ' CD2' HG23 ' A' ' 89' ' ' ILE . 42.4 tp -97.17 117.3 31.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.877 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -113.77 146.6 39.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.941 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 66.5 mt -111.71 124.38 32.57 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.569 0.699 . . . . 0.0 111.15 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 154.02 68.47 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.684 2.256 . . . . 0.0 112.382 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -104.14 119.77 39.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.88 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 84.5 t -127.59 135.52 62.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.126 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 62.04 48.94 4.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.876 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 42.15 39.2 1.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.843 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -163.94 154.48 15.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.864 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.1 tt -58.36 152.15 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.114 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.421 ' C ' HD22 ' A' ' 110' ' ' LEU . 5.5 tt -97.48 124.63 41.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -85.75 76.0 10.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.871 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -53.3 -28.84 30.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.569 ' CD2' ' HG3' ' A' ' 82' ' ' LYS . 5.9 t80 -58.18 -52.59 64.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.936 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.447 ' O ' ' C ' ' A' ' 115' ' ' LEU . 23.9 m -63.06 -59.86 4.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 114' ' ' SER . 28.4 tp -34.74 -67.84 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.868 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 117' ' ' LYS . 68.6 m -54.16 -60.23 3.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.857 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 116' ' ' SER . 22.8 mmtt -37.7 -49.14 1.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.9 mt -62.65 -45.04 99.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.186 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.8 t -51.06 -65.89 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.119 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 83.5 mt -51.55 -52.47 20.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.136 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -46.55 -49.16 19.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.465 ' CB ' HG23 ' A' ' 128' ' ' ILE . 44.7 mm-40 -53.28 -48.46 68.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.89 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 153.8 34.4 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.498 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 96.14 -178.12 34.29 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.478 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.499 ' C ' ' CD1' ' A' ' 125' ' ' TYR . 1.0 OUTLIER -88.07 -35.91 17.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 0.0 110.912 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -69.56 -38.91 77.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.905 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.2 -57.87 6.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.105 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.567 HD13 ' CZ2' ' A' ' 134' ' ' TRP . 2.2 pp -56.57 -35.99 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.156 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.442 ' N ' HD11 ' A' ' 128' ' ' ILE . 39.1 m -67.71 -35.91 79.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -65.27 -46.06 81.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.448 ' O ' ' C ' ' A' ' 132' ' ' ARG . 3.7 t0 -88.18 24.55 1.83 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.448 ' C ' ' O ' ' A' ' 131' ' ' ASP . 60.0 mtp180 34.31 52.23 0.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.457 ' O ' ' C ' ' A' ' 134' ' ' TRP . 16.8 mmt180 -74.27 -24.39 59.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.848 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.567 ' CZ2' HD13 ' A' ' 128' ' ' ILE . 25.2 m95 -33.57 -45.39 0.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.33 -56.51 17.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.09 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.6 -40.59 92.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 90.2 t -54.14 -39.35 41.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.097 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.87 -52.86 15.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.145 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -54.25 -29.12 45.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -60.13 -35.25 74.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.867 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.0 tp -85.22 24.65 1.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.939 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 59.18 34.59 23.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.847 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -82.34 153.41 68.64 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.663 0.744 . . . . 0.0 110.954 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 113.55 3.41 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.666 2.244 . . . . 0.0 112.32 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 94.8 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.624 2.216 . . . . 0.0 112.322 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 173.54 -71.5 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.457 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -49.56 168.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.806 0.336 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -83.39 43.8 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 63.5 mt -54.59 -49.37 67.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.146 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -37.89 -52.36 2.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.466 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.2 t -62.21 -47.82 82.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.93 0.395 . . . . 0.0 110.84 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.57 HD22 ' CD2' ' A' ' 156' ' ' HIS . 6.5 tt -52.04 -46.56 65.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.951 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 154' ' ' ARG . 6.2 mt -59.93 -66.04 0.58 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.536 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 18.3 ttp180 -37.84 -49.2 1.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 74.5 m -57.07 -68.6 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.57 ' CD2' HD22 ' A' ' 152' ' ' LEU . 1.8 m-70 -38.15 -45.26 0.92 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.843 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.545 ' CE2' HG21 ' A' ' 161' ' ' ILE . 4.0 t80 -60.22 -59.37 5.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.434 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 5.5 mm-40 -67.14 -9.97 45.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -86.89 -54.39 4.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.8 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 38.6 mt -108.85 -39.92 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.075 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.545 HG21 ' CE2' ' A' ' 157' ' ' TYR . 15.0 mt -77.33 0.66 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.118 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.586 ' CE1' ' SD ' ' A' ' 166' ' ' MET . 0.2 OUTLIER -72.53 -60.48 2.06 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.662 0.744 . . . . 0.0 110.932 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.564 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.0 Cg_endo -69.79 -42.96 2.92 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.695 2.263 . . . . 0.0 112.326 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -56.82 -39.74 74.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.916 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -72.17 -65.5 0.77 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.897 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.586 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 8.5 ptt? -47.95 -42.3 27.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.833 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -71.96 -57.49 4.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.874 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.65 49.52 0.51 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 12.6 t -114.75 40.93 2.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.909 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 45.9 80.48 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.502 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.323 0 CA-C-O 120.777 0.322 . . . . 0.0 111.143 179.945 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.4 m -104.47 109.02 20.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 0.0 110.866 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.1 t -154.98 122.73 5.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.871 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -119.91 -76.68 0.48 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.486 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.1 p -56.71 91.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.897 0.379 . . . . 0.0 110.858 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 78.0 p -146.94 141.56 26.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.813 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -145.98 38.92 1.16 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.506 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 80' ' ' ARG . 16.7 m -67.18 -39.68 86.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.773 0.32 . . . . 0.0 111.117 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.423 ' C ' ' O ' ' A' ' 79' ' ' THR . 20.7 tpp180 -35.61 -44.79 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.886 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 84' ' ' ASN . 96.1 t -76.88 -59.52 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.099 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 81' ' ' VAL . 11.4 mptt -35.9 -31.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 81' ' ' VAL . 26.9 mt -71.8 -46.85 56.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.951 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.494 ' N ' ' O ' ' A' ' 81' ' ' VAL . 6.6 t30 -37.98 -48.63 1.2 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.417 ' CD2' ' HA ' ' A' ' 113' ' ' TYR . 29.4 t80 -63.76 -42.54 97.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.948 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 83' ' ' LEU . 25.1 mt -63.75 -56.4 15.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.913 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -57.75 -24.82 58.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.887 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -77.88 -60.98 2.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.539 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 20.7 tt -62.19 -31.07 50.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.151 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.41 -51.93 38.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.088 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -47.29 -27.88 1.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.875 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -80.24 -44.22 20.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -69.5 -55.35 10.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -40.1 -41.65 1.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.843 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 84.7 mt -68.02 -54.27 23.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.154 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -45.74 -32.76 2.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 129.94 -37.94 2.07 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.482 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 41.3 t -89.22 121.81 31.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.906 0.384 . . . . 0.0 110.856 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.7 t -60.09 172.45 0.79 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.85 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 19.5 tp -97.94 127.86 44.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.889 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.3 mttm -130.56 128.53 41.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 45.9 mm -95.63 123.31 56.58 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.609 0.719 . . . . 0.0 111.165 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.555 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 54.1 Cg_endo -69.77 146.82 61.31 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.625 2.217 . . . . 0.0 112.389 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -95.92 113.9 25.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.925 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 79.1 t -115.53 141.43 32.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.428 ' HG3' ' CD ' ' A' ' 144' ' ' PRO . 23.2 mm-40 47.39 53.76 10.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.908 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 19.7 ptt-85 43.04 42.58 3.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.85 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -163.6 153.52 15.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.907 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.8 tp -63.56 143.57 15.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.086 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.6 tt -89.82 123.75 34.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -86.14 68.24 10.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.846 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -47.55 -32.64 5.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.417 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 6.9 t80 -56.33 -65.28 0.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.923 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.3 p -51.79 -45.5 63.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.6 tp -45.92 -66.91 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.902 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.9 t -47.56 -51.38 21.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -47.67 -59.43 3.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.891 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 77.7 mt -50.99 -50.05 25.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.139 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 98.9 t -49.65 -63.21 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.126 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 74.4 mt -51.18 -48.74 31.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.125 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -52.58 -57.24 10.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.875 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -45.36 -49.51 12.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.916 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 154.51 36.62 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.499 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.07 175.12 40.91 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.491 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.506 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 1.2 t80 -82.78 -40.19 20.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.839 0.352 . . . . 0.0 110.892 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -64.2 -40.02 95.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.878 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.1 -64.47 0.92 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.126 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.43 ' CD1' ' CE2' ' A' ' 134' ' ' TRP . 2.0 pp -54.7 -34.5 30.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.156 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.506 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 22.5 m -66.88 -36.57 82.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.6 tptt -71.62 -42.1 68.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 132' ' ' ARG . 38.7 m-20 -88.34 22.88 2.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.868 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 131' ' ' ASP . 35.3 mtp180 34.46 43.43 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.844 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -74.76 -8.11 55.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.43 ' CE2' ' CD1' ' A' ' 128' ' ' ILE . 16.7 m95 -45.61 -47.55 14.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.902 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -46.66 -56.97 5.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.098 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -67.73 -56.67 8.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 87.0 t -43.23 -29.42 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.138 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.0 -49.18 11.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.141 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -59.56 -27.73 66.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -60.6 -26.16 66.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.837 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.467 HD22 ' CE2' ' A' ' 143' ' ' TYR . 20.3 tp -90.03 12.12 18.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.878 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 71.42 48.88 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.467 ' CE2' HD22 ' A' ' 141' ' ' LEU . 2.8 m-85 -99.94 158.59 31.78 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.681 0.753 . . . . 0.0 110.9 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.428 ' CD ' ' HG3' ' A' ' 106' ' ' GLU . 54.4 Cg_endo -69.72 111.42 2.8 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.714 2.276 . . . . 0.0 112.372 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 95.27 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.711 2.274 . . . . 0.0 112.307 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.52 -73.74 0.12 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.452 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -54.74 145.08 20.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.836 0.35 . . . . 0.0 110.888 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -63.76 81.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.864 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 71.4 mt -88.27 -45.59 15.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.101 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -37.98 -45.96 1.7 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.482 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.6 m -60.66 -51.38 69.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.372 . . . . 0.0 110.877 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.552 HD22 ' CD2' ' A' ' 156' ' ' HIS . 5.9 tt -50.2 -48.83 54.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.915 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 22.2 mt -57.32 -65.96 0.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -38.99 -46.38 1.33 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 157' ' ' TYR . 41.0 t -60.2 -68.53 0.28 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.555 ' CE1' ' HG3' ' A' ' 103' ' ' PRO . 2.4 m-70 -41.9 -24.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.842 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.55 ' CD2' HD13 ' A' ' 161' ' ' ILE . 7.9 t80 -78.42 -50.14 12.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.918 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.408 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 5.2 mm-40 -81.62 -9.86 59.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.87 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -96.0 -41.48 8.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 76.9 mt -112.49 -49.18 5.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.113 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.55 HD13 ' CD2' ' A' ' 157' ' ' TYR . 9.8 mt -76.88 6.39 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.152 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.645 ' C ' ' CD1' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -75.35 -62.63 0.79 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.666 0.745 . . . . 0.0 110.907 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.555 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.1 Cg_endo -69.81 -35.26 12.84 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.675 2.25 . . . . 0.0 112.329 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.539 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 65.3 t80 -60.51 -42.53 96.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.945 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -70.04 -55.07 10.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.883 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 2.7 mtm -62.74 -58.63 6.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.856 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.462 ' CB ' ' O ' ' A' ' 163' ' ' PRO . 29.3 t80 -47.99 -54.74 11.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.83 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -93.91 46.28 1.17 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.885 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 8.6 t -96.74 98.33 10.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.885 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -163.44 85.21 0.11 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.514 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.783 0.325 . . . . 0.0 111.128 179.97 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.8 p -166.95 155.25 9.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.841 0.353 . . . . 0.0 110.899 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 79.6 p -81.24 -49.7 10.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.845 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.61 85.78 0.18 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.53 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.7 t -40.7 105.31 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.835 0.35 . . . . 0.0 110.892 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 72.1 m -117.53 132.8 56.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.28 -98.34 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.526 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.7 t -95.64 126.1 40.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.769 0.318 . . . . 0.0 111.11 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -130.82 -64.79 0.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.878 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.459 ' O ' ' N ' ' A' ' 83' ' ' LEU . 61.1 t -80.74 -47.28 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.151 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.4 mttp -38.99 -27.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.926 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' ' 81' ' ' VAL . 36.9 mt -69.74 -49.29 54.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.925 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 81' ' ' VAL . 49.3 t-20 -40.67 -65.19 0.44 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -39.8 -47.4 2.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 12.6 mt -63.15 -66.77 0.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -44.51 -26.16 0.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -78.74 -70.58 0.49 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.9 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.532 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 7.5 tt -49.46 -32.26 6.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.131 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.442 ' N ' HG23 ' A' ' 89' ' ' ILE . . . -73.6 -49.82 24.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.103 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -52.63 -20.03 2.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -90.82 -42.12 10.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -68.3 -50.57 52.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 4.4 pt-20 -45.24 -29.36 0.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.862 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.411 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 86.5 mt -78.69 -54.67 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.089 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -45.67 -32.59 2.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 132.18 -30.0 3.25 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.479 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.3 m -98.72 146.63 25.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.904 0.383 . . . . 0.0 110.833 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 65.5 m -78.25 174.93 10.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.837 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 22.0 tp -90.67 117.12 29.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.921 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -115.84 141.98 47.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.863 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 25.8 mm -117.28 121.62 32.07 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.649 0.738 . . . . 0.0 111.116 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 166.42 27.63 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.72 2.28 . . . . 0.0 112.315 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -114.04 126.57 55.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 52.0 t -125.4 132.95 70.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.459 ' HG3' ' CD ' ' A' ' 144' ' ' PRO . 29.1 mm-40 56.9 52.05 9.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.404 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 11.8 ptp180 44.64 35.93 1.58 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.909 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.467 ' HG3' ' N ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -157.82 151.95 24.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.9 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.467 ' N ' ' HG3' ' A' ' 108' ' ' LYS . 15.7 tt -57.51 149.2 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.149 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.433 HD21 ' N ' ' A' ' 111' ' ' ASP . 5.9 tt -94.32 123.84 37.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.973 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.433 ' N ' HD21 ' A' ' 110' ' ' LEU . 22.1 t0 -79.99 69.56 6.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.851 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -51.25 -23.08 3.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.476 ' CE1' ' HG3' ' A' ' 117' ' ' LYS . 2.4 t80 -66.06 -57.51 7.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.95 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 115' ' ' LEU . 3.3 m -60.5 -59.43 5.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.867 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.423 ' C ' ' O ' ' A' ' 114' ' ' SER . 13.0 tp -36.21 -68.23 0.14 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.897 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 119' ' ' VAL . 42.0 t -50.78 -66.24 0.42 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.87 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.476 ' HG3' ' CE1' ' A' ' 113' ' ' TYR . 13.2 mmtp -36.85 -43.83 0.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.886 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 77.1 mt -64.82 -42.47 95.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.135 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.478 ' N ' ' O ' ' A' ' 116' ' ' SER . 95.2 t -59.22 -56.89 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.105 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 70.0 mt -61.46 -45.58 98.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -56.4 -52.09 65.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -50.89 -47.17 60.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.865 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 155.57 38.56 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.467 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 87.44 176.27 48.6 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.481 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.566 ' C ' ' CD1' ' A' ' 125' ' ' TYR . 0.6 OUTLIER -83.52 -36.94 23.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.368 . . . . 0.0 110.919 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -63.57 -41.09 98.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.85 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.56 -64.36 0.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.136 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.431 ' C ' HD11 ' A' ' 128' ' ' ILE . 2.2 pp -47.84 -32.17 3.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.136 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.468 ' SG ' ' CE1' ' A' ' 125' ' ' TYR . 22.1 m -70.18 -46.61 64.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.864 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -59.88 -40.62 89.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.897 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 132' ' ' ARG . 2.7 m-20 -86.65 17.35 3.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.85 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.413 ' HB3' ' NH1' ' A' ' 132' ' ' ARG . 14.5 mtp-105 37.7 45.72 0.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 134' ' ' TRP . 4.1 mmp_? -71.77 -20.15 61.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.56 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 50.5 m95 -36.01 -40.27 0.2 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.908 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.45 -52.65 64.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.076 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.5 mmt-85 -68.5 -38.85 81.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.887 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 78.2 t -56.27 -40.11 63.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -72.4 -47.69 47.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -62.04 -27.32 68.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.4 mmp_? -60.97 -35.7 77.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.854 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.55 HD22 ' CE2' ' A' ' 143' ' ' TYR . 14.8 tp -82.79 13.49 3.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.971 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 62.82 51.13 3.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.55 ' CE2' HD22 ' A' ' 141' ' ' LEU . 2.5 m-85 -91.43 159.68 38.5 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.677 0.751 . . . . 0.0 110.873 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.459 ' CD ' ' HG3' ' A' ' 106' ' ' GLU . 53.8 Cg_endo -69.78 118.47 5.7 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.683 2.255 . . . . 0.0 112.343 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 97.78 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.693 2.262 . . . . 0.0 112.36 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.54 -82.39 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.46 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 9.3 tttp -47.31 147.8 1.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.804 0.335 . . . . 0.0 110.88 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -66.68 82.68 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.895 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.444 ' CD1' ' HB3' ' A' ' 143' ' ' TYR . 64.0 mt -83.06 -50.77 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.136 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.11 -53.21 1.24 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.526 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.1 t -57.16 -61.59 2.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.903 0.382 . . . . 0.0 110.801 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.563 HD23 ' CD2' ' A' ' 156' ' ' HIS . 5.5 tt -39.12 -55.95 1.54 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.935 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 23.9 mt -50.57 -65.9 0.48 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.56 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 13.2 ttp180 -38.84 -45.78 1.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.4 t -61.12 -69.01 0.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.854 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.563 ' CD2' HD23 ' A' ' 152' ' ' LEU . 2.0 m-70 -39.91 -36.16 0.43 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.799 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.538 ' CE2' HG21 ' A' ' 161' ' ' ILE . 3.4 t80 -69.78 -58.93 3.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 18.4 mt-10 -66.92 -10.08 45.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.901 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -92.95 -53.08 4.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.812 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 60.7 mt -104.73 -43.47 8.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.07 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.538 HG21 ' CE2' ' A' ' 157' ' ' TYR . 32.3 mt -76.02 -2.29 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.163 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.624 ' C ' ' CD1' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -72.2 -60.45 2.24 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.656 0.741 . . . . 0.0 110.931 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 162' ' ' TYR . 53.9 Cg_endo -69.73 -43.56 2.61 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.699 2.266 . . . . 0.0 112.337 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.532 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 17.6 t80 -54.66 -41.55 70.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -76.26 -68.44 0.59 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.34 -30.25 0.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -75.7 -55.59 5.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.9 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -93.52 41.98 1.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.873 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 54.5 m -144.44 129.68 18.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 100.78 48.87 1.44 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.476 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.822 0.344 . . . . 0.0 111.075 179.959 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 79.4 p -98.47 101.01 12.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.866 0.365 . . . . 0.0 110.866 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.5 t -97.66 92.4 5.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.912 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.39 -170.31 12.5 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.499 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m -90.69 114.31 26.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.905 0.383 . . . . 0.0 110.869 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 t -160.24 165.41 31.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.846 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 86.71 48.91 4.29 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.513 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 80' ' ' ARG . 99.0 m -122.31 -41.81 2.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.765 0.316 . . . . 0.0 111.11 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 79' ' ' THR . 23.2 mmt180 -35.84 -50.06 0.64 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.929 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.429 ' O ' ' N ' ' A' ' 84' ' ' ASN . 89.3 t -88.74 -39.43 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.093 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 81' ' ' VAL . 74.4 tttt -37.22 -33.09 0.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 81' ' ' VAL . 21.1 mt -84.09 -43.73 14.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.892 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 81' ' ' VAL . 39.1 t30 -40.16 -53.31 2.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.601 ' CE1' ' NZ ' ' A' ' 117' ' ' LYS . 42.4 t80 -55.18 -50.34 69.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.939 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.3 mt -55.44 -59.88 4.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.906 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.3 -39.27 66.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.862 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -62.9 -57.83 9.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.444 HG23 ' N ' ' A' ' 90' ' ' ALA . 18.0 tt -61.02 -34.99 62.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.14 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.444 ' N ' HG23 ' A' ' 89' ' ' ILE . . . -68.26 -51.27 46.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.09 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -44.14 -35.31 2.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.929 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -72.41 -50.54 25.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.407 ' O ' ' C ' ' A' ' 94' ' ' GLU . 87.0 m95 -63.38 -58.5 6.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.949 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.438 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 21.7 pt-20 -37.68 -39.34 0.33 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.438 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 97.2 mt -71.24 -55.09 15.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.125 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -44.71 -35.81 2.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.923 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 120.31 -30.52 5.58 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.497 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.403 ' O ' ' C ' ' A' ' 99' ' ' SER . 0.7 OUTLIER -86.87 94.85 9.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.907 0.384 . . . . 0.0 110.84 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 98' ' ' SER . 51.3 p -38.02 150.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.837 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 18.5 tp -88.06 107.42 18.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.931 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -102.28 115.55 30.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.89 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.4 mp -81.12 123.1 82.08 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.647 0.737 . . . . 0.0 111.12 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 144.55 54.44 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.671 2.248 . . . . 0.0 112.325 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -102.63 109.47 21.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.916 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 90.4 t -113.32 140.48 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.105 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.47 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 5.7 mm-40 57.45 43.62 22.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.912 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.47 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 5.3 ptm180 48.22 33.49 3.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.901 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -153.71 157.47 39.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 6.8 tt -63.6 139.63 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.114 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.1 tt -84.85 122.11 28.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.941 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -80.03 74.04 6.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.4 ' HG ' ' N ' ' A' ' 113' ' ' TYR . 1.5 pt? -57.48 -32.08 66.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.901 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.529 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -56.57 -64.32 0.91 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.921 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 115' ' ' LEU . 5.3 m -53.11 -63.97 0.97 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.849 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 114' ' ' SER . 13.7 tp -34.19 -53.89 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.879 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.3 t -56.46 -64.32 0.91 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.601 ' NZ ' ' CE1' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -45.23 -51.41 10.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.9 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 69.8 mt -54.33 -40.96 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.144 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 96.9 t -66.2 -39.46 84.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.089 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 62.0 mt -70.28 -55.21 15.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.128 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.465 ' HG3' ' N ' ' A' ' 122' ' ' GLU . 5.6 pt-20 -49.31 -37.55 24.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.889 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.465 ' N ' ' HG3' ' A' ' 121' ' ' GLU . 35.7 mt-10 -65.41 -27.23 68.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.845 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 134.86 28.44 0.45 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.462 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.99 -175.65 35.37 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.495 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.485 ' C ' ' CD1' ' A' ' 125' ' ' TYR . 1.1 t80 -86.25 -38.6 17.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.827 0.346 . . . . 0.0 110.933 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -62.37 -48.39 79.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.897 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -53.75 -71.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.09 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.6 pp -46.31 -34.86 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.415 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 25.7 m -69.01 -32.58 72.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.855 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -68.46 -46.64 69.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 132' ' ' ARG . 1.1 m-20 -90.11 24.62 2.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 131' ' ' ASP . 23.6 mmt85 35.45 44.9 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.415 ' NH1' ' HB2' ' A' ' 131' ' ' ASP . 71.1 mtt85 -83.91 21.69 1.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.842 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.525 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 28.5 m95 -66.16 -42.77 88.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.45 -47.9 75.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.086 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -47.53 78.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 73.1 t -53.88 -37.89 34.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.153 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.91 -53.12 35.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.097 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -58.31 -38.22 76.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.908 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -59.19 -31.61 69.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.551 HD13 ' CE2' ' A' ' 143' ' ' TYR . 1.5 tm? -80.77 12.52 3.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 65.71 53.53 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.839 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.551 ' CE2' HD13 ' A' ' 141' ' ' LEU . 6.6 m-85 -109.0 159.01 32.69 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.636 0.731 . . . . 0.0 110.956 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 112.5 3.1 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.712 2.274 . . . . 0.0 112.333 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 122.43 9.12 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.674 2.249 . . . . 0.0 112.372 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.96 -70.1 0.3 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.488 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -58.15 171.0 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.764 0.316 . . . . 0.0 110.915 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.2 42.2 1.02 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.917 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.423 ' O ' ' C ' ' A' ' 150' ' ' GLY . 92.1 mt -44.5 -45.02 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.151 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.05 -54.78 1.19 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.511 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.9 m -58.93 -50.26 74.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.948 0.404 . . . . 0.0 110.834 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.556 HD21 ' CD2' ' A' ' 156' ' ' HIS . 8.3 tt -51.74 -50.13 61.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.956 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 25.5 mt -52.94 -64.73 0.72 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.902 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.525 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 14.3 ttp180 -41.1 -46.02 2.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 47.3 t -57.92 -58.88 6.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.841 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.556 ' CD2' HD21 ' A' ' 152' ' ' LEU . 1.8 m-70 -51.98 -49.21 63.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.542 ' CD2' HD11 ' A' ' 161' ' ' ILE . 3.8 t80 -57.79 -57.59 12.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.963 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.471 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 39.0 mt-10 -66.88 -9.8 41.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.877 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 37.4 ttt-85 -87.76 -57.4 2.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.857 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 78.6 mt -104.76 -41.22 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.169 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.542 HD11 ' CD2' ' A' ' 157' ' ' TYR . 14.2 mt -75.96 -0.48 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.113 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.634 ' C ' ' CD1' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -73.32 -61.31 1.48 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.716 0.769 . . . . 0.0 110.941 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.468 ' CD ' ' CB ' ' A' ' 162' ' ' TYR . 53.8 Cg_endo -69.7 -33.65 16.38 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.737 2.292 . . . . 0.0 112.341 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.405 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 24.5 t80 -64.75 -46.38 82.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.887 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -69.29 -55.46 10.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.865 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.412 ' CG ' ' HA ' ' A' ' 163' ' ' PRO . 0.5 OUTLIER -55.02 -40.83 70.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -62.27 -45.7 92.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.878 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -114.22 81.47 1.54 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.901 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 15.8 t -127.36 87.85 2.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.841 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 179.61 -95.45 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.476 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.732 0.301 . . . . 0.0 111.102 179.963 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.1 m -130.41 146.68 52.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.86 0.362 . . . . 0.0 110.863 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 73.5 m -45.34 158.04 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.853 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.72 67.96 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.484 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.0 p -101.08 152.13 20.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.884 0.374 . . . . 0.0 110.873 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.8 t -117.1 35.0 4.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.897 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.44 -167.57 43.12 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.462 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.2 t -113.95 125.07 53.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.805 0.336 . . . . 0.0 111.152 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.1 tpp180 -131.48 -69.46 0.62 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.838 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.433 ' O ' ' N ' ' A' ' 83' ' ' LEU . 99.9 t -78.01 -41.33 27.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.121 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 81' ' ' VAL . 3.3 mptt -36.12 -33.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.915 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 81' ' ' VAL . 35.5 mt -65.42 -51.25 61.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.958 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.432 ' O ' ' N ' ' A' ' 87' ' ' ASP . 64.1 t-20 -38.13 -68.0 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.5 ' CD2' ' HA ' ' A' ' 113' ' ' TYR . 29.9 t80 -36.79 -50.51 0.85 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.938 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.6 mt -62.55 -41.99 99.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.899 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 84' ' ' ASN . 62.3 m-20 -61.76 -18.06 58.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -91.55 -57.33 2.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.96 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.6 tt -63.5 -39.39 85.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.149 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.03 -38.86 86.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.09 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -61.29 -28.5 69.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -82.58 -39.44 22.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.875 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.487 ' O ' ' N ' ' A' ' 96' ' ' GLN . 27.0 m95 -68.35 -61.05 2.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.432 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 5.7 pt-20 -36.96 -31.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.925 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 93' ' ' TRP . 96.7 mt -73.4 -45.41 52.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.101 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 93' ' ' TRP . 61.2 mm-40 -56.51 -33.07 65.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 131.78 -42.24 1.41 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.472 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 37.9 m -86.71 140.32 29.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.913 0.387 . . . . 0.0 110.848 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.0 p -71.17 175.31 5.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.87 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 25.5 tp -104.35 112.12 25.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.1 ttpt -109.67 130.46 55.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.1 mp -96.04 124.17 52.82 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.586 0.707 . . . . 0.0 111.15 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.445 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 54.2 Cg_endo -69.76 142.87 49.1 Favored 'Trans proline' 0 N--CA 1.466 -0.125 0 C-N-CA 122.707 2.272 . . . . 0.0 112.363 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -94.27 113.7 25.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.898 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.5 t -113.17 142.68 24.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.091 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 19.1 mm-40 50.61 48.62 22.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.911 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.434 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 18.4 ptt-85 45.72 33.22 1.41 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.868 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.8 pttm -151.6 164.76 36.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.856 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.4 tt -69.22 144.82 13.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.119 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.433 HD21 ' N ' ' A' ' 112' ' ' LEU . 6.4 tt -92.97 121.76 34.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.939 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -79.88 57.36 2.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.876 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.433 ' N ' HD21 ' A' ' 110' ' ' LEU . 1.5 pt? -41.57 -29.29 0.16 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.5 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 4.9 t80 -59.31 -58.72 7.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.934 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 115' ' ' LEU . 11.0 t -56.05 -57.67 11.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.89 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 114' ' ' SER . 11.1 tp -36.76 -62.76 0.45 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.915 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.7 p -51.13 -53.93 29.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.853 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 18.2 mmtm -49.27 -54.2 17.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.409 ' O ' ' C ' ' A' ' 119' ' ' VAL . 64.6 mt -49.06 -69.22 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.13 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.409 ' C ' ' O ' ' A' ' 118' ' ' ILE . 90.8 t -37.09 -62.37 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.107 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 89.0 mt -45.18 -56.43 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -52.57 -56.89 12.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -38.36 -50.35 1.48 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 151.26 39.25 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.492 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.3 -179.43 40.65 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.504 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.516 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 1.9 t80 -87.56 -43.79 11.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.845 0.355 . . . . 0.0 110.931 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -61.28 -36.1 79.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.912 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.92 -65.58 0.66 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.13 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.592 ' CD1' ' CE2' ' A' ' 134' ' ' TRP . 1.8 pp -54.15 -31.8 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.087 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.516 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 26.8 m -70.81 -41.92 70.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.831 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -68.88 -26.44 65.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.855 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -103.03 15.71 28.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.821 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 67.5 mtp85 41.91 29.36 0.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.856 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 27.7 mtt-85 -62.15 -8.78 6.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.839 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.592 ' CE2' ' CD1' ' A' ' 128' ' ' ILE . 20.7 m95 -44.13 -52.18 7.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -40.83 -51.18 3.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.099 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -63.63 -51.38 65.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.857 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.6 t -49.4 -38.39 12.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.24 -57.48 4.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -57.87 -18.25 21.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -69.94 -25.36 63.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.857 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.516 HD21 ' CE2' ' A' ' 143' ' ' TYR . 14.6 tp -94.28 27.18 3.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 62.25 36.48 14.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.849 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.516 ' CE2' HD21 ' A' ' 141' ' ' LEU . 5.3 m-85 -92.2 147.29 34.33 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.706 0.765 . . . . 0.0 110.925 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 118.95 5.99 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.68 2.253 . . . . 0.0 112.34 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 125.81 12.58 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.702 2.268 . . . . 0.0 112.338 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 131.76 -55.61 0.76 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.427 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -54.6 168.67 0.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.762 0.315 . . . . 0.0 110.947 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.422 ' CG ' ' O ' ' A' ' 148' ' ' ASN . 13.1 p-10 -83.86 43.36 0.91 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.91 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.424 ' O ' ' C ' ' A' ' 150' ' ' GLY . 70.5 mt -67.74 -52.51 39.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.096 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.28 -53.07 1.3 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.488 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.2 t -57.53 -58.62 7.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 0.0 110.849 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.554 HD22 ' CD2' ' A' ' 156' ' ' HIS . 7.2 tt -42.06 -49.46 4.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.943 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 23.6 mt -55.98 -65.84 0.53 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.938 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.458 ' HD2' ' NE1' ' A' ' 134' ' ' TRP . 32.0 ttt180 -39.21 -39.97 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 156' ' ' HIS . 9.3 t -67.56 -70.01 0.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.861 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.554 ' CD2' HD22 ' A' ' 152' ' ' LEU . 2.0 m-70 -37.17 -33.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.86 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.549 ' CD2' HD11 ' A' ' 161' ' ' ILE . 12.0 t80 -70.38 -56.27 7.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -73.59 -9.81 59.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.858 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? -92.07 -49.0 6.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.908 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 88.3 mt -109.91 -44.18 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.118 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.549 HD11 ' CD2' ' A' ' 157' ' ' TYR . 14.3 mt -77.45 4.24 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.148 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.606 ' CE1' ' SD ' ' A' ' 166' ' ' MET . 0.1 OUTLIER -74.24 -61.48 1.21 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.662 0.744 . . . . 0.0 110.905 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.567 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 54.2 Cg_endo -69.73 -30.71 21.98 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.649 2.232 . . . . 0.0 112.354 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -69.2 -42.58 75.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.973 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -67.8 -57.65 5.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.878 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.606 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 24.7 ptm -53.42 -47.7 69.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -59.12 -49.07 79.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.897 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 -104.76 73.26 1.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.894 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 28.4 t -118.69 -51.22 2.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -153.0 -89.99 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.485 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.805 0.336 . . . . 0.0 111.069 179.955 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 92.4 p -119.32 118.94 32.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 0.0 110.856 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.6 p -81.87 105.18 12.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.835 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -138.11 132.77 5.99 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.522 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 61.9 p -64.97 147.54 53.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.874 0.369 . . . . 0.0 110.87 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 55.4 m -118.64 117.27 28.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.825 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.42 70.23 0.19 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.471 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.1 t -104.59 41.69 1.29 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.806 0.336 . . . . 0.0 111.155 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -75.48 -66.78 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.859 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 57.8 t -80.01 -37.23 17.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.156 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.546 ' HD3' ' CD2' ' A' ' 113' ' ' TYR . 1.2 tppt? -40.64 -28.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.891 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.5 mt -77.66 -49.59 14.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.924 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -40.49 -56.84 1.96 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.412 ' CE1' ' HE2' ' A' ' 117' ' ' LYS . 40.3 t80 -41.42 -36.17 0.81 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.2 mt -76.48 -44.29 36.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -59.33 -38.81 81.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.859 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -66.25 -63.76 1.01 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.898 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.557 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 19.4 tt -52.54 -30.5 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.03 -56.24 6.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.059 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -44.24 -27.5 0.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.939 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -78.68 -46.75 18.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.43 ' O ' ' N ' ' A' ' 95' ' ' ILE . 66.2 m95 -69.2 -57.68 5.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.96 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 93' ' ' TRP . 9.2 pt-20 -36.91 -32.53 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.43 ' N ' ' O ' ' A' ' 93' ' ' TRP . 96.7 mt -76.22 -51.75 19.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.173 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -47.58 -40.12 18.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.06 -40.57 1.17 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.47 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.7 m -96.56 144.51 26.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.892 0.377 . . . . 0.0 110.833 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.5 t -76.64 171.68 14.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.86 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.5 tp -82.46 104.71 12.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.964 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -96.13 111.07 23.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.0 mt -94.35 119.56 66.33 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.603 0.716 . . . . 0.0 111.158 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.405 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 53.5 Cg_endo -69.75 151.22 69.1 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.676 2.251 . . . . 0.0 112.36 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -102.52 115.17 30.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.853 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.499 ' CG1' ' CD ' ' A' ' 106' ' ' GLU . 26.2 t -122.04 144.61 30.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.174 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.499 ' CD ' ' CG1' ' A' ' 105' ' ' VAL . 49.1 mp0 60.76 44.74 10.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.92 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.496 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 15.2 ptm180 46.43 39.79 7.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.876 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -171.0 154.0 3.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.865 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.8 tt -52.29 138.67 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.4 tt -75.04 144.73 42.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -103.41 75.05 1.31 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.873 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -65.12 -36.18 83.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.9 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.546 ' CD2' ' HD3' ' A' ' 82' ' ' LYS . 38.1 t80 -46.71 -64.76 0.69 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 115' ' ' LEU . 36.6 m -56.93 -60.01 4.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.87 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 114' ' ' SER . 13.1 tp -34.93 -65.24 0.23 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.917 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 52.4 m -48.37 -56.88 7.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.868 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.412 ' HE2' ' CE1' ' A' ' 85' ' ' TYR . 2.2 mptp? -49.77 -62.58 1.48 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.891 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 95.6 mt -38.46 -64.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.157 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.2 t -45.0 -59.13 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.112 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 79.2 mt -45.91 -34.81 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.141 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -76.67 -51.77 10.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.895 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.422 ' CB ' HG22 ' A' ' 128' ' ' ILE . 21.0 mt-10 -43.54 -46.36 6.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.896 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 151.69 37.15 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.505 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.59 173.97 47.08 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.477 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 2.4 t80 -82.47 -44.34 16.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.849 0.357 . . . . 0.0 110.929 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -59.67 -42.59 93.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.848 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.15 -70.96 0.18 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.094 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.422 HG22 ' CB ' ' A' ' 122' ' ' GLU . 1.9 pp -45.28 -32.74 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.157 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 22.3 m -68.77 -39.66 80.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -66.27 -41.77 89.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 132' ' ' ARG . 2.1 t70 -88.56 19.89 3.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.886 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.429 ' C ' ' O ' ' A' ' 131' ' ' ASP . 26.1 mtt180 35.47 51.92 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 134' ' ' TRP . 23.4 mtp180 -80.75 -14.54 58.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.827 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.549 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 42.6 m95 -37.56 -56.61 1.01 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.921 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -40.08 -55.83 2.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.105 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 19.8 mmt85 -60.97 -51.49 69.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 84.1 t -46.17 -37.94 3.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.124 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -73.61 -45.47 52.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.088 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -62.99 -17.41 62.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.932 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.9 mmt85 -76.61 -28.99 56.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.528 HD23 ' CE2' ' A' ' 143' ' ' TYR . 14.7 tp -91.88 20.1 6.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.938 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 54.62 52.98 11.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.841 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.528 ' CE2' HD23 ' A' ' 141' ' ' LEU . 4.9 m-85 -89.42 148.33 40.19 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.676 0.75 . . . . 0.0 110.9 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.468 ' CD ' ' HG2' ' A' ' 106' ' ' GLU . 54.0 Cg_endo -69.71 114.57 3.74 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.733 2.288 . . . . 0.0 112.362 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 132.62 23.77 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.701 2.267 . . . . 0.0 112.37 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.36 -63.14 0.6 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.459 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -70.23 156.78 38.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.822 0.344 . . . . 0.0 110.911 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.417 ' CG ' ' O ' ' A' ' 148' ' ' ASN . 16.5 p-10 -75.14 83.84 2.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.873 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.428 ' O ' ' C ' ' A' ' 150' ' ' GLY . 51.5 mt -92.2 -52.09 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.124 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.25 -54.97 1.24 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.473 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 68.0 m -57.91 -53.83 53.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.862 0.363 . . . . 0.0 110.862 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.64 ' CD2' ' CD2' ' A' ' 156' ' ' HIS . 5.3 tt -46.37 -49.76 17.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.928 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 26.5 mt -56.33 -66.07 0.5 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.549 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 9.7 ttt-85 -38.32 -40.31 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 156' ' ' HIS . 11.5 t -68.16 -71.15 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.64 ' CD2' ' CD2' ' A' ' 152' ' ' LEU . 2.2 m-70 -37.03 -37.91 0.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.872 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.414 ' CD2' HD13 ' A' ' 161' ' ' ILE . 7.8 t80 -65.01 -66.58 0.52 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.933 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 20.2 mm-40 -64.91 -9.94 25.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.911 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 20.3 mmm-85 -86.81 -56.25 3.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.845 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 62.2 mt -105.7 -43.74 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.096 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.414 HD13 ' CD2' ' A' ' 157' ' ' TYR . 13.2 mt -72.61 -0.69 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.159 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.647 ' C ' ' CD1' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -75.67 -63.24 0.68 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.675 0.75 . . . . 0.0 110.89 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.561 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 54.3 Cg_endo -69.75 -31.26 20.93 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.661 2.241 . . . . 0.0 112.355 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.557 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 14.5 t80 -64.5 -36.31 83.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.925 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -77.32 -56.17 4.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.846 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.51 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 13.1 ptt? -52.4 -43.79 64.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.878 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.408 ' N ' ' CG ' ' A' ' 166' ' ' MET . 54.5 t80 -66.09 -56.88 9.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.888 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -88.29 38.99 0.88 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 12.2 t -86.29 -52.11 5.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.835 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 168.77 -75.12 0.12 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.48 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.792 0.329 . . . . 0.0 111.089 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.0 p -50.74 155.19 1.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.864 0.364 . . . . 0.0 110.862 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.8 t -74.96 -49.53 19.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.849 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.05 -130.13 1.76 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.519 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.1 p -159.9 122.45 3.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.84 0.352 . . . . 0.0 110.894 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.4 t -112.27 -52.11 2.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.818 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 141.87 166.72 10.99 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.484 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 95.7 m -60.83 92.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.777 0.322 . . . . 0.0 111.162 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.2 mmp_? -119.77 -50.14 2.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.471 ' O ' ' N ' ' A' ' 83' ' ' LEU . 73.1 t -77.63 -43.51 29.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.14 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 81' ' ' VAL . 4.2 mptt -35.24 -32.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.913 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 81' ' ' VAL . 63.5 mt -66.62 -53.33 35.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.912 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' A' ' 81' ' ' VAL . 4.6 t30 -39.57 -56.68 1.61 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -54.11 -37.74 64.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.92 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.456 ' CD2' HD21 ' A' ' 112' ' ' LEU . 28.1 mt -70.13 -59.31 2.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.945 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.42 -33.14 42.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -66.49 -67.75 0.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.548 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 8.2 tt -50.18 -37.27 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.093 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.28 -52.76 44.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.073 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.0 tttm -45.32 -30.68 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.551 ' CD1' ' CD2' ' A' ' 167' ' ' PHE . 8.3 t80 -79.46 -39.67 31.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.891 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.478 ' O ' ' N ' ' A' ' 95' ' ' ILE . 61.9 m95 -70.31 -64.21 0.94 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.924 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 93' ' ' TRP . 6.0 pt-20 -34.82 -33.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' A' ' 93' ' ' TRP . 96.5 mt -74.02 -50.33 29.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.116 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 93' ' ' TRP . 28.8 mm-40 -55.59 -18.64 8.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.929 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 104.12 -37.42 3.77 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.496 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.7 p -79.35 92.77 5.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.824 0.345 . . . . 0.0 110.842 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 40.8 t -41.46 159.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.832 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.405 HD11 ' CD1' ' A' ' 93' ' ' TRP . 64.4 tp -93.29 143.78 25.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.958 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -138.61 121.14 16.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.918 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 60.8 mt -88.68 123.11 68.61 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.627 0.727 . . . . 0.0 111.118 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 158.8 55.7 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.665 2.243 . . . . 0.0 112.388 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -110.76 107.38 16.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.906 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 58.3 t -110.72 136.1 47.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.092 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.499 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 36.2 mm-40 61.35 44.46 9.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.944 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.499 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 14.3 ptp180 46.57 33.55 2.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.873 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.3 ptmm? -155.82 155.47 33.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.926 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.4 tt -57.5 145.57 8.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.158 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.8 tt -96.14 113.66 25.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.935 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -79.84 80.72 6.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.463 ' HG ' ' N ' ' A' ' 113' ' ' TYR . 1.9 pt? -53.13 -42.42 66.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.926 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.463 ' N ' ' HG ' ' A' ' 112' ' ' LEU . 15.0 t80 -41.25 -53.59 3.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.918 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.8 m -61.27 -45.84 92.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.85 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.6 tp -55.95 -63.76 1.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 73.5 m -50.52 -44.69 56.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.857 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.438 ' HE2' ' CE1' ' A' ' 113' ' ' TYR . 28.7 mmtt -60.44 -66.11 0.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.908 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.466 ' CG2' HG11 ' A' ' 137' ' ' VAL . 21.3 mt -43.72 -28.17 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.133 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 43.3 t -77.12 -40.88 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.12 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 67.9 mt -72.3 -41.4 65.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.171 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -62.42 -37.15 84.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.404 ' OE1' ' CG2' ' A' ' 128' ' ' ILE . 10.5 mt-10 -66.21 -26.96 67.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.905 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 135.08 29.86 0.38 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.461 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.3 -173.37 34.21 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.494 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.537 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 2.6 t80 -86.98 -43.79 12.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.884 0.373 . . . . 0.0 110.914 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -60.97 -37.43 82.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.876 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.8 -68.64 0.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.058 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.496 HD12 ' CE2' ' A' ' 134' ' ' TRP . 1.6 pp -52.34 -35.78 20.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.119 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.537 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 54.5 m -64.5 -36.47 84.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.59 -41.39 79.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 132' ' ' ARG . 16.3 m-20 -94.78 20.48 8.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.892 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 131' ' ' ASP . 24.7 ptt85 35.21 48.2 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.839 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -85.72 17.92 3.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.841 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.553 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 41.8 m95 -60.39 -48.85 79.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.938 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -48.42 -47.4 37.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.126 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.431 ' NH1' ' HB3' ' A' ' 136' ' ' ARG . 5.4 mmm180 -61.91 -58.56 7.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.466 HG11 ' CG2' ' A' ' 118' ' ' ILE . 98.5 t -46.75 -31.88 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.61 -58.34 4.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.088 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -52.59 -29.51 26.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 140' ' ' ARG . 5.9 mmm180 -52.82 -39.68 62.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.883 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.557 HD21 ' CE2' ' A' ' 143' ' ' TYR . 14.8 tp -82.93 17.93 1.77 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.92 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 61.67 43.09 10.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.557 ' CE2' HD21 ' A' ' 141' ' ' LEU . 3.3 m-85 -83.25 152.37 64.57 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.689 0.757 . . . . 0.0 110.947 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 114.13 3.6 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.692 2.261 . . . . 0.0 112.331 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 109.33 2.28 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.679 2.252 . . . . 0.0 112.349 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 154.94 -67.95 0.3 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.49 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -60.93 152.02 28.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.801 0.334 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -68.11 82.55 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.849 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 90.5 mt -92.61 -46.52 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -37.39 -58.3 1.36 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.491 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.8 m -56.71 -48.01 78.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.91 0.386 . . . . 0.0 110.846 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.55 HD22 ' CD2' ' A' ' 156' ' ' HIS . 6.7 tt -50.57 -51.34 49.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.9 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 11.1 mt -57.51 -65.96 0.54 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.553 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 23.9 ttp180 -38.45 -55.02 1.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.86 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.428 ' OG ' ' N ' ' A' ' 156' ' ' HIS . 48.1 p -50.41 -64.72 0.72 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.824 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.55 ' CD2' HD22 ' A' ' 152' ' ' LEU . 2.0 m-70 -43.04 -34.06 0.95 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.543 ' CD2' HD12 ' A' ' 161' ' ' ILE . 3.1 t80 -69.71 -69.55 0.34 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.476 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 3.3 mp0 -61.24 -10.11 6.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.88 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 10.6 tpp85 -84.59 -53.35 5.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 74.1 mt -110.48 -39.18 3.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.151 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.543 HD12 ' CD2' ' A' ' 157' ' ' TYR . 13.7 mt -77.04 -0.69 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.115 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.543 ' C ' ' CD1' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -72.02 -60.34 2.38 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.65 0.738 . . . . 0.0 110.882 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.499 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.8 Cg_endo -69.78 -36.69 10.29 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.668 2.245 . . . . 0.0 112.324 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.548 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 15.3 t80 -59.47 -46.32 89.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.975 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -69.03 -60.17 2.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.924 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -39.33 66.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.551 ' CD2' ' CD1' ' A' ' 92' ' ' PHE . 57.5 t80 -60.16 -51.21 70.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.866 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -92.55 48.05 1.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 54.3 p -123.06 118.3 27.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.811 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 176.84 -93.42 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.461 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.793 0.33 . . . . 0.0 111.094 -179.975 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.549 -0.22 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.0 t -119.98 42.24 2.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.905 0.383 . . . . 0.0 110.867 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.6 p -122.92 144.04 49.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.844 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.84 111.83 0.5 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.52 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.1 m -71.54 -61.89 1.61 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.851 0.357 . . . . 0.0 110.914 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.3 t -78.78 -51.61 9.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.837 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.68 -179.96 41.79 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.479 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.6 m -102.67 90.43 3.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.748 0.308 . . . . 0.0 111.155 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.3 mmt-85 -113.36 -58.63 2.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 83' ' ' LEU . 67.6 t -76.71 -42.03 33.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.161 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 81' ' ' VAL . 1.1 mptm? -36.34 -31.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.913 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' ' 81' ' ' VAL . 18.5 mt -76.75 -51.8 10.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 83' ' ' LEU . 44.1 t-20 -38.35 -64.98 0.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.868 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.452 ' CD2' ' HA ' ' A' ' 113' ' ' TYR . 69.3 t80 -45.4 -39.94 7.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.927 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 35.0 mt -70.15 -63.68 1.04 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -44.46 -27.21 0.42 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.849 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -78.15 -67.6 0.72 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.93 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.569 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 7.9 tt -45.64 -43.0 3.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.34 -53.42 55.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.079 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -42.07 -41.54 2.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.867 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -68.77 -43.8 74.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.871 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.427 ' O ' ' C ' ' A' ' 94' ' ' GLU . 45.4 m95 -62.27 -64.52 0.9 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 93' ' ' TRP . 7.7 pt-20 -36.37 -41.38 0.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.858 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.425 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 85.6 mt -65.09 -49.82 77.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.133 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -49.61 -44.56 47.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.39 -49.64 0.61 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.488 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 32.5 t -90.15 130.98 36.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.908 0.385 . . . . 0.0 110.884 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.7 m -65.14 164.51 12.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.862 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.8 tp -93.34 154.17 18.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.942 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.7 mmmt -145.09 126.47 14.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.873 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.65 122.67 67.94 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.661 0.743 . . . . 0.0 111.149 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.457 ' HG2' ' CD1' ' A' ' 110' ' ' LEU . 53.9 Cg_endo -69.77 161.49 45.74 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.709 2.273 . . . . 0.0 112.329 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -117.08 117.66 30.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 72.2 t -121.57 140.26 46.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.143 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 107' ' ' ARG . 2.6 mm-40 56.29 54.99 7.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.415 ' HB3' ' NH1' ' A' ' 107' ' ' ARG . 4.2 ptp180 37.09 39.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -157.42 150.16 23.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.9 tt -54.47 140.03 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.155 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.457 ' CD1' ' HG2' ' A' ' 103' ' ' PRO . 4.1 tt -86.45 119.13 26.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -86.76 88.62 7.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -73.72 -22.38 59.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.452 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 5.6 t80 -59.65 -54.71 43.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 115' ' ' LEU . 58.9 p -61.13 -55.22 34.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.887 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.448 ' C ' ' O ' ' A' ' 114' ' ' SER . 27.3 tp -34.67 -59.28 0.47 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.917 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.8 t -59.99 -55.77 29.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.863 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -43.42 -45.54 6.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.884 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 27.3 mt -63.44 -45.69 97.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.13 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.9 t -51.33 -56.03 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.135 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 84.1 mt -56.32 -46.58 81.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.123 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -56.46 -56.8 16.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.447 ' HB2' ' CG2' ' A' ' 128' ' ' ILE . 33.2 mm-40 -40.69 -52.85 2.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 155.26 34.16 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.488 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.39 178.58 34.13 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.479 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.574 ' CE2' ' SG ' ' A' ' 129' ' ' CYS . 3.4 t80 -81.7 -55.77 4.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.889 0.376 . . . . 0.0 110.951 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -51.47 -29.64 17.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.905 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.06 -71.21 0.29 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.091 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.561 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.9 pp -50.38 -31.7 8.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.096 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.574 ' SG ' ' CE2' ' A' ' 125' ' ' TYR . 94.3 m -69.5 -44.07 71.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.886 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.1 tttm -64.26 -39.57 94.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 132' ' ' ARG . 80.2 m-20 -91.83 23.31 3.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.453 ' C ' ' O ' ' A' ' 131' ' ' ASP . 83.9 mtm180 34.24 35.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.9 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 131' ' ' ASP . 10.7 mmp_? -60.23 -19.49 54.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.846 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.561 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 24.8 m95 -36.6 -43.44 0.41 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.925 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.42 -56.99 14.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.036 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.426 ' NH1' ' HB2' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -59.91 -43.28 94.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 69.2 t -54.76 -36.61 37.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.107 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.09 -52.41 24.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.083 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -56.23 -37.24 69.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -51.39 -32.44 26.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.839 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.561 HD23 ' CE2' ' A' ' 143' ' ' TYR . 14.6 tp -83.52 17.48 2.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.931 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 66.65 33.99 6.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.84 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.561 ' CE2' HD23 ' A' ' 141' ' ' LEU . 2.5 m-85 -84.34 157.81 61.5 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.658 0.742 . . . . 0.0 110.947 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.403 ' HA ' ' HD2' ' A' ' 145' ' ' PRO . 53.8 Cg_endo -69.78 110.36 2.54 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.685 2.257 . . . . 0.0 112.364 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 53.6 Cg_endo -69.74 94.51 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.695 2.264 . . . . 0.0 112.315 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 165.25 -61.46 0.24 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.445 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 61.5 mttt -57.12 152.98 12.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.816 0.341 . . . . 0.0 110.913 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -69.88 75.75 0.46 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.401 ' O ' ' C ' ' A' ' 150' ' ' GLY . 84.7 mt -89.22 -54.94 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.146 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.46 -47.99 1.19 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.455 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.3 m -61.64 -53.3 57.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.905 0.384 . . . . 0.0 110.889 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.46 HD23 ' CD2' ' A' ' 156' ' ' HIS . 5.5 tt -51.33 -51.56 53.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.927 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 30.4 mt -57.61 -65.79 0.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.943 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.521 ' HG3' ' CE2' ' A' ' 134' ' ' TRP . 1.7 ttm105 -39.93 -38.77 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.844 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 69.6 m -66.6 -57.82 6.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.46 ' CD2' HD23 ' A' ' 152' ' ' LEU . 2.5 m-70 -56.03 -26.2 47.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.866 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.53 ' CD2' HD11 ' A' ' 161' ' ' ILE . 5.0 t80 -78.82 -46.92 17.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.923 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.488 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 2.5 mm-40 -79.97 -10.14 59.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.873 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 44.6 ttt85 -100.85 -35.19 9.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 62.0 mt -112.54 -50.93 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.108 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.53 HD11 ' CD2' ' A' ' 157' ' ' TYR . 18.9 mt -77.17 0.04 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.152 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.52 ' C ' ' CD1' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -72.29 -60.46 2.19 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.63 0.728 . . . . 0.0 110.92 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.507 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.8 Cg_endo -69.79 -37.66 8.79 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.654 2.236 . . . . 0.0 112.355 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.569 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 28.7 t80 -60.31 -38.83 84.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -74.45 -58.09 3.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.899 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 16.7 ptt? -51.17 -40.23 58.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -65.11 -59.88 3.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.882 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 48.9 mm-40 -42.96 -39.54 2.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.913 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.1 t -84.13 47.92 1.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -121.68 67.21 0.45 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.519 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.779 0.323 . . . . 0.0 111.108 179.972 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.6 p -124.17 127.53 47.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.901 0.381 . . . . 0.0 110.867 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.4 m -59.07 134.36 56.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.873 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.08 -156.24 32.49 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.494 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 68.9 m -101.5 80.84 2.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.884 0.373 . . . . 0.0 110.878 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.1 t -57.2 159.52 4.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.86 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -127.38 68.92 0.53 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.5 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.407 ' O ' ' CD1' ' A' ' 83' ' ' LEU . 3.9 p -114.74 36.59 3.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.792 0.33 . . . . 0.0 111.124 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.424 ' NE ' ' HA ' ' A' ' 80' ' ' ARG . 2.7 tpm_? -57.49 -50.23 73.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.88 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 83' ' ' LEU . 58.4 t -75.76 -64.71 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.102 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.54 ' HG2' ' CD2' ' A' ' 113' ' ' TYR . 69.0 mttt -37.47 -28.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 81' ' ' VAL . 26.7 mt -81.11 -47.02 14.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 81' ' ' VAL . 20.3 t30 -45.25 -52.83 9.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -54.31 -36.61 63.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.948 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.8 mt -71.21 -61.02 1.92 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.896 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -52.11 -24.05 6.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.817 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -77.89 -69.96 0.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.423 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 9.0 tt -43.98 -36.11 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.133 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.8 -44.78 54.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.086 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -54.61 -27.93 42.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.849 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.48 ' CE2' ' HA ' ' A' ' 164' ' ' TYR . 4.4 t80 -85.71 -29.97 23.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.874 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 30.4 m95 -75.42 -59.23 2.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.929 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -42.45 -29.55 0.28 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.885 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 85.9 mt -75.72 -47.61 32.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.166 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -51.91 -42.39 62.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 148.54 -36.49 1.08 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.476 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 40.1 m -101.77 155.9 17.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 110.9 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.5 t -83.27 178.08 8.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.851 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 29.4 tp -93.79 138.58 31.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.871 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -137.55 123.6 20.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 51.0 mm -96.25 124.24 52.15 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.584 0.706 . . . . 0.0 111.193 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.523 ' HG3' ' CD2' ' A' ' 156' ' ' HIS . 53.9 Cg_endo -69.72 152.05 69.44 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.679 2.252 . . . . 0.0 112.321 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -101.96 111.41 23.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.876 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.3 t -108.79 137.57 40.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.13 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.413 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 57.7 mm-40 50.07 54.22 11.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.413 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 1.2 ptp180 43.61 37.51 1.55 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.822 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -155.32 169.88 23.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.867 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.5 tt -75.05 143.96 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.6 tt -89.86 119.28 30.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.935 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -73.32 71.36 1.24 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -56.24 -21.26 22.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.54 ' CD2' ' HG2' ' A' ' 82' ' ' LYS . 3.3 t80 -71.67 -62.59 1.36 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.929 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 115' ' ' LEU . 4.2 t -50.02 -58.9 4.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.884 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.449 ' C ' ' O ' ' A' ' 114' ' ' SER . 10.0 tp -34.59 -67.48 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.928 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.1 p -48.07 -52.88 18.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -48.36 -52.51 21.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.944 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 77.7 mt -57.82 -42.15 81.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.111 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.2 t -59.81 -38.45 76.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.135 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 82.3 mt -71.27 -57.92 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.15 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.529 ' CG ' ' N ' ' A' ' 122' ' ' GLU . 8.1 pt-20 -56.57 -49.49 74.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.916 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.529 ' N ' ' CG ' ' A' ' 121' ' ' GLU . 38.0 mm-40 -47.91 -35.05 9.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.905 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 139.1 43.16 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.448 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.79 -179.42 52.58 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.472 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.51 ' C ' ' CD1' ' A' ' 125' ' ' TYR . 1.1 t80 -89.06 -40.12 13.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.853 0.359 . . . . 0.0 110.931 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -60.94 -45.85 93.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.858 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 130' ' ' LYS . . . -62.09 -71.35 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.086 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.558 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 2.2 pp -41.96 -36.32 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.145 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.462 ' N ' HD12 ' A' ' 128' ' ' ILE . 22.1 m -65.83 -40.97 92.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 127' ' ' ALA . 12.9 ttmm -68.95 -26.24 64.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 132' ' ' ARG . 4.2 t0 -100.87 19.38 17.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 131' ' ' ASP . 13.3 mmt85 36.11 54.6 0.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' A' ' 134' ' ' TRP . 14.7 mmt180 -81.81 -25.21 35.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.864 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.558 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 24.2 m95 -34.04 -40.06 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.59 -59.86 4.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.113 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.455 ' O ' ' CD ' ' A' ' 140' ' ' ARG . 38.2 mmt180 -62.28 -50.38 71.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.859 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 89.4 t -43.57 -46.84 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.146 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.87 -47.85 73.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.075 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -55.27 -32.97 62.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.455 ' CD ' ' O ' ' A' ' 136' ' ' ARG . 0.2 OUTLIER -59.81 -32.04 70.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.848 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.568 HD22 ' CE2' ' A' ' 143' ' ' TYR . 12.8 tp -80.38 13.74 2.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.911 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 65.0 51.31 1.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.568 ' CE2' HD22 ' A' ' 141' ' ' LEU . 2.5 m-85 -94.87 156.78 37.7 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.679 0.752 . . . . 0.0 110.94 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 122.23 8.89 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.718 2.279 . . . . 0.0 112.328 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 118.34 5.62 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.701 2.267 . . . . 0.0 112.295 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.53 -67.56 0.56 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.476 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.04 135.61 12.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.802 0.334 . . . . 0.0 110.9 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -65.86 75.43 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.412 ' O ' ' C ' ' A' ' 150' ' ' GLY . 89.9 mt -86.93 -51.17 13.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.165 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -37.12 -47.66 1.41 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.492 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.0 t -63.86 -52.39 60.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.923 0.392 . . . . 0.0 110.887 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.57 HD23 ' CD2' ' A' ' 156' ' ' HIS . 7.2 tt -47.21 -53.3 13.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.878 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 30.9 mt -56.04 -65.72 0.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.929 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.54 ' NE ' ' CD1' ' A' ' 134' ' ' TRP . 6.4 ttm180 -40.64 -33.2 0.26 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.882 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 36.1 t -71.86 -52.57 16.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.862 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.57 ' CD2' HD23 ' A' ' 152' ' ' LEU . 3.6 m-70 -60.46 -31.48 70.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.845 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.492 ' C ' ' CD1' ' A' ' 157' ' ' TYR . 2.3 t80 -79.25 -30.54 43.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.891 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.505 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 1.9 mm-40 -91.06 -9.93 43.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.913 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -107.5 -45.81 3.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.868 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 59.3 mt -97.07 -53.73 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.142 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.428 ' CG1' ' HA ' ' A' ' 157' ' ' TYR . 20.0 mt -75.17 -6.07 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.13 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.528 ' CD2' ' HD3' ' A' ' 163' ' ' PRO . 0.3 OUTLIER -70.57 -59.79 3.61 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.619 0.723 . . . . 0.0 110.907 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.528 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.9 Cg_endo -69.71 -36.34 11.12 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.699 2.266 . . . . 0.0 112.313 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.48 ' HA ' ' CE2' ' A' ' 92' ' ' PHE . 4.6 t80 -64.77 -35.76 82.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.924 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -75.09 -61.14 1.99 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.914 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -47.96 -40.27 21.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.875 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -67.29 -54.32 21.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.863 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.7 48.67 0.47 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.9 t -127.22 -60.3 1.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.85 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 147.26 112.44 0.71 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.478 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 120.759 0.314 . . . . 0.0 111.083 179.985 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.8 m -145.62 122.44 11.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.922 0.391 . . . . 0.0 110.816 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.4 t -93.86 118.85 32.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.858 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.65 80.5 1.25 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.475 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.7 m -40.76 -59.12 1.48 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.851 0.358 . . . . 0.0 110.859 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 61.3 p -57.07 104.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.838 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -113.6 84.16 0.35 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.521 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.0 t -114.77 38.49 3.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.792 0.329 . . . . 0.0 111.123 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 39.2 mmm-85 -77.35 -59.1 2.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.842 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 91.9 t -76.74 -39.78 31.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.12 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.508 ' HA ' ' CD1' ' A' ' 113' ' ' TYR . 27.6 ttmt -41.19 -29.45 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.6 mt -89.35 -47.08 8.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.936 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -46.59 -45.08 18.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.917 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.564 ' CD2' ' HA ' ' A' ' 113' ' ' TYR . 89.4 t80 -46.94 -31.32 3.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.897 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.419 ' HA ' ' CG2' ' A' ' 89' ' ' ILE . 29.2 mt -80.72 -33.57 35.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.932 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.01 -39.1 66.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.447 ' NE2' ' HH ' ' A' ' 164' ' ' TYR . 7.5 pt20 -73.56 -37.67 65.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.919 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.42 ' HA ' ' CE1' ' A' ' 164' ' ' TYR . 7.2 tt -78.6 -29.93 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.143 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.63 -43.31 56.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.13 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -51.27 -25.68 6.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.908 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -86.33 -41.26 14.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.565 ' CD1' HD12 ' A' ' 100' ' ' LEU . 55.6 m95 -70.7 -56.58 6.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 4.2 pt-20 -42.66 -29.55 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.883 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.424 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 96.8 mt -77.54 -48.98 23.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.164 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -48.87 -42.27 36.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.14 -37.44 1.5 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.476 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.2 m -101.77 112.15 24.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.858 0.361 . . . . 0.0 110.895 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 58.8 m -54.28 162.08 1.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.82 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.565 HD12 ' CD1' ' A' ' 93' ' ' TRP . 27.9 tp -74.01 135.32 43.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.924 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -135.48 128.96 32.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.6 mp -94.95 121.16 63.25 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.619 0.723 . . . . 0.0 111.108 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.488 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 53.5 Cg_endo -69.78 161.82 44.44 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.66 2.24 . . . . 0.0 112.359 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -107.43 121.02 43.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.85 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.43 HG12 ' N ' ' A' ' 106' ' ' GLU . 67.7 t -124.79 134.51 66.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.117 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.43 ' N ' HG12 ' A' ' 105' ' ' VAL . 27.4 mm-40 61.01 52.3 4.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.849 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 42.4 37.93 1.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.457 ' HD3' ' N ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -159.55 153.1 22.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.457 ' N ' ' HD3' ' A' ' 108' ' ' LYS . 7.8 tt -60.06 142.9 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.142 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.417 ' C ' HD22 ' A' ' 110' ' ' LEU . 6.2 tt -95.98 139.23 32.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -97.58 108.54 21.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.86 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.24 -24.89 32.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.564 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 5.7 t80 -63.26 -56.26 18.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.953 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 115' ' ' LEU . 32.0 p -59.4 -61.03 2.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.834 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 114' ' ' SER . 22.2 tp -35.04 -68.88 0.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.914 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.8 t -51.24 -52.73 42.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.835 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.1 mmtt -46.79 -63.7 0.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.933 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 62.1 mt -43.09 -53.54 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.137 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 43.1 t -49.47 -57.47 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.122 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 76.3 mt -46.1 -52.18 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.118 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -57.73 -58.93 6.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.891 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.467 ' CB ' HG22 ' A' ' 128' ' ' ILE . 29.1 mm-40 -35.01 -54.66 0.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 152.93 33.8 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.467 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.02 -178.71 33.49 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.445 ' CE2' ' SG ' ' A' ' 129' ' ' CYS . 4.8 t80 -85.0 -43.8 13.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.845 0.355 . . . . 0.0 110.908 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -62.05 -36.23 81.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.924 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.49 -68.91 0.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.149 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.467 HG22 ' CB ' ' A' ' 122' ' ' GLU . 2.2 pp -50.01 -36.23 11.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.164 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.445 ' SG ' ' CE2' ' A' ' 125' ' ' TYR . 49.1 m -66.33 -41.0 90.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -66.45 -44.48 82.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.92 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 132' ' ' ARG . 1.2 m-20 -85.02 22.61 1.37 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.449 ' C ' ' O ' ' A' ' 131' ' ' ASP . 57.8 mtt-85 34.63 43.93 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.88 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' A' ' 134' ' ' TRP . 20.4 mtp85 -71.5 -22.45 61.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.535 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 12.2 m95 -34.33 -42.29 0.13 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.927 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.6 -54.19 49.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.112 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 5.0 tpp85 -66.21 -42.54 88.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 84.3 t -59.41 -28.22 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -78.37 -48.69 15.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.116 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -60.06 -28.63 67.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -56.53 -38.85 72.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.56 HD23 ' CE2' ' A' ' 143' ' ' TYR . 13.8 tp -83.81 21.31 1.3 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.927 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 58.12 51.8 8.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.872 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.56 ' CE2' HD23 ' A' ' 141' ' ' LEU . 2.5 m-85 -96.73 159.1 32.42 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.667 0.746 . . . . 0.0 110.915 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 111.74 2.88 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.673 2.249 . . . . 0.0 112.375 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 117.13 4.9 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.69 2.26 . . . . 0.0 112.328 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 136.6 -59.64 0.63 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.477 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -55.38 159.55 2.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.761 0.315 . . . . 0.0 110.907 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -78.06 79.13 4.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.422 ' O ' ' C ' ' A' ' 150' ' ' GLY . 78.3 mt -95.07 -55.47 6.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.09 -44.91 0.82 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.464 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.3 t -65.92 -52.18 52.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.898 0.38 . . . . 0.0 110.861 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.533 HD23 ' CD2' ' A' ' 156' ' ' HIS . 6.7 tt -50.02 -49.37 51.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.921 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 25.7 mt -57.06 -64.79 0.76 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.535 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 11.8 ttt180 -40.47 -36.21 0.54 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 25.2 m -68.89 -62.08 1.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.805 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.533 ' CD2' HD23 ' A' ' 152' ' ' LEU . 2.5 m-70 -47.49 -34.06 6.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.848 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.565 ' CD2' HD13 ' A' ' 161' ' ' ILE . 3.9 t80 -70.22 -53.16 18.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.911 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 29.3 mm-40 -74.23 -9.47 58.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.877 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -96.15 -42.94 7.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.858 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 89.2 mt -110.4 -47.31 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.15 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.565 HD13 ' CD2' ' A' ' 157' ' ' TYR . 21.4 mt -76.88 1.08 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.089 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.602 ' CE1' ' SD ' ' A' ' 166' ' ' MET . 0.2 OUTLIER -73.52 -60.75 1.57 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.674 0.75 . . . . 0.0 110.879 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.57 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.6 Cg_endo -69.78 -41.76 3.96 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.663 2.242 . . . . 0.0 112.348 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.447 ' HH ' ' NE2' ' A' ' 88' ' ' GLN . 11.4 t80 -53.79 -35.25 61.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.922 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -78.81 -62.47 1.68 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.875 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.602 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 5.3 ptt? -48.46 -42.76 33.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -68.02 -56.06 10.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.872 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -91.02 41.5 1.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.897 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 48.1 t -86.16 79.16 9.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.858 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 45.24 93.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.453 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.75 0.31 . . . . 0.0 111.081 179.972 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.526 -0.23 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.0 m -112.16 93.85 4.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.883 0.373 . . . . 0.0 110.806 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 26.9 t -102.54 136.8 41.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.845 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.83 -173.81 30.94 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.475 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.8 t -163.17 174.72 11.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.9 0.381 . . . . 0.0 110.851 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.3 p -94.49 40.57 1.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.86 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -130.88 -53.83 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.48 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.6 m -43.5 105.89 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.778 0.323 . . . . 0.0 111.148 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.6 tpt85 -127.19 -69.25 0.76 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.426 ' O ' ' N ' ' A' ' 84' ' ' ASN . 58.5 t -72.62 -39.27 60.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.129 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -39.03 -30.7 0.05 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.895 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.1 mt -74.07 -46.65 41.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 81' ' ' VAL . 63.7 t-20 -40.14 -55.41 2.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.867 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -55.22 -47.73 74.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.942 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 65.8 mt -56.18 -63.71 1.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.951 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -46.45 -38.45 9.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.856 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -61.5 -62.15 2.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.947 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 90' ' ' ALA . 14.8 tt -61.11 -27.46 41.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.126 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.403 ' N ' HG22 ' A' ' 89' ' ' ILE . . . -73.18 -46.67 49.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.087 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.7 tttp -54.54 -22.63 13.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -85.24 -49.1 8.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 56.6 m95 -62.53 -56.54 17.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -40.91 -35.32 0.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 90.1 mt -71.98 -51.26 32.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.135 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -48.44 -39.55 23.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.956 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.31 -47.3 0.91 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.526 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.9 t -85.22 151.9 23.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.888 0.375 . . . . 0.0 110.847 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 55.7 p -81.24 172.46 13.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.88 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 29.1 tp -96.95 116.98 30.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.935 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.76 147.03 30.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 45.0 mm -119.79 121.84 29.51 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.578 0.704 . . . . 0.0 111.117 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.443 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 54.2 Cg_endo -69.72 163.66 37.41 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.69 2.26 . . . . 0.0 112.361 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -107.9 128.15 54.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 65.3 t -132.44 135.32 57.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.108 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 56.06 54.26 8.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 40.97 38.84 0.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.9 ttpp -162.63 152.78 16.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.9 tt -57.69 152.0 3.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.123 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.464 HD23 ' N ' ' A' ' 111' ' ' ASP . 5.9 tt -95.11 127.28 41.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.464 ' N ' HD23 ' A' ' 110' ' ' LEU . 8.2 t70 -86.57 69.99 10.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.821 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -47.96 -22.56 0.61 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -68.45 -44.25 75.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.4 t -71.23 -51.11 26.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.873 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.4 tp -47.07 -54.89 9.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.9 t -60.52 -58.85 6.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.83 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.1 mmtt -43.92 -54.74 5.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.901 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.44 ' O ' ' N ' ' A' ' 121' ' ' GLU . 29.6 mt -51.5 -67.49 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 50.6 t -37.73 -48.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.162 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 74.6 mt -64.91 -39.74 86.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.108 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 118' ' ' ILE . 5.5 mm-40 -59.11 -50.91 72.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.42 ' OE1' ' CG2' ' A' ' 137' ' ' VAL . 28.3 mt-10 -51.84 -42.6 62.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.912 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 150.64 35.27 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.512 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.02 -175.13 34.86 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.496 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.433 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 1.9 t80 -88.83 -41.03 12.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.855 0.359 . . . . 0.0 110.915 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -66.13 -37.53 85.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.898 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.5 -61.56 2.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.128 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.458 HD11 ' CE2' ' A' ' 134' ' ' TRP . 1.7 pp -58.44 -35.41 54.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.442 ' N ' HD12 ' A' ' 128' ' ' ILE . 22.1 m -65.1 -38.03 89.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.859 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -68.46 -39.45 81.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.45 ' O ' ' C ' ' A' ' 132' ' ' ARG . 0.7 OUTLIER -93.39 22.03 5.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.843 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 131' ' ' ASP . 25.1 mtp85 34.45 46.74 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.889 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -87.33 18.72 3.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.482 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 27.5 m95 -63.9 -47.65 79.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.913 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.55 -41.7 61.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.092 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -68.24 -63.11 1.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.854 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.42 ' CG2' ' OE1' ' A' ' 122' ' ' GLU . 86.4 t -41.17 -38.12 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.115 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.433 ' HB1' ' CD1' ' A' ' 153' ' ' LEU . . . -68.02 -53.93 22.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -51.22 -33.44 27.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.468 ' HA ' ' CZ ' ' A' ' 140' ' ' ARG . 1.7 mmp_? -52.72 -35.7 56.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.489 HD22 ' CE2' ' A' ' 143' ' ' TYR . 14.9 tp -84.73 23.32 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 62.91 28.0 16.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.817 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.489 ' CE2' HD22 ' A' ' 141' ' ' LEU . 3.4 m-85 -75.89 147.77 81.14 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.653 0.739 . . . . 0.0 110.914 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 115.72 4.22 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.706 2.271 . . . . 0.0 112.343 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.79 89.18 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.69 2.26 . . . . 0.0 112.323 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 177.13 -80.03 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.474 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 32.0 mttp -45.38 166.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.817 0.341 . . . . 0.0 110.89 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.79 80.8 3.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.419 ' O ' ' C ' ' A' ' 150' ' ' GLY . 76.9 mt -91.6 -57.41 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.21 -50.1 1.23 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.503 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.3 t -61.11 -55.18 35.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.871 0.367 . . . . 0.0 110.839 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.568 HD23 ' CD2' ' A' ' 156' ' ' HIS . 6.4 tt -46.92 -52.02 15.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.878 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.433 ' CD1' ' HB1' ' A' ' 138' ' ' ALA . 15.1 mt -54.52 -65.94 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.954 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.482 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 11.2 ttp180 -38.75 -47.75 1.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.864 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.6 t -57.87 -66.11 0.53 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.844 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.568 ' CD2' HD23 ' A' ' 152' ' ' LEU . 2.0 m-70 -42.9 -39.97 2.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.907 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.509 ' CZ ' HG22 ' A' ' 161' ' ' ILE . 4.6 t80 -63.81 -55.07 25.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 43.6 mt-10 -72.23 -9.97 59.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.898 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -88.87 -48.17 7.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.867 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 77.3 mt -112.56 -43.66 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.509 HG22 ' CZ ' ' A' ' 157' ' ' TYR . 11.0 mt -77.02 5.08 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.128 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.635 ' C ' ' CD1' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -74.4 -62.22 1.03 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.673 0.749 . . . . 0.0 110.895 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.516 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.3 Cg_endo -69.76 -35.66 12.22 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.689 2.259 . . . . 0.0 112.336 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -60.87 -38.32 85.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -79.94 -65.02 1.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.858 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.455 ' SD ' ' N ' ' A' ' 167' ' ' PHE . 0.0 OUTLIER -40.64 -39.42 1.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.862 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.455 ' N ' ' SD ' ' A' ' 166' ' ' MET . 2.4 t80 -74.73 -56.13 5.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.85 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 63.0 mm-40 -87.59 38.72 0.84 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.919 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 32.9 t -98.36 -57.5 2.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.841 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -109.21 -67.66 0.59 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.533 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.792 0.329 . . . . 0.0 111.105 179.954 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.2 m -46.52 -46.34 19.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 0.0 110.868 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 60.7 p -141.79 115.09 8.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.35 -54.11 0.78 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.508 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.8 t -82.82 132.86 35.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.872 0.368 . . . . 0.0 110.888 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.0 t 58.76 42.8 19.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.873 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -113.4 -62.29 0.43 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.505 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 43.0 m -106.11 94.8 5.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.789 0.328 . . . . 0.0 111.124 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -123.47 -57.52 1.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 57.3 t -84.19 -35.23 10.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.17 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.457 ' HG3' ' CD2' ' A' ' 113' ' ' TYR . 10.2 mptt -45.22 -26.83 0.54 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.413 ' O ' ' N ' ' A' ' 86' ' ' LEU . 61.3 mt -80.24 -53.05 7.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -39.19 -61.09 0.81 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -46.38 -33.26 3.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.955 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.425 ' HA ' ' CG2' ' A' ' 89' ' ' ILE . 36.5 mt -81.13 -39.32 25.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.924 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -64.09 -39.42 94.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.407 ' O ' ' NE2' ' A' ' 168' ' ' GLN . 41.9 mm-40 -72.96 -55.71 6.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.88 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.568 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 12.3 tt -55.46 -47.65 78.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.117 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.16 -47.96 83.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.14 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.404 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 21.5 ttmt -44.54 -37.83 3.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.957 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.665 ' CD1' ' CG ' ' A' ' 167' ' ' PHE . 3.2 t80 -71.89 -51.63 21.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.452 ' O ' ' C ' ' A' ' 94' ' ' GLU . 80.5 m95 -61.59 -62.36 1.87 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 93' ' ' TRP . 8.9 pt-20 -34.48 -37.97 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.426 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 52.1 mt -72.4 -49.48 41.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.13 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 93' ' ' TRP . 73.2 mm-40 -45.0 -46.21 11.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.889 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.21 -36.87 1.35 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.49 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.6 m -96.39 109.55 22.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.91 0.386 . . . . 0.0 110.888 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.7 m -47.18 158.69 0.14 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.854 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.4 tp -75.41 126.82 31.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.91 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -129.83 110.61 11.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.1 mt -77.17 123.88 87.17 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.628 0.728 . . . . 0.0 111.165 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 147.17 62.5 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.696 2.264 . . . . 0.0 112.359 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -100.36 111.05 23.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.935 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 106' ' ' GLU . 87.1 t -119.82 136.55 56.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.115 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.455 ' N ' HG12 ' A' ' 105' ' ' VAL . 46.6 mm-40 62.9 49.15 3.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.903 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 42.61 38.39 1.27 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.84 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.2 tttp -166.92 152.95 8.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.6 tt -50.4 150.01 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.124 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.412 ' C ' ' CD2' ' A' ' 110' ' ' LEU . 4.5 tt -92.96 112.06 23.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -69.05 75.11 0.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.79 -36.65 78.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.457 ' CD2' ' HG3' ' A' ' 82' ' ' LYS . 2.2 t80 -53.61 -59.93 3.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.963 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.457 ' O ' ' C ' ' A' ' 115' ' ' LEU . 4.8 t -59.07 -59.21 5.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.867 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' A' ' 114' ' ' SER . 9.0 tp -32.89 -58.7 0.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.924 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.6 t -57.12 -54.64 44.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.824 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -43.48 -48.25 7.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.888 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 53.2 mt -61.98 -48.3 89.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.127 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.4 t -50.8 -63.0 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.108 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 61.7 mt -52.11 -53.33 18.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.141 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -46.69 -51.11 16.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.893 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.426 ' HB2' ' CG2' ' A' ' 128' ' ' ILE . 40.6 mt-10 -50.92 -49.27 59.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.86 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 154.49 40.94 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.467 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.55 -177.93 42.47 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.448 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -88.95 -45.68 9.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.847 0.356 . . . . 0.0 110.94 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -59.51 -36.49 76.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.876 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.75 -71.26 0.21 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.096 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.426 ' CG2' ' HB2' ' A' ' 122' ' ' GLU . 2.1 pp -44.76 -34.53 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.123 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 64.8 m -69.37 -39.57 77.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -63.89 -39.66 94.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 132' ' ' ARG . 28.1 m-20 -92.1 29.76 1.56 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.877 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.465 ' C ' ' O ' ' A' ' 131' ' ' ASP . 3.0 mpt_? 33.48 40.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.462 ' O ' ' C ' ' A' ' 134' ' ' TRP . 22.5 mmt180 -65.29 -26.99 68.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.476 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 28.4 m95 -33.22 -44.19 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.913 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.82 -61.71 2.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.107 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -58.98 -45.09 91.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 92.6 t -54.03 -39.73 42.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.153 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.2 -52.88 52.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -58.88 -35.99 73.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.933 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.2 mmp_? -69.53 -28.04 65.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.868 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.557 ' HB3' ' CD2' ' A' ' 143' ' ' TYR . 1.5 tm? -78.46 10.23 3.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.913 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 62.99 38.42 11.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.557 ' CD2' ' HB3' ' A' ' 141' ' ' LEU . 9.6 m-85 -89.72 158.61 44.92 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.702 0.763 . . . . 0.0 110.937 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 113.76 3.48 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.65 2.234 . . . . 0.0 112.359 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.72 132.47 23.46 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.731 2.287 . . . . 0.0 112.34 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.61 -66.58 0.57 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.511 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -70.46 140.64 51.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.785 0.326 . . . . 0.0 110.934 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -64.58 76.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.421 ' O ' ' C ' ' A' ' 150' ' ' GLY . 97.0 mt -80.45 -39.85 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.165 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -35.98 -51.35 1.19 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.459 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.5 t -56.94 -54.86 41.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.886 0.374 . . . . 0.0 110.892 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.565 HD22 ' CD2' ' A' ' 156' ' ' HIS . 5.4 tt -45.58 -51.17 12.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.948 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' A' ' 154' ' ' ARG . 18.9 mt -53.99 -66.09 0.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.937 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.476 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 15.0 ttt180 -37.35 -41.56 0.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.1 m -65.04 -68.74 0.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.824 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.565 ' CD2' HD22 ' A' ' 152' ' ' LEU . 3.0 m-70 -43.12 -36.95 1.84 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.889 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.571 ' CD2' HD13 ' A' ' 161' ' ' ILE . 3.0 t80 -71.82 -43.88 64.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.933 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -79.87 -8.68 59.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.876 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 9.0 tpt85 -106.43 -30.3 9.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 70.7 mt -112.83 -59.0 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.107 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.571 HD13 ' CD2' ' A' ' 157' ' ' TYR . 66.3 mt -67.01 -11.95 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.119 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.593 ' CE1' ' SD ' ' A' ' 166' ' ' MET . 0.1 OUTLIER -74.21 -61.58 1.2 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.656 0.741 . . . . 0.0 110.934 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.555 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 54.0 Cg_endo -69.7 -27.82 26.27 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.714 2.276 . . . . 0.0 112.345 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.568 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 3.8 t80 -68.11 -41.91 81.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -72.84 -60.33 2.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.897 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.593 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 6.7 ptt? -47.08 -43.2 20.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.665 ' CG ' ' CD1' ' A' ' 92' ' ' PHE . 61.0 t80 -66.05 -44.78 83.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.407 ' NE2' ' O ' ' A' ' 88' ' ' GLN . 52.2 mt-30 -98.52 38.08 1.4 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.889 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.8 t -75.66 -55.47 5.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 141.6 -55.42 0.6 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.511 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.815 0.34 . . . . 0.0 111.089 179.973 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.1 p -94.52 82.36 4.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.879 0.371 . . . . 0.0 110.852 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.0 m -65.92 162.97 18.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.884 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.55 148.8 24.62 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.484 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 72.0 m -48.31 125.37 9.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.875 0.369 . . . . 0.0 110.836 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.4 t -163.85 128.02 2.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.873 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.4 126.08 1.18 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.444 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 25.7 m -62.57 96.17 0.08 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.772 0.32 . . . . 0.0 111.147 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -124.51 -49.12 1.79 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 84' ' ' ASN . 87.6 t -81.41 -39.71 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 81' ' ' VAL . 28.0 tttm -36.87 -32.96 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.906 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 81' ' ' VAL . 11.2 mt -91.23 -35.68 14.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.884 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 81' ' ' VAL . 43.0 t-20 -51.03 -29.29 12.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.879 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.503 ' CD2' ' HA ' ' A' ' 113' ' ' TYR . 86.8 t80 -78.8 -25.54 44.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 37.9 mt -79.95 -36.08 36.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.942 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -78.78 -47.55 16.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.835 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.428 ' CG ' ' N ' ' A' ' 89' ' ' ILE . 2.2 pt20 -54.72 -45.82 74.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.467 ' HA ' ' CE1' ' A' ' 164' ' ' TYR . 15.7 tt -72.84 -32.04 38.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.139 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 93' ' ' TRP . . . -67.48 -57.1 7.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.095 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.8 tptm -40.94 -31.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -78.45 -43.05 28.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.404 ' N ' ' O ' ' A' ' 90' ' ' ALA . 41.3 m95 -68.23 -55.17 13.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.911 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -43.52 -35.12 1.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.929 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.3 mt -73.03 -51.49 26.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.143 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -42.45 -47.57 5.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 136.88 30.63 0.27 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.483 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.8 m -161.05 161.78 31.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.893 0.378 . . . . 0.0 110.864 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.2 m -89.52 155.95 18.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.829 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.9 tp -91.57 103.89 16.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.909 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.8 pttt -97.48 152.59 18.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.909 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 18.7 mt -115.62 123.87 30.75 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.604 0.716 . . . . 0.0 111.155 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 148.07 64.3 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.687 2.258 . . . . 0.0 112.36 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -99.73 121.07 40.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.3 t -118.26 147.36 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.136 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.452 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 65.4 mm-40 39.8 53.21 2.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.863 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.452 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 11.8 ptm180 45.8 38.47 4.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.3 tptp -160.91 151.11 17.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.8 tt -56.75 145.36 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.113 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.426 HD23 ' N ' ' A' ' 111' ' ' ASP . 4.9 tt -90.72 129.49 36.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.426 ' N ' HD23 ' A' ' 110' ' ' LEU . 26.3 t0 -79.42 66.82 4.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -54.02 -23.02 11.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.503 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 3.9 t80 -72.4 -58.63 3.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.4 t -55.78 -41.46 74.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.864 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.4 tp -52.71 -55.8 20.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.915 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 18.0 p -60.26 -42.9 96.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -58.33 -61.2 2.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.878 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 64.9 mt -49.62 -36.36 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.176 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.2 t -71.27 -48.43 54.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.175 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 85.5 mt -62.4 -37.17 78.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.074 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -72.84 -54.79 7.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.913 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -38.95 -53.87 1.71 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.892 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 158.28 34.79 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.501 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.15 179.12 37.2 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.449 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.502 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 9.3 t80 -82.52 -39.98 21.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.826 0.346 . . . . 0.0 110.899 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -66.11 -43.03 88.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.92 -61.71 2.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.142 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.557 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 1.7 pp -60.09 -33.67 54.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.116 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.502 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 22.1 m -70.41 -28.42 65.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -81.05 -36.48 30.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.439 ' O ' ' C ' ' A' ' 132' ' ' ARG . 0.5 OUTLIER -91.15 21.04 4.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 131' ' ' ASP . 8.7 mmm180 35.53 50.76 0.6 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.88 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.425 ' O ' ' C ' ' A' ' 134' ' ' TRP . 4.3 mmp_? -80.03 -19.49 47.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.9 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.557 ' CZ2' HD12 ' A' ' 128' ' ' ILE . 28.2 m95 -36.34 -41.64 0.29 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.19 -55.32 34.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.092 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -66.82 -41.35 87.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 82.7 t -51.16 -43.58 27.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.078 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.64 -53.5 15.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.069 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -56.04 -22.44 27.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -68.74 -32.03 71.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.54 HD21 ' CE2' ' A' ' 143' ' ' TYR . 10.2 tp -89.84 25.57 2.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 61.55 51.17 4.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.815 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.54 ' CE2' HD21 ' A' ' 141' ' ' LEU . 3.7 m-85 -103.7 150.65 38.35 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.698 0.761 . . . . 0.0 110.886 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 113.48 3.39 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.677 2.252 . . . . 0.0 112.319 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 99.99 0.79 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.671 2.248 . . . . 0.0 112.333 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 161.96 -70.27 0.22 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.493 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -51.99 151.45 3.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.816 0.341 . . . . 0.0 110.915 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.406 ' O ' ' CG ' ' A' ' 148' ' ' ASN . 15.5 p-10 -65.0 75.51 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.423 ' O ' ' C ' ' A' ' 150' ' ' GLY . 75.5 mt -92.44 -54.06 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.17 -52.05 1.26 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.445 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 8.7 t -58.44 -56.94 15.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.927 0.394 . . . . 0.0 110.85 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.566 HD23 ' CD2' ' A' ' 156' ' ' HIS . 5.6 tt -42.05 -49.39 4.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.926 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 15.5 mt -58.94 -65.97 0.58 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.494 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 15.5 ttp180 -38.82 -45.39 1.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.818 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 41.0 m -60.19 -62.75 1.63 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.842 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.566 ' CD2' HD23 ' A' ' 152' ' ' LEU . 2.8 m-70 -47.27 -27.1 1.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.855 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.55 ' CD2' ' CD1' ' A' ' 161' ' ' ILE . 7.7 t80 -83.65 -31.26 26.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.49 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 11.4 mt-10 -91.04 -10.16 43.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 14.8 tpt85 -105.02 -30.7 9.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.858 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 42.0 mt -112.12 -54.38 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.55 ' CD1' ' CD2' ' A' ' 157' ' ' TYR . 15.5 mt -77.07 -0.8 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.101 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.537 ' CD2' ' HD3' ' A' ' 163' ' ' PRO . 0.2 OUTLIER -71.9 -60.31 2.46 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.643 0.735 . . . . 0.0 110.905 -179.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.537 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.5 Cg_endo -69.79 -34.96 13.43 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.708 2.272 . . . . 0.0 112.294 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.467 ' CE1' ' HA ' ' A' ' 89' ' ' ILE . 55.2 t80 -62.36 -44.09 97.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.911 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -68.72 -55.45 11.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.44 -35.07 74.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.899 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.463 ' CB ' ' O ' ' A' ' 163' ' ' PRO . 40.7 t80 -71.41 -58.03 3.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.914 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -53.38 -47.97 69.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.912 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 16.3 t -62.04 -57.49 11.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.839 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.17 44.95 1.65 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.481 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.765 0.317 . . . . 0.0 111.068 179.984 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 95.5 p 39.22 42.1 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.898 0.38 . . . . 0.0 110.853 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.6 t -103.92 148.01 26.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.862 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.19 -152.67 11.85 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.451 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.9 m 42.45 41.52 2.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.878 0.37 . . . . 0.0 110.885 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.3 t -128.68 137.73 51.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.828 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -142.53 -169.14 12.09 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.495 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.7 p -73.8 98.33 2.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.816 0.341 . . . . 0.0 111.149 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -115.06 -56.87 2.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.841 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 99.0 t -88.77 -39.91 12.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.113 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -42.64 -26.95 0.14 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.877 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 86' ' ' LEU . 19.2 mt -91.21 -47.02 7.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.494 ' O ' ' CG ' ' A' ' 88' ' ' GLN . 50.8 t30 -42.89 -36.91 1.66 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.419 ' CE2' HD13 ' A' ' 112' ' ' LEU . 59.5 t80 -71.28 -33.89 70.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.938 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 83' ' ' LEU . 61.2 mt -80.94 -59.11 2.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.891 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -52.63 -25.85 11.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.845 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.494 ' CG ' ' O ' ' A' ' 84' ' ' ASN . 11.2 mm100 -77.42 -67.32 0.73 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.558 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 10.0 tt -47.5 -35.59 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.17 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.74 -47.75 68.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.093 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -53.09 -26.2 15.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.593 ' CD1' ' CD2' ' A' ' 167' ' ' PHE . 0.8 OUTLIER -81.27 -50.83 9.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.52 ' CD1' HD12 ' A' ' 100' ' ' LEU . 81.3 m95 -64.51 -55.98 17.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.95 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -41.02 -29.77 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.913 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.5 mt -78.3 -49.33 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.171 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 88.6 mm-40 -50.21 -44.73 53.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 142.11 -46.94 0.85 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.453 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.6 m -83.22 108.85 16.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.887 0.375 . . . . 0.0 110.874 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.6 m -50.69 162.35 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.52 HD12 ' CD1' ' A' ' 93' ' ' TRP . 40.4 tp -86.82 100.47 12.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.91 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -102.41 106.2 16.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 44.0 mm -69.16 124.86 91.32 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.579 0.704 . . . . 0.0 111.134 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.519 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 54.0 Cg_endo -69.76 151.29 69.03 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.725 2.283 . . . . 0.0 112.334 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -101.12 110.93 23.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.843 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.8 t -119.19 137.9 51.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.143 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 107' ' ' ARG . 49.4 mm-40 58.9 55.02 4.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 106' ' ' GLU . 6.6 ptp85 35.53 43.05 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.857 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -168.14 150.71 5.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.874 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.1 tt -57.69 144.42 10.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.143 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.543 ' CD2' ' N ' ' A' ' 111' ' ' ASP . 6.2 tt -93.12 151.0 20.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.543 ' N ' ' CD2' ' A' ' 110' ' ' LEU . 11.9 t0 -107.81 121.7 45.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.835 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.419 HD13 ' CE2' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -98.3 -28.12 13.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.92 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -67.19 -61.56 1.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.903 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 115' ' ' LEU . 23.3 m -51.64 -58.76 5.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 114' ' ' SER . 17.3 tp -38.0 -63.09 0.5 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.907 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.9 t -50.28 -53.1 30.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.837 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -51.22 -43.73 61.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 58.6 mt -62.33 -48.68 87.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.1 t -58.41 -58.91 4.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.159 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 82.4 mt -49.4 -45.58 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.124 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 122' ' ' GLU . 38.5 mt-10 -62.92 -58.36 7.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.865 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.438 ' OE2' ' CG2' ' A' ' 137' ' ' VAL . 42.7 mt-10 -37.73 -54.27 1.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.855 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 157.85 37.25 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.52 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.98 -173.55 39.75 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.472 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.583 ' CE2' ' SG ' ' A' ' 129' ' ' CYS . 7.7 t80 -88.84 -56.63 3.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.806 0.336 . . . . 0.0 110.884 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -51.14 -34.73 32.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.886 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.38 -71.36 0.21 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.122 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.427 HG23 ' CB ' ' A' ' 122' ' ' GLU . 1.8 pp -51.5 -32.04 12.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.583 ' SG ' ' CE2' ' A' ' 125' ' ' TYR . 99.3 m -69.63 -36.47 76.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.885 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -71.12 -43.28 67.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' A' ' 132' ' ' ARG . 0.9 OUTLIER -85.61 23.57 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 131' ' ' ASP . 59.1 mtt180 34.23 38.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.833 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' A' ' 134' ' ' TRP . 21.1 mmm180 -66.08 -19.14 65.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.435 ' C ' ' O ' ' A' ' 133' ' ' ARG . 29.5 m95 -35.54 -37.22 0.08 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.33 -57.12 14.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.116 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 -60.09 -43.87 95.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.438 ' CG2' ' OE2' ' A' ' 122' ' ' GLU . 59.4 t -58.21 -34.11 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.121 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.19 -59.06 3.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.138 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -53.99 -31.07 49.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.97 -38.38 64.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.899 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.518 HD23 ' CE2' ' A' ' 143' ' ' TYR . 14.8 tp -85.39 20.94 1.87 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 64.22 40.33 6.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.841 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.518 ' CE2' HD23 ' A' ' 141' ' ' LEU . 3.1 m-85 -89.67 153.16 47.71 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.662 0.744 . . . . 0.0 110.929 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 114.07 3.58 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.732 2.288 . . . . 0.0 112.337 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 90.88 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.678 2.252 . . . . 0.0 112.365 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.67 -73.93 0.1 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.468 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -50.56 153.18 1.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.832 0.348 . . . . 0.0 110.852 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -67.29 81.33 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.427 ' O ' ' C ' ' A' ' 150' ' ' GLY . 90.1 mt -92.97 -53.85 8.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.19 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.0 -48.52 1.08 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.511 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.0 t -61.5 -53.87 50.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.864 0.364 . . . . 0.0 110.866 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.476 HD22 ' CD2' ' A' ' 156' ' ' HIS . 8.2 tt -47.14 -50.6 20.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.885 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.415 ' O ' ' C ' ' A' ' 154' ' ' ARG . 24.1 mt -55.02 -65.91 0.5 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 153' ' ' LEU . 11.4 ttt-85 -36.89 -44.99 0.53 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.918 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.7 t -59.76 -65.37 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.911 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.519 ' CE1' ' HG3' ' A' ' 103' ' ' PRO . 2.1 m-70 -39.6 -49.11 2.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.564 ' CD2' HD12 ' A' ' 161' ' ' ILE . 3.6 t80 -52.83 -67.6 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.916 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -62.15 -8.53 5.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.857 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.94 -53.82 5.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.908 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.407 ' CG2' ' HE1' ' A' ' 93' ' ' TRP . 27.0 mt -112.91 -46.3 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.133 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.564 HD12 ' CD2' ' A' ' 157' ' ' TYR . 73.7 mt -61.2 -14.14 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.661 ' C ' ' CD1' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -76.88 -63.3 0.54 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.707 0.765 . . . . 0.0 110.927 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.567 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.9 Cg_endo -69.73 -23.44 30.92 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.744 2.296 . . . . 0.0 112.328 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.558 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 1.0 OUTLIER -74.25 -46.62 40.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.875 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -69.11 -49.38 57.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.893 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.401 ' CG ' ' HA ' ' A' ' 163' ' ' PRO . 0.0 OUTLIER -61.23 -38.14 85.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.593 ' CD2' ' CD1' ' A' ' 92' ' ' PHE . 18.3 t80 -62.03 -50.65 71.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -64.01 -23.77 67.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.938 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 8.5 t -71.01 -59.25 2.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.876 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.56 88.67 0.92 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.502 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.798 0.332 . . . . 0.0 111.102 -179.999 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.7 p -144.7 171.47 14.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.903 0.382 . . . . 0.0 110.883 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 54.7 p -151.38 124.37 8.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.868 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.07 -92.29 0.13 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.51 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.2 t -84.02 177.13 8.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.857 0.36 . . . . 0.0 110.867 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.6 t -64.49 137.05 57.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.86 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -139.81 -126.11 2.29 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.455 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.2 t -89.89 41.12 1.03 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.794 0.33 . . . . 0.0 111.15 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -74.51 -57.75 3.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.891 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 63.4 t -82.79 -39.86 16.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.704 ' CD ' ' CD2' ' A' ' 113' ' ' TYR . 16.5 tptm -45.69 -25.17 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.93 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 86.4 mt -84.25 -45.84 12.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.911 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -45.95 -51.59 13.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -55.07 -34.44 63.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.933 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.21 -64.08 1.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.966 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -52.74 -32.28 42.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 44.8 mm-40 -67.16 -69.08 0.33 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.485 HG13 ' CG ' ' A' ' 164' ' ' TYR . 19.7 tt -51.09 -39.28 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.133 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.51 -40.82 93.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -59.73 -23.96 63.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.918 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.459 ' O ' ' CD1' ' A' ' 92' ' ' PHE . 1.1 t80 -84.7 -36.56 21.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.893 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.48 ' O ' ' N ' ' A' ' 95' ' ' ILE . 69.4 m95 -78.03 -56.72 4.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -39.41 -25.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.48 ' N ' ' O ' ' A' ' 93' ' ' TRP . 87.3 mt -81.81 -50.35 16.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -49.18 -34.08 13.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.889 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 130.21 -25.11 4.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.47 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.5 m -103.97 115.52 30.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 0.0 110.868 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.4 t -53.75 167.88 0.22 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.875 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.9 tp -85.28 124.5 31.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.967 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -125.96 134.51 51.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 81.9 mt -107.05 129.64 24.04 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.586 0.707 . . . . 0.0 111.132 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 174.64 9.18 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.69 2.26 . . . . 0.0 112.325 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -124.73 111.83 16.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.7 t -115.2 133.27 61.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.153 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 60.06 54.72 4.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.916 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 38.42 36.91 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.841 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.71 153.66 28.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.9 tt -60.31 137.04 23.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.109 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.1 tt -78.47 140.55 38.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.946 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -90.43 76.25 6.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.827 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -61.77 -22.46 65.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.936 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.704 ' CD2' ' CD ' ' A' ' 82' ' ' LYS . 1.7 t80 -71.73 -65.84 0.71 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 115' ' ' LEU . 3.7 t -54.34 -54.08 45.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.845 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.43 ' C ' ' O ' ' A' ' 114' ' ' SER . 16.9 tp -35.3 -65.43 0.23 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.941 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.5 t -53.15 -51.89 60.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.871 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -46.78 -54.22 10.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.905 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 65.3 mt -56.67 -46.81 83.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.084 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.1 t -56.88 -61.99 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.154 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 84.6 mt -56.97 -40.31 71.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.141 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -60.1 -57.99 10.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -44.87 -45.1 10.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.434 ' O ' ' CB ' ' A' ' 127' ' ' ALA . . . 152.48 38.12 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.487 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.16 -170.04 32.61 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.467 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -88.8 -43.3 11.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.945 0.402 . . . . 0.0 110.951 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -64.24 -39.37 93.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.866 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' A' ' 123' ' ' GLY . . . -58.37 -68.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.075 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.422 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 1.7 pp -51.73 -34.88 16.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.087 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 53.6 m -67.74 -33.95 75.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.845 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.3 mtpp -68.05 -46.85 69.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.429 ' OD2' ' CZ ' ' A' ' 133' ' ' ARG . 2.3 t70 -84.61 12.23 7.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 44.63 54.12 6.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.849 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.449 ' O ' ' C ' ' A' ' 134' ' ' TRP . 3.2 mmp_? -80.32 -19.07 47.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.905 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.534 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 18.8 m95 -34.27 -44.54 0.19 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.2 -52.12 66.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.11 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 37.5 mmt-85 -68.93 -51.22 42.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 97.5 t -44.4 -44.47 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.127 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.53 -53.09 25.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.08 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -55.72 -25.92 42.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.908 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 23.9 mtt180 -64.21 -26.5 68.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.912 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.0 tp -89.54 18.45 5.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.939 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 64.45 46.73 3.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -95.36 152.59 39.43 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.656 0.741 . . . . 0.0 110.948 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 120.1 6.94 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.652 2.235 . . . . 0.0 112.356 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 115.65 4.19 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.683 2.255 . . . . 0.0 112.344 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.66 -64.25 0.44 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.465 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -53.08 160.33 1.04 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.79 0.329 . . . . 0.0 110.925 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -80.96 52.43 1.75 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.407 ' O ' ' C ' ' A' ' 150' ' ' GLY . 42.6 mt -62.92 -49.8 82.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.165 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.21 -56.94 1.14 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.452 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.8 t -57.29 -61.0 2.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.914 0.387 . . . . 0.0 110.897 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.571 HD22 ' CD2' ' A' ' 156' ' ' HIS . 7.3 tt -38.94 -55.11 1.59 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.926 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 25.1 mt -51.9 -65.99 0.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.534 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 20.0 ttp180 -41.18 -46.23 3.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.823 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.9 m -58.99 -64.5 0.92 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.845 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.571 ' CD2' HD22 ' A' ' 152' ' ' LEU . 1.7 m-70 -42.05 -53.38 3.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.864 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.538 ' CD2' HD13 ' A' ' 161' ' ' ILE . 5.3 t80 -50.81 -65.35 0.57 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 42.6 mt-10 -63.53 -9.8 14.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.906 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 41.5 ttt-85 -84.08 -50.74 7.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 40.6 mt -112.54 -40.07 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.152 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.538 HD13 ' CD2' ' A' ' 157' ' ' TYR . 22.9 mt -76.2 0.28 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.139 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.588 ' CE1' ' SD ' ' A' ' 166' ' ' MET . 0.1 OUTLIER -73.34 -61.17 1.51 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.7 0.762 . . . . 0.0 110.897 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.565 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 54.4 Cg_endo -69.73 -32.56 18.47 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.68 2.253 . . . . 0.0 112.393 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.485 ' CG ' HG13 ' A' ' 89' ' ' ILE . 12.3 t80 -66.07 -39.04 89.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.931 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -72.02 -53.37 13.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.935 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.588 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 6.7 ptt? -63.48 -41.58 98.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.851 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.468 ' CB ' ' O ' ' A' ' 163' ' ' PRO . 47.9 t80 -59.53 -52.12 66.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.901 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -96.76 41.62 1.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.1 t -74.88 -57.11 4.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.852 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 170.35 -55.56 0.19 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.487 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.792 0.329 . . . . 0.0 111.119 179.95 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.579 ' HE2' HD12 ' A' ' 112' ' ' LEU . 29.5 t80 . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.904 0.383 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.8 mt -65.29 -50.99 63.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.03 -35.08 75.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -68.45 -64.16 0.92 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.935 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.664 HG23 HD22 ' A' ' 100' ' ' LEU . 6.5 tt -55.5 -33.75 33.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.16 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.98 -58.58 3.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.088 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.41 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 2.4 ttmp? -45.65 -24.66 0.37 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.892 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -85.63 -42.45 14.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 32.8 m95 -72.61 -59.25 2.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.916 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.47 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 2.7 pt-20 -39.31 -31.96 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.873 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.47 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 97.3 mt -74.08 -52.59 19.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.171 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -48.55 -40.34 26.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 136.58 -45.71 1.07 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.477 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.4 t -81.69 118.69 23.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.841 0.353 . . . . 0.0 110.881 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.5 p -56.49 151.86 12.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.664 HD22 HG23 ' A' ' 89' ' ' ILE . 13.5 tp -77.84 118.58 20.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -119.57 141.91 48.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.0 mp -107.69 128.74 25.28 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.627 0.727 . . . . 0.0 111.104 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 154.24 67.77 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.646 2.23 . . . . 0.0 112.334 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -102.18 111.32 23.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.511 HG12 ' HG2' ' A' ' 106' ' ' GLU . 71.4 t -119.03 134.67 61.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.117 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.511 ' HG2' HG12 ' A' ' 105' ' ' VAL . 13.2 mm-40 61.21 53.45 3.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 106' ' ' GLU . 7.7 ptp180 36.94 41.68 0.2 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.3 ttmp? -162.5 152.13 15.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.461 HG13 ' N ' ' A' ' 110' ' ' LEU . 1.8 tp -62.25 139.23 21.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.112 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.529 HD23 ' N ' ' A' ' 111' ' ' ASP . 5.7 tt -87.65 130.62 34.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.916 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.529 ' N ' HD23 ' A' ' 110' ' ' LEU . 44.3 t0 -90.55 74.24 6.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.579 HD12 ' HE2' ' A' ' 85' ' ' TYR . 2.0 pt? -48.52 -20.91 0.48 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -71.27 -45.59 62.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.3 t -65.61 -52.81 49.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.886 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.7 tp -49.03 -60.53 2.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 52.6 p -55.11 -52.9 61.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.863 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.3 mmtt -47.96 -61.45 1.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 66.5 mt -45.34 -64.27 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.155 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 43.1 t -39.35 -64.18 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.139 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 73.4 mt -42.35 -46.35 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.092 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -65.34 -54.69 25.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -39.49 -50.91 2.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 127' ' ' ALA . . . 155.36 35.15 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.525 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.92 -177.73 41.79 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.528 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.483 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 3.1 t80 -87.42 -47.92 8.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.851 0.357 . . . . 0.0 110.901 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -57.78 -40.73 80.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.91 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 123' ' ' GLY . . . -63.09 -68.86 0.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.083 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.483 HD12 ' C ' ' A' ' 128' ' ' ILE . 1.9 pp -52.0 -31.43 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.128 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.483 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 26.2 m -70.13 -42.2 72.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -66.31 -36.92 84.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.861 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 132' ' ' ARG . 2.2 m-20 -91.99 21.44 4.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.859 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' A' ' 131' ' ' ASP . 16.8 mmm-85 35.36 41.28 0.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -71.35 -14.07 62.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.869 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.505 ' CE2' ' HG3' ' A' ' 154' ' ' ARG . 49.5 m95 -38.28 -37.44 0.29 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.24 -52.56 65.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.06 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -66.4 -39.73 89.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.842 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.3 t -57.3 -36.09 51.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.107 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.47 ' HB2' ' CD1' ' A' ' 153' ' ' LEU . . . -74.14 -49.85 21.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.094 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -57.99 -26.07 61.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.868 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -57.6 -38.93 75.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.838 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.517 HD23 ' CZ ' ' A' ' 143' ' ' TYR . 13.6 tp -82.44 16.09 2.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.95 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 63.36 44.66 5.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.835 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.517 ' CZ ' HD23 ' A' ' 141' ' ' LEU . 2.6 m-85 -85.21 155.96 60.18 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.657 0.741 . . . . 0.0 110.956 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.455 ' HA ' ' HD2' ' A' ' 145' ' ' PRO . 53.7 Cg_endo -69.79 110.37 2.54 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.656 2.238 . . . . 0.0 112.345 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 53.9 Cg_endo -69.72 108.27 2.03 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.712 2.274 . . . . 0.0 112.348 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 147.44 -34.64 1.26 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.459 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -83.93 147.24 27.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 0.0 110.923 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.418 ' CG ' ' O ' ' A' ' 148' ' ' ASN . 26.3 p-10 -66.53 72.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.857 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.42 ' O ' ' C ' ' A' ' 150' ' ' GLY . 75.4 mt -90.65 -50.04 13.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.099 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.1 -50.71 1.22 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.498 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.6 m -60.03 -49.29 78.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.887 0.375 . . . . 0.0 110.882 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.672 HD21 ' CD2' ' A' ' 156' ' ' HIS . 6.5 tt -51.18 -53.97 29.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.888 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.47 ' CD1' ' HB2' ' A' ' 138' ' ' ALA . 23.1 mt -54.35 -65.8 0.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.927 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.505 ' HG3' ' CE2' ' A' ' 134' ' ' TRP . 16.0 ttt180 -40.41 -41.57 1.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.889 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 156' ' ' HIS . 39.7 m -66.67 -69.78 0.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.672 ' CD2' HD21 ' A' ' 152' ' ' LEU . 2.4 m-70 -36.96 -39.22 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.879 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.422 ' HA ' ' CG1' ' A' ' 161' ' ' ILE . 4.2 t80 -65.44 -57.23 8.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -70.82 -10.13 58.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.878 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -90.22 -48.17 7.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.824 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 60.7 mt -112.45 -41.97 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.162 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.534 ' O ' HG22 ' A' ' 161' ' ' ILE . 16.7 mt -78.48 3.23 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.091 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.584 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -72.36 -60.66 2.07 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.691 0.758 . . . . 0.0 110.928 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 162' ' ' TYR . 53.8 Cg_endo -69.72 -40.19 5.68 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.69 2.26 . . . . 0.0 112.358 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.491 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 23.8 t80 -55.57 -40.26 71.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.911 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -76.85 -66.32 0.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.883 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.447 ' SD ' ' N ' ' A' ' 167' ' ' PHE . 0.0 OUTLIER -42.7 -40.06 2.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.874 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.447 ' N ' ' SD ' ' A' ' 166' ' ' MET . 21.4 t80 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.484 ' O ' HG22 ' A' ' 89' ' ' ILE . 73.0 t80 . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.876 0.37 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.6 mt -77.25 -43.14 34.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.05 -41.97 75.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.06 -62.97 1.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.534 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 15.0 tt -52.42 -39.71 29.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.143 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.1 -42.81 93.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.11 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -59.02 -29.21 67.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -77.2 -39.75 47.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.915 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 54.7 m95 -72.74 -58.39 3.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.433 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 9.6 pt-20 -39.17 -36.91 0.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.433 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 95.4 mt -69.85 -47.07 71.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.096 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -53.5 -35.34 60.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.925 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 130.56 -33.19 2.92 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.482 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.4 m -93.5 145.33 24.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.928 0.394 . . . . 0.0 110.89 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 27.7 p -79.27 159.55 27.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 39.1 tp -90.04 138.34 31.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.93 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 49.7 tttt -134.4 144.63 48.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.957 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 62.9 mt -109.82 124.51 33.44 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.608 0.718 . . . . 0.0 111.116 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 157.38 60.42 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.634 2.223 . . . . 0.0 112.296 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -107.71 121.48 44.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 62.4 t -116.09 140.84 36.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.149 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.473 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 63.1 mm-40 44.76 52.86 7.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.473 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 12.0 ptm180 47.36 36.7 5.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.835 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -154.14 150.58 28.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 6.9 tt -62.3 140.26 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.131 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.634 HD23 ' N ' ' A' ' 111' ' ' ASP . 3.6 tt -89.22 121.86 31.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.953 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.634 ' N ' HD23 ' A' ' 110' ' ' LEU . 7.9 t0 -82.46 79.75 8.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.695 HD23 ' H ' ' A' ' 112' ' ' LEU . 1.4 pt? -58.71 -23.83 60.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.436 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 3.7 t80 -65.26 -56.12 14.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 115' ' ' LEU . 44.3 m -58.22 -59.84 4.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.875 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.448 ' C ' ' O ' ' A' ' 114' ' ' SER . 19.6 tp -34.48 -68.47 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.948 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.5 t -48.2 -54.71 12.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.852 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt -46.61 -54.75 8.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.904 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.607 HG22 ' OE1' ' A' ' 122' ' ' GLU . 81.5 mt -51.72 -54.25 13.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.141 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.408 HG13 HG12 ' A' ' 128' ' ' ILE . 76.4 t -53.33 -60.02 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.144 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 97.0 mt -43.28 -44.89 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.153 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -68.54 -48.61 63.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.607 ' OE1' HG22 ' A' ' 118' ' ' ILE . 24.7 mt-10 -44.95 -42.62 8.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.898 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 144.13 37.8 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.486 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.97 -179.45 45.49 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.516 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.516 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 0.9 OUTLIER -86.88 -41.51 13.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.855 0.36 . . . . 0.0 110.934 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -62.75 -33.45 75.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.899 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.8 -69.84 0.29 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.07 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.515 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.9 pp -51.07 -32.6 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.163 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.451 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 27.3 m -69.6 -41.5 75.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.1 mtpp -67.11 -28.03 67.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -101.03 13.81 34.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.852 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 39.07 50.87 1.87 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -84.13 -3.6 58.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.86 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.515 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 56.4 m95 -45.95 -39.06 8.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.925 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.53 -54.1 50.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.118 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -64.48 -46.85 81.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.908 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.454 ' CG2' ' OE2' ' A' ' 122' ' ' GLU . 52.0 t -50.39 -37.48 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.095 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.96 -49.35 38.2 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -59.03 -24.71 63.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -62.95 -30.54 71.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.551 HD23 ' CE2' ' A' ' 143' ' ' TYR . 14.8 tp -91.64 26.48 2.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 57.57 51.04 10.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.551 ' CE2' HD23 ' A' ' 141' ' ' LEU . 3.5 m-85 -102.68 151.62 38.31 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.709 0.766 . . . . 0.0 110.883 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.554 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.7 Cg_endo -69.76 110.31 2.52 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.739 2.293 . . . . 0.0 112.324 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 131.56 21.55 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.726 2.284 . . . . 0.0 112.358 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.65 -55.3 0.76 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.505 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -59.85 179.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.777 0.322 . . . . 0.0 110.912 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -93.97 42.22 1.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.554 HD11 ' HG2' ' A' ' 144' ' ' PRO . 61.8 mt -59.46 -50.07 81.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.115 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.22 -58.88 1.01 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.478 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.9 t -51.56 -60.49 3.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.926 0.393 . . . . 0.0 110.878 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.5 tt -38.98 -49.9 1.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.934 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 17.3 mt -59.74 -65.92 0.6 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.914 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.481 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 6.2 ttt-85 -38.3 -40.06 0.49 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.867 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 158' ' ' GLU . 3.8 m -66.84 -66.35 0.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -43.6 -29.69 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.831 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.514 ' CD1' ' C ' ' A' ' 157' ' ' TYR . 2.2 t80 -79.57 -34.92 40.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.924 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 155' ' ' SER . 26.0 mt-10 -88.93 -9.9 49.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.872 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 12.7 mmt85 -102.15 -39.86 7.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 86.3 mt -109.86 -49.86 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.131 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 157' ' ' TYR . 14.0 mt -78.47 3.3 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.095 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.641 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -72.57 -60.54 2.01 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.665 0.745 . . . . 0.0 110.893 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 162' ' ' TYR . 53.7 Cg_endo -69.79 -49.35 0.56 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.668 2.245 . . . . 0.0 112.343 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.534 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 34.4 t80 -48.31 -38.02 17.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.929 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -75.2 -63.24 1.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.892 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 11.8 ptt? -48.65 -31.05 6.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.869 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 21.6 t80 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.866 -179.913 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.624 ' HE2' HD12 ' A' ' 112' ' ' LEU . 39.3 t80 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.901 0.382 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.9 mt -74.73 -59.13 2.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.908 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -49.61 -29.07 6.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -76.79 -68.2 0.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.959 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.548 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 9.9 tt -46.16 -34.84 2.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.16 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.27 -46.53 67.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.136 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -55.98 -22.86 29.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -84.95 -46.49 11.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.879 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 54.2 m95 -67.74 -51.25 51.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.894 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -45.88 -32.1 2.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 89.8 mt -74.93 -46.04 41.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.128 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -56.35 -36.74 69.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.88 -52.67 0.7 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.467 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 71.4 m -83.32 119.98 25.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.865 0.364 . . . . 0.0 110.874 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 59.4 p -55.51 173.26 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.84 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.1 tp -82.68 132.96 35.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.951 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -131.92 134.4 45.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.0 mt -110.0 127.45 27.07 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.594 0.712 . . . . 0.0 111.148 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.432 ' CG ' ' CE1' ' A' ' 156' ' ' HIS . 53.2 Cg_endo -69.77 166.53 27.29 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.661 2.24 . . . . 0.0 112.329 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -113.09 122.86 48.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.4 t -123.75 148.64 27.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.155 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.448 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 58.1 mm-40 41.72 52.92 4.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.448 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 13.0 ptp180 45.16 43.01 7.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.875 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -164.58 152.22 11.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.926 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.1 tt -62.29 142.89 15.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.121 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.712 HD23 ' N ' ' A' ' 111' ' ' ASP . 5.3 tt -91.63 132.49 36.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.712 ' N ' HD23 ' A' ' 110' ' ' LEU . 24.2 t70 -94.6 100.92 12.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.838 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.755 HD23 ' H ' ' A' ' 112' ' ' LEU . 0.9 OUTLIER -72.53 -26.64 61.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.563 ' CE1' ' HG3' ' A' ' 117' ' ' LYS . 4.4 t80 -61.06 -55.89 27.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.886 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.4 m -61.85 -56.98 13.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.83 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.414 ' O ' HG23 ' A' ' 119' ' ' VAL . 26.2 tp -40.73 -60.74 1.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.1 t -58.17 -50.59 73.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.802 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.563 ' HG3' ' CE1' ' A' ' 113' ' ' TYR . 13.9 mmmt -47.92 -46.3 31.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.535 HG22 ' OE1' ' A' ' 122' ' ' GLU . 63.8 mt -64.45 -38.58 82.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.431 HG13 HG12 ' A' ' 128' ' ' ILE . 71.6 t -64.17 -59.96 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 83.3 mt -59.71 -43.58 91.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.118 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -58.79 -56.56 20.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.535 ' OE1' HG22 ' A' ' 118' ' ' ILE . 20.9 mt-10 -44.36 -51.07 8.84 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 159.11 34.42 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.473 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.98 -175.02 33.36 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.528 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.517 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 2.1 t80 -87.41 -46.59 9.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.838 0.352 . . . . 0.0 110.905 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -58.02 -37.53 74.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.58 -70.46 0.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.113 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.527 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.9 pp -50.09 -34.47 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.165 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.517 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 53.5 m -67.93 -44.18 77.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.914 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -64.53 -40.85 96.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.933 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 132' ' ' ARG . 69.5 m-20 -85.92 23.77 1.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.824 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 131' ' ' ASP . 41.3 mtp85 36.04 37.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.847 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 134' ' ' TRP . 29.7 mmt180 -66.71 -23.47 66.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.542 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 22.4 m95 -34.71 -43.85 0.19 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.89 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.35 -49.21 75.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.114 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 133' ' ' ARG . 13.0 tpp180 -69.11 -42.18 76.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.892 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 89.2 t -53.85 -34.7 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.485 ' HB2' HD11 ' A' ' 153' ' ' LEU . . . -76.78 -53.45 7.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.1 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -55.04 -28.21 50.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -64.89 -28.3 69.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.779 HD23 ' CE2' ' A' ' 143' ' ' TYR . 12.5 tp -88.27 22.67 2.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 15.5 m80 60.78 45.84 9.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.843 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.779 ' CE2' HD23 ' A' ' 141' ' ' LEU . 4.4 m-85 -97.71 147.37 32.93 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.692 0.758 . . . . 0.0 110.902 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 125.43 12.12 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.689 2.259 . . . . 0.0 112.289 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 96.68 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.676 2.251 . . . . 0.0 112.324 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 165.02 -75.24 0.16 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.543 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 149' ' ' ILE . 0.3 OUTLIER -45.96 138.47 5.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.798 0.332 . . . . 0.0 110.929 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -62.87 75.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.915 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 147' ' ' LYS . 94.1 mt -87.38 -48.91 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.138 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.13 -59.0 0.99 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.472 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.1 t -53.56 -55.25 27.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.945 0.402 . . . . 0.0 110.873 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.571 HD21 ' CE1' ' A' ' 156' ' ' HIS . 5.6 tt -44.28 -53.31 6.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 138' ' ' ALA . 18.6 mt -53.54 -65.85 0.49 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.542 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 16.3 ttp180 -39.75 -47.05 2.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 7.9 t -59.41 -66.51 0.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.842 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.571 ' CE1' HD21 ' A' ' 152' ' ' LEU . 9.6 m170 -40.6 -34.44 0.36 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.821 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.499 ' O ' ' N ' ' A' ' 161' ' ' ILE . 9.7 t80 -68.57 -70.27 0.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.4 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 3.9 mm-40 -61.09 -10.08 5.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.867 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -85.0 -55.85 3.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 49.7 mt -109.43 -37.27 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.118 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.499 ' N ' ' O ' ' A' ' 157' ' ' TYR . 26.7 mt -75.4 -5.93 7.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.113 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.513 ' CD2' ' HD3' ' A' ' 163' ' ' PRO . 0.3 OUTLIER -71.25 -59.26 3.39 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.679 0.752 . . . . 0.0 110.93 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.513 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.3 Cg_endo -69.85 -39.73 6.0 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.69 2.26 . . . . 0.0 112.335 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.548 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 3.7 t80 -64.78 -30.03 71.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.935 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.494 ' CG ' HG22 ' A' ' 161' ' ' ILE . 17.1 mm-40 -74.13 -57.24 4.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.876 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.464 ' HG3' ' N ' ' A' ' 167' ' ' PHE . 5.5 ptp -55.43 -29.52 58.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.464 ' N ' ' HG3' ' A' ' 166' ' ' MET . 54.3 t80 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.873 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.666 ' HE2' HD12 ' A' ' 112' ' ' LEU . 81.3 t80 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.891 0.376 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.417 ' O ' HG22 ' A' ' 89' ' ' ILE . 72.2 mt -80.56 -63.22 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.947 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -44.88 -31.39 1.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -72.26 -71.03 0.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.533 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 14.7 tt -43.29 -34.87 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.099 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.531 ' HB2' HD22 ' A' ' 100' ' ' LEU . . . -68.82 -50.18 52.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.107 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -51.89 -29.21 18.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.906 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.401 ' CD1' ' CD2' ' A' ' 167' ' ' PHE . 30.2 t80 -77.29 -37.81 52.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.875 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.451 ' O ' ' C ' ' A' ' 94' ' ' GLU . 67.7 m95 -76.19 -59.24 2.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.921 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.456 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 11.2 pt-20 -34.65 -40.54 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.456 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 95.5 mt -66.62 -53.87 31.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.126 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -46.81 -45.32 19.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 125.83 42.14 0.32 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.436 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.4 t -167.02 110.27 0.7 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.903 0.382 . . . . 0.0 110.869 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 78.1 p -43.84 163.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.902 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.531 HD22 ' HB2' ' A' ' 90' ' ' ALA . 10.6 tp -93.58 111.44 23.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -107.35 149.1 28.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 53.7 mt -119.95 129.93 25.1 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.655 0.741 . . . . 0.0 111.134 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 160.45 49.65 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.692 2.261 . . . . 0.0 112.303 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -111.81 126.05 54.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.906 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.3 t -121.32 144.22 31.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.161 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.429 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 62.7 mm-40 41.76 54.54 3.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.429 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 1.4 ptp180 43.88 40.07 2.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.03 152.72 26.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.4 tt -63.06 141.91 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.106 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.694 HD23 ' N ' ' A' ' 111' ' ' ASP . 5.4 tt -86.25 133.52 33.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.694 ' N ' HD23 ' A' ' 110' ' ' LEU . 17.8 t0 -91.95 74.33 5.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.699 HD23 ' H ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -54.63 -29.69 52.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.934 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -60.57 -66.94 0.45 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.932 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.8 m -50.97 -53.96 28.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.839 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.9 tp -39.46 -61.08 0.84 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.945 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.2 t -55.13 -66.59 0.38 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.473 ' N ' ' HE2' ' A' ' 117' ' ' LYS . 1.0 OUTLIER -40.96 -64.03 0.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.849 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 80.9 mt -40.81 -63.3 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.104 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.8 t -40.82 -58.14 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.099 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 69.9 mt -48.86 -42.12 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.161 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -65.92 -50.23 65.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.856 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -47.79 -40.14 20.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.846 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.66 ' O ' ' HB3' ' A' ' 127' ' ' ALA . . . 144.82 42.33 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.516 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.419 ' O ' HG23 ' A' ' 128' ' ' ILE . . . 83.03 174.74 50.61 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.525 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 0.6 OUTLIER -86.83 -37.13 18.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.846 0.355 . . . . 0.0 110.946 -179.824 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -66.06 -40.45 90.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.866 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.66 ' HB3' ' O ' ' A' ' 123' ' ' GLY . . . -66.72 -63.44 1.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.073 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.574 HD12 ' N ' ' A' ' 129' ' ' CYS . 2.4 pp -49.11 -37.07 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.123 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.574 ' N ' HD12 ' A' ' 128' ' ' ILE . 22.0 m -62.82 -50.7 69.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.849 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -62.31 -33.77 75.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 132' ' ' ARG . 2.5 m-20 -90.91 16.35 9.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 131' ' ' ASP . 78.0 mtt180 36.98 44.56 0.38 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 15.0 mtp85 -77.62 -13.6 59.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 21.4 m95 -39.66 -40.35 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.72 -45.55 81.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.129 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.4 tpp85 -73.57 -44.99 55.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.1 t -57.04 -24.25 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.148 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -85.06 -55.34 4.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.087 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -55.42 -29.57 58.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -54.2 -36.45 63.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.869 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.498 HD23 ' CE2' ' A' ' 143' ' ' TYR . 17.6 tp -83.27 14.57 3.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 25.8 m80 68.99 44.16 1.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.498 ' CE2' HD23 ' A' ' 141' ' ' LEU . 2.7 m-85 -92.32 158.33 39.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.731 0.777 . . . . 0.0 110.91 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.446 ' HA ' ' HD2' ' A' ' 145' ' ' PRO . 53.6 Cg_endo -69.76 110.67 2.61 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.661 2.241 . . . . 0.0 112.349 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 53.9 Cg_endo -69.8 105.67 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.699 2.266 . . . . 0.0 112.356 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.94 -58.82 0.41 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.524 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.443 ' HD3' ' N ' ' A' ' 148' ' ' ASN . 10.7 tmtt? -61.95 150.3 38.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.79 0.329 . . . . 0.0 110.889 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.443 ' N ' ' HD3' ' A' ' 147' ' ' LYS . 46.9 t30 -66.68 81.39 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.431 HD11 ' HG2' ' A' ' 144' ' ' PRO . 42.9 mt -94.87 -52.75 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.124 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.04 -53.05 1.22 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.492 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 75.5 m -57.69 -57.88 10.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.901 0.381 . . . . 0.0 110.831 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.444 ' C ' HD23 ' A' ' 152' ' ' LEU . 6.6 tt -43.6 -50.24 7.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.881 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 154' ' ' ARG . 26.7 mt -55.37 -65.91 0.51 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.95 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 153' ' ' LEU . 20.0 ttp180 -38.17 -50.34 1.4 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.87 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 49.0 m -55.84 -69.21 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -38.84 -43.03 0.89 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.858 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.487 ' O ' ' N ' ' A' ' 161' ' ' ILE . 8.6 t80 -60.52 -66.2 0.57 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 41.4 mt-10 -63.06 -10.2 13.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.933 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -85.69 -53.81 4.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.435 HG22 HD11 ' A' ' 89' ' ' ILE . 42.8 mt -109.54 -39.35 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.091 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.58 HG22 ' HG3' ' A' ' 165' ' ' GLU . 18.4 mt -76.25 -2.28 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.156 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.543 ' CD2' ' HD3' ' A' ' 163' ' ' PRO . 0.2 OUTLIER -72.08 -60.29 2.37 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.672 0.749 . . . . 0.0 110.915 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.543 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.6 Cg_endo -69.78 -41.05 4.58 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.64 2.227 . . . . 0.0 112.323 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.533 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 8.1 t80 -63.33 -27.95 69.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.946 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.58 ' HG3' HG22 ' A' ' 161' ' ' ILE . 9.3 mm-40 -76.97 -59.06 2.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.882 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.469 ' CE ' ' CZ ' ' A' ' 162' ' ' TYR . 2.2 ptp -56.22 -25.39 47.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.858 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.401 ' CD2' ' CD1' ' A' ' 92' ' ' PHE . 67.9 t80 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.869 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.605 ' HE2' HD12 ' A' ' 112' ' ' LEU . 48.9 t80 . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.895 0.379 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.515 ' HA ' HG22 ' A' ' 89' ' ' ILE . 52.0 mt -73.03 -47.65 43.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -54.03 -29.95 45.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -83.91 -64.03 1.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.924 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.515 HG22 ' HA ' ' A' ' 86' ' ' LEU . 9.2 tt -51.15 -28.63 7.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.139 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.1 -34.21 59.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.085 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.3 tttp -69.71 -25.09 63.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.942 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -82.4 -49.19 10.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -63.79 -49.41 73.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.961 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.466 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 7.2 pt-20 -46.27 -35.84 5.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.466 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 96.4 mt -70.13 -44.53 78.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.138 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 -57.76 -36.19 71.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 130.94 -40.04 1.7 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.491 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.7 m -88.41 109.88 20.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.87 0.367 . . . . 0.0 110.841 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 88.7 p -49.88 166.68 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.869 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.9 tp -85.05 122.36 29.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.916 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -127.76 134.78 49.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.492 HG23 ' HD2' ' A' ' 103' ' ' PRO . 5.4 mp -99.04 134.16 21.62 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.64 0.733 . . . . 0.0 111.108 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.492 ' HD2' HG23 ' A' ' 102' ' ' ILE . 53.8 Cg_endo -69.76 159.39 53.58 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.674 2.249 . . . . 0.0 112.357 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -112.63 103.66 11.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.731 HG12 ' HG2' ' A' ' 106' ' ' GLU . 87.1 t -106.35 138.35 32.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.137 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.731 ' HG2' HG12 ' A' ' 105' ' ' VAL . 73.5 mm-40 53.16 47.55 24.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.898 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.493 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 28.0 ptt180 47.95 32.88 3.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.82 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.5 pttm -150.48 157.47 43.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.407 HG13 ' N ' ' A' ' 110' ' ' LEU . 3.0 tp -63.09 140.12 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.097 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.717 HD23 ' N ' ' A' ' 111' ' ' ASP . 5.5 tt -84.6 142.06 30.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.869 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.717 ' N ' HD23 ' A' ' 110' ' ' LEU . 19.5 t0 -93.08 93.38 8.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.847 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.726 HD23 ' H ' ' A' ' 112' ' ' LEU . 1.4 pt? -82.97 -19.88 36.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.875 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.621 ' CE1' ' CE ' ' A' ' 117' ' ' LYS . 65.7 t80 -71.04 -67.08 0.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.975 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.9 m -50.82 -54.37 24.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.885 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.776 ' O ' HG23 ' A' ' 119' ' ' VAL . 13.3 tp -41.53 -50.07 4.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.954 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.0 t -58.04 -61.22 2.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.621 ' CE ' ' CE1' ' A' ' 113' ' ' TYR . 0.1 OUTLIER -56.12 -63.92 1.03 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.885 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.402 ' C ' ' O ' ' A' ' 117' ' ' LYS . 71.9 mt -36.06 -58.61 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.122 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 115' ' ' LEU . 84.2 t -51.03 -54.42 10.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.168 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 65.3 mt -57.62 -29.63 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.088 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -74.48 -56.2 5.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -43.52 -50.15 7.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.508 ' O ' ' HB3' ' A' ' 127' ' ' ALA . . . 160.51 33.09 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.498 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.587 ' O ' HG23 ' A' ' 128' ' ' ILE . . . 89.12 173.35 46.34 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.464 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.524 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 0.8 OUTLIER -78.44 -44.84 23.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.832 0.349 . . . . 0.0 110.897 -179.817 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 56.0 mp0 -59.93 -40.25 88.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.933 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 123' ' ' GLY . . . -65.52 -64.04 0.96 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.12 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.606 HG12 HG13 ' A' ' 119' ' ' VAL . 1.6 pp -55.1 -32.84 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.133 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.52 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 29.8 m -69.56 -42.03 75.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.8 tttm -66.55 -34.86 78.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' A' ' 132' ' ' ARG . 6.5 m-20 -94.2 23.01 5.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 131' ' ' ASP . 0.8 OUTLIER 34.39 35.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.836 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 131' ' ' ASP . 10.8 mmt85 -71.0 -1.54 12.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.569 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 44.3 m95 -49.32 -38.99 29.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.92 -47.92 76.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.103 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 -66.16 -44.7 83.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.887 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 99.2 t -56.94 -39.98 69.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.085 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.97 -57.84 6.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.084 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -52.83 -29.84 30.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.935 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.0 mmt-85 -60.73 -29.44 69.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.546 HD11 ' CB ' ' A' ' 111' ' ' ASP . 14.4 tp -87.53 13.32 10.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.91 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 13.0 m80 71.91 35.82 1.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.882 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.496 ' HB3' HD12 ' A' ' 149' ' ' ILE . 3.1 m-85 -82.21 154.82 69.69 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.65 0.738 . . . . 0.0 110.95 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 122.77 9.45 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.673 2.248 . . . . 0.0 112.367 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 120.03 6.87 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.666 2.244 . . . . 0.0 112.305 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 134.8 -64.67 0.59 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.511 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.451 ' HE2' ' N ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -59.81 142.32 53.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.788 0.328 . . . . 0.0 110.887 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.98 85.91 2.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.496 HD12 ' HB3' ' A' ' 143' ' ' TYR . 56.0 mt -91.6 -34.05 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.133 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -41.02 -48.96 4.33 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.445 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.5 m -57.83 -51.58 69.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.362 . . . . 0.0 110.851 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.416 ' CD2' ' CD2' ' A' ' 156' ' ' HIS . 5.4 tt -48.52 -53.92 16.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.92 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 15.4 mt -53.76 -65.94 0.48 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.917 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.551 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 12.6 ttp180 -37.99 -46.01 0.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.866 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 3.3 m -61.34 -71.93 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.817 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.47 ' CD2' ' HG3' ' A' ' 103' ' ' PRO . 2.3 m-70 -37.37 -34.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.816 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.561 ' CD2' HD12 ' A' ' 161' ' ' ILE . 4.0 t80 -70.08 -57.48 4.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.9 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.5 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 20.2 mm-40 -71.11 -9.74 58.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.919 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.1 tpp85 -98.46 -36.87 9.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.878 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 66.3 mt -112.68 -50.12 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.101 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.661 HG22 ' HG3' ' A' ' 165' ' ' GLU . 34.3 mt -76.34 -0.14 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.546 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -73.08 -60.87 1.66 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.674 0.749 . . . . 0.0 110.942 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.508 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.5 Cg_endo -69.8 -40.45 5.25 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.67 2.247 . . . . 0.0 112.331 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.473 ' CD2' HD12 ' A' ' 89' ' ' ILE . 8.0 t80 -61.04 -36.19 78.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.946 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.661 ' HG3' HG22 ' A' ' 161' ' ' ILE . 9.8 mm-40 -72.35 -61.31 1.84 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.908 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.508 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 11.1 ptt? -54.55 -37.96 66.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.841 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 47.2 t80 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.916 -179.929 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.512 ' HE2' HD12 ' A' ' 112' ' ' LEU . 41.8 t80 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.915 0.388 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.402 HD21 HD21 ' A' ' 112' ' ' LEU . 59.0 mt -69.3 -66.48 0.58 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.889 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -44.2 -24.39 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.935 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -80.73 -62.75 1.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.94 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.451 HG23 ' CD2' ' A' ' 100' ' ' LEU . 15.1 tt -56.89 -26.4 24.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.131 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.09 -55.17 5.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.121 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -53.46 -33.18 53.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.928 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -69.46 -53.3 19.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.871 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.617 ' CD1' HD13 ' A' ' 100' ' ' LEU . 21.7 m95 -54.11 -55.04 31.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.894 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 11.3 pt-20 -48.59 -43.91 36.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.921 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.451 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 62.8 mt -61.61 -45.84 97.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.111 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -54.59 -41.05 69.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.984 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 126.86 42.26 0.29 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.472 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.2 m -164.24 169.9 16.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.881 0.372 . . . . 0.0 110.836 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.7 t -100.44 151.5 21.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.843 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.617 HD13 ' CD1' ' A' ' 93' ' ' TRP . 42.4 tp -97.17 117.3 31.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.877 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -113.77 146.6 39.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.941 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 66.5 mt -111.71 124.38 32.57 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.569 0.699 . . . . 0.0 111.15 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 154.02 68.47 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.684 2.256 . . . . 0.0 112.382 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -104.14 119.77 39.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.88 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 84.5 t -127.59 135.52 62.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.126 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 62.04 48.94 4.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.876 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 42.15 39.2 1.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.843 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -163.94 154.48 15.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.864 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.1 tt -58.36 152.15 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.114 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.5 tt -97.48 124.63 41.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -85.75 76.0 10.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.871 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.689 HD23 ' H ' ' A' ' 112' ' ' LEU . 1.1 pt? -53.3 -28.84 30.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -58.18 -52.59 64.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.936 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.447 ' O ' ' C ' ' A' ' 115' ' ' LEU . 23.9 m -63.06 -59.86 4.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 114' ' ' SER . 28.4 tp -34.74 -67.84 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.868 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 117' ' ' LYS . 68.6 m -54.16 -60.23 3.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.857 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 116' ' ' SER . 22.8 mmtt -37.7 -49.14 1.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.9 mt -62.65 -45.04 99.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.186 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.8 t -51.06 -65.89 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.119 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 83.5 mt -51.55 -52.47 20.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.136 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -46.55 -49.16 19.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.413 ' HB3' HG22 ' A' ' 128' ' ' ILE . 44.7 mm-40 -53.28 -48.46 68.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.89 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 153.8 34.4 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.498 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.491 ' O ' HG23 ' A' ' 128' ' ' ILE . . . 96.14 -178.12 34.29 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.478 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.499 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 1.0 OUTLIER -88.07 -35.91 17.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 0.0 110.912 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -69.56 -38.91 77.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.905 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.2 -57.87 6.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.105 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.576 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 2.2 pp -56.57 -35.99 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.156 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.448 ' N ' HD12 ' A' ' 128' ' ' ILE . 39.1 m -67.71 -35.91 79.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -65.27 -46.06 81.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.448 ' O ' ' C ' ' A' ' 132' ' ' ARG . 3.7 t0 -88.18 24.55 1.83 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.448 ' C ' ' O ' ' A' ' 131' ' ' ASP . 60.0 mtp180 34.31 52.23 0.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.457 ' O ' ' C ' ' A' ' 134' ' ' TRP . 16.8 mmt180 -74.27 -24.39 59.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.848 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.576 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 25.2 m95 -33.57 -45.39 0.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.33 -56.51 17.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.09 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.6 -40.59 92.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 90.2 t -54.14 -39.35 41.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.097 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.477 ' HB2' HD11 ' A' ' 153' ' ' LEU . . . -71.87 -52.86 15.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.145 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -54.25 -29.12 45.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -60.13 -35.25 74.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.867 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.7 HD23 ' CE2' ' A' ' 143' ' ' TYR . 15.0 tp -85.22 24.65 1.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.939 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 59.18 34.59 23.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.847 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.7 ' CE2' HD23 ' A' ' 141' ' ' LEU . 3.2 m-85 -82.34 153.41 68.64 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.663 0.744 . . . . 0.0 110.954 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.699 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.5 Cg_endo -69.75 113.55 3.41 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.666 2.244 . . . . 0.0 112.32 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 53.3 Cg_endo -69.79 94.8 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.624 2.216 . . . . 0.0 112.322 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 173.54 -71.5 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.457 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -49.56 168.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.806 0.336 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -83.39 43.8 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.699 HD11 ' HG2' ' A' ' 144' ' ' PRO . 63.5 mt -54.59 -49.37 67.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.146 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.571 ' HA2' HD12 ' A' ' 153' ' ' LEU . . . -37.89 -52.36 2.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.466 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.2 t -62.21 -47.82 82.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.93 0.395 . . . . 0.0 110.84 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.5 tt -52.04 -46.56 65.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.951 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.571 HD12 ' HA2' ' A' ' 150' ' ' GLY . 6.2 mt -59.93 -66.04 0.58 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.534 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 18.3 ttp180 -37.84 -49.2 1.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 74.5 m -57.07 -68.6 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -38.15 -45.26 0.92 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.843 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.514 ' HA ' HD12 ' A' ' 161' ' ' ILE . 4.0 t80 -60.22 -59.37 5.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.434 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 5.5 mm-40 -67.14 -9.97 45.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -86.89 -54.39 4.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.8 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 38.6 mt -108.85 -39.92 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.075 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 157' ' ' TYR . 15.0 mt -77.33 0.66 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.118 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.586 ' CE1' ' SD ' ' A' ' 166' ' ' MET . 0.2 OUTLIER -72.53 -60.48 2.06 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.662 0.744 . . . . 0.0 110.932 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.557 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.0 Cg_endo -69.79 -42.96 2.92 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.695 2.263 . . . . 0.0 112.326 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.403 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 26.6 t80 -56.82 -39.74 74.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.916 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.501 ' HG3' HG22 ' A' ' 161' ' ' ILE . 16.3 mm-40 -72.17 -65.5 0.77 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.897 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.586 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 8.5 ptt? -47.95 -42.3 27.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.833 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 17.8 t80 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.874 -179.956 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.416 ' CD2' ' HA ' ' A' ' 113' ' ' TYR . 29.4 t80 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.916 0.388 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.1 mt -63.75 -56.4 15.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.913 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -57.75 -24.82 58.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.887 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -77.88 -60.98 2.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.541 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 20.7 tt -62.19 -31.07 50.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.151 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.753 ' HB2' HD22 ' A' ' 100' ' ' LEU . . . -68.41 -51.93 38.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.088 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -47.29 -27.88 1.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.875 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -80.24 -44.22 20.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -69.5 -55.35 10.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 12.1 pt-20 -40.1 -41.65 1.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.843 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.41 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 84.7 mt -68.02 -54.27 23.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.154 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -45.74 -32.76 2.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 129.94 -37.94 2.07 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.482 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 41.3 t -89.22 121.81 31.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.906 0.384 . . . . 0.0 110.856 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.7 t -60.09 172.45 0.79 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.85 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.753 HD22 ' HB2' ' A' ' 90' ' ' ALA . 19.5 tp -97.94 127.86 44.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.889 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.3 mttm -130.56 128.53 41.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.493 HD12 HD22 ' A' ' 112' ' ' LEU . 45.9 mm -95.63 123.31 56.58 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.609 0.719 . . . . 0.0 111.165 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.561 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 54.1 Cg_endo -69.77 146.82 61.31 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.625 2.217 . . . . 0.0 112.389 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -95.92 113.9 25.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.925 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 79.1 t -115.53 141.43 32.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.441 ' HG3' ' CD ' ' A' ' 144' ' ' PRO . 23.2 mm-40 47.39 53.76 10.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.908 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 19.7 ptt-85 43.04 42.58 3.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.85 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -163.6 153.52 15.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.907 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.8 tp -63.56 143.57 15.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.086 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.631 HD23 ' N ' ' A' ' 111' ' ' ASP . 4.6 tt -89.82 123.75 34.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.631 ' N ' HD23 ' A' ' 110' ' ' LEU . 37.1 t0 -86.14 68.24 10.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.846 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.493 HD22 HD12 ' A' ' 102' ' ' ILE . 2.0 pt? -47.55 -32.64 5.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.416 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 6.9 t80 -56.33 -65.28 0.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.923 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.3 p -51.79 -45.5 63.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.6 tp -45.92 -66.91 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.902 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.9 t -47.56 -51.38 21.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -47.67 -59.43 3.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.891 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.609 ' CG2' HG13 ' A' ' 137' ' ' VAL . 77.7 mt -50.99 -50.05 25.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.139 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 98.9 t -49.65 -63.21 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.126 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 74.4 mt -51.18 -48.74 31.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.125 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -52.58 -57.24 10.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.875 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -45.36 -49.51 12.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.916 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 154.51 36.62 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.499 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.07 175.12 40.91 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.491 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.504 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 1.2 t80 -82.78 -40.19 20.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.839 0.352 . . . . 0.0 110.892 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -64.2 -40.02 95.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.878 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.1 -64.47 0.92 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.126 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.677 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 2.0 pp -54.7 -34.5 30.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.156 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.504 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 22.5 m -66.88 -36.57 82.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.6 tptt -71.62 -42.1 68.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 132' ' ' ARG . 38.7 m-20 -88.34 22.88 2.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.868 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 131' ' ' ASP . 35.3 mtp180 34.46 43.43 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.844 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -74.76 -8.11 55.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.677 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 16.7 m95 -45.61 -47.55 14.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.902 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -46.66 -56.97 5.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.098 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -67.73 -56.67 8.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.609 HG13 ' CG2' ' A' ' 118' ' ' ILE . 87.0 t -43.23 -29.42 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.138 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.547 ' HB2' HD11 ' A' ' 153' ' ' LEU . . . -81.0 -49.18 11.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.141 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -59.56 -27.73 66.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -60.6 -26.16 66.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.837 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.505 HD23 ' CE2' ' A' ' 143' ' ' TYR . 20.3 tp -90.03 12.12 18.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.878 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 71.42 48.88 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.505 ' CE2' HD23 ' A' ' 141' ' ' LEU . 2.8 m-85 -99.94 158.59 31.78 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.681 0.753 . . . . 0.0 110.9 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.623 ' HG2' HD11 ' A' ' 149' ' ' ILE . 54.4 Cg_endo -69.72 111.42 2.8 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.714 2.276 . . . . 0.0 112.372 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 53.5 Cg_endo -69.8 95.27 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.711 2.274 . . . . 0.0 112.307 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.52 -73.74 0.12 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.452 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -54.74 145.08 20.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.836 0.35 . . . . 0.0 110.888 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -63.76 81.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.864 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.623 HD11 ' HG2' ' A' ' 144' ' ' PRO . 71.4 mt -88.27 -45.59 15.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.101 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -37.98 -45.96 1.7 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.482 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.6 m -60.66 -51.38 69.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.372 . . . . 0.0 110.877 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.528 HD21 ' CD2' ' A' ' 156' ' ' HIS . 5.9 tt -50.2 -48.83 54.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.915 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.547 HD11 ' HB2' ' A' ' 138' ' ' ALA . 22.2 mt -57.32 -65.96 0.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.42 ' CD ' ' HE1' ' A' ' 134' ' ' TRP . 17.8 ttp180 -38.99 -46.38 1.33 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 157' ' ' TYR . 41.0 t -60.2 -68.53 0.28 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.561 ' CE1' ' HG3' ' A' ' 103' ' ' PRO . 2.4 m-70 -41.9 -24.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.842 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 155' ' ' SER . 7.9 t80 -78.42 -50.14 12.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.918 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.408 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 5.2 mm-40 -81.62 -9.86 59.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.87 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -96.0 -41.48 8.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 76.9 mt -112.49 -49.18 5.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.113 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.778 HG22 ' HG3' ' A' ' 165' ' ' GLU . 9.8 mt -76.88 6.39 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.152 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.645 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -75.35 -62.63 0.79 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.666 0.745 . . . . 0.0 110.907 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.556 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.1 Cg_endo -69.81 -35.26 12.84 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.675 2.25 . . . . 0.0 112.329 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.541 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 65.3 t80 -60.51 -42.53 96.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.945 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.778 ' HG3' HG22 ' A' ' 161' ' ' ILE . 8.0 mt-10 -70.04 -55.07 10.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.883 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 2.7 mtm -62.74 -58.63 6.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.856 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.462 ' CB ' ' O ' ' A' ' 163' ' ' PRO . 29.3 t80 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.83 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.461 ' HE2' HD12 ' A' ' 112' ' ' LEU . 34.7 t80 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.891 0.376 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 12.6 mt -63.15 -66.77 0.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -44.51 -26.16 0.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -78.74 -70.58 0.49 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.9 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.636 HD11 HG22 ' A' ' 160' ' ' ILE . 7.5 tt -49.46 -32.26 6.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.131 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.918 ' HB2' HD22 ' A' ' 100' ' ' LEU . . . -73.6 -49.82 24.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.103 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -52.63 -20.03 2.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -90.82 -42.12 10.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -68.3 -50.57 52.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.417 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 4.4 pt-20 -45.24 -29.36 0.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.862 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.417 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 86.5 mt -78.69 -54.67 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.089 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -45.67 -32.59 2.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 132.18 -30.0 3.25 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.479 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.3 m -98.72 146.63 25.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.904 0.383 . . . . 0.0 110.833 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 65.5 m -78.25 174.93 10.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.837 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.918 HD22 ' HB2' ' A' ' 90' ' ' ALA . 22.0 tp -90.67 117.12 29.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.921 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -115.84 141.98 47.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.863 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 25.8 mm -117.28 121.62 32.07 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.649 0.738 . . . . 0.0 111.116 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 166.42 27.63 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.72 2.28 . . . . 0.0 112.315 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -114.04 126.57 55.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.412 HG12 ' HG2' ' A' ' 106' ' ' GLU . 52.0 t -125.4 132.95 70.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.467 ' HG3' ' CD ' ' A' ' 144' ' ' PRO . 29.1 mm-40 56.9 52.05 9.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.404 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 11.8 ptp180 44.64 35.93 1.58 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.909 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.46 ' HG3' ' N ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -157.82 151.95 24.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.9 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.46 ' N ' ' HG3' ' A' ' 108' ' ' LYS . 15.7 tt -57.51 149.2 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.149 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.438 HD23 ' N ' ' A' ' 111' ' ' ASP . 5.9 tt -94.32 123.84 37.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.973 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.438 ' N ' HD23 ' A' ' 110' ' ' LEU . 22.1 t0 -79.99 69.56 6.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.851 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.461 HD12 ' HE2' ' A' ' 85' ' ' TYR . 2.5 pt? -51.25 -23.08 3.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.495 ' CE1' ' HG3' ' A' ' 117' ' ' LYS . 2.4 t80 -66.06 -57.51 7.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.95 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 115' ' ' LEU . 3.3 m -60.5 -59.43 5.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.867 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.423 ' C ' ' O ' ' A' ' 114' ' ' SER . 13.0 tp -36.21 -68.23 0.14 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.897 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 119' ' ' VAL . 42.0 t -50.78 -66.24 0.42 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.87 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.495 ' HG3' ' CE1' ' A' ' 113' ' ' TYR . 13.2 mmtp -36.85 -43.83 0.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.886 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 77.1 mt -64.82 -42.47 95.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.135 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.712 HG13 HG12 ' A' ' 128' ' ' ILE . 95.2 t -59.22 -56.89 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.105 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 70.0 mt -61.46 -45.58 98.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -56.4 -52.09 65.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -50.89 -47.17 60.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.865 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 127' ' ' ALA . . . 155.57 38.56 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.467 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.526 ' O ' HG23 ' A' ' 128' ' ' ILE . . . 87.44 176.27 48.6 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.481 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.566 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 0.6 OUTLIER -83.52 -36.94 23.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.368 . . . . 0.0 110.919 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -63.57 -41.09 98.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.85 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 123' ' ' GLY . . . -68.56 -64.36 0.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.136 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.712 HG12 HG13 ' A' ' 119' ' ' VAL . 2.2 pp -47.84 -32.17 3.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.136 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.439 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 22.1 m -70.18 -46.61 64.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.864 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -59.88 -40.62 89.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.897 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 132' ' ' ARG . 2.7 m-20 -86.65 17.35 3.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.85 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.428 ' HB3' ' NH1' ' A' ' 132' ' ' ARG . 14.5 mtp-105 37.7 45.72 0.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 134' ' ' TRP . 4.1 mmp_? -71.77 -20.15 61.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.561 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 50.5 m95 -36.01 -40.27 0.2 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.908 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.45 -52.65 64.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.076 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.5 mmt-85 -68.5 -38.85 81.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.887 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 78.2 t -56.27 -40.11 63.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.614 ' HB2' HD11 ' A' ' 153' ' ' LEU . . . -72.4 -47.69 47.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -62.04 -27.32 68.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.4 mmp_? -60.97 -35.7 77.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.854 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.495 HD23 ' CZ ' ' A' ' 143' ' ' TYR . 14.8 tp -82.79 13.49 3.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.971 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 62.82 51.13 3.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.668 ' HB3' HD13 ' A' ' 149' ' ' ILE . 2.5 m-85 -91.43 159.68 38.5 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.677 0.751 . . . . 0.0 110.873 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.467 ' CD ' ' HG3' ' A' ' 106' ' ' GLU . 53.8 Cg_endo -69.78 118.47 5.7 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.683 2.255 . . . . 0.0 112.343 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 54.0 Cg_endo -69.72 97.78 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.693 2.262 . . . . 0.0 112.36 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.54 -82.39 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.46 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 9.3 tttp -47.31 147.8 1.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.804 0.335 . . . . 0.0 110.88 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -66.68 82.68 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.895 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.668 HD13 ' HB3' ' A' ' 143' ' ' TYR . 64.0 mt -83.06 -50.77 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.136 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.11 -53.21 1.24 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.526 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.1 t -57.16 -61.59 2.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.903 0.382 . . . . 0.0 110.801 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.424 HD21 ' CD2' ' A' ' 156' ' ' HIS . 5.5 tt -39.12 -55.95 1.54 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.935 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.614 HD11 ' HB2' ' A' ' 138' ' ' ALA . 23.9 mt -50.57 -65.9 0.48 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.561 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 13.2 ttp180 -38.84 -45.78 1.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.4 t -61.12 -69.01 0.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.854 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.424 ' CD2' HD21 ' A' ' 152' ' ' LEU . 2.0 m-70 -39.91 -36.16 0.43 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.799 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.463 ' CD1' ' C ' ' A' ' 157' ' ' TYR . 3.4 t80 -69.78 -58.93 3.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 18.4 mt-10 -66.92 -10.08 45.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.901 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -92.95 -53.08 4.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.812 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.636 HG22 HD11 ' A' ' 89' ' ' ILE . 60.7 mt -104.73 -43.47 8.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.07 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.563 HG22 ' HG3' ' A' ' 165' ' ' GLU . 32.3 mt -76.02 -2.29 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.163 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.624 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -72.2 -60.45 2.24 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.656 0.741 . . . . 0.0 110.931 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 162' ' ' TYR . 53.9 Cg_endo -69.73 -43.56 2.61 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.699 2.266 . . . . 0.0 112.337 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.54 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 17.6 t80 -54.66 -41.55 70.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.563 ' HG3' HG22 ' A' ' 161' ' ' ILE . 14.5 mm-40 -76.26 -68.44 0.59 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.408 ' HG3' ' HA ' ' A' ' 163' ' ' PRO . 0.0 OUTLIER -42.34 -30.25 0.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 24.8 t80 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.9 -179.95 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.601 ' CE1' ' NZ ' ' A' ' 117' ' ' LYS . 42.4 t80 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.905 0.384 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.741 ' CD2' HD21 ' A' ' 112' ' ' LEU . 43.3 mt -55.44 -59.88 4.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.906 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.3 -39.27 66.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.862 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -62.9 -57.83 9.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.456 HD11 HG22 ' A' ' 160' ' ' ILE . 18.0 tt -61.02 -34.99 62.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.14 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.26 -51.27 46.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.09 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -44.14 -35.31 2.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.929 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -72.41 -50.54 25.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.586 ' CD1' HD13 ' A' ' 100' ' ' LEU . 87.0 m95 -63.38 -58.5 6.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.949 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 21.7 pt-20 -37.68 -39.34 0.33 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.451 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 97.2 mt -71.24 -55.09 15.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.125 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -44.71 -35.81 2.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.923 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 120.31 -30.52 5.58 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.497 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.403 ' O ' ' C ' ' A' ' 99' ' ' SER . 0.7 OUTLIER -86.87 94.85 9.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.907 0.384 . . . . 0.0 110.84 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 98' ' ' SER . 51.3 p -38.02 150.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.837 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.586 HD13 ' CD1' ' A' ' 93' ' ' TRP . 18.5 tp -88.06 107.42 18.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.931 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -102.28 115.55 30.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.89 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.47 ' H ' HD12 ' A' ' 102' ' ' ILE . 5.4 mp -81.12 123.1 82.08 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.647 0.737 . . . . 0.0 111.12 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 144.55 54.44 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.671 2.248 . . . . 0.0 112.325 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -102.63 109.47 21.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.916 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 90.4 t -113.32 140.48 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.105 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.47 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 5.7 mm-40 57.45 43.62 22.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.912 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.47 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 5.3 ptm180 48.22 33.49 3.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.901 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -153.71 157.47 39.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 6.8 tt -63.6 139.63 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.114 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.584 HD23 ' N ' ' A' ' 111' ' ' ASP . 4.1 tt -84.85 122.11 28.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.941 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.584 ' N ' HD23 ' A' ' 110' ' ' LEU . 29.8 t0 -80.03 74.04 6.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.741 HD21 ' CD2' ' A' ' 86' ' ' LEU . 1.5 pt? -57.48 -32.08 66.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.901 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.531 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -56.57 -64.32 0.91 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.921 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 115' ' ' LEU . 5.3 m -53.11 -63.97 0.97 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.849 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.74 ' O ' HG23 ' A' ' 119' ' ' VAL . 13.7 tp -34.19 -53.89 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.879 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.3 t -56.46 -64.32 0.91 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.601 ' NZ ' ' CE1' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -45.23 -51.41 10.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.9 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 69.8 mt -54.33 -40.96 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.144 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 115' ' ' LEU . 96.9 t -66.2 -39.46 84.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.089 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 62.0 mt -70.28 -55.21 15.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.128 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.481 ' HG3' ' N ' ' A' ' 122' ' ' GLU . 5.6 pt-20 -49.31 -37.55 24.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.889 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.481 ' N ' ' HG3' ' A' ' 121' ' ' GLU . 35.7 mt-10 -65.41 -27.23 68.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.845 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 134.86 28.44 0.45 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.462 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.99 -175.65 35.37 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.495 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.485 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 1.1 t80 -86.25 -38.6 17.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.827 0.346 . . . . 0.0 110.933 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -62.37 -48.39 79.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.897 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -53.75 -71.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.09 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.522 HG12 HG13 ' A' ' 119' ' ' VAL . 1.6 pp -46.31 -34.86 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 25.7 m -69.01 -32.58 72.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.855 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -68.46 -46.64 69.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 132' ' ' ARG . 1.1 m-20 -90.11 24.62 2.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 131' ' ' ASP . 23.6 mmt85 35.45 44.9 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.624 ' O ' HG23 ' A' ' 137' ' ' VAL . 71.1 mtt85 -83.91 21.69 1.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.842 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.525 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 28.5 m95 -66.16 -42.77 88.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.45 -47.9 75.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.086 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -47.53 78.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 133' ' ' ARG . 73.1 t -53.88 -37.89 34.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.153 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.614 ' HB2' HD11 ' A' ' 153' ' ' LEU . . . -66.91 -53.12 35.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.097 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -58.31 -38.22 76.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.908 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -59.19 -31.61 69.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.96 HD12 ' CE2' ' A' ' 143' ' ' TYR . 1.5 tm? -80.77 12.52 3.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 65.71 53.53 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.839 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.96 ' CE2' HD12 ' A' ' 141' ' ' LEU . 6.6 m-85 -109.0 159.01 32.69 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.636 0.731 . . . . 0.0 110.956 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 112.5 3.1 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.712 2.274 . . . . 0.0 112.333 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 122.43 9.12 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.674 2.249 . . . . 0.0 112.372 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.96 -70.1 0.3 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.488 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -58.15 171.0 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.764 0.316 . . . . 0.0 110.915 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.2 42.2 1.02 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.917 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.423 ' O ' ' C ' ' A' ' 150' ' ' GLY . 92.1 mt -44.5 -45.02 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.151 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.05 -54.78 1.19 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.511 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.9 m -58.93 -50.26 74.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.948 0.404 . . . . 0.0 110.834 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.54 ' C ' HD23 ' A' ' 152' ' ' LEU . 8.3 tt -51.74 -50.13 61.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.956 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.614 HD11 ' HB2' ' A' ' 138' ' ' ALA . 25.5 mt -52.94 -64.73 0.72 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.902 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.525 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 14.3 ttp180 -41.1 -46.02 2.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 47.3 t -57.92 -58.88 6.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.841 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -51.98 -49.21 63.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.535 ' HA ' HD12 ' A' ' 161' ' ' ILE . 3.8 t80 -57.79 -57.59 12.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.963 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.471 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 39.0 mt-10 -66.88 -9.8 41.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.877 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 37.4 ttt-85 -87.76 -57.4 2.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.857 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.456 HG22 HD11 ' A' ' 89' ' ' ILE . 78.6 mt -104.76 -41.22 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.169 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.574 HG22 ' HG3' ' A' ' 165' ' ' GLU . 14.2 mt -75.96 -0.48 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.113 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.634 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -73.32 -61.31 1.48 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.716 0.769 . . . . 0.0 110.941 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.477 ' HA ' ' CG ' ' A' ' 166' ' ' MET . 53.8 Cg_endo -69.7 -33.65 16.38 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.737 2.292 . . . . 0.0 112.341 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.409 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 24.5 t80 -64.75 -46.38 82.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.887 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.574 ' HG3' HG22 ' A' ' 161' ' ' ILE . 4.9 mm-40 -69.29 -55.46 10.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.865 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.477 ' CG ' ' HA ' ' A' ' 163' ' ' PRO . 0.5 OUTLIER -55.02 -40.83 70.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 44.7 t80 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.878 -179.961 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.503 ' CD2' ' HA ' ' A' ' 113' ' ' TYR . 29.9 t80 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.905 0.384 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.8 HD21 HD21 ' A' ' 112' ' ' LEU . 95.6 mt -62.55 -41.99 99.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.899 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -61.76 -18.06 58.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -91.55 -57.33 2.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.96 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.498 HD11 HG22 ' A' ' 160' ' ' ILE . 15.6 tt -63.5 -39.39 85.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.149 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.485 ' HB2' ' CD2' ' A' ' 100' ' ' LEU . . . -67.03 -38.86 86.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.09 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -61.29 -28.5 69.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -82.58 -39.44 22.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.875 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.487 ' O ' ' N ' ' A' ' 96' ' ' GLN . 27.0 m95 -68.35 -61.05 2.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.442 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 5.7 pt-20 -36.96 -31.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.925 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 93' ' ' TRP . 96.7 mt -73.4 -45.41 52.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.101 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 93' ' ' TRP . 61.2 mm-40 -56.51 -33.07 65.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 131.78 -42.24 1.41 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.472 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 37.9 m -86.71 140.32 29.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.913 0.387 . . . . 0.0 110.848 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.0 p -71.17 175.31 5.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.87 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.489 HD22 HG23 ' A' ' 89' ' ' ILE . 25.5 tp -104.35 112.12 25.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.1 ttpt -109.67 130.46 55.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.1 mp -96.04 124.17 52.82 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.586 0.707 . . . . 0.0 111.15 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.444 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 54.2 Cg_endo -69.76 142.87 49.1 Favored 'Trans proline' 0 N--CA 1.466 -0.125 0 C-N-CA 122.707 2.272 . . . . 0.0 112.363 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -94.27 113.7 25.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.898 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.5 t -113.17 142.68 24.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.091 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 19.1 mm-40 50.61 48.62 22.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.911 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.434 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 18.4 ptt-85 45.72 33.22 1.41 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.868 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.8 pttm -151.6 164.76 36.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.856 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.4 tt -69.22 144.82 13.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.119 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 112' ' ' LEU . 6.4 tt -92.97 121.76 34.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.939 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -79.88 57.36 2.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.876 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.8 HD21 HD21 ' A' ' 86' ' ' LEU . 1.5 pt? -41.57 -29.29 0.16 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.503 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 4.9 t80 -59.31 -58.72 7.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.934 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 115' ' ' LEU . 11.0 t -56.05 -57.67 11.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.89 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 114' ' ' SER . 11.1 tp -36.76 -62.76 0.45 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.915 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.7 p -51.13 -53.93 29.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.853 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 18.2 mmtm -49.27 -54.2 17.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.409 ' O ' ' C ' ' A' ' 119' ' ' VAL . 64.6 mt -49.06 -69.22 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.13 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.631 HG13 HG12 ' A' ' 128' ' ' ILE . 90.8 t -37.09 -62.37 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.107 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 89.0 mt -45.18 -56.43 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -52.57 -56.89 12.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.45 ' OE1' HG21 ' A' ' 128' ' ' ILE . 46.8 mt-10 -38.36 -50.35 1.48 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 151.26 39.25 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.492 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.3 -179.43 40.65 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.504 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.499 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 1.9 t80 -87.56 -43.79 11.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.845 0.355 . . . . 0.0 110.931 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -61.28 -36.1 79.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.912 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.92 -65.58 0.66 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.13 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.849 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.8 pp -54.15 -31.8 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.087 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.499 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 26.8 m -70.81 -41.92 70.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.831 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -68.88 -26.44 65.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.855 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -103.03 15.71 28.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.821 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 67.5 mtp85 41.91 29.36 0.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.856 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 27.7 mtt-85 -62.15 -8.78 6.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.839 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.849 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 20.7 m95 -44.13 -52.18 7.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -40.83 -51.18 3.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.099 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -63.63 -51.38 65.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.857 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.6 t -49.4 -38.39 12.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.54 ' HB2' ' CD1' ' A' ' 153' ' ' LEU . . . -70.24 -57.48 4.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -57.87 -18.25 21.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -69.94 -25.36 63.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.857 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.58 HD23 ' CE2' ' A' ' 143' ' ' TYR . 14.6 tp -94.28 27.18 3.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 62.25 36.48 14.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.849 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.58 ' CE2' HD23 ' A' ' 141' ' ' LEU . 5.3 m-85 -92.2 147.29 34.33 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.706 0.765 . . . . 0.0 110.925 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.472 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.6 Cg_endo -69.79 118.95 5.99 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.68 2.253 . . . . 0.0 112.34 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 125.81 12.58 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.702 2.268 . . . . 0.0 112.338 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 131.76 -55.61 0.76 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.427 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -54.6 168.67 0.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.762 0.315 . . . . 0.0 110.947 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.422 ' CG ' ' O ' ' A' ' 148' ' ' ASN . 13.1 p-10 -83.86 43.36 0.91 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.91 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.472 HD11 ' HG2' ' A' ' 144' ' ' PRO . 70.5 mt -67.74 -52.51 39.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.096 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.28 -53.07 1.3 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.488 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.2 t -57.53 -58.62 7.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 0.0 110.849 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.647 HD21 ' CD2' ' A' ' 156' ' ' HIS . 7.2 tt -42.06 -49.46 4.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.943 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.54 ' CD1' ' HB2' ' A' ' 138' ' ' ALA . 23.6 mt -55.98 -65.84 0.53 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.938 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.443 ' HD2' ' NE1' ' A' ' 134' ' ' TRP . 32.0 ttt180 -39.21 -39.97 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 156' ' ' HIS . 9.3 t -67.56 -70.01 0.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.861 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.647 ' CD2' HD21 ' A' ' 152' ' ' LEU . 2.0 m-70 -37.17 -33.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.86 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.447 ' HA ' ' CG1' ' A' ' 161' ' ' ILE . 12.0 t80 -70.38 -56.27 7.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -73.59 -9.81 59.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.858 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? -92.07 -49.0 6.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.908 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.498 HG22 HD11 ' A' ' 89' ' ' ILE . 88.3 mt -109.91 -44.18 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.118 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.553 HG22 ' CG ' ' A' ' 165' ' ' GLU . 14.3 mt -77.45 4.24 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.148 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.606 ' CE1' ' SD ' ' A' ' 166' ' ' MET . 0.1 OUTLIER -74.24 -61.48 1.21 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.662 0.744 . . . . 0.0 110.905 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.564 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 54.2 Cg_endo -69.73 -30.71 21.98 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.649 2.232 . . . . 0.0 112.354 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -69.2 -42.58 75.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.973 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.553 ' CG ' HG22 ' A' ' 161' ' ' ILE . 3.9 mm-40 -67.8 -57.65 5.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.878 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.606 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 24.7 ptm -53.42 -47.7 69.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 31.8 t80 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.897 -179.926 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.497 ' HE2' HD12 ' A' ' 112' ' ' LEU . 40.3 t80 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.883 0.373 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.2 mt -76.48 -44.29 36.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -59.33 -38.81 81.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.859 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -66.25 -63.76 1.01 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.898 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.564 ' HA ' ' CE1' ' A' ' 164' ' ' TYR . 19.4 tt -52.54 -30.5 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.03 -56.24 6.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.059 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -44.24 -27.5 0.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.939 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -78.68 -46.75 18.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.43 ' O ' ' N ' ' A' ' 95' ' ' ILE . 66.2 m95 -69.2 -57.68 5.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.96 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 93' ' ' TRP . 9.2 pt-20 -36.91 -32.53 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.43 ' N ' ' O ' ' A' ' 93' ' ' TRP . 96.7 mt -76.22 -51.75 19.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.173 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -47.58 -40.12 18.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.06 -40.57 1.17 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.47 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.7 m -96.56 144.51 26.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.892 0.377 . . . . 0.0 110.833 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.5 t -76.64 171.68 14.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.86 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.5 tp -82.46 104.71 12.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.964 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -96.13 111.07 23.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.0 mt -94.35 119.56 66.33 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.603 0.716 . . . . 0.0 111.158 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.408 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 53.5 Cg_endo -69.75 151.22 69.1 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.676 2.251 . . . . 0.0 112.36 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -102.52 115.17 30.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.853 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.916 HG12 ' CD ' ' A' ' 106' ' ' GLU . 26.2 t -122.04 144.61 30.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.174 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.916 ' CD ' HG12 ' A' ' 105' ' ' VAL . 49.1 mp0 60.76 44.74 10.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.92 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.496 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 15.2 ptm180 46.43 39.79 7.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.876 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -171.0 154.0 3.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.865 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.8 tt -52.29 138.67 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.877 HD23 ' N ' ' A' ' 111' ' ' ASP . 5.4 tt -75.04 144.73 42.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.877 ' N ' HD23 ' A' ' 110' ' ' LEU . 13.3 t0 -103.41 75.05 1.31 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.873 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.779 HD23 ' H ' ' A' ' 112' ' ' LEU . 1.4 pt? -65.12 -36.18 83.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.9 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -46.71 -64.76 0.69 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 115' ' ' LEU . 36.6 m -56.93 -60.01 4.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.87 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 114' ' ' SER . 13.1 tp -34.93 -65.24 0.23 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.917 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 52.4 m -48.37 -56.88 7.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.868 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.415 ' HD2' ' N ' ' A' ' 117' ' ' LYS . 2.2 mptp? -49.77 -62.58 1.48 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.891 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 95.6 mt -38.46 -64.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.157 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.537 HG13 HG12 ' A' ' 128' ' ' ILE . 76.2 t -45.0 -59.13 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.112 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 79.2 mt -45.91 -34.81 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.141 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -76.67 -51.77 10.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.895 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -43.54 -46.36 6.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.896 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 127' ' ' ALA . . . 151.69 37.15 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.505 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.461 ' O ' HG23 ' A' ' 128' ' ' ILE . . . 88.59 173.97 47.08 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.477 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 2.4 t80 -82.47 -44.34 16.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.849 0.357 . . . . 0.0 110.929 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -59.67 -42.59 93.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.848 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 123' ' ' GLY . . . -63.15 -70.96 0.18 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.094 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.537 HG12 HG13 ' A' ' 119' ' ' VAL . 1.9 pp -45.28 -32.74 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.157 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.457 ' N ' HD12 ' A' ' 128' ' ' ILE . 22.3 m -68.77 -39.66 80.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -66.27 -41.77 89.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 132' ' ' ARG . 2.1 t70 -88.56 19.89 3.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.886 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.429 ' C ' ' O ' ' A' ' 131' ' ' ASP . 26.1 mtt180 35.47 51.92 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 134' ' ' TRP . 23.4 mtp180 -80.75 -14.54 58.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.827 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.556 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 42.6 m95 -37.56 -56.61 1.01 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.921 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -40.08 -55.83 2.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.105 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 19.8 mmt85 -60.97 -51.49 69.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 84.1 t -46.17 -37.94 3.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.124 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -73.61 -45.47 52.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.088 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -62.99 -17.41 62.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.932 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.9 mmt85 -76.61 -28.99 56.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.92 HD23 ' CZ ' ' A' ' 143' ' ' TYR . 14.7 tp -91.88 20.1 6.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.938 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 5.7 m80 54.62 52.98 11.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.841 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.92 ' CZ ' HD23 ' A' ' 141' ' ' LEU . 4.9 m-85 -89.42 148.33 40.19 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.676 0.75 . . . . 0.0 110.9 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.49 ' CD ' ' HG2' ' A' ' 106' ' ' GLU . 54.0 Cg_endo -69.71 114.57 3.74 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.733 2.288 . . . . 0.0 112.362 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 132.62 23.77 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.701 2.267 . . . . 0.0 112.37 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.36 -63.14 0.6 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.459 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -70.23 156.78 38.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.822 0.344 . . . . 0.0 110.911 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.417 ' CG ' ' O ' ' A' ' 148' ' ' ASN . 16.5 p-10 -75.14 83.84 2.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.873 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.428 ' O ' ' C ' ' A' ' 150' ' ' GLY . 51.5 mt -92.2 -52.09 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.124 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.25 -54.97 1.24 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.473 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 68.0 m -57.91 -53.83 53.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.862 0.363 . . . . 0.0 110.862 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.766 HD21 ' CD2' ' A' ' 156' ' ' HIS . 5.3 tt -46.37 -49.76 17.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.928 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 26.5 mt -56.33 -66.07 0.5 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.556 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 9.7 ttt-85 -38.32 -40.31 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 156' ' ' HIS . 11.5 t -68.16 -71.15 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.766 ' CD2' HD21 ' A' ' 152' ' ' LEU . 2.2 m-70 -37.03 -37.91 0.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.872 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.415 ' HA ' ' CG1' ' A' ' 161' ' ' ILE . 7.8 t80 -65.01 -66.58 0.52 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.933 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 20.2 mm-40 -64.91 -9.94 25.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.911 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 20.3 mmm-85 -86.81 -56.25 3.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.845 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.409 HG22 HD11 ' A' ' 89' ' ' ILE . 62.2 mt -105.7 -43.74 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.096 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.48 ' O ' HG22 ' A' ' 161' ' ' ILE . 13.2 mt -72.61 -0.69 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.159 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.647 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -75.67 -63.24 0.68 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.675 0.75 . . . . 0.0 110.89 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.559 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 54.3 Cg_endo -69.75 -31.26 20.93 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.661 2.241 . . . . 0.0 112.355 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.564 ' CE1' ' HA ' ' A' ' 89' ' ' ILE . 14.5 t80 -64.5 -36.31 83.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.925 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.431 ' HG3' HG22 ' A' ' 161' ' ' ILE . 13.4 mt-10 -77.32 -56.17 4.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.846 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.51 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 13.1 ptt? -52.4 -43.79 64.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.878 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.408 ' N ' ' CG ' ' A' ' 166' ' ' MET . 54.5 t80 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.888 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.488 ' HE2' HD12 ' A' ' 112' ' ' LEU . 33.0 t80 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.953 0.406 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.579 ' CD2' HD21 ' A' ' 112' ' ' LEU . 28.1 mt -70.13 -59.31 2.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.945 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.42 -33.14 42.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -66.49 -67.75 0.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.552 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 8.2 tt -50.18 -37.27 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.093 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.28 -52.76 44.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.073 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.0 tttm -45.32 -30.68 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.551 ' CD1' ' CD2' ' A' ' 167' ' ' PHE . 8.3 t80 -79.46 -39.67 31.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.891 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.505 ' CD1' HD13 ' A' ' 100' ' ' LEU . 61.9 m95 -70.31 -64.21 0.94 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.924 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.447 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 6.0 pt-20 -34.82 -33.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' A' ' 93' ' ' TRP . 96.5 mt -74.02 -50.33 29.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.116 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 93' ' ' TRP . 28.8 mm-40 -55.59 -18.64 8.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.929 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 104.12 -37.42 3.77 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.496 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.7 p -79.35 92.77 5.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.824 0.345 . . . . 0.0 110.842 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 40.8 t -41.46 159.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.832 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.505 HD13 ' CD1' ' A' ' 93' ' ' TRP . 64.4 tp -93.29 143.78 25.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.958 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -138.61 121.14 16.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.918 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 60.8 mt -88.68 123.11 68.61 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.627 0.727 . . . . 0.0 111.118 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 158.8 55.7 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.665 2.243 . . . . 0.0 112.388 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -110.76 107.38 16.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.906 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 58.3 t -110.72 136.1 47.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.092 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.499 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 36.2 mm-40 61.35 44.46 9.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.944 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.499 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 14.3 ptp180 46.57 33.55 2.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.873 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.3 ptmm? -155.82 155.47 33.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.926 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.4 tt -57.5 145.57 8.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.158 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.527 ' C ' HD23 ' A' ' 110' ' ' LEU . 4.8 tt -96.14 113.66 25.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.935 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.449 ' N ' HD23 ' A' ' 110' ' ' LEU . 16.9 t70 -79.84 80.72 6.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.617 HD23 ' H ' ' A' ' 112' ' ' LEU . 1.9 pt? -53.13 -42.42 66.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.926 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.478 ' N ' ' HG ' ' A' ' 112' ' ' LEU . 15.0 t80 -41.25 -53.59 3.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.918 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.8 m -61.27 -45.84 92.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.85 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.402 ' O ' HG23 ' A' ' 119' ' ' VAL . 15.6 tp -55.95 -63.76 1.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 73.5 m -50.52 -44.69 56.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.857 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.46 ' HE2' ' CE1' ' A' ' 113' ' ' TYR . 28.7 mmtt -60.44 -66.11 0.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.908 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.485 ' CG2' HG13 ' A' ' 137' ' ' VAL . 21.3 mt -43.72 -28.17 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.133 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 115' ' ' LEU . 43.3 t -77.12 -40.88 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.12 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 67.9 mt -72.3 -41.4 65.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.171 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -62.42 -37.15 84.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.457 ' OE1' HG22 ' A' ' 128' ' ' ILE . 10.5 mt-10 -66.21 -26.96 67.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.905 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 135.08 29.86 0.38 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.461 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.3 -173.37 34.21 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.494 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.525 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 2.6 t80 -86.98 -43.79 12.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.884 0.373 . . . . 0.0 110.914 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -60.97 -37.43 82.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.876 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.8 -68.64 0.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.058 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.704 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.6 pp -52.34 -35.78 20.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.119 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.525 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 54.5 m -64.5 -36.47 84.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.59 -41.39 79.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 132' ' ' ARG . 16.3 m-20 -94.78 20.48 8.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.892 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 131' ' ' ASP . 24.7 ptt85 35.21 48.2 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.839 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -85.72 17.92 3.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.841 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.704 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 41.8 m95 -60.39 -48.85 79.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.938 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -48.42 -47.4 37.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.126 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.42 ' HB3' ' NH1' ' A' ' 136' ' ' ARG . 5.4 mmm180 -61.91 -58.56 7.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.485 HG13 ' CG2' ' A' ' 118' ' ' ILE . 98.5 t -46.75 -31.88 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.61 -58.34 4.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.088 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -52.59 -29.51 26.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 140' ' ' ARG . 5.9 mmm180 -52.82 -39.68 62.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.883 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.64 HD23 ' CZ ' ' A' ' 143' ' ' TYR . 14.8 tp -82.93 17.93 1.77 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.92 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 61.67 43.09 10.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.64 ' CZ ' HD23 ' A' ' 141' ' ' LEU . 3.3 m-85 -83.25 152.37 64.57 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.689 0.757 . . . . 0.0 110.947 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.533 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.8 Cg_endo -69.76 114.13 3.6 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.692 2.261 . . . . 0.0 112.331 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 53.7 Cg_endo -69.76 109.33 2.28 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.679 2.252 . . . . 0.0 112.349 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 154.94 -67.95 0.3 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.49 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -60.93 152.02 28.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.801 0.334 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -68.11 82.55 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.849 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.533 HD11 ' HG2' ' A' ' 144' ' ' PRO . 90.5 mt -92.61 -46.52 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -37.39 -58.3 1.36 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.491 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.8 m -56.71 -48.01 78.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.91 0.386 . . . . 0.0 110.846 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.415 ' C ' HD23 ' A' ' 152' ' ' LEU . 6.7 tt -50.57 -51.34 49.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.9 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 11.1 mt -57.51 -65.96 0.54 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.557 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 23.9 ttp180 -38.45 -55.02 1.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.86 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.428 ' OG ' ' N ' ' A' ' 156' ' ' HIS . 48.1 p -50.41 -64.72 0.72 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.824 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.428 ' N ' ' OG ' ' A' ' 155' ' ' SER . 2.0 m-70 -43.04 -34.06 0.95 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.517 ' CD1' ' HB ' ' A' ' 161' ' ' ILE . 3.1 t80 -69.71 -69.55 0.34 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.476 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 3.3 mp0 -61.24 -10.11 6.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.88 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 10.6 tpp85 -84.59 -53.35 5.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.435 HG22 HD11 ' A' ' 89' ' ' ILE . 74.1 mt -110.48 -39.18 3.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.151 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.517 ' HB ' ' CD1' ' A' ' 157' ' ' TYR . 13.7 mt -77.04 -0.69 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.115 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.543 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -72.02 -60.34 2.38 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.65 0.738 . . . . 0.0 110.882 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.495 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.8 Cg_endo -69.78 -36.69 10.29 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.668 2.245 . . . . 0.0 112.324 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.552 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 15.3 t80 -59.47 -46.32 89.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.975 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -69.03 -60.17 2.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.924 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.443 ' CG ' ' HA ' ' A' ' 163' ' ' PRO . 0.0 OUTLIER -54.15 -39.33 66.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.551 ' CD2' ' CD1' ' A' ' 92' ' ' PHE . 57.5 t80 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.866 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.467 ' HE2' HD12 ' A' ' 112' ' ' LEU . 69.3 t80 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.936 0.398 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.756 ' CD2' HD21 ' A' ' 112' ' ' LEU . 35.0 mt -70.15 -63.68 1.04 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.887 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -44.46 -27.21 0.42 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.849 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -78.15 -67.6 0.72 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.93 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.575 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 7.9 tt -45.64 -43.0 3.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.412 ' N ' HG23 ' A' ' 89' ' ' ILE . . . -62.34 -53.42 55.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.079 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -42.07 -41.54 2.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.867 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -68.77 -43.8 74.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.871 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.642 ' CD1' HD13 ' A' ' 100' ' ' LEU . 45.4 m95 -62.27 -64.52 0.9 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 7.7 pt-20 -36.37 -41.38 0.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.858 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.435 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 85.6 mt -65.09 -49.82 77.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.133 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -49.61 -44.56 47.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.39 -49.64 0.61 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.488 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 32.5 t -90.15 130.98 36.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.908 0.385 . . . . 0.0 110.884 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.7 m -65.14 164.51 12.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.862 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.642 HD13 ' CD1' ' A' ' 93' ' ' TRP . 54.8 tp -93.34 154.17 18.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.942 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.7 mmmt -145.09 126.47 14.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.873 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.65 122.67 67.94 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.661 0.743 . . . . 0.0 111.149 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.718 ' HG2' HD13 ' A' ' 110' ' ' LEU . 53.9 Cg_endo -69.77 161.49 45.74 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.709 2.273 . . . . 0.0 112.329 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -117.08 117.66 30.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 72.2 t -121.57 140.26 46.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.143 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 107' ' ' ARG . 2.6 mm-40 56.29 54.99 7.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.43 ' NH1' ' HB3' ' A' ' 107' ' ' ARG . 4.2 ptp180 37.09 39.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -157.42 150.16 23.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.9 tt -54.47 140.03 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.155 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.718 HD13 ' HG2' ' A' ' 103' ' ' PRO . 4.1 tt -86.45 119.13 26.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.511 ' N ' HD23 ' A' ' 110' ' ' LEU . 28.5 t0 -86.76 88.62 7.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.81 HD23 ' H ' ' A' ' 112' ' ' LEU . 1.5 pt? -73.72 -22.38 59.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.455 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 5.6 t80 -59.65 -54.71 43.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 115' ' ' LEU . 58.9 p -61.13 -55.22 34.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.887 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.448 ' C ' ' O ' ' A' ' 114' ' ' SER . 27.3 tp -34.67 -59.28 0.47 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.917 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.8 t -59.99 -55.77 29.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.863 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -43.42 -45.54 6.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.884 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.42 HG21 HG13 ' A' ' 137' ' ' VAL . 27.3 mt -63.44 -45.69 97.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.13 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.9 t -51.33 -56.03 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.135 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 84.1 mt -56.32 -46.58 81.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.123 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -56.46 -56.8 16.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.462 ' HB2' ' CG2' ' A' ' 128' ' ' ILE . 33.2 mm-40 -40.69 -52.85 2.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 155.26 34.16 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.488 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.39 178.58 34.13 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.479 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.574 ' CE2' ' SG ' ' A' ' 129' ' ' CYS . 3.4 t80 -81.7 -55.77 4.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.889 0.376 . . . . 0.0 110.951 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -51.47 -29.64 17.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.905 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.06 -71.21 0.29 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.091 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.747 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.9 pp -50.38 -31.7 8.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.096 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.574 ' SG ' ' CE2' ' A' ' 125' ' ' TYR . 94.3 m -69.5 -44.07 71.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.886 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.1 tttm -64.26 -39.57 94.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 132' ' ' ARG . 80.2 m-20 -91.83 23.31 3.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.453 ' C ' ' O ' ' A' ' 131' ' ' ASP . 83.9 mtm180 34.24 35.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.9 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 131' ' ' ASP . 10.7 mmp_? -60.23 -19.49 54.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.846 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.747 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 24.8 m95 -36.6 -43.44 0.41 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.925 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.42 -56.99 14.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.036 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.419 ' HB2' ' NH1' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -59.91 -43.28 94.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.42 HG13 HG21 ' A' ' 118' ' ' ILE . 69.2 t -54.76 -36.61 37.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.107 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.09 -52.41 24.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.083 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -56.23 -37.24 69.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -51.39 -32.44 26.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.839 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.717 HD23 ' CE2' ' A' ' 143' ' ' TYR . 14.6 tp -83.52 17.48 2.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.931 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 66.65 33.99 6.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.84 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.717 ' CE2' HD23 ' A' ' 141' ' ' LEU . 2.5 m-85 -84.34 157.81 61.5 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.658 0.742 . . . . 0.0 110.947 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.55 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.8 Cg_endo -69.78 110.36 2.54 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.685 2.257 . . . . 0.0 112.364 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.474 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 53.6 Cg_endo -69.74 94.51 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.695 2.264 . . . . 0.0 112.315 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 165.25 -61.46 0.24 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.445 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 61.5 mttt -57.12 152.98 12.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.816 0.341 . . . . 0.0 110.913 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -69.88 75.75 0.46 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.55 HD11 ' HG2' ' A' ' 144' ' ' PRO . 84.7 mt -89.22 -54.94 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.146 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.46 -47.99 1.19 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.455 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.3 m -61.64 -53.3 57.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.905 0.384 . . . . 0.0 110.889 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.5 tt -51.33 -51.56 53.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.927 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.446 ' CD1' HG22 ' A' ' 149' ' ' ILE . 30.4 mt -57.61 -65.79 0.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.943 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.536 ' HG3' ' CE2' ' A' ' 134' ' ' TRP . 1.7 ttm105 -39.93 -38.77 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.844 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 69.6 m -66.6 -57.82 6.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -56.03 -26.2 47.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.866 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.524 ' CD2' HD12 ' A' ' 161' ' ' ILE . 5.0 t80 -78.82 -46.92 17.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.923 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.488 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 2.5 mm-40 -79.97 -10.14 59.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.873 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 44.6 ttt85 -100.85 -35.19 9.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.482 HG22 HD11 ' A' ' 89' ' ' ILE . 62.0 mt -112.54 -50.93 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.108 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.524 HD12 ' CD2' ' A' ' 157' ' ' TYR . 18.9 mt -77.17 0.04 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.152 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.52 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -72.29 -60.46 2.19 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.63 0.728 . . . . 0.0 110.92 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.505 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.8 Cg_endo -69.79 -37.66 8.79 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.654 2.236 . . . . 0.0 112.355 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.575 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 28.7 t80 -60.31 -38.83 84.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -74.45 -58.09 3.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.899 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 16.7 ptt? -51.17 -40.23 58.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 36.2 t80 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.882 -179.94 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 58.7 t80 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.893 0.378 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.8 mt -71.21 -61.02 1.92 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.896 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -52.11 -24.05 6.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.817 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -77.89 -69.96 0.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.531 HD11 HG22 ' A' ' 160' ' ' ILE . 9.0 tt -43.98 -36.11 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.133 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.55 ' HB2' HD22 ' A' ' 100' ' ' LEU . . . -73.8 -44.78 54.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.086 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -54.61 -27.93 42.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.849 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.483 ' CE2' ' HA ' ' A' ' 164' ' ' TYR . 4.4 t80 -85.71 -29.97 23.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.874 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 30.4 m95 -75.42 -59.23 2.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.929 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -42.45 -29.55 0.28 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.885 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 85.9 mt -75.72 -47.61 32.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.166 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -51.91 -42.39 62.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 148.54 -36.49 1.08 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.476 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 40.1 m -101.77 155.9 17.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 110.9 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.5 t -83.27 178.08 8.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.851 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.55 HD22 ' HB2' ' A' ' 90' ' ' ALA . 29.4 tp -93.79 138.58 31.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.871 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -137.55 123.6 20.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.546 HD12 HD22 ' A' ' 112' ' ' LEU . 51.0 mm -96.25 124.24 52.15 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.584 0.706 . . . . 0.0 111.193 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.544 ' HG3' ' CD2' ' A' ' 156' ' ' HIS . 53.9 Cg_endo -69.72 152.05 69.44 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.679 2.252 . . . . 0.0 112.321 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -101.96 111.41 23.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.876 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.3 t -108.79 137.57 40.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.13 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.413 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 57.7 mm-40 50.07 54.22 11.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.413 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 1.2 ptp180 43.61 37.51 1.55 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.822 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -155.32 169.88 23.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.867 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.5 tt -75.05 143.96 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.524 HD23 ' N ' ' A' ' 111' ' ' ASP . 4.6 tt -89.86 119.28 30.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.935 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.524 ' N ' HD23 ' A' ' 110' ' ' LEU . 40.0 t0 -73.32 71.36 1.24 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.596 HD23 ' H ' ' A' ' 112' ' ' LEU . 1.6 pt? -56.24 -21.26 22.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -71.67 -62.59 1.36 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.929 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 115' ' ' LEU . 4.2 t -50.02 -58.9 4.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.884 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.449 ' C ' ' O ' ' A' ' 114' ' ' SER . 10.0 tp -34.59 -67.48 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.928 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.1 p -48.07 -52.88 18.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -48.36 -52.51 21.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.944 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.605 HG21 HG13 ' A' ' 137' ' ' VAL . 77.7 mt -57.82 -42.15 81.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.111 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.508 HG13 HG12 ' A' ' 128' ' ' ILE . 95.2 t -59.81 -38.45 76.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.135 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 82.3 mt -71.27 -57.92 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.15 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.529 ' CG ' ' N ' ' A' ' 122' ' ' GLU . 8.1 pt-20 -56.57 -49.49 74.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.916 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.529 ' N ' ' CG ' ' A' ' 121' ' ' GLU . 38.0 mm-40 -47.91 -35.05 9.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.905 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.662 ' O ' ' HB3' ' A' ' 127' ' ' ALA . . . 139.1 43.16 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.448 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.79 -179.42 52.58 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.472 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.51 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 1.1 t80 -89.06 -40.12 13.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.853 0.359 . . . . 0.0 110.931 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -60.94 -45.85 93.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.858 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.662 ' HB3' ' O ' ' A' ' 123' ' ' GLY . . . -62.09 -71.35 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.086 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.567 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 2.2 pp -41.96 -36.32 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.145 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.468 ' N ' HD12 ' A' ' 128' ' ' ILE . 22.1 m -65.83 -40.97 92.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 127' ' ' ALA . 12.9 ttmm -68.95 -26.24 64.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 132' ' ' ARG . 4.2 t0 -100.87 19.38 17.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 131' ' ' ASP . 13.3 mmt85 36.11 54.6 0.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' A' ' 134' ' ' TRP . 14.7 mmt180 -81.81 -25.21 35.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.864 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.567 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 24.2 m95 -34.04 -40.06 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.59 -59.86 4.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.113 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.455 ' O ' ' CD ' ' A' ' 140' ' ' ARG . 38.2 mmt180 -62.28 -50.38 71.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.859 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.605 HG13 HG21 ' A' ' 118' ' ' ILE . 89.4 t -43.57 -46.84 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.146 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.87 -47.85 73.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.075 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -55.27 -32.97 62.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.455 ' CD ' ' O ' ' A' ' 136' ' ' ARG . 0.2 OUTLIER -59.81 -32.04 70.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.848 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.458 HD23 ' CZ ' ' A' ' 143' ' ' TYR . 12.8 tp -80.38 13.74 2.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.911 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 9.6 m80 65.0 51.31 1.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.458 ' CZ ' HD23 ' A' ' 141' ' ' LEU . 2.5 m-85 -94.87 156.78 37.7 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.679 0.752 . . . . 0.0 110.94 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.465 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.8 Cg_endo -69.81 122.23 8.89 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.718 2.279 . . . . 0.0 112.328 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 118.34 5.62 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.701 2.267 . . . . 0.0 112.295 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.53 -67.56 0.56 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.476 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.04 135.61 12.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.802 0.334 . . . . 0.0 110.9 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -65.86 75.43 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.465 HD11 ' HG2' ' A' ' 144' ' ' PRO . 89.9 mt -86.93 -51.17 13.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.165 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -37.12 -47.66 1.41 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.492 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.0 t -63.86 -52.39 60.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.923 0.392 . . . . 0.0 110.887 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.424 ' C ' HD23 ' A' ' 152' ' ' LEU . 7.2 tt -47.21 -53.3 13.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.878 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 30.9 mt -56.04 -65.72 0.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.929 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.54 ' NE ' ' CD1' ' A' ' 134' ' ' TRP . 6.4 ttm180 -40.64 -33.2 0.26 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.882 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 36.1 t -71.86 -52.57 16.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.862 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.544 ' CD2' ' HG3' ' A' ' 103' ' ' PRO . 3.6 m-70 -60.46 -31.48 70.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.845 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.492 ' CD1' ' C ' ' A' ' 157' ' ' TYR . 2.3 t80 -79.25 -30.54 43.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.891 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.505 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 1.9 mm-40 -91.06 -9.93 43.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.913 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -107.5 -45.81 3.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.868 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.531 HG22 HD11 ' A' ' 89' ' ' ILE . 59.3 mt -97.07 -53.73 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.142 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.437 ' CG1' ' HA ' ' A' ' 157' ' ' TYR . 20.0 mt -75.17 -6.07 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.13 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.524 ' CD2' ' HD3' ' A' ' 163' ' ' PRO . 0.3 OUTLIER -70.57 -59.79 3.61 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.619 0.723 . . . . 0.0 110.907 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.524 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.9 Cg_endo -69.71 -36.34 11.12 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.699 2.266 . . . . 0.0 112.313 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.483 ' HA ' ' CE2' ' A' ' 92' ' ' PHE . 4.6 t80 -64.77 -35.76 82.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.924 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -75.09 -61.14 1.99 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.914 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.406 ' HG2' ' HA ' ' A' ' 163' ' ' PRO . 20.4 ptt? -47.96 -40.27 21.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.875 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 13.7 t80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.863 -179.933 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.648 ' O ' HG22 ' A' ' 89' ' ' ILE . 89.4 t80 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.893 0.378 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.809 HD21 HD21 ' A' ' 112' ' ' LEU . 29.2 mt -80.72 -33.57 35.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.932 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.01 -39.1 66.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -73.56 -37.67 65.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.919 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.648 HG22 ' O ' ' A' ' 85' ' ' TYR . 7.2 tt -78.6 -29.93 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.143 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.63 -43.31 56.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.13 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -51.27 -25.68 6.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.908 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -86.33 -41.26 14.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.455 ' CD1' HD13 ' A' ' 100' ' ' LEU . 55.6 m95 -70.7 -56.58 6.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 4.2 pt-20 -42.66 -29.55 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.883 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.437 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 96.8 mt -77.54 -48.98 23.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.164 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -48.87 -42.27 36.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.14 -37.44 1.5 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.476 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.2 m -101.77 112.15 24.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.858 0.361 . . . . 0.0 110.895 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 58.8 m -54.28 162.08 1.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.82 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.555 HD22 HG23 ' A' ' 89' ' ' ILE . 27.9 tp -74.01 135.32 43.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.924 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -135.48 128.96 32.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 102' ' ' ILE . 4.6 mp -94.95 121.16 63.25 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.619 0.723 . . . . 0.0 111.108 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.493 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 53.5 Cg_endo -69.78 161.82 44.44 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.66 2.24 . . . . 0.0 112.359 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -107.43 121.02 43.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.85 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.546 ' CG2' HD12 ' A' ' 110' ' ' LEU . 67.7 t -124.79 134.51 66.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.117 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.491 ' HG2' HG12 ' A' ' 105' ' ' VAL . 27.4 mm-40 61.01 52.3 4.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.849 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 42.4 37.93 1.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.619 ' HD3' HG22 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -159.55 153.1 22.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.619 HG22 ' HD3' ' A' ' 108' ' ' LYS . 7.8 tt -60.06 142.9 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.142 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.805 HD23 ' N ' ' A' ' 111' ' ' ASP . 6.2 tt -95.98 139.23 32.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.805 ' N ' HD23 ' A' ' 110' ' ' LEU . 23.6 t0 -97.58 108.54 21.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.86 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.809 HD21 HD21 ' A' ' 86' ' ' LEU . 0.9 OUTLIER -83.24 -24.89 32.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.566 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 5.7 t80 -63.26 -56.26 18.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.953 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 115' ' ' LEU . 32.0 p -59.4 -61.03 2.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.834 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 114' ' ' SER . 22.2 tp -35.04 -68.88 0.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.914 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.8 t -51.24 -52.73 42.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.835 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.1 mmtt -46.79 -63.7 0.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.933 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.658 HG21 HG13 ' A' ' 137' ' ' VAL . 62.1 mt -43.09 -53.54 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.137 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 43.1 t -49.47 -57.47 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.122 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 76.3 mt -46.1 -52.18 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.118 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -57.73 -58.93 6.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.891 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.613 ' HB3' HG22 ' A' ' 128' ' ' ILE . 29.1 mm-40 -35.01 -54.66 0.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 152.93 33.8 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.467 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.02 -178.71 33.49 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.445 ' CE2' ' SG ' ' A' ' 129' ' ' CYS . 4.8 t80 -85.0 -43.8 13.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.845 0.355 . . . . 0.0 110.908 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -62.05 -36.23 81.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.924 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.49 -68.91 0.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.149 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.613 HG22 ' HB3' ' A' ' 122' ' ' GLU . 2.2 pp -50.01 -36.23 11.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.164 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.47 ' N ' HD12 ' A' ' 128' ' ' ILE . 49.1 m -66.33 -41.0 90.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -66.45 -44.48 82.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.92 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 132' ' ' ARG . 1.2 m-20 -85.02 22.61 1.37 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.449 ' C ' ' O ' ' A' ' 131' ' ' ASP . 57.8 mtt-85 34.63 43.93 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.88 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' A' ' 134' ' ' TRP . 20.4 mtp85 -71.5 -22.45 61.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.541 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 12.2 m95 -34.33 -42.29 0.13 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.927 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.6 -54.19 49.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.112 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 5.0 tpp85 -66.21 -42.54 88.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.658 HG13 HG21 ' A' ' 118' ' ' ILE . 84.3 t -59.41 -28.22 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -78.37 -48.69 15.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.116 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -60.06 -28.63 67.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -56.53 -38.85 72.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.537 HD23 ' CE2' ' A' ' 143' ' ' TYR . 13.8 tp -83.81 21.31 1.3 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.927 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 3.5 m80 58.12 51.8 8.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.872 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.537 ' CE2' HD23 ' A' ' 141' ' ' LEU . 2.5 m-85 -96.73 159.1 32.42 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.667 0.746 . . . . 0.0 110.915 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.595 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.9 Cg_endo -69.69 111.74 2.88 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.673 2.249 . . . . 0.0 112.375 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 53.7 Cg_endo -69.8 117.13 4.9 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.69 2.26 . . . . 0.0 112.328 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 136.6 -59.64 0.63 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.477 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -55.38 159.55 2.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.761 0.315 . . . . 0.0 110.907 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -78.06 79.13 4.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.595 HD11 ' HG2' ' A' ' 144' ' ' PRO . 78.3 mt -95.07 -55.47 6.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.09 -44.91 0.82 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.464 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.3 t -65.92 -52.18 52.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.898 0.38 . . . . 0.0 110.861 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.442 ' C ' HD23 ' A' ' 152' ' ' LEU . 6.7 tt -50.02 -49.37 51.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.921 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 25.7 mt -57.06 -64.79 0.76 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.541 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 11.8 ttt180 -40.47 -36.21 0.54 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 25.2 m -68.89 -62.08 1.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.805 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.493 ' CE1' ' HG3' ' A' ' 103' ' ' PRO . 2.5 m-70 -47.49 -34.06 6.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.848 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.432 ' CD2' HD12 ' A' ' 161' ' ' ILE . 3.9 t80 -70.22 -53.16 18.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.911 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 29.3 mm-40 -74.23 -9.47 58.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.877 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -96.15 -42.94 7.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.858 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 89.2 mt -110.4 -47.31 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.15 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.517 ' O ' HG22 ' A' ' 161' ' ' ILE . 21.4 mt -76.88 1.08 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.089 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.602 ' CE1' ' SD ' ' A' ' 166' ' ' MET . 0.2 OUTLIER -73.52 -60.75 1.57 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.674 0.75 . . . . 0.0 110.879 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.566 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.6 Cg_endo -69.78 -41.76 3.96 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.663 2.242 . . . . 0.0 112.348 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.432 ' CE1' ' HA ' ' A' ' 89' ' ' ILE . 11.4 t80 -53.79 -35.25 61.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.922 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.405 ' HG3' HG22 ' A' ' 161' ' ' ILE . 11.4 mt-10 -78.81 -62.47 1.68 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.875 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.602 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 5.3 ptt? -48.46 -42.76 33.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 31.0 t80 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.872 -179.952 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 61.9 t80 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.959 0.409 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.428 ' O ' HG22 ' A' ' 89' ' ' ILE . 65.8 mt -56.18 -63.71 1.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.951 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -46.45 -38.45 9.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.856 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -61.5 -62.15 2.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.947 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.713 HD12 ' CD2' ' A' ' 164' ' ' TYR . 14.8 tt -61.11 -27.46 41.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.126 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.18 -46.67 49.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.087 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.7 tttp -54.54 -22.63 13.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -85.24 -49.1 8.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.491 ' CD1' HD13 ' A' ' 100' ' ' LEU . 56.6 m95 -62.53 -56.54 17.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -40.91 -35.32 0.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 90.1 mt -71.98 -51.26 32.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.135 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -48.44 -39.55 23.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.956 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.31 -47.3 0.91 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.526 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.9 t -85.22 151.9 23.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.888 0.375 . . . . 0.0 110.847 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 55.7 p -81.24 172.46 13.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.88 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.528 HD22 HG23 ' A' ' 89' ' ' ILE . 29.1 tp -96.95 116.98 30.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.935 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.76 147.03 30.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.571 HD12 HD22 ' A' ' 112' ' ' LEU . 45.0 mm -119.79 121.84 29.51 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.578 0.704 . . . . 0.0 111.117 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.438 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 54.2 Cg_endo -69.72 163.66 37.41 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.69 2.26 . . . . 0.0 112.361 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -107.9 128.15 54.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.434 HG21 HD12 ' A' ' 110' ' ' LEU . 65.3 t -132.44 135.32 57.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.108 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 56.06 54.26 8.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 40.97 38.84 0.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.9 ttpp -162.63 152.78 16.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.9 tt -57.69 152.0 3.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.123 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.538 HD23 ' N ' ' A' ' 111' ' ' ASP . 5.9 tt -95.11 127.28 41.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.538 ' N ' HD23 ' A' ' 110' ' ' LEU . 8.2 t70 -86.57 69.99 10.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.821 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.595 HD23 ' H ' ' A' ' 112' ' ' LEU . 1.8 pt? -47.96 -22.56 0.61 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -68.45 -44.25 75.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.4 t -71.23 -51.11 26.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.873 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.4 tp -47.07 -54.89 9.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.9 t -60.52 -58.85 6.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.83 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.1 mmtt -43.92 -54.74 5.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.901 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.871 ' CG2' HG13 ' A' ' 137' ' ' VAL . 29.6 mt -51.5 -67.49 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.412 HG13 HG12 ' A' ' 128' ' ' ILE . 50.6 t -37.73 -48.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.162 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 74.6 mt -64.91 -39.74 86.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.108 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 118' ' ' ILE . 5.5 mm-40 -59.11 -50.91 72.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.452 ' CD ' HG22 ' A' ' 137' ' ' VAL . 28.3 mt-10 -51.84 -42.6 62.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.912 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 150.64 35.27 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.512 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.02 -175.13 34.86 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.496 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.422 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 1.9 t80 -88.83 -41.03 12.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.855 0.359 . . . . 0.0 110.915 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -66.13 -37.53 85.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.898 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.5 -61.56 2.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.128 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.641 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.7 pp -58.44 -35.41 54.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.598 ' N ' HD12 ' A' ' 128' ' ' ILE . 22.1 m -65.1 -38.03 89.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.859 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -68.46 -39.45 81.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.45 ' O ' ' C ' ' A' ' 132' ' ' ARG . 0.7 OUTLIER -93.39 22.03 5.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.843 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 131' ' ' ASP . 25.1 mtp85 34.45 46.74 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.889 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.435 ' O ' HG23 ' A' ' 137' ' ' VAL . 58.8 mtp180 -87.33 18.72 3.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.641 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 27.5 m95 -63.9 -47.65 79.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.913 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.55 -41.7 61.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.092 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -68.24 -63.11 1.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.854 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.871 HG13 ' CG2' ' A' ' 118' ' ' ILE . 86.4 t -41.17 -38.12 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.115 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.02 -53.93 22.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -51.22 -33.44 27.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.473 ' HA ' ' CZ ' ' A' ' 140' ' ' ARG . 1.7 mmp_? -52.72 -35.7 56.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.594 HD23 ' CE2' ' A' ' 143' ' ' TYR . 14.9 tp -84.73 23.32 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 62.91 28.0 16.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.817 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.594 ' CE2' HD23 ' A' ' 141' ' ' LEU . 3.4 m-85 -75.89 147.77 81.14 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.653 0.739 . . . . 0.0 110.914 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.469 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.6 Cg_endo -69.72 115.72 4.22 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.706 2.271 . . . . 0.0 112.343 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 53.0 Cg_endo -69.79 89.18 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.69 2.26 . . . . 0.0 112.323 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 177.13 -80.03 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.474 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 32.0 mttp -45.38 166.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.817 0.341 . . . . 0.0 110.89 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.79 80.8 3.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.469 HD11 ' HG2' ' A' ' 144' ' ' PRO . 76.9 mt -91.6 -57.41 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.21 -50.1 1.23 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.503 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.3 t -61.11 -55.18 35.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.871 0.367 . . . . 0.0 110.839 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.409 ' C ' HD23 ' A' ' 152' ' ' LEU . 6.4 tt -46.92 -52.02 15.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.878 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.462 HD11 HG22 ' A' ' 149' ' ' ILE . 15.1 mt -54.52 -65.94 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.954 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.478 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 11.2 ttp180 -38.75 -47.75 1.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.864 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.6 t -57.87 -66.11 0.53 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.844 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.438 ' CE1' ' HG3' ' A' ' 103' ' ' PRO . 2.0 m-70 -42.9 -39.97 2.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.907 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.41 ' CD1' ' C ' ' A' ' 157' ' ' TYR . 4.6 t80 -63.81 -55.07 25.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 43.6 mt-10 -72.23 -9.97 59.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.898 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -88.87 -48.17 7.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.867 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 77.3 mt -112.56 -43.66 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.514 ' O ' HG22 ' A' ' 161' ' ' ILE . 11.0 mt -77.02 5.08 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.128 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.635 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -74.4 -62.22 1.03 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.673 0.749 . . . . 0.0 110.895 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.518 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.3 Cg_endo -69.76 -35.66 12.22 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.689 2.259 . . . . 0.0 112.336 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.713 ' CD2' HD12 ' A' ' 89' ' ' ILE . 11.0 t80 -60.87 -38.32 85.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -79.94 -65.02 1.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.858 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.455 ' SD ' ' N ' ' A' ' 167' ' ' PHE . 0.0 OUTLIER -40.64 -39.42 1.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.862 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.455 ' N ' ' SD ' ' A' ' 166' ' ' MET . 2.4 t80 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.85 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.693 ' HE2' HD12 ' A' ' 112' ' ' LEU . 69.5 t80 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.932 0.396 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.446 ' HA ' HG22 ' A' ' 89' ' ' ILE . 36.5 mt -81.13 -39.32 25.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.924 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -64.09 -39.42 94.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -72.96 -55.71 6.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.88 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 85' ' ' TYR . 12.3 tt -55.46 -47.65 78.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.117 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.853 ' HB2' HD22 ' A' ' 100' ' ' LEU . . . -59.16 -47.96 83.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.14 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.404 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 21.5 ttmt -44.54 -37.83 3.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.957 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.665 ' CD1' ' CG ' ' A' ' 167' ' ' PHE . 3.2 t80 -71.89 -51.63 21.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.452 ' O ' ' C ' ' A' ' 94' ' ' GLU . 80.5 m95 -61.59 -62.36 1.87 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 93' ' ' TRP . 8.9 pt-20 -34.48 -37.97 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.444 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 52.1 mt -72.4 -49.48 41.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.13 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 93' ' ' TRP . 73.2 mm-40 -45.0 -46.21 11.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.889 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.21 -36.87 1.35 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.49 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.6 m -96.39 109.55 22.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.91 0.386 . . . . 0.0 110.888 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.7 m -47.18 158.69 0.14 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.854 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.853 HD22 ' HB2' ' A' ' 90' ' ' ALA . 15.4 tp -75.41 126.82 31.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.91 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -129.83 110.61 11.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.1 mt -77.17 123.88 87.17 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.628 0.728 . . . . 0.0 111.165 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 147.17 62.5 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.696 2.264 . . . . 0.0 112.359 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -100.36 111.05 23.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.935 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.674 HG12 ' HG2' ' A' ' 106' ' ' GLU . 87.1 t -119.82 136.55 56.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.115 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.674 ' HG2' HG12 ' A' ' 105' ' ' VAL . 46.6 mm-40 62.9 49.15 3.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.903 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 42.61 38.39 1.27 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.84 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.2 tttp -166.92 152.95 8.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.6 tt -50.4 150.01 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.124 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.555 ' C ' HD23 ' A' ' 110' ' ' LEU . 4.5 tt -92.96 112.06 23.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.442 ' N ' HD23 ' A' ' 110' ' ' LEU . 19.8 t0 -69.05 75.11 0.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.756 HD23 ' H ' ' A' ' 112' ' ' LEU . 0.9 OUTLIER -68.79 -36.65 78.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -53.61 -59.93 3.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.963 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.457 ' O ' ' C ' ' A' ' 115' ' ' LEU . 4.8 t -59.07 -59.21 5.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.867 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' A' ' 114' ' ' SER . 9.0 tp -32.89 -58.7 0.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.924 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.6 t -57.12 -54.64 44.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.824 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -43.48 -48.25 7.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.888 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 53.2 mt -61.98 -48.3 89.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.127 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.503 HG13 HG12 ' A' ' 128' ' ' ILE . 55.4 t -50.8 -63.0 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.108 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 61.7 mt -52.11 -53.33 18.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.141 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -46.69 -51.11 16.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.893 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.449 ' OE2' HG22 ' A' ' 137' ' ' VAL . 40.6 mt-10 -50.92 -49.27 59.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.86 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 127' ' ' ALA . . . 154.49 40.94 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.467 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.55 -177.93 42.47 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.448 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -88.95 -45.68 9.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.847 0.356 . . . . 0.0 110.94 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -59.51 -36.49 76.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.876 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 123' ' ' GLY . . . -67.75 -71.26 0.21 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.096 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.503 HG12 HG13 ' A' ' 119' ' ' VAL . 2.1 pp -44.76 -34.53 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.123 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.409 ' N ' HD12 ' A' ' 128' ' ' ILE . 64.8 m -69.37 -39.57 77.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -63.89 -39.66 94.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 132' ' ' ARG . 28.1 m-20 -92.1 29.76 1.56 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.877 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.465 ' C ' ' O ' ' A' ' 131' ' ' ASP . 3.0 mpt_? 33.48 40.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.462 ' O ' ' C ' ' A' ' 134' ' ' TRP . 22.5 mmt180 -65.29 -26.99 68.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.482 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 28.4 m95 -33.22 -44.19 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.913 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.82 -61.71 2.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.107 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -58.98 -45.09 91.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.449 HG22 ' OE2' ' A' ' 122' ' ' GLU . 92.6 t -54.03 -39.73 42.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.153 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.2 -52.88 52.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -58.88 -35.99 73.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.933 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.2 mmp_? -69.53 -28.04 65.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.868 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.945 HD13 ' O ' ' A' ' 141' ' ' LEU . 1.5 tm? -78.46 10.23 3.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.913 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 62.99 38.42 11.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.904 ' CE2' HD12 ' A' ' 141' ' ' LEU . 9.6 m-85 -89.72 158.61 44.92 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.702 0.763 . . . . 0.0 110.937 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.786 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.8 Cg_endo -69.78 113.76 3.48 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.65 2.234 . . . . 0.0 112.359 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.72 132.47 23.46 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.731 2.287 . . . . 0.0 112.34 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.61 -66.58 0.57 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.511 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -70.46 140.64 51.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.785 0.326 . . . . 0.0 110.934 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -64.58 76.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.786 HD11 ' HG2' ' A' ' 144' ' ' PRO . 97.0 mt -80.45 -39.85 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.165 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -35.98 -51.35 1.19 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.459 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.5 t -56.94 -54.86 41.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.886 0.374 . . . . 0.0 110.892 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.4 tt -45.58 -51.17 12.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.948 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' A' ' 154' ' ' ARG . 18.9 mt -53.99 -66.09 0.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.937 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.482 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 15.0 ttt180 -37.35 -41.56 0.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.1 m -65.04 -68.74 0.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.824 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 6.2 m170 -43.12 -36.95 1.84 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.889 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.692 ' CD2' HD12 ' A' ' 161' ' ' ILE . 3.0 t80 -71.82 -43.88 64.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.933 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.402 ' O ' ' HB3' ' A' ' 162' ' ' TYR . 7.5 mt-10 -79.87 -8.68 59.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.876 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 9.0 tpt85 -106.43 -30.3 9.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.465 HG22 HD11 ' A' ' 89' ' ' ILE . 70.7 mt -112.83 -59.0 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.107 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.692 HD12 ' CD2' ' A' ' 157' ' ' TYR . 66.3 mt -67.01 -11.95 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.119 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.593 ' CE1' ' SD ' ' A' ' 166' ' ' MET . 0.1 OUTLIER -74.21 -61.58 1.2 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.656 0.741 . . . . 0.0 110.934 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.55 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 54.0 Cg_endo -69.7 -27.82 26.27 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.714 2.276 . . . . 0.0 112.345 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.572 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 3.8 t80 -68.11 -41.91 81.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -72.84 -60.33 2.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.897 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.593 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 6.7 ptt? -47.08 -43.2 20.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.665 ' CG ' ' CD1' ' A' ' 92' ' ' PHE . 61.0 t80 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.534 ' O ' HG22 ' A' ' 89' ' ' ILE . 86.8 t80 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.906 0.384 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.681 HD21 HD21 ' A' ' 112' ' ' LEU . 37.9 mt -79.95 -36.08 36.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.942 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -78.78 -47.55 16.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.835 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.428 ' CG ' ' N ' ' A' ' 89' ' ' ILE . 2.2 pt20 -54.72 -45.82 74.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.644 HG23 HD22 ' A' ' 100' ' ' LEU . 15.7 tt -72.84 -32.04 38.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.139 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 93' ' ' TRP . . . -67.48 -57.1 7.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.095 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.8 tptm -40.94 -31.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -78.45 -43.05 28.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.404 ' N ' ' O ' ' A' ' 90' ' ' ALA . 41.3 m95 -68.23 -55.17 13.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.911 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -43.52 -35.12 1.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.929 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.3 mt -73.03 -51.49 26.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.143 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.9 mm100 -42.45 -47.57 5.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 136.88 30.63 0.27 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.483 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.8 m -161.05 161.78 31.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.893 0.378 . . . . 0.0 110.864 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.2 m -89.52 155.95 18.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.829 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.644 HD22 HG23 ' A' ' 89' ' ' ILE . 16.9 tp -91.57 103.89 16.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.909 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.8 pttt -97.48 152.59 18.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.909 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 18.7 mt -115.62 123.87 30.75 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.604 0.716 . . . . 0.0 111.155 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 148.07 64.3 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.687 2.258 . . . . 0.0 112.36 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -99.73 121.07 40.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.3 t -118.26 147.36 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.136 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.452 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 65.4 mm-40 39.8 53.21 2.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.863 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.452 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 11.8 ptm180 45.8 38.47 4.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.3 tptp -160.91 151.11 17.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.8 tt -56.75 145.36 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.113 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.773 HD23 ' N ' ' A' ' 111' ' ' ASP . 4.9 tt -90.72 129.49 36.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.773 ' N ' HD23 ' A' ' 110' ' ' LEU . 26.3 t0 -79.42 66.82 4.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.681 HD21 HD21 ' A' ' 86' ' ' LEU . 1.8 pt? -54.02 -23.02 11.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.505 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 3.9 t80 -72.4 -58.63 3.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.4 t -55.78 -41.46 74.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.864 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.606 ' O ' HG23 ' A' ' 119' ' ' VAL . 27.4 tp -52.71 -55.8 20.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.915 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 18.0 p -60.26 -42.9 96.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -58.33 -61.2 2.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.878 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 64.9 mt -49.62 -36.36 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.176 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 115' ' ' LEU . 73.2 t -71.27 -48.43 54.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.175 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 85.5 mt -62.4 -37.17 78.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.074 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -72.84 -54.79 7.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.913 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -38.95 -53.87 1.71 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.892 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 158.28 34.79 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.501 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.15 179.12 37.2 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.449 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.488 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 9.3 t80 -82.52 -39.98 21.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.826 0.346 . . . . 0.0 110.899 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -66.11 -43.03 88.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.92 -61.71 2.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.142 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.559 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.7 pp -60.09 -33.67 54.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.116 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.488 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 22.1 m -70.41 -28.42 65.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -81.05 -36.48 30.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.439 ' O ' ' C ' ' A' ' 132' ' ' ARG . 0.5 OUTLIER -91.15 21.04 4.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 131' ' ' ASP . 8.7 mmm180 35.53 50.76 0.6 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.88 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.425 ' O ' ' C ' ' A' ' 134' ' ' TRP . 4.3 mmp_? -80.03 -19.49 47.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.9 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.559 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 28.2 m95 -36.34 -41.64 0.29 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.19 -55.32 34.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.092 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -66.82 -41.35 87.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 82.7 t -51.16 -43.58 27.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.078 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.451 ' HB2' HD11 ' A' ' 153' ' ' LEU . . . -70.64 -53.5 15.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.069 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -56.04 -22.44 27.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -68.74 -32.03 71.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.432 HD23 ' CE2' ' A' ' 143' ' ' TYR . 10.2 tp -89.84 25.57 2.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 61.55 51.17 4.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.815 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.432 ' CE2' HD23 ' A' ' 141' ' ' LEU . 3.7 m-85 -103.7 150.65 38.35 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.698 0.761 . . . . 0.0 110.886 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.577 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.9 Cg_endo -69.78 113.48 3.39 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.677 2.252 . . . . 0.0 112.319 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 99.99 0.79 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.671 2.248 . . . . 0.0 112.333 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 161.96 -70.27 0.22 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.493 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -51.99 151.45 3.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.816 0.341 . . . . 0.0 110.915 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.406 ' O ' ' CG ' ' A' ' 148' ' ' ASN . 15.5 p-10 -65.0 75.51 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.577 HD11 ' HG2' ' A' ' 144' ' ' PRO . 75.5 mt -92.44 -54.06 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.17 -52.05 1.26 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.445 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 8.7 t -58.44 -56.94 15.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.927 0.394 . . . . 0.0 110.85 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.6 tt -42.05 -49.39 4.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.926 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.451 HD11 ' HB2' ' A' ' 138' ' ' ALA . 15.5 mt -58.94 -65.97 0.58 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.495 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 15.5 ttp180 -38.82 -45.39 1.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.818 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 41.0 m -60.19 -62.75 1.63 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.842 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -47.27 -27.1 1.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.855 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.864 ' CD2' HD12 ' A' ' 161' ' ' ILE . 7.7 t80 -83.65 -31.26 26.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.49 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 11.4 mt-10 -91.04 -10.16 43.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 14.8 tpt85 -105.02 -30.7 9.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.858 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 42.0 mt -112.12 -54.38 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.864 HD12 ' CD2' ' A' ' 157' ' ' TYR . 15.5 mt -77.07 -0.8 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.101 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.536 ' CD2' ' HD3' ' A' ' 163' ' ' PRO . 0.2 OUTLIER -71.9 -60.31 2.46 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.643 0.735 . . . . 0.0 110.905 -179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.536 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.5 Cg_endo -69.79 -34.96 13.43 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.708 2.272 . . . . 0.0 112.294 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.479 ' CE1' ' HA ' ' A' ' 89' ' ' ILE . 55.2 t80 -62.36 -44.09 97.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.911 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -68.72 -55.45 11.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.41 ' HG3' ' HA ' ' A' ' 163' ' ' PRO . 0.0 OUTLIER -60.44 -35.07 74.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.899 179.93 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.463 ' CB ' ' O ' ' A' ' 163' ' ' PRO . 40.7 t80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.914 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.639 ' CE2' HD12 ' A' ' 112' ' ' LEU . 59.5 t80 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.941 0.4 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.619 HD23 HD11 ' A' ' 112' ' ' LEU . 61.2 mt -80.94 -59.11 2.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.891 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -52.63 -25.85 11.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.845 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -77.42 -67.32 0.73 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.794 HD11 HG22 ' A' ' 160' ' ' ILE . 10.0 tt -47.5 -35.59 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.17 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.74 -47.75 68.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.093 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -53.09 -26.2 15.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.593 ' CD1' ' CD2' ' A' ' 167' ' ' PHE . 0.8 OUTLIER -81.27 -50.83 9.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.545 ' CD1' HD13 ' A' ' 100' ' ' LEU . 81.3 m95 -64.51 -55.98 17.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.95 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -41.02 -29.77 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.913 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.5 mt -78.3 -49.33 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.171 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 88.6 mm-40 -50.21 -44.73 53.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 142.11 -46.94 0.85 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.453 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.6 m -83.22 108.85 16.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.887 0.375 . . . . 0.0 110.874 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.6 m -50.69 162.35 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.545 HD13 ' CD1' ' A' ' 93' ' ' TRP . 40.4 tp -86.82 100.47 12.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.91 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -102.41 106.2 16.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.507 HD12 HD22 ' A' ' 112' ' ' LEU . 44.0 mm -69.16 124.86 91.32 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.579 0.704 . . . . 0.0 111.134 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 151.29 69.03 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.725 2.283 . . . . 0.0 112.334 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -101.12 110.93 23.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.843 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.8 t -119.19 137.9 51.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.143 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 107' ' ' ARG . 49.4 mm-40 58.9 55.02 4.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 106' ' ' GLU . 6.6 ptp85 35.53 43.05 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.857 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -168.14 150.71 5.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.874 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.1 tt -57.69 144.42 10.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.143 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 1.025 HD23 ' N ' ' A' ' 111' ' ' ASP . 6.2 tt -93.12 151.0 20.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 1.025 ' N ' HD23 ' A' ' 110' ' ' LEU . 11.9 t0 -107.81 121.7 45.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.835 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.639 HD12 ' CE2' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -98.3 -28.12 13.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.92 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -67.19 -61.56 1.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.903 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 115' ' ' LEU . 23.3 m -51.64 -58.76 5.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 114' ' ' SER . 17.3 tp -38.0 -63.09 0.5 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.907 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.9 t -50.28 -53.1 30.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.837 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -51.22 -43.73 61.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 58.6 mt -62.33 -48.68 87.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.1 t -58.41 -58.91 4.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.159 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 82.4 mt -49.4 -45.58 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.124 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 122' ' ' GLU . 38.5 mt-10 -62.92 -58.36 7.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.865 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.502 ' OE2' HG22 ' A' ' 137' ' ' VAL . 42.7 mt-10 -37.73 -54.27 1.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.855 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 157.85 37.25 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.52 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.98 -173.55 39.75 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.472 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.583 ' CE2' ' SG ' ' A' ' 129' ' ' CYS . 7.7 t80 -88.84 -56.63 3.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.806 0.336 . . . . 0.0 110.884 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -51.14 -34.73 32.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.886 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.38 -71.36 0.21 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.122 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.54 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.8 pp -51.5 -32.04 12.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.583 ' SG ' ' CE2' ' A' ' 125' ' ' TYR . 99.3 m -69.63 -36.47 76.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.885 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -71.12 -43.28 67.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' A' ' 132' ' ' ARG . 0.9 OUTLIER -85.61 23.57 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 131' ' ' ASP . 59.1 mtt180 34.23 38.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.833 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' A' ' 134' ' ' TRP . 21.1 mmm180 -66.08 -19.14 65.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.54 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 29.5 m95 -35.54 -37.22 0.08 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.33 -57.12 14.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.116 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 -60.09 -43.87 95.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.502 HG22 ' OE2' ' A' ' 122' ' ' GLU . 59.4 t -58.21 -34.11 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.121 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.19 -59.06 3.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.138 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -53.99 -31.07 49.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.97 -38.38 64.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.899 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.467 HD23 ' CE2' ' A' ' 143' ' ' TYR . 14.8 tp -85.39 20.94 1.87 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 64.22 40.33 6.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.841 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.467 ' CE2' HD23 ' A' ' 141' ' ' LEU . 3.1 m-85 -89.67 153.16 47.71 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.662 0.744 . . . . 0.0 110.929 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.622 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.9 Cg_endo -69.75 114.07 3.58 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.732 2.288 . . . . 0.0 112.337 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 54.0 Cg_endo -69.75 90.88 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.678 2.252 . . . . 0.0 112.365 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.67 -73.93 0.1 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.468 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -50.56 153.18 1.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.832 0.348 . . . . 0.0 110.852 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -67.29 81.33 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.622 HD11 ' HG2' ' A' ' 144' ' ' PRO . 90.1 mt -92.97 -53.85 8.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.19 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.0 -48.52 1.08 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.511 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.0 t -61.5 -53.87 50.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.864 0.364 . . . . 0.0 110.866 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.497 ' C ' HD23 ' A' ' 152' ' ' LEU . 8.2 tt -47.14 -50.6 20.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.885 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.415 ' O ' ' C ' ' A' ' 154' ' ' ARG . 24.1 mt -55.02 -65.91 0.5 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 153' ' ' LEU . 11.4 ttt-85 -36.89 -44.99 0.53 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.918 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.7 t -59.76 -65.37 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.911 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -39.6 -49.11 2.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.512 ' HA ' HD12 ' A' ' 161' ' ' ILE . 3.6 t80 -52.83 -67.6 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.916 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.426 ' HA ' ' HB2' ' A' ' 162' ' ' TYR . 17.3 mm-40 -62.15 -8.53 5.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.857 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.94 -53.82 5.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.908 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.794 HG22 HD11 ' A' ' 89' ' ' ILE . 27.0 mt -112.91 -46.3 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.133 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.512 HD12 ' HA ' ' A' ' 157' ' ' TYR . 73.7 mt -61.2 -14.14 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.661 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -76.88 -63.3 0.54 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.707 0.765 . . . . 0.0 110.927 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.563 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.9 Cg_endo -69.73 -23.44 30.92 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.744 2.296 . . . . 0.0 112.328 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.739 ' CD2' HD12 ' A' ' 89' ' ' ILE . 1.0 OUTLIER -74.25 -46.62 40.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.875 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -69.11 -49.38 57.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.893 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.466 ' CG ' ' HA ' ' A' ' 163' ' ' PRO . 0.0 OUTLIER -61.23 -38.14 85.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.593 ' CD2' ' CD1' ' A' ' 92' ' ' PHE . 18.3 t80 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.426 ' HE2' HD12 ' A' ' 112' ' ' LEU . 55.1 t80 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.924 0.393 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.401 HD21 HD21 ' A' ' 112' ' ' LEU . 96.7 mt -73.21 -64.08 1.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.966 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -52.74 -32.28 42.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 44.8 mm-40 -67.16 -69.08 0.33 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.476 HG13 ' CG ' ' A' ' 164' ' ' TYR . 19.7 tt -51.09 -39.28 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.133 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.565 ' HB2' HD22 ' A' ' 100' ' ' LEU . . . -65.51 -40.82 93.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -59.73 -23.96 63.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.918 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.459 ' CD1' ' O ' ' A' ' 92' ' ' PHE . 1.1 t80 -84.7 -36.56 21.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.893 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.48 ' O ' ' N ' ' A' ' 95' ' ' ILE . 69.4 m95 -78.03 -56.72 4.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -39.41 -25.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.48 ' N ' ' O ' ' A' ' 93' ' ' TRP . 87.3 mt -81.81 -50.35 16.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -49.18 -34.08 13.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.889 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 130.21 -25.11 4.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.47 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.5 m -103.97 115.52 30.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 0.0 110.868 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.4 t -53.75 167.88 0.22 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.875 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.565 HD22 ' HB2' ' A' ' 90' ' ' ALA . 30.9 tp -85.28 124.5 31.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.967 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -125.96 134.51 51.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 81.9 mt -107.05 129.64 24.04 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.586 0.707 . . . . 0.0 111.132 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 174.64 9.18 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.69 2.26 . . . . 0.0 112.325 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -124.73 111.83 16.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.7 t -115.2 133.27 61.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.153 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 60.06 54.72 4.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.916 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 38.42 36.91 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.841 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.71 153.66 28.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.9 tt -60.31 137.04 23.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.109 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.82 HD23 ' N ' ' A' ' 111' ' ' ASP . 5.1 tt -78.47 140.55 38.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.946 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.82 ' N ' HD23 ' A' ' 110' ' ' LEU . 52.0 t0 -90.43 76.25 6.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.827 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.426 HD12 ' HE2' ' A' ' 85' ' ' TYR . 1.4 pt? -61.77 -22.46 65.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.936 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -71.73 -65.84 0.71 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 115' ' ' LEU . 3.7 t -54.34 -54.08 45.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.845 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.43 ' C ' ' O ' ' A' ' 114' ' ' SER . 16.9 tp -35.3 -65.43 0.23 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.941 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.5 t -53.15 -51.89 60.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.871 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -46.78 -54.22 10.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.905 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 65.3 mt -56.67 -46.81 83.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.084 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.1 t -56.88 -61.99 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.154 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 84.6 mt -56.97 -40.31 71.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.141 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -60.1 -57.99 10.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.467 ' HB3' HG22 ' A' ' 128' ' ' ILE . 28.7 mm-40 -44.87 -45.1 10.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.434 ' O ' ' CB ' ' A' ' 127' ' ' ALA . . . 152.48 38.12 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.487 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.16 -170.04 32.61 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.467 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -88.8 -43.3 11.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.945 0.402 . . . . 0.0 110.951 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -64.24 -39.37 93.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.866 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' A' ' 123' ' ' GLY . . . -58.37 -68.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.075 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.629 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.7 pp -51.73 -34.88 16.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.087 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.405 ' N ' HD12 ' A' ' 128' ' ' ILE . 53.6 m -67.74 -33.95 75.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.845 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.3 mtpp -68.05 -46.85 69.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.429 ' OD2' ' CZ ' ' A' ' 133' ' ' ARG . 2.3 t70 -84.61 12.23 7.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 44.63 54.12 6.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.849 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.449 ' O ' ' C ' ' A' ' 134' ' ' TRP . 3.2 mmp_? -80.32 -19.07 47.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.905 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.629 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 18.8 m95 -34.27 -44.54 0.19 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.2 -52.12 66.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.11 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 37.5 mmt-85 -68.93 -51.22 42.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 97.5 t -44.4 -44.47 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.127 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.645 ' HB2' ' CD1' ' A' ' 153' ' ' LEU . . . -68.53 -53.09 25.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.08 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -55.72 -25.92 42.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.908 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 23.9 mtt180 -64.21 -26.5 68.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.912 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.0 tp -89.54 18.45 5.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.939 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 64.45 46.73 3.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.577 ' HB3' HD13 ' A' ' 149' ' ' ILE . 3.6 m-85 -95.36 152.59 39.43 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.656 0.741 . . . . 0.0 110.948 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 120.1 6.94 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.652 2.235 . . . . 0.0 112.356 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 115.65 4.19 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.683 2.255 . . . . 0.0 112.344 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.66 -64.25 0.44 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.465 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -53.08 160.33 1.04 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.79 0.329 . . . . 0.0 110.925 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -80.96 52.43 1.75 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.577 HD13 ' HB3' ' A' ' 143' ' ' TYR . 42.6 mt -62.92 -49.8 82.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.165 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.21 -56.94 1.14 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.452 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.8 t -57.29 -61.0 2.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.914 0.387 . . . . 0.0 110.897 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.47 ' C ' HD23 ' A' ' 152' ' ' LEU . 7.3 tt -38.94 -55.11 1.59 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.926 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.645 ' CD1' ' HB2' ' A' ' 138' ' ' ALA . 25.1 mt -51.9 -65.99 0.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.53 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 20.0 ttp180 -41.18 -46.23 3.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.823 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.9 m -58.99 -64.5 0.92 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.845 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -42.05 -53.38 3.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.864 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.488 ' O ' ' N ' ' A' ' 161' ' ' ILE . 5.3 t80 -50.81 -65.35 0.57 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 42.6 mt-10 -63.53 -9.8 14.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.906 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 41.5 ttt-85 -84.08 -50.74 7.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 40.6 mt -112.54 -40.07 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.152 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.559 ' O ' HG22 ' A' ' 161' ' ' ILE . 22.9 mt -76.2 0.28 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.139 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.588 ' CE1' ' SD ' ' A' ' 166' ' ' MET . 0.1 OUTLIER -73.34 -61.17 1.51 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.7 0.762 . . . . 0.0 110.897 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.562 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 54.4 Cg_endo -69.73 -32.56 18.47 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.68 2.253 . . . . 0.0 112.393 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.476 ' CG ' HG13 ' A' ' 89' ' ' ILE . 12.3 t80 -66.07 -39.04 89.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.931 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -72.02 -53.37 13.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.935 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.588 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 6.7 ptt? -63.48 -41.58 98.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.851 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.468 ' CB ' ' O ' ' A' ' 163' ' ' PRO . 47.9 t80 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.901 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.1 m -131.33 154.35 48.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.9 0.381 . . . . 0.0 110.846 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.8 m -132.33 166.62 21.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -125.21 -137.68 4.81 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.51 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 92.6 p -170.53 135.4 1.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.856 0.36 . . . . 0.0 110.878 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 76.8 p -55.84 138.5 48.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.832 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -144.7 -135.24 2.87 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.459 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 79' ' ' THR . 14.0 t -94.84 38.58 1.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.78 0.324 . . . . 0.0 111.122 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -79.29 -74.14 0.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.872 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.462 ' O ' ' N ' ' A' ' 84' ' ' ASN . 88.8 t -64.85 -40.53 89.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.086 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.529 ' HG3' ' CD2' ' A' ' 113' ' ' TYR . 41.4 tttm -39.86 -27.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.948 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.425 ' N ' ' O ' ' A' ' 81' ' ' VAL . 32.7 mt -82.22 -41.62 20.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 81' ' ' VAL . 39.3 t-20 -45.56 -40.5 8.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.579 ' HE2' HD12 ' A' ' 112' ' ' LEU . 29.5 t80 -60.01 -45.3 93.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.8 mt -65.29 -50.99 63.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.03 -35.08 75.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -68.45 -64.16 0.92 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.935 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.664 HG23 HD22 ' A' ' 100' ' ' LEU . 6.5 tt -55.5 -33.75 33.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.16 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.98 -58.58 3.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.088 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.41 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 2.4 ttmp? -45.65 -24.66 0.37 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.892 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -85.63 -42.45 14.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 32.8 m95 -72.61 -59.25 2.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.916 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.47 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 2.7 pt-20 -39.31 -31.96 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.873 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.47 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 97.3 mt -74.08 -52.59 19.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.171 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -48.55 -40.34 26.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 136.58 -45.71 1.07 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.477 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.4 t -81.69 118.69 23.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.841 0.353 . . . . 0.0 110.881 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.5 p -56.49 151.86 12.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.664 HD22 HG23 ' A' ' 89' ' ' ILE . 13.5 tp -77.84 118.58 20.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -119.57 141.91 48.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.0 mp -107.69 128.74 25.28 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.627 0.727 . . . . 0.0 111.104 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 154.24 67.77 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.646 2.23 . . . . 0.0 112.334 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -102.18 111.32 23.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.511 HG12 ' HG2' ' A' ' 106' ' ' GLU . 71.4 t -119.03 134.67 61.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.117 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.511 ' HG2' HG12 ' A' ' 105' ' ' VAL . 13.2 mm-40 61.21 53.45 3.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 106' ' ' GLU . 7.7 ptp180 36.94 41.68 0.2 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.3 ttmp? -162.5 152.13 15.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.461 HG13 ' N ' ' A' ' 110' ' ' LEU . 1.8 tp -62.25 139.23 21.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.112 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.529 HD23 ' N ' ' A' ' 111' ' ' ASP . 5.7 tt -87.65 130.62 34.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.916 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.529 ' N ' HD23 ' A' ' 110' ' ' LEU . 44.3 t0 -90.55 74.24 6.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.579 HD12 ' HE2' ' A' ' 85' ' ' TYR . 2.0 pt? -48.52 -20.91 0.48 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.529 ' CD2' ' HG3' ' A' ' 82' ' ' LYS . 11.7 t80 -71.27 -45.59 62.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.3 t -65.61 -52.81 49.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.886 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.7 tp -49.03 -60.53 2.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 52.6 p -55.11 -52.9 61.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.863 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.3 mmtt -47.96 -61.45 1.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 66.5 mt -45.34 -64.27 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.155 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 43.1 t -39.35 -64.18 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.139 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 73.4 mt -42.35 -46.35 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.092 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -65.34 -54.69 25.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -39.49 -50.91 2.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 127' ' ' ALA . . . 155.36 35.15 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.525 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.92 -177.73 41.79 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.528 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.483 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 3.1 t80 -87.42 -47.92 8.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.851 0.357 . . . . 0.0 110.901 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -57.78 -40.73 80.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.91 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 123' ' ' GLY . . . -63.09 -68.86 0.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.083 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.483 HD12 ' C ' ' A' ' 128' ' ' ILE . 1.9 pp -52.0 -31.43 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.128 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.483 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 26.2 m -70.13 -42.2 72.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -66.31 -36.92 84.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.861 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 132' ' ' ARG . 2.2 m-20 -91.99 21.44 4.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.859 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' A' ' 131' ' ' ASP . 16.8 mmm-85 35.36 41.28 0.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -71.35 -14.07 62.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.869 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.505 ' CE2' ' HG3' ' A' ' 154' ' ' ARG . 49.5 m95 -38.28 -37.44 0.29 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.24 -52.56 65.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.06 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -66.4 -39.73 89.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.842 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.3 t -57.3 -36.09 51.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.107 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.47 ' HB2' ' CD1' ' A' ' 153' ' ' LEU . . . -74.14 -49.85 21.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.094 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -57.99 -26.07 61.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.868 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -57.6 -38.93 75.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.838 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.517 HD23 ' CZ ' ' A' ' 143' ' ' TYR . 13.6 tp -82.44 16.09 2.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.95 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 63.36 44.66 5.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.835 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.517 ' CZ ' HD23 ' A' ' 141' ' ' LEU . 2.6 m-85 -85.21 155.96 60.18 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.657 0.741 . . . . 0.0 110.956 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.455 ' HA ' ' HD2' ' A' ' 145' ' ' PRO . 53.7 Cg_endo -69.79 110.37 2.54 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.656 2.238 . . . . 0.0 112.345 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 53.9 Cg_endo -69.72 108.27 2.03 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.712 2.274 . . . . 0.0 112.348 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 147.44 -34.64 1.26 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.459 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -83.93 147.24 27.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 0.0 110.923 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.418 ' CG ' ' O ' ' A' ' 148' ' ' ASN . 26.3 p-10 -66.53 72.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.857 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.42 ' O ' ' C ' ' A' ' 150' ' ' GLY . 75.4 mt -90.65 -50.04 13.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.099 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.1 -50.71 1.22 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.498 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.6 m -60.03 -49.29 78.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.887 0.375 . . . . 0.0 110.882 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.672 HD21 ' CD2' ' A' ' 156' ' ' HIS . 6.5 tt -51.18 -53.97 29.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.888 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.47 ' CD1' ' HB2' ' A' ' 138' ' ' ALA . 23.1 mt -54.35 -65.8 0.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.927 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.505 ' HG3' ' CE2' ' A' ' 134' ' ' TRP . 16.0 ttt180 -40.41 -41.57 1.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.889 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 156' ' ' HIS . 39.7 m -66.67 -69.78 0.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.672 ' CD2' HD21 ' A' ' 152' ' ' LEU . 2.4 m-70 -36.96 -39.22 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.879 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.422 ' HA ' ' CG1' ' A' ' 161' ' ' ILE . 4.2 t80 -65.44 -57.23 8.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -70.82 -10.13 58.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.878 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -90.22 -48.17 7.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.824 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 60.7 mt -112.45 -41.97 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.162 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.534 ' O ' HG22 ' A' ' 161' ' ' ILE . 16.7 mt -78.48 3.23 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.091 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.584 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -72.36 -60.66 2.07 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.691 0.758 . . . . 0.0 110.928 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 162' ' ' TYR . 53.8 Cg_endo -69.72 -40.19 5.68 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.69 2.26 . . . . 0.0 112.358 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.491 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 23.8 t80 -55.57 -40.26 71.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.911 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -76.85 -66.32 0.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.883 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.447 ' SD ' ' N ' ' A' ' 167' ' ' PHE . 0.0 OUTLIER -42.7 -40.06 2.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.874 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.447 ' N ' ' SD ' ' A' ' 166' ' ' MET . 21.4 t80 -71.15 -52.07 21.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -84.69 41.27 0.84 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.916 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 5.2 t -123.61 120.47 32.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 90.35 109.73 1.41 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.476 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.784 0.326 . . . . 0.0 111.117 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.448 -0.261 . . . . 0.0 112.448 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.4 m 51.53 41.92 29.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.896 0.379 . . . . 0.0 110.895 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 79.9 p -138.33 164.85 28.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.845 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.15 178.42 51.58 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.451 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.7 t -131.02 134.17 46.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.904 0.383 . . . . 0.0 110.863 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.5 t -45.75 123.9 4.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.891 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.07 -83.17 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.507 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 53.8 m -49.42 95.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.804 0.335 . . . . 0.0 111.183 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 21.1 tpt85 -118.09 -56.7 2.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 83' ' ' LEU . 49.0 t -87.98 -35.42 8.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.099 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.416 ' HG3' ' CD2' ' A' ' 113' ' ' TYR . 17.0 mttp -40.14 -27.43 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.431 ' N ' ' O ' ' A' ' 81' ' ' VAL . 33.7 mt -74.58 -55.11 6.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.916 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.535 ' OD1' ' NE2' ' A' ' 88' ' ' GLN . 50.5 t30 -40.9 -61.71 0.93 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.87 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.484 ' O ' HG22 ' A' ' 89' ' ' ILE . 73.0 t80 -39.53 -32.89 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.6 mt -77.25 -43.14 34.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.466 ' HB2' ' NE2' ' A' ' 88' ' ' GLN . 1.0 OUTLIER -56.05 -41.97 75.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 179.832 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.535 ' NE2' ' OD1' ' A' ' 84' ' ' ASN . 0.7 OUTLIER -66.06 -62.97 1.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.534 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 15.0 tt -52.42 -39.71 29.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.143 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.1 -42.81 93.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.11 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -59.02 -29.21 67.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -77.2 -39.75 47.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.915 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 54.7 m95 -72.74 -58.39 3.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.433 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 9.6 pt-20 -39.17 -36.91 0.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.433 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 95.4 mt -69.85 -47.07 71.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.096 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -53.5 -35.34 60.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.925 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 130.56 -33.19 2.92 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.482 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.4 m -93.5 145.33 24.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.928 0.394 . . . . 0.0 110.89 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 27.7 p -79.27 159.55 27.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 39.1 tp -90.04 138.34 31.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.93 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 49.7 tttt -134.4 144.63 48.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.957 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 62.9 mt -109.82 124.51 33.44 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.608 0.718 . . . . 0.0 111.116 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 157.38 60.42 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.634 2.223 . . . . 0.0 112.296 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -107.71 121.48 44.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 62.4 t -116.09 140.84 36.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.149 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.473 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 63.1 mm-40 44.76 52.86 7.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.473 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 12.0 ptm180 47.36 36.7 5.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.835 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -154.14 150.58 28.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 6.9 tt -62.3 140.26 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.131 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.634 HD23 ' N ' ' A' ' 111' ' ' ASP . 3.6 tt -89.22 121.86 31.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.953 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.634 ' N ' HD23 ' A' ' 110' ' ' LEU . 7.9 t0 -82.46 79.75 8.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.695 HD23 ' H ' ' A' ' 112' ' ' LEU . 1.4 pt? -58.71 -23.83 60.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.436 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 3.7 t80 -65.26 -56.12 14.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 115' ' ' LEU . 44.3 m -58.22 -59.84 4.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.875 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.448 ' C ' ' O ' ' A' ' 114' ' ' SER . 19.6 tp -34.48 -68.47 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.948 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.5 t -48.2 -54.71 12.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.852 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt -46.61 -54.75 8.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.904 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.607 HG22 ' OE1' ' A' ' 122' ' ' GLU . 81.5 mt -51.72 -54.25 13.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.141 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.408 HG13 HG12 ' A' ' 128' ' ' ILE . 76.4 t -53.33 -60.02 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.144 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 97.0 mt -43.28 -44.89 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.153 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -68.54 -48.61 63.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.607 ' OE1' HG22 ' A' ' 118' ' ' ILE . 24.7 mt-10 -44.95 -42.62 8.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.898 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 144.13 37.8 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.486 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.97 -179.45 45.49 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.516 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.516 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 0.9 OUTLIER -86.88 -41.51 13.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.855 0.36 . . . . 0.0 110.934 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -62.75 -33.45 75.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.899 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.8 -69.84 0.29 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.07 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.515 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.9 pp -51.07 -32.6 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.163 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.451 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 27.3 m -69.6 -41.5 75.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.1 mtpp -67.11 -28.03 67.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -101.03 13.81 34.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.852 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 39.07 50.87 1.87 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -84.13 -3.6 58.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.86 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.515 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 56.4 m95 -45.95 -39.06 8.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.925 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.53 -54.1 50.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.118 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -64.48 -46.85 81.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.908 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.454 ' CG2' ' OE2' ' A' ' 122' ' ' GLU . 52.0 t -50.39 -37.48 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.095 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.96 -49.35 38.2 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -59.03 -24.71 63.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -62.95 -30.54 71.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.551 HD23 ' CE2' ' A' ' 143' ' ' TYR . 14.8 tp -91.64 26.48 2.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 57.57 51.04 10.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.551 ' CE2' HD23 ' A' ' 141' ' ' LEU . 3.5 m-85 -102.68 151.62 38.31 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.709 0.766 . . . . 0.0 110.883 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.554 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.7 Cg_endo -69.76 110.31 2.52 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.739 2.293 . . . . 0.0 112.324 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 131.56 21.55 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.726 2.284 . . . . 0.0 112.358 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.65 -55.3 0.76 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.505 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -59.85 179.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.777 0.322 . . . . 0.0 110.912 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -93.97 42.22 1.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.554 HD11 ' HG2' ' A' ' 144' ' ' PRO . 61.8 mt -59.46 -50.07 81.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.115 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.22 -58.88 1.01 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.478 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.9 t -51.56 -60.49 3.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.926 0.393 . . . . 0.0 110.878 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.5 tt -38.98 -49.9 1.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.934 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 17.3 mt -59.74 -65.92 0.6 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.914 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.481 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 6.2 ttt-85 -38.3 -40.06 0.49 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.867 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 158' ' ' GLU . 3.8 m -66.84 -66.35 0.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -43.6 -29.69 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.831 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.514 ' CD1' ' C ' ' A' ' 157' ' ' TYR . 2.2 t80 -79.57 -34.92 40.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.924 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 155' ' ' SER . 26.0 mt-10 -88.93 -9.9 49.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.872 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 12.7 mmt85 -102.15 -39.86 7.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 86.3 mt -109.86 -49.86 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.131 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 157' ' ' TYR . 14.0 mt -78.47 3.3 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.095 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.641 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -72.57 -60.54 2.01 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.665 0.745 . . . . 0.0 110.893 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 162' ' ' TYR . 53.7 Cg_endo -69.79 -49.35 0.56 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.668 2.245 . . . . 0.0 112.343 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.534 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 34.4 t80 -48.31 -38.02 17.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.929 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -75.2 -63.24 1.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.892 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 11.8 ptt? -48.65 -31.05 6.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.869 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -75.1 -46.93 31.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.866 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -56.21 -44.41 79.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.888 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.7 t -73.75 95.54 2.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.881 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 174.81 -100.16 0.14 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.511 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.755 0.312 . . . . 0.0 111.141 179.923 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.7 p -100.97 168.34 9.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.846 0.355 . . . . 0.0 110.886 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.1 t 40.58 41.66 1.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.858 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -138.86 105.26 0.47 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.516 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 74.4 p -125.84 167.22 15.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.925 0.393 . . . . 0.0 110.841 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.7 p -149.79 170.79 17.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.852 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.94 -48.27 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.477 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 25.8 m -91.94 96.48 10.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.76 0.314 . . . . 0.0 111.156 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -124.87 -63.42 1.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.876 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.485 ' O ' ' N ' ' A' ' 83' ' ' LEU . 81.0 t -71.49 -43.36 72.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.137 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 81' ' ' VAL . 23.5 ttmt -35.13 -31.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.943 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 81' ' ' VAL . 13.8 mt -81.63 -48.18 12.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.922 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 81' ' ' VAL . 47.4 t30 -42.02 -47.55 4.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.857 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.624 ' HE2' HD12 ' A' ' 112' ' ' LEU . 39.3 t80 -57.62 -37.71 73.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.956 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.9 mt -74.73 -59.13 2.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.908 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -49.61 -29.07 6.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -76.79 -68.2 0.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.959 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.548 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 9.9 tt -46.16 -34.84 2.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.16 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.27 -46.53 67.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.136 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -55.98 -22.86 29.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -84.95 -46.49 11.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.879 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 54.2 m95 -67.74 -51.25 51.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.894 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -45.88 -32.1 2.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 89.8 mt -74.93 -46.04 41.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.128 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -56.35 -36.74 69.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.88 -52.67 0.7 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.467 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 71.4 m -83.32 119.98 25.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.865 0.364 . . . . 0.0 110.874 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 59.4 p -55.51 173.26 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.84 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.1 tp -82.68 132.96 35.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.951 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -131.92 134.4 45.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.0 mt -110.0 127.45 27.07 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.594 0.712 . . . . 0.0 111.148 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.432 ' CG ' ' CE1' ' A' ' 156' ' ' HIS . 53.2 Cg_endo -69.77 166.53 27.29 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.661 2.24 . . . . 0.0 112.329 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -113.09 122.86 48.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.4 t -123.75 148.64 27.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.155 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.448 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 58.1 mm-40 41.72 52.92 4.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.448 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 13.0 ptp180 45.16 43.01 7.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.875 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -164.58 152.22 11.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.926 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.1 tt -62.29 142.89 15.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.121 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.712 HD23 ' N ' ' A' ' 111' ' ' ASP . 5.3 tt -91.63 132.49 36.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.712 ' N ' HD23 ' A' ' 110' ' ' LEU . 24.2 t70 -94.6 100.92 12.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.838 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.755 HD23 ' H ' ' A' ' 112' ' ' LEU . 0.9 OUTLIER -72.53 -26.64 61.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.563 ' CE1' ' HG3' ' A' ' 117' ' ' LYS . 4.4 t80 -61.06 -55.89 27.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.886 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.4 m -61.85 -56.98 13.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.83 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.414 ' O ' HG23 ' A' ' 119' ' ' VAL . 26.2 tp -40.73 -60.74 1.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.1 t -58.17 -50.59 73.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.802 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.563 ' HG3' ' CE1' ' A' ' 113' ' ' TYR . 13.9 mmmt -47.92 -46.3 31.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.535 HG22 ' OE1' ' A' ' 122' ' ' GLU . 63.8 mt -64.45 -38.58 82.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.431 HG13 HG12 ' A' ' 128' ' ' ILE . 71.6 t -64.17 -59.96 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 83.3 mt -59.71 -43.58 91.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.118 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -58.79 -56.56 20.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.535 ' OE1' HG22 ' A' ' 118' ' ' ILE . 20.9 mt-10 -44.36 -51.07 8.84 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 159.11 34.42 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.473 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.98 -175.02 33.36 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.528 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.517 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 2.1 t80 -87.41 -46.59 9.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.838 0.352 . . . . 0.0 110.905 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -58.02 -37.53 74.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.58 -70.46 0.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.113 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.527 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.9 pp -50.09 -34.47 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.165 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.517 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 53.5 m -67.93 -44.18 77.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.914 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -64.53 -40.85 96.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.933 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 132' ' ' ARG . 69.5 m-20 -85.92 23.77 1.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.824 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 131' ' ' ASP . 41.3 mtp85 36.04 37.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.847 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 134' ' ' TRP . 29.7 mmt180 -66.71 -23.47 66.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.542 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 22.4 m95 -34.71 -43.85 0.19 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.89 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.35 -49.21 75.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.114 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 133' ' ' ARG . 13.0 tpp180 -69.11 -42.18 76.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.892 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 89.2 t -53.85 -34.7 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.485 ' HB2' HD11 ' A' ' 153' ' ' LEU . . . -76.78 -53.45 7.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.1 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -55.04 -28.21 50.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -64.89 -28.3 69.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.779 HD23 ' CE2' ' A' ' 143' ' ' TYR . 12.5 tp -88.27 22.67 2.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 15.5 m80 60.78 45.84 9.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.843 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.779 ' CE2' HD23 ' A' ' 141' ' ' LEU . 4.4 m-85 -97.71 147.37 32.93 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.692 0.758 . . . . 0.0 110.902 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 125.43 12.12 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.689 2.259 . . . . 0.0 112.289 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 96.68 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.676 2.251 . . . . 0.0 112.324 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 165.02 -75.24 0.16 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.543 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 149' ' ' ILE . 0.3 OUTLIER -45.96 138.47 5.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.798 0.332 . . . . 0.0 110.929 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -62.87 75.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.915 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 147' ' ' LYS . 94.1 mt -87.38 -48.91 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.138 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.13 -59.0 0.99 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.472 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.1 t -53.56 -55.25 27.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.945 0.402 . . . . 0.0 110.873 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.571 HD21 ' CE1' ' A' ' 156' ' ' HIS . 5.6 tt -44.28 -53.31 6.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 138' ' ' ALA . 18.6 mt -53.54 -65.85 0.49 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.542 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 16.3 ttp180 -39.75 -47.05 2.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 7.9 t -59.41 -66.51 0.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.842 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.571 ' CE1' HD21 ' A' ' 152' ' ' LEU . 9.6 m170 -40.6 -34.44 0.36 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.821 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.499 ' O ' ' N ' ' A' ' 161' ' ' ILE . 9.7 t80 -68.57 -70.27 0.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.4 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 3.9 mm-40 -61.09 -10.08 5.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.867 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -85.0 -55.85 3.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 49.7 mt -109.43 -37.27 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.118 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.499 ' N ' ' O ' ' A' ' 157' ' ' TYR . 26.7 mt -75.4 -5.93 7.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.113 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.513 ' CD2' ' HD3' ' A' ' 163' ' ' PRO . 0.3 OUTLIER -71.25 -59.26 3.39 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.679 0.752 . . . . 0.0 110.93 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.513 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.3 Cg_endo -69.85 -39.73 6.0 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.69 2.26 . . . . 0.0 112.335 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.548 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 3.7 t80 -64.78 -30.03 71.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.935 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.494 ' CG ' HG22 ' A' ' 161' ' ' ILE . 17.1 mm-40 -74.13 -57.24 4.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.876 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.464 ' HG3' ' N ' ' A' ' 167' ' ' PHE . 5.5 ptp -55.43 -29.52 58.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.464 ' N ' ' HG3' ' A' ' 166' ' ' MET . 54.3 t80 -71.83 -55.72 7.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.873 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -54.81 -50.23 69.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.3 t -53.74 -53.94 45.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.836 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 127.9 117.98 2.1 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.48 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 120.795 0.331 . . . . 0.0 111.119 179.988 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.0 p -55.37 -52.63 62.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.9 0.381 . . . . 0.0 110.881 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.5 t -53.45 140.73 26.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.849 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -109.84 -138.14 7.96 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.491 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.7 m -130.79 114.04 14.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.919 0.39 . . . . 0.0 110.858 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.9 p -69.77 -44.07 70.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.836 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.415 ' HA3' ' NH1' ' A' ' 80' ' ' ARG . . . -173.89 -155.55 12.12 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.487 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 99.3 m -85.27 94.76 9.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.774 0.321 . . . . 0.0 111.129 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.415 ' NH1' ' HA3' ' A' ' 78' ' ' GLY . 7.4 mpt_? -119.39 -67.81 0.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.841 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.429 ' O ' ' N ' ' A' ' 84' ' ' ASN . 93.7 t -53.7 -48.31 60.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.099 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.589 ' HG3' ' CD2' ' A' ' 113' ' ' TYR . 9.9 mtmt -45.48 -21.91 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.885 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.5 mt -88.01 -34.12 18.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.941 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 81' ' ' VAL . 30.9 t30 -63.39 -38.99 93.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.927 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.666 ' HE2' HD12 ' A' ' 112' ' ' LEU . 81.3 t80 -71.04 -27.13 63.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.417 ' O ' HG22 ' A' ' 89' ' ' ILE . 72.2 mt -80.56 -63.22 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.947 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -44.88 -31.39 1.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -72.26 -71.03 0.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.533 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 14.7 tt -43.29 -34.87 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.099 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.531 ' HB2' HD22 ' A' ' 100' ' ' LEU . . . -68.82 -50.18 52.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.107 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -51.89 -29.21 18.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.906 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.401 ' CD1' ' CD2' ' A' ' 167' ' ' PHE . 30.2 t80 -77.29 -37.81 52.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.875 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.451 ' O ' ' C ' ' A' ' 94' ' ' GLU . 67.7 m95 -76.19 -59.24 2.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.921 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.456 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 11.2 pt-20 -34.65 -40.54 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.456 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 95.5 mt -66.62 -53.87 31.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.126 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -46.81 -45.32 19.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 125.83 42.14 0.32 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.436 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.4 t -167.02 110.27 0.7 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.903 0.382 . . . . 0.0 110.869 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 78.1 p -43.84 163.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.902 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.531 HD22 ' HB2' ' A' ' 90' ' ' ALA . 10.6 tp -93.58 111.44 23.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -107.35 149.1 28.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 53.7 mt -119.95 129.93 25.1 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.655 0.741 . . . . 0.0 111.134 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 160.45 49.65 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.692 2.261 . . . . 0.0 112.303 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -111.81 126.05 54.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.906 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.3 t -121.32 144.22 31.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.161 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.429 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 62.7 mm-40 41.76 54.54 3.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.429 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 1.4 ptp180 43.88 40.07 2.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.03 152.72 26.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.4 tt -63.06 141.91 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.106 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.694 HD23 ' N ' ' A' ' 111' ' ' ASP . 5.4 tt -86.25 133.52 33.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.694 ' N ' HD23 ' A' ' 110' ' ' LEU . 17.8 t0 -91.95 74.33 5.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.699 HD23 ' H ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -54.63 -29.69 52.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.934 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.589 ' CD2' ' HG3' ' A' ' 82' ' ' LYS . 1.3 t80 -60.57 -66.94 0.45 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.932 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.8 m -50.97 -53.96 28.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.839 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.9 tp -39.46 -61.08 0.84 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.945 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.2 t -55.13 -66.59 0.38 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.473 ' N ' ' HE2' ' A' ' 117' ' ' LYS . 1.0 OUTLIER -40.96 -64.03 0.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.849 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 80.9 mt -40.81 -63.3 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.104 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.8 t -40.82 -58.14 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.099 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 69.9 mt -48.86 -42.12 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.161 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -65.92 -50.23 65.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.856 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -47.79 -40.14 20.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.846 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.66 ' O ' ' HB3' ' A' ' 127' ' ' ALA . . . 144.82 42.33 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.516 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.419 ' O ' HG23 ' A' ' 128' ' ' ILE . . . 83.03 174.74 50.61 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.525 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 0.6 OUTLIER -86.83 -37.13 18.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.846 0.355 . . . . 0.0 110.946 -179.824 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -66.06 -40.45 90.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.866 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.66 ' HB3' ' O ' ' A' ' 123' ' ' GLY . . . -66.72 -63.44 1.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.073 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.574 HD12 ' N ' ' A' ' 129' ' ' CYS . 2.4 pp -49.11 -37.07 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.123 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.574 ' N ' HD12 ' A' ' 128' ' ' ILE . 22.0 m -62.82 -50.7 69.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.849 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -62.31 -33.77 75.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 132' ' ' ARG . 2.5 m-20 -90.91 16.35 9.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 131' ' ' ASP . 78.0 mtt180 36.98 44.56 0.38 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 15.0 mtp85 -77.62 -13.6 59.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 21.4 m95 -39.66 -40.35 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.72 -45.55 81.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.129 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.4 tpp85 -73.57 -44.99 55.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.1 t -57.04 -24.25 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.148 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -85.06 -55.34 4.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.087 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -55.42 -29.57 58.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -54.2 -36.45 63.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.869 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.498 HD23 ' CE2' ' A' ' 143' ' ' TYR . 17.6 tp -83.27 14.57 3.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 25.8 m80 68.99 44.16 1.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.498 ' CE2' HD23 ' A' ' 141' ' ' LEU . 2.7 m-85 -92.32 158.33 39.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.731 0.777 . . . . 0.0 110.91 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.446 ' HA ' ' HD2' ' A' ' 145' ' ' PRO . 53.6 Cg_endo -69.76 110.67 2.61 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.661 2.241 . . . . 0.0 112.349 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 53.9 Cg_endo -69.8 105.67 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.699 2.266 . . . . 0.0 112.356 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.94 -58.82 0.41 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.524 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.443 ' HD3' ' N ' ' A' ' 148' ' ' ASN . 10.7 tmtt? -61.95 150.3 38.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.79 0.329 . . . . 0.0 110.889 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.443 ' N ' ' HD3' ' A' ' 147' ' ' LYS . 46.9 t30 -66.68 81.39 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.431 HD11 ' HG2' ' A' ' 144' ' ' PRO . 42.9 mt -94.87 -52.75 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.124 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.04 -53.05 1.22 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.492 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 75.5 m -57.69 -57.88 10.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.901 0.381 . . . . 0.0 110.831 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.444 ' C ' HD23 ' A' ' 152' ' ' LEU . 6.6 tt -43.6 -50.24 7.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.881 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 154' ' ' ARG . 26.7 mt -55.37 -65.91 0.51 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.95 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 153' ' ' LEU . 20.0 ttp180 -38.17 -50.34 1.4 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.87 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 49.0 m -55.84 -69.21 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -38.84 -43.03 0.89 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.858 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.487 ' O ' ' N ' ' A' ' 161' ' ' ILE . 8.6 t80 -60.52 -66.2 0.57 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 41.4 mt-10 -63.06 -10.2 13.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.933 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -85.69 -53.81 4.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.435 HG22 HD11 ' A' ' 89' ' ' ILE . 42.8 mt -109.54 -39.35 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.091 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.58 HG22 ' HG3' ' A' ' 165' ' ' GLU . 18.4 mt -76.25 -2.28 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.156 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.543 ' CD2' ' HD3' ' A' ' 163' ' ' PRO . 0.2 OUTLIER -72.08 -60.29 2.37 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.672 0.749 . . . . 0.0 110.915 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.543 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.6 Cg_endo -69.78 -41.05 4.58 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.64 2.227 . . . . 0.0 112.323 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.533 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 8.1 t80 -63.33 -27.95 69.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.946 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.58 ' HG3' HG22 ' A' ' 161' ' ' ILE . 9.3 mm-40 -76.97 -59.06 2.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.882 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.469 ' CE ' ' CZ ' ' A' ' 162' ' ' TYR . 2.2 ptp -56.22 -25.39 47.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.858 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.401 ' CD2' ' CD1' ' A' ' 92' ' ' PHE . 67.9 t80 -78.25 -49.28 14.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.869 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -53.08 -48.32 67.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.962 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 5.8 t -60.12 96.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.836 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -92.91 -66.38 1.09 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.493 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.775 0.322 . . . . 0.0 111.128 179.971 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.0 m -133.03 157.27 45.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.856 0.36 . . . . 0.0 110.89 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 96.9 p -124.1 149.99 45.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.832 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.78 130.41 3.04 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.513 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.5 t -151.86 156.55 40.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.832 0.348 . . . . 0.0 110.874 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 66.5 m -146.86 156.8 43.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.818 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.82 -163.31 34.1 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.494 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.512 HG23 ' HB2' ' A' ' 82' ' ' LYS . 86.7 m -82.16 91.23 6.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.784 0.326 . . . . 0.0 111.173 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -119.53 -56.93 2.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.876 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 83' ' ' LEU . 43.6 t -81.51 -34.13 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.147 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.584 ' HG2' ' CD2' ' A' ' 113' ' ' TYR . 22.8 mtpt -41.02 -27.47 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 81' ' ' VAL . 23.4 mt -82.34 -54.23 5.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.926 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -42.84 -33.71 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.892 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.605 ' HE2' HD12 ' A' ' 112' ' ' LEU . 48.9 t80 -66.83 -45.11 79.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.515 ' HA ' HG22 ' A' ' 89' ' ' ILE . 52.0 mt -73.03 -47.65 43.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -54.03 -29.95 45.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -83.91 -64.03 1.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.924 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.515 HG22 ' HA ' ' A' ' 86' ' ' LEU . 9.2 tt -51.15 -28.63 7.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.139 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.1 -34.21 59.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.085 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.3 tttp -69.71 -25.09 63.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.942 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -82.4 -49.19 10.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -63.79 -49.41 73.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.961 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.466 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 7.2 pt-20 -46.27 -35.84 5.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.466 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 96.4 mt -70.13 -44.53 78.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.138 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 -57.76 -36.19 71.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 130.94 -40.04 1.7 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.491 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.7 m -88.41 109.88 20.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.87 0.367 . . . . 0.0 110.841 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 88.7 p -49.88 166.68 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.869 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.9 tp -85.05 122.36 29.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.916 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -127.76 134.78 49.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.492 HG23 ' HD2' ' A' ' 103' ' ' PRO . 5.4 mp -99.04 134.16 21.62 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.64 0.733 . . . . 0.0 111.108 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.492 ' HD2' HG23 ' A' ' 102' ' ' ILE . 53.8 Cg_endo -69.76 159.39 53.58 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.674 2.249 . . . . 0.0 112.357 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -112.63 103.66 11.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.731 HG12 ' HG2' ' A' ' 106' ' ' GLU . 87.1 t -106.35 138.35 32.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.137 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.731 ' HG2' HG12 ' A' ' 105' ' ' VAL . 73.5 mm-40 53.16 47.55 24.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.898 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.493 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 28.0 ptt180 47.95 32.88 3.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.82 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.5 pttm -150.48 157.47 43.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.407 HG13 ' N ' ' A' ' 110' ' ' LEU . 3.0 tp -63.09 140.12 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.097 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.717 HD23 ' N ' ' A' ' 111' ' ' ASP . 5.5 tt -84.6 142.06 30.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.869 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.717 ' N ' HD23 ' A' ' 110' ' ' LEU . 19.5 t0 -93.08 93.38 8.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.847 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.726 HD23 ' H ' ' A' ' 112' ' ' LEU . 1.4 pt? -82.97 -19.88 36.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.875 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.621 ' CE1' ' CE ' ' A' ' 117' ' ' LYS . 65.7 t80 -71.04 -67.08 0.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.975 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.9 m -50.82 -54.37 24.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.885 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.776 ' O ' HG23 ' A' ' 119' ' ' VAL . 13.3 tp -41.53 -50.07 4.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.954 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.0 t -58.04 -61.22 2.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.621 ' CE ' ' CE1' ' A' ' 113' ' ' TYR . 0.1 OUTLIER -56.12 -63.92 1.03 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.885 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.402 ' C ' ' O ' ' A' ' 117' ' ' LYS . 71.9 mt -36.06 -58.61 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.122 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 115' ' ' LEU . 84.2 t -51.03 -54.42 10.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.168 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 65.3 mt -57.62 -29.63 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.088 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -74.48 -56.2 5.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -43.52 -50.15 7.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.508 ' O ' ' HB3' ' A' ' 127' ' ' ALA . . . 160.51 33.09 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.498 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.587 ' O ' HG23 ' A' ' 128' ' ' ILE . . . 89.12 173.35 46.34 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.464 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.524 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 0.8 OUTLIER -78.44 -44.84 23.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.832 0.349 . . . . 0.0 110.897 -179.817 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 56.0 mp0 -59.93 -40.25 88.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.933 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 123' ' ' GLY . . . -65.52 -64.04 0.96 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.12 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.606 HG12 HG13 ' A' ' 119' ' ' VAL . 1.6 pp -55.1 -32.84 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.133 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.52 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 29.8 m -69.56 -42.03 75.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.8 tttm -66.55 -34.86 78.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' A' ' 132' ' ' ARG . 6.5 m-20 -94.2 23.01 5.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 131' ' ' ASP . 0.8 OUTLIER 34.39 35.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.836 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 131' ' ' ASP . 10.8 mmt85 -71.0 -1.54 12.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.569 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 44.3 m95 -49.32 -38.99 29.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.92 -47.92 76.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.103 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 -66.16 -44.7 83.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.887 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 99.2 t -56.94 -39.98 69.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.085 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.97 -57.84 6.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.084 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -52.83 -29.84 30.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.935 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.0 mmt-85 -60.73 -29.44 69.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.546 HD11 ' CB ' ' A' ' 111' ' ' ASP . 14.4 tp -87.53 13.32 10.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.91 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 13.0 m80 71.91 35.82 1.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.882 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.496 ' HB3' HD12 ' A' ' 149' ' ' ILE . 3.1 m-85 -82.21 154.82 69.69 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.65 0.738 . . . . 0.0 110.95 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 122.77 9.45 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.673 2.248 . . . . 0.0 112.367 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 120.03 6.87 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.666 2.244 . . . . 0.0 112.305 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 134.8 -64.67 0.59 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.511 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.451 ' HE2' ' N ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -59.81 142.32 53.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.788 0.328 . . . . 0.0 110.887 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.98 85.91 2.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.496 HD12 ' HB3' ' A' ' 143' ' ' TYR . 56.0 mt -91.6 -34.05 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.133 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -41.02 -48.96 4.33 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.445 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.5 m -57.83 -51.58 69.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.362 . . . . 0.0 110.851 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.416 ' CD2' ' CD2' ' A' ' 156' ' ' HIS . 5.4 tt -48.52 -53.92 16.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.92 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 15.4 mt -53.76 -65.94 0.48 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.917 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.551 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 12.6 ttp180 -37.99 -46.01 0.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.866 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 3.3 m -61.34 -71.93 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.817 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.47 ' CD2' ' HG3' ' A' ' 103' ' ' PRO . 2.3 m-70 -37.37 -34.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.816 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.561 ' CD2' HD12 ' A' ' 161' ' ' ILE . 4.0 t80 -70.08 -57.48 4.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.9 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.5 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 20.2 mm-40 -71.11 -9.74 58.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.919 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.1 tpp85 -98.46 -36.87 9.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.878 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 66.3 mt -112.68 -50.12 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.101 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.661 HG22 ' HG3' ' A' ' 165' ' ' GLU . 34.3 mt -76.34 -0.14 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.546 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -73.08 -60.87 1.66 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.674 0.749 . . . . 0.0 110.942 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.508 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.5 Cg_endo -69.8 -40.45 5.25 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.67 2.247 . . . . 0.0 112.331 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.473 ' CD2' HD12 ' A' ' 89' ' ' ILE . 8.0 t80 -61.04 -36.19 78.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.946 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.661 ' HG3' HG22 ' A' ' 161' ' ' ILE . 9.8 mm-40 -72.35 -61.31 1.84 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.908 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.508 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 11.1 ptt? -54.55 -37.96 66.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.841 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -65.4 -44.19 88.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.916 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 -96.03 38.07 1.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.96 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.7 m -142.29 118.7 10.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 162.86 -54.53 0.3 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.793 0.33 . . . . 0.0 111.111 179.978 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.6 t -95.17 130.3 41.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.85 0.357 . . . . 0.0 110.861 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.7 p -49.85 142.67 8.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.878 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.2 115.17 1.98 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.464 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.0 m 46.87 30.1 1.15 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.851 0.357 . . . . 0.0 110.879 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.7 t -67.22 132.28 47.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -133.3 63.83 0.61 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.5 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.615 HG23 ' HB2' ' A' ' 82' ' ' LYS . 48.4 m -109.41 102.76 11.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.807 0.337 . . . . 0.0 111.149 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 9.7 mmp_? -123.94 -53.69 1.74 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.46 ' O ' ' N ' ' A' ' 83' ' ' LEU . 66.4 t -83.86 -43.23 17.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.152 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.615 ' HB2' HG23 ' A' ' 79' ' ' THR . 1.0 OUTLIER -36.93 -30.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.836 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.46 ' N ' ' O ' ' A' ' 81' ' ' VAL . 13.5 mt -72.11 -60.6 2.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.927 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 83' ' ' LEU . 49.9 t30 -37.04 -56.75 0.87 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.512 ' HE2' HD12 ' A' ' 112' ' ' LEU . 41.8 t80 -50.03 -44.81 51.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.92 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.402 HD21 HD21 ' A' ' 112' ' ' LEU . 59.0 mt -69.3 -66.48 0.58 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.889 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -44.2 -24.39 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.935 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -80.73 -62.75 1.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.94 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.451 HG23 ' CD2' ' A' ' 100' ' ' LEU . 15.1 tt -56.89 -26.4 24.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.131 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.09 -55.17 5.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.121 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -53.46 -33.18 53.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.928 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -69.46 -53.3 19.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.871 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.617 ' CD1' HD13 ' A' ' 100' ' ' LEU . 21.7 m95 -54.11 -55.04 31.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.894 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 11.3 pt-20 -48.59 -43.91 36.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.921 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.451 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 62.8 mt -61.61 -45.84 97.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.111 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -54.59 -41.05 69.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.984 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 126.86 42.26 0.29 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.472 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.2 m -164.24 169.9 16.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.881 0.372 . . . . 0.0 110.836 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.7 t -100.44 151.5 21.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.843 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.617 HD13 ' CD1' ' A' ' 93' ' ' TRP . 42.4 tp -97.17 117.3 31.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.877 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -113.77 146.6 39.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.941 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 66.5 mt -111.71 124.38 32.57 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.569 0.699 . . . . 0.0 111.15 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 154.02 68.47 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.684 2.256 . . . . 0.0 112.382 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -104.14 119.77 39.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.88 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 84.5 t -127.59 135.52 62.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.126 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 62.04 48.94 4.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.876 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 42.15 39.2 1.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.843 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -163.94 154.48 15.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.864 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.1 tt -58.36 152.15 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.114 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.5 tt -97.48 124.63 41.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -85.75 76.0 10.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.871 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.689 HD23 ' H ' ' A' ' 112' ' ' LEU . 1.1 pt? -53.3 -28.84 30.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.579 ' CD2' ' HG3' ' A' ' 82' ' ' LYS . 5.9 t80 -58.18 -52.59 64.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.936 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.447 ' O ' ' C ' ' A' ' 115' ' ' LEU . 23.9 m -63.06 -59.86 4.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 114' ' ' SER . 28.4 tp -34.74 -67.84 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.868 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 117' ' ' LYS . 68.6 m -54.16 -60.23 3.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.857 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 116' ' ' SER . 22.8 mmtt -37.7 -49.14 1.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.9 mt -62.65 -45.04 99.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.186 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.8 t -51.06 -65.89 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.119 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 83.5 mt -51.55 -52.47 20.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.136 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -46.55 -49.16 19.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.413 ' HB3' HG22 ' A' ' 128' ' ' ILE . 44.7 mm-40 -53.28 -48.46 68.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.89 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 153.8 34.4 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.498 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.491 ' O ' HG23 ' A' ' 128' ' ' ILE . . . 96.14 -178.12 34.29 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.478 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.499 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 1.0 OUTLIER -88.07 -35.91 17.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 0.0 110.912 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -69.56 -38.91 77.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.905 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.2 -57.87 6.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.105 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.576 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 2.2 pp -56.57 -35.99 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.156 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.448 ' N ' HD12 ' A' ' 128' ' ' ILE . 39.1 m -67.71 -35.91 79.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -65.27 -46.06 81.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.448 ' O ' ' C ' ' A' ' 132' ' ' ARG . 3.7 t0 -88.18 24.55 1.83 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.448 ' C ' ' O ' ' A' ' 131' ' ' ASP . 60.0 mtp180 34.31 52.23 0.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.457 ' O ' ' C ' ' A' ' 134' ' ' TRP . 16.8 mmt180 -74.27 -24.39 59.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.848 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.576 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 25.2 m95 -33.57 -45.39 0.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.33 -56.51 17.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.09 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.6 -40.59 92.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 90.2 t -54.14 -39.35 41.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.097 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.477 ' HB2' HD11 ' A' ' 153' ' ' LEU . . . -71.87 -52.86 15.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.145 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -54.25 -29.12 45.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -60.13 -35.25 74.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.867 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.7 HD23 ' CE2' ' A' ' 143' ' ' TYR . 15.0 tp -85.22 24.65 1.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.939 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 59.18 34.59 23.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.847 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.7 ' CE2' HD23 ' A' ' 141' ' ' LEU . 3.2 m-85 -82.34 153.41 68.64 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.663 0.744 . . . . 0.0 110.954 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.699 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.5 Cg_endo -69.75 113.55 3.41 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.666 2.244 . . . . 0.0 112.32 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 53.3 Cg_endo -69.79 94.8 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.624 2.216 . . . . 0.0 112.322 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 173.54 -71.5 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.457 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -49.56 168.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.806 0.336 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -83.39 43.8 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.699 HD11 ' HG2' ' A' ' 144' ' ' PRO . 63.5 mt -54.59 -49.37 67.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.146 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.571 ' HA2' HD12 ' A' ' 153' ' ' LEU . . . -37.89 -52.36 2.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.466 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.2 t -62.21 -47.82 82.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.93 0.395 . . . . 0.0 110.84 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.5 tt -52.04 -46.56 65.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.951 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.571 HD12 ' HA2' ' A' ' 150' ' ' GLY . 6.2 mt -59.93 -66.04 0.58 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.534 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 18.3 ttp180 -37.84 -49.2 1.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 74.5 m -57.07 -68.6 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -38.15 -45.26 0.92 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.843 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.514 ' HA ' HD12 ' A' ' 161' ' ' ILE . 4.0 t80 -60.22 -59.37 5.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.434 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 5.5 mm-40 -67.14 -9.97 45.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -86.89 -54.39 4.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.8 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 38.6 mt -108.85 -39.92 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.075 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 157' ' ' TYR . 15.0 mt -77.33 0.66 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.118 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.586 ' CE1' ' SD ' ' A' ' 166' ' ' MET . 0.2 OUTLIER -72.53 -60.48 2.06 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.662 0.744 . . . . 0.0 110.932 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.557 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.0 Cg_endo -69.79 -42.96 2.92 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.695 2.263 . . . . 0.0 112.326 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.403 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 26.6 t80 -56.82 -39.74 74.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.916 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.501 ' HG3' HG22 ' A' ' 161' ' ' ILE . 16.3 mm-40 -72.17 -65.5 0.77 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.897 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.586 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 8.5 ptt? -47.95 -42.3 27.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.833 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -71.96 -57.49 4.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.874 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.65 49.52 0.51 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 12.6 t -114.75 40.93 2.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.909 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 45.9 80.48 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.502 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.323 0 CA-C-O 120.777 0.322 . . . . 0.0 111.143 179.945 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.4 m -104.47 109.02 20.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 0.0 110.866 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.1 t -154.98 122.73 5.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.871 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -119.91 -76.68 0.48 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.486 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.1 p -56.71 91.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.897 0.379 . . . . 0.0 110.858 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 78.0 p -146.94 141.56 26.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.813 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -145.98 38.92 1.16 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.506 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 80' ' ' ARG . 16.7 m -67.18 -39.68 86.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.773 0.32 . . . . 0.0 111.117 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.423 ' C ' ' O ' ' A' ' 79' ' ' THR . 20.7 tpp180 -35.61 -44.79 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.886 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 84' ' ' ASN . 96.1 t -76.88 -59.52 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.099 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 81' ' ' VAL . 11.4 mptt -35.9 -31.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.623 ' HA ' HD12 ' A' ' 86' ' ' LEU . 26.9 mt -71.8 -46.85 56.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.951 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.494 ' N ' ' O ' ' A' ' 81' ' ' VAL . 6.6 t30 -37.98 -48.63 1.2 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.416 ' CD2' ' HA ' ' A' ' 113' ' ' TYR . 29.4 t80 -63.76 -42.54 97.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.948 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.623 HD12 ' HA ' ' A' ' 83' ' ' LEU . 25.1 mt -63.75 -56.4 15.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.913 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -57.75 -24.82 58.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.887 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -77.88 -60.98 2.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.541 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 20.7 tt -62.19 -31.07 50.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.151 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.753 ' HB2' HD22 ' A' ' 100' ' ' LEU . . . -68.41 -51.93 38.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.088 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -47.29 -27.88 1.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.875 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -80.24 -44.22 20.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -69.5 -55.35 10.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 12.1 pt-20 -40.1 -41.65 1.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.843 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.41 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 84.7 mt -68.02 -54.27 23.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.154 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -45.74 -32.76 2.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 129.94 -37.94 2.07 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.482 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 41.3 t -89.22 121.81 31.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.906 0.384 . . . . 0.0 110.856 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.7 t -60.09 172.45 0.79 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.85 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.753 HD22 ' HB2' ' A' ' 90' ' ' ALA . 19.5 tp -97.94 127.86 44.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.889 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.3 mttm -130.56 128.53 41.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.493 HD12 HD22 ' A' ' 112' ' ' LEU . 45.9 mm -95.63 123.31 56.58 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.609 0.719 . . . . 0.0 111.165 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.561 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 54.1 Cg_endo -69.77 146.82 61.31 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.625 2.217 . . . . 0.0 112.389 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -95.92 113.9 25.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.925 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 79.1 t -115.53 141.43 32.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.441 ' HG3' ' CD ' ' A' ' 144' ' ' PRO . 23.2 mm-40 47.39 53.76 10.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.908 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 19.7 ptt-85 43.04 42.58 3.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.85 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -163.6 153.52 15.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.907 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.8 tp -63.56 143.57 15.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.086 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.631 HD23 ' N ' ' A' ' 111' ' ' ASP . 4.6 tt -89.82 123.75 34.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.631 ' N ' HD23 ' A' ' 110' ' ' LEU . 37.1 t0 -86.14 68.24 10.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.846 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.493 HD22 HD12 ' A' ' 102' ' ' ILE . 2.0 pt? -47.55 -32.64 5.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.416 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 6.9 t80 -56.33 -65.28 0.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.923 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.3 p -51.79 -45.5 63.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.6 tp -45.92 -66.91 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.902 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.9 t -47.56 -51.38 21.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -47.67 -59.43 3.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.891 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.609 ' CG2' HG13 ' A' ' 137' ' ' VAL . 77.7 mt -50.99 -50.05 25.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.139 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 98.9 t -49.65 -63.21 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.126 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 74.4 mt -51.18 -48.74 31.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.125 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -52.58 -57.24 10.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.875 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -45.36 -49.51 12.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.916 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 154.51 36.62 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.499 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.07 175.12 40.91 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.491 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.504 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 1.2 t80 -82.78 -40.19 20.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.839 0.352 . . . . 0.0 110.892 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -64.2 -40.02 95.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.878 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.1 -64.47 0.92 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.126 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.677 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 2.0 pp -54.7 -34.5 30.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.156 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.504 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 22.5 m -66.88 -36.57 82.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.6 tptt -71.62 -42.1 68.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 132' ' ' ARG . 38.7 m-20 -88.34 22.88 2.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.868 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 131' ' ' ASP . 35.3 mtp180 34.46 43.43 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.844 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -74.76 -8.11 55.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.677 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 16.7 m95 -45.61 -47.55 14.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.902 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -46.66 -56.97 5.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.098 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -67.73 -56.67 8.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.609 HG13 ' CG2' ' A' ' 118' ' ' ILE . 87.0 t -43.23 -29.42 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.138 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.547 ' HB2' HD11 ' A' ' 153' ' ' LEU . . . -81.0 -49.18 11.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.141 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -59.56 -27.73 66.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -60.6 -26.16 66.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.837 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.505 HD23 ' CE2' ' A' ' 143' ' ' TYR . 20.3 tp -90.03 12.12 18.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.878 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 71.42 48.88 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.505 ' CE2' HD23 ' A' ' 141' ' ' LEU . 2.8 m-85 -99.94 158.59 31.78 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.681 0.753 . . . . 0.0 110.9 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.623 ' HG2' HD11 ' A' ' 149' ' ' ILE . 54.4 Cg_endo -69.72 111.42 2.8 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.714 2.276 . . . . 0.0 112.372 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 53.5 Cg_endo -69.8 95.27 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.711 2.274 . . . . 0.0 112.307 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.52 -73.74 0.12 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.452 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -54.74 145.08 20.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.836 0.35 . . . . 0.0 110.888 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -63.76 81.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.864 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.623 HD11 ' HG2' ' A' ' 144' ' ' PRO . 71.4 mt -88.27 -45.59 15.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.101 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -37.98 -45.96 1.7 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.482 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.6 m -60.66 -51.38 69.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.372 . . . . 0.0 110.877 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.528 HD21 ' CD2' ' A' ' 156' ' ' HIS . 5.9 tt -50.2 -48.83 54.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.915 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.547 HD11 ' HB2' ' A' ' 138' ' ' ALA . 22.2 mt -57.32 -65.96 0.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.42 ' CD ' ' HE1' ' A' ' 134' ' ' TRP . 17.8 ttp180 -38.99 -46.38 1.33 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 157' ' ' TYR . 41.0 t -60.2 -68.53 0.28 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.561 ' CE1' ' HG3' ' A' ' 103' ' ' PRO . 2.4 m-70 -41.9 -24.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.842 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 155' ' ' SER . 7.9 t80 -78.42 -50.14 12.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.918 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.408 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 5.2 mm-40 -81.62 -9.86 59.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.87 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -96.0 -41.48 8.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 76.9 mt -112.49 -49.18 5.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.113 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.778 HG22 ' HG3' ' A' ' 165' ' ' GLU . 9.8 mt -76.88 6.39 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.152 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.645 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -75.35 -62.63 0.79 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.666 0.745 . . . . 0.0 110.907 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.556 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.1 Cg_endo -69.81 -35.26 12.84 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.675 2.25 . . . . 0.0 112.329 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.541 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 65.3 t80 -60.51 -42.53 96.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.945 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.778 ' HG3' HG22 ' A' ' 161' ' ' ILE . 8.0 mt-10 -70.04 -55.07 10.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.883 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 2.7 mtm -62.74 -58.63 6.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.856 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.462 ' CB ' ' O ' ' A' ' 163' ' ' PRO . 29.3 t80 -47.99 -54.74 11.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.83 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -93.91 46.28 1.17 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.885 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 8.6 t -96.74 98.33 10.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.885 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -163.44 85.21 0.11 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.514 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.783 0.325 . . . . 0.0 111.128 179.97 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.8 p -166.95 155.25 9.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.841 0.353 . . . . 0.0 110.899 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 79.6 p -81.24 -49.7 10.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.845 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.61 85.78 0.18 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.53 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.7 t -40.7 105.31 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.835 0.35 . . . . 0.0 110.892 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 72.1 m -117.53 132.8 56.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.28 -98.34 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.526 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 79' ' ' THR . 9.7 t -95.64 126.1 40.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.769 0.318 . . . . 0.0 111.11 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -130.82 -64.79 0.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.878 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.459 ' O ' ' N ' ' A' ' 83' ' ' LEU . 61.1 t -80.74 -47.28 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.151 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.4 mttp -38.99 -27.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.926 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.632 ' HA ' HD12 ' A' ' 86' ' ' LEU . 36.9 mt -69.74 -49.29 54.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.925 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 81' ' ' VAL . 49.3 t-20 -40.67 -65.19 0.44 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.461 ' HE2' HD12 ' A' ' 112' ' ' LEU . 34.7 t80 -39.8 -47.4 2.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.632 HD12 ' HA ' ' A' ' 83' ' ' LEU . 12.6 mt -63.15 -66.77 0.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -44.51 -26.16 0.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -78.74 -70.58 0.49 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.9 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.636 HD11 HG22 ' A' ' 160' ' ' ILE . 7.5 tt -49.46 -32.26 6.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.131 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.918 ' HB2' HD22 ' A' ' 100' ' ' LEU . . . -73.6 -49.82 24.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.103 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -52.63 -20.03 2.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -90.82 -42.12 10.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -68.3 -50.57 52.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.417 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 4.4 pt-20 -45.24 -29.36 0.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.862 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.417 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 86.5 mt -78.69 -54.67 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.089 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -45.67 -32.59 2.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 132.18 -30.0 3.25 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.479 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.3 m -98.72 146.63 25.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.904 0.383 . . . . 0.0 110.833 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 65.5 m -78.25 174.93 10.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.837 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.918 HD22 ' HB2' ' A' ' 90' ' ' ALA . 22.0 tp -90.67 117.12 29.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.921 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -115.84 141.98 47.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.863 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 25.8 mm -117.28 121.62 32.07 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.649 0.738 . . . . 0.0 111.116 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 166.42 27.63 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.72 2.28 . . . . 0.0 112.315 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -114.04 126.57 55.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.412 HG12 ' HG2' ' A' ' 106' ' ' GLU . 52.0 t -125.4 132.95 70.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.467 ' HG3' ' CD ' ' A' ' 144' ' ' PRO . 29.1 mm-40 56.9 52.05 9.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.404 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 11.8 ptp180 44.64 35.93 1.58 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.909 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.46 ' HG3' ' N ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -157.82 151.95 24.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.9 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.46 ' N ' ' HG3' ' A' ' 108' ' ' LYS . 15.7 tt -57.51 149.2 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.149 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.438 HD23 ' N ' ' A' ' 111' ' ' ASP . 5.9 tt -94.32 123.84 37.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.973 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.438 ' N ' HD23 ' A' ' 110' ' ' LEU . 22.1 t0 -79.99 69.56 6.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.851 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.461 HD12 ' HE2' ' A' ' 85' ' ' TYR . 2.5 pt? -51.25 -23.08 3.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.495 ' CE1' ' HG3' ' A' ' 117' ' ' LYS . 2.4 t80 -66.06 -57.51 7.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.95 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 115' ' ' LEU . 3.3 m -60.5 -59.43 5.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.867 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.423 ' C ' ' O ' ' A' ' 114' ' ' SER . 13.0 tp -36.21 -68.23 0.14 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.897 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 119' ' ' VAL . 42.0 t -50.78 -66.24 0.42 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.87 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.495 ' HG3' ' CE1' ' A' ' 113' ' ' TYR . 13.2 mmtp -36.85 -43.83 0.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.886 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 77.1 mt -64.82 -42.47 95.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.135 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.712 HG13 HG12 ' A' ' 128' ' ' ILE . 95.2 t -59.22 -56.89 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.105 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 70.0 mt -61.46 -45.58 98.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -56.4 -52.09 65.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -50.89 -47.17 60.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.865 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 127' ' ' ALA . . . 155.57 38.56 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.467 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.526 ' O ' HG23 ' A' ' 128' ' ' ILE . . . 87.44 176.27 48.6 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.481 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.566 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 0.6 OUTLIER -83.52 -36.94 23.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.368 . . . . 0.0 110.919 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -63.57 -41.09 98.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.85 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 123' ' ' GLY . . . -68.56 -64.36 0.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.136 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.712 HG12 HG13 ' A' ' 119' ' ' VAL . 2.2 pp -47.84 -32.17 3.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.136 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.439 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 22.1 m -70.18 -46.61 64.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.864 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -59.88 -40.62 89.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.897 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 132' ' ' ARG . 2.7 m-20 -86.65 17.35 3.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.85 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.428 ' HB3' ' NH1' ' A' ' 132' ' ' ARG . 14.5 mtp-105 37.7 45.72 0.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 134' ' ' TRP . 4.1 mmp_? -71.77 -20.15 61.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.561 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 50.5 m95 -36.01 -40.27 0.2 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.908 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.45 -52.65 64.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.076 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.5 mmt-85 -68.5 -38.85 81.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.887 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 78.2 t -56.27 -40.11 63.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.614 ' HB2' HD11 ' A' ' 153' ' ' LEU . . . -72.4 -47.69 47.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -62.04 -27.32 68.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.4 mmp_? -60.97 -35.7 77.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.854 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.495 HD23 ' CZ ' ' A' ' 143' ' ' TYR . 14.8 tp -82.79 13.49 3.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.971 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 62.82 51.13 3.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.668 ' HB3' HD13 ' A' ' 149' ' ' ILE . 2.5 m-85 -91.43 159.68 38.5 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.677 0.751 . . . . 0.0 110.873 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.467 ' CD ' ' HG3' ' A' ' 106' ' ' GLU . 53.8 Cg_endo -69.78 118.47 5.7 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.683 2.255 . . . . 0.0 112.343 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 54.0 Cg_endo -69.72 97.78 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.693 2.262 . . . . 0.0 112.36 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.54 -82.39 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.46 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 9.3 tttp -47.31 147.8 1.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.804 0.335 . . . . 0.0 110.88 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -66.68 82.68 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.895 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.668 HD13 ' HB3' ' A' ' 143' ' ' TYR . 64.0 mt -83.06 -50.77 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.136 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.11 -53.21 1.24 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.526 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.1 t -57.16 -61.59 2.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.903 0.382 . . . . 0.0 110.801 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.424 HD21 ' CD2' ' A' ' 156' ' ' HIS . 5.5 tt -39.12 -55.95 1.54 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.935 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.614 HD11 ' HB2' ' A' ' 138' ' ' ALA . 23.9 mt -50.57 -65.9 0.48 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.561 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 13.2 ttp180 -38.84 -45.78 1.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.4 t -61.12 -69.01 0.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.854 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.424 ' CD2' HD21 ' A' ' 152' ' ' LEU . 2.0 m-70 -39.91 -36.16 0.43 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.799 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.463 ' CD1' ' C ' ' A' ' 157' ' ' TYR . 3.4 t80 -69.78 -58.93 3.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 18.4 mt-10 -66.92 -10.08 45.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.901 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -92.95 -53.08 4.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.812 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.636 HG22 HD11 ' A' ' 89' ' ' ILE . 60.7 mt -104.73 -43.47 8.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.07 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.563 HG22 ' HG3' ' A' ' 165' ' ' GLU . 32.3 mt -76.02 -2.29 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.163 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.624 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -72.2 -60.45 2.24 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.656 0.741 . . . . 0.0 110.931 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 162' ' ' TYR . 53.9 Cg_endo -69.73 -43.56 2.61 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.699 2.266 . . . . 0.0 112.337 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.54 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 17.6 t80 -54.66 -41.55 70.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.563 ' HG3' HG22 ' A' ' 161' ' ' ILE . 14.5 mm-40 -76.26 -68.44 0.59 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.408 ' HG3' ' HA ' ' A' ' 163' ' ' PRO . 0.0 OUTLIER -42.34 -30.25 0.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -75.7 -55.59 5.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.9 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -93.52 41.98 1.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.873 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 54.5 m -144.44 129.68 18.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 100.78 48.87 1.44 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.476 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.822 0.344 . . . . 0.0 111.075 179.959 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 79.4 p -98.47 101.01 12.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.866 0.365 . . . . 0.0 110.866 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.5 t -97.66 92.4 5.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.912 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.39 -170.31 12.5 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.499 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m -90.69 114.31 26.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.905 0.383 . . . . 0.0 110.869 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 t -160.24 165.41 31.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.846 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 86.71 48.91 4.29 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.513 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 80' ' ' ARG . 99.0 m -122.31 -41.81 2.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.765 0.316 . . . . 0.0 111.11 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 79' ' ' THR . 23.2 mmt180 -35.84 -50.06 0.64 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.929 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.429 ' O ' ' N ' ' A' ' 84' ' ' ASN . 89.3 t -88.74 -39.43 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.093 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 81' ' ' VAL . 74.4 tttt -37.22 -33.09 0.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.451 ' HA ' HD12 ' A' ' 86' ' ' LEU . 21.1 mt -84.09 -43.73 14.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.892 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 81' ' ' VAL . 39.1 t30 -40.16 -53.31 2.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.601 ' CE1' ' NZ ' ' A' ' 117' ' ' LYS . 42.4 t80 -55.18 -50.34 69.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.939 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.741 ' CD2' HD21 ' A' ' 112' ' ' LEU . 43.3 mt -55.44 -59.88 4.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.906 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.3 -39.27 66.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.862 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -62.9 -57.83 9.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.456 HD11 HG22 ' A' ' 160' ' ' ILE . 18.0 tt -61.02 -34.99 62.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.14 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.26 -51.27 46.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.09 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -44.14 -35.31 2.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.929 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -72.41 -50.54 25.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.586 ' CD1' HD13 ' A' ' 100' ' ' LEU . 87.0 m95 -63.38 -58.5 6.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.949 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 21.7 pt-20 -37.68 -39.34 0.33 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.451 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 97.2 mt -71.24 -55.09 15.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.125 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -44.71 -35.81 2.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.923 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 120.31 -30.52 5.58 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.497 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.403 ' O ' ' C ' ' A' ' 99' ' ' SER . 0.7 OUTLIER -86.87 94.85 9.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.907 0.384 . . . . 0.0 110.84 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 98' ' ' SER . 51.3 p -38.02 150.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.837 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.586 HD13 ' CD1' ' A' ' 93' ' ' TRP . 18.5 tp -88.06 107.42 18.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.931 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -102.28 115.55 30.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.89 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.47 ' H ' HD12 ' A' ' 102' ' ' ILE . 5.4 mp -81.12 123.1 82.08 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.647 0.737 . . . . 0.0 111.12 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 144.55 54.44 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.671 2.248 . . . . 0.0 112.325 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -102.63 109.47 21.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.916 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 90.4 t -113.32 140.48 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.105 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.47 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 5.7 mm-40 57.45 43.62 22.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.912 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.47 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 5.3 ptm180 48.22 33.49 3.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.901 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -153.71 157.47 39.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 6.8 tt -63.6 139.63 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.114 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.584 HD23 ' N ' ' A' ' 111' ' ' ASP . 4.1 tt -84.85 122.11 28.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.941 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.584 ' N ' HD23 ' A' ' 110' ' ' LEU . 29.8 t0 -80.03 74.04 6.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.741 HD21 ' CD2' ' A' ' 86' ' ' LEU . 1.5 pt? -57.48 -32.08 66.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.901 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.531 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -56.57 -64.32 0.91 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.921 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 115' ' ' LEU . 5.3 m -53.11 -63.97 0.97 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.849 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.74 ' O ' HG23 ' A' ' 119' ' ' VAL . 13.7 tp -34.19 -53.89 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.879 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.3 t -56.46 -64.32 0.91 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.601 ' NZ ' ' CE1' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -45.23 -51.41 10.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.9 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 69.8 mt -54.33 -40.96 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.144 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 115' ' ' LEU . 96.9 t -66.2 -39.46 84.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.089 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 62.0 mt -70.28 -55.21 15.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.128 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.481 ' HG3' ' N ' ' A' ' 122' ' ' GLU . 5.6 pt-20 -49.31 -37.55 24.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.889 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.481 ' N ' ' HG3' ' A' ' 121' ' ' GLU . 35.7 mt-10 -65.41 -27.23 68.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.845 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 134.86 28.44 0.45 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.462 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.99 -175.65 35.37 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.495 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.485 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 1.1 t80 -86.25 -38.6 17.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.827 0.346 . . . . 0.0 110.933 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -62.37 -48.39 79.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.897 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -53.75 -71.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.09 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.522 HG12 HG13 ' A' ' 119' ' ' VAL . 1.6 pp -46.31 -34.86 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 25.7 m -69.01 -32.58 72.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.855 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -68.46 -46.64 69.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 132' ' ' ARG . 1.1 m-20 -90.11 24.62 2.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 131' ' ' ASP . 23.6 mmt85 35.45 44.9 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.624 ' O ' HG23 ' A' ' 137' ' ' VAL . 71.1 mtt85 -83.91 21.69 1.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.842 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.525 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 28.5 m95 -66.16 -42.77 88.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.45 -47.9 75.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.086 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -47.53 78.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 133' ' ' ARG . 73.1 t -53.88 -37.89 34.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.153 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.614 ' HB2' HD11 ' A' ' 153' ' ' LEU . . . -66.91 -53.12 35.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.097 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -58.31 -38.22 76.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.908 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -59.19 -31.61 69.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.96 HD12 ' CE2' ' A' ' 143' ' ' TYR . 1.5 tm? -80.77 12.52 3.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 65.71 53.53 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.839 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.96 ' CE2' HD12 ' A' ' 141' ' ' LEU . 6.6 m-85 -109.0 159.01 32.69 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.636 0.731 . . . . 0.0 110.956 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 112.5 3.1 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.712 2.274 . . . . 0.0 112.333 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 122.43 9.12 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.674 2.249 . . . . 0.0 112.372 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.96 -70.1 0.3 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.488 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -58.15 171.0 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.764 0.316 . . . . 0.0 110.915 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.2 42.2 1.02 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.917 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.423 ' O ' ' C ' ' A' ' 150' ' ' GLY . 92.1 mt -44.5 -45.02 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.151 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.05 -54.78 1.19 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.511 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.9 m -58.93 -50.26 74.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.948 0.404 . . . . 0.0 110.834 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.54 ' C ' HD23 ' A' ' 152' ' ' LEU . 8.3 tt -51.74 -50.13 61.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.956 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.614 HD11 ' HB2' ' A' ' 138' ' ' ALA . 25.5 mt -52.94 -64.73 0.72 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.902 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.525 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 14.3 ttp180 -41.1 -46.02 2.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 47.3 t -57.92 -58.88 6.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.841 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -51.98 -49.21 63.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.535 ' HA ' HD12 ' A' ' 161' ' ' ILE . 3.8 t80 -57.79 -57.59 12.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.963 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.471 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 39.0 mt-10 -66.88 -9.8 41.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.877 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 37.4 ttt-85 -87.76 -57.4 2.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.857 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.456 HG22 HD11 ' A' ' 89' ' ' ILE . 78.6 mt -104.76 -41.22 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.169 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.574 HG22 ' HG3' ' A' ' 165' ' ' GLU . 14.2 mt -75.96 -0.48 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.113 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.634 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -73.32 -61.31 1.48 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.716 0.769 . . . . 0.0 110.941 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.477 ' HA ' ' CG ' ' A' ' 166' ' ' MET . 53.8 Cg_endo -69.7 -33.65 16.38 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.737 2.292 . . . . 0.0 112.341 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.409 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 24.5 t80 -64.75 -46.38 82.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.887 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.574 ' HG3' HG22 ' A' ' 161' ' ' ILE . 4.9 mm-40 -69.29 -55.46 10.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.865 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.477 ' CG ' ' HA ' ' A' ' 163' ' ' PRO . 0.5 OUTLIER -55.02 -40.83 70.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -62.27 -45.7 92.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.878 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -114.22 81.47 1.54 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.901 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 15.8 t -127.36 87.85 2.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.841 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 179.61 -95.45 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.476 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.732 0.301 . . . . 0.0 111.102 179.963 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.1 m -130.41 146.68 52.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.86 0.362 . . . . 0.0 110.863 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 73.5 m -45.34 158.04 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.853 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.72 67.96 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.484 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.0 p -101.08 152.13 20.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.884 0.374 . . . . 0.0 110.873 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.8 t -117.1 35.0 4.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.897 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.44 -167.57 43.12 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.462 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 79' ' ' THR . 9.2 t -113.95 125.07 53.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.805 0.336 . . . . 0.0 111.152 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.1 tpp180 -131.48 -69.46 0.62 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.838 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.433 ' O ' ' N ' ' A' ' 83' ' ' LEU . 99.9 t -78.01 -41.33 27.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.121 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 81' ' ' VAL . 3.3 mptt -36.12 -33.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.915 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 81' ' ' VAL . 35.5 mt -65.42 -51.25 61.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.958 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.432 ' O ' ' N ' ' A' ' 87' ' ' ASP . 64.1 t-20 -38.13 -68.0 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.503 ' CD2' ' HA ' ' A' ' 113' ' ' TYR . 29.9 t80 -36.79 -50.51 0.85 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.938 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.8 HD21 HD21 ' A' ' 112' ' ' LEU . 95.6 mt -62.55 -41.99 99.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.899 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 84' ' ' ASN . 62.3 m-20 -61.76 -18.06 58.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -91.55 -57.33 2.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.96 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.498 HD11 HG22 ' A' ' 160' ' ' ILE . 15.6 tt -63.5 -39.39 85.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.149 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.485 ' HB2' ' CD2' ' A' ' 100' ' ' LEU . . . -67.03 -38.86 86.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.09 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -61.29 -28.5 69.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -82.58 -39.44 22.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.875 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.487 ' O ' ' N ' ' A' ' 96' ' ' GLN . 27.0 m95 -68.35 -61.05 2.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.442 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 5.7 pt-20 -36.96 -31.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.925 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 93' ' ' TRP . 96.7 mt -73.4 -45.41 52.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.101 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 93' ' ' TRP . 61.2 mm-40 -56.51 -33.07 65.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 131.78 -42.24 1.41 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.472 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 37.9 m -86.71 140.32 29.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.913 0.387 . . . . 0.0 110.848 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.0 p -71.17 175.31 5.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.87 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.489 HD22 HG23 ' A' ' 89' ' ' ILE . 25.5 tp -104.35 112.12 25.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.1 ttpt -109.67 130.46 55.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.1 mp -96.04 124.17 52.82 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.586 0.707 . . . . 0.0 111.15 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.444 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 54.2 Cg_endo -69.76 142.87 49.1 Favored 'Trans proline' 0 N--CA 1.466 -0.125 0 C-N-CA 122.707 2.272 . . . . 0.0 112.363 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -94.27 113.7 25.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.898 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.5 t -113.17 142.68 24.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.091 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 19.1 mm-40 50.61 48.62 22.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.911 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.434 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 18.4 ptt-85 45.72 33.22 1.41 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.868 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.8 pttm -151.6 164.76 36.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.856 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.4 tt -69.22 144.82 13.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.119 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 112' ' ' LEU . 6.4 tt -92.97 121.76 34.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.939 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -79.88 57.36 2.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.876 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.8 HD21 HD21 ' A' ' 86' ' ' LEU . 1.5 pt? -41.57 -29.29 0.16 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.503 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 4.9 t80 -59.31 -58.72 7.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.934 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 115' ' ' LEU . 11.0 t -56.05 -57.67 11.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.89 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 114' ' ' SER . 11.1 tp -36.76 -62.76 0.45 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.915 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.7 p -51.13 -53.93 29.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.853 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 18.2 mmtm -49.27 -54.2 17.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.409 ' O ' ' C ' ' A' ' 119' ' ' VAL . 64.6 mt -49.06 -69.22 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.13 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.631 HG13 HG12 ' A' ' 128' ' ' ILE . 90.8 t -37.09 -62.37 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.107 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 89.0 mt -45.18 -56.43 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -52.57 -56.89 12.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.45 ' OE1' HG21 ' A' ' 128' ' ' ILE . 46.8 mt-10 -38.36 -50.35 1.48 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 151.26 39.25 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.492 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.3 -179.43 40.65 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.504 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.499 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 1.9 t80 -87.56 -43.79 11.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.845 0.355 . . . . 0.0 110.931 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -61.28 -36.1 79.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.912 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.92 -65.58 0.66 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.13 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.849 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.8 pp -54.15 -31.8 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.087 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.499 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 26.8 m -70.81 -41.92 70.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.831 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -68.88 -26.44 65.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.855 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -103.03 15.71 28.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.821 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 67.5 mtp85 41.91 29.36 0.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.856 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 27.7 mtt-85 -62.15 -8.78 6.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.839 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.849 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 20.7 m95 -44.13 -52.18 7.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -40.83 -51.18 3.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.099 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -63.63 -51.38 65.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.857 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.6 t -49.4 -38.39 12.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.54 ' HB2' ' CD1' ' A' ' 153' ' ' LEU . . . -70.24 -57.48 4.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -57.87 -18.25 21.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -69.94 -25.36 63.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.857 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.58 HD23 ' CE2' ' A' ' 143' ' ' TYR . 14.6 tp -94.28 27.18 3.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 62.25 36.48 14.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.849 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.58 ' CE2' HD23 ' A' ' 141' ' ' LEU . 5.3 m-85 -92.2 147.29 34.33 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.706 0.765 . . . . 0.0 110.925 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.472 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.6 Cg_endo -69.79 118.95 5.99 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.68 2.253 . . . . 0.0 112.34 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 125.81 12.58 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.702 2.268 . . . . 0.0 112.338 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 131.76 -55.61 0.76 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.427 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -54.6 168.67 0.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.762 0.315 . . . . 0.0 110.947 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.422 ' CG ' ' O ' ' A' ' 148' ' ' ASN . 13.1 p-10 -83.86 43.36 0.91 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.91 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.472 HD11 ' HG2' ' A' ' 144' ' ' PRO . 70.5 mt -67.74 -52.51 39.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.096 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.28 -53.07 1.3 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.488 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.2 t -57.53 -58.62 7.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 0.0 110.849 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.647 HD21 ' CD2' ' A' ' 156' ' ' HIS . 7.2 tt -42.06 -49.46 4.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.943 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.54 ' CD1' ' HB2' ' A' ' 138' ' ' ALA . 23.6 mt -55.98 -65.84 0.53 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.938 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.443 ' HD2' ' NE1' ' A' ' 134' ' ' TRP . 32.0 ttt180 -39.21 -39.97 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 156' ' ' HIS . 9.3 t -67.56 -70.01 0.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.861 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.647 ' CD2' HD21 ' A' ' 152' ' ' LEU . 2.0 m-70 -37.17 -33.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.86 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.447 ' HA ' ' CG1' ' A' ' 161' ' ' ILE . 12.0 t80 -70.38 -56.27 7.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -73.59 -9.81 59.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.858 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? -92.07 -49.0 6.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.908 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.498 HG22 HD11 ' A' ' 89' ' ' ILE . 88.3 mt -109.91 -44.18 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.118 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.553 HG22 ' CG ' ' A' ' 165' ' ' GLU . 14.3 mt -77.45 4.24 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.148 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.606 ' CE1' ' SD ' ' A' ' 166' ' ' MET . 0.1 OUTLIER -74.24 -61.48 1.21 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.662 0.744 . . . . 0.0 110.905 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.564 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 54.2 Cg_endo -69.73 -30.71 21.98 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.649 2.232 . . . . 0.0 112.354 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -69.2 -42.58 75.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.973 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.553 ' CG ' HG22 ' A' ' 161' ' ' ILE . 3.9 mm-40 -67.8 -57.65 5.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.878 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.606 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 24.7 ptm -53.42 -47.7 69.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -59.12 -49.07 79.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.897 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 -104.76 73.26 1.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.894 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 28.4 t -118.69 -51.22 2.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -153.0 -89.99 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.485 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.805 0.336 . . . . 0.0 111.069 179.955 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 92.4 p -119.32 118.94 32.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 0.0 110.856 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.6 p -81.87 105.18 12.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.835 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -138.11 132.77 5.99 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.522 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 61.9 p -64.97 147.54 53.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.874 0.369 . . . . 0.0 110.87 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 55.4 m -118.64 117.27 28.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.825 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.42 70.23 0.19 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.471 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.1 t -104.59 41.69 1.29 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.806 0.336 . . . . 0.0 111.155 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -75.48 -66.78 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.859 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 57.8 t -80.01 -37.23 17.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.156 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.568 ' HD3' ' CD2' ' A' ' 113' ' ' TYR . 1.2 tppt? -40.64 -28.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.891 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.5 mt -77.66 -49.59 14.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.924 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -40.49 -56.84 1.96 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.497 ' HE2' HD12 ' A' ' 112' ' ' LEU . 40.3 t80 -41.42 -36.17 0.81 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.2 mt -76.48 -44.29 36.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -59.33 -38.81 81.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.859 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -66.25 -63.76 1.01 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.898 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.564 ' HA ' ' CE1' ' A' ' 164' ' ' TYR . 19.4 tt -52.54 -30.5 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.03 -56.24 6.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.059 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -44.24 -27.5 0.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.939 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -78.68 -46.75 18.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.43 ' O ' ' N ' ' A' ' 95' ' ' ILE . 66.2 m95 -69.2 -57.68 5.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.96 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 93' ' ' TRP . 9.2 pt-20 -36.91 -32.53 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.43 ' N ' ' O ' ' A' ' 93' ' ' TRP . 96.7 mt -76.22 -51.75 19.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.173 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -47.58 -40.12 18.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.06 -40.57 1.17 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.47 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.7 m -96.56 144.51 26.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.892 0.377 . . . . 0.0 110.833 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.5 t -76.64 171.68 14.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.86 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.5 tp -82.46 104.71 12.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.964 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -96.13 111.07 23.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.0 mt -94.35 119.56 66.33 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.603 0.716 . . . . 0.0 111.158 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.408 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 53.5 Cg_endo -69.75 151.22 69.1 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.676 2.251 . . . . 0.0 112.36 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -102.52 115.17 30.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.853 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.916 HG12 ' CD ' ' A' ' 106' ' ' GLU . 26.2 t -122.04 144.61 30.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.174 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.916 ' CD ' HG12 ' A' ' 105' ' ' VAL . 49.1 mp0 60.76 44.74 10.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.92 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.496 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 15.2 ptm180 46.43 39.79 7.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.876 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -171.0 154.0 3.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.865 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.8 tt -52.29 138.67 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.877 HD23 ' N ' ' A' ' 111' ' ' ASP . 5.4 tt -75.04 144.73 42.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.877 ' N ' HD23 ' A' ' 110' ' ' LEU . 13.3 t0 -103.41 75.05 1.31 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.873 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.779 HD23 ' H ' ' A' ' 112' ' ' LEU . 1.4 pt? -65.12 -36.18 83.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.9 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.568 ' CD2' ' HD3' ' A' ' 82' ' ' LYS . 38.1 t80 -46.71 -64.76 0.69 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 115' ' ' LEU . 36.6 m -56.93 -60.01 4.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.87 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 114' ' ' SER . 13.1 tp -34.93 -65.24 0.23 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.917 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 52.4 m -48.37 -56.88 7.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.868 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.415 ' HD2' ' N ' ' A' ' 117' ' ' LYS . 2.2 mptp? -49.77 -62.58 1.48 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.891 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 95.6 mt -38.46 -64.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.157 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.537 HG13 HG12 ' A' ' 128' ' ' ILE . 76.2 t -45.0 -59.13 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.112 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 79.2 mt -45.91 -34.81 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.141 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -76.67 -51.77 10.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.895 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -43.54 -46.36 6.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.896 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 127' ' ' ALA . . . 151.69 37.15 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.505 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.461 ' O ' HG23 ' A' ' 128' ' ' ILE . . . 88.59 173.97 47.08 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.477 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 2.4 t80 -82.47 -44.34 16.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.849 0.357 . . . . 0.0 110.929 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -59.67 -42.59 93.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.848 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 123' ' ' GLY . . . -63.15 -70.96 0.18 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.094 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.537 HG12 HG13 ' A' ' 119' ' ' VAL . 1.9 pp -45.28 -32.74 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.157 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.457 ' N ' HD12 ' A' ' 128' ' ' ILE . 22.3 m -68.77 -39.66 80.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -66.27 -41.77 89.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 132' ' ' ARG . 2.1 t70 -88.56 19.89 3.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.886 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.429 ' C ' ' O ' ' A' ' 131' ' ' ASP . 26.1 mtt180 35.47 51.92 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 134' ' ' TRP . 23.4 mtp180 -80.75 -14.54 58.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.827 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.556 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 42.6 m95 -37.56 -56.61 1.01 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.921 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -40.08 -55.83 2.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.105 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 19.8 mmt85 -60.97 -51.49 69.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 84.1 t -46.17 -37.94 3.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.124 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -73.61 -45.47 52.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.088 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -62.99 -17.41 62.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.932 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.9 mmt85 -76.61 -28.99 56.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.92 HD23 ' CZ ' ' A' ' 143' ' ' TYR . 14.7 tp -91.88 20.1 6.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.938 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 5.7 m80 54.62 52.98 11.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.841 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.92 ' CZ ' HD23 ' A' ' 141' ' ' LEU . 4.9 m-85 -89.42 148.33 40.19 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.676 0.75 . . . . 0.0 110.9 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.49 ' CD ' ' HG2' ' A' ' 106' ' ' GLU . 54.0 Cg_endo -69.71 114.57 3.74 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.733 2.288 . . . . 0.0 112.362 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 132.62 23.77 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.701 2.267 . . . . 0.0 112.37 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.36 -63.14 0.6 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.459 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -70.23 156.78 38.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.822 0.344 . . . . 0.0 110.911 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.417 ' CG ' ' O ' ' A' ' 148' ' ' ASN . 16.5 p-10 -75.14 83.84 2.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.873 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.428 ' O ' ' C ' ' A' ' 150' ' ' GLY . 51.5 mt -92.2 -52.09 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.124 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.25 -54.97 1.24 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.473 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 68.0 m -57.91 -53.83 53.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.862 0.363 . . . . 0.0 110.862 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.766 HD21 ' CD2' ' A' ' 156' ' ' HIS . 5.3 tt -46.37 -49.76 17.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.928 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 26.5 mt -56.33 -66.07 0.5 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.556 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 9.7 ttt-85 -38.32 -40.31 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 156' ' ' HIS . 11.5 t -68.16 -71.15 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.766 ' CD2' HD21 ' A' ' 152' ' ' LEU . 2.2 m-70 -37.03 -37.91 0.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.872 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.415 ' HA ' ' CG1' ' A' ' 161' ' ' ILE . 7.8 t80 -65.01 -66.58 0.52 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.933 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 20.2 mm-40 -64.91 -9.94 25.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.911 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 20.3 mmm-85 -86.81 -56.25 3.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.845 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.409 HG22 HD11 ' A' ' 89' ' ' ILE . 62.2 mt -105.7 -43.74 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.096 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.48 ' O ' HG22 ' A' ' 161' ' ' ILE . 13.2 mt -72.61 -0.69 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.159 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.647 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -75.67 -63.24 0.68 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.675 0.75 . . . . 0.0 110.89 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.559 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 54.3 Cg_endo -69.75 -31.26 20.93 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.661 2.241 . . . . 0.0 112.355 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.564 ' CE1' ' HA ' ' A' ' 89' ' ' ILE . 14.5 t80 -64.5 -36.31 83.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.925 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.431 ' HG3' HG22 ' A' ' 161' ' ' ILE . 13.4 mt-10 -77.32 -56.17 4.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.846 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.51 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 13.1 ptt? -52.4 -43.79 64.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.878 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.408 ' N ' ' CG ' ' A' ' 166' ' ' MET . 54.5 t80 -66.09 -56.88 9.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.888 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -88.29 38.99 0.88 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 12.2 t -86.29 -52.11 5.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.835 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 168.77 -75.12 0.12 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.48 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.792 0.329 . . . . 0.0 111.089 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.0 p -50.74 155.19 1.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.864 0.364 . . . . 0.0 110.862 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.8 t -74.96 -49.53 19.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.849 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.05 -130.13 1.76 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.519 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.1 p -159.9 122.45 3.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.84 0.352 . . . . 0.0 110.894 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.4 t -112.27 -52.11 2.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.818 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 141.87 166.72 10.99 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.484 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.627 HG23 ' HB2' ' A' ' 82' ' ' LYS . 95.7 m -60.83 92.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.777 0.322 . . . . 0.0 111.162 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.2 mmp_? -119.77 -50.14 2.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.471 ' O ' ' N ' ' A' ' 83' ' ' LEU . 73.1 t -77.63 -43.51 29.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.14 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.627 ' HB2' HG23 ' A' ' 79' ' ' THR . 4.2 mptt -35.24 -32.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.913 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.617 ' HA ' HD12 ' A' ' 86' ' ' LEU . 63.5 mt -66.62 -53.33 35.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.912 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' A' ' 81' ' ' VAL . 4.6 t30 -39.57 -56.68 1.61 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.488 ' HE2' HD12 ' A' ' 112' ' ' LEU . 33.0 t80 -54.11 -37.74 64.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.92 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.617 HD12 ' HA ' ' A' ' 83' ' ' LEU . 28.1 mt -70.13 -59.31 2.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.945 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.42 -33.14 42.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -66.49 -67.75 0.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.552 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 8.2 tt -50.18 -37.27 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.093 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.28 -52.76 44.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.073 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.0 tttm -45.32 -30.68 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.551 ' CD1' ' CD2' ' A' ' 167' ' ' PHE . 8.3 t80 -79.46 -39.67 31.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.891 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.505 ' CD1' HD13 ' A' ' 100' ' ' LEU . 61.9 m95 -70.31 -64.21 0.94 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.924 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.447 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 6.0 pt-20 -34.82 -33.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' A' ' 93' ' ' TRP . 96.5 mt -74.02 -50.33 29.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.116 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 93' ' ' TRP . 28.8 mm-40 -55.59 -18.64 8.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.929 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 104.12 -37.42 3.77 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.496 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.7 p -79.35 92.77 5.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.824 0.345 . . . . 0.0 110.842 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 40.8 t -41.46 159.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.832 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.505 HD13 ' CD1' ' A' ' 93' ' ' TRP . 64.4 tp -93.29 143.78 25.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.958 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -138.61 121.14 16.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.918 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 60.8 mt -88.68 123.11 68.61 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.627 0.727 . . . . 0.0 111.118 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 158.8 55.7 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.665 2.243 . . . . 0.0 112.388 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -110.76 107.38 16.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.906 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 58.3 t -110.72 136.1 47.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.092 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.499 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 36.2 mm-40 61.35 44.46 9.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.944 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.499 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 14.3 ptp180 46.57 33.55 2.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.873 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.3 ptmm? -155.82 155.47 33.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.926 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.4 tt -57.5 145.57 8.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.158 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.527 ' C ' HD23 ' A' ' 110' ' ' LEU . 4.8 tt -96.14 113.66 25.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.935 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.449 ' N ' HD23 ' A' ' 110' ' ' LEU . 16.9 t70 -79.84 80.72 6.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.617 HD23 ' H ' ' A' ' 112' ' ' LEU . 1.9 pt? -53.13 -42.42 66.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.926 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.478 ' N ' ' HG ' ' A' ' 112' ' ' LEU . 15.0 t80 -41.25 -53.59 3.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.918 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.8 m -61.27 -45.84 92.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.85 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.402 ' O ' HG23 ' A' ' 119' ' ' VAL . 15.6 tp -55.95 -63.76 1.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 73.5 m -50.52 -44.69 56.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.857 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.46 ' HE2' ' CE1' ' A' ' 113' ' ' TYR . 28.7 mmtt -60.44 -66.11 0.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.908 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.485 ' CG2' HG13 ' A' ' 137' ' ' VAL . 21.3 mt -43.72 -28.17 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.133 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 115' ' ' LEU . 43.3 t -77.12 -40.88 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.12 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 67.9 mt -72.3 -41.4 65.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.171 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -62.42 -37.15 84.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.457 ' OE1' HG22 ' A' ' 128' ' ' ILE . 10.5 mt-10 -66.21 -26.96 67.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.905 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 135.08 29.86 0.38 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.461 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.3 -173.37 34.21 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.494 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.525 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 2.6 t80 -86.98 -43.79 12.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.884 0.373 . . . . 0.0 110.914 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -60.97 -37.43 82.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.876 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.8 -68.64 0.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.058 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.704 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.6 pp -52.34 -35.78 20.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.119 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.525 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 54.5 m -64.5 -36.47 84.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.59 -41.39 79.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 132' ' ' ARG . 16.3 m-20 -94.78 20.48 8.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.892 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 131' ' ' ASP . 24.7 ptt85 35.21 48.2 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.839 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -85.72 17.92 3.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.841 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.704 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 41.8 m95 -60.39 -48.85 79.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.938 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -48.42 -47.4 37.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.126 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.42 ' HB3' ' NH1' ' A' ' 136' ' ' ARG . 5.4 mmm180 -61.91 -58.56 7.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.485 HG13 ' CG2' ' A' ' 118' ' ' ILE . 98.5 t -46.75 -31.88 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.61 -58.34 4.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.088 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -52.59 -29.51 26.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 140' ' ' ARG . 5.9 mmm180 -52.82 -39.68 62.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.883 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.64 HD23 ' CZ ' ' A' ' 143' ' ' TYR . 14.8 tp -82.93 17.93 1.77 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.92 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 61.67 43.09 10.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.64 ' CZ ' HD23 ' A' ' 141' ' ' LEU . 3.3 m-85 -83.25 152.37 64.57 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.689 0.757 . . . . 0.0 110.947 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.533 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.8 Cg_endo -69.76 114.13 3.6 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.692 2.261 . . . . 0.0 112.331 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 53.7 Cg_endo -69.76 109.33 2.28 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.679 2.252 . . . . 0.0 112.349 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 154.94 -67.95 0.3 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.49 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -60.93 152.02 28.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.801 0.334 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -68.11 82.55 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.849 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.533 HD11 ' HG2' ' A' ' 144' ' ' PRO . 90.5 mt -92.61 -46.52 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -37.39 -58.3 1.36 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.491 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.8 m -56.71 -48.01 78.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.91 0.386 . . . . 0.0 110.846 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.415 ' C ' HD23 ' A' ' 152' ' ' LEU . 6.7 tt -50.57 -51.34 49.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.9 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 11.1 mt -57.51 -65.96 0.54 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.557 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 23.9 ttp180 -38.45 -55.02 1.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.86 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.428 ' OG ' ' N ' ' A' ' 156' ' ' HIS . 48.1 p -50.41 -64.72 0.72 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.824 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.428 ' N ' ' OG ' ' A' ' 155' ' ' SER . 2.0 m-70 -43.04 -34.06 0.95 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.517 ' CD1' ' HB ' ' A' ' 161' ' ' ILE . 3.1 t80 -69.71 -69.55 0.34 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.476 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 3.3 mp0 -61.24 -10.11 6.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.88 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 10.6 tpp85 -84.59 -53.35 5.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.435 HG22 HD11 ' A' ' 89' ' ' ILE . 74.1 mt -110.48 -39.18 3.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.151 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.517 ' HB ' ' CD1' ' A' ' 157' ' ' TYR . 13.7 mt -77.04 -0.69 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.115 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.543 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -72.02 -60.34 2.38 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.65 0.738 . . . . 0.0 110.882 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.495 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.8 Cg_endo -69.78 -36.69 10.29 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.668 2.245 . . . . 0.0 112.324 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.552 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 15.3 t80 -59.47 -46.32 89.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.975 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -69.03 -60.17 2.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.924 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.443 ' CG ' ' HA ' ' A' ' 163' ' ' PRO . 0.0 OUTLIER -54.15 -39.33 66.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.551 ' CD2' ' CD1' ' A' ' 92' ' ' PHE . 57.5 t80 -60.16 -51.21 70.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.866 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -92.55 48.05 1.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 54.3 p -123.06 118.3 27.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.811 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 176.84 -93.42 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.461 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.793 0.33 . . . . 0.0 111.094 -179.975 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.549 -0.22 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.0 t -119.98 42.24 2.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.905 0.383 . . . . 0.0 110.867 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.6 p -122.92 144.04 49.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.844 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.84 111.83 0.5 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.52 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.1 m -71.54 -61.89 1.61 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.851 0.357 . . . . 0.0 110.914 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.3 t -78.78 -51.61 9.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.837 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.68 -179.96 41.79 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.479 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.584 HG23 ' HB2' ' A' ' 82' ' ' LYS . 24.6 m -102.67 90.43 3.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.748 0.308 . . . . 0.0 111.155 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.3 mmt-85 -113.36 -58.63 2.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 83' ' ' LEU . 67.6 t -76.71 -42.03 33.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.161 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.584 ' HB2' HG23 ' A' ' 79' ' ' THR . 1.1 mptm? -36.34 -31.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.913 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.525 ' HA ' HD12 ' A' ' 86' ' ' LEU . 18.5 mt -76.75 -51.8 10.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 83' ' ' LEU . 44.1 t-20 -38.35 -64.98 0.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.868 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.467 ' HE2' HD12 ' A' ' 112' ' ' LEU . 69.3 t80 -45.4 -39.94 7.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.927 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.756 ' CD2' HD21 ' A' ' 112' ' ' LEU . 35.0 mt -70.15 -63.68 1.04 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.887 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -44.46 -27.21 0.42 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.849 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -78.15 -67.6 0.72 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.93 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.575 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 7.9 tt -45.64 -43.0 3.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.412 ' N ' HG23 ' A' ' 89' ' ' ILE . . . -62.34 -53.42 55.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.079 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -42.07 -41.54 2.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.867 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -68.77 -43.8 74.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.871 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.642 ' CD1' HD13 ' A' ' 100' ' ' LEU . 45.4 m95 -62.27 -64.52 0.9 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 7.7 pt-20 -36.37 -41.38 0.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.858 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.435 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 85.6 mt -65.09 -49.82 77.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.133 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -49.61 -44.56 47.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.39 -49.64 0.61 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.488 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 32.5 t -90.15 130.98 36.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.908 0.385 . . . . 0.0 110.884 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.7 m -65.14 164.51 12.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.862 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.642 HD13 ' CD1' ' A' ' 93' ' ' TRP . 54.8 tp -93.34 154.17 18.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.942 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.7 mmmt -145.09 126.47 14.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.873 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.65 122.67 67.94 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.661 0.743 . . . . 0.0 111.149 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.718 ' HG2' HD13 ' A' ' 110' ' ' LEU . 53.9 Cg_endo -69.77 161.49 45.74 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.709 2.273 . . . . 0.0 112.329 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -117.08 117.66 30.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 72.2 t -121.57 140.26 46.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.143 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 107' ' ' ARG . 2.6 mm-40 56.29 54.99 7.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.43 ' NH1' ' HB3' ' A' ' 107' ' ' ARG . 4.2 ptp180 37.09 39.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -157.42 150.16 23.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.9 tt -54.47 140.03 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.155 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.718 HD13 ' HG2' ' A' ' 103' ' ' PRO . 4.1 tt -86.45 119.13 26.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.511 ' N ' HD23 ' A' ' 110' ' ' LEU . 28.5 t0 -86.76 88.62 7.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.81 HD23 ' H ' ' A' ' 112' ' ' LEU . 1.5 pt? -73.72 -22.38 59.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.455 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 5.6 t80 -59.65 -54.71 43.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 115' ' ' LEU . 58.9 p -61.13 -55.22 34.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.887 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.448 ' C ' ' O ' ' A' ' 114' ' ' SER . 27.3 tp -34.67 -59.28 0.47 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.917 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.8 t -59.99 -55.77 29.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.863 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -43.42 -45.54 6.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.884 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.42 HG21 HG13 ' A' ' 137' ' ' VAL . 27.3 mt -63.44 -45.69 97.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.13 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.9 t -51.33 -56.03 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.135 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 84.1 mt -56.32 -46.58 81.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.123 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -56.46 -56.8 16.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.462 ' HB2' ' CG2' ' A' ' 128' ' ' ILE . 33.2 mm-40 -40.69 -52.85 2.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 155.26 34.16 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.488 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.39 178.58 34.13 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.479 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.574 ' CE2' ' SG ' ' A' ' 129' ' ' CYS . 3.4 t80 -81.7 -55.77 4.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.889 0.376 . . . . 0.0 110.951 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -51.47 -29.64 17.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.905 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.06 -71.21 0.29 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.091 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.747 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.9 pp -50.38 -31.7 8.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.096 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.574 ' SG ' ' CE2' ' A' ' 125' ' ' TYR . 94.3 m -69.5 -44.07 71.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.886 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.1 tttm -64.26 -39.57 94.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 132' ' ' ARG . 80.2 m-20 -91.83 23.31 3.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.453 ' C ' ' O ' ' A' ' 131' ' ' ASP . 83.9 mtm180 34.24 35.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.9 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 131' ' ' ASP . 10.7 mmp_? -60.23 -19.49 54.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.846 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.747 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 24.8 m95 -36.6 -43.44 0.41 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.925 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.42 -56.99 14.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.036 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.419 ' HB2' ' NH1' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -59.91 -43.28 94.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.42 HG13 HG21 ' A' ' 118' ' ' ILE . 69.2 t -54.76 -36.61 37.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.107 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.09 -52.41 24.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.083 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -56.23 -37.24 69.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -51.39 -32.44 26.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.839 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.717 HD23 ' CE2' ' A' ' 143' ' ' TYR . 14.6 tp -83.52 17.48 2.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.931 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 66.65 33.99 6.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.84 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.717 ' CE2' HD23 ' A' ' 141' ' ' LEU . 2.5 m-85 -84.34 157.81 61.5 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.658 0.742 . . . . 0.0 110.947 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.55 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.8 Cg_endo -69.78 110.36 2.54 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.685 2.257 . . . . 0.0 112.364 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.474 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 53.6 Cg_endo -69.74 94.51 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.695 2.264 . . . . 0.0 112.315 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 165.25 -61.46 0.24 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.445 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 61.5 mttt -57.12 152.98 12.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.816 0.341 . . . . 0.0 110.913 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -69.88 75.75 0.46 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.55 HD11 ' HG2' ' A' ' 144' ' ' PRO . 84.7 mt -89.22 -54.94 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.146 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.46 -47.99 1.19 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.455 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.3 m -61.64 -53.3 57.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.905 0.384 . . . . 0.0 110.889 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.5 tt -51.33 -51.56 53.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.927 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.446 ' CD1' HG22 ' A' ' 149' ' ' ILE . 30.4 mt -57.61 -65.79 0.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.943 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.536 ' HG3' ' CE2' ' A' ' 134' ' ' TRP . 1.7 ttm105 -39.93 -38.77 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.844 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 69.6 m -66.6 -57.82 6.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -56.03 -26.2 47.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.866 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.524 ' CD2' HD12 ' A' ' 161' ' ' ILE . 5.0 t80 -78.82 -46.92 17.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.923 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.488 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 2.5 mm-40 -79.97 -10.14 59.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.873 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 44.6 ttt85 -100.85 -35.19 9.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.482 HG22 HD11 ' A' ' 89' ' ' ILE . 62.0 mt -112.54 -50.93 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.108 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.524 HD12 ' CD2' ' A' ' 157' ' ' TYR . 18.9 mt -77.17 0.04 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.152 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.52 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -72.29 -60.46 2.19 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.63 0.728 . . . . 0.0 110.92 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.505 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.8 Cg_endo -69.79 -37.66 8.79 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.654 2.236 . . . . 0.0 112.355 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.575 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 28.7 t80 -60.31 -38.83 84.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -74.45 -58.09 3.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.899 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 16.7 ptt? -51.17 -40.23 58.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -65.11 -59.88 3.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.882 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 48.9 mm-40 -42.96 -39.54 2.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.913 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.1 t -84.13 47.92 1.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -121.68 67.21 0.45 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.519 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.779 0.323 . . . . 0.0 111.108 179.972 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.6 p -124.17 127.53 47.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.901 0.381 . . . . 0.0 110.867 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.4 m -59.07 134.36 56.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.873 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.08 -156.24 32.49 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.494 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 68.9 m -101.5 80.84 2.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.884 0.373 . . . . 0.0 110.878 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.1 t -57.2 159.52 4.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.86 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -127.38 68.92 0.53 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.5 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.64 ' O ' HD12 ' A' ' 83' ' ' LEU . 3.9 p -114.74 36.59 3.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.792 0.33 . . . . 0.0 111.124 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.43 ' NE ' ' HA ' ' A' ' 80' ' ' ARG . 2.7 tpm_? -57.49 -50.23 73.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.88 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 83' ' ' LEU . 58.4 t -75.76 -64.71 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.102 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.561 ' HG2' ' CD2' ' A' ' 113' ' ' TYR . 69.0 mttt -37.47 -28.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.708 ' HA ' HD12 ' A' ' 86' ' ' LEU . 26.7 mt -81.11 -47.02 14.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 81' ' ' VAL . 20.3 t30 -45.25 -52.83 9.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -54.31 -36.61 63.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.948 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.708 HD12 ' HA ' ' A' ' 83' ' ' LEU . 17.8 mt -71.21 -61.02 1.92 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.896 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -52.11 -24.05 6.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.817 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -77.89 -69.96 0.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.531 HD11 HG22 ' A' ' 160' ' ' ILE . 9.0 tt -43.98 -36.11 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.133 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.55 ' HB2' HD22 ' A' ' 100' ' ' LEU . . . -73.8 -44.78 54.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.086 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -54.61 -27.93 42.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.849 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.483 ' CE2' ' HA ' ' A' ' 164' ' ' TYR . 4.4 t80 -85.71 -29.97 23.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.874 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 30.4 m95 -75.42 -59.23 2.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.929 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -42.45 -29.55 0.28 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.885 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 85.9 mt -75.72 -47.61 32.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.166 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -51.91 -42.39 62.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 148.54 -36.49 1.08 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.476 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 40.1 m -101.77 155.9 17.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 110.9 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.5 t -83.27 178.08 8.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.851 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.55 HD22 ' HB2' ' A' ' 90' ' ' ALA . 29.4 tp -93.79 138.58 31.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.871 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -137.55 123.6 20.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.546 HD12 HD22 ' A' ' 112' ' ' LEU . 51.0 mm -96.25 124.24 52.15 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.584 0.706 . . . . 0.0 111.193 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.544 ' HG3' ' CD2' ' A' ' 156' ' ' HIS . 53.9 Cg_endo -69.72 152.05 69.44 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.679 2.252 . . . . 0.0 112.321 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -101.96 111.41 23.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.876 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.3 t -108.79 137.57 40.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.13 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.413 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 57.7 mm-40 50.07 54.22 11.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.413 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 1.2 ptp180 43.61 37.51 1.55 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.822 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -155.32 169.88 23.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.867 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.5 tt -75.05 143.96 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.524 HD23 ' N ' ' A' ' 111' ' ' ASP . 4.6 tt -89.86 119.28 30.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.935 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.524 ' N ' HD23 ' A' ' 110' ' ' LEU . 40.0 t0 -73.32 71.36 1.24 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.596 HD23 ' H ' ' A' ' 112' ' ' LEU . 1.6 pt? -56.24 -21.26 22.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.561 ' CD2' ' HG2' ' A' ' 82' ' ' LYS . 3.3 t80 -71.67 -62.59 1.36 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.929 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 115' ' ' LEU . 4.2 t -50.02 -58.9 4.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.884 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.449 ' C ' ' O ' ' A' ' 114' ' ' SER . 10.0 tp -34.59 -67.48 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.928 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.1 p -48.07 -52.88 18.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -48.36 -52.51 21.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.944 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.605 HG21 HG13 ' A' ' 137' ' ' VAL . 77.7 mt -57.82 -42.15 81.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.111 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.508 HG13 HG12 ' A' ' 128' ' ' ILE . 95.2 t -59.81 -38.45 76.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.135 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 82.3 mt -71.27 -57.92 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.15 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.529 ' CG ' ' N ' ' A' ' 122' ' ' GLU . 8.1 pt-20 -56.57 -49.49 74.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.916 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.529 ' N ' ' CG ' ' A' ' 121' ' ' GLU . 38.0 mm-40 -47.91 -35.05 9.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.905 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.662 ' O ' ' HB3' ' A' ' 127' ' ' ALA . . . 139.1 43.16 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.448 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.79 -179.42 52.58 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.472 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.51 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 1.1 t80 -89.06 -40.12 13.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.853 0.359 . . . . 0.0 110.931 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -60.94 -45.85 93.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.858 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.662 ' HB3' ' O ' ' A' ' 123' ' ' GLY . . . -62.09 -71.35 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.086 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.567 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 2.2 pp -41.96 -36.32 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.145 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.468 ' N ' HD12 ' A' ' 128' ' ' ILE . 22.1 m -65.83 -40.97 92.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 127' ' ' ALA . 12.9 ttmm -68.95 -26.24 64.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 132' ' ' ARG . 4.2 t0 -100.87 19.38 17.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 131' ' ' ASP . 13.3 mmt85 36.11 54.6 0.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' A' ' 134' ' ' TRP . 14.7 mmt180 -81.81 -25.21 35.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.864 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.567 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 24.2 m95 -34.04 -40.06 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.59 -59.86 4.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.113 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.455 ' O ' ' CD ' ' A' ' 140' ' ' ARG . 38.2 mmt180 -62.28 -50.38 71.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.859 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.605 HG13 HG21 ' A' ' 118' ' ' ILE . 89.4 t -43.57 -46.84 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.146 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.87 -47.85 73.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.075 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -55.27 -32.97 62.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.455 ' CD ' ' O ' ' A' ' 136' ' ' ARG . 0.2 OUTLIER -59.81 -32.04 70.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.848 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.458 HD23 ' CZ ' ' A' ' 143' ' ' TYR . 12.8 tp -80.38 13.74 2.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.911 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 9.6 m80 65.0 51.31 1.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.458 ' CZ ' HD23 ' A' ' 141' ' ' LEU . 2.5 m-85 -94.87 156.78 37.7 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.679 0.752 . . . . 0.0 110.94 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.465 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.8 Cg_endo -69.81 122.23 8.89 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.718 2.279 . . . . 0.0 112.328 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 118.34 5.62 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.701 2.267 . . . . 0.0 112.295 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.53 -67.56 0.56 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.476 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.04 135.61 12.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.802 0.334 . . . . 0.0 110.9 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -65.86 75.43 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.465 HD11 ' HG2' ' A' ' 144' ' ' PRO . 89.9 mt -86.93 -51.17 13.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.165 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -37.12 -47.66 1.41 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.492 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.0 t -63.86 -52.39 60.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.923 0.392 . . . . 0.0 110.887 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.424 ' C ' HD23 ' A' ' 152' ' ' LEU . 7.2 tt -47.21 -53.3 13.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.878 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 30.9 mt -56.04 -65.72 0.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.929 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.54 ' NE ' ' CD1' ' A' ' 134' ' ' TRP . 6.4 ttm180 -40.64 -33.2 0.26 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.882 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 36.1 t -71.86 -52.57 16.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.862 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.544 ' CD2' ' HG3' ' A' ' 103' ' ' PRO . 3.6 m-70 -60.46 -31.48 70.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.845 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.492 ' CD1' ' C ' ' A' ' 157' ' ' TYR . 2.3 t80 -79.25 -30.54 43.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.891 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.505 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 1.9 mm-40 -91.06 -9.93 43.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.913 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -107.5 -45.81 3.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.868 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.531 HG22 HD11 ' A' ' 89' ' ' ILE . 59.3 mt -97.07 -53.73 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.142 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.437 ' CG1' ' HA ' ' A' ' 157' ' ' TYR . 20.0 mt -75.17 -6.07 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.13 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.524 ' CD2' ' HD3' ' A' ' 163' ' ' PRO . 0.3 OUTLIER -70.57 -59.79 3.61 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.619 0.723 . . . . 0.0 110.907 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.524 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.9 Cg_endo -69.71 -36.34 11.12 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.699 2.266 . . . . 0.0 112.313 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.483 ' HA ' ' CE2' ' A' ' 92' ' ' PHE . 4.6 t80 -64.77 -35.76 82.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.924 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -75.09 -61.14 1.99 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.914 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.406 ' HG2' ' HA ' ' A' ' 163' ' ' PRO . 20.4 ptt? -47.96 -40.27 21.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.875 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -67.29 -54.32 21.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.863 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.7 48.67 0.47 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.9 t -127.22 -60.3 1.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.85 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 147.26 112.44 0.71 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.478 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 120.759 0.314 . . . . 0.0 111.083 179.985 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.8 m -145.62 122.44 11.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.922 0.391 . . . . 0.0 110.816 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.4 t -93.86 118.85 32.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.858 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.65 80.5 1.25 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.475 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.7 m -40.76 -59.12 1.48 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.851 0.358 . . . . 0.0 110.859 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 61.3 p -57.07 104.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.838 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -113.6 84.16 0.35 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.521 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.0 t -114.77 38.49 3.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.792 0.329 . . . . 0.0 111.123 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 39.2 mmm-85 -77.35 -59.1 2.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.842 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 91.9 t -76.74 -39.78 31.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.12 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.519 ' HA ' ' CD1' ' A' ' 113' ' ' TYR . 27.6 ttmt -41.19 -29.45 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.6 mt -89.35 -47.08 8.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.936 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -46.59 -45.08 18.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.917 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.648 ' O ' HG22 ' A' ' 89' ' ' ILE . 89.4 t80 -46.94 -31.32 3.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.897 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.809 HD21 HD21 ' A' ' 112' ' ' LEU . 29.2 mt -80.72 -33.57 35.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.932 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.01 -39.1 66.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -73.56 -37.67 65.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.919 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.648 HG22 ' O ' ' A' ' 85' ' ' TYR . 7.2 tt -78.6 -29.93 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.143 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.63 -43.31 56.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.13 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -51.27 -25.68 6.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.908 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -86.33 -41.26 14.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.455 ' CD1' HD13 ' A' ' 100' ' ' LEU . 55.6 m95 -70.7 -56.58 6.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 4.2 pt-20 -42.66 -29.55 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.883 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.437 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 96.8 mt -77.54 -48.98 23.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.164 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -48.87 -42.27 36.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.14 -37.44 1.5 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.476 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.2 m -101.77 112.15 24.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.858 0.361 . . . . 0.0 110.895 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 58.8 m -54.28 162.08 1.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.82 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.555 HD22 HG23 ' A' ' 89' ' ' ILE . 27.9 tp -74.01 135.32 43.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.924 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -135.48 128.96 32.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 102' ' ' ILE . 4.6 mp -94.95 121.16 63.25 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.619 0.723 . . . . 0.0 111.108 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.493 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 53.5 Cg_endo -69.78 161.82 44.44 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.66 2.24 . . . . 0.0 112.359 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -107.43 121.02 43.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.85 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.546 ' CG2' HD12 ' A' ' 110' ' ' LEU . 67.7 t -124.79 134.51 66.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.117 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.491 ' HG2' HG12 ' A' ' 105' ' ' VAL . 27.4 mm-40 61.01 52.3 4.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.849 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 42.4 37.93 1.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.619 ' HD3' HG22 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -159.55 153.1 22.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.619 HG22 ' HD3' ' A' ' 108' ' ' LYS . 7.8 tt -60.06 142.9 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.142 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.805 HD23 ' N ' ' A' ' 111' ' ' ASP . 6.2 tt -95.98 139.23 32.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.805 ' N ' HD23 ' A' ' 110' ' ' LEU . 23.6 t0 -97.58 108.54 21.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.86 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.809 HD21 HD21 ' A' ' 86' ' ' LEU . 0.9 OUTLIER -83.24 -24.89 32.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.566 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 5.7 t80 -63.26 -56.26 18.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.953 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 115' ' ' LEU . 32.0 p -59.4 -61.03 2.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.834 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 114' ' ' SER . 22.2 tp -35.04 -68.88 0.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.914 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.8 t -51.24 -52.73 42.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.835 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.1 mmtt -46.79 -63.7 0.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.933 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.658 HG21 HG13 ' A' ' 137' ' ' VAL . 62.1 mt -43.09 -53.54 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.137 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 43.1 t -49.47 -57.47 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.122 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 76.3 mt -46.1 -52.18 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.118 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -57.73 -58.93 6.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.891 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.613 ' HB3' HG22 ' A' ' 128' ' ' ILE . 29.1 mm-40 -35.01 -54.66 0.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 152.93 33.8 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.467 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.02 -178.71 33.49 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.445 ' CE2' ' SG ' ' A' ' 129' ' ' CYS . 4.8 t80 -85.0 -43.8 13.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.845 0.355 . . . . 0.0 110.908 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -62.05 -36.23 81.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.924 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.49 -68.91 0.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.149 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.613 HG22 ' HB3' ' A' ' 122' ' ' GLU . 2.2 pp -50.01 -36.23 11.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.164 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.47 ' N ' HD12 ' A' ' 128' ' ' ILE . 49.1 m -66.33 -41.0 90.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -66.45 -44.48 82.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.92 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 132' ' ' ARG . 1.2 m-20 -85.02 22.61 1.37 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.449 ' C ' ' O ' ' A' ' 131' ' ' ASP . 57.8 mtt-85 34.63 43.93 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.88 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' A' ' 134' ' ' TRP . 20.4 mtp85 -71.5 -22.45 61.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.541 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 12.2 m95 -34.33 -42.29 0.13 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.927 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.6 -54.19 49.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.112 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 5.0 tpp85 -66.21 -42.54 88.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.658 HG13 HG21 ' A' ' 118' ' ' ILE . 84.3 t -59.41 -28.22 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -78.37 -48.69 15.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.116 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -60.06 -28.63 67.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -56.53 -38.85 72.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.537 HD23 ' CE2' ' A' ' 143' ' ' TYR . 13.8 tp -83.81 21.31 1.3 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.927 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 3.5 m80 58.12 51.8 8.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.872 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.537 ' CE2' HD23 ' A' ' 141' ' ' LEU . 2.5 m-85 -96.73 159.1 32.42 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.667 0.746 . . . . 0.0 110.915 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.595 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.9 Cg_endo -69.69 111.74 2.88 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.673 2.249 . . . . 0.0 112.375 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 53.7 Cg_endo -69.8 117.13 4.9 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.69 2.26 . . . . 0.0 112.328 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 136.6 -59.64 0.63 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.477 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -55.38 159.55 2.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.761 0.315 . . . . 0.0 110.907 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -78.06 79.13 4.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.595 HD11 ' HG2' ' A' ' 144' ' ' PRO . 78.3 mt -95.07 -55.47 6.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.09 -44.91 0.82 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.464 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.3 t -65.92 -52.18 52.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.898 0.38 . . . . 0.0 110.861 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.442 ' C ' HD23 ' A' ' 152' ' ' LEU . 6.7 tt -50.02 -49.37 51.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.921 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 25.7 mt -57.06 -64.79 0.76 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.541 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 11.8 ttt180 -40.47 -36.21 0.54 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 25.2 m -68.89 -62.08 1.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.805 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.493 ' CE1' ' HG3' ' A' ' 103' ' ' PRO . 2.5 m-70 -47.49 -34.06 6.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.848 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.432 ' CD2' HD12 ' A' ' 161' ' ' ILE . 3.9 t80 -70.22 -53.16 18.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.911 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 29.3 mm-40 -74.23 -9.47 58.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.877 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -96.15 -42.94 7.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.858 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 89.2 mt -110.4 -47.31 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.15 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.517 ' O ' HG22 ' A' ' 161' ' ' ILE . 21.4 mt -76.88 1.08 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.089 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.602 ' CE1' ' SD ' ' A' ' 166' ' ' MET . 0.2 OUTLIER -73.52 -60.75 1.57 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.674 0.75 . . . . 0.0 110.879 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.566 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.6 Cg_endo -69.78 -41.76 3.96 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.663 2.242 . . . . 0.0 112.348 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.432 ' CE1' ' HA ' ' A' ' 89' ' ' ILE . 11.4 t80 -53.79 -35.25 61.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.922 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.405 ' HG3' HG22 ' A' ' 161' ' ' ILE . 11.4 mt-10 -78.81 -62.47 1.68 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.875 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.602 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 5.3 ptt? -48.46 -42.76 33.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -68.02 -56.06 10.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.872 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -91.02 41.5 1.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.897 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 48.1 t -86.16 79.16 9.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.858 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 45.24 93.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.453 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.75 0.31 . . . . 0.0 111.081 179.972 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.526 -0.23 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.0 m -112.16 93.85 4.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.883 0.373 . . . . 0.0 110.806 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 26.9 t -102.54 136.8 41.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.845 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.83 -173.81 30.94 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.475 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.8 t -163.17 174.72 11.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.9 0.381 . . . . 0.0 110.851 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.3 p -94.49 40.57 1.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.86 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -130.88 -53.83 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.48 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.6 m -43.5 105.89 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.778 0.323 . . . . 0.0 111.148 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.6 tpt85 -127.19 -69.25 0.76 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.426 ' O ' ' N ' ' A' ' 84' ' ' ASN . 58.5 t -72.62 -39.27 60.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.129 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -39.03 -30.7 0.05 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.895 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.449 ' HA ' HD12 ' A' ' 86' ' ' LEU . 51.1 mt -74.07 -46.65 41.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 81' ' ' VAL . 63.7 t-20 -40.14 -55.41 2.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.867 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -55.22 -47.73 74.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.942 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 83' ' ' LEU . 65.8 mt -56.18 -63.71 1.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.951 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -46.45 -38.45 9.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.856 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -61.5 -62.15 2.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.947 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.713 HD12 ' CD2' ' A' ' 164' ' ' TYR . 14.8 tt -61.11 -27.46 41.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.126 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.18 -46.67 49.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.087 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.7 tttp -54.54 -22.63 13.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -85.24 -49.1 8.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.491 ' CD1' HD13 ' A' ' 100' ' ' LEU . 56.6 m95 -62.53 -56.54 17.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -40.91 -35.32 0.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 90.1 mt -71.98 -51.26 32.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.135 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -48.44 -39.55 23.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.956 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.31 -47.3 0.91 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.526 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.9 t -85.22 151.9 23.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.888 0.375 . . . . 0.0 110.847 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 55.7 p -81.24 172.46 13.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.88 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.528 HD22 HG23 ' A' ' 89' ' ' ILE . 29.1 tp -96.95 116.98 30.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.935 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.76 147.03 30.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.571 HD12 HD22 ' A' ' 112' ' ' LEU . 45.0 mm -119.79 121.84 29.51 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.578 0.704 . . . . 0.0 111.117 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.438 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 54.2 Cg_endo -69.72 163.66 37.41 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.69 2.26 . . . . 0.0 112.361 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -107.9 128.15 54.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.434 HG21 HD12 ' A' ' 110' ' ' LEU . 65.3 t -132.44 135.32 57.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.108 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 56.06 54.26 8.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 40.97 38.84 0.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.9 ttpp -162.63 152.78 16.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.9 tt -57.69 152.0 3.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.123 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.538 HD23 ' N ' ' A' ' 111' ' ' ASP . 5.9 tt -95.11 127.28 41.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.538 ' N ' HD23 ' A' ' 110' ' ' LEU . 8.2 t70 -86.57 69.99 10.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.821 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.595 HD23 ' H ' ' A' ' 112' ' ' LEU . 1.8 pt? -47.96 -22.56 0.61 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -68.45 -44.25 75.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.4 t -71.23 -51.11 26.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.873 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.4 tp -47.07 -54.89 9.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.9 t -60.52 -58.85 6.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.83 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.1 mmtt -43.92 -54.74 5.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.901 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.871 ' CG2' HG13 ' A' ' 137' ' ' VAL . 29.6 mt -51.5 -67.49 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.412 HG13 HG12 ' A' ' 128' ' ' ILE . 50.6 t -37.73 -48.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.162 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 74.6 mt -64.91 -39.74 86.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.108 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 118' ' ' ILE . 5.5 mm-40 -59.11 -50.91 72.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.452 ' CD ' HG22 ' A' ' 137' ' ' VAL . 28.3 mt-10 -51.84 -42.6 62.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.912 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 150.64 35.27 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.512 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.02 -175.13 34.86 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.496 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.422 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 1.9 t80 -88.83 -41.03 12.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.855 0.359 . . . . 0.0 110.915 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -66.13 -37.53 85.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.898 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.5 -61.56 2.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.128 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.641 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.7 pp -58.44 -35.41 54.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.598 ' N ' HD12 ' A' ' 128' ' ' ILE . 22.1 m -65.1 -38.03 89.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.859 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -68.46 -39.45 81.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.45 ' O ' ' C ' ' A' ' 132' ' ' ARG . 0.7 OUTLIER -93.39 22.03 5.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.843 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 131' ' ' ASP . 25.1 mtp85 34.45 46.74 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.889 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.435 ' O ' HG23 ' A' ' 137' ' ' VAL . 58.8 mtp180 -87.33 18.72 3.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.641 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 27.5 m95 -63.9 -47.65 79.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.913 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.55 -41.7 61.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.092 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -68.24 -63.11 1.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.854 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.871 HG13 ' CG2' ' A' ' 118' ' ' ILE . 86.4 t -41.17 -38.12 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.115 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.02 -53.93 22.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -51.22 -33.44 27.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.473 ' HA ' ' CZ ' ' A' ' 140' ' ' ARG . 1.7 mmp_? -52.72 -35.7 56.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.594 HD23 ' CE2' ' A' ' 143' ' ' TYR . 14.9 tp -84.73 23.32 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 62.91 28.0 16.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.817 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.594 ' CE2' HD23 ' A' ' 141' ' ' LEU . 3.4 m-85 -75.89 147.77 81.14 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.653 0.739 . . . . 0.0 110.914 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.469 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.6 Cg_endo -69.72 115.72 4.22 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.706 2.271 . . . . 0.0 112.343 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 53.0 Cg_endo -69.79 89.18 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.69 2.26 . . . . 0.0 112.323 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 177.13 -80.03 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.474 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 32.0 mttp -45.38 166.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.817 0.341 . . . . 0.0 110.89 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.79 80.8 3.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.469 HD11 ' HG2' ' A' ' 144' ' ' PRO . 76.9 mt -91.6 -57.41 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.21 -50.1 1.23 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.503 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.3 t -61.11 -55.18 35.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.871 0.367 . . . . 0.0 110.839 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.409 ' C ' HD23 ' A' ' 152' ' ' LEU . 6.4 tt -46.92 -52.02 15.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.878 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.462 HD11 HG22 ' A' ' 149' ' ' ILE . 15.1 mt -54.52 -65.94 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.954 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.478 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 11.2 ttp180 -38.75 -47.75 1.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.864 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.6 t -57.87 -66.11 0.53 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.844 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.438 ' CE1' ' HG3' ' A' ' 103' ' ' PRO . 2.0 m-70 -42.9 -39.97 2.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.907 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.41 ' CD1' ' C ' ' A' ' 157' ' ' TYR . 4.6 t80 -63.81 -55.07 25.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 43.6 mt-10 -72.23 -9.97 59.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.898 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -88.87 -48.17 7.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.867 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 77.3 mt -112.56 -43.66 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.514 ' O ' HG22 ' A' ' 161' ' ' ILE . 11.0 mt -77.02 5.08 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.128 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.635 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -74.4 -62.22 1.03 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.673 0.749 . . . . 0.0 110.895 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.518 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.3 Cg_endo -69.76 -35.66 12.22 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.689 2.259 . . . . 0.0 112.336 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.713 ' CD2' HD12 ' A' ' 89' ' ' ILE . 11.0 t80 -60.87 -38.32 85.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -79.94 -65.02 1.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.858 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.455 ' SD ' ' N ' ' A' ' 167' ' ' PHE . 0.0 OUTLIER -40.64 -39.42 1.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.862 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.455 ' N ' ' SD ' ' A' ' 166' ' ' MET . 2.4 t80 -74.73 -56.13 5.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.85 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 63.0 mm-40 -87.59 38.72 0.84 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.919 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 32.9 t -98.36 -57.5 2.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.841 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -109.21 -67.66 0.59 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.533 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.792 0.329 . . . . 0.0 111.105 179.954 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.2 m -46.52 -46.34 19.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 0.0 110.868 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 60.7 p -141.79 115.09 8.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.35 -54.11 0.78 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.508 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.8 t -82.82 132.86 35.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.872 0.368 . . . . 0.0 110.888 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.0 t 58.76 42.8 19.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.873 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -113.4 -62.29 0.43 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.505 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 43.0 m -106.11 94.8 5.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.789 0.328 . . . . 0.0 111.124 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -123.47 -57.52 1.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 57.3 t -84.19 -35.23 10.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.17 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.466 ' HG3' ' CD2' ' A' ' 113' ' ' TYR . 10.2 mptt -45.22 -26.83 0.54 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.413 ' O ' ' N ' ' A' ' 86' ' ' LEU . 61.3 mt -80.24 -53.05 7.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -39.19 -61.09 0.81 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.693 ' HE2' HD12 ' A' ' 112' ' ' LEU . 69.5 t80 -46.38 -33.26 3.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.955 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.446 ' HA ' HG22 ' A' ' 89' ' ' ILE . 36.5 mt -81.13 -39.32 25.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.924 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -64.09 -39.42 94.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.407 ' O ' ' NE2' ' A' ' 168' ' ' GLN . 41.9 mm-40 -72.96 -55.71 6.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.88 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 85' ' ' TYR . 12.3 tt -55.46 -47.65 78.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.117 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.853 ' HB2' HD22 ' A' ' 100' ' ' LEU . . . -59.16 -47.96 83.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.14 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.404 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 21.5 ttmt -44.54 -37.83 3.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.957 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.665 ' CD1' ' CG ' ' A' ' 167' ' ' PHE . 3.2 t80 -71.89 -51.63 21.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.452 ' O ' ' C ' ' A' ' 94' ' ' GLU . 80.5 m95 -61.59 -62.36 1.87 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 93' ' ' TRP . 8.9 pt-20 -34.48 -37.97 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.444 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 52.1 mt -72.4 -49.48 41.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.13 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 93' ' ' TRP . 73.2 mm-40 -45.0 -46.21 11.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.889 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.21 -36.87 1.35 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.49 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.6 m -96.39 109.55 22.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.91 0.386 . . . . 0.0 110.888 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.7 m -47.18 158.69 0.14 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.854 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.853 HD22 ' HB2' ' A' ' 90' ' ' ALA . 15.4 tp -75.41 126.82 31.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.91 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -129.83 110.61 11.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.1 mt -77.17 123.88 87.17 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.628 0.728 . . . . 0.0 111.165 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 147.17 62.5 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.696 2.264 . . . . 0.0 112.359 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -100.36 111.05 23.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.935 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.674 HG12 ' HG2' ' A' ' 106' ' ' GLU . 87.1 t -119.82 136.55 56.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.115 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.674 ' HG2' HG12 ' A' ' 105' ' ' VAL . 46.6 mm-40 62.9 49.15 3.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.903 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 42.61 38.39 1.27 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.84 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.2 tttp -166.92 152.95 8.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.6 tt -50.4 150.01 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.124 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.555 ' C ' HD23 ' A' ' 110' ' ' LEU . 4.5 tt -92.96 112.06 23.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.442 ' N ' HD23 ' A' ' 110' ' ' LEU . 19.8 t0 -69.05 75.11 0.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.756 HD23 ' H ' ' A' ' 112' ' ' LEU . 0.9 OUTLIER -68.79 -36.65 78.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.466 ' CD2' ' HG3' ' A' ' 82' ' ' LYS . 2.2 t80 -53.61 -59.93 3.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.963 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.457 ' O ' ' C ' ' A' ' 115' ' ' LEU . 4.8 t -59.07 -59.21 5.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.867 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' A' ' 114' ' ' SER . 9.0 tp -32.89 -58.7 0.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.924 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.6 t -57.12 -54.64 44.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.824 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -43.48 -48.25 7.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.888 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 53.2 mt -61.98 -48.3 89.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.127 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.503 HG13 HG12 ' A' ' 128' ' ' ILE . 55.4 t -50.8 -63.0 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.108 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 61.7 mt -52.11 -53.33 18.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.141 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -46.69 -51.11 16.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.893 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.449 ' OE2' HG22 ' A' ' 137' ' ' VAL . 40.6 mt-10 -50.92 -49.27 59.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.86 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 127' ' ' ALA . . . 154.49 40.94 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.467 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.55 -177.93 42.47 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.448 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -88.95 -45.68 9.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.847 0.356 . . . . 0.0 110.94 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -59.51 -36.49 76.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.876 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 123' ' ' GLY . . . -67.75 -71.26 0.21 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.096 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.503 HG12 HG13 ' A' ' 119' ' ' VAL . 2.1 pp -44.76 -34.53 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.123 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.409 ' N ' HD12 ' A' ' 128' ' ' ILE . 64.8 m -69.37 -39.57 77.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -63.89 -39.66 94.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 132' ' ' ARG . 28.1 m-20 -92.1 29.76 1.56 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.877 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.465 ' C ' ' O ' ' A' ' 131' ' ' ASP . 3.0 mpt_? 33.48 40.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.462 ' O ' ' C ' ' A' ' 134' ' ' TRP . 22.5 mmt180 -65.29 -26.99 68.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.482 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 28.4 m95 -33.22 -44.19 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.913 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.82 -61.71 2.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.107 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -58.98 -45.09 91.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.449 HG22 ' OE2' ' A' ' 122' ' ' GLU . 92.6 t -54.03 -39.73 42.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.153 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.2 -52.88 52.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -58.88 -35.99 73.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.933 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.2 mmp_? -69.53 -28.04 65.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.868 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.945 HD13 ' O ' ' A' ' 141' ' ' LEU . 1.5 tm? -78.46 10.23 3.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.913 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 62.99 38.42 11.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.904 ' CE2' HD12 ' A' ' 141' ' ' LEU . 9.6 m-85 -89.72 158.61 44.92 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.702 0.763 . . . . 0.0 110.937 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.786 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.8 Cg_endo -69.78 113.76 3.48 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.65 2.234 . . . . 0.0 112.359 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.72 132.47 23.46 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.731 2.287 . . . . 0.0 112.34 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.61 -66.58 0.57 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.511 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -70.46 140.64 51.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.785 0.326 . . . . 0.0 110.934 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -64.58 76.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.786 HD11 ' HG2' ' A' ' 144' ' ' PRO . 97.0 mt -80.45 -39.85 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.165 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -35.98 -51.35 1.19 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.459 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.5 t -56.94 -54.86 41.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.886 0.374 . . . . 0.0 110.892 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.4 tt -45.58 -51.17 12.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.948 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' A' ' 154' ' ' ARG . 18.9 mt -53.99 -66.09 0.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.937 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.482 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 15.0 ttt180 -37.35 -41.56 0.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.1 m -65.04 -68.74 0.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.824 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 6.2 m170 -43.12 -36.95 1.84 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.889 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.692 ' CD2' HD12 ' A' ' 161' ' ' ILE . 3.0 t80 -71.82 -43.88 64.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.933 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.402 ' O ' ' HB3' ' A' ' 162' ' ' TYR . 7.5 mt-10 -79.87 -8.68 59.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.876 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 9.0 tpt85 -106.43 -30.3 9.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.465 HG22 HD11 ' A' ' 89' ' ' ILE . 70.7 mt -112.83 -59.0 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.107 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.692 HD12 ' CD2' ' A' ' 157' ' ' TYR . 66.3 mt -67.01 -11.95 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.119 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.593 ' CE1' ' SD ' ' A' ' 166' ' ' MET . 0.1 OUTLIER -74.21 -61.58 1.2 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.656 0.741 . . . . 0.0 110.934 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.55 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 54.0 Cg_endo -69.7 -27.82 26.27 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.714 2.276 . . . . 0.0 112.345 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.572 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 3.8 t80 -68.11 -41.91 81.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -72.84 -60.33 2.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.897 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.593 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 6.7 ptt? -47.08 -43.2 20.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.665 ' CG ' ' CD1' ' A' ' 92' ' ' PHE . 61.0 t80 -66.05 -44.78 83.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.407 ' NE2' ' O ' ' A' ' 88' ' ' GLN . 52.2 mt-30 -98.52 38.08 1.4 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.889 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.8 t -75.66 -55.47 5.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 141.6 -55.42 0.6 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.511 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.815 0.34 . . . . 0.0 111.089 179.973 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.1 p -94.52 82.36 4.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.879 0.371 . . . . 0.0 110.852 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.0 m -65.92 162.97 18.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.884 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.55 148.8 24.62 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.484 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 72.0 m -48.31 125.37 9.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.875 0.369 . . . . 0.0 110.836 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.4 t -163.85 128.02 2.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.873 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.4 126.08 1.18 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.444 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 25.7 m -62.57 96.17 0.08 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.772 0.32 . . . . 0.0 111.147 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -124.51 -49.12 1.79 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 84' ' ' ASN . 87.6 t -81.41 -39.71 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 81' ' ' VAL . 28.0 tttm -36.87 -32.96 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.906 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.436 ' HA ' HD12 ' A' ' 86' ' ' LEU . 11.2 mt -91.23 -35.68 14.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.884 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 81' ' ' VAL . 43.0 t-20 -51.03 -29.29 12.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.879 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.534 ' O ' HG22 ' A' ' 89' ' ' ILE . 86.8 t80 -78.8 -25.54 44.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.681 HD21 HD21 ' A' ' 112' ' ' LEU . 37.9 mt -79.95 -36.08 36.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.942 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -78.78 -47.55 16.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.835 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.428 ' CG ' ' N ' ' A' ' 89' ' ' ILE . 2.2 pt20 -54.72 -45.82 74.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.644 HG23 HD22 ' A' ' 100' ' ' LEU . 15.7 tt -72.84 -32.04 38.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.139 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 93' ' ' TRP . . . -67.48 -57.1 7.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.095 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.8 tptm -40.94 -31.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -78.45 -43.05 28.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.404 ' N ' ' O ' ' A' ' 90' ' ' ALA . 41.3 m95 -68.23 -55.17 13.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.911 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -43.52 -35.12 1.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.929 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.3 mt -73.03 -51.49 26.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.143 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.9 mm100 -42.45 -47.57 5.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 136.88 30.63 0.27 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.483 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.8 m -161.05 161.78 31.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.893 0.378 . . . . 0.0 110.864 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.2 m -89.52 155.95 18.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.829 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.644 HD22 HG23 ' A' ' 89' ' ' ILE . 16.9 tp -91.57 103.89 16.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.909 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.8 pttt -97.48 152.59 18.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.909 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 18.7 mt -115.62 123.87 30.75 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.604 0.716 . . . . 0.0 111.155 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 148.07 64.3 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.687 2.258 . . . . 0.0 112.36 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -99.73 121.07 40.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.3 t -118.26 147.36 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.136 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.452 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 65.4 mm-40 39.8 53.21 2.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.863 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.452 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 11.8 ptm180 45.8 38.47 4.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.3 tptp -160.91 151.11 17.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.8 tt -56.75 145.36 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.113 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.773 HD23 ' N ' ' A' ' 111' ' ' ASP . 4.9 tt -90.72 129.49 36.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.773 ' N ' HD23 ' A' ' 110' ' ' LEU . 26.3 t0 -79.42 66.82 4.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.681 HD21 HD21 ' A' ' 86' ' ' LEU . 1.8 pt? -54.02 -23.02 11.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.505 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 3.9 t80 -72.4 -58.63 3.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.4 t -55.78 -41.46 74.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.864 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.606 ' O ' HG23 ' A' ' 119' ' ' VAL . 27.4 tp -52.71 -55.8 20.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.915 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 18.0 p -60.26 -42.9 96.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -58.33 -61.2 2.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.878 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 64.9 mt -49.62 -36.36 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.176 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 115' ' ' LEU . 73.2 t -71.27 -48.43 54.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.175 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 85.5 mt -62.4 -37.17 78.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.074 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -72.84 -54.79 7.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.913 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -38.95 -53.87 1.71 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.892 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 158.28 34.79 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.501 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.15 179.12 37.2 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.449 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.488 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 9.3 t80 -82.52 -39.98 21.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.826 0.346 . . . . 0.0 110.899 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -66.11 -43.03 88.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.92 -61.71 2.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.142 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.559 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.7 pp -60.09 -33.67 54.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.116 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.488 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 22.1 m -70.41 -28.42 65.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -81.05 -36.48 30.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.439 ' O ' ' C ' ' A' ' 132' ' ' ARG . 0.5 OUTLIER -91.15 21.04 4.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 131' ' ' ASP . 8.7 mmm180 35.53 50.76 0.6 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.88 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.425 ' O ' ' C ' ' A' ' 134' ' ' TRP . 4.3 mmp_? -80.03 -19.49 47.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.9 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.559 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 28.2 m95 -36.34 -41.64 0.29 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.19 -55.32 34.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.092 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -66.82 -41.35 87.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 82.7 t -51.16 -43.58 27.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.078 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.451 ' HB2' HD11 ' A' ' 153' ' ' LEU . . . -70.64 -53.5 15.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.069 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -56.04 -22.44 27.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -68.74 -32.03 71.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.432 HD23 ' CE2' ' A' ' 143' ' ' TYR . 10.2 tp -89.84 25.57 2.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 61.55 51.17 4.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.815 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.432 ' CE2' HD23 ' A' ' 141' ' ' LEU . 3.7 m-85 -103.7 150.65 38.35 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.698 0.761 . . . . 0.0 110.886 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.577 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.9 Cg_endo -69.78 113.48 3.39 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.677 2.252 . . . . 0.0 112.319 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 99.99 0.79 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.671 2.248 . . . . 0.0 112.333 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 161.96 -70.27 0.22 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.493 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -51.99 151.45 3.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.816 0.341 . . . . 0.0 110.915 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.406 ' O ' ' CG ' ' A' ' 148' ' ' ASN . 15.5 p-10 -65.0 75.51 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.577 HD11 ' HG2' ' A' ' 144' ' ' PRO . 75.5 mt -92.44 -54.06 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.17 -52.05 1.26 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.445 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 8.7 t -58.44 -56.94 15.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.927 0.394 . . . . 0.0 110.85 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.6 tt -42.05 -49.39 4.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.926 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.451 HD11 ' HB2' ' A' ' 138' ' ' ALA . 15.5 mt -58.94 -65.97 0.58 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.495 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 15.5 ttp180 -38.82 -45.39 1.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.818 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 41.0 m -60.19 -62.75 1.63 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.842 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -47.27 -27.1 1.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.855 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.864 ' CD2' HD12 ' A' ' 161' ' ' ILE . 7.7 t80 -83.65 -31.26 26.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.49 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 11.4 mt-10 -91.04 -10.16 43.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 14.8 tpt85 -105.02 -30.7 9.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.858 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 42.0 mt -112.12 -54.38 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.864 HD12 ' CD2' ' A' ' 157' ' ' TYR . 15.5 mt -77.07 -0.8 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.101 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.536 ' CD2' ' HD3' ' A' ' 163' ' ' PRO . 0.2 OUTLIER -71.9 -60.31 2.46 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.643 0.735 . . . . 0.0 110.905 -179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.536 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.5 Cg_endo -69.79 -34.96 13.43 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.708 2.272 . . . . 0.0 112.294 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.479 ' CE1' ' HA ' ' A' ' 89' ' ' ILE . 55.2 t80 -62.36 -44.09 97.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.911 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -68.72 -55.45 11.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.41 ' HG3' ' HA ' ' A' ' 163' ' ' PRO . 0.0 OUTLIER -60.44 -35.07 74.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.899 179.93 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.463 ' CB ' ' O ' ' A' ' 163' ' ' PRO . 40.7 t80 -71.41 -58.03 3.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.914 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -53.38 -47.97 69.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.912 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 16.3 t -62.04 -57.49 11.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.839 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.17 44.95 1.65 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.481 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.765 0.317 . . . . 0.0 111.068 179.984 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 95.5 p 39.22 42.1 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.898 0.38 . . . . 0.0 110.853 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.6 t -103.92 148.01 26.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.862 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.19 -152.67 11.85 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.451 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.9 m 42.45 41.52 2.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.878 0.37 . . . . 0.0 110.885 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.3 t -128.68 137.73 51.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.828 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -142.53 -169.14 12.09 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.495 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.7 p -73.8 98.33 2.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.816 0.341 . . . . 0.0 111.149 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -115.06 -56.87 2.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.841 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 99.0 t -88.77 -39.91 12.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.113 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -42.64 -26.95 0.14 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.877 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 86' ' ' LEU . 19.2 mt -91.21 -47.02 7.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.494 ' O ' ' CG ' ' A' ' 88' ' ' GLN . 50.8 t30 -42.89 -36.91 1.66 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.639 ' CE2' HD12 ' A' ' 112' ' ' LEU . 59.5 t80 -71.28 -33.89 70.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.938 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.619 HD23 HD11 ' A' ' 112' ' ' LEU . 61.2 mt -80.94 -59.11 2.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.891 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -52.63 -25.85 11.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.845 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.494 ' CG ' ' O ' ' A' ' 84' ' ' ASN . 11.2 mm100 -77.42 -67.32 0.73 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.794 HD11 HG22 ' A' ' 160' ' ' ILE . 10.0 tt -47.5 -35.59 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.17 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.74 -47.75 68.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.093 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -53.09 -26.2 15.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.593 ' CD1' ' CD2' ' A' ' 167' ' ' PHE . 0.8 OUTLIER -81.27 -50.83 9.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.545 ' CD1' HD13 ' A' ' 100' ' ' LEU . 81.3 m95 -64.51 -55.98 17.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.95 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -41.02 -29.77 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.913 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.5 mt -78.3 -49.33 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.171 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 88.6 mm-40 -50.21 -44.73 53.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 142.11 -46.94 0.85 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.453 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.6 m -83.22 108.85 16.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.887 0.375 . . . . 0.0 110.874 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.6 m -50.69 162.35 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.545 HD13 ' CD1' ' A' ' 93' ' ' TRP . 40.4 tp -86.82 100.47 12.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.91 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -102.41 106.2 16.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.507 HD12 HD22 ' A' ' 112' ' ' LEU . 44.0 mm -69.16 124.86 91.32 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.579 0.704 . . . . 0.0 111.134 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 151.29 69.03 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.725 2.283 . . . . 0.0 112.334 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -101.12 110.93 23.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.843 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.8 t -119.19 137.9 51.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.143 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 107' ' ' ARG . 49.4 mm-40 58.9 55.02 4.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 106' ' ' GLU . 6.6 ptp85 35.53 43.05 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.857 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -168.14 150.71 5.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.874 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.1 tt -57.69 144.42 10.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.143 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 1.025 HD23 ' N ' ' A' ' 111' ' ' ASP . 6.2 tt -93.12 151.0 20.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 1.025 ' N ' HD23 ' A' ' 110' ' ' LEU . 11.9 t0 -107.81 121.7 45.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.835 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.639 HD12 ' CE2' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -98.3 -28.12 13.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.92 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -67.19 -61.56 1.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.903 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 115' ' ' LEU . 23.3 m -51.64 -58.76 5.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 114' ' ' SER . 17.3 tp -38.0 -63.09 0.5 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.907 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.9 t -50.28 -53.1 30.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.837 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -51.22 -43.73 61.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 58.6 mt -62.33 -48.68 87.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.1 t -58.41 -58.91 4.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.159 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 82.4 mt -49.4 -45.58 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.124 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 122' ' ' GLU . 38.5 mt-10 -62.92 -58.36 7.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.865 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.502 ' OE2' HG22 ' A' ' 137' ' ' VAL . 42.7 mt-10 -37.73 -54.27 1.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.855 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 157.85 37.25 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.52 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.98 -173.55 39.75 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.472 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.583 ' CE2' ' SG ' ' A' ' 129' ' ' CYS . 7.7 t80 -88.84 -56.63 3.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.806 0.336 . . . . 0.0 110.884 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -51.14 -34.73 32.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.886 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.38 -71.36 0.21 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.122 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.54 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.8 pp -51.5 -32.04 12.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.583 ' SG ' ' CE2' ' A' ' 125' ' ' TYR . 99.3 m -69.63 -36.47 76.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.885 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -71.12 -43.28 67.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' A' ' 132' ' ' ARG . 0.9 OUTLIER -85.61 23.57 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 131' ' ' ASP . 59.1 mtt180 34.23 38.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.833 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' A' ' 134' ' ' TRP . 21.1 mmm180 -66.08 -19.14 65.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.54 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 29.5 m95 -35.54 -37.22 0.08 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.33 -57.12 14.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.116 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 -60.09 -43.87 95.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.502 HG22 ' OE2' ' A' ' 122' ' ' GLU . 59.4 t -58.21 -34.11 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.121 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.19 -59.06 3.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.138 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -53.99 -31.07 49.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.97 -38.38 64.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.899 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.467 HD23 ' CE2' ' A' ' 143' ' ' TYR . 14.8 tp -85.39 20.94 1.87 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 64.22 40.33 6.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.841 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.467 ' CE2' HD23 ' A' ' 141' ' ' LEU . 3.1 m-85 -89.67 153.16 47.71 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.662 0.744 . . . . 0.0 110.929 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.622 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.9 Cg_endo -69.75 114.07 3.58 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.732 2.288 . . . . 0.0 112.337 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 54.0 Cg_endo -69.75 90.88 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.678 2.252 . . . . 0.0 112.365 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.67 -73.93 0.1 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.468 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -50.56 153.18 1.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.832 0.348 . . . . 0.0 110.852 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -67.29 81.33 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.622 HD11 ' HG2' ' A' ' 144' ' ' PRO . 90.1 mt -92.97 -53.85 8.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.19 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.0 -48.52 1.08 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.511 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.0 t -61.5 -53.87 50.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.864 0.364 . . . . 0.0 110.866 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.497 ' C ' HD23 ' A' ' 152' ' ' LEU . 8.2 tt -47.14 -50.6 20.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.885 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.415 ' O ' ' C ' ' A' ' 154' ' ' ARG . 24.1 mt -55.02 -65.91 0.5 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 153' ' ' LEU . 11.4 ttt-85 -36.89 -44.99 0.53 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.918 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.7 t -59.76 -65.37 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.911 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -39.6 -49.11 2.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.512 ' HA ' HD12 ' A' ' 161' ' ' ILE . 3.6 t80 -52.83 -67.6 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.916 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.426 ' HA ' ' HB2' ' A' ' 162' ' ' TYR . 17.3 mm-40 -62.15 -8.53 5.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.857 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.94 -53.82 5.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.908 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.794 HG22 HD11 ' A' ' 89' ' ' ILE . 27.0 mt -112.91 -46.3 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.133 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.512 HD12 ' HA ' ' A' ' 157' ' ' TYR . 73.7 mt -61.2 -14.14 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.661 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -76.88 -63.3 0.54 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.707 0.765 . . . . 0.0 110.927 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.563 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.9 Cg_endo -69.73 -23.44 30.92 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.744 2.296 . . . . 0.0 112.328 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.739 ' CD2' HD12 ' A' ' 89' ' ' ILE . 1.0 OUTLIER -74.25 -46.62 40.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.875 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -69.11 -49.38 57.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.893 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.466 ' CG ' ' HA ' ' A' ' 163' ' ' PRO . 0.0 OUTLIER -61.23 -38.14 85.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.593 ' CD2' ' CD1' ' A' ' 92' ' ' PHE . 18.3 t80 -62.03 -50.65 71.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -64.01 -23.77 67.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.938 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 8.5 t -71.01 -59.25 2.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.876 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.56 88.67 0.92 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.502 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.798 0.332 . . . . 0.0 111.102 -179.999 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.7 p -144.7 171.47 14.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.903 0.382 . . . . 0.0 110.883 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 54.7 p -151.38 124.37 8.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.868 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.07 -92.29 0.13 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.51 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.2 t -84.02 177.13 8.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.857 0.36 . . . . 0.0 110.867 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.6 t -64.49 137.05 57.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.86 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -139.81 -126.11 2.29 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.455 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.2 t -89.89 41.12 1.03 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.794 0.33 . . . . 0.0 111.15 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -74.51 -57.75 3.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.891 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 63.4 t -82.79 -39.86 16.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.704 ' CD ' ' CD2' ' A' ' 113' ' ' TYR . 16.5 tptm -45.69 -25.17 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.93 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 86.4 mt -84.25 -45.84 12.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.911 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -45.95 -51.59 13.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.426 ' HE2' HD12 ' A' ' 112' ' ' LEU . 55.1 t80 -55.07 -34.44 63.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.933 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.401 HD21 HD21 ' A' ' 112' ' ' LEU . 96.7 mt -73.21 -64.08 1.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.966 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -52.74 -32.28 42.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 44.8 mm-40 -67.16 -69.08 0.33 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.476 HG13 ' CG ' ' A' ' 164' ' ' TYR . 19.7 tt -51.09 -39.28 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.133 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.565 ' HB2' HD22 ' A' ' 100' ' ' LEU . . . -65.51 -40.82 93.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -59.73 -23.96 63.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.918 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.459 ' CD1' ' O ' ' A' ' 92' ' ' PHE . 1.1 t80 -84.7 -36.56 21.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.893 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.48 ' O ' ' N ' ' A' ' 95' ' ' ILE . 69.4 m95 -78.03 -56.72 4.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -39.41 -25.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.48 ' N ' ' O ' ' A' ' 93' ' ' TRP . 87.3 mt -81.81 -50.35 16.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -49.18 -34.08 13.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.889 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 130.21 -25.11 4.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.47 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.5 m -103.97 115.52 30.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 0.0 110.868 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.4 t -53.75 167.88 0.22 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.875 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.565 HD22 ' HB2' ' A' ' 90' ' ' ALA . 30.9 tp -85.28 124.5 31.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.967 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -125.96 134.51 51.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 81.9 mt -107.05 129.64 24.04 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.586 0.707 . . . . 0.0 111.132 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 174.64 9.18 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.69 2.26 . . . . 0.0 112.325 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -124.73 111.83 16.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.7 t -115.2 133.27 61.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.153 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 60.06 54.72 4.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.916 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 38.42 36.91 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.841 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.71 153.66 28.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.9 tt -60.31 137.04 23.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.109 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.82 HD23 ' N ' ' A' ' 111' ' ' ASP . 5.1 tt -78.47 140.55 38.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.946 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.82 ' N ' HD23 ' A' ' 110' ' ' LEU . 52.0 t0 -90.43 76.25 6.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.827 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.426 HD12 ' HE2' ' A' ' 85' ' ' TYR . 1.4 pt? -61.77 -22.46 65.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.936 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.704 ' CD2' ' CD ' ' A' ' 82' ' ' LYS . 1.7 t80 -71.73 -65.84 0.71 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 115' ' ' LEU . 3.7 t -54.34 -54.08 45.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.845 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.43 ' C ' ' O ' ' A' ' 114' ' ' SER . 16.9 tp -35.3 -65.43 0.23 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.941 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.5 t -53.15 -51.89 60.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.871 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -46.78 -54.22 10.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.905 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 65.3 mt -56.67 -46.81 83.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.084 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.1 t -56.88 -61.99 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.154 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 84.6 mt -56.97 -40.31 71.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.141 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -60.1 -57.99 10.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.467 ' HB3' HG22 ' A' ' 128' ' ' ILE . 28.7 mm-40 -44.87 -45.1 10.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.434 ' O ' ' CB ' ' A' ' 127' ' ' ALA . . . 152.48 38.12 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.487 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.16 -170.04 32.61 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.467 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -88.8 -43.3 11.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.945 0.402 . . . . 0.0 110.951 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -64.24 -39.37 93.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.866 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' A' ' 123' ' ' GLY . . . -58.37 -68.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.075 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.629 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.7 pp -51.73 -34.88 16.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.087 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.405 ' N ' HD12 ' A' ' 128' ' ' ILE . 53.6 m -67.74 -33.95 75.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.845 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.3 mtpp -68.05 -46.85 69.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.429 ' OD2' ' CZ ' ' A' ' 133' ' ' ARG . 2.3 t70 -84.61 12.23 7.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 44.63 54.12 6.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.849 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.449 ' O ' ' C ' ' A' ' 134' ' ' TRP . 3.2 mmp_? -80.32 -19.07 47.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.905 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.629 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 18.8 m95 -34.27 -44.54 0.19 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.2 -52.12 66.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.11 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 37.5 mmt-85 -68.93 -51.22 42.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 97.5 t -44.4 -44.47 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.127 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.645 ' HB2' ' CD1' ' A' ' 153' ' ' LEU . . . -68.53 -53.09 25.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.08 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -55.72 -25.92 42.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.908 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 23.9 mtt180 -64.21 -26.5 68.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.912 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.0 tp -89.54 18.45 5.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.939 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 64.45 46.73 3.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.577 ' HB3' HD13 ' A' ' 149' ' ' ILE . 3.6 m-85 -95.36 152.59 39.43 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.656 0.741 . . . . 0.0 110.948 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 120.1 6.94 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.652 2.235 . . . . 0.0 112.356 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 115.65 4.19 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.683 2.255 . . . . 0.0 112.344 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.66 -64.25 0.44 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.465 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -53.08 160.33 1.04 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.79 0.329 . . . . 0.0 110.925 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -80.96 52.43 1.75 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.577 HD13 ' HB3' ' A' ' 143' ' ' TYR . 42.6 mt -62.92 -49.8 82.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.165 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.21 -56.94 1.14 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.452 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.8 t -57.29 -61.0 2.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.914 0.387 . . . . 0.0 110.897 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.47 ' C ' HD23 ' A' ' 152' ' ' LEU . 7.3 tt -38.94 -55.11 1.59 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.926 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.645 ' CD1' ' HB2' ' A' ' 138' ' ' ALA . 25.1 mt -51.9 -65.99 0.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.53 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 20.0 ttp180 -41.18 -46.23 3.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.823 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.9 m -58.99 -64.5 0.92 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.845 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -42.05 -53.38 3.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.864 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.488 ' O ' ' N ' ' A' ' 161' ' ' ILE . 5.3 t80 -50.81 -65.35 0.57 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 42.6 mt-10 -63.53 -9.8 14.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.906 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 41.5 ttt-85 -84.08 -50.74 7.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 40.6 mt -112.54 -40.07 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.152 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.559 ' O ' HG22 ' A' ' 161' ' ' ILE . 22.9 mt -76.2 0.28 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.139 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.588 ' CE1' ' SD ' ' A' ' 166' ' ' MET . 0.1 OUTLIER -73.34 -61.17 1.51 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.7 0.762 . . . . 0.0 110.897 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.562 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 54.4 Cg_endo -69.73 -32.56 18.47 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.68 2.253 . . . . 0.0 112.393 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.476 ' CG ' HG13 ' A' ' 89' ' ' ILE . 12.3 t80 -66.07 -39.04 89.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.931 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -72.02 -53.37 13.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.935 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.588 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 6.7 ptt? -63.48 -41.58 98.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.851 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.468 ' CB ' ' O ' ' A' ' 163' ' ' PRO . 47.9 t80 -59.53 -52.12 66.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.901 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -96.76 41.62 1.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.1 t -74.88 -57.11 4.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.852 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 170.35 -55.56 0.19 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.487 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.792 0.329 . . . . 0.0 111.119 179.95 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.579 ' HE2' HD12 ' A' ' 112' ' ' LEU . 29.5 t80 . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.904 0.383 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.8 mt -65.29 -50.99 63.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.03 -35.08 75.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -68.45 -64.16 0.92 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.935 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.664 HG23 HD22 ' A' ' 100' ' ' LEU . 6.5 tt -55.5 -33.75 33.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.16 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.98 -58.58 3.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.088 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.41 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 2.4 ttmp? -45.65 -24.66 0.37 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.892 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -85.63 -42.45 14.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 32.8 m95 -72.61 -59.25 2.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.916 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.47 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 2.7 pt-20 -39.31 -31.96 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.873 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.47 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 97.3 mt -74.08 -52.59 19.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.171 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -48.55 -40.34 26.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 136.58 -45.71 1.07 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.477 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.4 t -81.69 118.69 23.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.841 0.353 . . . . 0.0 110.881 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.5 p -56.49 151.86 12.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.664 HD22 HG23 ' A' ' 89' ' ' ILE . 13.5 tp -77.84 118.58 20.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -119.57 141.91 48.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.0 mp -107.69 128.74 25.28 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.627 0.727 . . . . 0.0 111.104 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 154.24 67.77 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.646 2.23 . . . . 0.0 112.334 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -102.18 111.32 23.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.511 HG12 ' HG2' ' A' ' 106' ' ' GLU . 71.4 t -119.03 134.67 61.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.117 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.511 ' HG2' HG12 ' A' ' 105' ' ' VAL . 13.2 mm-40 61.21 53.45 3.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 106' ' ' GLU . 7.7 ptp180 36.94 41.68 0.2 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.3 ttmp? -162.5 152.13 15.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.461 HG13 ' N ' ' A' ' 110' ' ' LEU . 1.8 tp -62.25 139.23 21.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.112 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.529 HD23 ' N ' ' A' ' 111' ' ' ASP . 5.7 tt -87.65 130.62 34.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.916 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.529 ' N ' HD23 ' A' ' 110' ' ' LEU . 44.3 t0 -90.55 74.24 6.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.579 HD12 ' HE2' ' A' ' 85' ' ' TYR . 2.0 pt? -48.52 -20.91 0.48 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -71.27 -45.59 62.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.3 t -65.61 -52.81 49.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.886 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.7 tp -49.03 -60.53 2.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 52.6 p -55.11 -52.9 61.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.863 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.3 mmtt -47.96 -61.45 1.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 66.5 mt -45.34 -64.27 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.155 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 43.1 t -39.35 -64.18 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.139 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 73.4 mt -42.35 -46.35 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.092 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -65.34 -54.69 25.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -39.49 -50.91 2.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 127' ' ' ALA . . . 155.36 35.15 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.525 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.92 -177.73 41.79 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.528 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.483 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 3.1 t80 -87.42 -47.92 8.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.851 0.357 . . . . 0.0 110.901 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -57.78 -40.73 80.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.91 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 123' ' ' GLY . . . -63.09 -68.86 0.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.083 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.483 HD12 ' C ' ' A' ' 128' ' ' ILE . 1.9 pp -52.0 -31.43 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.128 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.483 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 26.2 m -70.13 -42.2 72.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -66.31 -36.92 84.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.861 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 132' ' ' ARG . 2.2 m-20 -91.99 21.44 4.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.859 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' A' ' 131' ' ' ASP . 16.8 mmm-85 35.36 41.28 0.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -71.35 -14.07 62.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.869 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.505 ' CE2' ' HG3' ' A' ' 154' ' ' ARG . 49.5 m95 -38.28 -37.44 0.29 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.24 -52.56 65.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.06 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -66.4 -39.73 89.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.842 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.3 t -57.3 -36.09 51.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.107 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.47 ' HB2' ' CD1' ' A' ' 153' ' ' LEU . . . -74.14 -49.85 21.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.094 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -57.99 -26.07 61.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.868 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -57.6 -38.93 75.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.838 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.517 HD23 ' CZ ' ' A' ' 143' ' ' TYR . 13.6 tp -82.44 16.09 2.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.95 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 63.36 44.66 5.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.835 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.517 ' CZ ' HD23 ' A' ' 141' ' ' LEU . 2.6 m-85 -85.21 155.96 60.18 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.657 0.741 . . . . 0.0 110.956 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.455 ' HA ' ' HD2' ' A' ' 145' ' ' PRO . 53.7 Cg_endo -69.79 110.37 2.54 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.656 2.238 . . . . 0.0 112.345 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 53.9 Cg_endo -69.72 108.27 2.03 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.712 2.274 . . . . 0.0 112.348 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 147.44 -34.64 1.26 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.459 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -83.93 147.24 27.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 0.0 110.923 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.418 ' CG ' ' O ' ' A' ' 148' ' ' ASN . 26.3 p-10 -66.53 72.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.857 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.42 ' O ' ' C ' ' A' ' 150' ' ' GLY . 75.4 mt -90.65 -50.04 13.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.099 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.1 -50.71 1.22 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.498 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.6 m -60.03 -49.29 78.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.887 0.375 . . . . 0.0 110.882 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.672 HD21 ' CD2' ' A' ' 156' ' ' HIS . 6.5 tt -51.18 -53.97 29.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.888 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.47 ' CD1' ' HB2' ' A' ' 138' ' ' ALA . 23.1 mt -54.35 -65.8 0.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.927 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.505 ' HG3' ' CE2' ' A' ' 134' ' ' TRP . 16.0 ttt180 -40.41 -41.57 1.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.889 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 156' ' ' HIS . 39.7 m -66.67 -69.78 0.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.672 ' CD2' HD21 ' A' ' 152' ' ' LEU . 2.4 m-70 -36.96 -39.22 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.879 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.422 ' HA ' ' CG1' ' A' ' 161' ' ' ILE . 4.2 t80 -65.44 -57.23 8.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -70.82 -10.13 58.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.878 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -90.22 -48.17 7.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.824 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 60.7 mt -112.45 -41.97 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.162 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.534 ' O ' HG22 ' A' ' 161' ' ' ILE . 16.7 mt -78.48 3.23 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.091 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.584 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -72.36 -60.66 2.07 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.691 0.758 . . . . 0.0 110.928 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 162' ' ' TYR . 53.8 Cg_endo -69.72 -40.19 5.68 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.69 2.26 . . . . 0.0 112.358 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.491 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 23.8 t80 -55.57 -40.26 71.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.911 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -76.85 -66.32 0.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.883 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.447 ' SD ' ' N ' ' A' ' 167' ' ' PHE . 0.0 OUTLIER -42.7 -40.06 2.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.874 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.447 ' N ' ' SD ' ' A' ' 166' ' ' MET . 21.4 t80 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.484 ' O ' HG22 ' A' ' 89' ' ' ILE . 73.0 t80 . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.876 0.37 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.6 mt -77.25 -43.14 34.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.05 -41.97 75.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.06 -62.97 1.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.534 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 15.0 tt -52.42 -39.71 29.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.143 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.1 -42.81 93.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.11 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -59.02 -29.21 67.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -77.2 -39.75 47.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.915 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 54.7 m95 -72.74 -58.39 3.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.433 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 9.6 pt-20 -39.17 -36.91 0.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.433 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 95.4 mt -69.85 -47.07 71.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.096 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -53.5 -35.34 60.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.925 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 130.56 -33.19 2.92 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.482 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.4 m -93.5 145.33 24.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.928 0.394 . . . . 0.0 110.89 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 27.7 p -79.27 159.55 27.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 39.1 tp -90.04 138.34 31.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.93 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 49.7 tttt -134.4 144.63 48.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.957 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 62.9 mt -109.82 124.51 33.44 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.608 0.718 . . . . 0.0 111.116 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 157.38 60.42 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.634 2.223 . . . . 0.0 112.296 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -107.71 121.48 44.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 62.4 t -116.09 140.84 36.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.149 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.473 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 63.1 mm-40 44.76 52.86 7.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.473 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 12.0 ptm180 47.36 36.7 5.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.835 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -154.14 150.58 28.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 6.9 tt -62.3 140.26 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.131 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.634 HD23 ' N ' ' A' ' 111' ' ' ASP . 3.6 tt -89.22 121.86 31.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.953 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.634 ' N ' HD23 ' A' ' 110' ' ' LEU . 7.9 t0 -82.46 79.75 8.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.695 HD23 ' H ' ' A' ' 112' ' ' LEU . 1.4 pt? -58.71 -23.83 60.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.436 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 3.7 t80 -65.26 -56.12 14.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 115' ' ' LEU . 44.3 m -58.22 -59.84 4.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.875 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.448 ' C ' ' O ' ' A' ' 114' ' ' SER . 19.6 tp -34.48 -68.47 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.948 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.5 t -48.2 -54.71 12.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.852 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt -46.61 -54.75 8.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.904 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.607 HG22 ' OE1' ' A' ' 122' ' ' GLU . 81.5 mt -51.72 -54.25 13.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.141 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.408 HG13 HG12 ' A' ' 128' ' ' ILE . 76.4 t -53.33 -60.02 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.144 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 97.0 mt -43.28 -44.89 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.153 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -68.54 -48.61 63.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.607 ' OE1' HG22 ' A' ' 118' ' ' ILE . 24.7 mt-10 -44.95 -42.62 8.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.898 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 144.13 37.8 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.486 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.97 -179.45 45.49 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.516 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.516 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 0.9 OUTLIER -86.88 -41.51 13.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.855 0.36 . . . . 0.0 110.934 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -62.75 -33.45 75.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.899 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.8 -69.84 0.29 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.07 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.515 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.9 pp -51.07 -32.6 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.163 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.451 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 27.3 m -69.6 -41.5 75.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.1 mtpp -67.11 -28.03 67.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -101.03 13.81 34.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.852 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 39.07 50.87 1.87 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -84.13 -3.6 58.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.86 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.515 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 56.4 m95 -45.95 -39.06 8.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.925 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.53 -54.1 50.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.118 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -64.48 -46.85 81.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.908 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.454 ' CG2' ' OE2' ' A' ' 122' ' ' GLU . 52.0 t -50.39 -37.48 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.095 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.96 -49.35 38.2 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -59.03 -24.71 63.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -62.95 -30.54 71.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.551 HD23 ' CE2' ' A' ' 143' ' ' TYR . 14.8 tp -91.64 26.48 2.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 57.57 51.04 10.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.551 ' CE2' HD23 ' A' ' 141' ' ' LEU . 3.5 m-85 -102.68 151.62 38.31 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.709 0.766 . . . . 0.0 110.883 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.554 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.7 Cg_endo -69.76 110.31 2.52 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.739 2.293 . . . . 0.0 112.324 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 131.56 21.55 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.726 2.284 . . . . 0.0 112.358 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.65 -55.3 0.76 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.505 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -59.85 179.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.777 0.322 . . . . 0.0 110.912 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -93.97 42.22 1.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.554 HD11 ' HG2' ' A' ' 144' ' ' PRO . 61.8 mt -59.46 -50.07 81.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.115 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.22 -58.88 1.01 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.478 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.9 t -51.56 -60.49 3.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.926 0.393 . . . . 0.0 110.878 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.5 tt -38.98 -49.9 1.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.934 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 17.3 mt -59.74 -65.92 0.6 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.914 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.481 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 6.2 ttt-85 -38.3 -40.06 0.49 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.867 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 158' ' ' GLU . 3.8 m -66.84 -66.35 0.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -43.6 -29.69 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.831 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.514 ' CD1' ' C ' ' A' ' 157' ' ' TYR . 2.2 t80 -79.57 -34.92 40.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.924 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 155' ' ' SER . 26.0 mt-10 -88.93 -9.9 49.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.872 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 12.7 mmt85 -102.15 -39.86 7.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 86.3 mt -109.86 -49.86 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.131 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 157' ' ' TYR . 14.0 mt -78.47 3.3 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.095 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.641 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -72.57 -60.54 2.01 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.665 0.745 . . . . 0.0 110.893 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 162' ' ' TYR . 53.7 Cg_endo -69.79 -49.35 0.56 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.668 2.245 . . . . 0.0 112.343 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.534 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 34.4 t80 -48.31 -38.02 17.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.929 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -75.2 -63.24 1.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.892 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 11.8 ptt? -48.65 -31.05 6.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.869 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 21.6 t80 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.866 -179.913 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.624 ' HE2' HD12 ' A' ' 112' ' ' LEU . 39.3 t80 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.901 0.382 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.9 mt -74.73 -59.13 2.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.908 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -49.61 -29.07 6.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -76.79 -68.2 0.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.959 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.548 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 9.9 tt -46.16 -34.84 2.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.16 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.27 -46.53 67.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.136 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -55.98 -22.86 29.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -84.95 -46.49 11.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.879 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 54.2 m95 -67.74 -51.25 51.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.894 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -45.88 -32.1 2.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 89.8 mt -74.93 -46.04 41.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.128 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -56.35 -36.74 69.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.88 -52.67 0.7 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.467 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 71.4 m -83.32 119.98 25.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.865 0.364 . . . . 0.0 110.874 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 59.4 p -55.51 173.26 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.84 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.1 tp -82.68 132.96 35.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.951 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -131.92 134.4 45.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.0 mt -110.0 127.45 27.07 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.594 0.712 . . . . 0.0 111.148 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.565 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 53.2 Cg_endo -69.77 166.53 27.29 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.661 2.24 . . . . 0.0 112.329 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -113.09 122.86 48.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.4 t -123.75 148.64 27.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.155 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.448 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 58.1 mm-40 41.72 52.92 4.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.448 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 13.0 ptp180 45.16 43.01 7.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.875 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -164.58 152.22 11.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.926 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.1 tt -62.29 142.89 15.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.121 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.712 HD23 ' N ' ' A' ' 111' ' ' ASP . 5.3 tt -91.63 132.49 36.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.712 ' N ' HD23 ' A' ' 110' ' ' LEU . 24.2 t70 -94.6 100.92 12.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.838 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.755 HD23 ' H ' ' A' ' 112' ' ' LEU . 0.9 OUTLIER -72.53 -26.64 61.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.563 ' CE1' ' HG3' ' A' ' 117' ' ' LYS . 4.4 t80 -61.06 -55.89 27.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.886 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.4 m -61.85 -56.98 13.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.83 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.414 ' O ' HG23 ' A' ' 119' ' ' VAL . 26.2 tp -40.73 -60.74 1.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.1 t -58.17 -50.59 73.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.802 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.563 ' HG3' ' CE1' ' A' ' 113' ' ' TYR . 13.9 mmmt -47.92 -46.3 31.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.535 HG22 ' OE1' ' A' ' 122' ' ' GLU . 63.8 mt -64.45 -38.58 82.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.431 HG13 HG12 ' A' ' 128' ' ' ILE . 71.6 t -64.17 -59.96 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 83.3 mt -59.71 -43.58 91.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.118 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -58.79 -56.56 20.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.535 ' OE1' HG22 ' A' ' 118' ' ' ILE . 20.9 mt-10 -44.36 -51.07 8.84 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 159.11 34.42 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.473 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.98 -175.02 33.36 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.528 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.517 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 2.1 t80 -87.41 -46.59 9.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.838 0.352 . . . . 0.0 110.905 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -58.02 -37.53 74.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.58 -70.46 0.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.113 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.527 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.9 pp -50.09 -34.47 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.165 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.517 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 53.5 m -67.93 -44.18 77.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.914 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -64.53 -40.85 96.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.933 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 132' ' ' ARG . 69.5 m-20 -85.92 23.77 1.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.824 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 131' ' ' ASP . 41.3 mtp85 36.04 37.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.847 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 134' ' ' TRP . 29.7 mmt180 -66.71 -23.47 66.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.542 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 22.4 m95 -34.71 -43.85 0.19 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.89 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.35 -49.21 75.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.114 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 133' ' ' ARG . 13.0 tpp180 -69.11 -42.18 76.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.892 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 89.2 t -53.85 -34.7 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.485 ' HB2' HD11 ' A' ' 153' ' ' LEU . . . -76.78 -53.45 7.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.1 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -55.04 -28.21 50.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -64.89 -28.3 69.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.779 HD23 ' CE2' ' A' ' 143' ' ' TYR . 12.5 tp -88.27 22.67 2.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 60.78 45.84 9.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.843 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.779 ' CE2' HD23 ' A' ' 141' ' ' LEU . 4.4 m-85 -97.71 147.37 32.93 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.692 0.758 . . . . 0.0 110.902 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 125.43 12.12 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.689 2.259 . . . . 0.0 112.289 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 96.68 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.676 2.251 . . . . 0.0 112.324 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 165.02 -75.24 0.16 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.543 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 149' ' ' ILE . 0.3 OUTLIER -45.96 138.47 5.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.798 0.332 . . . . 0.0 110.929 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -62.87 75.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.915 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 147' ' ' LYS . 94.1 mt -87.38 -48.91 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.138 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.13 -59.0 0.99 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.472 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.1 t -53.56 -55.25 27.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.945 0.402 . . . . 0.0 110.873 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.608 ' CD2' ' CD2' ' A' ' 156' ' ' HIS . 5.6 tt -44.28 -53.31 6.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 138' ' ' ALA . 18.6 mt -53.54 -65.85 0.49 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.542 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 16.3 ttp180 -39.75 -47.05 2.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 7.9 t -59.41 -66.51 0.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.842 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.608 ' CD2' ' CD2' ' A' ' 152' ' ' LEU . 3.2 m-70 -40.6 -34.44 0.36 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.821 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.499 ' O ' ' N ' ' A' ' 161' ' ' ILE . 9.7 t80 -68.57 -70.27 0.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.4 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 3.9 mm-40 -61.09 -10.08 5.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.867 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -85.0 -55.85 3.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 49.7 mt -109.43 -37.27 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.118 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.499 ' N ' ' O ' ' A' ' 157' ' ' TYR . 26.7 mt -75.4 -5.93 7.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.113 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.513 ' CD2' ' HD3' ' A' ' 163' ' ' PRO . 0.3 OUTLIER -71.25 -59.26 3.39 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.679 0.752 . . . . 0.0 110.93 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.513 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.3 Cg_endo -69.85 -39.73 6.0 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.69 2.26 . . . . 0.0 112.335 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.548 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 3.7 t80 -64.78 -30.03 71.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.935 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.494 ' CG ' HG22 ' A' ' 161' ' ' ILE . 17.1 mm-40 -74.13 -57.24 4.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.876 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.464 ' HG3' ' N ' ' A' ' 167' ' ' PHE . 5.5 ptp -55.43 -29.52 58.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.464 ' N ' ' HG3' ' A' ' 166' ' ' MET . 54.3 t80 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.873 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.666 ' HE2' HD12 ' A' ' 112' ' ' LEU . 81.3 t80 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.891 0.376 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.417 ' O ' HG22 ' A' ' 89' ' ' ILE . 72.2 mt -80.56 -63.22 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.947 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -44.88 -31.39 1.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -72.26 -71.03 0.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.533 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 14.7 tt -43.29 -34.87 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.099 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.531 ' HB2' HD22 ' A' ' 100' ' ' LEU . . . -68.82 -50.18 52.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.107 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -51.89 -29.21 18.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.906 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.401 ' CD1' ' CD2' ' A' ' 167' ' ' PHE . 30.2 t80 -77.29 -37.81 52.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.875 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.451 ' O ' ' C ' ' A' ' 94' ' ' GLU . 67.7 m95 -76.19 -59.24 2.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.921 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.456 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 11.2 pt-20 -34.65 -40.54 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.456 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 95.5 mt -66.62 -53.87 31.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.126 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -46.81 -45.32 19.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 125.83 42.14 0.32 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.436 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.4 t -167.02 110.27 0.7 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.903 0.382 . . . . 0.0 110.869 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 78.1 p -43.84 163.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.902 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.531 HD22 ' HB2' ' A' ' 90' ' ' ALA . 10.6 tp -93.58 111.44 23.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -107.35 149.1 28.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 53.7 mt -119.95 129.93 25.1 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.655 0.741 . . . . 0.0 111.134 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 160.45 49.65 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.692 2.261 . . . . 0.0 112.303 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -111.81 126.05 54.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.906 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.3 t -121.32 144.22 31.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.161 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.429 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 62.7 mm-40 41.76 54.54 3.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.429 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 1.4 ptp180 43.88 40.07 2.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.03 152.72 26.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.4 tt -63.06 141.91 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.106 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.694 HD23 ' N ' ' A' ' 111' ' ' ASP . 5.4 tt -86.25 133.52 33.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.694 ' N ' HD23 ' A' ' 110' ' ' LEU . 17.8 t0 -91.95 74.33 5.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.699 HD23 ' H ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -54.63 -29.69 52.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.934 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -60.57 -66.94 0.45 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.932 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.8 m -50.97 -53.96 28.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.839 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.9 tp -39.46 -61.08 0.84 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.945 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.2 t -55.13 -66.59 0.38 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.473 ' N ' ' HE2' ' A' ' 117' ' ' LYS . 1.0 OUTLIER -40.96 -64.03 0.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.849 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 80.9 mt -40.81 -63.3 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.104 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.8 t -40.82 -58.14 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.099 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 69.9 mt -48.86 -42.12 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.161 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -65.92 -50.23 65.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.856 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -47.79 -40.14 20.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.846 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.66 ' O ' ' HB3' ' A' ' 127' ' ' ALA . . . 144.82 42.33 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.516 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.419 ' O ' HG23 ' A' ' 128' ' ' ILE . . . 83.03 174.74 50.61 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.525 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 0.6 OUTLIER -86.83 -37.13 18.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.846 0.355 . . . . 0.0 110.946 -179.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -66.06 -40.45 90.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.866 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.66 ' HB3' ' O ' ' A' ' 123' ' ' GLY . . . -66.72 -63.44 1.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.073 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.574 HD12 ' N ' ' A' ' 129' ' ' CYS . 2.4 pp -49.11 -37.07 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.123 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.574 ' N ' HD12 ' A' ' 128' ' ' ILE . 22.0 m -62.82 -50.7 69.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.849 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -62.31 -33.77 75.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 132' ' ' ARG . 2.5 m-20 -90.91 16.35 9.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 131' ' ' ASP . 78.0 mtt180 36.98 44.56 0.38 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 15.0 mtp85 -77.62 -13.6 59.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 21.4 m95 -39.66 -40.35 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.72 -45.55 81.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.129 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.4 tpp85 -73.57 -44.99 55.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.1 t -57.04 -24.25 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.148 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -85.06 -55.34 4.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.087 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -55.42 -29.57 58.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -54.2 -36.45 63.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.869 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.498 HD23 ' CE2' ' A' ' 143' ' ' TYR . 17.6 tp -83.27 14.57 3.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 68.99 44.16 1.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.498 ' CE2' HD23 ' A' ' 141' ' ' LEU . 2.7 m-85 -92.32 158.33 39.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.731 0.777 . . . . 0.0 110.91 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.446 ' HA ' ' HD2' ' A' ' 145' ' ' PRO . 53.6 Cg_endo -69.76 110.67 2.61 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.661 2.241 . . . . 0.0 112.349 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 53.9 Cg_endo -69.8 105.67 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.699 2.266 . . . . 0.0 112.356 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.94 -58.82 0.41 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.524 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.443 ' HD3' ' N ' ' A' ' 148' ' ' ASN . 10.7 tmtt? -61.95 150.3 38.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.79 0.329 . . . . 0.0 110.889 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.443 ' N ' ' HD3' ' A' ' 147' ' ' LYS . 46.9 t30 -66.68 81.39 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.431 HD11 ' HG2' ' A' ' 144' ' ' PRO . 42.9 mt -94.87 -52.75 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.124 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.04 -53.05 1.22 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.492 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 75.5 m -57.69 -57.88 10.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.901 0.381 . . . . 0.0 110.831 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.444 ' C ' HD23 ' A' ' 152' ' ' LEU . 6.6 tt -43.6 -50.24 7.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.881 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 154' ' ' ARG . 26.7 mt -55.37 -65.91 0.51 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.95 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 153' ' ' LEU . 20.0 ttp180 -38.17 -50.34 1.4 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.87 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 49.0 m -55.84 -69.21 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -38.84 -43.03 0.89 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.858 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.487 ' O ' ' N ' ' A' ' 161' ' ' ILE . 8.6 t80 -60.52 -66.2 0.57 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 41.4 mt-10 -63.06 -10.2 13.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.933 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -85.69 -53.81 4.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.435 HG22 HD11 ' A' ' 89' ' ' ILE . 42.8 mt -109.54 -39.35 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.091 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.58 HG22 ' HG3' ' A' ' 165' ' ' GLU . 18.4 mt -76.25 -2.28 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.156 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.543 ' CD2' ' HD3' ' A' ' 163' ' ' PRO . 0.2 OUTLIER -72.08 -60.29 2.37 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.672 0.749 . . . . 0.0 110.915 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.543 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.6 Cg_endo -69.78 -41.05 4.58 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.64 2.227 . . . . 0.0 112.323 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.533 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 8.1 t80 -63.33 -27.95 69.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.946 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.58 ' HG3' HG22 ' A' ' 161' ' ' ILE . 9.3 mm-40 -76.97 -59.06 2.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.882 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.469 ' CE ' ' CZ ' ' A' ' 162' ' ' TYR . 2.2 ptp -56.22 -25.39 47.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.858 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.401 ' CD2' ' CD1' ' A' ' 92' ' ' PHE . 67.9 t80 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.869 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.605 ' HE2' HD12 ' A' ' 112' ' ' LEU . 48.9 t80 . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.895 0.379 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.515 ' HA ' HG22 ' A' ' 89' ' ' ILE . 52.0 mt -73.03 -47.65 43.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -54.03 -29.95 45.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -83.91 -64.03 1.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.924 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.515 HG22 ' HA ' ' A' ' 86' ' ' LEU . 9.2 tt -51.15 -28.63 7.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.139 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.1 -34.21 59.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.085 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.3 tttp -69.71 -25.09 63.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.942 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -82.4 -49.19 10.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -63.79 -49.41 73.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.961 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.466 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 7.2 pt-20 -46.27 -35.84 5.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.466 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 96.4 mt -70.13 -44.53 78.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.138 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 -57.76 -36.19 71.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 130.94 -40.04 1.7 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.491 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.7 m -88.41 109.88 20.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.87 0.367 . . . . 0.0 110.841 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 88.7 p -49.88 166.68 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.869 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.9 tp -85.05 122.36 29.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.916 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -127.76 134.78 49.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.492 HG23 ' HD2' ' A' ' 103' ' ' PRO . 5.4 mp -99.04 134.16 21.62 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.64 0.733 . . . . 0.0 111.108 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.492 ' HD2' HG23 ' A' ' 102' ' ' ILE . 53.8 Cg_endo -69.76 159.39 53.58 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.674 2.249 . . . . 0.0 112.357 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -112.63 103.66 11.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.731 HG12 ' HG2' ' A' ' 106' ' ' GLU . 87.1 t -106.35 138.35 32.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.137 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.731 ' HG2' HG12 ' A' ' 105' ' ' VAL . 73.5 mm-40 53.16 47.55 24.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.898 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.493 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 28.0 ptt180 47.95 32.88 3.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.82 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.5 pttm -150.48 157.47 43.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.407 HG13 ' N ' ' A' ' 110' ' ' LEU . 3.0 tp -63.09 140.12 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.097 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.717 HD23 ' N ' ' A' ' 111' ' ' ASP . 5.5 tt -84.6 142.06 30.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.869 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.717 ' N ' HD23 ' A' ' 110' ' ' LEU . 19.5 t0 -93.08 93.38 8.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.847 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.726 HD23 ' H ' ' A' ' 112' ' ' LEU . 1.4 pt? -82.97 -19.88 36.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.875 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.621 ' CE1' ' CE ' ' A' ' 117' ' ' LYS . 65.7 t80 -71.04 -67.08 0.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.975 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.9 m -50.82 -54.37 24.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.885 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.776 ' O ' HG23 ' A' ' 119' ' ' VAL . 13.3 tp -41.53 -50.07 4.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.954 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.0 t -58.04 -61.22 2.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.621 ' CE ' ' CE1' ' A' ' 113' ' ' TYR . 0.1 OUTLIER -56.12 -63.92 1.03 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.885 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.402 ' C ' ' O ' ' A' ' 117' ' ' LYS . 71.9 mt -36.06 -58.61 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.122 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 115' ' ' LEU . 84.2 t -51.03 -54.42 10.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.168 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 65.3 mt -57.62 -29.63 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.088 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -74.48 -56.2 5.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -43.52 -50.15 7.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.508 ' O ' ' HB3' ' A' ' 127' ' ' ALA . . . 160.51 33.09 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.498 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.587 ' O ' HG23 ' A' ' 128' ' ' ILE . . . 89.12 173.35 46.34 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.464 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.524 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 0.8 OUTLIER -78.44 -44.84 23.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.832 0.349 . . . . 0.0 110.897 -179.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 56.0 mp0 -59.93 -40.25 88.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.933 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 123' ' ' GLY . . . -65.52 -64.04 0.96 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.12 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.606 HG12 HG13 ' A' ' 119' ' ' VAL . 1.6 pp -55.1 -32.84 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.133 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.52 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 29.8 m -69.56 -42.03 75.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.8 tttm -66.55 -34.86 78.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' A' ' 132' ' ' ARG . 6.5 m-20 -94.2 23.01 5.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 131' ' ' ASP . 0.8 OUTLIER 34.39 35.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.836 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 131' ' ' ASP . 10.8 mmt85 -71.0 -1.54 12.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.569 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 44.3 m95 -49.32 -38.99 29.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.92 -47.92 76.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.103 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 -66.16 -44.7 83.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.887 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 99.2 t -56.94 -39.98 69.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.085 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.97 -57.84 6.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.084 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -52.83 -29.84 30.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.935 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.0 mmt-85 -60.73 -29.44 69.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.546 HD11 ' CB ' ' A' ' 111' ' ' ASP . 14.4 tp -87.53 13.32 10.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.91 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 71.91 35.82 1.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.882 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.496 ' HB3' HD12 ' A' ' 149' ' ' ILE . 3.1 m-85 -82.21 154.82 69.69 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.65 0.738 . . . . 0.0 110.95 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 122.77 9.45 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.673 2.248 . . . . 0.0 112.367 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 120.03 6.87 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.666 2.244 . . . . 0.0 112.305 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 134.8 -64.67 0.59 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.511 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.451 ' HE2' ' N ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -59.81 142.32 53.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.788 0.328 . . . . 0.0 110.887 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.98 85.91 2.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.496 HD12 ' HB3' ' A' ' 143' ' ' TYR . 56.0 mt -91.6 -34.05 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.133 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -41.02 -48.96 4.33 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.445 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.5 m -57.83 -51.58 69.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.362 . . . . 0.0 110.851 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.416 ' CD2' ' CD2' ' A' ' 156' ' ' HIS . 5.4 tt -48.52 -53.92 16.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.92 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 15.4 mt -53.76 -65.94 0.48 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.917 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.551 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 12.6 ttp180 -37.99 -46.01 0.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.866 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 3.3 m -61.34 -71.93 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.817 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.47 ' CD2' ' HG3' ' A' ' 103' ' ' PRO . 2.3 m-70 -37.37 -34.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.816 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.561 ' CD2' HD12 ' A' ' 161' ' ' ILE . 4.0 t80 -70.08 -57.48 4.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.9 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.5 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 20.2 mm-40 -71.11 -9.74 58.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.919 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.1 tpp85 -98.46 -36.87 9.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.878 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 66.3 mt -112.68 -50.12 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.101 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.661 HG22 ' HG3' ' A' ' 165' ' ' GLU . 34.3 mt -76.34 -0.14 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.546 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -73.08 -60.87 1.66 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.674 0.749 . . . . 0.0 110.942 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.508 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.5 Cg_endo -69.8 -40.45 5.25 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.67 2.247 . . . . 0.0 112.331 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.473 ' CD2' HD12 ' A' ' 89' ' ' ILE . 8.0 t80 -61.04 -36.19 78.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.946 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.661 ' HG3' HG22 ' A' ' 161' ' ' ILE . 9.8 mm-40 -72.35 -61.31 1.84 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.908 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.508 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 11.1 ptt? -54.55 -37.96 66.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.841 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 47.2 t80 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.916 -179.929 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.512 ' HE2' HD12 ' A' ' 112' ' ' LEU . 41.8 t80 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.915 0.388 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.402 HD21 HD21 ' A' ' 112' ' ' LEU . 59.0 mt -69.3 -66.48 0.58 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.889 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -44.2 -24.39 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.935 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -80.73 -62.75 1.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.94 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.451 HG23 ' CD2' ' A' ' 100' ' ' LEU . 15.1 tt -56.89 -26.4 24.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.131 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.09 -55.17 5.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.121 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -53.46 -33.18 53.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.928 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -69.46 -53.3 19.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.871 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.617 ' CD1' HD13 ' A' ' 100' ' ' LEU . 21.7 m95 -54.11 -55.04 31.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.894 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 11.3 pt-20 -48.59 -43.91 36.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.921 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.451 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 62.8 mt -61.61 -45.84 97.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.111 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -54.59 -41.05 69.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.984 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 126.86 42.26 0.29 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.472 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.2 m -164.24 169.9 16.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.881 0.372 . . . . 0.0 110.836 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.7 t -100.44 151.5 21.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.843 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.617 HD13 ' CD1' ' A' ' 93' ' ' TRP . 42.4 tp -97.17 117.3 31.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.877 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -113.77 146.6 39.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.941 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 66.5 mt -111.71 124.38 32.57 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.569 0.699 . . . . 0.0 111.15 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 154.02 68.47 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.684 2.256 . . . . 0.0 112.382 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -104.14 119.77 39.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.88 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 84.5 t -127.59 135.52 62.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.126 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 62.04 48.94 4.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.876 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 42.15 39.2 1.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.843 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -163.94 154.48 15.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.864 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.1 tt -58.36 152.15 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.114 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.5 tt -97.48 124.63 41.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -85.75 76.0 10.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.871 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.689 HD23 ' H ' ' A' ' 112' ' ' LEU . 1.1 pt? -53.3 -28.84 30.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -58.18 -52.59 64.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.936 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.447 ' O ' ' C ' ' A' ' 115' ' ' LEU . 23.9 m -63.06 -59.86 4.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 114' ' ' SER . 28.4 tp -34.74 -67.84 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.868 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 117' ' ' LYS . 68.6 m -54.16 -60.23 3.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.857 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 116' ' ' SER . 22.8 mmtt -37.7 -49.14 1.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.9 mt -62.65 -45.04 99.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.186 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.8 t -51.06 -65.89 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.119 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 83.5 mt -51.55 -52.47 20.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.136 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -46.55 -49.16 19.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.413 ' HB3' HG22 ' A' ' 128' ' ' ILE . 44.7 mm-40 -53.28 -48.46 68.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.89 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 153.8 34.4 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.498 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.491 ' O ' HG23 ' A' ' 128' ' ' ILE . . . 96.14 -178.12 34.29 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.478 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.499 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 1.0 OUTLIER -88.07 -35.91 17.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 0.0 110.912 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -69.56 -38.91 77.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.905 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.2 -57.87 6.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.105 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.576 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 2.2 pp -56.57 -35.99 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.156 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.448 ' N ' HD12 ' A' ' 128' ' ' ILE . 39.1 m -67.71 -35.91 79.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -65.27 -46.06 81.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.448 ' O ' ' C ' ' A' ' 132' ' ' ARG . 3.7 t0 -88.18 24.55 1.83 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.448 ' C ' ' O ' ' A' ' 131' ' ' ASP . 60.0 mtp180 34.31 52.23 0.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.457 ' O ' ' C ' ' A' ' 134' ' ' TRP . 16.8 mmt180 -74.27 -24.39 59.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.848 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.576 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 25.2 m95 -33.57 -45.39 0.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.33 -56.51 17.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.09 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.6 -40.59 92.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 90.2 t -54.14 -39.35 41.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.097 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.477 ' HB2' HD11 ' A' ' 153' ' ' LEU . . . -71.87 -52.86 15.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.145 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -54.25 -29.12 45.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -60.13 -35.25 74.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.867 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.7 HD23 ' CE2' ' A' ' 143' ' ' TYR . 15.0 tp -85.22 24.65 1.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.939 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 59.18 34.59 23.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.847 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.7 ' CE2' HD23 ' A' ' 141' ' ' LEU . 3.2 m-85 -82.34 153.41 68.64 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.663 0.744 . . . . 0.0 110.954 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.699 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.5 Cg_endo -69.75 113.55 3.41 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.666 2.244 . . . . 0.0 112.32 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 53.3 Cg_endo -69.79 94.8 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.624 2.216 . . . . 0.0 112.322 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 173.54 -71.5 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.457 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -49.56 168.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.806 0.336 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -83.39 43.8 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.699 HD11 ' HG2' ' A' ' 144' ' ' PRO . 63.5 mt -54.59 -49.37 67.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.146 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.571 ' HA2' HD12 ' A' ' 153' ' ' LEU . . . -37.89 -52.36 2.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.466 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.2 t -62.21 -47.82 82.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.93 0.395 . . . . 0.0 110.84 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.5 tt -52.04 -46.56 65.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.951 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.571 HD12 ' HA2' ' A' ' 150' ' ' GLY . 6.2 mt -59.93 -66.04 0.58 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.534 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 18.3 ttp180 -37.84 -49.2 1.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 74.5 m -57.07 -68.6 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -38.15 -45.26 0.92 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.843 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.514 ' HA ' HD12 ' A' ' 161' ' ' ILE . 4.0 t80 -60.22 -59.37 5.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.434 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 5.5 mm-40 -67.14 -9.97 45.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -86.89 -54.39 4.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.8 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 38.6 mt -108.85 -39.92 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.075 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 157' ' ' TYR . 15.0 mt -77.33 0.66 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.118 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.586 ' CE1' ' SD ' ' A' ' 166' ' ' MET . 0.2 OUTLIER -72.53 -60.48 2.06 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.662 0.744 . . . . 0.0 110.932 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.557 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.0 Cg_endo -69.79 -42.96 2.92 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.695 2.263 . . . . 0.0 112.326 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.403 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 26.6 t80 -56.82 -39.74 74.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.916 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.501 ' HG3' HG22 ' A' ' 161' ' ' ILE . 16.3 mm-40 -72.17 -65.5 0.77 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.897 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.586 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 8.5 ptt? -47.95 -42.3 27.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.833 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 17.8 t80 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.874 -179.956 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.416 ' CD2' ' HA ' ' A' ' 113' ' ' TYR . 29.4 t80 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.916 0.388 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.1 mt -63.75 -56.4 15.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.913 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -57.75 -24.82 58.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.887 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -77.88 -60.98 2.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.541 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 20.7 tt -62.19 -31.07 50.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.151 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.753 ' HB2' HD22 ' A' ' 100' ' ' LEU . . . -68.41 -51.93 38.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.088 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -47.29 -27.88 1.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.875 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -80.24 -44.22 20.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -69.5 -55.35 10.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 12.1 pt-20 -40.1 -41.65 1.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.843 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.41 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 84.7 mt -68.02 -54.27 23.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.154 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -45.74 -32.76 2.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 129.94 -37.94 2.07 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.482 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 41.3 t -89.22 121.81 31.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.906 0.384 . . . . 0.0 110.856 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.7 t -60.09 172.45 0.79 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.85 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.753 HD22 ' HB2' ' A' ' 90' ' ' ALA . 19.5 tp -97.94 127.86 44.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.889 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.3 mttm -130.56 128.53 41.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.493 HD12 HD22 ' A' ' 112' ' ' LEU . 45.9 mm -95.63 123.31 56.58 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.609 0.719 . . . . 0.0 111.165 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.561 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 54.1 Cg_endo -69.77 146.82 61.31 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.625 2.217 . . . . 0.0 112.389 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -95.92 113.9 25.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.925 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 79.1 t -115.53 141.43 32.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.441 ' HG3' ' CD ' ' A' ' 144' ' ' PRO . 23.2 mm-40 47.39 53.76 10.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.908 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 19.7 ptt-85 43.04 42.58 3.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.85 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -163.6 153.52 15.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.907 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.8 tp -63.56 143.57 15.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.086 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.631 HD23 ' N ' ' A' ' 111' ' ' ASP . 4.6 tt -89.82 123.75 34.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.631 ' N ' HD23 ' A' ' 110' ' ' LEU . 37.1 t0 -86.14 68.24 10.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.846 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.493 HD22 HD12 ' A' ' 102' ' ' ILE . 2.0 pt? -47.55 -32.64 5.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.416 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 6.9 t80 -56.33 -65.28 0.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.923 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.3 p -51.79 -45.5 63.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.6 tp -45.92 -66.91 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.902 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.9 t -47.56 -51.38 21.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -47.67 -59.43 3.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.891 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.609 ' CG2' HG13 ' A' ' 137' ' ' VAL . 77.7 mt -50.99 -50.05 25.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.139 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 98.9 t -49.65 -63.21 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.126 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 74.4 mt -51.18 -48.74 31.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.125 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -52.58 -57.24 10.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.875 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -45.36 -49.51 12.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.916 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 154.51 36.62 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.499 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.07 175.12 40.91 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.491 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.504 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 1.2 t80 -82.78 -40.19 20.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.839 0.352 . . . . 0.0 110.892 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -64.2 -40.02 95.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.878 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.1 -64.47 0.92 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.126 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.677 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 2.0 pp -54.7 -34.5 30.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.156 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.504 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 22.5 m -66.88 -36.57 82.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.6 tptt -71.62 -42.1 68.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 132' ' ' ARG . 38.7 m-20 -88.34 22.88 2.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.868 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 131' ' ' ASP . 35.3 mtp180 34.46 43.43 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.844 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -74.76 -8.11 55.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.677 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 16.7 m95 -45.61 -47.55 14.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.902 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -46.66 -56.97 5.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.098 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -67.73 -56.67 8.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.609 HG13 ' CG2' ' A' ' 118' ' ' ILE . 87.0 t -43.23 -29.42 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.138 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.547 ' HB2' HD11 ' A' ' 153' ' ' LEU . . . -81.0 -49.18 11.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.141 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -59.56 -27.73 66.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -60.6 -26.16 66.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.837 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.505 HD23 ' CE2' ' A' ' 143' ' ' TYR . 20.3 tp -90.03 12.12 18.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.878 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 71.42 48.88 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.505 ' CE2' HD23 ' A' ' 141' ' ' LEU . 2.8 m-85 -99.94 158.59 31.78 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.681 0.753 . . . . 0.0 110.9 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.623 ' HG2' HD11 ' A' ' 149' ' ' ILE . 54.4 Cg_endo -69.72 111.42 2.8 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.714 2.276 . . . . 0.0 112.372 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 53.5 Cg_endo -69.8 95.27 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.711 2.274 . . . . 0.0 112.307 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.52 -73.74 0.12 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.452 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -54.74 145.08 20.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.836 0.35 . . . . 0.0 110.888 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -63.76 81.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.864 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.623 HD11 ' HG2' ' A' ' 144' ' ' PRO . 71.4 mt -88.27 -45.59 15.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.101 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -37.98 -45.96 1.7 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.482 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.6 m -60.66 -51.38 69.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.372 . . . . 0.0 110.877 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.528 HD21 ' CD2' ' A' ' 156' ' ' HIS . 5.9 tt -50.2 -48.83 54.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.915 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.547 HD11 ' HB2' ' A' ' 138' ' ' ALA . 22.2 mt -57.32 -65.96 0.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.42 ' CD ' ' HE1' ' A' ' 134' ' ' TRP . 17.8 ttp180 -38.99 -46.38 1.33 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 157' ' ' TYR . 41.0 t -60.2 -68.53 0.28 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.561 ' CE1' ' HG3' ' A' ' 103' ' ' PRO . 2.4 m-70 -41.9 -24.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.842 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 155' ' ' SER . 7.9 t80 -78.42 -50.14 12.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.918 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.408 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 5.2 mm-40 -81.62 -9.86 59.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.87 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -96.0 -41.48 8.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 76.9 mt -112.49 -49.18 5.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.113 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.778 HG22 ' HG3' ' A' ' 165' ' ' GLU . 9.8 mt -76.88 6.39 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.152 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.645 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -75.35 -62.63 0.79 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.666 0.745 . . . . 0.0 110.907 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.556 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.1 Cg_endo -69.81 -35.26 12.84 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.675 2.25 . . . . 0.0 112.329 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.541 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 65.3 t80 -60.51 -42.53 96.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.945 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.778 ' HG3' HG22 ' A' ' 161' ' ' ILE . 8.0 mt-10 -70.04 -55.07 10.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.883 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 2.7 mtm -62.74 -58.63 6.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.856 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.462 ' CB ' ' O ' ' A' ' 163' ' ' PRO . 29.3 t80 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.83 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.461 ' HE2' HD12 ' A' ' 112' ' ' LEU . 34.7 t80 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.891 0.376 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 12.6 mt -63.15 -66.77 0.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -44.51 -26.16 0.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -78.74 -70.58 0.49 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.9 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.636 HD11 HG22 ' A' ' 160' ' ' ILE . 7.5 tt -49.46 -32.26 6.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.131 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.918 ' HB2' HD22 ' A' ' 100' ' ' LEU . . . -73.6 -49.82 24.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.103 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -52.63 -20.03 2.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -90.82 -42.12 10.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -68.3 -50.57 52.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.417 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 4.4 pt-20 -45.24 -29.36 0.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.862 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.417 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 86.5 mt -78.69 -54.67 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.089 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -45.67 -32.59 2.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 132.18 -30.0 3.25 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.479 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.3 m -98.72 146.63 25.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.904 0.383 . . . . 0.0 110.833 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 65.5 m -78.25 174.93 10.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.837 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.918 HD22 ' HB2' ' A' ' 90' ' ' ALA . 22.0 tp -90.67 117.12 29.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.921 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -115.84 141.98 47.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.863 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 25.8 mm -117.28 121.62 32.07 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.649 0.738 . . . . 0.0 111.116 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 166.42 27.63 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.72 2.28 . . . . 0.0 112.315 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -114.04 126.57 55.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.412 HG12 ' HG2' ' A' ' 106' ' ' GLU . 52.0 t -125.4 132.95 70.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.467 ' HG3' ' CD ' ' A' ' 144' ' ' PRO . 29.1 mm-40 56.9 52.05 9.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.404 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 11.8 ptp180 44.64 35.93 1.58 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.909 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.46 ' HG3' ' N ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -157.82 151.95 24.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.9 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.46 ' N ' ' HG3' ' A' ' 108' ' ' LYS . 15.7 tt -57.51 149.2 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.149 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.438 HD23 ' N ' ' A' ' 111' ' ' ASP . 5.9 tt -94.32 123.84 37.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.973 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.438 ' N ' HD23 ' A' ' 110' ' ' LEU . 22.1 t0 -79.99 69.56 6.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.851 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.461 HD12 ' HE2' ' A' ' 85' ' ' TYR . 2.5 pt? -51.25 -23.08 3.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.495 ' CE1' ' HG3' ' A' ' 117' ' ' LYS . 2.4 t80 -66.06 -57.51 7.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.95 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 115' ' ' LEU . 3.3 m -60.5 -59.43 5.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.867 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.423 ' C ' ' O ' ' A' ' 114' ' ' SER . 13.0 tp -36.21 -68.23 0.14 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.897 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 119' ' ' VAL . 42.0 t -50.78 -66.24 0.42 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.87 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.495 ' HG3' ' CE1' ' A' ' 113' ' ' TYR . 13.2 mmtp -36.85 -43.83 0.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.886 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 77.1 mt -64.82 -42.47 95.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.135 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.712 HG13 HG12 ' A' ' 128' ' ' ILE . 95.2 t -59.22 -56.89 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.105 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 70.0 mt -61.46 -45.58 98.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -56.4 -52.09 65.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -50.89 -47.17 60.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.865 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 127' ' ' ALA . . . 155.57 38.56 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.467 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.526 ' O ' HG23 ' A' ' 128' ' ' ILE . . . 87.44 176.27 48.6 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.481 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.566 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 0.6 OUTLIER -83.52 -36.94 23.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.368 . . . . 0.0 110.919 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -63.57 -41.09 98.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.85 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 123' ' ' GLY . . . -68.56 -64.36 0.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.136 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.712 HG12 HG13 ' A' ' 119' ' ' VAL . 2.2 pp -47.84 -32.17 3.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.136 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.439 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 22.1 m -70.18 -46.61 64.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.864 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -59.88 -40.62 89.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.897 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 132' ' ' ARG . 2.7 m-20 -86.65 17.35 3.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.85 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.428 ' HB3' ' NH1' ' A' ' 132' ' ' ARG . 14.5 mtp-105 37.7 45.72 0.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 134' ' ' TRP . 4.1 mmp_? -71.77 -20.15 61.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.561 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 50.5 m95 -36.01 -40.27 0.2 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.908 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.45 -52.65 64.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.076 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.5 mmt-85 -68.5 -38.85 81.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.887 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 78.2 t -56.27 -40.11 63.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.614 ' HB2' HD11 ' A' ' 153' ' ' LEU . . . -72.4 -47.69 47.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -62.04 -27.32 68.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.4 mmp_? -60.97 -35.7 77.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.854 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.495 HD23 ' CZ ' ' A' ' 143' ' ' TYR . 14.8 tp -82.79 13.49 3.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.971 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 62.82 51.13 3.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.668 ' HB3' HD13 ' A' ' 149' ' ' ILE . 2.5 m-85 -91.43 159.68 38.5 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.677 0.751 . . . . 0.0 110.873 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.467 ' CD ' ' HG3' ' A' ' 106' ' ' GLU . 53.8 Cg_endo -69.78 118.47 5.7 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.683 2.255 . . . . 0.0 112.343 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 54.0 Cg_endo -69.72 97.78 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.693 2.262 . . . . 0.0 112.36 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.54 -82.39 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.46 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 9.3 tttp -47.31 147.8 1.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.804 0.335 . . . . 0.0 110.88 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -66.68 82.68 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.895 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.668 HD13 ' HB3' ' A' ' 143' ' ' TYR . 64.0 mt -83.06 -50.77 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.136 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.11 -53.21 1.24 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.526 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.1 t -57.16 -61.59 2.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.903 0.382 . . . . 0.0 110.801 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.424 HD21 ' CD2' ' A' ' 156' ' ' HIS . 5.5 tt -39.12 -55.95 1.54 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.935 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.614 HD11 ' HB2' ' A' ' 138' ' ' ALA . 23.9 mt -50.57 -65.9 0.48 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.561 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 13.2 ttp180 -38.84 -45.78 1.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.4 t -61.12 -69.01 0.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.854 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.424 ' CD2' HD21 ' A' ' 152' ' ' LEU . 2.0 m-70 -39.91 -36.16 0.43 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.799 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.463 ' CD1' ' C ' ' A' ' 157' ' ' TYR . 3.4 t80 -69.78 -58.93 3.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 18.4 mt-10 -66.92 -10.08 45.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.901 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -92.95 -53.08 4.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.812 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.636 HG22 HD11 ' A' ' 89' ' ' ILE . 60.7 mt -104.73 -43.47 8.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.07 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.563 HG22 ' HG3' ' A' ' 165' ' ' GLU . 32.3 mt -76.02 -2.29 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.163 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.624 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -72.2 -60.45 2.24 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.656 0.741 . . . . 0.0 110.931 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 162' ' ' TYR . 53.9 Cg_endo -69.73 -43.56 2.61 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.699 2.266 . . . . 0.0 112.337 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.54 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 17.6 t80 -54.66 -41.55 70.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.563 ' HG3' HG22 ' A' ' 161' ' ' ILE . 14.5 mm-40 -76.26 -68.44 0.59 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.408 ' HG3' ' HA ' ' A' ' 163' ' ' PRO . 0.0 OUTLIER -42.34 -30.25 0.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 24.8 t80 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.9 -179.95 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.601 ' CE1' ' NZ ' ' A' ' 117' ' ' LYS . 42.4 t80 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.905 0.384 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.741 ' CD2' HD21 ' A' ' 112' ' ' LEU . 43.3 mt -55.44 -59.88 4.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.906 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.3 -39.27 66.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.862 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -62.9 -57.83 9.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.456 HD11 HG22 ' A' ' 160' ' ' ILE . 18.0 tt -61.02 -34.99 62.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.14 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.26 -51.27 46.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.09 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -44.14 -35.31 2.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.929 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -72.41 -50.54 25.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.586 ' CD1' HD13 ' A' ' 100' ' ' LEU . 87.0 m95 -63.38 -58.5 6.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.949 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 21.7 pt-20 -37.68 -39.34 0.33 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.451 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 97.2 mt -71.24 -55.09 15.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.125 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -44.71 -35.81 2.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.923 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 120.31 -30.52 5.58 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.497 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.403 ' O ' ' C ' ' A' ' 99' ' ' SER . 0.7 OUTLIER -86.87 94.85 9.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.907 0.384 . . . . 0.0 110.84 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 98' ' ' SER . 51.3 p -38.02 150.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.837 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.586 HD13 ' CD1' ' A' ' 93' ' ' TRP . 18.5 tp -88.06 107.42 18.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.931 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -102.28 115.55 30.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.89 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.47 ' H ' HD12 ' A' ' 102' ' ' ILE . 5.4 mp -81.12 123.1 82.08 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.647 0.737 . . . . 0.0 111.12 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 144.55 54.44 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.671 2.248 . . . . 0.0 112.325 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -102.63 109.47 21.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.916 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 90.4 t -113.32 140.48 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.105 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.47 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 5.7 mm-40 57.45 43.62 22.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.912 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.47 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 5.3 ptm180 48.22 33.49 3.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.901 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -153.71 157.47 39.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 6.8 tt -63.6 139.63 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.114 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.584 HD23 ' N ' ' A' ' 111' ' ' ASP . 4.1 tt -84.85 122.11 28.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.941 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.584 ' N ' HD23 ' A' ' 110' ' ' LEU . 29.8 t0 -80.03 74.04 6.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.741 HD21 ' CD2' ' A' ' 86' ' ' LEU . 1.5 pt? -57.48 -32.08 66.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.901 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.531 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -56.57 -64.32 0.91 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.921 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 115' ' ' LEU . 5.3 m -53.11 -63.97 0.97 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.849 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.74 ' O ' HG23 ' A' ' 119' ' ' VAL . 13.7 tp -34.19 -53.89 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.879 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.3 t -56.46 -64.32 0.91 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.601 ' NZ ' ' CE1' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -45.23 -51.41 10.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.9 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 69.8 mt -54.33 -40.96 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.144 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 115' ' ' LEU . 96.9 t -66.2 -39.46 84.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.089 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 62.0 mt -70.28 -55.21 15.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.128 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.481 ' HG3' ' N ' ' A' ' 122' ' ' GLU . 5.6 pt-20 -49.31 -37.55 24.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.889 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.481 ' N ' ' HG3' ' A' ' 121' ' ' GLU . 35.7 mt-10 -65.41 -27.23 68.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.845 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 134.86 28.44 0.45 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.462 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.99 -175.65 35.37 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.495 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.485 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 1.1 t80 -86.25 -38.6 17.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.827 0.346 . . . . 0.0 110.933 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -62.37 -48.39 79.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.897 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -53.75 -71.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.09 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.522 HG12 HG13 ' A' ' 119' ' ' VAL . 1.6 pp -46.31 -34.86 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 25.7 m -69.01 -32.58 72.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.855 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -68.46 -46.64 69.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 132' ' ' ARG . 1.1 m-20 -90.11 24.62 2.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 131' ' ' ASP . 23.6 mmt85 35.45 44.9 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.624 ' O ' HG23 ' A' ' 137' ' ' VAL . 71.1 mtt85 -83.91 21.69 1.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.842 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.525 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 28.5 m95 -66.16 -42.77 88.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.45 -47.9 75.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.086 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -47.53 78.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 133' ' ' ARG . 73.1 t -53.88 -37.89 34.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.153 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.614 ' HB2' HD11 ' A' ' 153' ' ' LEU . . . -66.91 -53.12 35.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.097 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -58.31 -38.22 76.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.908 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -59.19 -31.61 69.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.96 HD12 ' CE2' ' A' ' 143' ' ' TYR . 1.5 tm? -80.77 12.52 3.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 65.71 53.53 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.839 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.96 ' CE2' HD12 ' A' ' 141' ' ' LEU . 6.6 m-85 -109.0 159.01 32.69 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.636 0.731 . . . . 0.0 110.956 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 112.5 3.1 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.712 2.274 . . . . 0.0 112.333 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 122.43 9.12 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.674 2.249 . . . . 0.0 112.372 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.96 -70.1 0.3 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.488 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -58.15 171.0 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.764 0.316 . . . . 0.0 110.915 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.2 42.2 1.02 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.917 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.423 ' O ' ' C ' ' A' ' 150' ' ' GLY . 92.1 mt -44.5 -45.02 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.151 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.05 -54.78 1.19 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.511 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.9 m -58.93 -50.26 74.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.948 0.404 . . . . 0.0 110.834 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.54 ' C ' HD23 ' A' ' 152' ' ' LEU . 8.3 tt -51.74 -50.13 61.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.956 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.614 HD11 ' HB2' ' A' ' 138' ' ' ALA . 25.5 mt -52.94 -64.73 0.72 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.902 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.525 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 14.3 ttp180 -41.1 -46.02 2.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 47.3 t -57.92 -58.88 6.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.841 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -51.98 -49.21 63.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.535 ' HA ' HD12 ' A' ' 161' ' ' ILE . 3.8 t80 -57.79 -57.59 12.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.963 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.471 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 39.0 mt-10 -66.88 -9.8 41.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.877 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 37.4 ttt-85 -87.76 -57.4 2.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.857 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.456 HG22 HD11 ' A' ' 89' ' ' ILE . 78.6 mt -104.76 -41.22 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.169 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.574 HG22 ' HG3' ' A' ' 165' ' ' GLU . 14.2 mt -75.96 -0.48 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.113 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.634 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -73.32 -61.31 1.48 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.716 0.769 . . . . 0.0 110.941 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.477 ' HA ' ' CG ' ' A' ' 166' ' ' MET . 53.8 Cg_endo -69.7 -33.65 16.38 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.737 2.292 . . . . 0.0 112.341 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.409 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 24.5 t80 -64.75 -46.38 82.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.887 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.574 ' HG3' HG22 ' A' ' 161' ' ' ILE . 4.9 mm-40 -69.29 -55.46 10.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.865 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.477 ' CG ' ' HA ' ' A' ' 163' ' ' PRO . 0.5 OUTLIER -55.02 -40.83 70.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 44.7 t80 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.878 -179.961 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.503 ' CD2' ' HA ' ' A' ' 113' ' ' TYR . 29.9 t80 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.905 0.384 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.8 HD21 HD21 ' A' ' 112' ' ' LEU . 95.6 mt -62.55 -41.99 99.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.899 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -61.76 -18.06 58.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -91.55 -57.33 2.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.96 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.498 HD11 HG22 ' A' ' 160' ' ' ILE . 15.6 tt -63.5 -39.39 85.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.149 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.485 ' HB2' ' CD2' ' A' ' 100' ' ' LEU . . . -67.03 -38.86 86.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.09 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -61.29 -28.5 69.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -82.58 -39.44 22.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.875 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.487 ' O ' ' N ' ' A' ' 96' ' ' GLN . 27.0 m95 -68.35 -61.05 2.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.442 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 5.7 pt-20 -36.96 -31.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.925 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 93' ' ' TRP . 96.7 mt -73.4 -45.41 52.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.101 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 93' ' ' TRP . 61.2 mm-40 -56.51 -33.07 65.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 131.78 -42.24 1.41 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.472 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 37.9 m -86.71 140.32 29.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.913 0.387 . . . . 0.0 110.848 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.0 p -71.17 175.31 5.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.87 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.489 HD22 HG23 ' A' ' 89' ' ' ILE . 25.5 tp -104.35 112.12 25.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.1 ttpt -109.67 130.46 55.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.1 mp -96.04 124.17 52.82 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.586 0.707 . . . . 0.0 111.15 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.444 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 54.2 Cg_endo -69.76 142.87 49.1 Favored 'Trans proline' 0 N--CA 1.466 -0.125 0 C-N-CA 122.707 2.272 . . . . 0.0 112.363 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -94.27 113.7 25.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.898 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.5 t -113.17 142.68 24.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.091 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 19.1 mm-40 50.61 48.62 22.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.911 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.434 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 18.4 ptt-85 45.72 33.22 1.41 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.868 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.8 pttm -151.6 164.76 36.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.856 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.4 tt -69.22 144.82 13.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.119 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 112' ' ' LEU . 6.4 tt -92.97 121.76 34.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.939 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -79.88 57.36 2.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.876 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.8 HD21 HD21 ' A' ' 86' ' ' LEU . 1.5 pt? -41.57 -29.29 0.16 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.503 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 4.9 t80 -59.31 -58.72 7.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.934 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 115' ' ' LEU . 11.0 t -56.05 -57.67 11.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.89 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 114' ' ' SER . 11.1 tp -36.76 -62.76 0.45 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.915 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.7 p -51.13 -53.93 29.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.853 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 18.2 mmtm -49.27 -54.2 17.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.409 ' O ' ' C ' ' A' ' 119' ' ' VAL . 64.6 mt -49.06 -69.22 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.13 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.631 HG13 HG12 ' A' ' 128' ' ' ILE . 90.8 t -37.09 -62.37 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.107 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 89.0 mt -45.18 -56.43 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -52.57 -56.89 12.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.45 ' OE1' HG21 ' A' ' 128' ' ' ILE . 46.8 mt-10 -38.36 -50.35 1.48 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 151.26 39.25 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.492 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.3 -179.43 40.65 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.504 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.499 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 1.9 t80 -87.56 -43.79 11.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.845 0.355 . . . . 0.0 110.931 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -61.28 -36.1 79.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.912 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.92 -65.58 0.66 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.13 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.849 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.8 pp -54.15 -31.8 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.087 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.499 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 26.8 m -70.81 -41.92 70.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.831 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -68.88 -26.44 65.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.855 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -103.03 15.71 28.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.821 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 67.5 mtp85 41.91 29.36 0.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.856 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 27.7 mtt-85 -62.15 -8.78 6.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.839 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.849 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 20.7 m95 -44.13 -52.18 7.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -40.83 -51.18 3.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.099 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -63.63 -51.38 65.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.857 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.6 t -49.4 -38.39 12.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.54 ' HB2' ' CD1' ' A' ' 153' ' ' LEU . . . -70.24 -57.48 4.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -57.87 -18.25 21.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -69.94 -25.36 63.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.857 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.58 HD23 ' CE2' ' A' ' 143' ' ' TYR . 14.6 tp -94.28 27.18 3.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 62.25 36.48 14.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.849 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.58 ' CE2' HD23 ' A' ' 141' ' ' LEU . 5.3 m-85 -92.2 147.29 34.33 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.706 0.765 . . . . 0.0 110.925 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.472 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.6 Cg_endo -69.79 118.95 5.99 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.68 2.253 . . . . 0.0 112.34 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 125.81 12.58 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.702 2.268 . . . . 0.0 112.338 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 131.76 -55.61 0.76 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.427 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -54.6 168.67 0.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.762 0.315 . . . . 0.0 110.947 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.422 ' CG ' ' O ' ' A' ' 148' ' ' ASN . 13.1 p-10 -83.86 43.36 0.91 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.91 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.472 HD11 ' HG2' ' A' ' 144' ' ' PRO . 70.5 mt -67.74 -52.51 39.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.096 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.28 -53.07 1.3 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.488 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.2 t -57.53 -58.62 7.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 0.0 110.849 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.647 HD21 ' CD2' ' A' ' 156' ' ' HIS . 7.2 tt -42.06 -49.46 4.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.943 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.54 ' CD1' ' HB2' ' A' ' 138' ' ' ALA . 23.6 mt -55.98 -65.84 0.53 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.938 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.443 ' HD2' ' NE1' ' A' ' 134' ' ' TRP . 32.0 ttt180 -39.21 -39.97 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 156' ' ' HIS . 9.3 t -67.56 -70.01 0.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.861 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.647 ' CD2' HD21 ' A' ' 152' ' ' LEU . 2.0 m-70 -37.17 -33.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.86 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.447 ' HA ' ' CG1' ' A' ' 161' ' ' ILE . 12.0 t80 -70.38 -56.27 7.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -73.59 -9.81 59.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.858 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? -92.07 -49.0 6.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.908 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.498 HG22 HD11 ' A' ' 89' ' ' ILE . 88.3 mt -109.91 -44.18 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.118 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.553 HG22 ' CG ' ' A' ' 165' ' ' GLU . 14.3 mt -77.45 4.24 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.148 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.606 ' CE1' ' SD ' ' A' ' 166' ' ' MET . 0.1 OUTLIER -74.24 -61.48 1.21 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.662 0.744 . . . . 0.0 110.905 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.564 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 54.2 Cg_endo -69.73 -30.71 21.98 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.649 2.232 . . . . 0.0 112.354 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -69.2 -42.58 75.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.973 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.553 ' CG ' HG22 ' A' ' 161' ' ' ILE . 3.9 mm-40 -67.8 -57.65 5.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.878 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.606 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 24.7 ptm -53.42 -47.7 69.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 31.8 t80 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.897 -179.926 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.497 ' HE2' HD12 ' A' ' 112' ' ' LEU . 40.3 t80 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.883 0.373 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.2 mt -76.48 -44.29 36.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -59.33 -38.81 81.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.859 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -66.25 -63.76 1.01 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.898 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.564 ' HA ' ' CE1' ' A' ' 164' ' ' TYR . 19.4 tt -52.54 -30.5 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.03 -56.24 6.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.059 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -44.24 -27.5 0.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.939 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -78.68 -46.75 18.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.43 ' O ' ' N ' ' A' ' 95' ' ' ILE . 66.2 m95 -69.2 -57.68 5.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.96 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 93' ' ' TRP . 9.2 pt-20 -36.91 -32.53 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.43 ' N ' ' O ' ' A' ' 93' ' ' TRP . 96.7 mt -76.22 -51.75 19.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.173 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -47.58 -40.12 18.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.06 -40.57 1.17 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.47 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.7 m -96.56 144.51 26.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.892 0.377 . . . . 0.0 110.833 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.5 t -76.64 171.68 14.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.86 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.5 tp -82.46 104.71 12.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.964 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -96.13 111.07 23.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.0 mt -94.35 119.56 66.33 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.603 0.716 . . . . 0.0 111.158 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.408 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 53.5 Cg_endo -69.75 151.22 69.1 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.676 2.251 . . . . 0.0 112.36 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -102.52 115.17 30.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.853 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.916 HG12 ' CD ' ' A' ' 106' ' ' GLU . 26.2 t -122.04 144.61 30.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.174 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.916 ' CD ' HG12 ' A' ' 105' ' ' VAL . 49.1 mp0 60.76 44.74 10.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.92 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.496 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 15.2 ptm180 46.43 39.79 7.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.876 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -171.0 154.0 3.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.865 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.8 tt -52.29 138.67 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.877 HD23 ' N ' ' A' ' 111' ' ' ASP . 5.4 tt -75.04 144.73 42.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.877 ' N ' HD23 ' A' ' 110' ' ' LEU . 13.3 t0 -103.41 75.05 1.31 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.873 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.779 HD23 ' H ' ' A' ' 112' ' ' LEU . 1.4 pt? -65.12 -36.18 83.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.9 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -46.71 -64.76 0.69 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 115' ' ' LEU . 36.6 m -56.93 -60.01 4.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.87 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 114' ' ' SER . 13.1 tp -34.93 -65.24 0.23 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.917 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 52.4 m -48.37 -56.88 7.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.868 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.415 ' HD2' ' N ' ' A' ' 117' ' ' LYS . 2.2 mptp? -49.77 -62.58 1.48 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.891 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 95.6 mt -38.46 -64.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.157 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.537 HG13 HG12 ' A' ' 128' ' ' ILE . 76.2 t -45.0 -59.13 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.112 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 79.2 mt -45.91 -34.81 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.141 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -76.67 -51.77 10.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.895 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -43.54 -46.36 6.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.896 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 127' ' ' ALA . . . 151.69 37.15 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.505 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.461 ' O ' HG23 ' A' ' 128' ' ' ILE . . . 88.59 173.97 47.08 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.477 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 2.4 t80 -82.47 -44.34 16.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.849 0.357 . . . . 0.0 110.929 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -59.67 -42.59 93.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.848 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 123' ' ' GLY . . . -63.15 -70.96 0.18 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.094 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.537 HG12 HG13 ' A' ' 119' ' ' VAL . 1.9 pp -45.28 -32.74 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.157 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.457 ' N ' HD12 ' A' ' 128' ' ' ILE . 22.3 m -68.77 -39.66 80.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -66.27 -41.77 89.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 132' ' ' ARG . 2.1 t70 -88.56 19.89 3.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.886 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.429 ' C ' ' O ' ' A' ' 131' ' ' ASP . 26.1 mtt180 35.47 51.92 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 134' ' ' TRP . 23.4 mtp180 -80.75 -14.54 58.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.827 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.556 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 42.6 m95 -37.56 -56.61 1.01 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.921 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -40.08 -55.83 2.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.105 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 19.8 mmt85 -60.97 -51.49 69.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 84.1 t -46.17 -37.94 3.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.124 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -73.61 -45.47 52.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.088 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -62.99 -17.41 62.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.932 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.9 mmt85 -76.61 -28.99 56.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.92 HD23 ' CZ ' ' A' ' 143' ' ' TYR . 14.7 tp -91.88 20.1 6.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.938 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 54.62 52.98 11.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.841 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.92 ' CZ ' HD23 ' A' ' 141' ' ' LEU . 4.9 m-85 -89.42 148.33 40.19 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.676 0.75 . . . . 0.0 110.9 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.49 ' CD ' ' HG2' ' A' ' 106' ' ' GLU . 54.0 Cg_endo -69.71 114.57 3.74 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.733 2.288 . . . . 0.0 112.362 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 132.62 23.77 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.701 2.267 . . . . 0.0 112.37 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.36 -63.14 0.6 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.459 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -70.23 156.78 38.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.822 0.344 . . . . 0.0 110.911 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.417 ' CG ' ' O ' ' A' ' 148' ' ' ASN . 16.5 p-10 -75.14 83.84 2.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.873 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.428 ' O ' ' C ' ' A' ' 150' ' ' GLY . 51.5 mt -92.2 -52.09 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.124 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.25 -54.97 1.24 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.473 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 68.0 m -57.91 -53.83 53.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.862 0.363 . . . . 0.0 110.862 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.766 HD21 ' CD2' ' A' ' 156' ' ' HIS . 5.3 tt -46.37 -49.76 17.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.928 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 26.5 mt -56.33 -66.07 0.5 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.556 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 9.7 ttt-85 -38.32 -40.31 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 156' ' ' HIS . 11.5 t -68.16 -71.15 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.766 ' CD2' HD21 ' A' ' 152' ' ' LEU . 2.2 m-70 -37.03 -37.91 0.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.872 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.415 ' HA ' ' CG1' ' A' ' 161' ' ' ILE . 7.8 t80 -65.01 -66.58 0.52 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.933 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 20.2 mm-40 -64.91 -9.94 25.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.911 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 20.3 mmm-85 -86.81 -56.25 3.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.845 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.409 HG22 HD11 ' A' ' 89' ' ' ILE . 62.2 mt -105.7 -43.74 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.096 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.48 ' O ' HG22 ' A' ' 161' ' ' ILE . 13.2 mt -72.61 -0.69 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.159 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.647 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -75.67 -63.24 0.68 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.675 0.75 . . . . 0.0 110.89 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.559 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 54.3 Cg_endo -69.75 -31.26 20.93 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.661 2.241 . . . . 0.0 112.355 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.564 ' CE1' ' HA ' ' A' ' 89' ' ' ILE . 14.5 t80 -64.5 -36.31 83.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.925 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.431 ' HG3' HG22 ' A' ' 161' ' ' ILE . 13.4 mt-10 -77.32 -56.17 4.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.846 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.51 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 13.1 ptt? -52.4 -43.79 64.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.878 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.408 ' N ' ' CG ' ' A' ' 166' ' ' MET . 54.5 t80 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.888 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.488 ' HE2' HD12 ' A' ' 112' ' ' LEU . 33.0 t80 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.953 0.406 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.579 ' CD2' HD21 ' A' ' 112' ' ' LEU . 28.1 mt -70.13 -59.31 2.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.945 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.42 -33.14 42.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -66.49 -67.75 0.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.552 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 8.2 tt -50.18 -37.27 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.093 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.28 -52.76 44.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.073 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.0 tttm -45.32 -30.68 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.551 ' CD1' ' CD2' ' A' ' 167' ' ' PHE . 8.3 t80 -79.46 -39.67 31.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.891 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.505 ' CD1' HD13 ' A' ' 100' ' ' LEU . 61.9 m95 -70.31 -64.21 0.94 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.924 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.447 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 6.0 pt-20 -34.82 -33.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' A' ' 93' ' ' TRP . 96.5 mt -74.02 -50.33 29.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.116 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 93' ' ' TRP . 28.8 mm-40 -55.59 -18.64 8.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.929 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 104.12 -37.42 3.77 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.496 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.7 p -79.35 92.77 5.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.824 0.345 . . . . 0.0 110.842 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 40.8 t -41.46 159.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.832 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.505 HD13 ' CD1' ' A' ' 93' ' ' TRP . 64.4 tp -93.29 143.78 25.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.958 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -138.61 121.14 16.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.918 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 60.8 mt -88.68 123.11 68.61 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.627 0.727 . . . . 0.0 111.118 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 158.8 55.7 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.665 2.243 . . . . 0.0 112.388 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -110.76 107.38 16.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.906 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 58.3 t -110.72 136.1 47.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.092 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.499 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 36.2 mm-40 61.35 44.46 9.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.944 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.499 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 14.3 ptp180 46.57 33.55 2.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.873 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.3 ptmm? -155.82 155.47 33.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.926 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.4 tt -57.5 145.57 8.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.158 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.527 ' C ' HD23 ' A' ' 110' ' ' LEU . 4.8 tt -96.14 113.66 25.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.935 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.449 ' N ' HD23 ' A' ' 110' ' ' LEU . 16.9 t70 -79.84 80.72 6.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.617 HD23 ' H ' ' A' ' 112' ' ' LEU . 1.9 pt? -53.13 -42.42 66.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.926 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.478 ' N ' ' HG ' ' A' ' 112' ' ' LEU . 15.0 t80 -41.25 -53.59 3.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.918 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.8 m -61.27 -45.84 92.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.85 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.402 ' O ' HG23 ' A' ' 119' ' ' VAL . 15.6 tp -55.95 -63.76 1.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 73.5 m -50.52 -44.69 56.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.857 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.46 ' HE2' ' CE1' ' A' ' 113' ' ' TYR . 28.7 mmtt -60.44 -66.11 0.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.908 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.485 ' CG2' HG13 ' A' ' 137' ' ' VAL . 21.3 mt -43.72 -28.17 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.133 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 115' ' ' LEU . 43.3 t -77.12 -40.88 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.12 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 67.9 mt -72.3 -41.4 65.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.171 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -62.42 -37.15 84.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.457 ' OE1' HG22 ' A' ' 128' ' ' ILE . 10.5 mt-10 -66.21 -26.96 67.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.905 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 135.08 29.86 0.38 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.461 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.3 -173.37 34.21 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.494 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.525 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 2.6 t80 -86.98 -43.79 12.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.884 0.373 . . . . 0.0 110.914 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -60.97 -37.43 82.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.876 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.8 -68.64 0.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.058 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.704 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.6 pp -52.34 -35.78 20.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.119 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.525 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 54.5 m -64.5 -36.47 84.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.59 -41.39 79.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 132' ' ' ARG . 16.3 m-20 -94.78 20.48 8.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.892 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 131' ' ' ASP . 24.7 ptt85 35.21 48.2 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.839 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -85.72 17.92 3.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.841 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.704 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 41.8 m95 -60.39 -48.85 79.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.938 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -48.42 -47.4 37.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.126 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.42 ' HB3' ' NH1' ' A' ' 136' ' ' ARG . 5.4 mmm180 -61.91 -58.56 7.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.485 HG13 ' CG2' ' A' ' 118' ' ' ILE . 98.5 t -46.75 -31.88 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.61 -58.34 4.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.088 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -52.59 -29.51 26.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 140' ' ' ARG . 5.9 mmm180 -52.82 -39.68 62.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.883 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.64 HD23 ' CZ ' ' A' ' 143' ' ' TYR . 14.8 tp -82.93 17.93 1.77 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.92 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 61.67 43.09 10.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.64 ' CZ ' HD23 ' A' ' 141' ' ' LEU . 3.3 m-85 -83.25 152.37 64.57 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.689 0.757 . . . . 0.0 110.947 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.533 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.8 Cg_endo -69.76 114.13 3.6 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.692 2.261 . . . . 0.0 112.331 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 53.7 Cg_endo -69.76 109.33 2.28 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.679 2.252 . . . . 0.0 112.349 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 154.94 -67.95 0.3 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.49 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -60.93 152.02 28.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.801 0.334 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -68.11 82.55 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.849 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.533 HD11 ' HG2' ' A' ' 144' ' ' PRO . 90.5 mt -92.61 -46.52 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -37.39 -58.3 1.36 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.491 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.8 m -56.71 -48.01 78.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.91 0.386 . . . . 0.0 110.846 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.415 ' C ' HD23 ' A' ' 152' ' ' LEU . 6.7 tt -50.57 -51.34 49.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.9 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 11.1 mt -57.51 -65.96 0.54 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.557 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 23.9 ttp180 -38.45 -55.02 1.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.86 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.428 ' OG ' ' N ' ' A' ' 156' ' ' HIS . 48.1 p -50.41 -64.72 0.72 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.824 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.428 ' N ' ' OG ' ' A' ' 155' ' ' SER . 2.0 m-70 -43.04 -34.06 0.95 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.517 ' CD1' ' HB ' ' A' ' 161' ' ' ILE . 3.1 t80 -69.71 -69.55 0.34 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.476 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 3.3 mp0 -61.24 -10.11 6.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.88 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 10.6 tpp85 -84.59 -53.35 5.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.435 HG22 HD11 ' A' ' 89' ' ' ILE . 74.1 mt -110.48 -39.18 3.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.151 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.517 ' HB ' ' CD1' ' A' ' 157' ' ' TYR . 13.7 mt -77.04 -0.69 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.115 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.543 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -72.02 -60.34 2.38 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.65 0.738 . . . . 0.0 110.882 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.495 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.8 Cg_endo -69.78 -36.69 10.29 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.668 2.245 . . . . 0.0 112.324 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.552 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 15.3 t80 -59.47 -46.32 89.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.975 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -69.03 -60.17 2.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.924 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.443 ' CG ' ' HA ' ' A' ' 163' ' ' PRO . 0.0 OUTLIER -54.15 -39.33 66.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.551 ' CD2' ' CD1' ' A' ' 92' ' ' PHE . 57.5 t80 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.866 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.467 ' HE2' HD12 ' A' ' 112' ' ' LEU . 69.3 t80 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.936 0.398 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.756 ' CD2' HD21 ' A' ' 112' ' ' LEU . 35.0 mt -70.15 -63.68 1.04 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.887 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -44.46 -27.21 0.42 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.849 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -78.15 -67.6 0.72 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.93 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.575 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 7.9 tt -45.64 -43.0 3.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.412 ' N ' HG23 ' A' ' 89' ' ' ILE . . . -62.34 -53.42 55.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.079 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -42.07 -41.54 2.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.867 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -68.77 -43.8 74.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.871 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.642 ' CD1' HD13 ' A' ' 100' ' ' LEU . 45.4 m95 -62.27 -64.52 0.9 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 7.7 pt-20 -36.37 -41.38 0.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.858 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.435 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 85.6 mt -65.09 -49.82 77.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.133 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -49.61 -44.56 47.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.39 -49.64 0.61 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.488 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 32.5 t -90.15 130.98 36.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.908 0.385 . . . . 0.0 110.884 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.7 m -65.14 164.51 12.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.862 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.642 HD13 ' CD1' ' A' ' 93' ' ' TRP . 54.8 tp -93.34 154.17 18.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.942 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.7 mmmt -145.09 126.47 14.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.873 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.65 122.67 67.94 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.661 0.743 . . . . 0.0 111.149 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.718 ' HG2' HD13 ' A' ' 110' ' ' LEU . 53.9 Cg_endo -69.77 161.49 45.74 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.709 2.273 . . . . 0.0 112.329 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -117.08 117.66 30.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 72.2 t -121.57 140.26 46.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.143 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 107' ' ' ARG . 2.6 mm-40 56.29 54.99 7.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.43 ' NH1' ' HB3' ' A' ' 107' ' ' ARG . 4.2 ptp180 37.09 39.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -157.42 150.16 23.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.9 tt -54.47 140.03 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.155 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.718 HD13 ' HG2' ' A' ' 103' ' ' PRO . 4.1 tt -86.45 119.13 26.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.511 ' N ' HD23 ' A' ' 110' ' ' LEU . 28.5 t0 -86.76 88.62 7.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.81 HD23 ' H ' ' A' ' 112' ' ' LEU . 1.5 pt? -73.72 -22.38 59.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.455 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 5.6 t80 -59.65 -54.71 43.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 115' ' ' LEU . 58.9 p -61.13 -55.22 34.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.887 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.448 ' C ' ' O ' ' A' ' 114' ' ' SER . 27.3 tp -34.67 -59.28 0.47 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.917 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.8 t -59.99 -55.77 29.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.863 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -43.42 -45.54 6.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.884 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.42 HG21 HG13 ' A' ' 137' ' ' VAL . 27.3 mt -63.44 -45.69 97.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.13 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.9 t -51.33 -56.03 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.135 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 84.1 mt -56.32 -46.58 81.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.123 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -56.46 -56.8 16.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.462 ' HB2' ' CG2' ' A' ' 128' ' ' ILE . 33.2 mm-40 -40.69 -52.85 2.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 155.26 34.16 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.488 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.39 178.58 34.13 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.479 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.574 ' CE2' ' SG ' ' A' ' 129' ' ' CYS . 3.4 t80 -81.7 -55.77 4.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.889 0.376 . . . . 0.0 110.951 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -51.47 -29.64 17.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.905 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.06 -71.21 0.29 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.091 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.747 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.9 pp -50.38 -31.7 8.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.096 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.574 ' SG ' ' CE2' ' A' ' 125' ' ' TYR . 94.3 m -69.5 -44.07 71.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.886 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.1 tttm -64.26 -39.57 94.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 132' ' ' ARG . 80.2 m-20 -91.83 23.31 3.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.453 ' C ' ' O ' ' A' ' 131' ' ' ASP . 83.9 mtm180 34.24 35.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.9 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 131' ' ' ASP . 10.7 mmp_? -60.23 -19.49 54.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.846 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.747 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 24.8 m95 -36.6 -43.44 0.41 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.925 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.42 -56.99 14.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.036 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.419 ' HB2' ' NH1' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -59.91 -43.28 94.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.42 HG13 HG21 ' A' ' 118' ' ' ILE . 69.2 t -54.76 -36.61 37.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.107 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.09 -52.41 24.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.083 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -56.23 -37.24 69.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -51.39 -32.44 26.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.839 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.717 HD23 ' CE2' ' A' ' 143' ' ' TYR . 14.6 tp -83.52 17.48 2.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.931 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 66.65 33.99 6.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.84 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.717 ' CE2' HD23 ' A' ' 141' ' ' LEU . 2.5 m-85 -84.34 157.81 61.5 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.658 0.742 . . . . 0.0 110.947 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.55 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.8 Cg_endo -69.78 110.36 2.54 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.685 2.257 . . . . 0.0 112.364 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.474 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 53.6 Cg_endo -69.74 94.51 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.695 2.264 . . . . 0.0 112.315 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 165.25 -61.46 0.24 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.445 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 61.5 mttt -57.12 152.98 12.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.816 0.341 . . . . 0.0 110.913 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -69.88 75.75 0.46 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.55 HD11 ' HG2' ' A' ' 144' ' ' PRO . 84.7 mt -89.22 -54.94 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.146 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.46 -47.99 1.19 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.455 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.3 m -61.64 -53.3 57.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.905 0.384 . . . . 0.0 110.889 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.5 tt -51.33 -51.56 53.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.927 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.446 ' CD1' HG22 ' A' ' 149' ' ' ILE . 30.4 mt -57.61 -65.79 0.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.943 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.536 ' HG3' ' CE2' ' A' ' 134' ' ' TRP . 1.7 ttm105 -39.93 -38.77 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.844 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 69.6 m -66.6 -57.82 6.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -56.03 -26.2 47.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.866 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.524 ' CD2' HD12 ' A' ' 161' ' ' ILE . 5.0 t80 -78.82 -46.92 17.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.923 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.488 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 2.5 mm-40 -79.97 -10.14 59.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.873 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 44.6 ttt85 -100.85 -35.19 9.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.482 HG22 HD11 ' A' ' 89' ' ' ILE . 62.0 mt -112.54 -50.93 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.108 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.524 HD12 ' CD2' ' A' ' 157' ' ' TYR . 18.9 mt -77.17 0.04 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.152 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.52 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -72.29 -60.46 2.19 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.63 0.728 . . . . 0.0 110.92 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.505 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.8 Cg_endo -69.79 -37.66 8.79 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.654 2.236 . . . . 0.0 112.355 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.575 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 28.7 t80 -60.31 -38.83 84.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -74.45 -58.09 3.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.899 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 16.7 ptt? -51.17 -40.23 58.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 36.2 t80 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.882 -179.94 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 58.7 t80 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.893 0.378 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.8 mt -71.21 -61.02 1.92 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.896 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -52.11 -24.05 6.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.817 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -77.89 -69.96 0.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.531 HD11 HG22 ' A' ' 160' ' ' ILE . 9.0 tt -43.98 -36.11 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.133 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.55 ' HB2' HD22 ' A' ' 100' ' ' LEU . . . -73.8 -44.78 54.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.086 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -54.61 -27.93 42.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.849 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.483 ' CE2' ' HA ' ' A' ' 164' ' ' TYR . 4.4 t80 -85.71 -29.97 23.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.874 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 30.4 m95 -75.42 -59.23 2.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.929 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -42.45 -29.55 0.28 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.885 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 85.9 mt -75.72 -47.61 32.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.166 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -51.91 -42.39 62.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 148.54 -36.49 1.08 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.476 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 40.1 m -101.77 155.9 17.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 110.9 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.5 t -83.27 178.08 8.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.851 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.55 HD22 ' HB2' ' A' ' 90' ' ' ALA . 29.4 tp -93.79 138.58 31.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.871 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -137.55 123.6 20.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.546 HD12 HD22 ' A' ' 112' ' ' LEU . 51.0 mm -96.25 124.24 52.15 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.584 0.706 . . . . 0.0 111.193 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.544 ' HG3' ' CD2' ' A' ' 156' ' ' HIS . 53.9 Cg_endo -69.72 152.05 69.44 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.679 2.252 . . . . 0.0 112.321 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -101.96 111.41 23.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.876 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.3 t -108.79 137.57 40.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.13 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.413 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 57.7 mm-40 50.07 54.22 11.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.413 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 1.2 ptp180 43.61 37.51 1.55 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.822 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -155.32 169.88 23.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.867 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.5 tt -75.05 143.96 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.524 HD23 ' N ' ' A' ' 111' ' ' ASP . 4.6 tt -89.86 119.28 30.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.935 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.524 ' N ' HD23 ' A' ' 110' ' ' LEU . 40.0 t0 -73.32 71.36 1.24 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.596 HD23 ' H ' ' A' ' 112' ' ' LEU . 1.6 pt? -56.24 -21.26 22.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -71.67 -62.59 1.36 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.929 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 115' ' ' LEU . 4.2 t -50.02 -58.9 4.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.884 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.449 ' C ' ' O ' ' A' ' 114' ' ' SER . 10.0 tp -34.59 -67.48 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.928 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.1 p -48.07 -52.88 18.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -48.36 -52.51 21.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.944 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.605 HG21 HG13 ' A' ' 137' ' ' VAL . 77.7 mt -57.82 -42.15 81.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.111 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.508 HG13 HG12 ' A' ' 128' ' ' ILE . 95.2 t -59.81 -38.45 76.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.135 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 82.3 mt -71.27 -57.92 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.15 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.529 ' CG ' ' N ' ' A' ' 122' ' ' GLU . 8.1 pt-20 -56.57 -49.49 74.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.916 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.529 ' N ' ' CG ' ' A' ' 121' ' ' GLU . 38.0 mm-40 -47.91 -35.05 9.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.905 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.662 ' O ' ' HB3' ' A' ' 127' ' ' ALA . . . 139.1 43.16 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.448 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.79 -179.42 52.58 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.472 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.51 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 1.1 t80 -89.06 -40.12 13.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.853 0.359 . . . . 0.0 110.931 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -60.94 -45.85 93.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.858 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.662 ' HB3' ' O ' ' A' ' 123' ' ' GLY . . . -62.09 -71.35 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.086 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.567 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 2.2 pp -41.96 -36.32 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.145 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.468 ' N ' HD12 ' A' ' 128' ' ' ILE . 22.1 m -65.83 -40.97 92.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 127' ' ' ALA . 12.9 ttmm -68.95 -26.24 64.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 132' ' ' ARG . 4.2 t0 -100.87 19.38 17.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 131' ' ' ASP . 13.3 mmt85 36.11 54.6 0.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' A' ' 134' ' ' TRP . 14.7 mmt180 -81.81 -25.21 35.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.864 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.567 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 24.2 m95 -34.04 -40.06 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.59 -59.86 4.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.113 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.455 ' O ' ' CD ' ' A' ' 140' ' ' ARG . 38.2 mmt180 -62.28 -50.38 71.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.859 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.605 HG13 HG21 ' A' ' 118' ' ' ILE . 89.4 t -43.57 -46.84 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.146 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.87 -47.85 73.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.075 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -55.27 -32.97 62.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.455 ' CD ' ' O ' ' A' ' 136' ' ' ARG . 0.2 OUTLIER -59.81 -32.04 70.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.848 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.458 HD23 ' CZ ' ' A' ' 143' ' ' TYR . 12.8 tp -80.38 13.74 2.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.911 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 65.0 51.31 1.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.458 ' CZ ' HD23 ' A' ' 141' ' ' LEU . 2.5 m-85 -94.87 156.78 37.7 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.679 0.752 . . . . 0.0 110.94 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.465 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.8 Cg_endo -69.81 122.23 8.89 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.718 2.279 . . . . 0.0 112.328 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 118.34 5.62 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.701 2.267 . . . . 0.0 112.295 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.53 -67.56 0.56 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.476 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.04 135.61 12.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.802 0.334 . . . . 0.0 110.9 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -65.86 75.43 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.465 HD11 ' HG2' ' A' ' 144' ' ' PRO . 89.9 mt -86.93 -51.17 13.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.165 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -37.12 -47.66 1.41 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.492 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.0 t -63.86 -52.39 60.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.923 0.392 . . . . 0.0 110.887 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.424 ' C ' HD23 ' A' ' 152' ' ' LEU . 7.2 tt -47.21 -53.3 13.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.878 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 30.9 mt -56.04 -65.72 0.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.929 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.54 ' NE ' ' CD1' ' A' ' 134' ' ' TRP . 6.4 ttm180 -40.64 -33.2 0.26 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.882 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 36.1 t -71.86 -52.57 16.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.862 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.544 ' CD2' ' HG3' ' A' ' 103' ' ' PRO . 3.6 m-70 -60.46 -31.48 70.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.845 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.492 ' CD1' ' C ' ' A' ' 157' ' ' TYR . 2.3 t80 -79.25 -30.54 43.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.891 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.505 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 1.9 mm-40 -91.06 -9.93 43.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.913 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -107.5 -45.81 3.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.868 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.531 HG22 HD11 ' A' ' 89' ' ' ILE . 59.3 mt -97.07 -53.73 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.142 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.437 ' CG1' ' HA ' ' A' ' 157' ' ' TYR . 20.0 mt -75.17 -6.07 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.13 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.524 ' CD2' ' HD3' ' A' ' 163' ' ' PRO . 0.3 OUTLIER -70.57 -59.79 3.61 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.619 0.723 . . . . 0.0 110.907 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.524 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.9 Cg_endo -69.71 -36.34 11.12 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.699 2.266 . . . . 0.0 112.313 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.483 ' HA ' ' CE2' ' A' ' 92' ' ' PHE . 4.6 t80 -64.77 -35.76 82.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.924 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -75.09 -61.14 1.99 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.914 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.406 ' HG2' ' HA ' ' A' ' 163' ' ' PRO . 20.4 ptt? -47.96 -40.27 21.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.875 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 13.7 t80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.863 -179.933 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.648 ' O ' HG22 ' A' ' 89' ' ' ILE . 89.4 t80 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.893 0.378 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.809 HD21 HD21 ' A' ' 112' ' ' LEU . 29.2 mt -80.72 -33.57 35.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.932 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.01 -39.1 66.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -73.56 -37.67 65.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.919 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.648 HG22 ' O ' ' A' ' 85' ' ' TYR . 7.2 tt -78.6 -29.93 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.143 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.63 -43.31 56.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.13 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -51.27 -25.68 6.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.908 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -86.33 -41.26 14.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.455 ' CD1' HD13 ' A' ' 100' ' ' LEU . 55.6 m95 -70.7 -56.58 6.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 4.2 pt-20 -42.66 -29.55 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.883 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.437 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 96.8 mt -77.54 -48.98 23.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.164 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -48.87 -42.27 36.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.14 -37.44 1.5 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.476 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.2 m -101.77 112.15 24.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.858 0.361 . . . . 0.0 110.895 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 58.8 m -54.28 162.08 1.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.82 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.555 HD22 HG23 ' A' ' 89' ' ' ILE . 27.9 tp -74.01 135.32 43.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.924 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -135.48 128.96 32.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 102' ' ' ILE . 4.6 mp -94.95 121.16 63.25 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.619 0.723 . . . . 0.0 111.108 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.493 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 53.5 Cg_endo -69.78 161.82 44.44 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.66 2.24 . . . . 0.0 112.359 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -107.43 121.02 43.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.85 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.546 ' CG2' HD12 ' A' ' 110' ' ' LEU . 67.7 t -124.79 134.51 66.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.117 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.491 ' HG2' HG12 ' A' ' 105' ' ' VAL . 27.4 mm-40 61.01 52.3 4.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.849 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 42.4 37.93 1.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.619 ' HD3' HG22 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -159.55 153.1 22.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.619 HG22 ' HD3' ' A' ' 108' ' ' LYS . 7.8 tt -60.06 142.9 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.142 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.805 HD23 ' N ' ' A' ' 111' ' ' ASP . 6.2 tt -95.98 139.23 32.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.805 ' N ' HD23 ' A' ' 110' ' ' LEU . 23.6 t0 -97.58 108.54 21.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.86 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.809 HD21 HD21 ' A' ' 86' ' ' LEU . 0.9 OUTLIER -83.24 -24.89 32.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.566 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 5.7 t80 -63.26 -56.26 18.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.953 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 115' ' ' LEU . 32.0 p -59.4 -61.03 2.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.834 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 114' ' ' SER . 22.2 tp -35.04 -68.88 0.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.914 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.8 t -51.24 -52.73 42.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.835 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.1 mmtt -46.79 -63.7 0.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.933 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.658 HG21 HG13 ' A' ' 137' ' ' VAL . 62.1 mt -43.09 -53.54 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.137 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 43.1 t -49.47 -57.47 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.122 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 76.3 mt -46.1 -52.18 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.118 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -57.73 -58.93 6.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.891 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.613 ' HB3' HG22 ' A' ' 128' ' ' ILE . 29.1 mm-40 -35.01 -54.66 0.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 152.93 33.8 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.467 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.02 -178.71 33.49 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.445 ' CE2' ' SG ' ' A' ' 129' ' ' CYS . 4.8 t80 -85.0 -43.8 13.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.845 0.355 . . . . 0.0 110.908 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -62.05 -36.23 81.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.924 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.49 -68.91 0.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.149 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.613 HG22 ' HB3' ' A' ' 122' ' ' GLU . 2.2 pp -50.01 -36.23 11.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.164 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.47 ' N ' HD12 ' A' ' 128' ' ' ILE . 49.1 m -66.33 -41.0 90.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -66.45 -44.48 82.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.92 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 132' ' ' ARG . 1.2 m-20 -85.02 22.61 1.37 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.449 ' C ' ' O ' ' A' ' 131' ' ' ASP . 57.8 mtt-85 34.63 43.93 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.88 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' A' ' 134' ' ' TRP . 20.4 mtp85 -71.5 -22.45 61.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.541 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 12.2 m95 -34.33 -42.29 0.13 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.927 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.6 -54.19 49.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.112 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 5.0 tpp85 -66.21 -42.54 88.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.658 HG13 HG21 ' A' ' 118' ' ' ILE . 84.3 t -59.41 -28.22 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -78.37 -48.69 15.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.116 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -60.06 -28.63 67.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -56.53 -38.85 72.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.537 HD23 ' CE2' ' A' ' 143' ' ' TYR . 13.8 tp -83.81 21.31 1.3 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.927 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 58.12 51.8 8.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.872 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.537 ' CE2' HD23 ' A' ' 141' ' ' LEU . 2.5 m-85 -96.73 159.1 32.42 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.667 0.746 . . . . 0.0 110.915 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.595 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.9 Cg_endo -69.69 111.74 2.88 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.673 2.249 . . . . 0.0 112.375 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 53.7 Cg_endo -69.8 117.13 4.9 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.69 2.26 . . . . 0.0 112.328 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 136.6 -59.64 0.63 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.477 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -55.38 159.55 2.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.761 0.315 . . . . 0.0 110.907 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -78.06 79.13 4.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.595 HD11 ' HG2' ' A' ' 144' ' ' PRO . 78.3 mt -95.07 -55.47 6.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.09 -44.91 0.82 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.464 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.3 t -65.92 -52.18 52.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.898 0.38 . . . . 0.0 110.861 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.442 ' C ' HD23 ' A' ' 152' ' ' LEU . 6.7 tt -50.02 -49.37 51.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.921 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 25.7 mt -57.06 -64.79 0.76 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.541 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 11.8 ttt180 -40.47 -36.21 0.54 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 25.2 m -68.89 -62.08 1.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.805 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.493 ' CE1' ' HG3' ' A' ' 103' ' ' PRO . 2.5 m-70 -47.49 -34.06 6.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.848 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.432 ' CD2' HD12 ' A' ' 161' ' ' ILE . 3.9 t80 -70.22 -53.16 18.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.911 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 29.3 mm-40 -74.23 -9.47 58.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.877 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -96.15 -42.94 7.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.858 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 89.2 mt -110.4 -47.31 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.15 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.517 ' O ' HG22 ' A' ' 161' ' ' ILE . 21.4 mt -76.88 1.08 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.089 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.602 ' CE1' ' SD ' ' A' ' 166' ' ' MET . 0.2 OUTLIER -73.52 -60.75 1.57 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.674 0.75 . . . . 0.0 110.879 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.566 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.6 Cg_endo -69.78 -41.76 3.96 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.663 2.242 . . . . 0.0 112.348 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.432 ' CE1' ' HA ' ' A' ' 89' ' ' ILE . 11.4 t80 -53.79 -35.25 61.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.922 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.405 ' HG3' HG22 ' A' ' 161' ' ' ILE . 11.4 mt-10 -78.81 -62.47 1.68 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.875 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.602 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 5.3 ptt? -48.46 -42.76 33.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 31.0 t80 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.872 -179.952 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 61.9 t80 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.959 0.409 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.428 ' O ' HG22 ' A' ' 89' ' ' ILE . 65.8 mt -56.18 -63.71 1.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.951 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -46.45 -38.45 9.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.856 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -61.5 -62.15 2.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.947 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.713 HD12 ' CD2' ' A' ' 164' ' ' TYR . 14.8 tt -61.11 -27.46 41.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.126 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.18 -46.67 49.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.087 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.7 tttp -54.54 -22.63 13.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -85.24 -49.1 8.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.491 ' CD1' HD13 ' A' ' 100' ' ' LEU . 56.6 m95 -62.53 -56.54 17.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -40.91 -35.32 0.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 90.1 mt -71.98 -51.26 32.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.135 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -48.44 -39.55 23.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.956 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.31 -47.3 0.91 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.526 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.9 t -85.22 151.9 23.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.888 0.375 . . . . 0.0 110.847 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 55.7 p -81.24 172.46 13.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.88 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.528 HD22 HG23 ' A' ' 89' ' ' ILE . 29.1 tp -96.95 116.98 30.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.935 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.76 147.03 30.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.571 HD12 HD22 ' A' ' 112' ' ' LEU . 45.0 mm -119.79 121.84 29.51 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.578 0.704 . . . . 0.0 111.117 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.438 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 54.2 Cg_endo -69.72 163.66 37.41 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.69 2.26 . . . . 0.0 112.361 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -107.9 128.15 54.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.434 HG21 HD12 ' A' ' 110' ' ' LEU . 65.3 t -132.44 135.32 57.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.108 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 56.06 54.26 8.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 40.97 38.84 0.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.9 ttpp -162.63 152.78 16.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.9 tt -57.69 152.0 3.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.123 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.538 HD23 ' N ' ' A' ' 111' ' ' ASP . 5.9 tt -95.11 127.28 41.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.538 ' N ' HD23 ' A' ' 110' ' ' LEU . 8.2 t70 -86.57 69.99 10.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.821 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.595 HD23 ' H ' ' A' ' 112' ' ' LEU . 1.8 pt? -47.96 -22.56 0.61 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -68.45 -44.25 75.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.4 t -71.23 -51.11 26.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.873 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.4 tp -47.07 -54.89 9.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.9 t -60.52 -58.85 6.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.83 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.1 mmtt -43.92 -54.74 5.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.901 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.871 ' CG2' HG13 ' A' ' 137' ' ' VAL . 29.6 mt -51.5 -67.49 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.412 HG13 HG12 ' A' ' 128' ' ' ILE . 50.6 t -37.73 -48.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.162 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 74.6 mt -64.91 -39.74 86.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.108 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 118' ' ' ILE . 5.5 mm-40 -59.11 -50.91 72.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.452 ' CD ' HG22 ' A' ' 137' ' ' VAL . 28.3 mt-10 -51.84 -42.6 62.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.912 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 150.64 35.27 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.512 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.02 -175.13 34.86 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.496 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.422 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 1.9 t80 -88.83 -41.03 12.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.855 0.359 . . . . 0.0 110.915 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -66.13 -37.53 85.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.898 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.5 -61.56 2.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.128 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.641 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.7 pp -58.44 -35.41 54.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.598 ' N ' HD12 ' A' ' 128' ' ' ILE . 22.1 m -65.1 -38.03 89.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.859 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -68.46 -39.45 81.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.45 ' O ' ' C ' ' A' ' 132' ' ' ARG . 0.7 OUTLIER -93.39 22.03 5.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.843 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 131' ' ' ASP . 25.1 mtp85 34.45 46.74 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.889 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.435 ' O ' HG23 ' A' ' 137' ' ' VAL . 58.8 mtp180 -87.33 18.72 3.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.641 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 27.5 m95 -63.9 -47.65 79.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.913 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.55 -41.7 61.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.092 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -68.24 -63.11 1.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.854 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.871 HG13 ' CG2' ' A' ' 118' ' ' ILE . 86.4 t -41.17 -38.12 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.115 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.02 -53.93 22.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -51.22 -33.44 27.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.473 ' HA ' ' CZ ' ' A' ' 140' ' ' ARG . 1.7 mmp_? -52.72 -35.7 56.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.594 HD23 ' CE2' ' A' ' 143' ' ' TYR . 14.9 tp -84.73 23.32 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 62.91 28.0 16.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.817 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.594 ' CE2' HD23 ' A' ' 141' ' ' LEU . 3.4 m-85 -75.89 147.77 81.14 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.653 0.739 . . . . 0.0 110.914 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.469 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.6 Cg_endo -69.72 115.72 4.22 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.706 2.271 . . . . 0.0 112.343 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 53.0 Cg_endo -69.79 89.18 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.69 2.26 . . . . 0.0 112.323 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 177.13 -80.03 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.474 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 32.0 mttp -45.38 166.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.817 0.341 . . . . 0.0 110.89 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.79 80.8 3.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.469 HD11 ' HG2' ' A' ' 144' ' ' PRO . 76.9 mt -91.6 -57.41 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.21 -50.1 1.23 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.503 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.3 t -61.11 -55.18 35.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.871 0.367 . . . . 0.0 110.839 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.409 ' C ' HD23 ' A' ' 152' ' ' LEU . 6.4 tt -46.92 -52.02 15.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.878 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.462 HD11 HG22 ' A' ' 149' ' ' ILE . 15.1 mt -54.52 -65.94 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.954 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.478 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 11.2 ttp180 -38.75 -47.75 1.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.864 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.6 t -57.87 -66.11 0.53 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.844 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.438 ' CE1' ' HG3' ' A' ' 103' ' ' PRO . 2.0 m-70 -42.9 -39.97 2.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.907 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.41 ' CD1' ' C ' ' A' ' 157' ' ' TYR . 4.6 t80 -63.81 -55.07 25.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 43.6 mt-10 -72.23 -9.97 59.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.898 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -88.87 -48.17 7.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.867 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 77.3 mt -112.56 -43.66 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.514 ' O ' HG22 ' A' ' 161' ' ' ILE . 11.0 mt -77.02 5.08 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.128 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.635 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -74.4 -62.22 1.03 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.673 0.749 . . . . 0.0 110.895 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.518 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.3 Cg_endo -69.76 -35.66 12.22 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.689 2.259 . . . . 0.0 112.336 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.713 ' CD2' HD12 ' A' ' 89' ' ' ILE . 11.0 t80 -60.87 -38.32 85.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -79.94 -65.02 1.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.858 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.455 ' SD ' ' N ' ' A' ' 167' ' ' PHE . 0.0 OUTLIER -40.64 -39.42 1.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.862 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.455 ' N ' ' SD ' ' A' ' 166' ' ' MET . 2.4 t80 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.85 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.693 ' HE2' HD12 ' A' ' 112' ' ' LEU . 69.5 t80 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.932 0.396 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.446 ' HA ' HG22 ' A' ' 89' ' ' ILE . 36.5 mt -81.13 -39.32 25.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.924 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -64.09 -39.42 94.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -72.96 -55.71 6.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.88 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 85' ' ' TYR . 12.3 tt -55.46 -47.65 78.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.117 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.853 ' HB2' HD22 ' A' ' 100' ' ' LEU . . . -59.16 -47.96 83.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.14 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.404 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 21.5 ttmt -44.54 -37.83 3.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.957 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.665 ' CD1' ' CG ' ' A' ' 167' ' ' PHE . 3.2 t80 -71.89 -51.63 21.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.452 ' O ' ' C ' ' A' ' 94' ' ' GLU . 80.5 m95 -61.59 -62.36 1.87 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 93' ' ' TRP . 8.9 pt-20 -34.48 -37.97 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.444 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 52.1 mt -72.4 -49.48 41.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.13 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 93' ' ' TRP . 73.2 mm-40 -45.0 -46.21 11.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.889 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.21 -36.87 1.35 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.49 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.6 m -96.39 109.55 22.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.91 0.386 . . . . 0.0 110.888 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.7 m -47.18 158.69 0.14 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.854 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.853 HD22 ' HB2' ' A' ' 90' ' ' ALA . 15.4 tp -75.41 126.82 31.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.91 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -129.83 110.61 11.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.1 mt -77.17 123.88 87.17 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.628 0.728 . . . . 0.0 111.165 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 147.17 62.5 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.696 2.264 . . . . 0.0 112.359 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -100.36 111.05 23.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.935 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.674 HG12 ' HG2' ' A' ' 106' ' ' GLU . 87.1 t -119.82 136.55 56.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.115 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.674 ' HG2' HG12 ' A' ' 105' ' ' VAL . 46.6 mm-40 62.9 49.15 3.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.903 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 42.61 38.39 1.27 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.84 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.2 tttp -166.92 152.95 8.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.6 tt -50.4 150.01 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.124 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.555 ' C ' HD23 ' A' ' 110' ' ' LEU . 4.5 tt -92.96 112.06 23.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.442 ' N ' HD23 ' A' ' 110' ' ' LEU . 19.8 t0 -69.05 75.11 0.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.756 HD23 ' H ' ' A' ' 112' ' ' LEU . 0.9 OUTLIER -68.79 -36.65 78.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -53.61 -59.93 3.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.963 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.457 ' O ' ' C ' ' A' ' 115' ' ' LEU . 4.8 t -59.07 -59.21 5.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.867 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' A' ' 114' ' ' SER . 9.0 tp -32.89 -58.7 0.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.924 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.6 t -57.12 -54.64 44.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.824 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -43.48 -48.25 7.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.888 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 53.2 mt -61.98 -48.3 89.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.127 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.503 HG13 HG12 ' A' ' 128' ' ' ILE . 55.4 t -50.8 -63.0 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.108 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 61.7 mt -52.11 -53.33 18.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.141 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -46.69 -51.11 16.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.893 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.449 ' OE2' HG22 ' A' ' 137' ' ' VAL . 40.6 mt-10 -50.92 -49.27 59.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.86 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 127' ' ' ALA . . . 154.49 40.94 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.467 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.55 -177.93 42.47 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.448 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -88.95 -45.68 9.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.847 0.356 . . . . 0.0 110.94 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -59.51 -36.49 76.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.876 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 123' ' ' GLY . . . -67.75 -71.26 0.21 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.096 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.503 HG12 HG13 ' A' ' 119' ' ' VAL . 2.1 pp -44.76 -34.53 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.123 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.409 ' N ' HD12 ' A' ' 128' ' ' ILE . 64.8 m -69.37 -39.57 77.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -63.89 -39.66 94.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 132' ' ' ARG . 28.1 m-20 -92.1 29.76 1.56 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.877 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.465 ' C ' ' O ' ' A' ' 131' ' ' ASP . 3.0 mpt_? 33.48 40.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.462 ' O ' ' C ' ' A' ' 134' ' ' TRP . 22.5 mmt180 -65.29 -26.99 68.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.482 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 28.4 m95 -33.22 -44.19 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.913 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.82 -61.71 2.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.107 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -58.98 -45.09 91.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.449 HG22 ' OE2' ' A' ' 122' ' ' GLU . 92.6 t -54.03 -39.73 42.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.153 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.2 -52.88 52.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -58.88 -35.99 73.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.933 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.2 mmp_? -69.53 -28.04 65.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.868 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.945 HD13 ' O ' ' A' ' 141' ' ' LEU . 1.5 tm? -78.46 10.23 3.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.913 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 62.99 38.42 11.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.904 ' CE2' HD12 ' A' ' 141' ' ' LEU . 9.6 m-85 -89.72 158.61 44.92 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.702 0.763 . . . . 0.0 110.937 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.786 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.8 Cg_endo -69.78 113.76 3.48 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.65 2.234 . . . . 0.0 112.359 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.72 132.47 23.46 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.731 2.287 . . . . 0.0 112.34 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.61 -66.58 0.57 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.511 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -70.46 140.64 51.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.785 0.326 . . . . 0.0 110.934 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -64.58 76.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.786 HD11 ' HG2' ' A' ' 144' ' ' PRO . 97.0 mt -80.45 -39.85 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.165 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -35.98 -51.35 1.19 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.459 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.5 t -56.94 -54.86 41.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.886 0.374 . . . . 0.0 110.892 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.4 tt -45.58 -51.17 12.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.948 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' A' ' 154' ' ' ARG . 18.9 mt -53.99 -66.09 0.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.937 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.482 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 15.0 ttt180 -37.35 -41.56 0.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.1 m -65.04 -68.74 0.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.824 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -43.12 -36.95 1.84 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.889 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.692 ' CD2' HD12 ' A' ' 161' ' ' ILE . 3.0 t80 -71.82 -43.88 64.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.933 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.402 ' O ' ' HB3' ' A' ' 162' ' ' TYR . 7.5 mt-10 -79.87 -8.68 59.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.876 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 9.0 tpt85 -106.43 -30.3 9.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.465 HG22 HD11 ' A' ' 89' ' ' ILE . 70.7 mt -112.83 -59.0 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.107 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.692 HD12 ' CD2' ' A' ' 157' ' ' TYR . 66.3 mt -67.01 -11.95 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.119 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.593 ' CE1' ' SD ' ' A' ' 166' ' ' MET . 0.1 OUTLIER -74.21 -61.58 1.2 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.656 0.741 . . . . 0.0 110.934 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.55 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 54.0 Cg_endo -69.7 -27.82 26.27 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.714 2.276 . . . . 0.0 112.345 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.572 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 3.8 t80 -68.11 -41.91 81.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -72.84 -60.33 2.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.897 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.593 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 6.7 ptt? -47.08 -43.2 20.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.665 ' CG ' ' CD1' ' A' ' 92' ' ' PHE . 61.0 t80 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.534 ' O ' HG22 ' A' ' 89' ' ' ILE . 86.8 t80 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.906 0.384 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.681 HD21 HD21 ' A' ' 112' ' ' LEU . 37.9 mt -79.95 -36.08 36.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.942 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -78.78 -47.55 16.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.835 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.428 ' CG ' ' N ' ' A' ' 89' ' ' ILE . 2.2 pt20 -54.72 -45.82 74.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.644 HG23 HD22 ' A' ' 100' ' ' LEU . 15.7 tt -72.84 -32.04 38.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.139 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 93' ' ' TRP . . . -67.48 -57.1 7.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.095 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.8 tptm -40.94 -31.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -78.45 -43.05 28.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.404 ' N ' ' O ' ' A' ' 90' ' ' ALA . 41.3 m95 -68.23 -55.17 13.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.911 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -43.52 -35.12 1.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.929 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.3 mt -73.03 -51.49 26.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.143 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -42.45 -47.57 5.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 136.88 30.63 0.27 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.483 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.8 m -161.05 161.78 31.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.893 0.378 . . . . 0.0 110.864 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.2 m -89.52 155.95 18.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.829 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.644 HD22 HG23 ' A' ' 89' ' ' ILE . 16.9 tp -91.57 103.89 16.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.909 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.8 pttt -97.48 152.59 18.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.909 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 18.7 mt -115.62 123.87 30.75 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.604 0.716 . . . . 0.0 111.155 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 148.07 64.3 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.687 2.258 . . . . 0.0 112.36 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -99.73 121.07 40.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.3 t -118.26 147.36 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.136 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.452 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 65.4 mm-40 39.8 53.21 2.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.863 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.452 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 11.8 ptm180 45.8 38.47 4.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.3 tptp -160.91 151.11 17.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.8 tt -56.75 145.36 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.113 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.773 HD23 ' N ' ' A' ' 111' ' ' ASP . 4.9 tt -90.72 129.49 36.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.773 ' N ' HD23 ' A' ' 110' ' ' LEU . 26.3 t0 -79.42 66.82 4.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.681 HD21 HD21 ' A' ' 86' ' ' LEU . 1.8 pt? -54.02 -23.02 11.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.505 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 3.9 t80 -72.4 -58.63 3.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.4 t -55.78 -41.46 74.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.864 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.606 ' O ' HG23 ' A' ' 119' ' ' VAL . 27.4 tp -52.71 -55.8 20.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.915 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 18.0 p -60.26 -42.9 96.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -58.33 -61.2 2.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.878 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 64.9 mt -49.62 -36.36 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.176 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 115' ' ' LEU . 73.2 t -71.27 -48.43 54.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.175 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 85.5 mt -62.4 -37.17 78.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.074 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -72.84 -54.79 7.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.913 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -38.95 -53.87 1.71 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.892 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 158.28 34.79 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.501 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.15 179.12 37.2 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.449 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.488 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 9.3 t80 -82.52 -39.98 21.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.826 0.346 . . . . 0.0 110.899 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -66.11 -43.03 88.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.92 -61.71 2.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.142 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.559 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.7 pp -60.09 -33.67 54.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.116 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.488 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 22.1 m -70.41 -28.42 65.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -81.05 -36.48 30.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.439 ' O ' ' C ' ' A' ' 132' ' ' ARG . 0.5 OUTLIER -91.15 21.04 4.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 131' ' ' ASP . 8.7 mmm180 35.53 50.76 0.6 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.88 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.425 ' O ' ' C ' ' A' ' 134' ' ' TRP . 4.3 mmp_? -80.03 -19.49 47.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.9 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.559 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 28.2 m95 -36.34 -41.64 0.29 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.19 -55.32 34.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.092 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -66.82 -41.35 87.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 82.7 t -51.16 -43.58 27.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.078 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.451 ' HB2' HD11 ' A' ' 153' ' ' LEU . . . -70.64 -53.5 15.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.069 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -56.04 -22.44 27.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -68.74 -32.03 71.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.432 HD23 ' CE2' ' A' ' 143' ' ' TYR . 10.2 tp -89.84 25.57 2.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 61.55 51.17 4.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.815 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.432 ' CE2' HD23 ' A' ' 141' ' ' LEU . 3.7 m-85 -103.7 150.65 38.35 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.698 0.761 . . . . 0.0 110.886 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.577 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.9 Cg_endo -69.78 113.48 3.39 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.677 2.252 . . . . 0.0 112.319 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 99.99 0.79 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.671 2.248 . . . . 0.0 112.333 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 161.96 -70.27 0.22 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.493 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -51.99 151.45 3.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.816 0.341 . . . . 0.0 110.915 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.406 ' O ' ' CG ' ' A' ' 148' ' ' ASN . 15.5 p-10 -65.0 75.51 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.577 HD11 ' HG2' ' A' ' 144' ' ' PRO . 75.5 mt -92.44 -54.06 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.17 -52.05 1.26 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.445 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 8.7 t -58.44 -56.94 15.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.927 0.394 . . . . 0.0 110.85 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.6 tt -42.05 -49.39 4.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.926 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.451 HD11 ' HB2' ' A' ' 138' ' ' ALA . 15.5 mt -58.94 -65.97 0.58 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.495 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 15.5 ttp180 -38.82 -45.39 1.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.818 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 41.0 m -60.19 -62.75 1.63 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.842 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -47.27 -27.1 1.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.855 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.864 ' CD2' HD12 ' A' ' 161' ' ' ILE . 7.7 t80 -83.65 -31.26 26.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.49 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 11.4 mt-10 -91.04 -10.16 43.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 14.8 tpt85 -105.02 -30.7 9.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.858 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 42.0 mt -112.12 -54.38 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.864 HD12 ' CD2' ' A' ' 157' ' ' TYR . 15.5 mt -77.07 -0.8 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.101 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.536 ' CD2' ' HD3' ' A' ' 163' ' ' PRO . 0.2 OUTLIER -71.9 -60.31 2.46 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.643 0.735 . . . . 0.0 110.905 -179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.536 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.5 Cg_endo -69.79 -34.96 13.43 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.708 2.272 . . . . 0.0 112.294 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.479 ' CE1' ' HA ' ' A' ' 89' ' ' ILE . 55.2 t80 -62.36 -44.09 97.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.911 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -68.72 -55.45 11.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.41 ' HG3' ' HA ' ' A' ' 163' ' ' PRO . 0.0 OUTLIER -60.44 -35.07 74.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.899 179.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.463 ' CB ' ' O ' ' A' ' 163' ' ' PRO . 40.7 t80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.914 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.639 ' CE2' HD12 ' A' ' 112' ' ' LEU . 59.5 t80 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.941 0.4 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.619 HD23 HD11 ' A' ' 112' ' ' LEU . 61.2 mt -80.94 -59.11 2.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.891 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -52.63 -25.85 11.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.845 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -77.42 -67.32 0.73 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.794 HD11 HG22 ' A' ' 160' ' ' ILE . 10.0 tt -47.5 -35.59 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.17 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.74 -47.75 68.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.093 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -53.09 -26.2 15.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.593 ' CD1' ' CD2' ' A' ' 167' ' ' PHE . 0.8 OUTLIER -81.27 -50.83 9.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.545 ' CD1' HD13 ' A' ' 100' ' ' LEU . 81.3 m95 -64.51 -55.98 17.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.95 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -41.02 -29.77 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.913 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.5 mt -78.3 -49.33 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.171 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 88.6 mm-40 -50.21 -44.73 53.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 142.11 -46.94 0.85 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.453 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.6 m -83.22 108.85 16.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.887 0.375 . . . . 0.0 110.874 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.6 m -50.69 162.35 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.545 HD13 ' CD1' ' A' ' 93' ' ' TRP . 40.4 tp -86.82 100.47 12.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.91 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -102.41 106.2 16.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.507 HD12 HD22 ' A' ' 112' ' ' LEU . 44.0 mm -69.16 124.86 91.32 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.579 0.704 . . . . 0.0 111.134 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.532 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 54.0 Cg_endo -69.76 151.29 69.03 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.725 2.283 . . . . 0.0 112.334 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -101.12 110.93 23.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.843 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.8 t -119.19 137.9 51.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.143 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 107' ' ' ARG . 49.4 mm-40 58.9 55.02 4.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 106' ' ' GLU . 6.6 ptp85 35.53 43.05 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.857 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -168.14 150.71 5.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.874 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.1 tt -57.69 144.42 10.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.143 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 1.025 HD23 ' N ' ' A' ' 111' ' ' ASP . 6.2 tt -93.12 151.0 20.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 1.025 ' N ' HD23 ' A' ' 110' ' ' LEU . 11.9 t0 -107.81 121.7 45.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.835 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.639 HD12 ' CE2' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -98.3 -28.12 13.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.92 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -67.19 -61.56 1.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.903 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 115' ' ' LEU . 23.3 m -51.64 -58.76 5.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 114' ' ' SER . 17.3 tp -38.0 -63.09 0.5 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.907 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.9 t -50.28 -53.1 30.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.837 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -51.22 -43.73 61.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 58.6 mt -62.33 -48.68 87.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.1 t -58.41 -58.91 4.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.159 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 82.4 mt -49.4 -45.58 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.124 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 122' ' ' GLU . 38.5 mt-10 -62.92 -58.36 7.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.865 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.502 ' OE2' HG22 ' A' ' 137' ' ' VAL . 42.7 mt-10 -37.73 -54.27 1.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.855 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 157.85 37.25 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.52 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.98 -173.55 39.75 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.472 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.583 ' CE2' ' SG ' ' A' ' 129' ' ' CYS . 7.7 t80 -88.84 -56.63 3.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.806 0.336 . . . . 0.0 110.884 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -51.14 -34.73 32.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.886 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.38 -71.36 0.21 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.122 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.54 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.8 pp -51.5 -32.04 12.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.583 ' SG ' ' CE2' ' A' ' 125' ' ' TYR . 99.3 m -69.63 -36.47 76.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.885 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -71.12 -43.28 67.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' A' ' 132' ' ' ARG . 0.9 OUTLIER -85.61 23.57 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 131' ' ' ASP . 59.1 mtt180 34.23 38.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.833 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' A' ' 134' ' ' TRP . 21.1 mmm180 -66.08 -19.14 65.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.54 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 29.5 m95 -35.54 -37.22 0.08 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.33 -57.12 14.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.116 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 -60.09 -43.87 95.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.502 HG22 ' OE2' ' A' ' 122' ' ' GLU . 59.4 t -58.21 -34.11 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.121 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.19 -59.06 3.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.138 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -53.99 -31.07 49.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.97 -38.38 64.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.899 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.467 HD23 ' CE2' ' A' ' 143' ' ' TYR . 14.8 tp -85.39 20.94 1.87 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 64.22 40.33 6.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.841 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.467 ' CE2' HD23 ' A' ' 141' ' ' LEU . 3.1 m-85 -89.67 153.16 47.71 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.662 0.744 . . . . 0.0 110.929 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.622 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.9 Cg_endo -69.75 114.07 3.58 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.732 2.288 . . . . 0.0 112.337 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 54.0 Cg_endo -69.75 90.88 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.678 2.252 . . . . 0.0 112.365 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.67 -73.93 0.1 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.468 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -50.56 153.18 1.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.832 0.348 . . . . 0.0 110.852 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -67.29 81.33 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.622 HD11 ' HG2' ' A' ' 144' ' ' PRO . 90.1 mt -92.97 -53.85 8.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.19 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.0 -48.52 1.08 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.511 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.0 t -61.5 -53.87 50.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.864 0.364 . . . . 0.0 110.866 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.497 ' C ' HD23 ' A' ' 152' ' ' LEU . 8.2 tt -47.14 -50.6 20.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.885 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.415 ' O ' ' C ' ' A' ' 154' ' ' ARG . 24.1 mt -55.02 -65.91 0.5 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 153' ' ' LEU . 11.4 ttt-85 -36.89 -44.99 0.53 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.918 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.7 t -59.76 -65.37 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.911 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.532 ' CE1' ' HG3' ' A' ' 103' ' ' PRO . 2.1 m-70 -39.6 -49.11 2.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.512 ' HA ' HD12 ' A' ' 161' ' ' ILE . 3.6 t80 -52.83 -67.6 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.916 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.426 ' HA ' ' HB2' ' A' ' 162' ' ' TYR . 17.3 mm-40 -62.15 -8.53 5.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.857 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.94 -53.82 5.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.908 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.794 HG22 HD11 ' A' ' 89' ' ' ILE . 27.0 mt -112.91 -46.3 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.133 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.512 HD12 ' HA ' ' A' ' 157' ' ' TYR . 73.7 mt -61.2 -14.14 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.661 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -76.88 -63.3 0.54 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.707 0.765 . . . . 0.0 110.927 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.563 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.9 Cg_endo -69.73 -23.44 30.92 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.744 2.296 . . . . 0.0 112.328 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.739 ' CD2' HD12 ' A' ' 89' ' ' ILE . 1.0 OUTLIER -74.25 -46.62 40.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.875 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -69.11 -49.38 57.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.893 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.466 ' CG ' ' HA ' ' A' ' 163' ' ' PRO . 0.0 OUTLIER -61.23 -38.14 85.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.593 ' CD2' ' CD1' ' A' ' 92' ' ' PHE . 18.3 t80 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.426 ' HE2' HD12 ' A' ' 112' ' ' LEU . 55.1 t80 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.924 0.393 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.401 HD21 HD21 ' A' ' 112' ' ' LEU . 96.7 mt -73.21 -64.08 1.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.966 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -52.74 -32.28 42.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 44.8 mm-40 -67.16 -69.08 0.33 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.476 HG13 ' CG ' ' A' ' 164' ' ' TYR . 19.7 tt -51.09 -39.28 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.133 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.565 ' HB2' HD22 ' A' ' 100' ' ' LEU . . . -65.51 -40.82 93.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -59.73 -23.96 63.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.918 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.459 ' CD1' ' O ' ' A' ' 92' ' ' PHE . 1.1 t80 -84.7 -36.56 21.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.893 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.48 ' O ' ' N ' ' A' ' 95' ' ' ILE . 69.4 m95 -78.03 -56.72 4.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -39.41 -25.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.48 ' N ' ' O ' ' A' ' 93' ' ' TRP . 87.3 mt -81.81 -50.35 16.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -49.18 -34.08 13.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.889 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 130.21 -25.11 4.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.47 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.5 m -103.97 115.52 30.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 0.0 110.868 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.4 t -53.75 167.88 0.22 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.875 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.565 HD22 ' HB2' ' A' ' 90' ' ' ALA . 30.9 tp -85.28 124.5 31.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.967 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -125.96 134.51 51.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 81.9 mt -107.05 129.64 24.04 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.586 0.707 . . . . 0.0 111.132 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 174.64 9.18 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.69 2.26 . . . . 0.0 112.325 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -124.73 111.83 16.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.7 t -115.2 133.27 61.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.153 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 60.06 54.72 4.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.916 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 38.42 36.91 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.841 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.71 153.66 28.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.9 tt -60.31 137.04 23.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.109 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.82 HD23 ' N ' ' A' ' 111' ' ' ASP . 5.1 tt -78.47 140.55 38.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.946 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.82 ' N ' HD23 ' A' ' 110' ' ' LEU . 52.0 t0 -90.43 76.25 6.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.827 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.426 HD12 ' HE2' ' A' ' 85' ' ' TYR . 1.4 pt? -61.77 -22.46 65.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.936 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -71.73 -65.84 0.71 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 115' ' ' LEU . 3.7 t -54.34 -54.08 45.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.845 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.43 ' C ' ' O ' ' A' ' 114' ' ' SER . 16.9 tp -35.3 -65.43 0.23 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.941 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.5 t -53.15 -51.89 60.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.871 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -46.78 -54.22 10.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.905 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 65.3 mt -56.67 -46.81 83.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.084 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.1 t -56.88 -61.99 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.154 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 84.6 mt -56.97 -40.31 71.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.141 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -60.1 -57.99 10.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.467 ' HB3' HG22 ' A' ' 128' ' ' ILE . 28.7 mm-40 -44.87 -45.1 10.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.434 ' O ' ' CB ' ' A' ' 127' ' ' ALA . . . 152.48 38.12 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.487 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.16 -170.04 32.61 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.467 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -88.8 -43.3 11.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.945 0.402 . . . . 0.0 110.951 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -64.24 -39.37 93.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.866 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' A' ' 123' ' ' GLY . . . -58.37 -68.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.075 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.629 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.7 pp -51.73 -34.88 16.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.087 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.405 ' N ' HD12 ' A' ' 128' ' ' ILE . 53.6 m -67.74 -33.95 75.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.845 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.3 mtpp -68.05 -46.85 69.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.429 ' OD2' ' CZ ' ' A' ' 133' ' ' ARG . 2.3 t70 -84.61 12.23 7.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 44.63 54.12 6.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.849 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.449 ' O ' ' C ' ' A' ' 134' ' ' TRP . 3.2 mmp_? -80.32 -19.07 47.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.905 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.629 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 18.8 m95 -34.27 -44.54 0.19 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.2 -52.12 66.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.11 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 37.5 mmt-85 -68.93 -51.22 42.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 97.5 t -44.4 -44.47 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.127 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.645 ' HB2' ' CD1' ' A' ' 153' ' ' LEU . . . -68.53 -53.09 25.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.08 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -55.72 -25.92 42.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.908 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 23.9 mtt180 -64.21 -26.5 68.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.912 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.0 tp -89.54 18.45 5.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.939 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 64.45 46.73 3.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.577 ' HB3' HD13 ' A' ' 149' ' ' ILE . 3.6 m-85 -95.36 152.59 39.43 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.656 0.741 . . . . 0.0 110.948 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 120.1 6.94 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.652 2.235 . . . . 0.0 112.356 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 115.65 4.19 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.683 2.255 . . . . 0.0 112.344 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.66 -64.25 0.44 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.465 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -53.08 160.33 1.04 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.79 0.329 . . . . 0.0 110.925 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -80.96 52.43 1.75 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.577 HD13 ' HB3' ' A' ' 143' ' ' TYR . 42.6 mt -62.92 -49.8 82.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.165 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.21 -56.94 1.14 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.452 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.8 t -57.29 -61.0 2.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.914 0.387 . . . . 0.0 110.897 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.47 ' C ' HD23 ' A' ' 152' ' ' LEU . 7.3 tt -38.94 -55.11 1.59 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.926 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.645 ' CD1' ' HB2' ' A' ' 138' ' ' ALA . 25.1 mt -51.9 -65.99 0.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.53 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 20.0 ttp180 -41.18 -46.23 3.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.823 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.9 m -58.99 -64.5 0.92 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.845 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -42.05 -53.38 3.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.864 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.488 ' O ' ' N ' ' A' ' 161' ' ' ILE . 5.3 t80 -50.81 -65.35 0.57 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 42.6 mt-10 -63.53 -9.8 14.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.906 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 41.5 ttt-85 -84.08 -50.74 7.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 40.6 mt -112.54 -40.07 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.152 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.559 ' O ' HG22 ' A' ' 161' ' ' ILE . 22.9 mt -76.2 0.28 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.139 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.588 ' CE1' ' SD ' ' A' ' 166' ' ' MET . 0.1 OUTLIER -73.34 -61.17 1.51 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.7 0.762 . . . . 0.0 110.897 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.562 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 54.4 Cg_endo -69.73 -32.56 18.47 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.68 2.253 . . . . 0.0 112.393 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.476 ' CG ' HG13 ' A' ' 89' ' ' ILE . 12.3 t80 -66.07 -39.04 89.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.931 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -72.02 -53.37 13.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.935 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.588 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 6.7 ptt? -63.48 -41.58 98.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.851 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.468 ' CB ' ' O ' ' A' ' 163' ' ' PRO . 47.9 t80 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.901 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.1 m -131.33 154.35 48.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.9 0.381 . . . . 0.0 110.846 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.8 m -132.33 166.62 21.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -125.21 -137.68 4.81 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.51 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 92.6 p -170.53 135.4 1.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.856 0.36 . . . . 0.0 110.878 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 76.8 p -55.84 138.5 48.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.832 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -144.7 -135.24 2.87 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.459 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 79' ' ' THR . 14.0 t -94.84 38.58 1.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.78 0.324 . . . . 0.0 111.122 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -79.29 -74.14 0.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.872 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.462 ' O ' ' N ' ' A' ' 84' ' ' ASN . 88.8 t -64.85 -40.53 89.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.086 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.529 ' HG3' ' CD2' ' A' ' 113' ' ' TYR . 41.4 tttm -39.86 -27.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.948 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.425 ' N ' ' O ' ' A' ' 81' ' ' VAL . 32.7 mt -82.22 -41.62 20.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 81' ' ' VAL . 39.3 t-20 -45.56 -40.5 8.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.579 ' HE2' HD12 ' A' ' 112' ' ' LEU . 29.5 t80 -60.01 -45.3 93.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.8 mt -65.29 -50.99 63.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.03 -35.08 75.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -68.45 -64.16 0.92 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.935 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.664 HG23 HD22 ' A' ' 100' ' ' LEU . 6.5 tt -55.5 -33.75 33.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.16 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.98 -58.58 3.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.088 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.41 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 2.4 ttmp? -45.65 -24.66 0.37 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.892 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -85.63 -42.45 14.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 32.8 m95 -72.61 -59.25 2.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.916 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.47 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 2.7 pt-20 -39.31 -31.96 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.873 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.47 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 97.3 mt -74.08 -52.59 19.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.171 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -48.55 -40.34 26.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 136.58 -45.71 1.07 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.477 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.4 t -81.69 118.69 23.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.841 0.353 . . . . 0.0 110.881 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.5 p -56.49 151.86 12.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.664 HD22 HG23 ' A' ' 89' ' ' ILE . 13.5 tp -77.84 118.58 20.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -119.57 141.91 48.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.0 mp -107.69 128.74 25.28 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.627 0.727 . . . . 0.0 111.104 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 154.24 67.77 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.646 2.23 . . . . 0.0 112.334 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -102.18 111.32 23.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.511 HG12 ' HG2' ' A' ' 106' ' ' GLU . 71.4 t -119.03 134.67 61.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.117 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.511 ' HG2' HG12 ' A' ' 105' ' ' VAL . 13.2 mm-40 61.21 53.45 3.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 106' ' ' GLU . 7.7 ptp180 36.94 41.68 0.2 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.3 ttmp? -162.5 152.13 15.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.461 HG13 ' N ' ' A' ' 110' ' ' LEU . 1.8 tp -62.25 139.23 21.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.112 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.529 HD23 ' N ' ' A' ' 111' ' ' ASP . 5.7 tt -87.65 130.62 34.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.916 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.529 ' N ' HD23 ' A' ' 110' ' ' LEU . 44.3 t0 -90.55 74.24 6.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.579 HD12 ' HE2' ' A' ' 85' ' ' TYR . 2.0 pt? -48.52 -20.91 0.48 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.529 ' CD2' ' HG3' ' A' ' 82' ' ' LYS . 11.7 t80 -71.27 -45.59 62.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.3 t -65.61 -52.81 49.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.886 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.7 tp -49.03 -60.53 2.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 52.6 p -55.11 -52.9 61.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.863 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.3 mmtt -47.96 -61.45 1.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 66.5 mt -45.34 -64.27 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.155 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 43.1 t -39.35 -64.18 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.139 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 73.4 mt -42.35 -46.35 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.092 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -65.34 -54.69 25.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -39.49 -50.91 2.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 127' ' ' ALA . . . 155.36 35.15 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.525 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.92 -177.73 41.79 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.528 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.483 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 3.1 t80 -87.42 -47.92 8.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.851 0.357 . . . . 0.0 110.901 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -57.78 -40.73 80.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.91 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 123' ' ' GLY . . . -63.09 -68.86 0.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.083 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.483 HD12 ' C ' ' A' ' 128' ' ' ILE . 1.9 pp -52.0 -31.43 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.128 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.483 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 26.2 m -70.13 -42.2 72.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -66.31 -36.92 84.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.861 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 132' ' ' ARG . 2.2 m-20 -91.99 21.44 4.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.859 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' A' ' 131' ' ' ASP . 16.8 mmm-85 35.36 41.28 0.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -71.35 -14.07 62.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.869 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.505 ' CE2' ' HG3' ' A' ' 154' ' ' ARG . 49.5 m95 -38.28 -37.44 0.29 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.24 -52.56 65.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.06 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -66.4 -39.73 89.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.842 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.3 t -57.3 -36.09 51.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.107 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.47 ' HB2' ' CD1' ' A' ' 153' ' ' LEU . . . -74.14 -49.85 21.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.094 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -57.99 -26.07 61.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.868 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -57.6 -38.93 75.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.838 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.517 HD23 ' CZ ' ' A' ' 143' ' ' TYR . 13.6 tp -82.44 16.09 2.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.95 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 63.36 44.66 5.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.835 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.517 ' CZ ' HD23 ' A' ' 141' ' ' LEU . 2.6 m-85 -85.21 155.96 60.18 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.657 0.741 . . . . 0.0 110.956 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.455 ' HA ' ' HD2' ' A' ' 145' ' ' PRO . 53.7 Cg_endo -69.79 110.37 2.54 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.656 2.238 . . . . 0.0 112.345 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 53.9 Cg_endo -69.72 108.27 2.03 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.712 2.274 . . . . 0.0 112.348 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 147.44 -34.64 1.26 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.459 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -83.93 147.24 27.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 0.0 110.923 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.418 ' CG ' ' O ' ' A' ' 148' ' ' ASN . 26.3 p-10 -66.53 72.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.857 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.42 ' O ' ' C ' ' A' ' 150' ' ' GLY . 75.4 mt -90.65 -50.04 13.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.099 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.1 -50.71 1.22 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.498 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.6 m -60.03 -49.29 78.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.887 0.375 . . . . 0.0 110.882 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.672 HD21 ' CD2' ' A' ' 156' ' ' HIS . 6.5 tt -51.18 -53.97 29.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.888 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.47 ' CD1' ' HB2' ' A' ' 138' ' ' ALA . 23.1 mt -54.35 -65.8 0.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.927 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.505 ' HG3' ' CE2' ' A' ' 134' ' ' TRP . 16.0 ttt180 -40.41 -41.57 1.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.889 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 156' ' ' HIS . 39.7 m -66.67 -69.78 0.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.672 ' CD2' HD21 ' A' ' 152' ' ' LEU . 2.4 m-70 -36.96 -39.22 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.879 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.422 ' HA ' ' CG1' ' A' ' 161' ' ' ILE . 4.2 t80 -65.44 -57.23 8.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -70.82 -10.13 58.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.878 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -90.22 -48.17 7.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.824 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 60.7 mt -112.45 -41.97 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.162 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.534 ' O ' HG22 ' A' ' 161' ' ' ILE . 16.7 mt -78.48 3.23 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.091 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.584 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -72.36 -60.66 2.07 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.691 0.758 . . . . 0.0 110.928 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 162' ' ' TYR . 53.8 Cg_endo -69.72 -40.19 5.68 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.69 2.26 . . . . 0.0 112.358 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.491 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 23.8 t80 -55.57 -40.26 71.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.911 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -76.85 -66.32 0.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.883 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.447 ' SD ' ' N ' ' A' ' 167' ' ' PHE . 0.0 OUTLIER -42.7 -40.06 2.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.874 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.447 ' N ' ' SD ' ' A' ' 166' ' ' MET . 21.4 t80 -71.15 -52.07 21.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -84.69 41.27 0.84 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.916 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 5.2 t -123.61 120.47 32.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 90.35 109.73 1.41 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.476 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.784 0.326 . . . . 0.0 111.117 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.448 -0.261 . . . . 0.0 112.448 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.4 m 51.53 41.92 29.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.896 0.379 . . . . 0.0 110.895 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 79.9 p -138.33 164.85 28.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.845 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.15 178.42 51.58 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.451 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.7 t -131.02 134.17 46.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.904 0.383 . . . . 0.0 110.863 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.5 t -45.75 123.9 4.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.891 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.07 -83.17 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.507 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 53.8 m -49.42 95.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.804 0.335 . . . . 0.0 111.183 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 21.1 tpt85 -118.09 -56.7 2.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 83' ' ' LEU . 49.0 t -87.98 -35.42 8.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.099 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.416 ' HG3' ' CD2' ' A' ' 113' ' ' TYR . 17.0 mttp -40.14 -27.43 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.431 ' N ' ' O ' ' A' ' 81' ' ' VAL . 33.7 mt -74.58 -55.11 6.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.916 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.431 ' O ' ' N ' ' A' ' 87' ' ' ASP . 50.5 t30 -40.9 -61.71 0.93 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.87 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.484 ' O ' HG22 ' A' ' 89' ' ' ILE . 73.0 t80 -39.53 -32.89 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.6 mt -77.25 -43.14 34.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 84' ' ' ASN . 1.0 OUTLIER -56.05 -41.97 75.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 179.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.06 -62.97 1.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.534 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 15.0 tt -52.42 -39.71 29.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.143 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.1 -42.81 93.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.11 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -59.02 -29.21 67.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -77.2 -39.75 47.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.915 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 54.7 m95 -72.74 -58.39 3.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.433 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 9.6 pt-20 -39.17 -36.91 0.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.433 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 95.4 mt -69.85 -47.07 71.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.096 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -53.5 -35.34 60.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.925 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 130.56 -33.19 2.92 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.482 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.4 m -93.5 145.33 24.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.928 0.394 . . . . 0.0 110.89 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 27.7 p -79.27 159.55 27.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 39.1 tp -90.04 138.34 31.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.93 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 49.7 tttt -134.4 144.63 48.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.957 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 62.9 mt -109.82 124.51 33.44 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.608 0.718 . . . . 0.0 111.116 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 157.38 60.42 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.634 2.223 . . . . 0.0 112.296 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -107.71 121.48 44.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 62.4 t -116.09 140.84 36.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.149 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.473 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 63.1 mm-40 44.76 52.86 7.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.473 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 12.0 ptm180 47.36 36.7 5.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.835 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -154.14 150.58 28.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 6.9 tt -62.3 140.26 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.131 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.634 HD23 ' N ' ' A' ' 111' ' ' ASP . 3.6 tt -89.22 121.86 31.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.953 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.634 ' N ' HD23 ' A' ' 110' ' ' LEU . 7.9 t0 -82.46 79.75 8.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.695 HD23 ' H ' ' A' ' 112' ' ' LEU . 1.4 pt? -58.71 -23.83 60.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.436 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 3.7 t80 -65.26 -56.12 14.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 115' ' ' LEU . 44.3 m -58.22 -59.84 4.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.875 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.448 ' C ' ' O ' ' A' ' 114' ' ' SER . 19.6 tp -34.48 -68.47 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.948 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.5 t -48.2 -54.71 12.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.852 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt -46.61 -54.75 8.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.904 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.607 HG22 ' OE1' ' A' ' 122' ' ' GLU . 81.5 mt -51.72 -54.25 13.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.141 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.408 HG13 HG12 ' A' ' 128' ' ' ILE . 76.4 t -53.33 -60.02 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.144 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 97.0 mt -43.28 -44.89 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.153 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -68.54 -48.61 63.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.607 ' OE1' HG22 ' A' ' 118' ' ' ILE . 24.7 mt-10 -44.95 -42.62 8.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.898 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 144.13 37.8 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.486 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.97 -179.45 45.49 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.516 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.516 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 0.9 OUTLIER -86.88 -41.51 13.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.855 0.36 . . . . 0.0 110.934 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -62.75 -33.45 75.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.899 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.8 -69.84 0.29 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.07 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.515 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.9 pp -51.07 -32.6 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.163 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.451 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 27.3 m -69.6 -41.5 75.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.1 mtpp -67.11 -28.03 67.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -101.03 13.81 34.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.852 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 39.07 50.87 1.87 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -84.13 -3.6 58.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.86 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.515 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 56.4 m95 -45.95 -39.06 8.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.925 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.53 -54.1 50.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.118 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -64.48 -46.85 81.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.908 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.454 ' CG2' ' OE2' ' A' ' 122' ' ' GLU . 52.0 t -50.39 -37.48 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.095 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.96 -49.35 38.2 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -59.03 -24.71 63.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -62.95 -30.54 71.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.551 HD23 ' CE2' ' A' ' 143' ' ' TYR . 14.8 tp -91.64 26.48 2.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 57.57 51.04 10.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.551 ' CE2' HD23 ' A' ' 141' ' ' LEU . 3.5 m-85 -102.68 151.62 38.31 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.709 0.766 . . . . 0.0 110.883 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.554 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.7 Cg_endo -69.76 110.31 2.52 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.739 2.293 . . . . 0.0 112.324 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 131.56 21.55 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.726 2.284 . . . . 0.0 112.358 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.65 -55.3 0.76 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.505 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -59.85 179.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.777 0.322 . . . . 0.0 110.912 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -93.97 42.22 1.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.554 HD11 ' HG2' ' A' ' 144' ' ' PRO . 61.8 mt -59.46 -50.07 81.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.115 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.22 -58.88 1.01 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.478 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.9 t -51.56 -60.49 3.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.926 0.393 . . . . 0.0 110.878 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.5 tt -38.98 -49.9 1.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.934 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 17.3 mt -59.74 -65.92 0.6 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.914 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.481 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 6.2 ttt-85 -38.3 -40.06 0.49 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.867 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 158' ' ' GLU . 3.8 m -66.84 -66.35 0.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -43.6 -29.69 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.831 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.514 ' CD1' ' C ' ' A' ' 157' ' ' TYR . 2.2 t80 -79.57 -34.92 40.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.924 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 155' ' ' SER . 26.0 mt-10 -88.93 -9.9 49.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.872 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 12.7 mmt85 -102.15 -39.86 7.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 86.3 mt -109.86 -49.86 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.131 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 157' ' ' TYR . 14.0 mt -78.47 3.3 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.095 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.641 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -72.57 -60.54 2.01 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.665 0.745 . . . . 0.0 110.893 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 162' ' ' TYR . 53.7 Cg_endo -69.79 -49.35 0.56 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.668 2.245 . . . . 0.0 112.343 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.534 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 34.4 t80 -48.31 -38.02 17.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.929 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -75.2 -63.24 1.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.892 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 11.8 ptt? -48.65 -31.05 6.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.869 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -75.1 -46.93 31.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.866 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -56.21 -44.41 79.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.888 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.7 t -73.75 95.54 2.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.881 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 174.81 -100.16 0.14 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.511 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.755 0.312 . . . . 0.0 111.141 179.923 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.7 p -100.97 168.34 9.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.846 0.355 . . . . 0.0 110.886 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.1 t 40.58 41.66 1.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.858 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -138.86 105.26 0.47 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.516 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 74.4 p -125.84 167.22 15.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.925 0.393 . . . . 0.0 110.841 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.7 p -149.79 170.79 17.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.852 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.94 -48.27 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.477 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 25.8 m -91.94 96.48 10.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.76 0.314 . . . . 0.0 111.156 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -124.87 -63.42 1.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.876 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.485 ' O ' ' N ' ' A' ' 83' ' ' LEU . 81.0 t -71.49 -43.36 72.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.137 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 81' ' ' VAL . 23.5 ttmt -35.13 -31.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.943 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 81' ' ' VAL . 13.8 mt -81.63 -48.18 12.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.922 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 81' ' ' VAL . 47.4 t30 -42.02 -47.55 4.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.857 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.624 ' HE2' HD12 ' A' ' 112' ' ' LEU . 39.3 t80 -57.62 -37.71 73.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.956 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.9 mt -74.73 -59.13 2.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.908 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -49.61 -29.07 6.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -76.79 -68.2 0.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.959 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.548 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 9.9 tt -46.16 -34.84 2.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.16 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.27 -46.53 67.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.136 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -55.98 -22.86 29.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -84.95 -46.49 11.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.879 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 54.2 m95 -67.74 -51.25 51.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.894 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -45.88 -32.1 2.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 89.8 mt -74.93 -46.04 41.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.128 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -56.35 -36.74 69.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.88 -52.67 0.7 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.467 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 71.4 m -83.32 119.98 25.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.865 0.364 . . . . 0.0 110.874 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 59.4 p -55.51 173.26 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.84 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.1 tp -82.68 132.96 35.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.951 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -131.92 134.4 45.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.0 mt -110.0 127.45 27.07 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.594 0.712 . . . . 0.0 111.148 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.565 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 53.2 Cg_endo -69.77 166.53 27.29 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.661 2.24 . . . . 0.0 112.329 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -113.09 122.86 48.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.4 t -123.75 148.64 27.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.155 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.448 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 58.1 mm-40 41.72 52.92 4.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.448 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 13.0 ptp180 45.16 43.01 7.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.875 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -164.58 152.22 11.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.926 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.1 tt -62.29 142.89 15.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.121 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.712 HD23 ' N ' ' A' ' 111' ' ' ASP . 5.3 tt -91.63 132.49 36.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.712 ' N ' HD23 ' A' ' 110' ' ' LEU . 24.2 t70 -94.6 100.92 12.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.838 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.755 HD23 ' H ' ' A' ' 112' ' ' LEU . 0.9 OUTLIER -72.53 -26.64 61.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.563 ' CE1' ' HG3' ' A' ' 117' ' ' LYS . 4.4 t80 -61.06 -55.89 27.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.886 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.4 m -61.85 -56.98 13.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.83 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.414 ' O ' HG23 ' A' ' 119' ' ' VAL . 26.2 tp -40.73 -60.74 1.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.1 t -58.17 -50.59 73.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.802 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.563 ' HG3' ' CE1' ' A' ' 113' ' ' TYR . 13.9 mmmt -47.92 -46.3 31.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.535 HG22 ' OE1' ' A' ' 122' ' ' GLU . 63.8 mt -64.45 -38.58 82.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.431 HG13 HG12 ' A' ' 128' ' ' ILE . 71.6 t -64.17 -59.96 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 83.3 mt -59.71 -43.58 91.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.118 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -58.79 -56.56 20.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.535 ' OE1' HG22 ' A' ' 118' ' ' ILE . 20.9 mt-10 -44.36 -51.07 8.84 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 159.11 34.42 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.473 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.98 -175.02 33.36 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.528 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.517 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 2.1 t80 -87.41 -46.59 9.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.838 0.352 . . . . 0.0 110.905 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -58.02 -37.53 74.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.58 -70.46 0.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.113 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.527 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.9 pp -50.09 -34.47 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.165 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.517 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 53.5 m -67.93 -44.18 77.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.914 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -64.53 -40.85 96.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.933 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 132' ' ' ARG . 69.5 m-20 -85.92 23.77 1.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.824 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 131' ' ' ASP . 41.3 mtp85 36.04 37.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.847 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 134' ' ' TRP . 29.7 mmt180 -66.71 -23.47 66.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.542 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 22.4 m95 -34.71 -43.85 0.19 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.89 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.35 -49.21 75.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.114 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 133' ' ' ARG . 13.0 tpp180 -69.11 -42.18 76.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.892 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 89.2 t -53.85 -34.7 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.485 ' HB2' HD11 ' A' ' 153' ' ' LEU . . . -76.78 -53.45 7.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.1 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -55.04 -28.21 50.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -64.89 -28.3 69.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.779 HD23 ' CE2' ' A' ' 143' ' ' TYR . 12.5 tp -88.27 22.67 2.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 60.78 45.84 9.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.843 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.779 ' CE2' HD23 ' A' ' 141' ' ' LEU . 4.4 m-85 -97.71 147.37 32.93 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.692 0.758 . . . . 0.0 110.902 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 125.43 12.12 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.689 2.259 . . . . 0.0 112.289 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 96.68 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.676 2.251 . . . . 0.0 112.324 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 165.02 -75.24 0.16 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.543 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 149' ' ' ILE . 0.3 OUTLIER -45.96 138.47 5.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.798 0.332 . . . . 0.0 110.929 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -62.87 75.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.915 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 147' ' ' LYS . 94.1 mt -87.38 -48.91 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.138 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.13 -59.0 0.99 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.472 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.1 t -53.56 -55.25 27.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.945 0.402 . . . . 0.0 110.873 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.608 ' CD2' ' CD2' ' A' ' 156' ' ' HIS . 5.6 tt -44.28 -53.31 6.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 138' ' ' ALA . 18.6 mt -53.54 -65.85 0.49 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.542 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 16.3 ttp180 -39.75 -47.05 2.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 7.9 t -59.41 -66.51 0.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.842 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.608 ' CD2' ' CD2' ' A' ' 152' ' ' LEU . 3.2 m-70 -40.6 -34.44 0.36 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.821 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.499 ' O ' ' N ' ' A' ' 161' ' ' ILE . 9.7 t80 -68.57 -70.27 0.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.4 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 3.9 mm-40 -61.09 -10.08 5.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.867 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -85.0 -55.85 3.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 49.7 mt -109.43 -37.27 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.118 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.499 ' N ' ' O ' ' A' ' 157' ' ' TYR . 26.7 mt -75.4 -5.93 7.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.113 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.513 ' CD2' ' HD3' ' A' ' 163' ' ' PRO . 0.3 OUTLIER -71.25 -59.26 3.39 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.679 0.752 . . . . 0.0 110.93 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.513 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.3 Cg_endo -69.85 -39.73 6.0 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.69 2.26 . . . . 0.0 112.335 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.548 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 3.7 t80 -64.78 -30.03 71.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.935 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.494 ' CG ' HG22 ' A' ' 161' ' ' ILE . 17.1 mm-40 -74.13 -57.24 4.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.876 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.464 ' HG3' ' N ' ' A' ' 167' ' ' PHE . 5.5 ptp -55.43 -29.52 58.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.464 ' N ' ' HG3' ' A' ' 166' ' ' MET . 54.3 t80 -71.83 -55.72 7.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.873 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -54.81 -50.23 69.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.3 t -53.74 -53.94 45.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.836 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 127.9 117.98 2.1 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.48 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 120.795 0.331 . . . . 0.0 111.119 179.988 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.0 p -55.37 -52.63 62.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.9 0.381 . . . . 0.0 110.881 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.5 t -53.45 140.73 26.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.849 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -109.84 -138.14 7.96 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.491 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.7 m -130.79 114.04 14.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.919 0.39 . . . . 0.0 110.858 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.9 p -69.77 -44.07 70.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.836 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.415 ' HA3' ' NH1' ' A' ' 80' ' ' ARG . . . -173.89 -155.55 12.12 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.487 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 99.3 m -85.27 94.76 9.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.774 0.321 . . . . 0.0 111.129 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.415 ' NH1' ' HA3' ' A' ' 78' ' ' GLY . 7.4 mpt_? -119.39 -67.81 0.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.841 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.429 ' O ' ' N ' ' A' ' 84' ' ' ASN . 93.7 t -53.7 -48.31 60.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.099 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.589 ' HG3' ' CD2' ' A' ' 113' ' ' TYR . 9.9 mtmt -45.48 -21.91 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.885 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.5 mt -88.01 -34.12 18.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.941 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 81' ' ' VAL . 30.9 t30 -63.39 -38.99 93.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.927 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.666 ' HE2' HD12 ' A' ' 112' ' ' LEU . 81.3 t80 -71.04 -27.13 63.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.417 ' O ' HG22 ' A' ' 89' ' ' ILE . 72.2 mt -80.56 -63.22 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.947 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -44.88 -31.39 1.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -72.26 -71.03 0.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.533 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 14.7 tt -43.29 -34.87 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.099 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.531 ' HB2' HD22 ' A' ' 100' ' ' LEU . . . -68.82 -50.18 52.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.107 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -51.89 -29.21 18.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.906 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.401 ' CD1' ' CD2' ' A' ' 167' ' ' PHE . 30.2 t80 -77.29 -37.81 52.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.875 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.451 ' O ' ' C ' ' A' ' 94' ' ' GLU . 67.7 m95 -76.19 -59.24 2.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.921 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.456 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 11.2 pt-20 -34.65 -40.54 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.456 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 95.5 mt -66.62 -53.87 31.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.126 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -46.81 -45.32 19.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 125.83 42.14 0.32 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.436 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.4 t -167.02 110.27 0.7 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.903 0.382 . . . . 0.0 110.869 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 78.1 p -43.84 163.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.902 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.531 HD22 ' HB2' ' A' ' 90' ' ' ALA . 10.6 tp -93.58 111.44 23.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -107.35 149.1 28.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 53.7 mt -119.95 129.93 25.1 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.655 0.741 . . . . 0.0 111.134 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 160.45 49.65 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.692 2.261 . . . . 0.0 112.303 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -111.81 126.05 54.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.906 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.3 t -121.32 144.22 31.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.161 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.429 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 62.7 mm-40 41.76 54.54 3.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.429 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 1.4 ptp180 43.88 40.07 2.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.03 152.72 26.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.4 tt -63.06 141.91 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.106 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.694 HD23 ' N ' ' A' ' 111' ' ' ASP . 5.4 tt -86.25 133.52 33.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.694 ' N ' HD23 ' A' ' 110' ' ' LEU . 17.8 t0 -91.95 74.33 5.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.699 HD23 ' H ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -54.63 -29.69 52.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.934 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.589 ' CD2' ' HG3' ' A' ' 82' ' ' LYS . 1.3 t80 -60.57 -66.94 0.45 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.932 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.8 m -50.97 -53.96 28.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.839 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.9 tp -39.46 -61.08 0.84 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.945 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.2 t -55.13 -66.59 0.38 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.473 ' N ' ' HE2' ' A' ' 117' ' ' LYS . 1.0 OUTLIER -40.96 -64.03 0.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.849 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 80.9 mt -40.81 -63.3 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.104 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.8 t -40.82 -58.14 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.099 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 69.9 mt -48.86 -42.12 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.161 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -65.92 -50.23 65.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.856 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -47.79 -40.14 20.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.846 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.66 ' O ' ' HB3' ' A' ' 127' ' ' ALA . . . 144.82 42.33 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.516 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.419 ' O ' HG23 ' A' ' 128' ' ' ILE . . . 83.03 174.74 50.61 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.525 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 0.6 OUTLIER -86.83 -37.13 18.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.846 0.355 . . . . 0.0 110.946 -179.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -66.06 -40.45 90.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.866 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.66 ' HB3' ' O ' ' A' ' 123' ' ' GLY . . . -66.72 -63.44 1.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.073 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.574 HD12 ' N ' ' A' ' 129' ' ' CYS . 2.4 pp -49.11 -37.07 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.123 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.574 ' N ' HD12 ' A' ' 128' ' ' ILE . 22.0 m -62.82 -50.7 69.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.849 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -62.31 -33.77 75.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 132' ' ' ARG . 2.5 m-20 -90.91 16.35 9.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 131' ' ' ASP . 78.0 mtt180 36.98 44.56 0.38 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 15.0 mtp85 -77.62 -13.6 59.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 21.4 m95 -39.66 -40.35 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.72 -45.55 81.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.129 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.4 tpp85 -73.57 -44.99 55.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.1 t -57.04 -24.25 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.148 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -85.06 -55.34 4.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.087 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -55.42 -29.57 58.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -54.2 -36.45 63.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.869 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.498 HD23 ' CE2' ' A' ' 143' ' ' TYR . 17.6 tp -83.27 14.57 3.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 68.99 44.16 1.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.498 ' CE2' HD23 ' A' ' 141' ' ' LEU . 2.7 m-85 -92.32 158.33 39.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.731 0.777 . . . . 0.0 110.91 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.446 ' HA ' ' HD2' ' A' ' 145' ' ' PRO . 53.6 Cg_endo -69.76 110.67 2.61 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.661 2.241 . . . . 0.0 112.349 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 53.9 Cg_endo -69.8 105.67 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.699 2.266 . . . . 0.0 112.356 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.94 -58.82 0.41 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.524 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.443 ' HD3' ' N ' ' A' ' 148' ' ' ASN . 10.7 tmtt? -61.95 150.3 38.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.79 0.329 . . . . 0.0 110.889 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.443 ' N ' ' HD3' ' A' ' 147' ' ' LYS . 46.9 t30 -66.68 81.39 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.431 HD11 ' HG2' ' A' ' 144' ' ' PRO . 42.9 mt -94.87 -52.75 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.124 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.04 -53.05 1.22 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.492 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 75.5 m -57.69 -57.88 10.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.901 0.381 . . . . 0.0 110.831 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.444 ' C ' HD23 ' A' ' 152' ' ' LEU . 6.6 tt -43.6 -50.24 7.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.881 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 154' ' ' ARG . 26.7 mt -55.37 -65.91 0.51 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.95 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 153' ' ' LEU . 20.0 ttp180 -38.17 -50.34 1.4 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.87 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 49.0 m -55.84 -69.21 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -38.84 -43.03 0.89 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.858 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.487 ' O ' ' N ' ' A' ' 161' ' ' ILE . 8.6 t80 -60.52 -66.2 0.57 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 41.4 mt-10 -63.06 -10.2 13.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.933 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -85.69 -53.81 4.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.435 HG22 HD11 ' A' ' 89' ' ' ILE . 42.8 mt -109.54 -39.35 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.091 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.58 HG22 ' HG3' ' A' ' 165' ' ' GLU . 18.4 mt -76.25 -2.28 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.156 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.543 ' CD2' ' HD3' ' A' ' 163' ' ' PRO . 0.2 OUTLIER -72.08 -60.29 2.37 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.672 0.749 . . . . 0.0 110.915 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.543 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.6 Cg_endo -69.78 -41.05 4.58 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.64 2.227 . . . . 0.0 112.323 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.533 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 8.1 t80 -63.33 -27.95 69.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.946 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.58 ' HG3' HG22 ' A' ' 161' ' ' ILE . 9.3 mm-40 -76.97 -59.06 2.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.882 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.469 ' CE ' ' CZ ' ' A' ' 162' ' ' TYR . 2.2 ptp -56.22 -25.39 47.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.858 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.401 ' CD2' ' CD1' ' A' ' 92' ' ' PHE . 67.9 t80 -78.25 -49.28 14.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.869 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -53.08 -48.32 67.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.962 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 5.8 t -60.12 96.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.836 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -92.91 -66.38 1.09 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.493 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.775 0.322 . . . . 0.0 111.128 179.971 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.0 m -133.03 157.27 45.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.856 0.36 . . . . 0.0 110.89 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 96.9 p -124.1 149.99 45.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.832 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.78 130.41 3.04 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.513 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.5 t -151.86 156.55 40.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.832 0.348 . . . . 0.0 110.874 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 66.5 m -146.86 156.8 43.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.818 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.82 -163.31 34.1 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.494 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.512 HG23 ' HB2' ' A' ' 82' ' ' LYS . 86.7 m -82.16 91.23 6.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.784 0.326 . . . . 0.0 111.173 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -119.53 -56.93 2.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.876 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 83' ' ' LEU . 43.6 t -81.51 -34.13 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.147 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.584 ' HG2' ' CD2' ' A' ' 113' ' ' TYR . 22.8 mtpt -41.02 -27.47 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 81' ' ' VAL . 23.4 mt -82.34 -54.23 5.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.926 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -42.84 -33.71 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.892 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.605 ' HE2' HD12 ' A' ' 112' ' ' LEU . 48.9 t80 -66.83 -45.11 79.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.515 ' HA ' HG22 ' A' ' 89' ' ' ILE . 52.0 mt -73.03 -47.65 43.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -54.03 -29.95 45.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -83.91 -64.03 1.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.924 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.515 HG22 ' HA ' ' A' ' 86' ' ' LEU . 9.2 tt -51.15 -28.63 7.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.139 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.1 -34.21 59.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.085 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.3 tttp -69.71 -25.09 63.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.942 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -82.4 -49.19 10.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -63.79 -49.41 73.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.961 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.466 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 7.2 pt-20 -46.27 -35.84 5.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.466 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 96.4 mt -70.13 -44.53 78.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.138 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 -57.76 -36.19 71.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 130.94 -40.04 1.7 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.491 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.7 m -88.41 109.88 20.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.87 0.367 . . . . 0.0 110.841 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 88.7 p -49.88 166.68 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.869 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.9 tp -85.05 122.36 29.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.916 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -127.76 134.78 49.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.492 HG23 ' HD2' ' A' ' 103' ' ' PRO . 5.4 mp -99.04 134.16 21.62 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.64 0.733 . . . . 0.0 111.108 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.492 ' HD2' HG23 ' A' ' 102' ' ' ILE . 53.8 Cg_endo -69.76 159.39 53.58 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.674 2.249 . . . . 0.0 112.357 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -112.63 103.66 11.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.731 HG12 ' HG2' ' A' ' 106' ' ' GLU . 87.1 t -106.35 138.35 32.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.137 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.731 ' HG2' HG12 ' A' ' 105' ' ' VAL . 73.5 mm-40 53.16 47.55 24.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.898 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.493 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 28.0 ptt180 47.95 32.88 3.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.82 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.5 pttm -150.48 157.47 43.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.407 HG13 ' N ' ' A' ' 110' ' ' LEU . 3.0 tp -63.09 140.12 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.097 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.717 HD23 ' N ' ' A' ' 111' ' ' ASP . 5.5 tt -84.6 142.06 30.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.869 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.717 ' N ' HD23 ' A' ' 110' ' ' LEU . 19.5 t0 -93.08 93.38 8.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.847 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.726 HD23 ' H ' ' A' ' 112' ' ' LEU . 1.4 pt? -82.97 -19.88 36.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.875 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.621 ' CE1' ' CE ' ' A' ' 117' ' ' LYS . 65.7 t80 -71.04 -67.08 0.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.975 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.9 m -50.82 -54.37 24.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.885 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.776 ' O ' HG23 ' A' ' 119' ' ' VAL . 13.3 tp -41.53 -50.07 4.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.954 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.0 t -58.04 -61.22 2.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.621 ' CE ' ' CE1' ' A' ' 113' ' ' TYR . 0.1 OUTLIER -56.12 -63.92 1.03 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.885 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.402 ' C ' ' O ' ' A' ' 117' ' ' LYS . 71.9 mt -36.06 -58.61 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.122 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 115' ' ' LEU . 84.2 t -51.03 -54.42 10.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.168 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 65.3 mt -57.62 -29.63 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.088 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -74.48 -56.2 5.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -43.52 -50.15 7.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.508 ' O ' ' HB3' ' A' ' 127' ' ' ALA . . . 160.51 33.09 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.498 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.587 ' O ' HG23 ' A' ' 128' ' ' ILE . . . 89.12 173.35 46.34 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.464 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.524 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 0.8 OUTLIER -78.44 -44.84 23.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.832 0.349 . . . . 0.0 110.897 -179.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 56.0 mp0 -59.93 -40.25 88.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.933 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 123' ' ' GLY . . . -65.52 -64.04 0.96 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.12 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.606 HG12 HG13 ' A' ' 119' ' ' VAL . 1.6 pp -55.1 -32.84 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.133 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.52 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 29.8 m -69.56 -42.03 75.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.8 tttm -66.55 -34.86 78.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' A' ' 132' ' ' ARG . 6.5 m-20 -94.2 23.01 5.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 131' ' ' ASP . 0.8 OUTLIER 34.39 35.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.836 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 131' ' ' ASP . 10.8 mmt85 -71.0 -1.54 12.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.569 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 44.3 m95 -49.32 -38.99 29.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.92 -47.92 76.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.103 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 -66.16 -44.7 83.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.887 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 99.2 t -56.94 -39.98 69.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.085 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.97 -57.84 6.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.084 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -52.83 -29.84 30.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.935 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.0 mmt-85 -60.73 -29.44 69.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.546 HD11 ' CB ' ' A' ' 111' ' ' ASP . 14.4 tp -87.53 13.32 10.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.91 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 71.91 35.82 1.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.882 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.496 ' HB3' HD12 ' A' ' 149' ' ' ILE . 3.1 m-85 -82.21 154.82 69.69 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.65 0.738 . . . . 0.0 110.95 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 122.77 9.45 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.673 2.248 . . . . 0.0 112.367 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 120.03 6.87 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.666 2.244 . . . . 0.0 112.305 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 134.8 -64.67 0.59 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.511 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.451 ' HE2' ' N ' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -59.81 142.32 53.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.788 0.328 . . . . 0.0 110.887 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.98 85.91 2.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.496 HD12 ' HB3' ' A' ' 143' ' ' TYR . 56.0 mt -91.6 -34.05 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.133 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -41.02 -48.96 4.33 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.445 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.5 m -57.83 -51.58 69.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.362 . . . . 0.0 110.851 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.416 ' CD2' ' CD2' ' A' ' 156' ' ' HIS . 5.4 tt -48.52 -53.92 16.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.92 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 15.4 mt -53.76 -65.94 0.48 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.917 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.551 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 12.6 ttp180 -37.99 -46.01 0.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.866 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 3.3 m -61.34 -71.93 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.817 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.47 ' CD2' ' HG3' ' A' ' 103' ' ' PRO . 2.3 m-70 -37.37 -34.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.816 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.561 ' CD2' HD12 ' A' ' 161' ' ' ILE . 4.0 t80 -70.08 -57.48 4.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.9 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.5 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 20.2 mm-40 -71.11 -9.74 58.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.919 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.1 tpp85 -98.46 -36.87 9.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.878 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 66.3 mt -112.68 -50.12 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.101 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.661 HG22 ' HG3' ' A' ' 165' ' ' GLU . 34.3 mt -76.34 -0.14 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.546 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -73.08 -60.87 1.66 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.674 0.749 . . . . 0.0 110.942 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.508 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.5 Cg_endo -69.8 -40.45 5.25 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.67 2.247 . . . . 0.0 112.331 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.473 ' CD2' HD12 ' A' ' 89' ' ' ILE . 8.0 t80 -61.04 -36.19 78.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.946 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.661 ' HG3' HG22 ' A' ' 161' ' ' ILE . 9.8 mm-40 -72.35 -61.31 1.84 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.908 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.508 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 11.1 ptt? -54.55 -37.96 66.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.841 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -65.4 -44.19 88.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.916 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 -96.03 38.07 1.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.96 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.7 m -142.29 118.7 10.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 162.86 -54.53 0.3 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.793 0.33 . . . . 0.0 111.111 179.978 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.6 t -95.17 130.3 41.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.85 0.357 . . . . 0.0 110.861 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.7 p -49.85 142.67 8.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.878 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.2 115.17 1.98 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.464 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.0 m 46.87 30.1 1.15 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.851 0.357 . . . . 0.0 110.879 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.7 t -67.22 132.28 47.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -133.3 63.83 0.61 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.5 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.615 HG23 ' HB2' ' A' ' 82' ' ' LYS . 48.4 m -109.41 102.76 11.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.807 0.337 . . . . 0.0 111.149 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 9.7 mmp_? -123.94 -53.69 1.74 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.46 ' O ' ' N ' ' A' ' 83' ' ' LEU . 66.4 t -83.86 -43.23 17.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.152 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.615 ' HB2' HG23 ' A' ' 79' ' ' THR . 1.0 OUTLIER -36.93 -30.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.836 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.46 ' N ' ' O ' ' A' ' 81' ' ' VAL . 13.5 mt -72.11 -60.6 2.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.927 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 83' ' ' LEU . 49.9 t30 -37.04 -56.75 0.87 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.512 ' HE2' HD12 ' A' ' 112' ' ' LEU . 41.8 t80 -50.03 -44.81 51.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.92 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.402 HD21 HD21 ' A' ' 112' ' ' LEU . 59.0 mt -69.3 -66.48 0.58 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.889 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -44.2 -24.39 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.935 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -80.73 -62.75 1.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.94 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.451 HG23 ' CD2' ' A' ' 100' ' ' LEU . 15.1 tt -56.89 -26.4 24.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.131 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.09 -55.17 5.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.121 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -53.46 -33.18 53.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.928 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -69.46 -53.3 19.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.871 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.617 ' CD1' HD13 ' A' ' 100' ' ' LEU . 21.7 m95 -54.11 -55.04 31.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.894 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 11.3 pt-20 -48.59 -43.91 36.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.921 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.451 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 62.8 mt -61.61 -45.84 97.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.111 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -54.59 -41.05 69.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.984 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 126.86 42.26 0.29 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.472 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.2 m -164.24 169.9 16.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.881 0.372 . . . . 0.0 110.836 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.7 t -100.44 151.5 21.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.843 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.617 HD13 ' CD1' ' A' ' 93' ' ' TRP . 42.4 tp -97.17 117.3 31.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.877 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -113.77 146.6 39.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.941 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 66.5 mt -111.71 124.38 32.57 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.569 0.699 . . . . 0.0 111.15 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 154.02 68.47 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.684 2.256 . . . . 0.0 112.382 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -104.14 119.77 39.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.88 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 84.5 t -127.59 135.52 62.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.126 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 62.04 48.94 4.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.876 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 42.15 39.2 1.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.843 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -163.94 154.48 15.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.864 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.1 tt -58.36 152.15 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.114 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.5 tt -97.48 124.63 41.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -85.75 76.0 10.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.871 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.689 HD23 ' H ' ' A' ' 112' ' ' LEU . 1.1 pt? -53.3 -28.84 30.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.579 ' CD2' ' HG3' ' A' ' 82' ' ' LYS . 5.9 t80 -58.18 -52.59 64.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.936 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.447 ' O ' ' C ' ' A' ' 115' ' ' LEU . 23.9 m -63.06 -59.86 4.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 114' ' ' SER . 28.4 tp -34.74 -67.84 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.868 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 117' ' ' LYS . 68.6 m -54.16 -60.23 3.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.857 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 116' ' ' SER . 22.8 mmtt -37.7 -49.14 1.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.9 mt -62.65 -45.04 99.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.186 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.8 t -51.06 -65.89 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.119 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 83.5 mt -51.55 -52.47 20.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.136 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -46.55 -49.16 19.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.413 ' HB3' HG22 ' A' ' 128' ' ' ILE . 44.7 mm-40 -53.28 -48.46 68.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.89 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 153.8 34.4 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.498 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.491 ' O ' HG23 ' A' ' 128' ' ' ILE . . . 96.14 -178.12 34.29 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.478 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.499 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 1.0 OUTLIER -88.07 -35.91 17.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 0.0 110.912 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -69.56 -38.91 77.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.905 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.2 -57.87 6.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.105 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.576 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 2.2 pp -56.57 -35.99 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.156 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.448 ' N ' HD12 ' A' ' 128' ' ' ILE . 39.1 m -67.71 -35.91 79.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -65.27 -46.06 81.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.448 ' O ' ' C ' ' A' ' 132' ' ' ARG . 3.7 t0 -88.18 24.55 1.83 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.448 ' C ' ' O ' ' A' ' 131' ' ' ASP . 60.0 mtp180 34.31 52.23 0.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.457 ' O ' ' C ' ' A' ' 134' ' ' TRP . 16.8 mmt180 -74.27 -24.39 59.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.848 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.576 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 25.2 m95 -33.57 -45.39 0.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.33 -56.51 17.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.09 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.6 -40.59 92.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 90.2 t -54.14 -39.35 41.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.097 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.477 ' HB2' HD11 ' A' ' 153' ' ' LEU . . . -71.87 -52.86 15.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.145 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -54.25 -29.12 45.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -60.13 -35.25 74.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.867 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.7 HD23 ' CE2' ' A' ' 143' ' ' TYR . 15.0 tp -85.22 24.65 1.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.939 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 59.18 34.59 23.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.847 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.7 ' CE2' HD23 ' A' ' 141' ' ' LEU . 3.2 m-85 -82.34 153.41 68.64 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.663 0.744 . . . . 0.0 110.954 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.699 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.5 Cg_endo -69.75 113.55 3.41 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.666 2.244 . . . . 0.0 112.32 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 53.3 Cg_endo -69.79 94.8 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.624 2.216 . . . . 0.0 112.322 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 173.54 -71.5 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.457 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -49.56 168.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.806 0.336 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -83.39 43.8 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.699 HD11 ' HG2' ' A' ' 144' ' ' PRO . 63.5 mt -54.59 -49.37 67.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.146 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.571 ' HA2' HD12 ' A' ' 153' ' ' LEU . . . -37.89 -52.36 2.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.466 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.2 t -62.21 -47.82 82.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.93 0.395 . . . . 0.0 110.84 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.5 tt -52.04 -46.56 65.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.951 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.571 HD12 ' HA2' ' A' ' 150' ' ' GLY . 6.2 mt -59.93 -66.04 0.58 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.534 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 18.3 ttp180 -37.84 -49.2 1.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 74.5 m -57.07 -68.6 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -38.15 -45.26 0.92 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.843 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.514 ' HA ' HD12 ' A' ' 161' ' ' ILE . 4.0 t80 -60.22 -59.37 5.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.434 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 5.5 mm-40 -67.14 -9.97 45.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -86.89 -54.39 4.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.8 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 38.6 mt -108.85 -39.92 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.075 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 157' ' ' TYR . 15.0 mt -77.33 0.66 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.118 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.586 ' CE1' ' SD ' ' A' ' 166' ' ' MET . 0.2 OUTLIER -72.53 -60.48 2.06 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.662 0.744 . . . . 0.0 110.932 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.557 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.0 Cg_endo -69.79 -42.96 2.92 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.695 2.263 . . . . 0.0 112.326 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.403 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 26.6 t80 -56.82 -39.74 74.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.916 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.501 ' HG3' HG22 ' A' ' 161' ' ' ILE . 16.3 mm-40 -72.17 -65.5 0.77 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.897 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.586 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 8.5 ptt? -47.95 -42.3 27.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.833 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -71.96 -57.49 4.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.874 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.65 49.52 0.51 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 12.6 t -114.75 40.93 2.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.909 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 45.9 80.48 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.502 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.323 0 CA-C-O 120.777 0.322 . . . . 0.0 111.143 179.945 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.4 m -104.47 109.02 20.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 0.0 110.866 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.1 t -154.98 122.73 5.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.871 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -119.91 -76.68 0.48 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.486 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.1 p -56.71 91.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.897 0.379 . . . . 0.0 110.858 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 78.0 p -146.94 141.56 26.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.813 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -145.98 38.92 1.16 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.506 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 80' ' ' ARG . 16.7 m -67.18 -39.68 86.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.773 0.32 . . . . 0.0 111.117 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.423 ' C ' ' O ' ' A' ' 79' ' ' THR . 20.7 tpp180 -35.61 -44.79 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.886 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 84' ' ' ASN . 96.1 t -76.88 -59.52 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.099 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 81' ' ' VAL . 11.4 mptt -35.9 -31.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.623 ' HA ' HD12 ' A' ' 86' ' ' LEU . 26.9 mt -71.8 -46.85 56.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.951 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.494 ' N ' ' O ' ' A' ' 81' ' ' VAL . 6.6 t30 -37.98 -48.63 1.2 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.416 ' CD2' ' HA ' ' A' ' 113' ' ' TYR . 29.4 t80 -63.76 -42.54 97.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.948 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.623 HD12 ' HA ' ' A' ' 83' ' ' LEU . 25.1 mt -63.75 -56.4 15.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.913 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -57.75 -24.82 58.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.887 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -77.88 -60.98 2.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.541 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 20.7 tt -62.19 -31.07 50.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.151 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.753 ' HB2' HD22 ' A' ' 100' ' ' LEU . . . -68.41 -51.93 38.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.088 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -47.29 -27.88 1.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.875 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -80.24 -44.22 20.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -69.5 -55.35 10.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 12.1 pt-20 -40.1 -41.65 1.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.843 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.41 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 84.7 mt -68.02 -54.27 23.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.154 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -45.74 -32.76 2.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 129.94 -37.94 2.07 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.482 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 41.3 t -89.22 121.81 31.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.906 0.384 . . . . 0.0 110.856 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.7 t -60.09 172.45 0.79 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.85 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.753 HD22 ' HB2' ' A' ' 90' ' ' ALA . 19.5 tp -97.94 127.86 44.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.889 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.3 mttm -130.56 128.53 41.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.493 HD12 HD22 ' A' ' 112' ' ' LEU . 45.9 mm -95.63 123.31 56.58 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.609 0.719 . . . . 0.0 111.165 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.561 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 54.1 Cg_endo -69.77 146.82 61.31 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.625 2.217 . . . . 0.0 112.389 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -95.92 113.9 25.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.925 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 79.1 t -115.53 141.43 32.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.441 ' HG3' ' CD ' ' A' ' 144' ' ' PRO . 23.2 mm-40 47.39 53.76 10.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.908 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 19.7 ptt-85 43.04 42.58 3.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.85 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -163.6 153.52 15.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.907 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.8 tp -63.56 143.57 15.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.086 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.631 HD23 ' N ' ' A' ' 111' ' ' ASP . 4.6 tt -89.82 123.75 34.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.631 ' N ' HD23 ' A' ' 110' ' ' LEU . 37.1 t0 -86.14 68.24 10.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.846 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.493 HD22 HD12 ' A' ' 102' ' ' ILE . 2.0 pt? -47.55 -32.64 5.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.416 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 6.9 t80 -56.33 -65.28 0.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.923 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.3 p -51.79 -45.5 63.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.6 tp -45.92 -66.91 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.902 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.9 t -47.56 -51.38 21.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -47.67 -59.43 3.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.891 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.609 ' CG2' HG13 ' A' ' 137' ' ' VAL . 77.7 mt -50.99 -50.05 25.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.139 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 98.9 t -49.65 -63.21 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.126 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 74.4 mt -51.18 -48.74 31.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.125 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -52.58 -57.24 10.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.875 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -45.36 -49.51 12.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.916 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 154.51 36.62 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.499 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.07 175.12 40.91 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.491 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.504 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 1.2 t80 -82.78 -40.19 20.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.839 0.352 . . . . 0.0 110.892 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -64.2 -40.02 95.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.878 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.1 -64.47 0.92 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.126 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.677 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 2.0 pp -54.7 -34.5 30.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.156 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.504 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 22.5 m -66.88 -36.57 82.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.6 tptt -71.62 -42.1 68.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 132' ' ' ARG . 38.7 m-20 -88.34 22.88 2.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.868 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 131' ' ' ASP . 35.3 mtp180 34.46 43.43 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.844 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -74.76 -8.11 55.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.677 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 16.7 m95 -45.61 -47.55 14.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.902 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -46.66 -56.97 5.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.098 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -67.73 -56.67 8.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.609 HG13 ' CG2' ' A' ' 118' ' ' ILE . 87.0 t -43.23 -29.42 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.138 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.547 ' HB2' HD11 ' A' ' 153' ' ' LEU . . . -81.0 -49.18 11.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.141 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -59.56 -27.73 66.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -60.6 -26.16 66.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.837 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.505 HD23 ' CE2' ' A' ' 143' ' ' TYR . 20.3 tp -90.03 12.12 18.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.878 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 71.42 48.88 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.505 ' CE2' HD23 ' A' ' 141' ' ' LEU . 2.8 m-85 -99.94 158.59 31.78 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.681 0.753 . . . . 0.0 110.9 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.623 ' HG2' HD11 ' A' ' 149' ' ' ILE . 54.4 Cg_endo -69.72 111.42 2.8 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.714 2.276 . . . . 0.0 112.372 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 53.5 Cg_endo -69.8 95.27 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.711 2.274 . . . . 0.0 112.307 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.52 -73.74 0.12 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.452 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -54.74 145.08 20.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.836 0.35 . . . . 0.0 110.888 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -63.76 81.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.864 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.623 HD11 ' HG2' ' A' ' 144' ' ' PRO . 71.4 mt -88.27 -45.59 15.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.101 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -37.98 -45.96 1.7 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.482 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.6 m -60.66 -51.38 69.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.372 . . . . 0.0 110.877 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.528 HD21 ' CD2' ' A' ' 156' ' ' HIS . 5.9 tt -50.2 -48.83 54.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.915 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.547 HD11 ' HB2' ' A' ' 138' ' ' ALA . 22.2 mt -57.32 -65.96 0.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.42 ' CD ' ' HE1' ' A' ' 134' ' ' TRP . 17.8 ttp180 -38.99 -46.38 1.33 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 157' ' ' TYR . 41.0 t -60.2 -68.53 0.28 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.561 ' CE1' ' HG3' ' A' ' 103' ' ' PRO . 2.4 m-70 -41.9 -24.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.842 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 155' ' ' SER . 7.9 t80 -78.42 -50.14 12.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.918 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.408 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 5.2 mm-40 -81.62 -9.86 59.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.87 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -96.0 -41.48 8.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 76.9 mt -112.49 -49.18 5.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.113 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.778 HG22 ' HG3' ' A' ' 165' ' ' GLU . 9.8 mt -76.88 6.39 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.152 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.645 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -75.35 -62.63 0.79 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.666 0.745 . . . . 0.0 110.907 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.556 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.1 Cg_endo -69.81 -35.26 12.84 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.675 2.25 . . . . 0.0 112.329 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.541 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 65.3 t80 -60.51 -42.53 96.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.945 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.778 ' HG3' HG22 ' A' ' 161' ' ' ILE . 8.0 mt-10 -70.04 -55.07 10.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.883 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 2.7 mtm -62.74 -58.63 6.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.856 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.462 ' CB ' ' O ' ' A' ' 163' ' ' PRO . 29.3 t80 -47.99 -54.74 11.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.83 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -93.91 46.28 1.17 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.885 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 8.6 t -96.74 98.33 10.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.885 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -163.44 85.21 0.11 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.514 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.783 0.325 . . . . 0.0 111.128 179.97 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.8 p -166.95 155.25 9.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.841 0.353 . . . . 0.0 110.899 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 79.6 p -81.24 -49.7 10.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.845 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.61 85.78 0.18 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.53 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.7 t -40.7 105.31 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.835 0.35 . . . . 0.0 110.892 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 72.1 m -117.53 132.8 56.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.28 -98.34 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.526 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 79' ' ' THR . 9.7 t -95.64 126.1 40.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.769 0.318 . . . . 0.0 111.11 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -130.82 -64.79 0.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.878 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.459 ' O ' ' N ' ' A' ' 83' ' ' LEU . 61.1 t -80.74 -47.28 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.151 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.4 mttp -38.99 -27.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.926 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.632 ' HA ' HD12 ' A' ' 86' ' ' LEU . 36.9 mt -69.74 -49.29 54.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.925 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 81' ' ' VAL . 49.3 t-20 -40.67 -65.19 0.44 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.461 ' HE2' HD12 ' A' ' 112' ' ' LEU . 34.7 t80 -39.8 -47.4 2.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.632 HD12 ' HA ' ' A' ' 83' ' ' LEU . 12.6 mt -63.15 -66.77 0.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -44.51 -26.16 0.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -78.74 -70.58 0.49 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.9 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.636 HD11 HG22 ' A' ' 160' ' ' ILE . 7.5 tt -49.46 -32.26 6.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.131 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.918 ' HB2' HD22 ' A' ' 100' ' ' LEU . . . -73.6 -49.82 24.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.103 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -52.63 -20.03 2.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -90.82 -42.12 10.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -68.3 -50.57 52.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.417 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 4.4 pt-20 -45.24 -29.36 0.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.862 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.417 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 86.5 mt -78.69 -54.67 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.089 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -45.67 -32.59 2.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 132.18 -30.0 3.25 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.479 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.3 m -98.72 146.63 25.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.904 0.383 . . . . 0.0 110.833 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 65.5 m -78.25 174.93 10.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.837 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.918 HD22 ' HB2' ' A' ' 90' ' ' ALA . 22.0 tp -90.67 117.12 29.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.921 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -115.84 141.98 47.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.863 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 25.8 mm -117.28 121.62 32.07 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.649 0.738 . . . . 0.0 111.116 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 166.42 27.63 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.72 2.28 . . . . 0.0 112.315 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -114.04 126.57 55.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.412 HG12 ' HG2' ' A' ' 106' ' ' GLU . 52.0 t -125.4 132.95 70.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.467 ' HG3' ' CD ' ' A' ' 144' ' ' PRO . 29.1 mm-40 56.9 52.05 9.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.404 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 11.8 ptp180 44.64 35.93 1.58 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.909 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.46 ' HG3' ' N ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -157.82 151.95 24.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.9 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.46 ' N ' ' HG3' ' A' ' 108' ' ' LYS . 15.7 tt -57.51 149.2 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.149 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.438 HD23 ' N ' ' A' ' 111' ' ' ASP . 5.9 tt -94.32 123.84 37.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.973 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.438 ' N ' HD23 ' A' ' 110' ' ' LEU . 22.1 t0 -79.99 69.56 6.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.851 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.461 HD12 ' HE2' ' A' ' 85' ' ' TYR . 2.5 pt? -51.25 -23.08 3.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.495 ' CE1' ' HG3' ' A' ' 117' ' ' LYS . 2.4 t80 -66.06 -57.51 7.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.95 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 115' ' ' LEU . 3.3 m -60.5 -59.43 5.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.867 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.423 ' C ' ' O ' ' A' ' 114' ' ' SER . 13.0 tp -36.21 -68.23 0.14 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.897 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 119' ' ' VAL . 42.0 t -50.78 -66.24 0.42 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.87 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.495 ' HG3' ' CE1' ' A' ' 113' ' ' TYR . 13.2 mmtp -36.85 -43.83 0.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.886 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 77.1 mt -64.82 -42.47 95.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.135 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.712 HG13 HG12 ' A' ' 128' ' ' ILE . 95.2 t -59.22 -56.89 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.105 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 70.0 mt -61.46 -45.58 98.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -56.4 -52.09 65.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -50.89 -47.17 60.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.865 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 127' ' ' ALA . . . 155.57 38.56 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.467 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.526 ' O ' HG23 ' A' ' 128' ' ' ILE . . . 87.44 176.27 48.6 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.481 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.566 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 0.6 OUTLIER -83.52 -36.94 23.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.368 . . . . 0.0 110.919 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -63.57 -41.09 98.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.85 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 123' ' ' GLY . . . -68.56 -64.36 0.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.136 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.712 HG12 HG13 ' A' ' 119' ' ' VAL . 2.2 pp -47.84 -32.17 3.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.136 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.439 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 22.1 m -70.18 -46.61 64.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.864 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -59.88 -40.62 89.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.897 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 132' ' ' ARG . 2.7 m-20 -86.65 17.35 3.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.85 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.428 ' HB3' ' NH1' ' A' ' 132' ' ' ARG . 14.5 mtp-105 37.7 45.72 0.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 134' ' ' TRP . 4.1 mmp_? -71.77 -20.15 61.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.561 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 50.5 m95 -36.01 -40.27 0.2 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.908 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.45 -52.65 64.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.076 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.5 mmt-85 -68.5 -38.85 81.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.887 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 78.2 t -56.27 -40.11 63.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.614 ' HB2' HD11 ' A' ' 153' ' ' LEU . . . -72.4 -47.69 47.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -62.04 -27.32 68.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.4 mmp_? -60.97 -35.7 77.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.854 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.495 HD23 ' CZ ' ' A' ' 143' ' ' TYR . 14.8 tp -82.79 13.49 3.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.971 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 62.82 51.13 3.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.668 ' HB3' HD13 ' A' ' 149' ' ' ILE . 2.5 m-85 -91.43 159.68 38.5 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.677 0.751 . . . . 0.0 110.873 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.467 ' CD ' ' HG3' ' A' ' 106' ' ' GLU . 53.8 Cg_endo -69.78 118.47 5.7 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.683 2.255 . . . . 0.0 112.343 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 54.0 Cg_endo -69.72 97.78 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.693 2.262 . . . . 0.0 112.36 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.54 -82.39 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.46 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 9.3 tttp -47.31 147.8 1.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.804 0.335 . . . . 0.0 110.88 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -66.68 82.68 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.895 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.668 HD13 ' HB3' ' A' ' 143' ' ' TYR . 64.0 mt -83.06 -50.77 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.136 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.11 -53.21 1.24 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.526 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.1 t -57.16 -61.59 2.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.903 0.382 . . . . 0.0 110.801 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.424 HD21 ' CD2' ' A' ' 156' ' ' HIS . 5.5 tt -39.12 -55.95 1.54 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.935 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.614 HD11 ' HB2' ' A' ' 138' ' ' ALA . 23.9 mt -50.57 -65.9 0.48 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.561 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 13.2 ttp180 -38.84 -45.78 1.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.4 t -61.12 -69.01 0.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.854 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.424 ' CD2' HD21 ' A' ' 152' ' ' LEU . 2.0 m-70 -39.91 -36.16 0.43 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.799 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.463 ' CD1' ' C ' ' A' ' 157' ' ' TYR . 3.4 t80 -69.78 -58.93 3.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 18.4 mt-10 -66.92 -10.08 45.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.901 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -92.95 -53.08 4.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.812 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.636 HG22 HD11 ' A' ' 89' ' ' ILE . 60.7 mt -104.73 -43.47 8.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.07 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.563 HG22 ' HG3' ' A' ' 165' ' ' GLU . 32.3 mt -76.02 -2.29 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.163 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.624 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -72.2 -60.45 2.24 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.656 0.741 . . . . 0.0 110.931 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 162' ' ' TYR . 53.9 Cg_endo -69.73 -43.56 2.61 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.699 2.266 . . . . 0.0 112.337 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.54 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 17.6 t80 -54.66 -41.55 70.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.563 ' HG3' HG22 ' A' ' 161' ' ' ILE . 14.5 mm-40 -76.26 -68.44 0.59 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.408 ' HG3' ' HA ' ' A' ' 163' ' ' PRO . 0.0 OUTLIER -42.34 -30.25 0.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -75.7 -55.59 5.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.9 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -93.52 41.98 1.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.873 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 54.5 m -144.44 129.68 18.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 100.78 48.87 1.44 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.476 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.822 0.344 . . . . 0.0 111.075 179.959 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 79.4 p -98.47 101.01 12.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.866 0.365 . . . . 0.0 110.866 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.5 t -97.66 92.4 5.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.912 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.39 -170.31 12.5 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.499 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m -90.69 114.31 26.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.905 0.383 . . . . 0.0 110.869 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 t -160.24 165.41 31.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.846 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 86.71 48.91 4.29 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.513 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 80' ' ' ARG . 99.0 m -122.31 -41.81 2.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.765 0.316 . . . . 0.0 111.11 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 79' ' ' THR . 23.2 mmt180 -35.84 -50.06 0.64 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.929 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.429 ' O ' ' N ' ' A' ' 84' ' ' ASN . 89.3 t -88.74 -39.43 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.093 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 81' ' ' VAL . 74.4 tttt -37.22 -33.09 0.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.451 ' HA ' HD12 ' A' ' 86' ' ' LEU . 21.1 mt -84.09 -43.73 14.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.892 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 81' ' ' VAL . 39.1 t30 -40.16 -53.31 2.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.601 ' CE1' ' NZ ' ' A' ' 117' ' ' LYS . 42.4 t80 -55.18 -50.34 69.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.939 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.741 ' CD2' HD21 ' A' ' 112' ' ' LEU . 43.3 mt -55.44 -59.88 4.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.906 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.3 -39.27 66.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.862 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -62.9 -57.83 9.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.456 HD11 HG22 ' A' ' 160' ' ' ILE . 18.0 tt -61.02 -34.99 62.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.14 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.26 -51.27 46.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.09 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -44.14 -35.31 2.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.929 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -72.41 -50.54 25.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.586 ' CD1' HD13 ' A' ' 100' ' ' LEU . 87.0 m95 -63.38 -58.5 6.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.949 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 21.7 pt-20 -37.68 -39.34 0.33 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.451 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 97.2 mt -71.24 -55.09 15.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.125 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -44.71 -35.81 2.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.923 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 120.31 -30.52 5.58 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.497 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.403 ' O ' ' C ' ' A' ' 99' ' ' SER . 0.7 OUTLIER -86.87 94.85 9.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.907 0.384 . . . . 0.0 110.84 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 98' ' ' SER . 51.3 p -38.02 150.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.837 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.586 HD13 ' CD1' ' A' ' 93' ' ' TRP . 18.5 tp -88.06 107.42 18.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.931 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -102.28 115.55 30.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.89 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.47 ' H ' HD12 ' A' ' 102' ' ' ILE . 5.4 mp -81.12 123.1 82.08 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.647 0.737 . . . . 0.0 111.12 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 144.55 54.44 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.671 2.248 . . . . 0.0 112.325 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -102.63 109.47 21.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.916 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 90.4 t -113.32 140.48 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.105 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.47 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 5.7 mm-40 57.45 43.62 22.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.912 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.47 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 5.3 ptm180 48.22 33.49 3.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.901 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -153.71 157.47 39.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 6.8 tt -63.6 139.63 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.114 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.584 HD23 ' N ' ' A' ' 111' ' ' ASP . 4.1 tt -84.85 122.11 28.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.941 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.584 ' N ' HD23 ' A' ' 110' ' ' LEU . 29.8 t0 -80.03 74.04 6.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.741 HD21 ' CD2' ' A' ' 86' ' ' LEU . 1.5 pt? -57.48 -32.08 66.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.901 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.531 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -56.57 -64.32 0.91 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.921 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 115' ' ' LEU . 5.3 m -53.11 -63.97 0.97 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.849 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.74 ' O ' HG23 ' A' ' 119' ' ' VAL . 13.7 tp -34.19 -53.89 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.879 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.3 t -56.46 -64.32 0.91 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.601 ' NZ ' ' CE1' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -45.23 -51.41 10.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.9 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 69.8 mt -54.33 -40.96 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.144 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 115' ' ' LEU . 96.9 t -66.2 -39.46 84.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.089 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 62.0 mt -70.28 -55.21 15.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.128 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.481 ' HG3' ' N ' ' A' ' 122' ' ' GLU . 5.6 pt-20 -49.31 -37.55 24.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.889 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.481 ' N ' ' HG3' ' A' ' 121' ' ' GLU . 35.7 mt-10 -65.41 -27.23 68.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.845 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 134.86 28.44 0.45 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.462 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.99 -175.65 35.37 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.495 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.485 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 1.1 t80 -86.25 -38.6 17.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.827 0.346 . . . . 0.0 110.933 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -62.37 -48.39 79.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.897 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -53.75 -71.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.09 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.522 HG12 HG13 ' A' ' 119' ' ' VAL . 1.6 pp -46.31 -34.86 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 25.7 m -69.01 -32.58 72.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.855 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -68.46 -46.64 69.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 132' ' ' ARG . 1.1 m-20 -90.11 24.62 2.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 131' ' ' ASP . 23.6 mmt85 35.45 44.9 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.624 ' O ' HG23 ' A' ' 137' ' ' VAL . 71.1 mtt85 -83.91 21.69 1.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.842 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.525 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 28.5 m95 -66.16 -42.77 88.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.45 -47.9 75.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.086 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -47.53 78.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 133' ' ' ARG . 73.1 t -53.88 -37.89 34.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.153 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.614 ' HB2' HD11 ' A' ' 153' ' ' LEU . . . -66.91 -53.12 35.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.097 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -58.31 -38.22 76.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.908 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -59.19 -31.61 69.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.96 HD12 ' CE2' ' A' ' 143' ' ' TYR . 1.5 tm? -80.77 12.52 3.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 65.71 53.53 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.839 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.96 ' CE2' HD12 ' A' ' 141' ' ' LEU . 6.6 m-85 -109.0 159.01 32.69 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.636 0.731 . . . . 0.0 110.956 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 112.5 3.1 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.712 2.274 . . . . 0.0 112.333 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 122.43 9.12 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.674 2.249 . . . . 0.0 112.372 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.96 -70.1 0.3 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.488 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -58.15 171.0 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.764 0.316 . . . . 0.0 110.915 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.2 42.2 1.02 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.917 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.423 ' O ' ' C ' ' A' ' 150' ' ' GLY . 92.1 mt -44.5 -45.02 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.151 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.05 -54.78 1.19 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.511 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.9 m -58.93 -50.26 74.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.948 0.404 . . . . 0.0 110.834 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.54 ' C ' HD23 ' A' ' 152' ' ' LEU . 8.3 tt -51.74 -50.13 61.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.956 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.614 HD11 ' HB2' ' A' ' 138' ' ' ALA . 25.5 mt -52.94 -64.73 0.72 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.902 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.525 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 14.3 ttp180 -41.1 -46.02 2.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 47.3 t -57.92 -58.88 6.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.841 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -51.98 -49.21 63.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.535 ' HA ' HD12 ' A' ' 161' ' ' ILE . 3.8 t80 -57.79 -57.59 12.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.963 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.471 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 39.0 mt-10 -66.88 -9.8 41.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.877 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 37.4 ttt-85 -87.76 -57.4 2.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.857 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.456 HG22 HD11 ' A' ' 89' ' ' ILE . 78.6 mt -104.76 -41.22 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.169 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.574 HG22 ' HG3' ' A' ' 165' ' ' GLU . 14.2 mt -75.96 -0.48 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.113 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.634 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -73.32 -61.31 1.48 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.716 0.769 . . . . 0.0 110.941 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.477 ' HA ' ' CG ' ' A' ' 166' ' ' MET . 53.8 Cg_endo -69.7 -33.65 16.38 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.737 2.292 . . . . 0.0 112.341 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.409 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 24.5 t80 -64.75 -46.38 82.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.887 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.574 ' HG3' HG22 ' A' ' 161' ' ' ILE . 4.9 mm-40 -69.29 -55.46 10.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.865 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.477 ' CG ' ' HA ' ' A' ' 163' ' ' PRO . 0.5 OUTLIER -55.02 -40.83 70.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -62.27 -45.7 92.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.878 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -114.22 81.47 1.54 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.901 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 15.8 t -127.36 87.85 2.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.841 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 179.61 -95.45 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.476 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.732 0.301 . . . . 0.0 111.102 179.963 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.1 m -130.41 146.68 52.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.86 0.362 . . . . 0.0 110.863 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 73.5 m -45.34 158.04 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.853 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.72 67.96 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.484 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.0 p -101.08 152.13 20.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.884 0.374 . . . . 0.0 110.873 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.8 t -117.1 35.0 4.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.897 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.44 -167.57 43.12 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.462 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 79' ' ' THR . 9.2 t -113.95 125.07 53.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.805 0.336 . . . . 0.0 111.152 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.1 tpp180 -131.48 -69.46 0.62 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.838 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.433 ' O ' ' N ' ' A' ' 83' ' ' LEU . 99.9 t -78.01 -41.33 27.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.121 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 81' ' ' VAL . 3.3 mptt -36.12 -33.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.915 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 81' ' ' VAL . 35.5 mt -65.42 -51.25 61.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.958 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.432 ' O ' ' N ' ' A' ' 87' ' ' ASP . 64.1 t-20 -38.13 -68.0 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.503 ' CD2' ' HA ' ' A' ' 113' ' ' TYR . 29.9 t80 -36.79 -50.51 0.85 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.938 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.8 HD21 HD21 ' A' ' 112' ' ' LEU . 95.6 mt -62.55 -41.99 99.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.899 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 84' ' ' ASN . 62.3 m-20 -61.76 -18.06 58.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -91.55 -57.33 2.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.96 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.498 HD11 HG22 ' A' ' 160' ' ' ILE . 15.6 tt -63.5 -39.39 85.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.149 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.485 ' HB2' ' CD2' ' A' ' 100' ' ' LEU . . . -67.03 -38.86 86.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.09 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -61.29 -28.5 69.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -82.58 -39.44 22.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.875 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.487 ' O ' ' N ' ' A' ' 96' ' ' GLN . 27.0 m95 -68.35 -61.05 2.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.442 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 5.7 pt-20 -36.96 -31.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.925 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 93' ' ' TRP . 96.7 mt -73.4 -45.41 52.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.101 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 93' ' ' TRP . 61.2 mm-40 -56.51 -33.07 65.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 131.78 -42.24 1.41 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.472 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 37.9 m -86.71 140.32 29.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.913 0.387 . . . . 0.0 110.848 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.0 p -71.17 175.31 5.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.87 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.489 HD22 HG23 ' A' ' 89' ' ' ILE . 25.5 tp -104.35 112.12 25.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.1 ttpt -109.67 130.46 55.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.1 mp -96.04 124.17 52.82 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.586 0.707 . . . . 0.0 111.15 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.444 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 54.2 Cg_endo -69.76 142.87 49.1 Favored 'Trans proline' 0 N--CA 1.466 -0.125 0 C-N-CA 122.707 2.272 . . . . 0.0 112.363 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -94.27 113.7 25.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.898 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.5 t -113.17 142.68 24.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.091 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 19.1 mm-40 50.61 48.62 22.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.911 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.434 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 18.4 ptt-85 45.72 33.22 1.41 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.868 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.8 pttm -151.6 164.76 36.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.856 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.4 tt -69.22 144.82 13.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.119 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 112' ' ' LEU . 6.4 tt -92.97 121.76 34.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.939 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -79.88 57.36 2.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.876 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.8 HD21 HD21 ' A' ' 86' ' ' LEU . 1.5 pt? -41.57 -29.29 0.16 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.503 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 4.9 t80 -59.31 -58.72 7.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.934 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 115' ' ' LEU . 11.0 t -56.05 -57.67 11.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.89 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 114' ' ' SER . 11.1 tp -36.76 -62.76 0.45 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.915 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.7 p -51.13 -53.93 29.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.853 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 18.2 mmtm -49.27 -54.2 17.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.409 ' O ' ' C ' ' A' ' 119' ' ' VAL . 64.6 mt -49.06 -69.22 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.13 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.631 HG13 HG12 ' A' ' 128' ' ' ILE . 90.8 t -37.09 -62.37 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.107 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 89.0 mt -45.18 -56.43 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -52.57 -56.89 12.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.45 ' OE1' HG21 ' A' ' 128' ' ' ILE . 46.8 mt-10 -38.36 -50.35 1.48 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 151.26 39.25 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.492 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.3 -179.43 40.65 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.504 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.499 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 1.9 t80 -87.56 -43.79 11.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.845 0.355 . . . . 0.0 110.931 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -61.28 -36.1 79.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.912 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.92 -65.58 0.66 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.13 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.849 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.8 pp -54.15 -31.8 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.087 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.499 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 26.8 m -70.81 -41.92 70.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.831 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -68.88 -26.44 65.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.855 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -103.03 15.71 28.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.821 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 67.5 mtp85 41.91 29.36 0.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.856 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 27.7 mtt-85 -62.15 -8.78 6.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.839 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.849 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 20.7 m95 -44.13 -52.18 7.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -40.83 -51.18 3.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.099 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -63.63 -51.38 65.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.857 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.6 t -49.4 -38.39 12.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.54 ' HB2' ' CD1' ' A' ' 153' ' ' LEU . . . -70.24 -57.48 4.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -57.87 -18.25 21.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -69.94 -25.36 63.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.857 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.58 HD23 ' CE2' ' A' ' 143' ' ' TYR . 14.6 tp -94.28 27.18 3.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 62.25 36.48 14.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.849 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.58 ' CE2' HD23 ' A' ' 141' ' ' LEU . 5.3 m-85 -92.2 147.29 34.33 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.706 0.765 . . . . 0.0 110.925 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.472 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.6 Cg_endo -69.79 118.95 5.99 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.68 2.253 . . . . 0.0 112.34 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 125.81 12.58 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.702 2.268 . . . . 0.0 112.338 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 131.76 -55.61 0.76 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.427 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -54.6 168.67 0.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.762 0.315 . . . . 0.0 110.947 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.422 ' CG ' ' O ' ' A' ' 148' ' ' ASN . 13.1 p-10 -83.86 43.36 0.91 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.91 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.472 HD11 ' HG2' ' A' ' 144' ' ' PRO . 70.5 mt -67.74 -52.51 39.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.096 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.28 -53.07 1.3 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.488 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.2 t -57.53 -58.62 7.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 0.0 110.849 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.647 HD21 ' CD2' ' A' ' 156' ' ' HIS . 7.2 tt -42.06 -49.46 4.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.943 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.54 ' CD1' ' HB2' ' A' ' 138' ' ' ALA . 23.6 mt -55.98 -65.84 0.53 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.938 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.443 ' HD2' ' NE1' ' A' ' 134' ' ' TRP . 32.0 ttt180 -39.21 -39.97 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 156' ' ' HIS . 9.3 t -67.56 -70.01 0.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.861 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.647 ' CD2' HD21 ' A' ' 152' ' ' LEU . 2.0 m-70 -37.17 -33.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.86 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.447 ' HA ' ' CG1' ' A' ' 161' ' ' ILE . 12.0 t80 -70.38 -56.27 7.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -73.59 -9.81 59.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.858 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? -92.07 -49.0 6.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.908 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.498 HG22 HD11 ' A' ' 89' ' ' ILE . 88.3 mt -109.91 -44.18 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.118 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.553 HG22 ' CG ' ' A' ' 165' ' ' GLU . 14.3 mt -77.45 4.24 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.148 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.606 ' CE1' ' SD ' ' A' ' 166' ' ' MET . 0.1 OUTLIER -74.24 -61.48 1.21 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.662 0.744 . . . . 0.0 110.905 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.564 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 54.2 Cg_endo -69.73 -30.71 21.98 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.649 2.232 . . . . 0.0 112.354 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -69.2 -42.58 75.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.973 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.553 ' CG ' HG22 ' A' ' 161' ' ' ILE . 3.9 mm-40 -67.8 -57.65 5.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.878 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.606 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 24.7 ptm -53.42 -47.7 69.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -59.12 -49.07 79.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.897 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 -104.76 73.26 1.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.894 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 28.4 t -118.69 -51.22 2.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -153.0 -89.99 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.485 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.805 0.336 . . . . 0.0 111.069 179.955 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 92.4 p -119.32 118.94 32.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 0.0 110.856 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.6 p -81.87 105.18 12.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.835 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -138.11 132.77 5.99 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.522 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 61.9 p -64.97 147.54 53.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.874 0.369 . . . . 0.0 110.87 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 55.4 m -118.64 117.27 28.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.825 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.42 70.23 0.19 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.471 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.1 t -104.59 41.69 1.29 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.806 0.336 . . . . 0.0 111.155 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -75.48 -66.78 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.859 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 57.8 t -80.01 -37.23 17.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.156 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.568 ' HD3' ' CD2' ' A' ' 113' ' ' TYR . 1.2 tppt? -40.64 -28.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.891 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.5 mt -77.66 -49.59 14.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.924 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -40.49 -56.84 1.96 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.497 ' HE2' HD12 ' A' ' 112' ' ' LEU . 40.3 t80 -41.42 -36.17 0.81 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.2 mt -76.48 -44.29 36.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -59.33 -38.81 81.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.859 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -66.25 -63.76 1.01 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.898 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.564 ' HA ' ' CE1' ' A' ' 164' ' ' TYR . 19.4 tt -52.54 -30.5 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.03 -56.24 6.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.059 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -44.24 -27.5 0.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.939 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -78.68 -46.75 18.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.43 ' O ' ' N ' ' A' ' 95' ' ' ILE . 66.2 m95 -69.2 -57.68 5.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.96 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 93' ' ' TRP . 9.2 pt-20 -36.91 -32.53 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.43 ' N ' ' O ' ' A' ' 93' ' ' TRP . 96.7 mt -76.22 -51.75 19.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.173 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -47.58 -40.12 18.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.06 -40.57 1.17 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.47 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.7 m -96.56 144.51 26.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.892 0.377 . . . . 0.0 110.833 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.5 t -76.64 171.68 14.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.86 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.5 tp -82.46 104.71 12.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.964 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -96.13 111.07 23.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.0 mt -94.35 119.56 66.33 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.603 0.716 . . . . 0.0 111.158 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.408 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 53.5 Cg_endo -69.75 151.22 69.1 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.676 2.251 . . . . 0.0 112.36 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -102.52 115.17 30.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.853 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.916 HG12 ' CD ' ' A' ' 106' ' ' GLU . 26.2 t -122.04 144.61 30.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.174 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.916 ' CD ' HG12 ' A' ' 105' ' ' VAL . 49.1 mp0 60.76 44.74 10.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.92 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.496 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 15.2 ptm180 46.43 39.79 7.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.876 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -171.0 154.0 3.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.865 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.8 tt -52.29 138.67 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.877 HD23 ' N ' ' A' ' 111' ' ' ASP . 5.4 tt -75.04 144.73 42.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.877 ' N ' HD23 ' A' ' 110' ' ' LEU . 13.3 t0 -103.41 75.05 1.31 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.873 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.779 HD23 ' H ' ' A' ' 112' ' ' LEU . 1.4 pt? -65.12 -36.18 83.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.9 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.568 ' CD2' ' HD3' ' A' ' 82' ' ' LYS . 38.1 t80 -46.71 -64.76 0.69 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 115' ' ' LEU . 36.6 m -56.93 -60.01 4.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.87 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 114' ' ' SER . 13.1 tp -34.93 -65.24 0.23 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.917 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 52.4 m -48.37 -56.88 7.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.868 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.415 ' HD2' ' N ' ' A' ' 117' ' ' LYS . 2.2 mptp? -49.77 -62.58 1.48 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.891 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 95.6 mt -38.46 -64.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.157 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.537 HG13 HG12 ' A' ' 128' ' ' ILE . 76.2 t -45.0 -59.13 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.112 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 79.2 mt -45.91 -34.81 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.141 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -76.67 -51.77 10.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.895 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -43.54 -46.36 6.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.896 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 127' ' ' ALA . . . 151.69 37.15 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.505 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.461 ' O ' HG23 ' A' ' 128' ' ' ILE . . . 88.59 173.97 47.08 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.477 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 2.4 t80 -82.47 -44.34 16.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.849 0.357 . . . . 0.0 110.929 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -59.67 -42.59 93.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.848 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 123' ' ' GLY . . . -63.15 -70.96 0.18 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.094 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.537 HG12 HG13 ' A' ' 119' ' ' VAL . 1.9 pp -45.28 -32.74 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.157 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.457 ' N ' HD12 ' A' ' 128' ' ' ILE . 22.3 m -68.77 -39.66 80.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -66.27 -41.77 89.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 132' ' ' ARG . 2.1 t70 -88.56 19.89 3.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.886 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.429 ' C ' ' O ' ' A' ' 131' ' ' ASP . 26.1 mtt180 35.47 51.92 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 134' ' ' TRP . 23.4 mtp180 -80.75 -14.54 58.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.827 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.556 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 42.6 m95 -37.56 -56.61 1.01 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.921 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -40.08 -55.83 2.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.105 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 19.8 mmt85 -60.97 -51.49 69.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 84.1 t -46.17 -37.94 3.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.124 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -73.61 -45.47 52.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.088 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -62.99 -17.41 62.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.932 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.9 mmt85 -76.61 -28.99 56.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.92 HD23 ' CZ ' ' A' ' 143' ' ' TYR . 14.7 tp -91.88 20.1 6.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.938 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 54.62 52.98 11.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.841 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.92 ' CZ ' HD23 ' A' ' 141' ' ' LEU . 4.9 m-85 -89.42 148.33 40.19 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.676 0.75 . . . . 0.0 110.9 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.49 ' CD ' ' HG2' ' A' ' 106' ' ' GLU . 54.0 Cg_endo -69.71 114.57 3.74 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.733 2.288 . . . . 0.0 112.362 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 132.62 23.77 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.701 2.267 . . . . 0.0 112.37 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.36 -63.14 0.6 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.459 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -70.23 156.78 38.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.822 0.344 . . . . 0.0 110.911 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.417 ' CG ' ' O ' ' A' ' 148' ' ' ASN . 16.5 p-10 -75.14 83.84 2.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.873 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.428 ' O ' ' C ' ' A' ' 150' ' ' GLY . 51.5 mt -92.2 -52.09 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.124 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.25 -54.97 1.24 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.473 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 68.0 m -57.91 -53.83 53.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.862 0.363 . . . . 0.0 110.862 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.766 HD21 ' CD2' ' A' ' 156' ' ' HIS . 5.3 tt -46.37 -49.76 17.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.928 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 26.5 mt -56.33 -66.07 0.5 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.556 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 9.7 ttt-85 -38.32 -40.31 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 156' ' ' HIS . 11.5 t -68.16 -71.15 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.766 ' CD2' HD21 ' A' ' 152' ' ' LEU . 2.2 m-70 -37.03 -37.91 0.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.872 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.415 ' HA ' ' CG1' ' A' ' 161' ' ' ILE . 7.8 t80 -65.01 -66.58 0.52 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.933 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 20.2 mm-40 -64.91 -9.94 25.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.911 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 20.3 mmm-85 -86.81 -56.25 3.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.845 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.409 HG22 HD11 ' A' ' 89' ' ' ILE . 62.2 mt -105.7 -43.74 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.096 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.48 ' O ' HG22 ' A' ' 161' ' ' ILE . 13.2 mt -72.61 -0.69 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.159 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.647 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -75.67 -63.24 0.68 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.675 0.75 . . . . 0.0 110.89 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.559 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 54.3 Cg_endo -69.75 -31.26 20.93 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.661 2.241 . . . . 0.0 112.355 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.564 ' CE1' ' HA ' ' A' ' 89' ' ' ILE . 14.5 t80 -64.5 -36.31 83.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.925 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.431 ' HG3' HG22 ' A' ' 161' ' ' ILE . 13.4 mt-10 -77.32 -56.17 4.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.846 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.51 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 13.1 ptt? -52.4 -43.79 64.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.878 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.408 ' N ' ' CG ' ' A' ' 166' ' ' MET . 54.5 t80 -66.09 -56.88 9.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.888 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -88.29 38.99 0.88 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 12.2 t -86.29 -52.11 5.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.835 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 168.77 -75.12 0.12 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.48 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.792 0.329 . . . . 0.0 111.089 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.0 p -50.74 155.19 1.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.864 0.364 . . . . 0.0 110.862 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.8 t -74.96 -49.53 19.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.849 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.05 -130.13 1.76 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.519 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.1 p -159.9 122.45 3.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.84 0.352 . . . . 0.0 110.894 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.4 t -112.27 -52.11 2.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.818 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 141.87 166.72 10.99 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.484 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.627 HG23 ' HB2' ' A' ' 82' ' ' LYS . 95.7 m -60.83 92.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.777 0.322 . . . . 0.0 111.162 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.2 mmp_? -119.77 -50.14 2.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.471 ' O ' ' N ' ' A' ' 83' ' ' LEU . 73.1 t -77.63 -43.51 29.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.14 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.627 ' HB2' HG23 ' A' ' 79' ' ' THR . 4.2 mptt -35.24 -32.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.913 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.617 ' HA ' HD12 ' A' ' 86' ' ' LEU . 63.5 mt -66.62 -53.33 35.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.912 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' A' ' 81' ' ' VAL . 4.6 t30 -39.57 -56.68 1.61 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.488 ' HE2' HD12 ' A' ' 112' ' ' LEU . 33.0 t80 -54.11 -37.74 64.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.92 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.617 HD12 ' HA ' ' A' ' 83' ' ' LEU . 28.1 mt -70.13 -59.31 2.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.945 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.42 -33.14 42.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -66.49 -67.75 0.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.552 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 8.2 tt -50.18 -37.27 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.093 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.28 -52.76 44.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.073 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.0 tttm -45.32 -30.68 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.551 ' CD1' ' CD2' ' A' ' 167' ' ' PHE . 8.3 t80 -79.46 -39.67 31.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.891 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.505 ' CD1' HD13 ' A' ' 100' ' ' LEU . 61.9 m95 -70.31 -64.21 0.94 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.924 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.447 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 6.0 pt-20 -34.82 -33.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' A' ' 93' ' ' TRP . 96.5 mt -74.02 -50.33 29.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.116 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 93' ' ' TRP . 28.8 mm-40 -55.59 -18.64 8.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.929 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 104.12 -37.42 3.77 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.496 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.7 p -79.35 92.77 5.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.824 0.345 . . . . 0.0 110.842 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 40.8 t -41.46 159.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.832 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.505 HD13 ' CD1' ' A' ' 93' ' ' TRP . 64.4 tp -93.29 143.78 25.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.958 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -138.61 121.14 16.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.918 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 60.8 mt -88.68 123.11 68.61 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.627 0.727 . . . . 0.0 111.118 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 158.8 55.7 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.665 2.243 . . . . 0.0 112.388 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -110.76 107.38 16.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.906 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 58.3 t -110.72 136.1 47.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.092 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.499 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 36.2 mm-40 61.35 44.46 9.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.944 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.499 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 14.3 ptp180 46.57 33.55 2.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.873 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.3 ptmm? -155.82 155.47 33.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.926 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.4 tt -57.5 145.57 8.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.158 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.527 ' C ' HD23 ' A' ' 110' ' ' LEU . 4.8 tt -96.14 113.66 25.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.935 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.449 ' N ' HD23 ' A' ' 110' ' ' LEU . 16.9 t70 -79.84 80.72 6.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.617 HD23 ' H ' ' A' ' 112' ' ' LEU . 1.9 pt? -53.13 -42.42 66.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.926 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.478 ' N ' ' HG ' ' A' ' 112' ' ' LEU . 15.0 t80 -41.25 -53.59 3.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.918 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.8 m -61.27 -45.84 92.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.85 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.402 ' O ' HG23 ' A' ' 119' ' ' VAL . 15.6 tp -55.95 -63.76 1.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 73.5 m -50.52 -44.69 56.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.857 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.46 ' HE2' ' CE1' ' A' ' 113' ' ' TYR . 28.7 mmtt -60.44 -66.11 0.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.908 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.485 ' CG2' HG13 ' A' ' 137' ' ' VAL . 21.3 mt -43.72 -28.17 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.133 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 115' ' ' LEU . 43.3 t -77.12 -40.88 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.12 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 67.9 mt -72.3 -41.4 65.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.171 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -62.42 -37.15 84.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.457 ' OE1' HG22 ' A' ' 128' ' ' ILE . 10.5 mt-10 -66.21 -26.96 67.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.905 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 135.08 29.86 0.38 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.461 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.3 -173.37 34.21 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.494 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.525 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 2.6 t80 -86.98 -43.79 12.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.884 0.373 . . . . 0.0 110.914 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -60.97 -37.43 82.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.876 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.8 -68.64 0.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.058 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.704 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.6 pp -52.34 -35.78 20.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.119 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.525 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 54.5 m -64.5 -36.47 84.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.59 -41.39 79.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 132' ' ' ARG . 16.3 m-20 -94.78 20.48 8.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.892 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 131' ' ' ASP . 24.7 ptt85 35.21 48.2 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.839 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -85.72 17.92 3.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.841 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.704 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 41.8 m95 -60.39 -48.85 79.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.938 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -48.42 -47.4 37.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.126 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.42 ' HB3' ' NH1' ' A' ' 136' ' ' ARG . 5.4 mmm180 -61.91 -58.56 7.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.485 HG13 ' CG2' ' A' ' 118' ' ' ILE . 98.5 t -46.75 -31.88 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.61 -58.34 4.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.088 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -52.59 -29.51 26.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 140' ' ' ARG . 5.9 mmm180 -52.82 -39.68 62.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.883 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.64 HD23 ' CZ ' ' A' ' 143' ' ' TYR . 14.8 tp -82.93 17.93 1.77 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.92 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 61.67 43.09 10.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.64 ' CZ ' HD23 ' A' ' 141' ' ' LEU . 3.3 m-85 -83.25 152.37 64.57 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.689 0.757 . . . . 0.0 110.947 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.533 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.8 Cg_endo -69.76 114.13 3.6 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.692 2.261 . . . . 0.0 112.331 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 53.7 Cg_endo -69.76 109.33 2.28 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.679 2.252 . . . . 0.0 112.349 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 154.94 -67.95 0.3 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.49 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -60.93 152.02 28.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.801 0.334 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -68.11 82.55 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.849 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.533 HD11 ' HG2' ' A' ' 144' ' ' PRO . 90.5 mt -92.61 -46.52 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -37.39 -58.3 1.36 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.491 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.8 m -56.71 -48.01 78.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.91 0.386 . . . . 0.0 110.846 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.415 ' C ' HD23 ' A' ' 152' ' ' LEU . 6.7 tt -50.57 -51.34 49.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.9 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 11.1 mt -57.51 -65.96 0.54 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.557 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 23.9 ttp180 -38.45 -55.02 1.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.86 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.428 ' OG ' ' N ' ' A' ' 156' ' ' HIS . 48.1 p -50.41 -64.72 0.72 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.824 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.428 ' N ' ' OG ' ' A' ' 155' ' ' SER . 2.0 m-70 -43.04 -34.06 0.95 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.517 ' CD1' ' HB ' ' A' ' 161' ' ' ILE . 3.1 t80 -69.71 -69.55 0.34 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.476 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 3.3 mp0 -61.24 -10.11 6.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.88 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 10.6 tpp85 -84.59 -53.35 5.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.435 HG22 HD11 ' A' ' 89' ' ' ILE . 74.1 mt -110.48 -39.18 3.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.151 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.517 ' HB ' ' CD1' ' A' ' 157' ' ' TYR . 13.7 mt -77.04 -0.69 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.115 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.543 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -72.02 -60.34 2.38 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.65 0.738 . . . . 0.0 110.882 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.495 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.8 Cg_endo -69.78 -36.69 10.29 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.668 2.245 . . . . 0.0 112.324 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.552 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 15.3 t80 -59.47 -46.32 89.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.975 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -69.03 -60.17 2.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.924 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.443 ' CG ' ' HA ' ' A' ' 163' ' ' PRO . 0.0 OUTLIER -54.15 -39.33 66.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.551 ' CD2' ' CD1' ' A' ' 92' ' ' PHE . 57.5 t80 -60.16 -51.21 70.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.866 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -92.55 48.05 1.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 54.3 p -123.06 118.3 27.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.811 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 176.84 -93.42 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.461 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.793 0.33 . . . . 0.0 111.094 -179.975 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.549 -0.22 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.0 t -119.98 42.24 2.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.905 0.383 . . . . 0.0 110.867 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.6 p -122.92 144.04 49.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.844 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.84 111.83 0.5 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.52 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.1 m -71.54 -61.89 1.61 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.851 0.357 . . . . 0.0 110.914 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.3 t -78.78 -51.61 9.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.837 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.68 -179.96 41.79 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.479 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.584 HG23 ' HB2' ' A' ' 82' ' ' LYS . 24.6 m -102.67 90.43 3.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.748 0.308 . . . . 0.0 111.155 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.3 mmt-85 -113.36 -58.63 2.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 83' ' ' LEU . 67.6 t -76.71 -42.03 33.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.161 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.584 ' HB2' HG23 ' A' ' 79' ' ' THR . 1.1 mptm? -36.34 -31.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.913 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.525 ' HA ' HD12 ' A' ' 86' ' ' LEU . 18.5 mt -76.75 -51.8 10.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 83' ' ' LEU . 44.1 t-20 -38.35 -64.98 0.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.868 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.467 ' HE2' HD12 ' A' ' 112' ' ' LEU . 69.3 t80 -45.4 -39.94 7.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.927 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.756 ' CD2' HD21 ' A' ' 112' ' ' LEU . 35.0 mt -70.15 -63.68 1.04 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.887 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -44.46 -27.21 0.42 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.849 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -78.15 -67.6 0.72 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.93 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.575 ' HA ' ' CD1' ' A' ' 164' ' ' TYR . 7.9 tt -45.64 -43.0 3.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.412 ' N ' HG23 ' A' ' 89' ' ' ILE . . . -62.34 -53.42 55.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.079 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -42.07 -41.54 2.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.867 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -68.77 -43.8 74.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.871 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.642 ' CD1' HD13 ' A' ' 100' ' ' LEU . 45.4 m95 -62.27 -64.52 0.9 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 7.7 pt-20 -36.37 -41.38 0.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.858 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.435 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 85.6 mt -65.09 -49.82 77.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.133 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -49.61 -44.56 47.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.39 -49.64 0.61 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.488 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 32.5 t -90.15 130.98 36.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.908 0.385 . . . . 0.0 110.884 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.7 m -65.14 164.51 12.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.862 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.642 HD13 ' CD1' ' A' ' 93' ' ' TRP . 54.8 tp -93.34 154.17 18.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.942 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.7 mmmt -145.09 126.47 14.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.873 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.65 122.67 67.94 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.661 0.743 . . . . 0.0 111.149 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.718 ' HG2' HD13 ' A' ' 110' ' ' LEU . 53.9 Cg_endo -69.77 161.49 45.74 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.709 2.273 . . . . 0.0 112.329 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -117.08 117.66 30.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 72.2 t -121.57 140.26 46.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.143 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 107' ' ' ARG . 2.6 mm-40 56.29 54.99 7.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.43 ' NH1' ' HB3' ' A' ' 107' ' ' ARG . 4.2 ptp180 37.09 39.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -157.42 150.16 23.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.9 tt -54.47 140.03 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.155 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.718 HD13 ' HG2' ' A' ' 103' ' ' PRO . 4.1 tt -86.45 119.13 26.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.511 ' N ' HD23 ' A' ' 110' ' ' LEU . 28.5 t0 -86.76 88.62 7.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.81 HD23 ' H ' ' A' ' 112' ' ' LEU . 1.5 pt? -73.72 -22.38 59.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.455 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 5.6 t80 -59.65 -54.71 43.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 115' ' ' LEU . 58.9 p -61.13 -55.22 34.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.887 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.448 ' C ' ' O ' ' A' ' 114' ' ' SER . 27.3 tp -34.67 -59.28 0.47 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.917 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.8 t -59.99 -55.77 29.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.863 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -43.42 -45.54 6.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.884 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.42 HG21 HG13 ' A' ' 137' ' ' VAL . 27.3 mt -63.44 -45.69 97.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.13 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.9 t -51.33 -56.03 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.135 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 84.1 mt -56.32 -46.58 81.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.123 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -56.46 -56.8 16.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.462 ' HB2' ' CG2' ' A' ' 128' ' ' ILE . 33.2 mm-40 -40.69 -52.85 2.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 155.26 34.16 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.488 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.39 178.58 34.13 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.479 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.574 ' CE2' ' SG ' ' A' ' 129' ' ' CYS . 3.4 t80 -81.7 -55.77 4.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.889 0.376 . . . . 0.0 110.951 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -51.47 -29.64 17.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.905 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.06 -71.21 0.29 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.091 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.747 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.9 pp -50.38 -31.7 8.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.096 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.574 ' SG ' ' CE2' ' A' ' 125' ' ' TYR . 94.3 m -69.5 -44.07 71.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.886 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.1 tttm -64.26 -39.57 94.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 132' ' ' ARG . 80.2 m-20 -91.83 23.31 3.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.453 ' C ' ' O ' ' A' ' 131' ' ' ASP . 83.9 mtm180 34.24 35.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.9 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 131' ' ' ASP . 10.7 mmp_? -60.23 -19.49 54.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.846 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.747 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 24.8 m95 -36.6 -43.44 0.41 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.925 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.42 -56.99 14.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.036 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.419 ' HB2' ' NH1' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -59.91 -43.28 94.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.42 HG13 HG21 ' A' ' 118' ' ' ILE . 69.2 t -54.76 -36.61 37.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.107 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.09 -52.41 24.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.083 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -56.23 -37.24 69.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -51.39 -32.44 26.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.839 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.717 HD23 ' CE2' ' A' ' 143' ' ' TYR . 14.6 tp -83.52 17.48 2.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.931 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 66.65 33.99 6.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.84 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.717 ' CE2' HD23 ' A' ' 141' ' ' LEU . 2.5 m-85 -84.34 157.81 61.5 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.658 0.742 . . . . 0.0 110.947 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.55 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.8 Cg_endo -69.78 110.36 2.54 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.685 2.257 . . . . 0.0 112.364 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.474 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 53.6 Cg_endo -69.74 94.51 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.695 2.264 . . . . 0.0 112.315 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 165.25 -61.46 0.24 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.445 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 61.5 mttt -57.12 152.98 12.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.816 0.341 . . . . 0.0 110.913 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -69.88 75.75 0.46 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.55 HD11 ' HG2' ' A' ' 144' ' ' PRO . 84.7 mt -89.22 -54.94 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.146 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.46 -47.99 1.19 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.455 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.3 m -61.64 -53.3 57.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.905 0.384 . . . . 0.0 110.889 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.5 tt -51.33 -51.56 53.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.927 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.446 ' CD1' HG22 ' A' ' 149' ' ' ILE . 30.4 mt -57.61 -65.79 0.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.943 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.536 ' HG3' ' CE2' ' A' ' 134' ' ' TRP . 1.7 ttm105 -39.93 -38.77 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.844 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 69.6 m -66.6 -57.82 6.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -56.03 -26.2 47.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.866 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.524 ' CD2' HD12 ' A' ' 161' ' ' ILE . 5.0 t80 -78.82 -46.92 17.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.923 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.488 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 2.5 mm-40 -79.97 -10.14 59.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.873 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 44.6 ttt85 -100.85 -35.19 9.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.482 HG22 HD11 ' A' ' 89' ' ' ILE . 62.0 mt -112.54 -50.93 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.108 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.524 HD12 ' CD2' ' A' ' 157' ' ' TYR . 18.9 mt -77.17 0.04 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.152 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.52 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -72.29 -60.46 2.19 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.63 0.728 . . . . 0.0 110.92 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.505 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.8 Cg_endo -69.79 -37.66 8.79 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.654 2.236 . . . . 0.0 112.355 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.575 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 28.7 t80 -60.31 -38.83 84.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -74.45 -58.09 3.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.899 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 16.7 ptt? -51.17 -40.23 58.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -65.11 -59.88 3.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.882 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 48.9 mm-40 -42.96 -39.54 2.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.913 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.1 t -84.13 47.92 1.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -121.68 67.21 0.45 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.519 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.779 0.323 . . . . 0.0 111.108 179.972 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.6 p -124.17 127.53 47.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.901 0.381 . . . . 0.0 110.867 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.4 m -59.07 134.36 56.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.873 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.08 -156.24 32.49 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.494 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 68.9 m -101.5 80.84 2.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.884 0.373 . . . . 0.0 110.878 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.1 t -57.2 159.52 4.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.86 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -127.38 68.92 0.53 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.5 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.64 ' O ' HD12 ' A' ' 83' ' ' LEU . 3.9 p -114.74 36.59 3.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.792 0.33 . . . . 0.0 111.124 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.43 ' NE ' ' HA ' ' A' ' 80' ' ' ARG . 2.7 tpm_? -57.49 -50.23 73.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.88 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 83' ' ' LEU . 58.4 t -75.76 -64.71 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.102 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.561 ' HG2' ' CD2' ' A' ' 113' ' ' TYR . 69.0 mttt -37.47 -28.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.708 ' HA ' HD12 ' A' ' 86' ' ' LEU . 26.7 mt -81.11 -47.02 14.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 81' ' ' VAL . 20.3 t30 -45.25 -52.83 9.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -54.31 -36.61 63.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.948 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.708 HD12 ' HA ' ' A' ' 83' ' ' LEU . 17.8 mt -71.21 -61.02 1.92 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.896 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -52.11 -24.05 6.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.817 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -77.89 -69.96 0.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.531 HD11 HG22 ' A' ' 160' ' ' ILE . 9.0 tt -43.98 -36.11 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.133 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.55 ' HB2' HD22 ' A' ' 100' ' ' LEU . . . -73.8 -44.78 54.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.086 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -54.61 -27.93 42.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.849 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.483 ' CE2' ' HA ' ' A' ' 164' ' ' TYR . 4.4 t80 -85.71 -29.97 23.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.874 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 30.4 m95 -75.42 -59.23 2.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.929 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -42.45 -29.55 0.28 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.885 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 85.9 mt -75.72 -47.61 32.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.166 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -51.91 -42.39 62.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 148.54 -36.49 1.08 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.476 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 40.1 m -101.77 155.9 17.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 110.9 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.5 t -83.27 178.08 8.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.851 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.55 HD22 ' HB2' ' A' ' 90' ' ' ALA . 29.4 tp -93.79 138.58 31.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.871 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -137.55 123.6 20.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.546 HD12 HD22 ' A' ' 112' ' ' LEU . 51.0 mm -96.25 124.24 52.15 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.584 0.706 . . . . 0.0 111.193 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.544 ' HG3' ' CD2' ' A' ' 156' ' ' HIS . 53.9 Cg_endo -69.72 152.05 69.44 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.679 2.252 . . . . 0.0 112.321 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -101.96 111.41 23.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.876 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.3 t -108.79 137.57 40.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.13 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.413 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 57.7 mm-40 50.07 54.22 11.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.413 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 1.2 ptp180 43.61 37.51 1.55 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.822 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -155.32 169.88 23.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.867 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.5 tt -75.05 143.96 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.524 HD23 ' N ' ' A' ' 111' ' ' ASP . 4.6 tt -89.86 119.28 30.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.935 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.524 ' N ' HD23 ' A' ' 110' ' ' LEU . 40.0 t0 -73.32 71.36 1.24 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.596 HD23 ' H ' ' A' ' 112' ' ' LEU . 1.6 pt? -56.24 -21.26 22.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.561 ' CD2' ' HG2' ' A' ' 82' ' ' LYS . 3.3 t80 -71.67 -62.59 1.36 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.929 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 115' ' ' LEU . 4.2 t -50.02 -58.9 4.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.884 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.449 ' C ' ' O ' ' A' ' 114' ' ' SER . 10.0 tp -34.59 -67.48 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.928 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.1 p -48.07 -52.88 18.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -48.36 -52.51 21.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.944 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.605 HG21 HG13 ' A' ' 137' ' ' VAL . 77.7 mt -57.82 -42.15 81.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.111 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.508 HG13 HG12 ' A' ' 128' ' ' ILE . 95.2 t -59.81 -38.45 76.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.135 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 82.3 mt -71.27 -57.92 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.15 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.529 ' CG ' ' N ' ' A' ' 122' ' ' GLU . 8.1 pt-20 -56.57 -49.49 74.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.916 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.529 ' N ' ' CG ' ' A' ' 121' ' ' GLU . 38.0 mm-40 -47.91 -35.05 9.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.905 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.662 ' O ' ' HB3' ' A' ' 127' ' ' ALA . . . 139.1 43.16 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.448 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.79 -179.42 52.58 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.472 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.51 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 1.1 t80 -89.06 -40.12 13.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.853 0.359 . . . . 0.0 110.931 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -60.94 -45.85 93.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.858 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.662 ' HB3' ' O ' ' A' ' 123' ' ' GLY . . . -62.09 -71.35 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.086 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.567 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 2.2 pp -41.96 -36.32 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.145 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.468 ' N ' HD12 ' A' ' 128' ' ' ILE . 22.1 m -65.83 -40.97 92.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 127' ' ' ALA . 12.9 ttmm -68.95 -26.24 64.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 132' ' ' ARG . 4.2 t0 -100.87 19.38 17.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 131' ' ' ASP . 13.3 mmt85 36.11 54.6 0.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' A' ' 134' ' ' TRP . 14.7 mmt180 -81.81 -25.21 35.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.864 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.567 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 24.2 m95 -34.04 -40.06 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.59 -59.86 4.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.113 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.455 ' O ' ' CD ' ' A' ' 140' ' ' ARG . 38.2 mmt180 -62.28 -50.38 71.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.859 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.605 HG13 HG21 ' A' ' 118' ' ' ILE . 89.4 t -43.57 -46.84 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.146 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.87 -47.85 73.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.075 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -55.27 -32.97 62.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.455 ' CD ' ' O ' ' A' ' 136' ' ' ARG . 0.2 OUTLIER -59.81 -32.04 70.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.848 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.458 HD23 ' CZ ' ' A' ' 143' ' ' TYR . 12.8 tp -80.38 13.74 2.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.911 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 65.0 51.31 1.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.458 ' CZ ' HD23 ' A' ' 141' ' ' LEU . 2.5 m-85 -94.87 156.78 37.7 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.679 0.752 . . . . 0.0 110.94 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.465 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.8 Cg_endo -69.81 122.23 8.89 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.718 2.279 . . . . 0.0 112.328 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 118.34 5.62 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.701 2.267 . . . . 0.0 112.295 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.53 -67.56 0.56 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.476 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.04 135.61 12.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.802 0.334 . . . . 0.0 110.9 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -65.86 75.43 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.465 HD11 ' HG2' ' A' ' 144' ' ' PRO . 89.9 mt -86.93 -51.17 13.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.165 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -37.12 -47.66 1.41 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.492 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.0 t -63.86 -52.39 60.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.923 0.392 . . . . 0.0 110.887 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.424 ' C ' HD23 ' A' ' 152' ' ' LEU . 7.2 tt -47.21 -53.3 13.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.878 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 30.9 mt -56.04 -65.72 0.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.929 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.54 ' NE ' ' CD1' ' A' ' 134' ' ' TRP . 6.4 ttm180 -40.64 -33.2 0.26 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.882 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 36.1 t -71.86 -52.57 16.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.862 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.544 ' CD2' ' HG3' ' A' ' 103' ' ' PRO . 3.6 m-70 -60.46 -31.48 70.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.845 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.492 ' CD1' ' C ' ' A' ' 157' ' ' TYR . 2.3 t80 -79.25 -30.54 43.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.891 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.505 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 1.9 mm-40 -91.06 -9.93 43.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.913 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -107.5 -45.81 3.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.868 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.531 HG22 HD11 ' A' ' 89' ' ' ILE . 59.3 mt -97.07 -53.73 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.142 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.437 ' CG1' ' HA ' ' A' ' 157' ' ' TYR . 20.0 mt -75.17 -6.07 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.13 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.524 ' CD2' ' HD3' ' A' ' 163' ' ' PRO . 0.3 OUTLIER -70.57 -59.79 3.61 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.619 0.723 . . . . 0.0 110.907 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.524 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.9 Cg_endo -69.71 -36.34 11.12 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.699 2.266 . . . . 0.0 112.313 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.483 ' HA ' ' CE2' ' A' ' 92' ' ' PHE . 4.6 t80 -64.77 -35.76 82.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.924 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -75.09 -61.14 1.99 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.914 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.406 ' HG2' ' HA ' ' A' ' 163' ' ' PRO . 20.4 ptt? -47.96 -40.27 21.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.875 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -67.29 -54.32 21.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.863 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.7 48.67 0.47 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.9 t -127.22 -60.3 1.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.85 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 147.26 112.44 0.71 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.478 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 120.759 0.314 . . . . 0.0 111.083 179.985 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.8 m -145.62 122.44 11.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.922 0.391 . . . . 0.0 110.816 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.4 t -93.86 118.85 32.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.858 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.65 80.5 1.25 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.475 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.7 m -40.76 -59.12 1.48 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.851 0.358 . . . . 0.0 110.859 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 61.3 p -57.07 104.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.838 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -113.6 84.16 0.35 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.521 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.0 t -114.77 38.49 3.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.792 0.329 . . . . 0.0 111.123 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 39.2 mmm-85 -77.35 -59.1 2.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.842 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 91.9 t -76.74 -39.78 31.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.12 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.519 ' HA ' ' CD1' ' A' ' 113' ' ' TYR . 27.6 ttmt -41.19 -29.45 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.6 mt -89.35 -47.08 8.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.936 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -46.59 -45.08 18.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.917 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.648 ' O ' HG22 ' A' ' 89' ' ' ILE . 89.4 t80 -46.94 -31.32 3.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.897 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.809 HD21 HD21 ' A' ' 112' ' ' LEU . 29.2 mt -80.72 -33.57 35.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.932 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.01 -39.1 66.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -73.56 -37.67 65.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.919 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.648 HG22 ' O ' ' A' ' 85' ' ' TYR . 7.2 tt -78.6 -29.93 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.143 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.63 -43.31 56.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.13 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -51.27 -25.68 6.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.908 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -86.33 -41.26 14.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.455 ' CD1' HD13 ' A' ' 100' ' ' LEU . 55.6 m95 -70.7 -56.58 6.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 95' ' ' ILE . 4.2 pt-20 -42.66 -29.55 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.883 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.437 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 96.8 mt -77.54 -48.98 23.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.164 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -48.87 -42.27 36.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.14 -37.44 1.5 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.476 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.2 m -101.77 112.15 24.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.858 0.361 . . . . 0.0 110.895 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 58.8 m -54.28 162.08 1.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.82 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.555 HD22 HG23 ' A' ' 89' ' ' ILE . 27.9 tp -74.01 135.32 43.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.924 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -135.48 128.96 32.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 102' ' ' ILE . 4.6 mp -94.95 121.16 63.25 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.619 0.723 . . . . 0.0 111.108 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.493 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 53.5 Cg_endo -69.78 161.82 44.44 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.66 2.24 . . . . 0.0 112.359 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -107.43 121.02 43.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.85 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.546 ' CG2' HD12 ' A' ' 110' ' ' LEU . 67.7 t -124.79 134.51 66.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.117 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.491 ' HG2' HG12 ' A' ' 105' ' ' VAL . 27.4 mm-40 61.01 52.3 4.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.849 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 42.4 37.93 1.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.619 ' HD3' HG22 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -159.55 153.1 22.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.619 HG22 ' HD3' ' A' ' 108' ' ' LYS . 7.8 tt -60.06 142.9 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.142 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.805 HD23 ' N ' ' A' ' 111' ' ' ASP . 6.2 tt -95.98 139.23 32.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.805 ' N ' HD23 ' A' ' 110' ' ' LEU . 23.6 t0 -97.58 108.54 21.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.86 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.809 HD21 HD21 ' A' ' 86' ' ' LEU . 0.9 OUTLIER -83.24 -24.89 32.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.566 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 5.7 t80 -63.26 -56.26 18.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.953 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 115' ' ' LEU . 32.0 p -59.4 -61.03 2.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.834 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 114' ' ' SER . 22.2 tp -35.04 -68.88 0.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.914 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.8 t -51.24 -52.73 42.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.835 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.1 mmtt -46.79 -63.7 0.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.933 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.658 HG21 HG13 ' A' ' 137' ' ' VAL . 62.1 mt -43.09 -53.54 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.137 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 43.1 t -49.47 -57.47 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.122 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 76.3 mt -46.1 -52.18 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.118 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -57.73 -58.93 6.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.891 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.613 ' HB3' HG22 ' A' ' 128' ' ' ILE . 29.1 mm-40 -35.01 -54.66 0.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 152.93 33.8 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.467 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.02 -178.71 33.49 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.445 ' CE2' ' SG ' ' A' ' 129' ' ' CYS . 4.8 t80 -85.0 -43.8 13.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.845 0.355 . . . . 0.0 110.908 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -62.05 -36.23 81.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.924 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.49 -68.91 0.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.149 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.613 HG22 ' HB3' ' A' ' 122' ' ' GLU . 2.2 pp -50.01 -36.23 11.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.164 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.47 ' N ' HD12 ' A' ' 128' ' ' ILE . 49.1 m -66.33 -41.0 90.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -66.45 -44.48 82.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.92 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 132' ' ' ARG . 1.2 m-20 -85.02 22.61 1.37 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.449 ' C ' ' O ' ' A' ' 131' ' ' ASP . 57.8 mtt-85 34.63 43.93 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.88 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' A' ' 134' ' ' TRP . 20.4 mtp85 -71.5 -22.45 61.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.541 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 12.2 m95 -34.33 -42.29 0.13 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.927 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.6 -54.19 49.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.112 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 5.0 tpp85 -66.21 -42.54 88.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.658 HG13 HG21 ' A' ' 118' ' ' ILE . 84.3 t -59.41 -28.22 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -78.37 -48.69 15.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.116 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -60.06 -28.63 67.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -56.53 -38.85 72.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.537 HD23 ' CE2' ' A' ' 143' ' ' TYR . 13.8 tp -83.81 21.31 1.3 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.927 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 58.12 51.8 8.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.872 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.537 ' CE2' HD23 ' A' ' 141' ' ' LEU . 2.5 m-85 -96.73 159.1 32.42 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.667 0.746 . . . . 0.0 110.915 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.595 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.9 Cg_endo -69.69 111.74 2.88 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.673 2.249 . . . . 0.0 112.375 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 53.7 Cg_endo -69.8 117.13 4.9 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.69 2.26 . . . . 0.0 112.328 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 136.6 -59.64 0.63 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.477 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -55.38 159.55 2.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.761 0.315 . . . . 0.0 110.907 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -78.06 79.13 4.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.595 HD11 ' HG2' ' A' ' 144' ' ' PRO . 78.3 mt -95.07 -55.47 6.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.09 -44.91 0.82 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.464 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.3 t -65.92 -52.18 52.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.898 0.38 . . . . 0.0 110.861 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.442 ' C ' HD23 ' A' ' 152' ' ' LEU . 6.7 tt -50.02 -49.37 51.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.921 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 25.7 mt -57.06 -64.79 0.76 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.541 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 11.8 ttt180 -40.47 -36.21 0.54 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 25.2 m -68.89 -62.08 1.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.805 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.493 ' CE1' ' HG3' ' A' ' 103' ' ' PRO . 2.5 m-70 -47.49 -34.06 6.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.848 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.432 ' CD2' HD12 ' A' ' 161' ' ' ILE . 3.9 t80 -70.22 -53.16 18.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.911 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 29.3 mm-40 -74.23 -9.47 58.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.877 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -96.15 -42.94 7.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.858 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 89.2 mt -110.4 -47.31 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.15 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.517 ' O ' HG22 ' A' ' 161' ' ' ILE . 21.4 mt -76.88 1.08 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.089 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.602 ' CE1' ' SD ' ' A' ' 166' ' ' MET . 0.2 OUTLIER -73.52 -60.75 1.57 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.674 0.75 . . . . 0.0 110.879 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.566 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.6 Cg_endo -69.78 -41.76 3.96 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.663 2.242 . . . . 0.0 112.348 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.432 ' CE1' ' HA ' ' A' ' 89' ' ' ILE . 11.4 t80 -53.79 -35.25 61.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.922 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.405 ' HG3' HG22 ' A' ' 161' ' ' ILE . 11.4 mt-10 -78.81 -62.47 1.68 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.875 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.602 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 5.3 ptt? -48.46 -42.76 33.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -68.02 -56.06 10.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.872 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -91.02 41.5 1.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.897 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 48.1 t -86.16 79.16 9.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.858 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 45.24 93.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.453 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.75 0.31 . . . . 0.0 111.081 179.972 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.526 -0.23 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.0 m -112.16 93.85 4.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.883 0.373 . . . . 0.0 110.806 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 26.9 t -102.54 136.8 41.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.845 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.83 -173.81 30.94 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.475 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.8 t -163.17 174.72 11.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.9 0.381 . . . . 0.0 110.851 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.3 p -94.49 40.57 1.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.86 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -130.88 -53.83 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.48 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.6 m -43.5 105.89 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.778 0.323 . . . . 0.0 111.148 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.6 tpt85 -127.19 -69.25 0.76 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.426 ' O ' ' N ' ' A' ' 84' ' ' ASN . 58.5 t -72.62 -39.27 60.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.129 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -39.03 -30.7 0.05 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.895 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.449 ' HA ' HD12 ' A' ' 86' ' ' LEU . 51.1 mt -74.07 -46.65 41.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 81' ' ' VAL . 63.7 t-20 -40.14 -55.41 2.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.867 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -55.22 -47.73 74.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.942 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 83' ' ' LEU . 65.8 mt -56.18 -63.71 1.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.951 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -46.45 -38.45 9.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.856 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -61.5 -62.15 2.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.947 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.713 HD12 ' CD2' ' A' ' 164' ' ' TYR . 14.8 tt -61.11 -27.46 41.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.126 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.18 -46.67 49.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.087 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.7 tttp -54.54 -22.63 13.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -85.24 -49.1 8.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.491 ' CD1' HD13 ' A' ' 100' ' ' LEU . 56.6 m95 -62.53 -56.54 17.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -40.91 -35.32 0.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 90.1 mt -71.98 -51.26 32.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.135 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -48.44 -39.55 23.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.956 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.31 -47.3 0.91 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.526 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.9 t -85.22 151.9 23.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.888 0.375 . . . . 0.0 110.847 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 55.7 p -81.24 172.46 13.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.88 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.528 HD22 HG23 ' A' ' 89' ' ' ILE . 29.1 tp -96.95 116.98 30.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.935 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.76 147.03 30.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.571 HD12 HD22 ' A' ' 112' ' ' LEU . 45.0 mm -119.79 121.84 29.51 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.578 0.704 . . . . 0.0 111.117 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.438 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 54.2 Cg_endo -69.72 163.66 37.41 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.69 2.26 . . . . 0.0 112.361 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -107.9 128.15 54.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.434 HG21 HD12 ' A' ' 110' ' ' LEU . 65.3 t -132.44 135.32 57.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.108 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 56.06 54.26 8.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 40.97 38.84 0.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.9 ttpp -162.63 152.78 16.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.9 tt -57.69 152.0 3.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.123 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.538 HD23 ' N ' ' A' ' 111' ' ' ASP . 5.9 tt -95.11 127.28 41.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.538 ' N ' HD23 ' A' ' 110' ' ' LEU . 8.2 t70 -86.57 69.99 10.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.821 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.595 HD23 ' H ' ' A' ' 112' ' ' LEU . 1.8 pt? -47.96 -22.56 0.61 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -68.45 -44.25 75.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.4 t -71.23 -51.11 26.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.873 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.4 tp -47.07 -54.89 9.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.9 t -60.52 -58.85 6.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.83 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.1 mmtt -43.92 -54.74 5.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.901 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.871 ' CG2' HG13 ' A' ' 137' ' ' VAL . 29.6 mt -51.5 -67.49 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.412 HG13 HG12 ' A' ' 128' ' ' ILE . 50.6 t -37.73 -48.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.162 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 74.6 mt -64.91 -39.74 86.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.108 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 118' ' ' ILE . 5.5 mm-40 -59.11 -50.91 72.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.452 ' CD ' HG22 ' A' ' 137' ' ' VAL . 28.3 mt-10 -51.84 -42.6 62.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.912 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 150.64 35.27 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.512 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.02 -175.13 34.86 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.496 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.422 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 1.9 t80 -88.83 -41.03 12.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.855 0.359 . . . . 0.0 110.915 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -66.13 -37.53 85.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.898 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.5 -61.56 2.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.128 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.641 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.7 pp -58.44 -35.41 54.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.598 ' N ' HD12 ' A' ' 128' ' ' ILE . 22.1 m -65.1 -38.03 89.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.859 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -68.46 -39.45 81.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.45 ' O ' ' C ' ' A' ' 132' ' ' ARG . 0.7 OUTLIER -93.39 22.03 5.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.843 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 131' ' ' ASP . 25.1 mtp85 34.45 46.74 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.889 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.435 ' O ' HG23 ' A' ' 137' ' ' VAL . 58.8 mtp180 -87.33 18.72 3.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.641 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 27.5 m95 -63.9 -47.65 79.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.913 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.55 -41.7 61.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.092 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -68.24 -63.11 1.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.854 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.871 HG13 ' CG2' ' A' ' 118' ' ' ILE . 86.4 t -41.17 -38.12 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.115 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.02 -53.93 22.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -51.22 -33.44 27.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.473 ' HA ' ' CZ ' ' A' ' 140' ' ' ARG . 1.7 mmp_? -52.72 -35.7 56.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.594 HD23 ' CE2' ' A' ' 143' ' ' TYR . 14.9 tp -84.73 23.32 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 62.91 28.0 16.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.817 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.594 ' CE2' HD23 ' A' ' 141' ' ' LEU . 3.4 m-85 -75.89 147.77 81.14 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.653 0.739 . . . . 0.0 110.914 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.469 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.6 Cg_endo -69.72 115.72 4.22 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.706 2.271 . . . . 0.0 112.343 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 53.0 Cg_endo -69.79 89.18 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.69 2.26 . . . . 0.0 112.323 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 177.13 -80.03 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.474 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 32.0 mttp -45.38 166.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.817 0.341 . . . . 0.0 110.89 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.79 80.8 3.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.469 HD11 ' HG2' ' A' ' 144' ' ' PRO . 76.9 mt -91.6 -57.41 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.21 -50.1 1.23 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.503 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.3 t -61.11 -55.18 35.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.871 0.367 . . . . 0.0 110.839 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.409 ' C ' HD23 ' A' ' 152' ' ' LEU . 6.4 tt -46.92 -52.02 15.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.878 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.462 HD11 HG22 ' A' ' 149' ' ' ILE . 15.1 mt -54.52 -65.94 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.954 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.478 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 11.2 ttp180 -38.75 -47.75 1.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.864 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.6 t -57.87 -66.11 0.53 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.844 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.438 ' CE1' ' HG3' ' A' ' 103' ' ' PRO . 2.0 m-70 -42.9 -39.97 2.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.907 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.41 ' CD1' ' C ' ' A' ' 157' ' ' TYR . 4.6 t80 -63.81 -55.07 25.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 43.6 mt-10 -72.23 -9.97 59.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.898 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -88.87 -48.17 7.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.867 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 77.3 mt -112.56 -43.66 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.514 ' O ' HG22 ' A' ' 161' ' ' ILE . 11.0 mt -77.02 5.08 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.128 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.635 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.1 OUTLIER -74.4 -62.22 1.03 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.673 0.749 . . . . 0.0 110.895 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.518 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.3 Cg_endo -69.76 -35.66 12.22 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.689 2.259 . . . . 0.0 112.336 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.713 ' CD2' HD12 ' A' ' 89' ' ' ILE . 11.0 t80 -60.87 -38.32 85.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -79.94 -65.02 1.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.858 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.455 ' SD ' ' N ' ' A' ' 167' ' ' PHE . 0.0 OUTLIER -40.64 -39.42 1.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.862 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.455 ' N ' ' SD ' ' A' ' 166' ' ' MET . 2.4 t80 -74.73 -56.13 5.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.85 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 63.0 mm-40 -87.59 38.72 0.84 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.919 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 32.9 t -98.36 -57.5 2.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.841 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -109.21 -67.66 0.59 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.533 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.792 0.329 . . . . 0.0 111.105 179.954 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.2 m -46.52 -46.34 19.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 0.0 110.868 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 60.7 p -141.79 115.09 8.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.35 -54.11 0.78 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.508 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.8 t -82.82 132.86 35.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.872 0.368 . . . . 0.0 110.888 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.0 t 58.76 42.8 19.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.873 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -113.4 -62.29 0.43 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.505 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 43.0 m -106.11 94.8 5.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.789 0.328 . . . . 0.0 111.124 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -123.47 -57.52 1.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 57.3 t -84.19 -35.23 10.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.17 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.466 ' HG3' ' CD2' ' A' ' 113' ' ' TYR . 10.2 mptt -45.22 -26.83 0.54 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.413 ' O ' ' N ' ' A' ' 86' ' ' LEU . 61.3 mt -80.24 -53.05 7.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -39.19 -61.09 0.81 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.693 ' HE2' HD12 ' A' ' 112' ' ' LEU . 69.5 t80 -46.38 -33.26 3.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.955 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.446 ' HA ' HG22 ' A' ' 89' ' ' ILE . 36.5 mt -81.13 -39.32 25.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.924 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -64.09 -39.42 94.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.407 ' O ' ' NE2' ' A' ' 168' ' ' GLN . 41.9 mm-40 -72.96 -55.71 6.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.88 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 85' ' ' TYR . 12.3 tt -55.46 -47.65 78.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.117 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.853 ' HB2' HD22 ' A' ' 100' ' ' LEU . . . -59.16 -47.96 83.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.14 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.404 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 21.5 ttmt -44.54 -37.83 3.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.957 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.665 ' CD1' ' CG ' ' A' ' 167' ' ' PHE . 3.2 t80 -71.89 -51.63 21.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.452 ' O ' ' C ' ' A' ' 94' ' ' GLU . 80.5 m95 -61.59 -62.36 1.87 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 93' ' ' TRP . 8.9 pt-20 -34.48 -37.97 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.444 ' N ' ' HG3' ' A' ' 94' ' ' GLU . 52.1 mt -72.4 -49.48 41.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.13 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 93' ' ' TRP . 73.2 mm-40 -45.0 -46.21 11.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.889 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.21 -36.87 1.35 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.49 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.6 m -96.39 109.55 22.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.91 0.386 . . . . 0.0 110.888 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.7 m -47.18 158.69 0.14 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.854 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.853 HD22 ' HB2' ' A' ' 90' ' ' ALA . 15.4 tp -75.41 126.82 31.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.91 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -129.83 110.61 11.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.1 mt -77.17 123.88 87.17 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.628 0.728 . . . . 0.0 111.165 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 147.17 62.5 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.696 2.264 . . . . 0.0 112.359 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -100.36 111.05 23.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.935 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.674 HG12 ' HG2' ' A' ' 106' ' ' GLU . 87.1 t -119.82 136.55 56.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.115 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.674 ' HG2' HG12 ' A' ' 105' ' ' VAL . 46.6 mm-40 62.9 49.15 3.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.903 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 42.61 38.39 1.27 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.84 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.2 tttp -166.92 152.95 8.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.6 tt -50.4 150.01 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.124 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.555 ' C ' HD23 ' A' ' 110' ' ' LEU . 4.5 tt -92.96 112.06 23.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.442 ' N ' HD23 ' A' ' 110' ' ' LEU . 19.8 t0 -69.05 75.11 0.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.756 HD23 ' H ' ' A' ' 112' ' ' LEU . 0.9 OUTLIER -68.79 -36.65 78.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.466 ' CD2' ' HG3' ' A' ' 82' ' ' LYS . 2.2 t80 -53.61 -59.93 3.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.963 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.457 ' O ' ' C ' ' A' ' 115' ' ' LEU . 4.8 t -59.07 -59.21 5.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.867 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' A' ' 114' ' ' SER . 9.0 tp -32.89 -58.7 0.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.924 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.6 t -57.12 -54.64 44.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.824 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -43.48 -48.25 7.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.888 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 53.2 mt -61.98 -48.3 89.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.127 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.503 HG13 HG12 ' A' ' 128' ' ' ILE . 55.4 t -50.8 -63.0 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.108 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 61.7 mt -52.11 -53.33 18.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.141 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -46.69 -51.11 16.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.893 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.449 ' OE2' HG22 ' A' ' 137' ' ' VAL . 40.6 mt-10 -50.92 -49.27 59.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.86 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 127' ' ' ALA . . . 154.49 40.94 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.467 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.55 -177.93 42.47 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.448 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -88.95 -45.68 9.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.847 0.356 . . . . 0.0 110.94 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -59.51 -36.49 76.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.876 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 123' ' ' GLY . . . -67.75 -71.26 0.21 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.096 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.503 HG12 HG13 ' A' ' 119' ' ' VAL . 2.1 pp -44.76 -34.53 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.123 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.409 ' N ' HD12 ' A' ' 128' ' ' ILE . 64.8 m -69.37 -39.57 77.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -63.89 -39.66 94.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 132' ' ' ARG . 28.1 m-20 -92.1 29.76 1.56 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.877 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.465 ' C ' ' O ' ' A' ' 131' ' ' ASP . 3.0 mpt_? 33.48 40.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.462 ' O ' ' C ' ' A' ' 134' ' ' TRP . 22.5 mmt180 -65.29 -26.99 68.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.482 ' CZ2' ' HG3' ' A' ' 154' ' ' ARG . 28.4 m95 -33.22 -44.19 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.913 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.82 -61.71 2.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.107 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -58.98 -45.09 91.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.449 HG22 ' OE2' ' A' ' 122' ' ' GLU . 92.6 t -54.03 -39.73 42.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.153 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.2 -52.88 52.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -58.88 -35.99 73.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.933 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.2 mmp_? -69.53 -28.04 65.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.868 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.945 HD13 ' O ' ' A' ' 141' ' ' LEU . 1.5 tm? -78.46 10.23 3.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.913 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 62.99 38.42 11.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.904 ' CE2' HD12 ' A' ' 141' ' ' LEU . 9.6 m-85 -89.72 158.61 44.92 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.702 0.763 . . . . 0.0 110.937 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.786 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.8 Cg_endo -69.78 113.76 3.48 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.65 2.234 . . . . 0.0 112.359 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.72 132.47 23.46 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.731 2.287 . . . . 0.0 112.34 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.61 -66.58 0.57 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.511 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -70.46 140.64 51.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.785 0.326 . . . . 0.0 110.934 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -64.58 76.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.786 HD11 ' HG2' ' A' ' 144' ' ' PRO . 97.0 mt -80.45 -39.85 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.165 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -35.98 -51.35 1.19 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.459 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.5 t -56.94 -54.86 41.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.886 0.374 . . . . 0.0 110.892 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.4 tt -45.58 -51.17 12.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.948 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' A' ' 154' ' ' ARG . 18.9 mt -53.99 -66.09 0.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.937 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.482 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 15.0 ttt180 -37.35 -41.56 0.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.1 m -65.04 -68.74 0.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.824 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -43.12 -36.95 1.84 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.889 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.692 ' CD2' HD12 ' A' ' 161' ' ' ILE . 3.0 t80 -71.82 -43.88 64.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.933 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.402 ' O ' ' HB3' ' A' ' 162' ' ' TYR . 7.5 mt-10 -79.87 -8.68 59.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.876 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 9.0 tpt85 -106.43 -30.3 9.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.465 HG22 HD11 ' A' ' 89' ' ' ILE . 70.7 mt -112.83 -59.0 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.107 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.692 HD12 ' CD2' ' A' ' 157' ' ' TYR . 66.3 mt -67.01 -11.95 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.119 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.593 ' CE1' ' SD ' ' A' ' 166' ' ' MET . 0.1 OUTLIER -74.21 -61.58 1.2 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.656 0.741 . . . . 0.0 110.934 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.55 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 54.0 Cg_endo -69.7 -27.82 26.27 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.714 2.276 . . . . 0.0 112.345 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.572 ' CD1' ' HA ' ' A' ' 89' ' ' ILE . 3.8 t80 -68.11 -41.91 81.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -72.84 -60.33 2.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.897 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.593 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 6.7 ptt? -47.08 -43.2 20.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.665 ' CG ' ' CD1' ' A' ' 92' ' ' PHE . 61.0 t80 -66.05 -44.78 83.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.407 ' NE2' ' O ' ' A' ' 88' ' ' GLN . 52.2 mt-30 -98.52 38.08 1.4 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.889 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.8 t -75.66 -55.47 5.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 141.6 -55.42 0.6 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.511 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.815 0.34 . . . . 0.0 111.089 179.973 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.1 p -94.52 82.36 4.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.879 0.371 . . . . 0.0 110.852 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.0 m -65.92 162.97 18.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.884 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.55 148.8 24.62 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.484 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 72.0 m -48.31 125.37 9.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.875 0.369 . . . . 0.0 110.836 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.4 t -163.85 128.02 2.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.873 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.4 126.08 1.18 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.444 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 25.7 m -62.57 96.17 0.08 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.772 0.32 . . . . 0.0 111.147 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -124.51 -49.12 1.79 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 84' ' ' ASN . 87.6 t -81.41 -39.71 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 81' ' ' VAL . 28.0 tttm -36.87 -32.96 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.906 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.436 ' HA ' HD12 ' A' ' 86' ' ' LEU . 11.2 mt -91.23 -35.68 14.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.884 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 81' ' ' VAL . 43.0 t-20 -51.03 -29.29 12.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.879 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.534 ' O ' HG22 ' A' ' 89' ' ' ILE . 86.8 t80 -78.8 -25.54 44.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.681 HD21 HD21 ' A' ' 112' ' ' LEU . 37.9 mt -79.95 -36.08 36.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.942 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -78.78 -47.55 16.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.835 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.428 ' CG ' ' N ' ' A' ' 89' ' ' ILE . 2.2 pt20 -54.72 -45.82 74.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.644 HG23 HD22 ' A' ' 100' ' ' LEU . 15.7 tt -72.84 -32.04 38.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.139 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 93' ' ' TRP . . . -67.48 -57.1 7.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.095 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.8 tptm -40.94 -31.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -78.45 -43.05 28.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.404 ' N ' ' O ' ' A' ' 90' ' ' ALA . 41.3 m95 -68.23 -55.17 13.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.911 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -43.52 -35.12 1.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.929 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.3 mt -73.03 -51.49 26.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.143 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -42.45 -47.57 5.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 136.88 30.63 0.27 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.483 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.8 m -161.05 161.78 31.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.893 0.378 . . . . 0.0 110.864 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.2 m -89.52 155.95 18.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.829 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.644 HD22 HG23 ' A' ' 89' ' ' ILE . 16.9 tp -91.57 103.89 16.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.909 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.8 pttt -97.48 152.59 18.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.909 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 18.7 mt -115.62 123.87 30.75 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.604 0.716 . . . . 0.0 111.155 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 148.07 64.3 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.687 2.258 . . . . 0.0 112.36 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -99.73 121.07 40.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.3 t -118.26 147.36 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.136 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.452 ' O ' ' CG ' ' A' ' 107' ' ' ARG . 65.4 mm-40 39.8 53.21 2.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.863 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.452 ' CG ' ' O ' ' A' ' 106' ' ' GLU . 11.8 ptm180 45.8 38.47 4.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.3 tptp -160.91 151.11 17.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.8 tt -56.75 145.36 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.113 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.773 HD23 ' N ' ' A' ' 111' ' ' ASP . 4.9 tt -90.72 129.49 36.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.773 ' N ' HD23 ' A' ' 110' ' ' LEU . 26.3 t0 -79.42 66.82 4.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.681 HD21 HD21 ' A' ' 86' ' ' LEU . 1.8 pt? -54.02 -23.02 11.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.505 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . 3.9 t80 -72.4 -58.63 3.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.4 t -55.78 -41.46 74.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.864 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.606 ' O ' HG23 ' A' ' 119' ' ' VAL . 27.4 tp -52.71 -55.8 20.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.915 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 18.0 p -60.26 -42.9 96.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -58.33 -61.2 2.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.878 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 64.9 mt -49.62 -36.36 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.176 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 115' ' ' LEU . 73.2 t -71.27 -48.43 54.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.175 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 85.5 mt -62.4 -37.17 78.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.074 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -72.84 -54.79 7.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.913 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -38.95 -53.87 1.71 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.892 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 158.28 34.79 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.501 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.15 179.12 37.2 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.449 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.488 ' CZ ' ' SG ' ' A' ' 129' ' ' CYS . 9.3 t80 -82.52 -39.98 21.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.826 0.346 . . . . 0.0 110.899 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -66.11 -43.03 88.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.92 -61.71 2.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.142 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.559 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.7 pp -60.09 -33.67 54.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.116 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.488 ' SG ' ' CZ ' ' A' ' 125' ' ' TYR . 22.1 m -70.41 -28.42 65.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -81.05 -36.48 30.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.439 ' O ' ' C ' ' A' ' 132' ' ' ARG . 0.5 OUTLIER -91.15 21.04 4.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 131' ' ' ASP . 8.7 mmm180 35.53 50.76 0.6 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.88 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.425 ' O ' ' C ' ' A' ' 134' ' ' TRP . 4.3 mmp_? -80.03 -19.49 47.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.9 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.559 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 28.2 m95 -36.34 -41.64 0.29 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.19 -55.32 34.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.092 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -66.82 -41.35 87.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 82.7 t -51.16 -43.58 27.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.078 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.451 ' HB2' HD11 ' A' ' 153' ' ' LEU . . . -70.64 -53.5 15.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.069 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -56.04 -22.44 27.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -68.74 -32.03 71.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.432 HD23 ' CE2' ' A' ' 143' ' ' TYR . 10.2 tp -89.84 25.57 2.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 61.55 51.17 4.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.815 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.432 ' CE2' HD23 ' A' ' 141' ' ' LEU . 3.7 m-85 -103.7 150.65 38.35 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.698 0.761 . . . . 0.0 110.886 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.577 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.9 Cg_endo -69.78 113.48 3.39 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.677 2.252 . . . . 0.0 112.319 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 99.99 0.79 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.671 2.248 . . . . 0.0 112.333 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 161.96 -70.27 0.22 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.493 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -51.99 151.45 3.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.816 0.341 . . . . 0.0 110.915 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.406 ' O ' ' CG ' ' A' ' 148' ' ' ASN . 15.5 p-10 -65.0 75.51 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.577 HD11 ' HG2' ' A' ' 144' ' ' PRO . 75.5 mt -92.44 -54.06 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.17 -52.05 1.26 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.445 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 8.7 t -58.44 -56.94 15.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.927 0.394 . . . . 0.0 110.85 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.6 tt -42.05 -49.39 4.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.926 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.451 HD11 ' HB2' ' A' ' 138' ' ' ALA . 15.5 mt -58.94 -65.97 0.58 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.495 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 15.5 ttp180 -38.82 -45.39 1.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.818 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 41.0 m -60.19 -62.75 1.63 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.842 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -47.27 -27.1 1.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.855 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.864 ' CD2' HD12 ' A' ' 161' ' ' ILE . 7.7 t80 -83.65 -31.26 26.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.49 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 11.4 mt-10 -91.04 -10.16 43.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 14.8 tpt85 -105.02 -30.7 9.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.858 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 42.0 mt -112.12 -54.38 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.864 HD12 ' CD2' ' A' ' 157' ' ' TYR . 15.5 mt -77.07 -0.8 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.101 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.536 ' CD2' ' HD3' ' A' ' 163' ' ' PRO . 0.2 OUTLIER -71.9 -60.31 2.46 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.643 0.735 . . . . 0.0 110.905 -179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.536 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.5 Cg_endo -69.79 -34.96 13.43 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.708 2.272 . . . . 0.0 112.294 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.479 ' CE1' ' HA ' ' A' ' 89' ' ' ILE . 55.2 t80 -62.36 -44.09 97.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.911 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -68.72 -55.45 11.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.41 ' HG3' ' HA ' ' A' ' 163' ' ' PRO . 0.0 OUTLIER -60.44 -35.07 74.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.899 179.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.463 ' CB ' ' O ' ' A' ' 163' ' ' PRO . 40.7 t80 -71.41 -58.03 3.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.914 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -53.38 -47.97 69.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.912 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 16.3 t -62.04 -57.49 11.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.839 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.17 44.95 1.65 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.481 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.765 0.317 . . . . 0.0 111.068 179.984 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 95.5 p 39.22 42.1 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.898 0.38 . . . . 0.0 110.853 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.6 t -103.92 148.01 26.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.862 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.19 -152.67 11.85 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.451 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.9 m 42.45 41.52 2.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.878 0.37 . . . . 0.0 110.885 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.3 t -128.68 137.73 51.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.828 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -142.53 -169.14 12.09 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.495 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.7 p -73.8 98.33 2.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.816 0.341 . . . . 0.0 111.149 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -115.06 -56.87 2.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.841 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 99.0 t -88.77 -39.91 12.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.113 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -42.64 -26.95 0.14 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.877 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 86' ' ' LEU . 19.2 mt -91.21 -47.02 7.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.494 ' O ' ' CG ' ' A' ' 88' ' ' GLN . 50.8 t30 -42.89 -36.91 1.66 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.639 ' CE2' HD12 ' A' ' 112' ' ' LEU . 59.5 t80 -71.28 -33.89 70.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.938 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.619 HD23 HD11 ' A' ' 112' ' ' LEU . 61.2 mt -80.94 -59.11 2.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.891 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -52.63 -25.85 11.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.845 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.494 ' CG ' ' O ' ' A' ' 84' ' ' ASN . 11.2 mm100 -77.42 -67.32 0.73 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.794 HD11 HG22 ' A' ' 160' ' ' ILE . 10.0 tt -47.5 -35.59 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.17 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.74 -47.75 68.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.093 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -53.09 -26.2 15.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.593 ' CD1' ' CD2' ' A' ' 167' ' ' PHE . 0.8 OUTLIER -81.27 -50.83 9.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.545 ' CD1' HD13 ' A' ' 100' ' ' LEU . 81.3 m95 -64.51 -55.98 17.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.95 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -41.02 -29.77 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.913 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.5 mt -78.3 -49.33 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.171 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 88.6 mm-40 -50.21 -44.73 53.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 142.11 -46.94 0.85 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.453 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.6 m -83.22 108.85 16.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.887 0.375 . . . . 0.0 110.874 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.6 m -50.69 162.35 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.545 HD13 ' CD1' ' A' ' 93' ' ' TRP . 40.4 tp -86.82 100.47 12.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.91 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -102.41 106.2 16.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.507 HD12 HD22 ' A' ' 112' ' ' LEU . 44.0 mm -69.16 124.86 91.32 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.579 0.704 . . . . 0.0 111.134 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.532 ' HG3' ' CE1' ' A' ' 156' ' ' HIS . 54.0 Cg_endo -69.76 151.29 69.03 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.725 2.283 . . . . 0.0 112.334 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -101.12 110.93 23.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.843 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.8 t -119.19 137.9 51.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.143 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 107' ' ' ARG . 49.4 mm-40 58.9 55.02 4.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 106' ' ' GLU . 6.6 ptp85 35.53 43.05 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.857 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -168.14 150.71 5.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.874 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.1 tt -57.69 144.42 10.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.143 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 1.025 HD23 ' N ' ' A' ' 111' ' ' ASP . 6.2 tt -93.12 151.0 20.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 1.025 ' N ' HD23 ' A' ' 110' ' ' LEU . 11.9 t0 -107.81 121.7 45.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.835 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.639 HD12 ' CE2' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -98.3 -28.12 13.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.92 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -67.19 -61.56 1.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.903 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 115' ' ' LEU . 23.3 m -51.64 -58.76 5.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 114' ' ' SER . 17.3 tp -38.0 -63.09 0.5 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.907 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.9 t -50.28 -53.1 30.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.837 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -51.22 -43.73 61.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 58.6 mt -62.33 -48.68 87.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.1 t -58.41 -58.91 4.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.159 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 82.4 mt -49.4 -45.58 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.124 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 122' ' ' GLU . 38.5 mt-10 -62.92 -58.36 7.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.865 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.502 ' OE2' HG22 ' A' ' 137' ' ' VAL . 42.7 mt-10 -37.73 -54.27 1.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.855 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 157.85 37.25 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.52 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.98 -173.55 39.75 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.472 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.583 ' CE2' ' SG ' ' A' ' 129' ' ' CYS . 7.7 t80 -88.84 -56.63 3.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.806 0.336 . . . . 0.0 110.884 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -51.14 -34.73 32.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.886 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.38 -71.36 0.21 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.122 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.54 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.8 pp -51.5 -32.04 12.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.583 ' SG ' ' CE2' ' A' ' 125' ' ' TYR . 99.3 m -69.63 -36.47 76.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.885 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -71.12 -43.28 67.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' A' ' 132' ' ' ARG . 0.9 OUTLIER -85.61 23.57 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 131' ' ' ASP . 59.1 mtt180 34.23 38.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.833 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' A' ' 134' ' ' TRP . 21.1 mmm180 -66.08 -19.14 65.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.54 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 29.5 m95 -35.54 -37.22 0.08 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.33 -57.12 14.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.116 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 -60.09 -43.87 95.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.502 HG22 ' OE2' ' A' ' 122' ' ' GLU . 59.4 t -58.21 -34.11 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.121 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.19 -59.06 3.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.138 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -53.99 -31.07 49.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.97 -38.38 64.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.899 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.467 HD23 ' CE2' ' A' ' 143' ' ' TYR . 14.8 tp -85.39 20.94 1.87 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 64.22 40.33 6.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.841 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.467 ' CE2' HD23 ' A' ' 141' ' ' LEU . 3.1 m-85 -89.67 153.16 47.71 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.662 0.744 . . . . 0.0 110.929 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.622 ' HG2' HD11 ' A' ' 149' ' ' ILE . 53.9 Cg_endo -69.75 114.07 3.58 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.732 2.288 . . . . 0.0 112.337 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 144' ' ' PRO . 54.0 Cg_endo -69.75 90.88 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.678 2.252 . . . . 0.0 112.365 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.67 -73.93 0.1 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.468 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -50.56 153.18 1.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.832 0.348 . . . . 0.0 110.852 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -67.29 81.33 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.622 HD11 ' HG2' ' A' ' 144' ' ' PRO . 90.1 mt -92.97 -53.85 8.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.19 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.0 -48.52 1.08 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.511 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.0 t -61.5 -53.87 50.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.864 0.364 . . . . 0.0 110.866 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.497 ' C ' HD23 ' A' ' 152' ' ' LEU . 8.2 tt -47.14 -50.6 20.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.885 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.415 ' O ' ' C ' ' A' ' 154' ' ' ARG . 24.1 mt -55.02 -65.91 0.5 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 153' ' ' LEU . 11.4 ttt-85 -36.89 -44.99 0.53 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.918 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.7 t -59.76 -65.37 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.911 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.532 ' CE1' ' HG3' ' A' ' 103' ' ' PRO . 2.1 m-70 -39.6 -49.11 2.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.512 ' HA ' HD12 ' A' ' 161' ' ' ILE . 3.6 t80 -52.83 -67.6 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.916 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.426 ' HA ' ' HB2' ' A' ' 162' ' ' TYR . 17.3 mm-40 -62.15 -8.53 5.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.857 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.94 -53.82 5.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.908 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.794 HG22 HD11 ' A' ' 89' ' ' ILE . 27.0 mt -112.91 -46.3 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.133 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.512 HD12 ' HA ' ' A' ' 157' ' ' TYR . 73.7 mt -61.2 -14.14 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.661 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -76.88 -63.3 0.54 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.707 0.765 . . . . 0.0 110.927 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.563 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 53.9 Cg_endo -69.73 -23.44 30.92 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.744 2.296 . . . . 0.0 112.328 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.739 ' CD2' HD12 ' A' ' 89' ' ' ILE . 1.0 OUTLIER -74.25 -46.62 40.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.875 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -69.11 -49.38 57.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.893 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.466 ' CG ' ' HA ' ' A' ' 163' ' ' PRO . 0.0 OUTLIER -61.23 -38.14 85.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.593 ' CD2' ' CD1' ' A' ' 92' ' ' PHE . 18.3 t80 -62.03 -50.65 71.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -64.01 -23.77 67.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.938 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 8.5 t -71.01 -59.25 2.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.876 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.56 88.67 0.92 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.502 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.798 0.332 . . . . 0.0 111.102 -179.999 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.7 p -144.7 171.47 14.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.903 0.382 . . . . 0.0 110.883 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 54.7 p -151.38 124.37 8.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.868 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.07 -92.29 0.13 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.51 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.2 t -84.02 177.13 8.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.857 0.36 . . . . 0.0 110.867 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.6 t -64.49 137.05 57.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.86 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -139.81 -126.11 2.29 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.455 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.2 t -89.89 41.12 1.03 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.794 0.33 . . . . 0.0 111.15 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -74.51 -57.75 3.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.891 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 63.4 t -82.79 -39.86 16.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.704 ' CD ' ' CD2' ' A' ' 113' ' ' TYR . 16.5 tptm -45.69 -25.17 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.93 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 86.4 mt -84.25 -45.84 12.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.911 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -45.95 -51.59 13.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.426 ' HE2' HD12 ' A' ' 112' ' ' LEU . 55.1 t80 -55.07 -34.44 63.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.933 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.401 HD21 HD21 ' A' ' 112' ' ' LEU . 96.7 mt -73.21 -64.08 1.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.966 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -52.74 -32.28 42.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 44.8 mm-40 -67.16 -69.08 0.33 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.476 HG13 ' CG ' ' A' ' 164' ' ' TYR . 19.7 tt -51.09 -39.28 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.133 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.565 ' HB2' HD22 ' A' ' 100' ' ' LEU . . . -65.51 -40.82 93.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -59.73 -23.96 63.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.918 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.459 ' CD1' ' O ' ' A' ' 92' ' ' PHE . 1.1 t80 -84.7 -36.56 21.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.893 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.48 ' O ' ' N ' ' A' ' 95' ' ' ILE . 69.4 m95 -78.03 -56.72 4.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -39.41 -25.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.48 ' N ' ' O ' ' A' ' 93' ' ' TRP . 87.3 mt -81.81 -50.35 16.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -49.18 -34.08 13.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.889 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 130.21 -25.11 4.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.47 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.5 m -103.97 115.52 30.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 0.0 110.868 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.4 t -53.75 167.88 0.22 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.875 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.565 HD22 ' HB2' ' A' ' 90' ' ' ALA . 30.9 tp -85.28 124.5 31.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.967 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -125.96 134.51 51.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 81.9 mt -107.05 129.64 24.04 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.586 0.707 . . . . 0.0 111.132 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 174.64 9.18 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.69 2.26 . . . . 0.0 112.325 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -124.73 111.83 16.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.7 t -115.2 133.27 61.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.153 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 60.06 54.72 4.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.916 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 38.42 36.91 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.841 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.71 153.66 28.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.9 tt -60.31 137.04 23.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.109 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.82 HD23 ' N ' ' A' ' 111' ' ' ASP . 5.1 tt -78.47 140.55 38.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.946 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.82 ' N ' HD23 ' A' ' 110' ' ' LEU . 52.0 t0 -90.43 76.25 6.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.827 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.426 HD12 ' HE2' ' A' ' 85' ' ' TYR . 1.4 pt? -61.77 -22.46 65.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.936 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.704 ' CD2' ' CD ' ' A' ' 82' ' ' LYS . 1.7 t80 -71.73 -65.84 0.71 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 115' ' ' LEU . 3.7 t -54.34 -54.08 45.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.845 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.43 ' C ' ' O ' ' A' ' 114' ' ' SER . 16.9 tp -35.3 -65.43 0.23 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.941 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.5 t -53.15 -51.89 60.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.871 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -46.78 -54.22 10.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.905 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 65.3 mt -56.67 -46.81 83.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.084 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.1 t -56.88 -61.99 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.154 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 84.6 mt -56.97 -40.31 71.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.141 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -60.1 -57.99 10.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.467 ' HB3' HG22 ' A' ' 128' ' ' ILE . 28.7 mm-40 -44.87 -45.1 10.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.434 ' O ' ' CB ' ' A' ' 127' ' ' ALA . . . 152.48 38.12 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.487 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.16 -170.04 32.61 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.467 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -88.8 -43.3 11.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.945 0.402 . . . . 0.0 110.951 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -64.24 -39.37 93.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.866 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' A' ' 123' ' ' GLY . . . -58.37 -68.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.075 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.629 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 1.7 pp -51.73 -34.88 16.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.087 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.405 ' N ' HD12 ' A' ' 128' ' ' ILE . 53.6 m -67.74 -33.95 75.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.845 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.3 mtpp -68.05 -46.85 69.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.429 ' OD2' ' CZ ' ' A' ' 133' ' ' ARG . 2.3 t70 -84.61 12.23 7.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 44.63 54.12 6.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.849 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.449 ' O ' ' C ' ' A' ' 134' ' ' TRP . 3.2 mmp_? -80.32 -19.07 47.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.905 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.629 ' CZ2' HD11 ' A' ' 128' ' ' ILE . 18.8 m95 -34.27 -44.54 0.19 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.2 -52.12 66.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.11 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 37.5 mmt-85 -68.93 -51.22 42.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 97.5 t -44.4 -44.47 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.127 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.645 ' HB2' ' CD1' ' A' ' 153' ' ' LEU . . . -68.53 -53.09 25.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.08 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -55.72 -25.92 42.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.908 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 23.9 mtt180 -64.21 -26.5 68.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.912 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.0 tp -89.54 18.45 5.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.939 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 64.45 46.73 3.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.577 ' HB3' HD13 ' A' ' 149' ' ' ILE . 3.6 m-85 -95.36 152.59 39.43 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.656 0.741 . . . . 0.0 110.948 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 120.1 6.94 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.652 2.235 . . . . 0.0 112.356 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 115.65 4.19 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.683 2.255 . . . . 0.0 112.344 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.66 -64.25 0.44 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.465 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -53.08 160.33 1.04 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.79 0.329 . . . . 0.0 110.925 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -80.96 52.43 1.75 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.577 HD13 ' HB3' ' A' ' 143' ' ' TYR . 42.6 mt -62.92 -49.8 82.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.165 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 149' ' ' ILE . . . -36.21 -56.94 1.14 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.452 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.8 t -57.29 -61.0 2.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.914 0.387 . . . . 0.0 110.897 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.47 ' C ' HD23 ' A' ' 152' ' ' LEU . 7.3 tt -38.94 -55.11 1.59 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.926 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.645 ' CD1' ' HB2' ' A' ' 138' ' ' ALA . 25.1 mt -51.9 -65.99 0.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.53 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 20.0 ttp180 -41.18 -46.23 3.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.823 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.9 m -58.99 -64.5 0.92 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.845 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -42.05 -53.38 3.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.864 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.488 ' O ' ' N ' ' A' ' 161' ' ' ILE . 5.3 t80 -50.81 -65.35 0.57 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 162' ' ' TYR . 42.6 mt-10 -63.53 -9.8 14.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.906 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 41.5 ttt-85 -84.08 -50.74 7.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 40.6 mt -112.54 -40.07 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.152 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.559 ' O ' HG22 ' A' ' 161' ' ' ILE . 22.9 mt -76.2 0.28 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.139 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.588 ' CE1' ' SD ' ' A' ' 166' ' ' MET . 0.1 OUTLIER -73.34 -61.17 1.51 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.7 0.762 . . . . 0.0 110.897 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.562 ' HD3' ' CD2' ' A' ' 162' ' ' TYR . 54.4 Cg_endo -69.73 -32.56 18.47 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.68 2.253 . . . . 0.0 112.393 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.476 ' CG ' HG13 ' A' ' 89' ' ' ILE . 12.3 t80 -66.07 -39.04 89.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.931 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -72.02 -53.37 13.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.935 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.588 ' SD ' ' CE1' ' A' ' 162' ' ' TYR . 6.7 ptt? -63.48 -41.58 98.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.851 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.468 ' CB ' ' O ' ' A' ' 163' ' ' PRO . 47.9 t80 -59.53 -52.12 66.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.901 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -96.76 41.62 1.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.1 t -74.88 -57.11 4.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.852 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 170.35 -55.56 0.19 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.487 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.792 0.329 . . . . 0.0 111.119 179.95 . . . . . . . . 0 0 . 1 stop_ save_